Sample	reference_db	ORF_ID	Contig	Contig_length	Contig_depth	Start	Stop	Strand	Gene_depth	Best_hit	ARO	Bitscore	Pass_Bitscore	Cut_Off	Percent_identity	Percent_coverage	AMR_family	Model_type	Mechanism	SNPs	Drug_class	Protein_sequence	Nucleotide_sequence	Note
5965	BLDB	prokka_00022	contig_1	580291	92	21813	22950	1	99	SRT-C42		515.3		Perfect	100.0	99.74	SRT-SST family class C beta-lactamase	protein homolog model			Beta-Lactam	MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYHIIQALEKR	ATGACGAAAATGAACCGCCTGGCGGCCGCGCTGATCGCCGCACTGATCCTGCCGACCGCGCACGCCGCACAGCAGCAGGATATCGACGCCGTTATTCAGCCGCTGATGAAAAAATACGGCGTGCCGGGCATGGCGATCGCCGTGTCGGTCGACGGCAAACAGCAGATTTACCCGTATGGCGTCGCCTCGAAGCAGACCGGTAAACCGATCACCGAGCAGACGCTGTTTGAAGTGGGCTCGCTGAGCAAAACCTTCACCGCGACGCTGGCGGTCTATGCTCAGCAGCAGGGCAAACTGTCGTTTAAAGACCCGGCCAGCCACTATCTGCCCGAGCTGCGCGGCAGCGCCTTCGACGGCGTCAGCCTGCTGAATCTGGCGACCCACACCTCCGGCCTGCCGCTGTTTGTGCCGGACGACGTGACCAACAACGCCCAGCTGATGGCCTATTACCGGGCCTGGCAGCCGAAACACCCGGCGGGCAGCTACCGCGTCTATTCCAACCTCGGCATCGGCATGCTGGGCATGATCGCCGCCAAGAGCCTCGACCAGCCGTTTATCCAGGCGATGGAACAGGGGATGCTGCCGGCATTGGGCATGAGCCACACCTACGTGCAGGTGCCGGCGGCGCAGATGGCCAACTATGCGCAGGGTTACAGCAAGGACGATAAGCCGGTGCGGGTCAATCCTGGCCCGCTGGACGCCGAGTCTTACGGCATCAAGTCCAACGCCCGCGATCTGATTCGCTATCTGGACGCCAACCTGCAGCAGGTGAAGGTAGCGCAGCCGTGGCGCGACGCGCTGGCCGCGACGCACGTCGGTTATTACAAGGCGGGCGCGTTCACGCAGGATCTGATGTGGGAGAACTACCCGTATCCGGTGAAACTGTCGCGTTTGATTGAAGGCAACAACGCCGGGATGATCATGAACGGCACGCCGGCCACCGCCATCACGCCGCCGCAGCCGGAATTGCGCGCCGGCTGGTATAACAAAACCGGCTCCACCGGCGGTTTCTCCACCTACGCGGTATTTATCCCGGCGAAGAATATCGCCGTGGTGATGCTGGCCAACAAGTGGTTCCCGAACGACGATCGCGTCGAAGCGGCTTACCACATCATCCAGGCGCTGGAGAAGCGCTGA	
5965	BLDB	prokka_00209	contig_1	580291	92	218703	219561	1	123	PAL-4		69.7		Perfect	100.0	99.65	class A beta-lactamase	protein homolog model			Beta-Lactam	MKLRLTIFATLVLSMPMAPSAFALTLQDQVKQYEKEGWKVGLSILSSDDKTISINGNQRFPLDSTVKSIACANVLAKVDAKKLSLNHSMVVTEKNIVTYSPVAKDYMNKPFTLEQACKAANEYSDNTAANFAIFSGGGPEALTEFMRSIGDTVTRSDRYEPELTVNPVDDLRDTTTPDAMSKSIKKILTGEVLSDASKAQLKEWMVNNKVADNMLRASLPKGWKIADRSGASDYGVRGITSMVWSNNHDPVFISIYVRKADTSLDERSAVIRTLGSHIFDEYLSH	ATGAAATTGCGACTTACAATATTTGCCACATTGGTATTAAGCATGCCTATGGCACCCTCTGCTTTTGCTTTGACTTTACAAGATCAAGTTAAACAGTACGAAAAAGAGGGCTGGAAGGTAGGGTTGTCAATTCTATCTTCAGATGATAAAACGATTTCTATAAATGGAAACCAACGCTTTCCTTTAGATAGCACAGTTAAATCAATTGCTTGTGCCAATGTCCTGGCAAAGGTTGATGCAAAGAAGCTTTCATTAAATCATTCTATGGTAGTGACTGAAAAAAATATTGTGACCTATTCACCCGTTGCTAAAGATTATATGAACAAGCCATTTACGCTTGAGCAAGCTTGCAAAGCGGCCAATGAATACAGTGATAATACAGCAGCTAATTTTGCTATTTTTTCGGGTGGAGGACCAGAAGCTCTGACCGAATTTATGAGATCTATAGGAGATACGGTTACTCGCTCTGACCGATATGAGCCAGAATTAACGGTCAATCCCGTGGATGATTTGCGAGATACAACGACTCCTGATGCGATGAGCAAGAGTATCAAGAAAATTTTGACCGGCGAAGTTCTCAGCGATGCATCAAAAGCGCAATTGAAAGAATGGATGGTCAATAACAAAGTCGCTGATAATATGCTTAGAGCGTCTCTTCCTAAAGGATGGAAAATCGCCGATAGGTCAGGTGCAAGTGATTATGGTGTCAGAGGGATAACGTCGATGGTCTGGTCAAATAATCATGATCCTGTATTCATCAGCATCTATGTGAGAAAAGCGGATACCTCTTTGGATGAACGCTCAGCGGTGATCCGTACTTTAGGTTCGCATATATTTGACGAATACCTTAGCCACTAA	
5965	BLDB	prokka_05097	contig_45	2231	219	427	823	1	222	OXA-204		109.8		Strict	100.0	49.06	OXA-48 family carbapenem-hydrolyzing class D beta-lactamase OXA-204	protein homolog model			Beta-Lactam	MSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP	ATGAGCAAGATGCTACATGCTTTCGATTATGGTAATGAGGACATTTCGGGCAATGTAGACAGTTTCTGGCTCGACGGTGGTATTCGAATTTCGGCCACGGAGCAAATCAGCTTTTTAAGAAAGCTGTATCACAATAAGTTACACGTATCGGAGCGCAGCCAGCGTATTGTCAAACAAGCCATGCTGACCGAAGCCAATGGTGACTATATTATTCGGGCTAAAACTGGATACTCGACTAGAATCGAACCTAAGATTGGCTGGTGGGTCGGTTGGGTTGAACTTGATGATAATGTGTGGTTTTTTGCGATGAATATGGATATGCCCACATCGGATGGTTTAGGGCTGCGCCAAGCCATCACAAAAGAAGTGCTCAAACAGGAAAAAATTATTCCCTAG	
5965	CARD	prokka_00256	contig_1	580291	92	279411	280581	1	71	tet(41)	3000569.0	738.413	700.0	Strict	99.49	98.98	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MLVILLTVLLDAVGIGLIMPILPALLRSLGGLDAGSVHYGALLAAYALMQFLFSPILGALSDRFGRRPVLLISLAGAAADYLLMAFAPTLAWLYLGRLLAGITGANMAVATAYVTDITPAGQRARRFGLVGAVFGVGFIVGPLLGGSLGEWHLHAPFLAAAMMNALNLVMAFFLLPESRKSRPRAAEKIRLNPFSSLRRLHGKPGLLPLAGIYLVMALVSQAPATLWILYGQDRFGWSMMVAGLSLAGYGACHALSQAFAIGPLVARLGERKALLIGLAADAVGLALLSVATRGWAPFALLPFFAAGGMALPALQALMAHKVDDDHQGELQGTLASMGSLIGVAGPLVATALYVATRDVWPGLVWALAAALYLVVPPLLARSRARDAAP	ATGCTGGTTATTTTGTTGACGGTGTTGCTGGATGCGGTGGGCATCGGTCTGATCATGCCTATTCTACCGGCGCTGTTGCGCTCGCTGGGCGGTCTCGATGCCGGCAGCGTGCATTACGGCGCCCTGCTGGCGGCCTATGCGTTGATGCAATTCCTGTTTTCGCCGATCCTCGGCGCGCTGAGCGATCGTTTCGGGCGGCGGCCGGTGCTGTTGATTTCGCTCGCCGGCGCGGCGGCCGACTATCTGCTGATGGCGTTCGCGCCGACGCTGGCCTGGCTCTATCTGGGGCGGTTGCTGGCGGGCATCACCGGCGCCAACATGGCGGTCGCCACCGCTTACGTCACCGATATTACCCCCGCCGGCCAGCGCGCTCGGCGTTTCGGCCTGGTGGGCGCGGTGTTCGGCGTCGGCTTTATCGTCGGCCCGCTGCTCGGCGGATCGCTGGGCGAATGGCATCTGCATGCGCCCTTCCTGGCGGCGGCGATGATGAATGCCCTCAACCTGGTGATGGCGTTTTTCCTGCTGCCCGAATCGCGTAAATCCCGCCCCCGCGCCGCCGAGAAAATTCGCCTTAATCCCTTCTCGTCATTGCGCCGGCTGCACGGCAAGCCTGGCCTGCTGCCGCTGGCCGGCATTTATCTGGTTATGGCGCTGGTTTCGCAGGCGCCGGCCACGCTGTGGATTTTATACGGTCAGGATCGTTTCGGCTGGAGCATGATGGTGGCGGGCCTGTCGCTGGCCGGCTACGGCGCCTGCCACGCGCTGTCGCAGGCCTTTGCCATCGGCCCGCTGGTCGCGCGGCTCGGCGAGCGCAAGGCGCTGCTGATCGGCCTGGCCGCCGACGCCGTGGGCCTGGCGCTGTTGTCTGTCGCCACACGCGGCTGGGCGCCGTTCGCCCTGCTGCCGTTCTTCGCCGCGGGCGGCATGGCGTTGCCCGCACTGCAGGCGCTGATGGCGCACAAGGTGGACGACGATCATCAGGGCGAGCTGCAAGGGACGCTCGCCAGCATGGGCAGCCTGATCGGCGTCGCGGGGCCGCTGGTGGCGACGGCGCTGTATGTCGCCACGCGCGATGTCTGGCCTGGGCTGGTGTGGGCGTTGGCCGCCGCCCTGTACCTGGTGGTGCCGCCGCTGCTGGCACGCTCACGCGCCAGGGATGCGGCGCCATAA	
5965	CARD	prokka_01034	contig_2	546148	104	525393	527142	1	147	msbA	3003950.0	1060.83	1000.0	Strict	87.46	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MMNDKDLSTWQTFRRLWPMITPFKTGLIVAAIALIMNAAGDTLMLSLLKPLLDDGFGKTDSSVLVWMPLAVIALMLMRGVTSFVSSYCISWVSGMVVMQMRRRLFGHMMRMPVAFFDQQSTGTLLSRITYDSEQVASSSSSALVTVVREGASIIGLFIMMFYYSWQLSVILIVLAPIVSIAIRLVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQQVETERFNSVSNRMRQQGMKLVSASSISDPIIQLIASLALAFVLFAASFPSVMSTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFSILDMEQEKDTGTREVKRAKGDIEFRNVTFYYPSKETPALRDINLKIAEGKTVALVGRSGSGKSTIANLLTRFYDIQEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTIANNIAYARESEYSREQIEKAAEMAYAMDFINKMENGLDTVIGENGVMLSGGQRQRIAIARALLRDCPILILDEATSALDTESERAIQAALDELQKDRTSLVIAHRLSTIEKADEILVVEDGRIVERGEHAELLERQGAYAQLHRMQFGQ	ATGATGAATGATAAAGATCTCTCGACCTGGCAGACGTTCCGTCGACTCTGGCCGATGATCACTCCTTTTAAGACCGGGCTGATTGTGGCCGCCATTGCGTTGATTATGAACGCAGCGGGGGACACGCTGATGCTGTCTCTGCTTAAACCGCTATTGGACGATGGGTTTGGAAAAACCGACAGCAGCGTGCTGGTGTGGATGCCGCTGGCGGTGATTGCGCTGATGCTGATGCGCGGCGTGACCAGCTTTGTTTCAAGCTACTGCATTTCCTGGGTTTCCGGCATGGTGGTGATGCAGATGCGCCGCCGCCTGTTTGGCCACATGATGAGAATGCCGGTGGCCTTCTTCGATCAGCAGTCTACCGGGACGCTGTTGTCGCGCATTACCTATGACTCCGAGCAGGTGGCCTCCTCCTCTTCCAGCGCCCTGGTGACCGTGGTGCGTGAAGGGGCCTCGATCATTGGCCTGTTCATCATGATGTTCTACTACAGCTGGCAGCTGTCGGTGATCCTGATCGTGCTGGCGCCGATCGTCTCCATCGCCATTCGCCTGGTGTCCAAGCGTTTCCGCAACATCAGCAAGAACATGCAGAACACCATGGGGCAGGTGACCACCAGCGCCGAGCAGATGCTGAAAGGCCATAAAGAAGTGCTGATCTTCGGTGGCCAGCAGGTGGAAACCGAGCGCTTTAACTCGGTCAGCAACCGCATGCGTCAACAGGGCATGAAACTGGTCTCCGCGTCTTCGATTTCCGATCCGATCATTCAGCTGATCGCTTCGCTGGCGCTGGCGTTCGTGCTGTTTGCCGCCAGCTTCCCTAGCGTGATGTCAACCCTGACCGCCGGTACCATTACCGTGGTGTTCTCGTCGATGATCGCGCTGATGCGCCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAACGCGGGATGGCGGCATGCCAGACGCTGTTCTCCATTTTGGATATGGAACAGGAAAAAGACACCGGCACCCGCGAAGTGAAGCGTGCGAAAGGCGATATCGAATTCCGCAACGTCACCTTCTACTACCCGTCCAAGGAAACGCCGGCGCTGCGCGATATCAACCTGAAAATCGCCGAAGGCAAGACCGTCGCATTGGTGGGCCGTTCCGGTTCGGGCAAATCCACCATCGCCAACCTGTTGACGCGCTTCTACGATATCCAGGAAGGCGAAATCCTGATGGATGGCCACGATCTGCGCGAATATACCCTGGCCTCACTGCGTAATCAGGTAGCGCTGGTCTCGCAAAACGTGCATCTGTTCAACGACACTATCGCCAATAACATTGCCTATGCGCGCGAAAGCGAATACAGCCGCGAGCAGATTGAGAAAGCGGCCGAAATGGCGTACGCGATGGACTTCATCAACAAGATGGAGAACGGTCTGGATACGGTGATCGGTGAGAACGGCGTAATGCTGTCCGGCGGCCAACGTCAGCGTATCGCCATCGCGCGTGCGTTACTGCGCGACTGCCCGATCCTGATCCTGGATGAAGCGACTTCTGCGCTGGATACAGAGTCCGAACGTGCCATCCAGGCTGCGCTGGACGAGTTGCAGAAAGACCGTACTTCGCTGGTGATCGCGCACCGTCTGTCGACGATTGAGAAGGCGGACGAGATCCTGGTGGTGGAGGACGGCCGCATCGTCGAACGCGGCGAGCACGCCGAATTGCTTGAACGGCAGGGCGCCTATGCGCAGCTGCACCGCATGCAGTTTGGTCAATAA	
5965	CARD	prokka_01065	contig_3	538529	97	13441	13771	-1	111	Klebsiella pneumoniae KpnF	3004583.0	157.14700000000005	150.0	Strict	73.39	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFELYHIGFLGLAIVLEIIANIFLKMSDGFRKIWLGLLSLLSVLGAFSALAQAVKGIDLSIAYALWGGFGIAATIAAGWIMFGQRLNAKGWIGLALLLTGMVILKLS	ATGCAACAGTTTGAGTTGTACCACATTGGGTTCCTGGGACTGGCGATCGTGCTGGAAATCATCGCCAACATCTTCCTGAAGATGTCGGACGGCTTCCGTAAAATTTGGCTGGGGCTGTTGTCGCTGCTGTCGGTACTCGGCGCGTTCAGCGCCCTGGCGCAGGCGGTGAAGGGCATCGATCTGTCGATCGCTTATGCGCTGTGGGGCGGTTTCGGTATCGCCGCCACCATCGCCGCAGGCTGGATCATGTTCGGCCAGCGGCTGAACGCCAAAGGCTGGATTGGCCTGGCGCTGCTGCTGACGGGGATGGTGATCCTCAAACTGTCCTGA	
5965	CARD	prokka_02116	contig_5	366431	114	204816	207963	1	138	adeF	3000777.0	758.829	750.0	Strict	41.69	98.96	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MAKFFIDRPIFAWVIAIIVMLAGVLAIMKLPIAQYPTIAPPAVSISANYPGADAKTVQDTVTQIIEQNMNGIDNLMYMSSTSDSSGSVTITLTFDSGTDPDIAQVQVQNKLSLATPLLPQEVQQQGLKVEKSSSSFLMVAGFVSDDPNMTQDDIADYVASNIKDPISRSSGVGEVQLFGAQYAMRIWLDPNKLNNYQLTTTDVTSAITEQNNQIAAGQLGGLPPVPGQQLNASIIAQTRLTSPEEFGKILLKVNTDGSQVRLRDVAHIERGAESYAVTARYNGKPAAGLGIKLATGANALNTAKGVKDELAKMAPFFPQGMKVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMSEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIPKGDHGVKTGFFGWFNRMFEKSTHHYTDSVGNILRSTGRYLIIYLLIVVGMGLLFLRLPSSFLPDEDQGILLTMVQLPAGATESRTNKVLEEVSDYFLNKEKDNVVSVFTVAGFGFNGNGQNNGLAFVSLKDWGERPGAGNKVEAIAGRAMGAFSQIKEGLVFPFNLPAIIELGTATGFDFELIDQGGLGHEKLTEARNQLLGMVAQHPDVLVGVRPNGLEDTPQFKLIVDQEKAKALGVSITTINSTLSTALGGSYVNDFIDRGRVKKVYVQAEAPFRMLPEDINKWYVRGTSGQMVPFSAFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMNLMEQLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISILVVFLCLAALYESWSVPFSVMLVLPLGVIGALLAATMRGMNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFFVPVFFVVVRRRFSKKSEDLEHSHPVEHH	ATGGCTAAGTTCTTTATAGATCGCCCAATTTTCGCCTGGGTAATCGCCATCATCGTCATGTTGGCGGGGGTGCTTGCAATAATGAAACTGCCTATCGCGCAGTATCCCACTATTGCACCGCCGGCGGTGAGCATTTCCGCCAACTACCCGGGCGCAGATGCCAAAACGGTGCAGGATACCGTCACGCAGATTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCCACCAGTGATTCCTCTGGTAGCGTCACCATTACCCTGACGTTTGATTCCGGCACCGATCCTGACATCGCGCAGGTTCAGGTCCAGAACAAACTGTCGTTGGCCACCCCGTTGCTGCCGCAAGAAGTTCAGCAACAGGGCCTGAAAGTAGAAAAATCCAGCAGCAGCTTCCTGATGGTGGCCGGCTTCGTTTCCGACGATCCGAACATGACTCAGGACGATATTGCGGACTATGTGGCGTCCAACATCAAGGACCCGATCAGCCGTTCGTCCGGCGTAGGTGAAGTGCAGCTGTTCGGTGCCCAGTACGCGATGCGTATCTGGCTGGATCCGAACAAGCTGAACAACTACCAGCTGACGACCACGGACGTAACCTCCGCCATCACCGAGCAGAACAACCAGATCGCCGCTGGCCAGCTGGGCGGCCTGCCGCCGGTGCCGGGGCAGCAGTTGAACGCCTCGATCATCGCGCAGACCCGTCTGACTTCGCCGGAAGAGTTCGGCAAGATCCTGCTGAAGGTGAATACCGACGGTTCCCAGGTGCGCCTGCGCGACGTCGCTCACATCGAGCGCGGCGCGGAAAGCTACGCGGTTACCGCTCGCTATAACGGCAAGCCTGCCGCCGGTCTGGGTATCAAACTGGCTACCGGTGCCAACGCCCTGAACACCGCCAAAGGTGTGAAAGACGAGTTGGCCAAGATGGCGCCATTCTTCCCGCAAGGGATGAAAGTGGTTTATCCGTACGACACCACCCCGTTCGTTAAAATCTCCATCAACGAAGTGGTGAAAACGCTGATCGAAGCCATCATCCTGGTATTCCTGGTGATGTATCTGTTCCTGCAGAACTTCCGCGCGACGCTGATCCCAACCATCGCGGTGCCGGTGGTACTGCTGGGGACCTTTGCGATCCTTGCGGCGTTCGGCTTCTCGATAAACACCCTGACGATGTTCGGCATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAAAACGTCGAGCGCGTCATGTCCGAAGAGGGGCTGCCGCCGAAAGAAGCGACCCGTAAATCGATGGGCCAGATCCAGGGCGCGCTGGTGGGTATCGCCATGGTGCTGTCGGCAGTATTCGTGCCGATGGCGTTCTTCGGCGGTTCAACCGGCGCCATCTATCGCCAGTTCTCGATCACCATCGTGTCCGCGATGGCGCTGTCGGTGCTGGTGGCCTTGATCCTGACGCCGGCGCTGTGCGCCACCATGCTCAAACCGATCCCGAAAGGCGATCACGGGGTTAAAACAGGCTTCTTCGGCTGGTTTAACCGCATGTTCGAGAAGAGCACGCATCACTATACCGACAGCGTGGGCAACATCCTGCGCAGCACCGGCCGCTATCTGATCATCTACCTGCTGATCGTGGTTGGCATGGGCCTGCTGTTCCTGCGCCTGCCTTCCTCGTTCCTGCCGGACGAAGATCAGGGCATCCTGTTAACTATGGTGCAGCTGCCTGCCGGCGCCACCGAGTCCCGCACCAACAAAGTGCTGGAAGAAGTCTCCGACTACTTCCTGAACAAGGAAAAGGACAACGTGGTTTCGGTGTTTACCGTCGCGGGCTTCGGCTTCAACGGTAACGGCCAGAACAACGGCCTGGCATTCGTCAGCCTGAAAGACTGGGGCGAGCGTCCAGGGGCCGGGAACAAGGTCGAAGCGATCGCGGGCCGTGCCATGGGCGCGTTCTCGCAGATTAAAGAAGGCCTGGTGTTCCCGTTCAACCTGCCGGCGATTATCGAACTCGGTACCGCAACCGGCTTCGACTTCGAGCTGATTGACCAGGGCGGCCTGGGGCACGAGAAACTGACCGAAGCGCGTAACCAGCTGTTGGGCATGGTTGCTCAACATCCGGACGTGCTGGTGGGCGTGCGCCCGAACGGCCTGGAAGATACGCCGCAGTTCAAACTGATCGTCGATCAGGAGAAAGCCAAGGCGCTGGGCGTCAGCATCACCACCATCAACAGCACGCTGAGCACCGCCCTGGGTGGTTCGTACGTCAACGACTTCATCGACCGCGGTCGTGTGAAGAAAGTGTACGTACAGGCCGAGGCGCCGTTCCGTATGCTGCCGGAAGACATCAACAAATGGTACGTGCGCGGTACGAGCGGCCAGATGGTGCCATTCTCCGCCTTCTCTTCGGCGAAATGGGAATACGGCTCACCGCGTCTGGAACGCTATAACGGCTTGCCGTCGATGGAAATTCTGGGCCAGGCCGCACCGGGCAAGAGTACCGGTGAAGCGATGAACCTGATGGAACAGCTGGCGTCCAAACTGCCAAGCGGCATCGGTTACGACTGGACCGGCATGTCCTATCAGGAACGTCTGTCGGGCAACCAGGCGCCGGCGCTGTACGCCATCTCGATTCTGGTGGTGTTCCTGTGTCTGGCGGCGCTGTATGAAAGCTGGTCCGTGCCGTTCTCGGTCATGCTGGTATTGCCGCTGGGGGTTATCGGTGCGTTGCTGGCCGCGACGATGCGCGGCATGAACAACGACGTGTACTTCCAGGTGGGGCTGCTGACCACCATAGGCCTGTCGGCGAAGAACGCCATCCTGATCGTGGAATTCGCCAAAGACCTGATGGAGAAAGAAGGCAAAGGCCTGATCGAAGCGACGTTGGAAGCGGTGCGTATGCGTCTGCGTCCAATCCTGATGACGTCTCTGGCCTTCATCCTCGGGGTTCTGCCGCTGGTTATCAGCAGCGGTGCAGGCTCCGGCGCACAGAACGCGGTAGGTACCGGCGTAATGGGCGGGATGATCACCGCCACCGTCTTGGCGATCTTCTTCGTACCGGTGTTCTTCGTGGTGGTTCGCCGCCGCTTCAGCAAGAAGAGCGAGGACCTGGAACACAGCCATCCGGTAGAGCACCACTGA	
5965	CARD	prokka_02405	contig_6	340603	118	132003	132444	-1	110	AAC(6')-Ic	3002549.0	297.36	275.0	Strict	97.95	100.0	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MIVICDHDNLDAWLALRTALWPSSSPEDHRAEMREILASPHHTAFMARGLDGAFVGFAEVALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIANLDSQRLHAALGFAETERVVFYRKTLG	ATGATCGTCATCTGCGACCACGACAACCTCGACGCCTGGCTGGCGCTGCGCACCGCGCTGTGGCCCTCCAGCTCGCCTGAAGATCACCGCGCGGAAATGCGCGAGATACTGGCTTCACCGCACCACACCGCGTTTATGGCGCGGGGGCTGGACGGCGCTTTCGTTGGCTTTGCCGAGGTCGCGCTGCGCTACGATTACGTCAACGGCTGCGAATCGTCACCGGTGGCGTTTTTGGAAGGGATTTATACCGTCGAGCGCGCGCGCCGCCAGGGCTGGGCCGCACGCTTGATCGCACAGGTGCAGGAGTGGGCGAAGCAGCAGGGGTGCAGCGAGCTGGCGTCGGATACCGACATCGCCAATCTGGACTCCCAGCGCCTGCATGCGGCGCTGGGCTTTGCCGAAACGGAGCGGGTGGTGTTTTACCGCAAAACGCTGGGCTGA	
5965	CARD	prokka_03661	contig_11	183652	121	158512	159145	-1	120	CRP	3000518.0	432.18	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMASRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTTCTCGGCAAACCGCAAACAGACCCTACTCTCGAATGGTTCCTGTCTCATTGCCATATCCACAAATATCCATCGAAGAGTACGCTGATTCACCAAGGTGAAAAGGCCGAAACGCTTTACTACATCGTGAAAGGCTCCGTCGCGGTGCTGATCAAGGATGAAGAAGGTAAAGAGATGATCCTGTCCTACCTCAACCAGGGGGATTTCATCGGCGAGCTCGGATTGTTCGAAGAAGGCCAGGAGCGCAGCGCCTGGGTTCGCGCGAAAACCGCCTGTGAAGTGGCCGAAATTTCCTACAAGAAATTCCGCCAGCTGATCCAGGTGAACCCGGACATCCTGATGCGTCTGTCCGCCCAAATGGCGAGCCGCCTGCAGGTCACCTCCGAAAAAGTGGGCAACCTCGCCTTCCTGGACGTTACCGGCCGCATCGCGCAAACCCTGCTGAATCTGGCGAAGCAACCCGACGCCATGACTCACCCGGACGGCATGCAGATCAAGATCACCCGTCAGGAGATCGGCCAGATCGTCGGCTGCTCGCGTGAAACCGTTGGCCGTATTCTGAAAATGCTGGAAGATCAAAACCTGATTTCCGCCCACGGCAAAACCATTGTCGTCTACGGCACCCGTTAA	
5965	CARD	prokka_03692	contig_12	165753	118	2295	2778	1	107	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	49.2914	32.0	Strict	28.47	90.4	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MIISLIAALAADRVIGMENAMPWHLPADLAWFKRNTLNKPVIMGRKTFESIGRPLPGRHNIVLSSRPGSEAGVTWVTSMDEALAAAGDVEEVMVIGGGRIYTQLLPRADRLYLTHIDAEVGGDTHFPDYEPDEWETTFSEFHDADDLNSHSYCFEILQRR	ATGATTATCAGCCTGATCGCTGCCTTGGCGGCGGATCGCGTTATTGGCATGGAAAACGCCATGCCGTGGCACCTGCCGGCGGACCTTGCGTGGTTTAAACGCAACACGTTGAATAAGCCGGTTATTATGGGCCGCAAGACCTTCGAGTCCATCGGCCGCCCGCTGCCGGGCCGCCACAATATCGTTTTGAGCAGCCGTCCGGGCAGCGAAGCCGGGGTGACCTGGGTGACCTCGATGGATGAAGCGCTGGCCGCCGCCGGCGACGTGGAAGAAGTGATGGTGATCGGCGGTGGGCGTATCTATACCCAGCTGCTGCCGCGCGCCGATCGCCTGTACCTGACGCACATCGACGCCGAGGTCGGCGGCGATACCCACTTCCCGGATTACGAGCCGGACGAGTGGGAAACCACGTTCAGCGAGTTCCACGACGCCGACGATCTGAACTCGCACAGCTACTGCTTCGAGATCCTGCAGCGCCGTTGA	
5965	CARD	prokka_03811	contig_12	165753	118	142636	142822	1	133	rsmA	3005069.0	108.612	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQTTY	ATGTTAATTCTGACTCGTCGAGTTGGTGAAACCCTCATGATTGGCGATGAGGTTACGGTCACTGTGCTAGGGGTAAAAGGCAACCAGGTGCGTATTGGTGTGAACGCCCCCAAAGAGGTTTCGGTTCACCGTGAAGAAATCTATCAGCGCATTCAGGCAGAGAAGTCTCAGCAGACGACTTACTGA	
5965	CARD	prokka_04498	contig_19	72226	107	8571	10110	-1	119	Klebsiella pneumoniae KpnH	3004597.0	847.81	700.0	Strict	83.92	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MPQKPLEGAQLAWMTVALAMATFMQVLDSTIANVAIPTISGNLGSSNSQGTWVITSFGVANAISIPITGWLAKRFGEVRLFLWSTALFALASWLCGISNSLGMLIFFRVIQGVVAGPLIPLSQSLLLNNYPPAKRAMALALWSMTVIVAPIFGPILGGYISDNYHWGWIFFINIPIGVFVIVAAMATLKGRETKTEIKPIDTVGLVLLIVGIGSLQIMLDQGKELDWFNSTEIITLTVVAVVALLFLVVWELTDDHPVVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGLIPVLLSPIIGKFGNRLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFVQGFAIACFFMPLTTITLSGLPPERMAAASSLSNFTRTLAGSIGTSITTTLWTQRESQHHSQLTEFVNPYNPQSQEMYRQLEQLGMSKQQASAYIANEITAQGLIISANEIFWLSAGVFLVLLVLVWVAKPPFSSGGGGGGGAH	TTGCCACAGAAACCGCTTGAAGGCGCCCAGCTTGCCTGGATGACGGTCGCGCTCGCCATGGCGACCTTCATGCAGGTGCTGGACTCCACCATCGCCAACGTGGCGATCCCCACCATTTCCGGTAACCTCGGGTCTTCCAACTCGCAGGGCACCTGGGTGATCACCTCGTTCGGCGTGGCGAACGCCATCTCGATTCCGATCACCGGCTGGCTGGCGAAGCGCTTCGGCGAAGTGCGGCTGTTCCTTTGGTCCACCGCGCTGTTCGCCCTCGCCTCCTGGCTGTGCGGCATCTCCAACAGCCTCGGCATGCTGATCTTCTTCCGCGTGATCCAGGGCGTGGTGGCCGGGCCGCTGATCCCGCTGTCGCAGAGCCTGTTGCTGAACAACTATCCGCCCGCCAAGCGAGCGATGGCCCTGGCGCTTTGGTCGATGACCGTTATCGTCGCGCCGATCTTTGGGCCGATCCTCGGCGGCTACATCAGCGACAACTACCATTGGGGCTGGATCTTCTTCATCAACATCCCGATCGGCGTCTTCGTGATCGTGGCGGCGATGGCGACGTTGAAGGGGCGGGAAACCAAAACCGAGATCAAACCGATCGACACCGTCGGCCTGGTATTGCTGATCGTCGGCATCGGTTCGCTGCAGATCATGCTCGATCAGGGCAAGGAGCTGGACTGGTTCAACTCGACCGAGATCATCACGCTCACCGTCGTCGCGGTGGTGGCGCTGCTGTTCCTGGTGGTGTGGGAGCTGACGGACGACCATCCGGTGGTGGATCTGTCGCTGTTCAAGTCGCGCAACTTCACCATCGGCTGCCTGTGTATCAGCCTGGCCTACATGCTGTACTTCGGCGCCATCGTGCTGTTGCCGCAGCTGCTGCAAGAGGTGTACGGCTATACCGCCACCTGGGCGGGGCTGGCGTCGGCGCCGGTTGGGCTGATCCCGGTGCTGCTGTCGCCGATCATCGGCAAGTTCGGCAACCGGCTCGACATGCGCCGGCTGGTCACCTTCAGCTTCATCATGTATGCCGTGTGCTTCTACTGGCGCGCCTATACATTTGAACCGGGCATGGACTTCGGCGCTTCCGCCTGGCCGCAGTTTGTCCAGGGCTTCGCCATCGCCTGCTTCTTCATGCCGTTGACCACCATCACGCTGTCCGGCCTGCCGCCGGAACGCATGGCGGCGGCGTCGAGCCTGTCGAACTTCACGCGAACGCTGGCGGGGTCGATCGGTACCTCGATCACCACCACCCTGTGGACGCAGCGCGAATCGCAGCACCATTCGCAGCTGACGGAGTTCGTCAACCCGTACAACCCGCAGTCGCAGGAGATGTACCGGCAGCTGGAGCAGCTCGGCATGAGCAAACAACAAGCGTCGGCGTATATCGCCAACGAGATCACCGCGCAGGGCCTGATCATCTCCGCCAACGAGATCTTCTGGCTGTCGGCCGGGGTATTCCTGGTGCTGCTGGTGCTGGTGTGGGTGGCGAAACCGCCGTTCAGCTCCGGCGGCGGTGGGGGCGGCGGCGCTCACTAA	
5965	CARD	prokka_04501	contig_19	72226	107	12803	13322	-1	102	emrR	3000516.0	287.345	280.0	Strict	83.13	97.73	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MESSFAPIEQMLNFRATRQKDFPYQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLDAQESHSIQPSELSSALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLHLTPQGEEFLSQLLPPQHQCLHFLWSTLTDDEQKQLEQLTRKLLARLDQMEITEQLS	ATGGAAAGCTCGTTTGCCCCCATAGAACAAATGCTGAATTTCCGTGCCACCCGGCAGAAAGATTTCCCTTATCAGGAAATCCTGCTGACCCGCCTGTGCATGCACATGCAAGGCAAGCTGCTGGAAAACCGCAATAAGATGCTGAAGGCGCAGGGGATTAACGAAACACTGTTTATGGCGCTGATCACCCTGGATGCGCAGGAAAGCCACAGCATCCAACCTTCTGAGCTAAGCTCTGCCTTAGGCTCCTCGCGCACCAATGCGACCCGCATCGCCGACGAGCTGGAGAAACGCGGCTGGATCGAGCGCCGGGAAAGCGACAACGATCGCCGCTGCCTGCATCTGCATCTGACGCCGCAGGGGGAAGAATTTCTCAGTCAACTGCTGCCGCCGCAGCACCAATGTCTGCATTTCCTGTGGTCCACGCTGACCGACGATGAGCAAAAACAGCTGGAACAGCTGACGCGCAAATTGCTGGCACGTCTGGATCAAATGGAAATCACAGAACAGTTATCCTAA	
5965	CARD	prokka_04800	contig_24	38726	110	29637	32775	-1	112	adeF	3000777.0	766.148	750.0	Strict	42.12	98.68	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MANFFIDRPIFAWVLAIILCLTGALAISSLPVEQYPNLAPPNVRISATYPGASAQTLENTVTQIIEQNMTGLDNMMYMSSQSTNTGQATVTLTFEAGTDPNEAMQQVQNQLQAAIKRLPQAVQNQGVTVSKSGDTTLMMVAFVSTDNSMDKQDIADYIVSNLQDPLSRINGVGSMDVYGSQYAMRIWLDPNKLNSYQLTTQDVVKAIQSQNAQVAVGQLGGTPSVDKQALNATINAQSQLQTPEQFRQITLRVNQDGSLVTLGNVATVELGGENYNYLSRYNGMQAAGMNIKLASGANELQTDQLVKDKIAELSQYFPHGLEAKVAYETTPFVKASIKDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAILSACGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEEGLPPREATRKSMGQIQSALVGIALVLSAVFVPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCATLLKPIAKGHHHGKRGFFGWFNRMFNRNAERYERGVGRILHASGRYMVIYLLLLGGMALLFIKLPTSFLPQEDRGIFTVQVQLPAGSTLQQTSKVVEKVEQYFLTEEKQDVVSVFAIIGSGPGGNGQNVARLFVRLKDWDLRTSGANSSFDIIDRATLAFNKINEARVIASSPPAITGLGNSSGFDMELEDHAGLGHAKLMAARDQLLQLAGQNPLLSRVRHNGLDDSPQLQIDIDQRKAQALGVSIDDINNTLSTAWGSTYVNDFVDRGRVKKVYVQAAAPFRMLPDDINKWYVRNSAGGMVPFSAFATSHWEYGSPRLERYNGSSALEIVGEAANGVSTGTAMAEMEKLVSQLPTGFGLEWTAMSYQERLSGSQAPALYAISLLVVFLCLAALYESWSIPFSVMLVVPLGVIGAVAATWLRGLENDVYFQVGLLTIIGLSAKNAILIVEFANELNHKGQDLMSATLDASRMRLRPILMTSLAFIFGVLPMATSSGAGSGSQHAVGTGVMGGMISATLLAIFFVPLFFVLVRRRFPGKAHPAGNTTAAGD	ATGGCTAATTTTTTTATTGATCGCCCGATTTTTGCCTGGGTGCTGGCAATTATTCTTTGCCTGACCGGGGCGTTGGCGATTTCTTCCCTACCGGTAGAACAATACCCGAATTTGGCGCCGCCGAACGTGCGCATCAGCGCAACTTACCCAGGTGCTTCGGCGCAAACGCTGGAAAACACCGTTACCCAAATCATTGAGCAGAATATGACCGGCCTCGACAACATGATGTATATGTCGTCGCAGAGCACCAATACCGGCCAGGCCACCGTCACGCTGACGTTCGAAGCCGGCACCGATCCCAACGAGGCGATGCAGCAGGTGCAAAACCAGCTGCAGGCGGCGATCAAACGTCTGCCGCAGGCGGTGCAGAATCAGGGGGTCACGGTGTCGAAATCCGGCGACACCACGCTAATGATGGTGGCGTTCGTCTCCACCGACAACAGCATGGACAAGCAGGACATCGCCGATTACATCGTCTCCAACCTGCAGGATCCGCTCAGCCGCATCAACGGCGTCGGCAGCATGGACGTGTACGGCTCGCAATACGCCATGCGCATCTGGCTCGATCCCAACAAGCTCAACAGCTACCAGCTCACGACCCAGGACGTGGTCAAGGCCATTCAGTCGCAGAACGCCCAGGTGGCAGTCGGCCAGCTGGGCGGCACGCCGTCGGTCGACAAGCAGGCGCTGAACGCCACCATCAACGCCCAGTCGCAGCTCCAGACGCCGGAACAGTTCCGCCAGATCACGCTGCGGGTCAATCAGGACGGCTCGCTGGTGACGCTGGGCAACGTCGCCACCGTCGAACTGGGCGGCGAGAACTACAACTACCTCAGCCGCTACAACGGCATGCAGGCCGCTGGCATGAACATCAAGCTGGCCTCCGGCGCCAACGAACTGCAGACCGACCAGCTGGTGAAGGACAAGATCGCCGAGCTGTCGCAGTACTTCCCGCATGGGCTGGAGGCCAAGGTGGCCTATGAAACCACCCCGTTCGTCAAAGCCTCGATCAAGGACGTGGTGAAAACGCTGCTGGAAGCCATCCTGCTGGTGTTCCTGGTGATGTACCTGTTCCTACAGAACTTCCGCGCCACGCTGATCCCCACCATCGCCGTGCCGGTCGTGCTGATGGGCACCTTCGCCATCCTTTCCGCCTGCGGTTTCAGTATCAATACCCTCACCATGTTCGCCATGGTGCTGGCGATCGGCCTGCTGGTGGACGACGCCATCGTGGTGGTGGAAAACGTCGAACGCGTGATGAGCGAGGAAGGCCTGCCGCCGCGTGAGGCCACGCGCAAATCCATGGGGCAAATCCAGAGCGCGCTGGTCGGCATCGCGCTGGTGCTGTCGGCGGTATTTGTGCCGATGGCGTTCTTCGGTGGCACCACCGGCGCCATCTATCGCCAGTTCTCCATTACCATCGTCTCCGCCATGGTGCTGTCGGTGCTGGTGGCGATGATCCTGACCCCGGCCCTGTGCGCCACGCTGCTCAAACCGATCGCCAAGGGGCACCATCACGGCAAGCGCGGCTTCTTCGGCTGGTTCAACCGCATGTTCAACCGCAACGCCGAACGCTATGAGCGCGGCGTGGGGCGGATCCTGCACGCCAGCGGCCGCTACATGGTGATTTATCTGCTGTTGCTCGGCGGCATGGCGCTGCTGTTCATCAAGCTGCCGACCTCGTTCCTGCCGCAGGAAGACCGCGGTATCTTCACCGTACAGGTGCAACTGCCGGCGGGCTCCACCCTGCAGCAAACCTCTAAGGTGGTGGAAAAGGTCGAGCAGTACTTCCTGACCGAAGAGAAACAGGATGTGGTGTCGGTGTTCGCCATCATCGGCTCCGGCCCGGGCGGCAACGGCCAGAACGTGGCGCGCCTGTTCGTGCGATTGAAAGACTGGGATCTGCGCACCTCGGGCGCCAACAGTTCGTTCGACATCATCGATCGCGCCACGCTGGCATTCAACAAGATTAACGAAGCGCGGGTGATCGCCAGCAGCCCGCCGGCGATCACCGGCCTCGGCAACTCCTCCGGCTTCGATATGGAGTTGGAAGACCACGCCGGGCTCGGCCACGCCAAGCTGATGGCGGCGCGCGATCAGCTGCTGCAGCTGGCCGGGCAAAACCCGCTGCTGTCGCGCGTGCGCCACAACGGCCTGGACGACAGCCCGCAGCTGCAAATCGATATCGATCAGCGCAAGGCCCAGGCGCTGGGCGTGTCTATCGACGACATCAACAACACCCTCTCCACCGCTTGGGGCTCGACCTACGTCAACGACTTCGTCGACCGCGGCCGGGTGAAAAAAGTCTACGTGCAGGCCGCGGCGCCGTTCCGCATGCTGCCGGATGACATCAACAAATGGTATGTACGCAACAGCGCAGGCGGCATGGTGCCGTTCTCGGCCTTCGCCACCTCACACTGGGAGTACGGCTCGCCGCGGCTGGAGCGCTATAACGGCAGCTCGGCGCTGGAGATCGTCGGCGAGGCGGCCAACGGTGTCAGCACCGGCACTGCCATGGCGGAAATGGAGAAACTGGTCAGCCAACTGCCGACCGGCTTTGGCCTGGAATGGACCGCAATGTCCTATCAGGAACGGCTGTCCGGCTCACAGGCGCCGGCGCTGTACGCCATCTCGCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTATGAGAGCTGGTCGATCCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATCGGCGCGGTCGCCGCCACCTGGCTGCGCGGCCTGGAGAACGACGTTTATTTCCAGGTTGGCCTGCTGACCATCATTGGGCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTGAACCATAAAGGGCAGGATCTGATGTCCGCCACGCTCGATGCGTCACGCATGCGTCTGCGGCCGATCCTGATGACCTCGCTGGCGTTTATCTTCGGCGTGCTGCCGATGGCCACCAGCAGCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGGGTCATGGGCGGCATGATCTCCGCCACCCTGCTGGCCATTTTCTTCGTGCCGCTGTTCTTCGTACTGGTGCGCCGCCGTTTCCCGGGTAAAGCGCATCCGGCAGGCAATACGACGGCCGCCGGGGACTGA	
5965	CARD	prokka_05000	contig_32	19371	94	3216	6360	1	114	adeF	3000777.0	1174.84	750.0	Strict	59.87	98.87	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MDFSRFFIDRPIFAAVLSILIFVAGAIAIPLLPISEYPDVVPPSVQVRAEYPGANPKEIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRQGITTQKQSPALTLVVHLVSPSGKYDSLYLRNYATLKVKDELARLPGVGQVQIFGAGEYAMRIWLDPNKVAARGLTASDVVSAMQEQNVQVSAGQLGAEPMPTRSDYLLSINAQGRLQTEEEFGNIILKSGDNGEIVRLRDVARIEMGSGSYALRAQLNNKDAVGIGIFQSPGANAIELSDAVRGKMAELATRFPDGMSWKSPYDPTVFVRDSIRAVVDTLLEAVILVVLVVILFLQTWRASIIPLLAVPISVVGTFAALYMLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLSPLAAAHQAMREVSGPIIAIAVVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAARLLKPHGAPKDLPSRLIDRLFGWLFRPFNRFFASGSQRYQRGVSRVLGRRGAVFVVYLLLLAAAGVMFKTVPGGFIPTQDKLYLIGGVKMPEGASLERTDAVIRKMSAIGLSVDGVTDAVAFPGLNALQFTNTPNTGTVFFALESLSTRTRTAAQINAEINARISQIQEGFAFSIMPPPILGIGQGSGYSLYVQDRAGLGYGALQTAINTMSGAIMQTPGMGFPISSYQANVPQLDAKIDRDKAKAQGVPLNALFSTLQTYLGSSYINDFNRYGRTWKVMAQADGQFRDSVEDIANLRTRNDKGEMVPIGSMVSIGTTYGPDPVIRYNGFPAADLIGDADPRVLSSTQAMGALTQMAGKLLPNGMNIQWTDLSYQQSTQGNAALVVFPVAVLLAFLALAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEMQGKGIVEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRRLVTRKAQPQTA	ATGGACTTTTCCCGTTTTTTCATCGACCGGCCGATCTTTGCCGCGGTGCTGTCGATCCTGATTTTTGTCGCCGGGGCGATCGCCATCCCGCTGCTGCCGATCAGCGAGTACCCGGACGTGGTACCGCCCAGCGTGCAGGTGCGCGCCGAATACCCGGGCGCCAACCCGAAAGAGATCGCTGAAACGGTGGCCACGCCGCTGGAAGAAGCGATCAACGGCGTCGAAAACATGATGTACATGAAATCGGTCGCCGGTTCCGACGGCGTGCTGGTGACCACCGTCACCTTCCGCCCCGGCACCGATCCCGATCAGGCGCAGGTACAGGTGCAAAACCGCGTGGCGCAGGCCGAAGCGCGCCTGCCGGAAGACGTGCGCCGCCAGGGCATCACCACTCAGAAGCAGTCCCCGGCGCTGACGCTGGTGGTGCATCTGGTCTCGCCTTCCGGCAAGTACGACTCGCTGTACCTGCGTAACTACGCCACCCTGAAGGTCAAGGATGAGCTCGCCCGTCTGCCGGGCGTCGGCCAGGTGCAGATCTTCGGCGCCGGTGAGTACGCGATGCGCATTTGGCTCGATCCGAACAAGGTCGCCGCGCGTGGCCTGACCGCCTCCGACGTGGTGAGCGCCATGCAGGAACAAAACGTGCAGGTCTCCGCCGGCCAGCTCGGCGCGGAGCCGATGCCGACGCGCAGCGACTATCTGCTGTCGATCAACGCCCAGGGCCGCCTGCAAACCGAAGAAGAGTTCGGCAACATCATCCTCAAGAGCGGCGACAACGGCGAGATCGTACGGTTGCGCGACGTGGCGCGCATCGAAATGGGCTCCGGCAGCTACGCGCTGCGCGCCCAGCTCAATAACAAGGATGCGGTCGGTATCGGTATCTTCCAGTCGCCGGGCGCCAACGCCATCGAGCTGTCTGACGCGGTGCGCGGCAAGATGGCCGAGCTGGCGACCCGCTTCCCGGACGGCATGAGCTGGAAATCGCCTTACGATCCGACGGTGTTCGTACGCGATTCGATCCGCGCGGTAGTGGATACCCTGCTGGAAGCGGTGATCCTGGTGGTGCTGGTGGTCATTCTGTTCCTGCAGACCTGGCGCGCCTCGATCATTCCGCTGCTGGCGGTCCCGATCTCCGTGGTCGGCACCTTTGCCGCGCTGTATATGCTGGGCTTTTCGCTCAATACCCTCAGCCTGTTCGGGCTGGTGCTGGCGATCGGCATCGTGGTGGATGACGCCATCGTGGTGGTGGAAAACGTCGAGCGTAATATCGAAGAGGGGCTGTCGCCGCTGGCGGCGGCGCACCAGGCGATGCGCGAGGTCTCCGGCCCGATCATCGCCATCGCCGTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTCCTCTCCGGCGTTACTGGCCAGTTCTACAAGCAGTTCGCCGTCACCATCGCCATCTCGACGGTGATCTCCGCCATCAACTCGCTGACCCTGTCGCCGGCGCTGGCGGCGCGCTTGCTTAAACCGCACGGCGCGCCGAAAGATCTGCCGTCACGCCTGATTGACCGGCTGTTCGGCTGGCTGTTCCGGCCGTTCAACCGCTTCTTCGCCAGCGGCTCGCAACGCTATCAGCGCGGCGTCTCCCGCGTGCTGGGCCGGCGCGGCGCGGTGTTCGTCGTCTATCTGCTGCTGCTGGCCGCCGCCGGCGTGATGTTCAAGACCGTACCCGGCGGCTTTATCCCGACGCAGGACAAGCTGTACCTGATCGGCGGCGTTAAGATGCCAGAAGGCGCCTCGCTGGAGCGCACCGATGCAGTGATCCGCAAGATGAGCGCCATCGGCCTGAGCGTGGACGGCGTCACCGATGCGGTGGCCTTCCCCGGCCTGAATGCGCTGCAGTTCACCAATACGCCGAATACCGGCACGGTGTTCTTCGCGCTGGAGTCGTTGAGCACCCGTACCCGCACCGCGGCGCAGATCAACGCCGAGATCAACGCGCGCATTTCACAGATTCAGGAAGGCTTCGCCTTCTCAATCATGCCGCCGCCGATCCTCGGCATTGGCCAAGGCTCCGGCTATTCGCTGTACGTGCAGGATCGTGCCGGGCTGGGCTACGGCGCGTTGCAAACGGCGATCAACACCATGTCCGGCGCCATTATGCAAACGCCGGGGATGGGGTTCCCGATCTCCTCGTATCAGGCCAACGTGCCGCAGCTGGACGCCAAAATCGATCGCGACAAGGCCAAGGCGCAAGGGGTACCGCTTAATGCGCTGTTCAGCACGCTGCAGACCTACCTCGGTTCGTCTTACATCAACGACTTCAACCGCTACGGCCGCACCTGGAAGGTGATGGCGCAGGCCGACGGCCAGTTCCGCGACAGCGTGGAGGACATCGCCAACCTGCGCACCCGCAACGACAAGGGCGAAATGGTGCCGATCGGCAGTATGGTCAGCATCGGTACCACCTACGGCCCGGATCCGGTGATCCGTTATAACGGCTTCCCGGCGGCGGACCTGATCGGCGACGCCGATCCGCGCGTGCTCTCCTCTACCCAGGCGATGGGCGCGCTGACGCAGATGGCCGGCAAGCTGCTGCCGAACGGCATGAACATCCAGTGGACCGATCTGAGCTACCAACAATCGACCCAGGGCAACGCCGCGCTGGTGGTGTTCCCGGTAGCGGTGCTGCTGGCGTTCCTCGCGCTGGCGGCGCTGTATGAGAGCTGGACGCTGCCGCTGGCGGTGATCCTGATCGTGCCGATGACCATGCTGTCGGCGCTGTTCGGGGTGTGGCTGACCGGCGGCGACAACAACGTGTTCGTGCAGGTCGGGTTGGTCGTTCTGATGGGGCTGGCCTGCAAGAACGCCATTCTGATCGTCGAGTTCGCCCGCGAGCTGGAAATGCAGGGCAAAGGCATCGTCGAGGCGGCGCTGGAGGCCTGTCGCCTGCGGTTGCGGCCGATCGTGATGACCTCCATCGCCTTCATCGCCGGCACCATCCCGCTGATCCTCGGCCACGGCGCCGGGGCCGAGGTGCGTGGCGTCACCGGCATCACGGTGTTCTCCGGCATGTTGGGGGTCACCCTGTTCGGGCTGTTCCTGACGCCGGTGTTCTACGTCACCCTGCGGCGCCTGGTGACACGCAAAGCGCAACCGCAGACGGCGTAA	
5965	CARD	prokka_02793	contig_7	285622	122	219196	220549	-1	139	Escherichia coli GlpT with mutation conferring resistance to fosfomycin	3003889.0	855.5139999999999	850.0	Strict	90.87	99.56	antibiotic-resistant GlpT	protein variant model	antibiotic target alteration	E448K	fosfomycin	MLSIFKPAAHTARVPSDKVDPLYRKLRWQIFLGIFFGYAAYYLVRKNFTLAMPYLIEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAIMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSIWNCAHNVGGGLPPLLFLLGMAWFNDWHAALYMPAFGAILVALIAFALMRDTPQSCGLPPIEEYKNDYPDDYSEKDEEELTAKQIFMQYILPNKLLWYIAVANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFKGNRGATGVFFMTLVTIATVVFWMNPAGNPTVDMICMLVIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGGVLAVILLLLTMLNEKKHHAEIAAKRG	ATGTTGAGTATTTTTAAGCCGGCCGCACACACCGCCCGTGTGCCGAGCGATAAGGTAGACCCGCTCTACCGTAAGCTGCGCTGGCAAATTTTCCTGGGGATCTTCTTCGGTTACGCCGCTTACTATCTGGTGCGTAAGAACTTCACCCTGGCCATGCCTTACCTGATCGAACAAGGCTTCAGCCGCGGTGACCTCGGCTTCGCGCTGTCGGGCATCTCCATCGCCTACGGCTTCTCCAAATTCATCATGGGTTCGGTCTCCGACCGTTCCAACCCGCGGGTGTTCCTGCCTGCCGGCCTGATCCTGGCGGCGGCGGTGATGTTGTTCATGGGCTTCGTGCCGTGGGCCACCTCCAGCATCGCCATCATGTTCGTCCTGCTGTTCCTGTGCGGCTGGTTCCAGGGCATGGGTTGGCCGCCGTGCGGCCGCACCATGGTGCACTGGTGGTCGCAGAAAGAACGCGGCGGCATCGTTTCCATCTGGAACTGCGCCCACAACGTGGGTGGCGGCCTGCCGCCGCTGCTGTTCCTGCTGGGTATGGCCTGGTTCAACGACTGGCACGCGGCGCTGTACATGCCGGCCTTCGGTGCCATCCTGGTGGCCCTGATCGCCTTCGCCCTGATGCGCGACACCCCGCAATCCTGCGGCCTGCCGCCGATTGAAGAGTACAAAAACGACTATCCGGACGACTACAGCGAAAAAGACGAAGAAGAGCTGACCGCCAAGCAGATCTTCATGCAGTACATTCTGCCGAACAAGCTGCTGTGGTACATCGCGGTCGCCAACGTATTCGTCTATCTGCTGCGTTACGGCATTCTGGACTGGTCGCCGACCTACCTGAAAGAAGTGAAACACTTCGCGCTGGACAAGTCGTCCTGGGCCTACTTCCTGTATGAATACGCCGGTATCCCGGGCACCCTGCTGTGCGGCTGGATGTCGGACAAAGTGTTCAAAGGCAACCGCGGCGCCACCGGTGTGTTCTTCATGACGCTGGTGACCATCGCCACCGTGGTGTTCTGGATGAACCCGGCCGGTAACCCGACCGTGGACATGATCTGTATGCTGGTCATCGGCTTCCTGATCTACGGCCCGGTGATGCTGATCGGCCTGCACGCGCTGGAGCTGGCGCCGAAGAAAGCCGCCGGCACCGCCGCAGGCTTCACCGGCCTGTTCGGTTACCTGGGCGGCTCGGTTGCAGCCAGCGCCATCGTCGGTTACACCGTGGACTTCTTCGGTTGGGACGGCGGCTTCATGGTGATGATCGGCGGCGGCGTGCTGGCGGTTATCCTGCTGCTGCTGACCATGCTGAACGAAAAGAAACACCACGCGGAAATCGCCGCCAAGCGCGGTTAA	
5965	CARD	prokka_03727	contig_12	165753	118	46341	48105	1	132	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	588.571	500.0	Strict	52.62	96.23	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N	cephalosporin; cephamycin; penam	MKAARPGKLRRQEDQASFVSWRFALLCGCILLAMVGLMLRVAYLQVINPDRLVKEGDMRSLRVQEVPTARGMISDRAGRPLAVSVPVNAVWADPKELNERGGITLDSRWKALSDALNIPLDQLSNRINANPKGRFVYLARQVNPAIGDYIHKLKLPGIYLRQESRRYYPAGQVTSHIIGVTNIDGQGIEGVEKSFDRWLTGQPGERTVRKDRFGRVIEDISSVDSQAAHNLVLSVDERLQALVYRELNNAVAFNKAESGTAVLIDVNTGEVLAMANSPSYNPNNMAGTPKETMRNRAITDIFEPGSTVKPMVVMTALQNGVVRENSVLNTIPYRIQGHEIKDVARYSELSLTGILQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGESSGIYPKKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSLGVYRPLSITKVDPPVAGERVFPEPLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGKYVNRYIAYTAGVAPASNPRFALVVVINDPQGGKYYGGAISAPVFGAIMGGVLRTMNVEPDALPTGDKSELVINKKEGSGGRS	ATGAAAGCAGCGCGCCCCGGTAAGTTGAGACGCCAGGAAGATCAGGCCAGCTTTGTCAGCTGGCGTTTTGCGTTGCTGTGCGGCTGCATTTTGCTGGCGATGGTTGGCCTGATGCTGCGCGTCGCGTACCTGCAGGTCATCAACCCCGATCGTCTGGTGAAAGAAGGCGACATGCGTTCGCTGCGCGTGCAGGAAGTGCCGACCGCGCGCGGCATGATCAGCGATCGCGCCGGCCGTCCGTTGGCGGTCAGCGTGCCGGTCAATGCGGTGTGGGCGGATCCGAAAGAGCTGAACGAGCGCGGCGGTATCACGCTGGACAGCCGTTGGAAAGCGCTTTCTGATGCGCTGAACATCCCGCTGGACCAACTCTCCAACCGCATCAACGCCAACCCGAAAGGGCGCTTCGTTTATCTGGCGCGCCAGGTGAACCCGGCGATCGGCGACTACATCCACAAGCTCAAGCTGCCGGGGATCTACCTGCGGCAGGAGTCGCGCCGGTACTACCCGGCGGGGCAGGTGACGTCGCACATCATCGGCGTGACCAACATCGACGGACAAGGCATTGAAGGCGTCGAGAAGAGCTTCGACCGCTGGCTGACCGGGCAACCGGGCGAGAGAACGGTGCGTAAGGACCGCTTCGGCCGGGTCATCGAAGATATTTCCTCCGTAGACAGCCAGGCGGCGCACAACCTGGTGCTGAGCGTCGATGAACGCCTGCAGGCGCTGGTGTATCGCGAGCTGAACAACGCGGTGGCGTTCAACAAGGCCGAGTCGGGCACTGCGGTGCTGATCGACGTGAACACCGGCGAAGTGCTGGCGATGGCCAACAGCCCGTCTTACAACCCGAACAACATGGCCGGTACGCCGAAAGAGACCATGCGTAACCGTGCTATCACCGATATTTTTGAACCCGGTTCAACCGTGAAGCCGATGGTGGTGATGACCGCGCTGCAAAACGGCGTGGTGAGAGAAAACAGTGTGTTGAACACCATCCCGTACCGCATTCAGGGCCACGAGATCAAAGATGTGGCGCGGTACTCGGAGCTGTCATTGACCGGGATCTTGCAGAAGTCGAGTAACGTCGGTGTTTCAAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCTCGTTTTGGGCTGGGAAAAGCGACCAATTTGGGGCTGGTCGGAGAAAGCAGTGGCATATACCCAAAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTGATGGTAACTCCGTTACAGTTGGCGCGAGTCTATGCAACGATCGGCAGCCTGGGCGTATATCGCCCATTGTCGATCACCAAGGTTGACCCTCCGGTCGCCGGCGAACGCGTTTTCCCTGAACCTCTGGTGCGCACCGTGGTGCACATGATGGAAAGCGTGGCCTTGCCGGGCGGCGGCGGCGTGAAAGCCGCCATCAAGGGATACCGTATCGCCATCAAAACCGGTACCGCGAAAAAAGTGGGCCCGGACGGCAAATACGTCAACCGATACATCGCTTATACCGCCGGCGTCGCGCCGGCAAGTAACCCCCGTTTTGCCCTGGTGGTCGTCATCAACGACCCGCAGGGTGGGAAATACTATGGTGGCGCAATCTCCGCGCCGGTGTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACGTCGAGCCTGACGCGTTGCCTACCGGTGACAAAAGCGAATTAGTGATTAACAAGAAAGAGGGTTCAGGTGGCAGATCGTAA	
8117	BLDB	prokka_00908	contig_9	88002	172	32980	34123	1	162	PRS-1		470.4		Perfect	100.0	98.7	Providencia stuartii	protein homolog model			Beta-Lactam	MKNIFRQGRLFIALSLAMTSISAFALTQQEVDDIIKPLMKQEQIPGMSVAISVNGKQAIYHYGVQSKQTQIPVSDRTLYEIGSLSKTFTATLATYAQIQGKLDFSQSVSHYLPELKGSAFDNVSVMNLATHTSGLSLFVPSDIKTNDQLMAYYQKWLPDNEVGQYRSYSNLGVGLLGIVTAKQLNMPFSQAMEKLMLPSLGLKHTYIHVPKSQEKYYAQGYNKQNQPVRLNLEILGPEAYGLKSNAKDLIRYLEINMQSIKVAKTWQEAIENTHTGVYLTDSFVQDMMWESYPWPVSLSQLLQGNRDDMALKPQKVELIKPAMAPEVRAYYNKTGSSNGFATYAIFIPEEKIAIVMLSNKWIPIPQRITATYQLLEKIER	ATGAAAAATATTTTTCGTCAGGGGCGGCTTTTTATCGCCTTAAGTTTAGCAATGACATCGATTTCCGCCTTTGCCCTTACACAGCAAGAGGTCGATGACATTATCAAGCCCCTGATGAAACAAGAACAGATCCCGGGTATGTCTGTTGCCATCTCAGTGAATGGCAAACAAGCTATTTACCATTACGGTGTTCAGTCAAAACAGACCCAAATTCCTGTTTCTGATAGGACGCTGTATGAAATTGGCTCCTTATCAAAAACCTTTACCGCAACACTGGCAACTTATGCGCAAATTCAAGGAAAACTCGACTTTAGCCAAAGTGTCAGTCACTACCTACCTGAATTAAAAGGCAGTGCTTTTGATAATGTTAGTGTGATGAATTTAGCCACCCATACATCGGGGTTATCGCTATTTGTACCTAGCGATATCAAAACCAACGATCAATTAATGGCGTATTATCAAAAATGGCTTCCTGACAATGAGGTTGGACAATATCGTTCTTATTCAAATTTAGGGGTTGGGTTACTTGGTATCGTGACGGCAAAGCAACTTAATATGCCTTTTTCTCAGGCTATGGAAAAATTGATGCTGCCTTCACTTGGCTTAAAACATACTTATATCCATGTTCCCAAAAGCCAAGAGAAATATTACGCACAAGGCTACAATAAGCAAAATCAGCCTGTTCGCTTAAACCTAGAAATCCTTGGTCCAGAGGCTTATGGCCTAAAGTCCAATGCCAAAGATTTGATCCGTTATTTAGAAATCAATATGCAATCCATTAAAGTGGCGAAAACTTGGCAAGAAGCGATTGAAAACACCCATACTGGCGTTTACCTAACCGATTCGTTTGTGCAGGATATGATGTGGGAAAGCTATCCATGGCCGGTGTCGCTTTCACAATTACTGCAAGGCAACCGTGATGATATGGCTCTCAAACCACAAAAAGTGGAATTGATTAAGCCAGCCATGGCACCAGAAGTACGCGCTTATTATAACAAGACTGGCTCTAGCAATGGCTTTGCGACATACGCGATATTTATTCCAGAAGAGAAGATTGCCATCGTTATGCTATCCAATAAATGGATACCTATTCCTCAGCGCATTACAGCGACTTACCAGTTACTAGAGAAAATCGAACGCTAA	
8117	BLDB	prokka_03449	contig_82	15681	143	3542	4403	1	160	TEM-1		80.1		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase TEM-1	protein homolog model			Beta-Lactam	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	ATGAGTATTCAACATTTTCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGTGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCTGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	
8117	BLDB	prokka_03854	contig_123	6438	160	154	955	-1	112	OXA-10		281.7		Perfect	100.0	99.62	oxacillin-hydrolyzing class D beta-lactamase OXA-10	protein homolog model			Beta-Lactam	MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG	ATGAAAACATTTGCCGCATATGTAATTATCGCGTGTCTTTCGAGTACGGCATTAGCTGGTTCAATTACAGAAAATACGTCTTGGAACAAAGAGTTCTCTGCCGAAGCCGTCAATGGTGTCTTCGTGCTTTGTAAAAGTAGCAGTAAATCCTGCGCTACCAATGACTTAGCTCGTGCATCAAAGGAATATCTTCCAGCATCAACATTTAAGATCCCCAACGCAATTATCGGCCTAGAAACTGGTGTCATAAAGAATGAGCATCAGGTTTTCAAATGGGACGGAAAGCCAAGAGCCATGAAGCAATGGGAAAGAGACTTGACCTTAAGAGGGGCAATACAAGTTTCAGCTGTTCCCGTATTTCAACAAATCGCCAGAGAAGTTGGCGAAGTAAGAATGCAGAAATACCTTAAAAAATTTTCCTATGGCAACCAGAATATCAGTGGTGGCATTGACAAATTCTGGTTGGAAGGCCAGCTTAGAATTTCCGCAGTTAATCAAGTGGAGTTTCTAGAGTCTCTATATTTAAATAAATTGTCAGCATCTAAAGAAAACCAGCTAATAGTAAAAGAGGCTTTGGTAACGGAGGCGGCACCTGAATATCTAGTGCATTCAAAAACTGGTTTTTCTGGTGTGGGAACTGAGTCAAATCCTGGTGTCGCATGGTGGGTTGGGTGGGTTGAGAAGGAGACAGAGGTTTACTTTTTCGCCTTTAACATGGATATAGACAACGAAAGTAAGTTGCCGCTAAGAAAATCCATTCCCACCAAAATCATGGAAAGTGAGGGCATCATTGGTGGCTAA	
8117	BLDB	prokka_03858	contig_123	6438	160	4014	4914	-1	38	VEB-1		71.7		Perfect	100.0	99.67	class A extended-spectrum beta-lactamase VEB-1	protein homolog model			Beta-Lactam	MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK	ATGAAAATCGTAAAAAGGATATTATTAGTATTGTTAAGTTTATTTTTTACAATTGTGTATTCAAATGCTCAAACTGACAACTTAACTTTGAAAATTGAGAATGTTTTAAAGGCAAAAAATGCCAGAATAGGAGTAGCAATATTCAACAGCAATGAGAAGGATACTTTGAAGATTAATAACGACTTCCATTTCCCGATGCAAAGCGTTATGAAATTTCCGATTGCTTTAGCCGTTTTGTCTGAGATAGATAAAGGGAATCTTTCTTTTGAACAAAAAATAGAGATTACCCCTCAAGACCTTTTGCCTAAAACGTGGAGTCCGATTAAAGAGGAATTCCCTAATGGAACAACTTTGACGATTGAACAAATACTAAATTATACAGTATCAGAGAGCGACAATATTGGTTGTGATATTTTGCTAAAATTAATCGGAGGAACTGATTCTGTTCAAAAATTCTTGAATGCTAATCATTTCACTGATATTTCAATCAAAGCAAACGAAGAACAAATGCACAAGGATTGGAATACCCAATATCAAAATTGGGCAACCCCAACAGCGATGAACAAACTGTTAATAGATACTTATAATAATAAGAACCAATTACTTTCTAAAAAAAGTTATGATTTTATTTGGAAAATTATGAGAGAAACAACAACAGGAAGTAACCGATTAAAAGGACAATTACCAAAGAATACAATTGTTGCTCATAAAACAGGGACTTCCGGAATAAATAATGGAATTGCAGCAGCCACTAATGATGTTGGGGTAATTACTTTACCGAATGGACAATTAATTTTTATAAGCGTATTTGTTGCAGAGTCCAAAGAAACTTCGGAAATTAATGAAAAGATTATTTCAGACATTGCAAAAATAACGTGGAATTACTATTTGAATAAATAA	
8117	BLDB	prokka_03952	contig_144	2381	155	182	983	1	174	VIM-1		236.9		Perfect	100.0	99.62	subclass B1 metallo-beta-lactamase VIM-1	protein homolog model			Beta-Lactam	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	ATGTTAAAAGTTATTAGTAGTTTATTGGTCTACATGACCGCGTCTGTCATGGCTGTCGCAAGTCCGTTAGCCCATTCCGGGGAGCCGAGTGGTGAGTATCCGACAGTCAACGAAATTCCGGTCGGAGAGGTCCGACTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCGGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAAAAGCAAATTGGACTTCCCGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGCAGAGGGGAACGAGATTCCCACGCATTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAGCTCTTCTATCCTGGTGCTGCGCATTCGACCGACAATCTGGTTGTATACGTCCCGTCAGCGAACGTGCTATACGGTGGTTGTGCCGTTCATGAGTTGTCAAGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCGTTGAGCGGATTCAAAAACACTACCCGGAAGCAGAGGTCGTCATTCCCGGGCACGGTCTACCGGGCGGTCTAGACTTGCTCCAGCACACAGCGAACGTTGTCAAAGCACACAAAAATCGCTCAGTCGCCGAGTAG	
8117	CARD	prokka_00590	contig_5	108136	152	96784	97288	-1	119	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	46.595	32.0	Strict	26.0	94.35	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MNISLIAAMAIDQVIGMEKAMPWHLPGDLAWFKRNTLNKPVIMGRVTYESIGRPLPQRVNIVLSSKPGSDKNVIWVSSVEEALAAAKQTKTGSDDDEVIVIGGGKVYQQFLPLANKLYLTHVDAEVIGDTHFPIYEPDEWDSIFTEYHEADENNSHGYCFEILTKRI	ATGAATATTAGTTTAATCGCAGCGATGGCGATTGATCAGGTTATCGGCATGGAAAAAGCGATGCCTTGGCATTTACCCGGTGATCTTGCTTGGTTTAAACGTAATACGTTAAATAAGCCAGTCATAATGGGTCGAGTGACTTACGAATCAATTGGTCGTCCGCTTCCACAGCGCGTCAACATTGTATTAAGTAGTAAGCCGGGTTCGGATAAAAATGTTATCTGGGTCTCCTCCGTAGAAGAAGCATTGGCGGCGGCTAAGCAAACCAAGACAGGCTCTGACGATGATGAAGTCATTGTGATTGGAGGCGGAAAAGTTTACCAACAGTTTTTACCTCTGGCGAATAAGCTGTATTTAACTCACGTGGATGCAGAAGTGATTGGCGACACTCATTTCCCAATTTACGAGCCAGATGAGTGGGATTCTATTTTCACCGAGTACCATGAGGCGGATGAGAACAATTCACATGGTTATTGTTTTGAGATTTTAACCAAAAGAATTTAA	
8117	CARD	prokka_01135	contig_12	79274	142	22033	22219	-1	98	rsmA	3005069.0	106.686	100.0	Strict	86.89	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKTQPDNQ	ATGCTTATTCTGACTCGTCGAGTTGGTGAAACACTCATGATAGGCGATGAGGTAACAGTTACGGTACTGGGAGTAAAAGGCAATCAAGTTCGTATTGGTGTCAATGCCCCAAAGGAAGTTTCTGTTCACCGTGAAGAAATTTATCAACGGATCCAGGCTGAAAAGACTCAACCAGACAATCAATAA	
8117	CARD	prokka_01358	contig_15	73890	156	22018	22651	1	162	CRP	3000518.0	429.098	400.0	Strict	98.1	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKSACEVAEISYKKFRQLIQVNPDILMRLSAQMASRLQTTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTTCTCGGCAAGCCACAAACAGACCCTACTCTTGAATGGTTTTTGTCACACTGCCATATTCATAAATATCCATCCAAGAGCACTCTGATTCATCAGGGTGAAAAAGCAGAAACCCTTTACTATATCGTTAAAGGCTCAGTGGCTGTTTTAATCAAAGATGAAGAAGGCAAAGAAATGATCCTCTCCTATTTAAATCAGGGAGATTTCATTGGTGAACTAGGGTTATTTGAAGAAGGACAAGAACGTTCAGCTTGGGTTAGAGCAAAAAGTGCCTGCGAAGTCGCTGAAATTTCTTACAAAAAATTCCGTCAACTTATTCAGGTCAATCCTGATATTCTTATGCGCCTTTCTGCGCAAATGGCAAGTCGCCTGCAAACCACCTCAGAAAAAGTAGGTAACCTTGCTTTCCTTGATGTGACAGGCCGTATTGCACAAACACTGCTTAATTTAGCGAAACAACCCGATGCGATGACGCATCCAGATGGGATGCAAATTAAGATCACTCGCCAAGAAATTGGCCAAATCGTTGGTTGTTCACGCGAAACCGTTGGTCGCATTTTGAAAATGCTAGAAGACCAAAATCTGATCTCCGCACACGGTAAAACGATTGTCGTGTACGGTACTCGTTAA	
8117	CARD	prokka_01789	contig_22	54581	119	40224	40761	-1	114	AAC(2')-Ia	3002523.0	366.311	300.0	Perfect	100.0	100.0	AAC(2')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MGIEYRSLHTSQLTLSEKEALYDLLIEGFEGDFSHDDFAHTLGGMHVMAFDQQKLVGHVAIIQRHMALDNTPISVGYVEAMVVEQSYRRQGIGRQLMLQTNKIIASCYQLGLLSASDDGQKLYHSVGWQIWKGKLFELKQGSYIRSIEEEGGVMGWKADGEVDFTASLYCDFRGGDQW	ATGGGCATAGAATACCGCAGTCTGCATACCAGCCAATTGACACTGAGTGAAAAAGAAGCGCTTTACGATTTATTAATTGAAGGTTTTGAAGGCGATTTTTCGCATGACGATTTCGCGCACACTTTAGGTGGAATGCACGTCATGGCTTTTGATCAACAAAAATTGGTTGGTCATGTTGCAATTATTCAACGCCATATGGCCCTAGATAATACGCCTATCTCTGTAGGGTATGTTGAAGCGATGGTAGTTGAACAAAGTTATCGTCGCCAAGGTATTGGGCGGCAATTGATGCTGCAAACCAATAAAATTATAGCTTCGTGTTATCAATTAGGGCTGCTGTCGGCTTCAGATGATGGACAAAAATTGTATCATTCGGTTGGATGGCAAATCTGGAAAGGTAAGTTGTTTGAATTGAAACAAGGGAGCTATATCCGTTCTATTGAAGAAGAAGGCGGAGTCATGGGCTGGAAAGCGGATGGTGAGGTTGATTTTACCGCTTCGCTTTACTGTGATTTTCGTGGCGGTGATCAGTGGTAA	
8117	CARD	prokka_02476	contig_39	35330	140	15377	18518	1	170	adeF	3000777.0	1217.22	750.0	Strict	60.34	98.77	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MNFPRFFIQRPIFAMVLSIFILIAGILSFYKLPLSEYPSVTPPTVQVIASYPGATPKVIADTVASPIEQAVNGVEGMLYMSSQMSTDGKMVLTISFRQDVDPDIAQIQVQNLVSRVIPRLPQEVQQIGVTTEKTSPDVLMVVHMYSPNNVYDPLFVSNYALLNVRDEIARLPGVASALVWGEGEYAMRAWIDPTKVASLGLTANDIVTAIREQNIQVATGSIGQQPNSTSSFQISVNALGRLTTEEQFGNIIIQTGEDGQSTYLKDVARLELGADNYSLRSLLNGQNAVGLQIVMSPGANALEVAESVRETMARLQANFIEGIDYKIAYDPTIFVSASLKSVAITLLEATILVVIVVVLFLQSWRASIIPLVAVPVSLVGTFAFMYLFGFSLNTLSLFGLVISIGIVVDDAIVVVENVERHITEGLTPKEAAFKAMEEVTGPIIAITSVLAAVFIPTAFLSGLQGEFYRQFSLTIVISTIISAINSLTLSPALSAILLKPHDKNSKPDWLTRIINAIFSRFFAKFNLFFNALSNKYVQIVRRCIRGSLIILVLYLGFVGLTALGFKVVPNGFVPAQDKYYLIGVAQLPSGASLDRTEAVVKEMSRLALMEPGVENVVAFPGLSVNGPVNLPNSALMFAMLKPFDERTDPSLSANAIAERLMGKFSQIPDGFVGIFPPPPVPGLGSMGGFKVQIEDRADLGFDALAQVQEQVLMKAMQAPELTGMMASFQTNSPQIDVDIDREKAKAQGVTLTDIFDALQINLGSLYVNDFNRFGRTYRVIVQADTPFRMDPKDIELIKVRNKHGEMIPLSSLVTITRTNGPDRVIHYNGYPSVDITGNAAPGFTSGQATDAMEKILRETLPEGMSFEWTDLTYQEQLAGNSALYIFPLAVLFAFLILAAQYNSWSLPFSVLLIAPMALLSAIAGVWLLNGDNNIFTQIAFIVLVGLAAKNAILIVEFAIAQEKQGKDPLAAVSEAAHLRLRPILMTSFAFIAGVIPLVLATGAGSEMRQAVGVAVFFGMLGVTLFGLLLTPVFYMMIRKLAGKKSP	ATGAATTTTCCCCGTTTCTTTATACAGCGCCCTATCTTTGCCATGGTCTTATCAATATTTATATTGATAGCAGGGATTTTGAGCTTTTATAAATTGCCCCTAAGCGAATATCCATCCGTGACTCCCCCTACGGTTCAGGTTATCGCCAGTTATCCAGGTGCAACACCCAAGGTGATTGCTGATACGGTGGCCTCCCCCATCGAACAAGCGGTTAATGGGGTAGAAGGCATGCTCTATATGAGCTCGCAAATGTCGACCGATGGAAAAATGGTACTGACCATCTCTTTTAGGCAAGATGTCGACCCCGATATTGCACAAATTCAAGTGCAAAACTTAGTTTCGCGCGTCATTCCTCGCTTGCCTCAAGAAGTTCAACAAATTGGCGTCACAACGGAAAAAACGTCACCGGATGTCCTAATGGTCGTCCATATGTACTCACCCAATAATGTCTATGACCCACTGTTTGTCTCTAATTACGCTTTACTCAATGTGCGTGATGAAATTGCTAGATTACCCGGTGTTGCCAGCGCATTAGTTTGGGGGGAAGGTGAATATGCGATGCGAGCATGGATTGATCCCACAAAAGTCGCATCATTAGGCTTAACGGCAAATGATATCGTTACGGCTATTCGCGAACAAAATATTCAAGTCGCTACAGGTTCGATTGGGCAGCAGCCGAACTCAACGTCCTCATTTCAAATCAGCGTCAATGCACTTGGTCGACTCACAACCGAAGAGCAATTTGGCAATATTATTATTCAAACAGGCGAAGATGGGCAGTCGACCTATTTAAAAGATGTCGCTCGATTAGAGCTAGGTGCCGATAATTATTCACTTCGCAGCTTACTGAATGGGCAAAACGCGGTTGGCTTACAGATTGTCATGAGCCCCGGAGCAAATGCGTTGGAAGTGGCGGAGTCGGTACGAGAAACCATGGCTCGTTTACAGGCTAACTTTATCGAAGGGATCGACTATAAAATTGCCTACGATCCAACTATTTTTGTCAGCGCCTCACTAAAATCGGTCGCTATCACCTTACTTGAAGCCACCATATTAGTGGTTATTGTCGTGGTGCTCTTTTTACAAAGTTGGCGAGCATCAATCATTCCGTTAGTAGCTGTTCCCGTATCACTCGTGGGAACATTTGCCTTTATGTACCTATTCGGCTTTTCTCTCAATACACTATCGCTATTCGGTTTAGTTATCTCAATAGGGATAGTGGTGGATGACGCGATAGTCGTCGTTGAAAACGTTGAAAGGCATATCACGGAAGGATTAACACCAAAAGAAGCCGCCTTTAAAGCGATGGAAGAGGTCACAGGCCCTATTATTGCCATTACATCAGTATTAGCGGCTGTTTTTATTCCAACCGCATTTTTATCCGGTTTACAAGGTGAGTTTTATCGACAATTTTCATTAACGATCGTGATTTCAACGATTATTTCTGCGATTAACTCATTGACCTTATCTCCTGCTCTCAGTGCTATCTTACTGAAGCCCCATGATAAAAATAGCAAACCAGACTGGTTGACTCGCATTATCAATGCGATATTTAGTCGCTTTTTCGCTAAATTTAATCTCTTTTTCAATGCATTATCCAACAAATACGTTCAGATTGTACGCCGCTGCATACGAGGAAGTTTAATTATTCTTGTGCTATATCTTGGCTTTGTTGGGCTAACCGCACTCGGGTTTAAAGTGGTTCCTAATGGCTTTGTTCCTGCACAGGATAAATATTACTTAATTGGCGTCGCGCAATTGCCTTCGGGTGCTTCTCTCGATAGAACAGAAGCGGTTGTGAAAGAGATGTCACGCCTCGCACTGATGGAGCCTGGTGTTGAAAACGTGGTAGCGTTCCCTGGCCTCTCTGTAAATGGCCCCGTTAACTTACCGAATTCAGCACTCATGTTTGCAATGCTCAAACCGTTTGATGAGCGTACAGATCCTTCACTATCAGCAAATGCCATCGCCGAACGCCTAATGGGTAAATTTAGTCAAATACCGGATGGTTTTGTTGGCATATTCCCTCCACCTCCGGTTCCCGGCTTGGGTTCGATGGGGGGCTTTAAGGTACAAATAGAAGATAGGGCTGATCTTGGCTTTGATGCGTTAGCGCAAGTGCAAGAGCAAGTGTTGATGAAAGCAATGCAAGCCCCCGAATTAACCGGCATGATGGCAAGTTTCCAGACCAATTCGCCACAAATCGATGTGGATATTGATCGCGAAAAAGCCAAAGCGCAAGGTGTTACGCTCACCGATATCTTTGATGCATTACAGATTAATTTGGGATCACTCTACGTCAATGATTTCAATCGTTTTGGTCGAACCTATCGCGTCATTGTGCAAGCAGATACGCCCTTTAGAATGGATCCTAAAGATATTGAACTCATCAAGGTACGTAATAAGCATGGGGAGATGATCCCTCTGAGTAGCTTAGTGACGATTACCCGTACAAATGGCCCTGATCGCGTGATCCACTATAACGGTTACCCTTCTGTCGATATCACCGGCAACGCGGCTCCTGGCTTTACTTCAGGACAAGCCACTGATGCGATGGAGAAGATCTTACGTGAAACATTGCCCGAAGGCATGAGCTTTGAATGGACAGATCTAACCTATCAAGAGCAGTTAGCGGGTAATTCAGCACTCTATATTTTCCCATTAGCAGTGCTATTTGCTTTCTTGATCTTGGCTGCTCAATATAACAGTTGGTCATTACCATTCTCTGTACTATTAATCGCGCCAATGGCTCTACTTTCTGCTATTGCCGGCGTATGGTTGCTGAATGGAGATAATAATATCTTCACACAAATCGCTTTCATTGTGCTGGTCGGCCTTGCTGCAAAAAATGCGATTTTGATTGTTGAATTTGCGATCGCCCAAGAGAAACAAGGAAAAGATCCTTTAGCCGCCGTATCAGAAGCCGCTCATCTACGATTACGCCCTATTTTGATGACATCCTTTGCCTTTATTGCTGGCGTGATCCCGCTTGTTTTAGCGACGGGAGCGGGTTCAGAGATGAGACAAGCCGTGGGGGTTGCGGTGTTCTTCGGCATGCTAGGTGTAACGCTATTTGGTTTACTATTAACCCCTGTTTTCTACATGATGATACGTAAATTAGCGGGTAAAAAATCCCCATAA	
8117	CARD	prokka_02861	contig_53	27243	166	121	730	1	51	APH(2'')-IIa	3002635.0	405.986	550.0	Strict	99.5	67.56	APH(2'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MPKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF	GTGCCTAAGTTGAGTGAAAAGGAAAAGGATGCCCTTGCATATGATGAAGCGACGTTTTTGAAAGAGTTACATTCCATAGAGATTGATTGTTCTGTCAGTTTGTTTTCAGATGCTCTGGTGAATAAGAAAGATAAGTTTTTGCAAGATAAAAAATTACTTATAAGTATTCTGGAAAAGGAGCAGCTGTTAACTGATGAGATGTTGGAACATATCGAAACAATATATGAAAACATATTAAGCAATGCTGTTTTATTTAAATATACCCCTTGTTTGGTACATAATGATTTCAGTGCAAATAACATGATTTTTAGAAATAATAGACTGTTTGGAGTTATTGATTTTGGCGATTTTAATGTAGGTGACCCGGATAATGATTTTTTGTGCTTGCTGGATTGTAGTACAGATGATTTCGGGAAAGAATTTGGCAGGAAGGTATTAAAATACTATCAGCATAAGGCGCCGGAAGTAGCAGAAAGAAAAGCAGAGCTTAATGATGTATATTGGTCGATAGACCAAATCATTTATGGTTATGAAAGAAAAGATAGGGAAATGTTGATTAAGGGTGTTTCTGAATTGCTACAAACACAAGCAGAGATGTTTATATTTTAG	loose hit with at least 95 percent identity pushed strict
8117	CARD	prokka_02862	contig_53	27243	166	773	1310	1	99	AAC(6')-Im	3004629.0	368.622	275.0	Perfect	100.0	100.0	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRVIIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVCQYLRTEMDADAVILDPRKNNLRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV	ATGTTGGAAAAAAAGCGAGTTTCCTTTCGCCCGATGAATGAGGATGATTTAGTTCTAATGTTAAAATGGCTGACAGATGACCGTGTTCTTGAATTCTACGACGGTAGAGATAAAAAACATACACAGAAAACGATTCGTGAGCATTATACAGAGCAATGGGCGGATGAGATTTATCGAGTCATCATTGAATATGATACAATTCCTATCGGTTACGCACAAATATATAGAATTCAGGGGGAACTTTTCGACGAATATAATTACCATGAGACGGAAGAAAAGATTTATGCGATGGACCAATTTATCGGTGAGCCGGAATATTGGAATATGGGAATCGGTGCAGAATATTGCAGAGTAGTATGCCAATATCTACGAACGGAAATGGATGCCGATGCGGTGATTCTTGACCCACGAAAAAATAATCTACGAGCAGTACGAGCATATCAGAAGGCAGGATTTAAAATAATTAAGGAACTTCCCGAACATGAGCTACACGAGGGGAAAAAGGAAGATTGTGTGCTGATGGAATGGAGAGTGTAA	
8117	CARD	prokka_02886	contig_53	27243	166	15878	16694	1	135	sul2	3000412.0	528.865	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	ATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	
8117	CARD	prokka_02887	contig_53	27243	166	16754	17558	1	158	APH(3'')-Ib	3002639.0	541.191	500.0	Strict	99.63	100.0	APH(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTCATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	
8117	CARD	prokka_02888	contig_53	27243	166	17557	18394	1	180	APH(6)-Id	3002660.0	568.155	500.0	Strict	99.64	100.0	APH(6)	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	
8117	CARD	prokka_02890	contig_53	27243	166	19729	20929	1	155	tet(A)	3000165.0	788.1039999999998	700.0	Strict	99.75	94.1	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT	GTGAAACCCAACAGACCCCTGATCGTAATTCTGAGCACTGTCGCGCTCGACGCTGTCGGCATCGGCCTGATTATGCCGGTGCTGCCGGGCCTCCTGCGCGATCTGGTTCACTCGAACGACGTCACCGCCCACTATGGCATTCTGCTGGCGCTGTATGCGTTGATGCAATTTGCCTGCGCACCTGTGCTGGGCGCGCTGTCGGATCGTTTCGGGCGGCGGCCGGTCTTGCTCGTCTCGCTGGCCGGCGCTGCTGTCGACTACGCCATCATGGCGACGGCGCCTTTCCTTTGGGTTCTCTATATCGGGCGGATCGTGGCCGGCATCACCGGGGCGACTGGGGCGGTAGCCGGCGCTTATATTGCCGATATCACTGATGGCGATGAGCGCGCGCGGCACTTCGGCTTCATGAGCGCCTGTTTCGGGTTCGGGATGGTCGCGGGACCTGTGCTCGGTGGGCTGATGGGCGGTTTCTCCCCCCACGCTCCGTTCTTCGCCGCGGCAGCCTTGAACGGCCTCAATTTCCTGACGGGCTGTTTCCTTTTGCCGGAGTCGCACAAAGGCGAACGCCGGCCGTTACGCCGGGAGGCTCTCAACCCGCTCGCTTCGTTCCGGTGGGCCCGGGGCATGACCGTCGTCGCCGCCCTGATGGCGGTCTTCTTCATCATGCAACTTGTCGGACAGGTGCCGGCCGCGCTTTGGGTCATTTTCGGCGAGGATCGCTTTCACTGGGACGCGACCACGATCGGCATTTCGCTTGCCGCATTTGGCATTCTGCATTCACTCGCCCAGGCAATGATCACCGGCCCTGTAGCCGCCCGGCTCGGCGAAAGGCGGGCACTCATGCTCGGAATGATTGCCGACGGCACAGGCTACATCCTGCTTGCCTTCGCGACACGGGGATGGATGGCGTTCCCGATCATGGTCCTGCTTGCTTCGGGTGGCATCGGAATGCCGGCGCTGCAAGCAATGTTGTCCAGGCAGGTGGATGAGGAACGTCAGGGGCAGCTGCAAGGCTCACTGGCGGCGCTCACCAGCCTGACCTCGATCGTCGGACCCCTCCTCTTCACGGCGATCTATGCGGCTTCTATAACAACGTGGAACGGGTGGGCATGGATTGCAGGCGCTGCCCTCTACTTGCTCTGCCTGCCGGCGCTGCGTCGCGGGCTTTGGAGAAATTCTTCAAATTCCCGTTGCACATAG	
8117	CARD	prokka_02893	contig_53	27243	166	21528	22743	-1	173	floR	3002705.0	783.097	750.0	Strict	99.75	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		phenicol antibiotic	MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTLAVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV	ATGACCACCACACGCCCCGCGTGGGCCTATACGCTGCCGGCAGCACTGCTGCTGATGGCTCCTTTCGACATCCTCGCTTCACTGGCGATGGATATTTATCTCCCTGTCGTTCCAGCGATGCCCGGCATCCTGAACACGACGCCCGCTATGATCCAACTCACGTTGAGCCTCTATATGGTGATGCTCGGCGTGGGCCAGGTGATTTTTGGTCCGCTCTCAGACAGAATCGGGCGACGGCCAATTCTACTTGCGGGCGCAACGGCTTTCGTCATTGCGTCTCTGGGAGCAGCTTGGTCTTCAACTGCACCGGCCTTTGTCGCTTTCCGTCTACTTCAAGCAGTGGGCGCGTCGGCCATGCTGGTGGCGACGTTCGCGACGGTTCGCGACGTTTATGCCAACCGTCCTGAGGGTGTCGTCATCTACGGCCTTTTCAGTTCGATGCTGGCGTTCGTGCCTGCGCTCGGCCCTATCGCCGGAGCATTGATCGGCGAGTTCTTGGGATGGCAGGCGATATTCATTACTTTGGCTATACTGGCGATGCTCGCACTCCTAAATGCGGGTTTCAGGTGGCACGAAACCCGCCCTCTGGATCAAGTCAAGACGCGCCGATCTGTCTTGCCGATCTTCGCGAGTCCGGCTTTTTGGGTTTACACTGTCGGCTTTAGCGCCGGTATGGGCACCTTCTTCGTCTTCTTCTCGACGGCTCCCCGTGTGCTCATAGGCCAAGCGGAATATTCCGAGATCGGATTCAGCTTTGCCTTCGCCACTGTCGCGCTTGTAATGATCGTGACAACCCGTTTCGCGAAGTCCTTTGTCGCCAGATGGGGCATCGCAGGATGCGTGGCGCGTGGGATGGCGTTGCTTGTTTGCGGAGCGGTCCTGTTGGGGATCGGCGAACTTTACGGCTCGCCGTCATTCCTCACCTTCATCCTACCGATGTGGGTTGTCGCGGTCGGTATTGTCTTCACGGTGTCCGTTACCGCGAACGGCGCTTTGGCAGAGTTCGACGACATCGCGGGATCAGCGGTCGCGTTCTACTTCTGCGTTCAAAGCCTGATAGTCAGCATTGTCGGGACATTGGCGGTGGCACTTTTAAACGGTGACACAGCGTGGCCCGTGATCTGTTACGCCACGGCGATGGCGGTACTGGTTTCGTTGGGGCTGGTGCTCCTTCGGCTCCGTGGGGCTGCCACCGAGAAGTCGCCAGTCGTCTAA	
8117	CARD	prokka_03255	contig_69	20570	109	18973	20179	1	141	tet(B)	3000166.0	786.563	700.0	Strict	99.5	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	ATGAATAGTTCGACAAAGATCGCATTGGTAATTACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAACGTTATTACGTGAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTGCACTTTATGCGTTAATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGATTTGGTCGGCGCCCAGTGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATTGCTGGCTTTTTCAAGTGCGCTTTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCACTGGAGCTACTGGGGCTGTCGCGGCATCGGTCATTGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGTTTAATAGCGGGGCCTATTATTGGTGGTTTTGCAGGAGAGATTTCACCGCATAGTCCCTTTTTTATCGCTGCGTTGCTAAATATTGTCACTTTCCTTGTGGTTATGTTTTGGTTCCGTGAAACCAAAAATACGCGTGATAATACAGATACCGAAGTAGGGGTTGAGACGCAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTTGATTATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATTTACCGAAAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGGTCTTTTACACTCAGTATTCCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGCGAAAAAACGGCAGTACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTTTATATCTGAAGGTTGGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTTACCTGCATTACAGGGAGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTACAGGGATTATTGGTGAGCCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGTTATTTATAATCATTCACTACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTTACTGTATTATTATCCTGCTATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAAACAGGAGACAAGTGCTTAG	
8117	CARD	prokka_03450	contig_82	15681	143	4572	5328	1	127	rmtB	3000860.0	514.612	450.0	Perfect	100.0	100.0	16S rRNA methyltransferase (G1405)	protein homolog model	antibiotic target alteration		aminoglycoside antibiotic	MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTPESLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALYERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLLEREQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTIGTELIYLIKKNG	ATGAACATCAACGATGCCCTCACCTCCATCCTGGCCTCAAAAAAATACCGCGCCCTTTGCCCGGATACCGTGCGGCGCATCCTGACTGAGGAATGGGGGCGGCATAAATCCCCCAAACAGACCGTAGAGGCTGCACGCACCCGGCTGCATGGAATTTGCGGGGCATATGTCACCCCGGAATCGCTCAAGGCTGCTGCCGCCGCGCTTTCTGCGGGCGATGTAAAAAAGGCATTGTCGCTGCATGCCTCCACCAAGGAGCGACTGGCCGAGCTGGATACCCTGTACGATTTTATCTTTTCAGCCGAAACTCCCCGCCGCGTGCTGGATATCGCCTGCGGTCTTAACCCCTTGGCGCTATACGAGCGCGGCATTGCATCCGTGTGGGGCTGTGATATCCACCAGGGATTGGGGGATGTCATCACCCCCTTTGCTAGGGAAAAAGATTGGGATTTTACCTTTGCCCTGCAGGATGTGCTGTGTGCGCCGCCCGCCGAAGCCGGCGACCTGGCGCTGATTTTTAAGCTTTTGCCCCTGCTGGAGCGGGAGCAGGCCGGTTCTGCCATGGCACTTTTACAATCCCTCAATACCCCGCGCATGGCTGTCAGCTTTCCCACGCGTAGTTTAGGCGGGCGTGGAAAAGGCATGGAGGCGAACTACGCCGCATGGTTCGAGGGCGGCTTGCCCGCCGAGTTTGAGATTGAGGATAAAAAGACCATCGGAACAGAACTTATATACTTGATAAAAAAGAATGGATAA	
8117	CARD	prokka_03457	contig_82	15681	143	10344	11520	-1	162	tet(D)	3000168.0	387.111	250.0	Strict	53.2	99.24	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MRSSAIIALLIVGLDAMGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPMLGQLSDSYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIADSTGEGSRARWFGYMGACYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETHHSHGGTGKPVRIKPFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQWNTATVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFVLLAFATQGWMVFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATAGAWNGWVWIVGAILYLICLPILRRPFATSL	GTGCGCAGCTCTGCCATCATTGCCCTGCTGATCGTGGGTCTTGACGCCATGGGTCTCGGCCTCATCATGCCCGTCCTTCCGACGCTTCTGCGTGAGCTTGTGCCAGCAGAGCAGGTCGCTGGACACTATGGTGCCTTGCTGTCGCTCTATGCATTGATGCAGGTCGTCTTCGCGCCCATGCTTGGACAGCTTTCGGATTCTTACGGTCGGCGTCCGGTACTTCTGGCTTCTCTTGCAGGAGCCGCAGTCGATTACACGATTATGGCATCAGCGCCGGTCTTATGGGTGCTCTATATCGGCCGACTCGTGTCCGGCGTCACGGGCGCAACCGGAGCTGTAGCAGCCTCAACCATTGCCGATTCGACGGGGGAAGGTTCTCGCGCACGCTGGTTCGGCTACATGGGGGCCTGTTATGGGGCGGGCATGATTGCCGGGCCAGCACTTGGTGGCATGCTCGGTGGTATCTCTGCTCATGCCCCGTTTATCGCCGCCGCCCTTCTCAACGGGTTCGCGTTCCTGCTTGCCTGCATTTTCCTCAAGGAGACTCATCACAGCCATGGCGGGACCGGAAAGCCGGTTCGCATCAAACCATTCGTTCTGTTACGGCTGGATGATGCATTGCGCGGGCTAGGTGCGCTTTTCGCAGTTTTCTTCATTATTCAACTGATCGGCCAAGTGCCTGCAGCCCTATGGGTCATATATGGCGAGGACCGTTTTCAGTGGAACACCGCGACCGTTGGTTTGTCGCTCGCGGCGTTTGGGGCAACACATGCGATCTTCCAAGCGTTTGTTACCGGCCCGCTTTCAAGCCGGCTTGGAGAGCGGCGCACGCTGCTGTTTGGCATGGCTGCGGATGCGACTGGCTTCGTTCTTCTGGCTTTTGCCACGCAGGGATGGATGGTGTTCCCGATTCTGTTGCTGCTTGCCGCCGGGGGTGTTGGCATGCCGGCCTTGCAGGCAATGCTCTCAAACAATGTCAGCAGTAACAAGCAAGGGGCTTTGCAAGGAACGCTAACGAGCCTCACCAATCTAAGCTCTATCGCAGGACCGCTTGGCTTCACAGCACTCTATTCTGCCACCGCCGGGGCATGGAACGGTTGGGTTTGGATTGTCGGCGCGATCCTCTATTTAATATGTCTGCCAATACTACGCAGACCATTCGCAACTTCATTGTGA	
8117	CARD	prokka_03459	contig_82	15681	143	12456	13497	-1	192	cmlA9	3005043.0	670.618	750.0	Strict	100.0	85.64	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		phenicol antibiotic	MVMLGVGQVIFGPLSDRVGRRPILLVGATAFVAASLGAACSSTALAFVAFRLVQAVGASAMLVATFATVRDVYANRPEGAVIYGLFSSMLAFVPALGPIAGALIGEFWGWQAIFITLAALASLALLNASFRWHETRPLDQARTQRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAGYSEIGFSLAFATVALVMVTTTRFAKSFVAKWGIAGCVARGMALLVSGAILLGIGQLFGSPSFFSFILPMWVVAVGIVFTVSVTANGALAQFDDIAGSAVAFYFCIQSLIVSIVGTLAVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV	ATGGTGATGCTCGGTGTGGGCCAAGTGATCTTTGGGCCACTCTCCGATCGCGTCGGGCGACGGCCGATCCTGCTTGTAGGCGCAACGGCTTTCGTTGCTGCGTCTCTGGGAGCGGCTTGTTCTTCAACTGCATTAGCCTTTGTTGCGTTTCGTCTGGTTCAGGCTGTTGGAGCATCGGCCATGCTGGTGGCCACCTTCGCGACCGTGCGCGACGTATATGCCAATCGTCCCGAAGGTGCCGTCATCTACGGCCTTTTCAGTTCGATGCTGGCGTTCGTGCCTGCGCTCGGCCCTATAGCCGGTGCGCTGATCGGCGAGTTTTGGGGATGGCAGGCGATCTTCATCACACTGGCTGCACTGGCTTCGCTCGCACTCTTAAACGCCAGTTTCAGGTGGCATGAAACCCGACCGTTGGATCAGGCCAGAACGCAACGATCTGTTTTGCCGATCTTCGCGAGTCCGGCCTTTTGGGTTTACACGGTCGGATTTAGTGCCGGCATGGGCACATTCTTCGTTTTCTTCTCGACAGCCCCCCGTGTTCTCATAGGCCAAGCCGGCTATTCCGAGATCGGATTTAGCTTGGCCTTCGCGACTGTCGCGCTGGTCATGGTCACGACAACCCGCTTCGCAAAGTCCTTCGTTGCCAAATGGGGTATCGCGGGATGCGTAGCGCGCGGGATGGCGTTGCTCGTTTCCGGCGCGATCCTGTTGGGGATCGGCCAACTTTTCGGATCGCCGTCATTTTTCAGCTTCATCCTGCCGATGTGGGTTGTCGCGGTCGGCATTGTCTTCACGGTGTCCGTTACCGCCAACGGCGCACTTGCGCAGTTCGACGACATCGCTGGATCAGCGGTTGCGTTCTACTTCTGCATCCAAAGCCTGATAGTCAGTATCGTCGGGACATTGGCGGTGACGCTGTTAAACGGCGATACAGCGTGGCCCGTGATTTGTTACGCCACGGCAATGGCAGTGCTGGTGTCGTTGGGGCTGGCGCTCCTTCGATCCCGTGATGCTGCCACCGAGAAGTCGCCAGTCGTCTAG	loose hit with at least 95 percent identity pushed strict
8117	CARD	prokka_03460	contig_82	15681	143	13887	14859	-1	115	sul1	3000410.0	355.525	500.0	Strict	100.0	115.77	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMDRRLVHGETADLAPTGFGQQVREAMDQRREHHIEQRDATRNRDGRIFYRRNLLATLREREVARAGAEMAEGKALPFRAAKDGESVSGKFTGTVQLTSGKFAIVEKSHEFTLVPWRPIIDRQLGREVAGIMQGGSVSWQLGRQRGLGL	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGACCGGCGATTGGTCCATGGCGAAACGGCCGACCTTGCGCCGACCGGCTTCGGGCAACAGGTCCGCGAAGCCATGGACCAGCGCCGCGAGCATCATATCGAACAGCGCGACGCCACGCGCAACAGGGACGGCCGAATCTTCTACCGGCGCAATCTTCTCGCCACCCTGCGCGAGCGGGAAGTTGCGCGCGCCGGTGCGGAGATGGCCGAGGGCAAGGCGCTGCCGTTCCGCGCCGCCAAGGATGGTGAGAGTGTCAGCGGCAAGTTCACCGGGACTGTCCAGCTAACGAGCGGCAAGTTCGCCATCGTGGAAAAGAGCCACGAGTTCACCCTTGTCCCGTGGCGGCCGATCATCGACCGCCAGCTCGGCCGCGAGGTCGCGGGTATCATGCAGGGCGGTTCGGTGTCGTGGCAGTTAGGGCGGCAGCGGGGGTTGGGGCTATAG	loose hit with at least 95 percent identity pushed strict
8117	CARD	prokka_03461	contig_82	15681	143	14852	15200	-1	147	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8117	CARD	prokka_03542	contig_89	13577	122	2121	3657	1	188	Klebsiella pneumoniae KpnH	3004597.0	804.668	700.0	Strict	76.55	99.8	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MTNTPLTGSKLAWMTIALSLATFMQVLDSTIANVAIPTIAGNLGASNSQGTWVITSFGVANAISIPITGWLARRIGEVRLFLWSTGLFALTSWLCGISGSLEMLILFRVLQGLVAGPLIPLSQSLLLNNYPPAKRNMALALWSMTIVIAPICGPILGGYISDNYHWGWIFFINVPFSIAIIFAIMQTLKGRETKISIQPIDTIGLVLLVIGIGALQIMLDQGKELDWFNSTEIIVLTVIAVVAISFLIVWELTDDHPVIDLSLFKERNFTIGCLSLSLAYMLYFGTIVLLPQLLQEVYGYTATWAGLASAPVGLLPLLITPIIGRFGNRIDMRYIVTFSFIVYAVCYYWRAYTFEPDMGFAAAAWPQFVQGLAIACFFMPLTTITLSGLPPEKMASASSLSNFTRTLAGAIGTSITTTMWTQREAMHHENLTEFINPYNPNSQHMYSELAQIGMNEQQSAAYLAKTITDQGLILSANEIFWLSAGIFILLMVIVWFAKPPFGAGSKGGGAH	GTGACAAATACACCGTTAACAGGATCAAAACTCGCGTGGATGACCATTGCTCTGTCATTGGCCACATTTATGCAAGTACTTGATTCAACAATTGCTAACGTTGCCATTCCAACGATTGCAGGTAATCTTGGCGCCTCTAACTCGCAGGGAACGTGGGTAATTACCTCTTTTGGTGTGGCAAATGCGATTTCAATTCCTATTACTGGATGGTTAGCCCGCAGGATTGGTGAAGTTAGGCTATTTTTATGGTCGACAGGCCTATTTGCACTAACTTCATGGTTATGTGGTATCTCTGGCAGCCTTGAAATGCTGATTTTATTCCGTGTGTTACAAGGGCTGGTTGCGGGGCCATTAATTCCCCTATCCCAAAGTTTATTGCTCAATAACTACCCCCCTGCCAAACGGAATATGGCCTTGGCGCTTTGGTCAATGACCATCGTTATCGCGCCAATTTGTGGGCCAATATTGGGTGGCTACATCAGTGATAATTATCATTGGGGTTGGATATTCTTTATCAACGTTCCATTTAGTATCGCAATTATCTTTGCCATTATGCAGACACTAAAAGGGCGTGAAACCAAAATTTCTATTCAACCCATTGATACTATCGGGCTAGTACTGCTAGTTATCGGTATTGGTGCCCTGCAAATCATGCTAGACCAAGGGAAAGAGCTAGATTGGTTTAATTCCACTGAAATTATTGTGCTGACCGTCATTGCTGTTGTTGCGATATCGTTCTTAATTGTTTGGGAACTCACTGACGATCACCCTGTCATTGATCTTTCGTTATTTAAGGAACGCAACTTCACCATCGGTTGTTTATCGCTAAGTCTTGCATATATGCTCTACTTCGGAACAATCGTACTACTTCCCCAACTCCTACAGGAAGTTTATGGTTATACAGCAACCTGGGCGGGTCTTGCTTCCGCCCCAGTAGGCTTATTGCCCTTGTTGATCACACCAATTATTGGACGTTTCGGTAATCGCATTGATATGCGTTATATCGTAACCTTTAGCTTTATTGTTTATGCTGTTTGTTACTATTGGCGTGCTTATACATTTGAGCCGGATATGGGATTTGCCGCCGCGGCATGGCCACAATTTGTGCAGGGGCTAGCGATTGCCTGTTTCTTTATGCCATTGACGACCATTACTTTATCAGGGCTTCCTCCTGAAAAAATGGCCTCAGCATCAAGTTTATCTAACTTCACACGGACATTAGCGGGTGCGATTGGTACATCCATTACAACCACAATGTGGACACAACGCGAAGCGATGCACCATGAGAATCTGACGGAGTTTATTAACCCGTACAATCCAAATTCTCAACATATGTACAGTGAATTAGCCCAAATTGGTATGAATGAGCAGCAAAGTGCCGCCTATTTAGCGAAAACAATTACCGACCAAGGGCTGATCTTATCTGCAAATGAAATTTTCTGGTTATCTGCTGGGATCTTTATTTTGCTCATGGTCATTGTTTGGTTCGCCAAACCACCTTTTGGCGCAGGCTCTAAAGGTGGCGGAGCACACTAA	
8117	CARD	prokka_03601	contig_93	12838	56	9728	10370	-1	32	catIII	3002685.0	443.736	400.0	Strict	99.06	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLGDSAYKFYPVMIYLIAQAVNQFDELRMAIKDDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVMERYKSDTKLFPQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEGDKLLLPLSVQVHHAVCDGFHVARFINRLQELCNSKLK	ATGAACTATACAAAATTTGATGTAAAAAATTGGGTTCGCCGTGAGCATTTTGAGTTTTATCGGCATCGTTTACCATGTGGTTTTAGCTTAACAAGCAAAATTGATATCACGACGTTAAAAAAATCATTGGGTGATTCAGCGTATAAGTTTTATCCGGTAATGATCTATCTGATTGCTCAGGCCGTGAATCAATTTGATGAGTTGAGAATGGCGATAAAAGATGATGAATTGATCGTATGGGATTCAGTCGACCCACAATTCACCGTATTCCATCAAGAAACAGAGACATTTTCAGCACTGAGTTGCCCATACTCATCCGATATTGATCAATTTATGGTGAATTATTTATCGGTAATGGAACGTTATAAAAGTGATACCAAATTATTTCCTCAAGGGGTAACACCAGAAAATCATTTAAATATTTCAGCATTACCTTGGGTTAATTTTGATAGCTTTAATTTAAATGTTGCTAATTTTACCGATTATTTTGCACCCATTATAACAATGGCAAAATATCAGCAAGAAGGGGATAAACTGTTATTGCCGCTCTCAGTACAGGTTCATCATGCAGTTTGTGATGGCTTCCATGTTGCACGCTTTATTAATCGGCTACAAGAGTTGTGTAACAGTAAATTAAAATAA	
8117	CARD	prokka_03657	contig_99	10586	91	236	677	1	44	vga(E) Staphylococcus cohnii	3004715.0	23.483	1000.0	Strict	100.0	27.86	ABC-F ATP-binding cassette ribosomal protection protein	protein homolog model	antibiotic target protection		macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	MRSQAPFIVAKGDDVEIIHDEKKAVIGLINNTSQSAYLFTSIYFFFFKRYSVMFSLKFAILFGFTMTFSLMPFSFSLAPELIANLHMLLLFLGLNLALFVLYFLLRMVYVKYANNDRYEITQQYLQNRVLEMNKKHLTIIDFLDLS	ATGAGGAGCCAAGCGCCATTTATTGTTGCAAAAGGGGATGATGTTGAGATTATCCATGATGAGAAAAAAGCGGTGATTGGTCTCATTAATAATACGAGTCAATCAGCTTACCTATTTACTTCAATATATTTTTTTTTCTTCAAAAGATATAGCGTAATGTTTTCATTAAAATTCGCCATTCTCTTTGGTTTCACTATGACATTCTCACTAATGCCTTTTTCTTTTTCCCTTGCTCCTGAACTTATAGCTAATCTACATATGCTGCTGTTATTCTTAGGACTCAACTTGGCACTTTTTGTGCTCTATTTTTTACTAAGAATGGTTTATGTGAAATATGCTAACAATGACCGTTATGAAATCACTCAGCAATATTTACAAAATCGAGTGTTAGAAATGAATAAAAAGCACTTGACCATTATTGATTTCTTAGATCTCTCATAA	loose hit with at least 95 percent identity pushed strict
8117	CARD	prokka_03835	contig_119	7053	158	6032	6593	1	170	dfrA23	3003019.0	386.726	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MPTVEIIVAVDPVGGFGRNGQIPWTCKEDMKRFTTISKEIRVCVMGKNTYKDMLDMQMKKEGAEERIKEKGILPERESYVVSSTLKPEDVIGATVVPDLRAVLNQYHDSDQRIAVIGGEKLYVQALASATKVHMTVMHKPYNCDRTLPMSYIDKKFVAGQGSITIQTAVDGETHPVKFITYERARP	ATGCCAACAGTTGAGATTATTGTTGCAGTTGATCCTGTTGGGGGATTTGGCCGGAATGGCCAAATCCCTTGGACGTGCAAGGAAGACATGAAGCGCTTCACCACCATATCCAAAGAGATTCGAGTGTGTGTGATGGGGAAGAACACATACAAAGACATGCTCGATATGCAAATGAAGAAGGAAGGCGCTGAAGAACGAATCAAAGAGAAGGGAATTCTTCCGGAGCGCGAATCTTACGTCGTGTCCTCGACTTTGAAGCCCGAGGACGTCATTGGAGCCACGGTAGTTCCGGACCTACGTGCGGTGCTCAATCAATATCACGACAGCGATCAACGAATAGCTGTCATTGGTGGAGAAAAGCTGTACGTGCAAGCCCTCGCATCTGCCACAAAAGTCCACATGACGGTAATGCACAAGCCATATAACTGCGATCGGACGTTGCCGATGTCATACATCGACAAAAAGTTTGTTGCAGGTCAAGGGTCTATCACCATTCAAACTGCGGTAGATGGTGAGACCCATCCCGTGAAGTTCATCACATATGAGCGCGCTCGGCCGTAA	
8117	CARD	prokka_03855	contig_123	6438	160	1219	2479	-1	205	cmlA5	3002695.0	824.313	750.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		phenicol antibiotic	MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR	GTGCGCTCAAAAAACTTTAGTTGGCGGTACTCCCTTGCCGCCACGGTGTTGTTGTTATCACCGTTCGATTTATTGGCATCACTCGGCATGGACATGTACTTGCCAGCAGTGCCGTTTATGCCAAACGCGCTTGGTACGACAGCGAGCACAATTCAGCTTACGCTGACAACGTACTTGGTCATGATTGGTGCCGGTCAGCTCTTGTTTGGACCGCTATCGGACCGACTGGGGCGCCGCCCCGTTCTACTGGGAGGTGGCCTCGCCTACGTTGTGGCGTCAATGGGCCTCGCTCTTACGTCATCGGCTGAAGTCTTTCTGGGGCTTCGGATTCTTCAGGCTTGTGGTGCCTCGGCGTGCCTTGTTTCCACATTTGCAACAGTACGTGACATTTACGCAGGTCGCGAGGAAAGTAATGTCATTTACGGCATACTCGGATCCATGCTGGCCATGGTCCCGGCGGTAGGCCCATTGCTCGGAGCGCTCGTCGACATGTGGCTTGGGTGGCGGGCTATCTTTGCGTTTCTAGGTTTGGGCATGATCGCTGCATCTGCAGCAGCGTGGCGATTCTGGCCTGAAACCCGGGTGCAACGAGTTGCGGGCTTGCAATGGTCGCAGCTGCTACTCCCCGTTAAGTGCCTGAACTTCTGGTTGTACACGTTGTGTTACGCCGCTGGAATGGGTAGCTTCTTCGTCTTTTTCTCCATTGCGCCCGGACTAATGATGGGCAGGCAAGGTGTGTCTCAGCTTGGCTTCAGCCTGCTGTTCGCCACAGTGGCAATTGCCATGGTGTTTACGGCTCGTTTTATGGGGCGTGTGATACCCAAGTGGGGCAGCCCAAGTGTCTTGCGAATGGGAATGGGATGCCTGATAGCTGGAGCAGTATTGCTTGCCATCACCGAAATATGGGCTTCGCAGTCCGTGTTAGGCTTTATTGCTCCAATGTGGCTAGTGGGTATTGGTGTCGCCACAGCGGTATCTGTGTCGCCCAATGGCGCTCTTCGAGGATTCGACCATGTTGCTGGAACGGTCACGGCAGTCTACTTCTGCTTGGGCGGTGTACTGCTAGGAAGCATCGGAACGTTGATCATTTCGCTGTTGCCGCGCAACACGGCTTGGCCGGTTGTCGTGTACTGTTTGACCCTTGCAACAGTCGTGCTCGGTCTGTCTTGTGTTTCCCGAGTGAAGGGCTCTCGCGGCCAGGGGGAGCATGATGTGGTCGCGCTACAAAGTGCGGAAAGTACATCAAATCCCAATCGTTGA	
8117	CARD	prokka_03856	contig_123	6438	160	2799	3252	-1	191	arr-2	3002847.0	311.997	250.0	Perfect	100.0	100.0	rifampin ADP-ribosyltransferase (Arr)	protein homolog model	antibiotic inactivation		rifamycin antibiotic	MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKKFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED	ATGGTAAAAGATTGGATTCCCATCTCTCATGATAATTACAAGCAGGTGCAAGGACCGTTCTATCATGGAACCAAAGCCAATTTGGCGATTGGTGACTTGCTAACCACAGGGTTCATCTCTCATTTCGAGGACGGTCGTATTCTTAAGCACATCTACTTTTCAGCCTTGATGGAGCCAGCAGTTTGGGGAGCTGAACTTGCTATGTCACTGTCTGGCCTCGAGGGTCGCGGCTACATATACATAGTTGAGCCAACAGGACCGTTCGAAGACGATCCGAATCTTACGAACAAAAAATTTCCCGGTAATCCAACACAGTCCTATAGAACCTGCGAACCCTTGAGAATTGTTGGCGTTGTTGAAGACTGGGAGGGGCATCCTGTTGAATTAATAAGGGGAATGTTGGATTCGTTAGAGGACTTAAAGCGCCGTGGTTTACACGTCATTGAAGACTAG	
8117	CARD	prokka_03857	contig_123	6438	160	3336	3870	-1	178	ANT(2'')-Ia	3000230.0	358.992	300.0	Perfect	100.0	100.0	ANT(2'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA	ATGGACACAACGCAGGTCACATTGATACACAAAATTCTAGCTGCGGCAGATGAGCGAAATCTGCCGCTCTGGATCGGTGGGGGCTGGGCGATCGATGCACGGCTAGGGCGTGTAACACGCAAGCACGATGATATTGATCTGACGTTTCCCGGCGAGAGGCGCGGCGAGCTCGAGGCAATAGTTGAAATGCTCGGCGGGCGCGTCATGGAGGAGTTGGACTATGGATTCTTAGCGGAGATCGGGGATGAGTTACTTGACTGCGAACCTGCTTGGTGGGCAGACGAAGCGTATGAAATCGCGGAGGCTCCGCAGGGCTCGTGCCCAGAGGCGGCTGAGGGCGTCATCGCCGGGCGGCCAGTCCGTTGTAACAGCTGGGAGGCGATCATCTGGGATTACTTTTACTATGCCGATGAAGTACCACCAGTGGACTGGCCTACAAAGCACATAGAGTCCTACAGGCTCGCATGCACCTCACTCGGGGCGGAAAAGGTTGAGGTCTTGCGTGCCGCTTTCAGGTCGCGATATGCGGCCTAA	
8117	CARD	prokka_03953	contig_144	2381	155	1076	1535	1	154	AAC(6')-Il	3004635.0	311.612	275.0	Perfect	100.0	100.0	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDGEALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFASDTQLTNSASTSAHLAAGFTEVAQVRCFRKPL	ATGGATAGTTCGCCGCTCGTCAGGCCTGTTGAAACTACCGATTCGGCCAGTTGGCTAAGCATGCGCTGTGAGCTGTGGCCAGATGGCACATGTCAAGAGCACCAGTCAGAGATCGCAGAATTTCTGTCCGGAAAAGTCGCCCGGCCTGCTGCTGTCCTCATTGCTGTAGCACCCGACGGAGAAGCACTAGGGTTTGCCGAGCTTTCGATCCGCCCGTATGCGGAGGAGTGCTACTCCGGCAACGTTGCGTTCTTGGAGGGTTGGTACGTTGTGCCAAGTGCGCGGCGTCAGGGCGTAGGTGTAGCTCTGGTAAAAGCCGCCGAGCATTGGGCTCGTGGTCGCGGATGCACCGAATTCGCCTCCGACACTCAACTTACCAACAGCGCAAGCACCTCGGCGCACCTGGCGGCTGGATTCACGGAGGTTGCTCAAGTACGCTGCTTCCGGAAACCGTTGTGA	
8117	CARD	prokka_03954	contig_144	2381	155	1677	2151	1	153	dfrA1	3002854.0	322.783	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG	GTGAAACTATCACTAATGGTAGCTATATCGAAGAATGGAGTTATCGGGAATGGCCCTGATATTCCATGGAGTGCCAAAGGTGAACAGCTCCTGTTTAAAGCTATTACCTATAACCAATGGCTGTTGGTTGGACGCAAGACTTTTGAATCAATGGGAGCATTACCCAACCGAAAGTATGCGGTCGTAACACGTTCAAGTTTTACATCTGACAATGAGAACGTAGTGATCTTTCCATCAATTAAAGATGCTTTAACCAACCTAAAGAAAATAACGGATCATGTCATTGTTTCAGGTGGTGGGGAGATATACAAAAGCCTGATCGATCAAGTAGATACACTACATATATCTACAATAGACATCGAGCCGGAAGGTGATGTTTACTTTCCTGAAATCCCCAGCAATTTTAGGCCAGTTTTTACCCAAGACTTCGCCTCTAACATAAATTATAGTTACCAAATCTGGCAAAAGGGTTAA	
8117	CARD	prokka_01737	contig_21	56831	114	36075	38679	-1	182	Salmonella enterica gyrA with mutation conferring resistance to triclosan	3004334.0	1546.18	1500.0	Strict	89.28	98.75	triclosan resistant gyrA	protein variant model	antibiotic target alteration	D87G	triclosan	MSDIAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNVLGNDWNKPYKKSARIVGDVIGKYHPHGDIAVYGTIVRLAQPFSMRYMLVDGQGNFGSVDGDSAAAMRYTEIRMAKIAHEMLADLEKETVDFVPNYDGTEQIPEVMPTKIPNLLVNGSSGIAVGMATNIPPHNLGEVISGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIIDAYRTGRGKVYIRARAEVEVDEKNGRETIIVSEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSLTQLQVSFGINMVALHQGQPKILNLKDIIAAFVRHRREVVTRRTIFELRKARERAHILEALAVALANIDPIIELIRRAPTPAEAKAGLIARPWDLGNVAAMLERAGDDAARPEWLEEQYGVHDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLEEYRDLLKQIEELLYILRSPERLMEVIREELEAIRELYNDARRTEITENTADINIEDLISQEDVVVTLSHQGYVKYQPLSDYEAQRRGGKGKSAARIKEEDFIERLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEQDERITAILPVREYEEGYYVFMATASGTVKKTALQDFSRPRSAGIIAVNLNEGDELIGVDLTNGSNEVMLFSAQGKVVRFAEDAVRPMGRTATGVRGIRLADEDKVVSLIIPRGEGHILTVTENGYGKRTAEQEYPTKSRATQGVISIKVSERNGNVVGAIQVDETDQIMMITNAGTLVRTRVSEVSVVGRNTQGVTLIRTAEEEKVVGLQRVAETEEDENSDEAGAEDIPSTDMGTNTPE	ATGAGCGACATTGCCAGAGAAATCACACCGGTCAATATCGAAGAAGAACTCAAAAGTTCGTATTTGGATTATGCGATGTCCGTTATTGTCGGGCGCGCGCTTCCAGATGTTCGAGATGGACTGAAGCCAGTACACCGCAGAGTACTGTTTGCGATGAATGTATTGGGAAATGATTGGAATAAACCCTATAAAAAATCTGCCCGTATAGTCGGGGACGTTATCGGTAAATACCATCCACATGGTGATATCGCTGTTTATGGGACAATCGTTCGTCTTGCTCAGCCTTTTTCTATGCGTTATATGCTGGTAGATGGTCAGGGGAACTTTGGTTCAGTTGACGGAGATTCCGCAGCTGCAATGCGTTATACGGAAATCCGTATGGCGAAAATTGCCCATGAAATGTTAGCGGATCTTGAAAAAGAGACCGTTGATTTCGTCCCAAACTATGATGGTACAGAGCAAATCCCTGAAGTTATGCCTACGAAAATCCCTAACCTATTGGTTAATGGTTCGTCAGGTATTGCTGTTGGGATGGCAACGAACATTCCTCCACACAACCTAGGGGAAGTGATCAGCGGTTGCCTTGCTTATATAGATGATGAAGATATTAGCATTGAAGGTCTGATGGAGCACATCCCAGGGCCTGATTTCCCGACTGCCGCTATCATTAATGGTCGCCGTGGAATTATCGATGCGTACCGTACTGGCCGTGGTAAGGTCTATATTCGTGCGCGTGCTGAGGTCGAAGTTGACGAAAAAAATGGCCGCGAAACGATTATTGTCAGCGAAATTCCTTATCAGGTAAACAAAGCTCGTCTTATTGAGAAAATAGCTGAACTCGTTAAAGAAAAACGTGTTGAAGGAATTAGTGCATTACGCGATGAGTCTGATAAAGACGGCATGCGTATCGTGATTGAAGTGAAACGTGATGCGGTAGGAGAGGTTGTCCTTAACAATCTTTACTCGCTGACTCAGCTTCAAGTCTCGTTCGGCATTAATATGGTAGCCTTGCATCAAGGCCAACCGAAAATCCTTAATTTAAAAGATATTATTGCTGCGTTCGTTCGCCACCGCCGTGAAGTGGTGACTCGCCGCACTATTTTTGAATTGCGTAAAGCACGTGAACGAGCACATATTCTTGAAGCATTAGCCGTTGCATTAGCTAACATTGATCCTATTATCGAGTTAATTCGTCGTGCACCGACGCCAGCAGAAGCGAAGGCAGGGTTGATTGCACGCCCTTGGGATCTTGGTAATGTGGCTGCGATGCTTGAGCGTGCCGGTGATGATGCAGCACGCCCAGAATGGCTTGAAGAACAATATGGCGTACACGACGGTCAATACTATCTGACTGAGCAACAAGCCCAAGCGATTTTGGATTTGCGTCTGCAAAAACTGACCGGGCTTGAGCATGAGAAACTGCTGGAAGAATACCGTGATCTTCTGAAGCAAATCGAAGAACTGTTGTATATTCTACGTAGCCCTGAGCGTTTAATGGAAGTTATTCGCGAAGAGTTAGAAGCTATCCGTGAACTGTATAATGATGCTCGTCGTACTGAGATCACCGAAAATACAGCGGATATCAACATTGAAGATTTGATTAGCCAAGAAGATGTGGTGGTAACACTGTCTCACCAAGGCTATGTGAAATATCAACCACTGTCTGATTACGAAGCGCAACGCCGTGGCGGTAAAGGTAAATCGGCAGCACGCATTAAAGAAGAAGACTTTATTGAGCGTTTGCTGGTGGCGAATACCCACGACACCATCCTATGCTTCTCTAGCCGTGGTCGCCTATATTGGATGAAAGTTTACCAATTACCAGAGGCCAGCCGTGGAGCACGGGGTCGTCCAATTGTGAACTTGTTGCCACTTGAACAAGATGAGCGTATTACCGCTATCTTGCCAGTTCGTGAATACGAAGAAGGCTACTATGTCTTTATGGCAACGGCGAGTGGTACGGTGAAGAAAACGGCATTGCAAGACTTTAGCCGCCCAAGAAGTGCCGGTATTATTGCCGTTAACCTCAATGAAGGCGATGAATTGATTGGTGTTGATTTAACCAATGGTTCAAATGAAGTCATGCTGTTCTCTGCTCAAGGTAAGGTTGTCCGTTTTGCCGAAGATGCGGTTCGCCCAATGGGACGTACTGCAACTGGGGTACGTGGTATTCGTCTAGCCGATGAAGACAAAGTGGTTTCACTGATTATCCCTCGCGGCGAAGGCCATATCTTAACTGTGACTGAAAACGGTTATGGTAAACGTACAGCTGAGCAAGAGTACCCAACGAAATCGCGGGCAACTCAAGGTGTGATCTCAATTAAAGTCAGTGAGCGTAATGGTAATGTGGTTGGGGCTATCCAAGTGGATGAAACCGATCAGATTATGATGATCACGAATGCTGGTACTTTAGTGCGTACACGCGTTTCGGAAGTTAGTGTTGTTGGCCGTAATACACAAGGTGTGACGCTGATTAGAACAGCGGAAGAAGAAAAAGTTGTTGGTTTACAACGTGTCGCTGAAACAGAGGAAGATGAAAACTCTGATGAAGCAGGTGCAGAGGATATACCTAGCACAGACATGGGAACCAATACGCCTGAATAA	
8117	CARD	prokka_02055	contig_28	46661	147	2201	3968	1	176	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	584.719	500.0	Strict	51.49	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAPKSARNKKQSENTSFVSWRFALLCGGILLALVGLLVRVAYLQIISPEKLVKEGDMRSLRVQEVSTARGMISDREGRQLAVSVPVNAIWADPKVVFEKGGVNNDEHWKALADALEIPLEQITAKISANPKGRFVYLARQVNPSIGEYITKLKLPGIYLRKESRRYYPSGPVAAHLIGVTNIDGEGIEGVEKSFERWLKGEPGERIVRKDRNGRVIETVSSVDSQAAHNLVLSIDERIQSIVYRELTKGVQENKAESGVAILVDVHTGEILAMANSPSYNPNNLAGTPMDAMRNRAITDIFEPGSTVKPLVVMSALNNRIVKENTVLNTYPYRVNGHEIKDVARYPELSITGILQKSSNVGVSKLALAMPATELVDVYSRFGFGKPTNLGLVGESSGIFPSKKTRWSDLERATFSFGYGQMVTPLQLARAYATIGSFGIYRPLSITKVDPPVPGTRVFPEHIMRTVVHMMESVALPGGGGTRASIKGYRIAIKTGTAKKVGPEGRYINQYIAYTAGVAPASNPRYALVVLINEPKAGKYYGGAVSAPVFGSIMGGVLRMMNVEPDALQTDDKNDTVLNRKEVKSGRS	ATGAAAGCACCTAAGTCAGCTAGGAATAAAAAACAGTCTGAAAATACCAGCTTTGTTAGCTGGCGTTTTGCCTTGTTGTGCGGCGGTATTCTACTGGCTTTAGTCGGGCTTTTAGTGCGTGTAGCTTATCTACAAATCATTTCGCCTGAAAAGTTAGTTAAAGAAGGGGATATGCGCTCCCTACGTGTTCAAGAGGTCTCTACAGCACGTGGTATGATAAGCGATAGGGAAGGGCGGCAACTGGCTGTTAGTGTGCCTGTTAATGCTATTTGGGCTGACCCAAAAGTGGTATTTGAAAAAGGTGGGGTGAACAATGATGAACATTGGAAAGCGCTCGCTGATGCATTGGAGATCCCACTTGAGCAGATCACCGCTAAAATTTCTGCCAATCCAAAAGGGCGCTTTGTGTACCTCGCTCGTCAAGTCAACCCTTCTATTGGCGAATACATCACGAAACTAAAATTACCCGGTATCTATTTACGCAAAGAGTCACGCCGTTACTACCCCTCAGGGCCTGTTGCAGCGCACTTAATTGGTGTGACAAATATTGATGGCGAAGGGATAGAAGGCGTCGAGAAAAGCTTTGAGCGCTGGTTAAAAGGGGAGCCAGGTGAGCGTATTGTTCGTAAAGACCGTAATGGGCGTGTGATTGAAACGGTTTCTTCCGTTGATAGCCAAGCGGCTCATAACTTAGTGCTAAGTATTGATGAACGCATTCAATCTATCGTTTATCGTGAATTAACGAAAGGTGTTCAGGAAAACAAAGCTGAATCAGGTGTTGCCATTTTAGTGGATGTGCACACGGGGGAGATTTTAGCGATGGCGAATAGCCCATCCTATAACCCGAACAATTTGGCAGGAACCCCCATGGATGCTATGCGTAACCGTGCGATCACCGATATTTTTGAACCGGGTTCAACGGTCAAGCCGCTCGTCGTTATGAGTGCATTAAATAACCGTATTGTCAAAGAAAATACCGTATTGAATACCTATCCATATCGAGTTAATGGTCATGAAATCAAAGACGTAGCTCGTTATCCTGAATTGTCAATTACAGGTATTTTACAGAAGTCGAGTAACGTGGGTGTGTCAAAACTGGCGTTAGCGATGCCTGCTACAGAGCTGGTGGATGTGTATAGCCGCTTTGGGTTTGGCAAGCCGACTAATCTGGGGTTAGTCGGGGAAAGTAGTGGCATCTTTCCAAGTAAAAAAACACGGTGGTCTGATTTAGAAAGGGCCACCTTTTCTTTCGGGTATGGGCAAATGGTAACACCGTTACAGTTAGCCCGTGCCTATGCAACAATTGGTAGTTTCGGGATTTATCGCCCGCTATCGATTACTAAAGTTGACCCTCCTGTGCCGGGAACACGCGTTTTTCCTGAGCATATAATGCGCACCGTTGTGCACATGATGGAAAGTGTTGCCTTGCCGGGTGGTGGGGGAACAAGAGCCTCAATAAAAGGCTATCGTATCGCGATAAAAACAGGTACTGCGAAAAAAGTAGGGCCGGAAGGGCGCTACATTAATCAATATATTGCTTATACCGCAGGCGTCGCGCCTGCAAGTAACCCACGCTATGCCCTTGTCGTTCTTATCAATGAGCCTAAAGCGGGTAAATATTATGGTGGTGCAGTATCGGCACCCGTGTTTGGTTCAATTATGGGCGGTGTTTTACGCATGATGAACGTTGAACCTGATGCACTACAAACAGACGATAAAAACGACACAGTTCTTAACAGAAAAGAGGTTAAAAGTGGCAGATCGTAA	
8117	CARD	prokka_03254	contig_69	20570	109	18268	18892	-1	158	tetR	3003479.0	427.172	400.0	Strict	100.0	99.52	major facilitator superfamily (MFS) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		tetracycline antibiotic	MSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	ATGTCTAGATTAGATAAAAGTAAAGTGATTAACAGCGCATTAGAGCTGCTTAATGAGGTCGGAATCGAAGGTTTAACAACCCGTAAACTCGCCCAGAAGCTAGGTGTAGAGCAGCCTACATTGTATTGGCATGTAAAAAATAAGCGGGCTTTGCTCGACGCCTTAGCCATTGAGATGTTAGATAGGCACCATACTCACTTTTGCCCTTTAGAAGGGGAAAGCTGGCAAGATTTTTTACGTAATAACGCTAAAAGTTTTAGATGTGCTTTACTAAGTCATCGCGATGGAGCAAAAGTACATTTAGGTACACGGCCTACAGAAAAACAGTATGAAACTCTCGAAAATCAATTAGCCTTTTTATGCCAACAAGGTTTTTCACTAGAGAATGCATTATATGCACTCAGCGCTGTGGGGCATTTTACTTTAGGTTGCGTATTGGAAGATCAAGAGCATCAAGTCGCTAAAGAAGAAAGGGAAACACCTACTACTGATAGTATGCCGCCATTATTACGACAAGCTATCGAATTATTTGATCACCAAGGTGCAGAGCCAGCCTTCTTATTCGGCCTTGAATTGATCATATGCGGATTAGAAAAACAACTTAAATGCGAAAGTGGGTCTTAA	
7932	BLDB	prokka_00271	contig_1	971478	85	295337	296198	-1	72	SHV-11		79.3		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase SHV-11	protein homolog model			Beta-Lactam	MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGCGTTATATTCGCCTGTGTATTATCTCCCTGTTAGCCACCCTGCCGCTGGCGGTACACGCCAGCCCGCAGCCGCTTGAGCAAATTAAACAAAGCGAAAGCCAGCTGTCGGGCCGCGTAGGCATGATAGAAATGGATCTGGCCAGCGGCCGCACGCTGACCGCCTGGCGCGCCGATGAACGCTTTCCCATGATGAGCACCTTTAAAGTAGTGCTCTGCGGCGCAGTGCTGGCGCGGGTGGATGCCGGTGACGAACAGCTGGAGCGAAAGATCCACTATCGCCAGCAGGATCTGGTGGACTACTCGCCGGTCAGCGAAAAACACCTTGCCGACGGCATGACGGTCGGCGAACTCTGTGCCGCCGCCATTACCATGAGCGATAACAGCGCCGCCAATCTGCTGCTGGCCACCGTCGGCGGCCCCGCAGGATTGACTGCCTTTTTGCGCCAGATCGGCGACAACGTAACCCGCCTTGACCGCTGGGAAACGGAACTGAATGAGGCGCTTCCCGGCGACGCCCGCGACACCACTACCCCGGCCAGCATGGCCGCGACCCTGCGCAAGCTGCTGACCAGCCAGCGTCTGAGCGCCCGTTCGCAACGGCAGCTGCTGCAGTGGATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAACGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATCGTGGTGATTTATCTGCGGGATACGCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA	
7932	BLDB	prokka_04961	contig_36	5937	60	4314	5127	-1	71	NDM-1		263.3		Perfect	100.0	99.63	subclass B1 metallo-beta-lactamase NDM-1	protein homolog model			Beta-Lactam	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	ATGGAATTGCCCAATATTATGCACCCGGTCGCGAAGCTGAGCACCGCATTAGCCGCTGCATTGATGCTGAGCGGGTGCATGCCCGGTGAAATCCGCCCGACGATTGGCCAGCAAATGGAAACTGGCGACCAACGGTTTGGCGATCTGGTTTTCCGCCAGCTCGCACCGAATGTCTGGCAGCACACTTCCTATCTCGACATGCCGGGTTTCGGGGCAGTCGCTTCCAACGGTTTGATCGTCAGGGATGGCGGCCGCGTGCTGGTGGTCGATACCGCCTGGACCGATGACCAGACCGCCCAGATCCTCAACTGGATCAAGCAGGAGATCAACCTGCCGGTCGCGCTGGCGGTGGTGACTCACGCGCATCAGGACAAGATGGGCGGTATGGACGCGCTGCATGCGGCGGGGATTGCGACTTATGCCAATGCGTTGTCGAACCAGCTTGCCCCGCAAGAGGGGATGGTTGCGGCGCAACACAGCCTGACTTTCGCCGCCAATGGCTGGGTCGAACCAGCAACCGCGCCCAACTTTGGCCCGCTCAAGGTATTTTACCCCGGCCCCGGCCACACCAGTGACAATATCACCGTTGGGATCGACGGCACCGACATCGCTTTTGGTGGCTGCCTGATCAAGGACAGCAAGGCCAAGTCGCTCGGCAATCTCGGTGATGCCGACACTGAGCACTACGCCGCGTCAGCGCGCGCGTTTGGTGCGGCGTTCCCCAAGGCCAGCATGATCGTGATGAGCCATTCCGCCCCCGATAGCCGCGCCGCAATCACTCATACGGCCCGCATGGCCGACAAGCTGCGCTGA	
7932	BLDB	prokka_04983	contig_41	3801	191	175	1051	1	190	CTX-M-15		90.0		Perfect	100.0	99.66	class A extended-spectrum beta-lactamase CTX-M-15	protein homolog model			Beta-Lactam	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	ATGGTTAAAAAATCACTGCGCCAGTTCACGCTGATGGCGACGGCAACCGTCACGCTGTTGTTAGGAAGTGTGCCGCTGTATGCGCAAACGGCGGACGTACAGCAAAAACTTGCCGAATTAGAGCGGCAGTCGGGAGGCAGACTGGGTGTGGCATTGATTAACACAGCAGATAATTCGCAAATACTTTATCGTGCTGATGAGCGCTTTGCGATGTGCAGCACCAGTAAAGTGATGGCCGCGGCCGCGGTGCTGAAGAAAAGTGAAAGCGAACCGAATCTGTTAAATCAGCGAGTTGAGATCAAAAAATCTGACCTTGTTAACTATAATCCGATTGCGGAAAAGCACGTCAATGGGACGATGTCACTGGCTGAGCTTAGCGCGGCCGCGCTACAGTACAGCGATAACGTGGCGATGAATAAGCTGATTGCTCACGTTGGCGGCCCGGCTAGCGTCACCGCGTTCGCCCGACAGCTGGGAGACGAAACGTTCCGTCTCGACCGTACCGAGCCGACGTTAAACACCGCCATTCCGGGCGATCCGCGTGATACCACTTCACCTCGGGCAATGGCGCAAACTCTGCGGAATCTGACGCTGGGTAAAGCATTGGGCGACAGCCAACGGGCGCAGCTGGTGACATGGATGAAAGGCAATACCACCGGTGCAGCGAGCATTCAGGCTGGACTGCCTGCTTCCTGGGTTGTGGGGGATAAAACCGGCAGCGGTGGCTATGGCACCACCAACGATATCGCGGTGATCTGGCCAAAAGATCGTGCGCCGCTGATTCTGGTCACTTACTTCACCCAGCCTCAACCTAAGGCAGAAAGCCGTCGCGATGTATTAGCGTCGGCGGCTAAAATCGTCACCGACGGTTTGTAA	
7932	BLDB	prokka_04997	contig_47	2438	158	901	1732	1	75	OXA-1		238.9		Perfect	100.0	99.64	oxacillin-hydrolyzing class D beta-lactamase OXA-1	protein homolog model			Beta-Lactam	MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL	ATGAAAAACACAATACATATCAACTTCGCTATTTTTTTAATAATTGCAAATATTATCTACAGCAGCGCCAGTGCATCAACAGATATCTCTACTGTTGCATCTCCATTATTTGAAGGAACTGAAGGTTGTTTTTTACTTTACGATGCATCCACAAACGCTGAAATTGCTCAATTCAATAAAGCAAAGTGTGCAACGCAAATGGCACCAGATTCAACTTTCAAGATCGCATTATCACTTATGGCATTTGATGCGGAAATAATAGATCAGAAAACCATATTCAAATGGGATAAAACCCCCAAAGGAATGGAGATCTGGAACAGCAATCATACACCAAAGACGTGGATGCAATTTTCTGTTGTTTGGGTTTCGCAAGAAATAACCCAAAAAATTGGATTAAATAAAATCAAGAATTATCTCAAAGATTTTGATTATGGAAATCAAGACTTCTCTGGAGATAAAGAAAGAAACAACGGATTAACAGAAGCATGGCTCGAAAGTAGCTTAAAAATTTCACCAGAAGAACAAATTCAATTCCTGCGTAAAATTATTAATCACAATCTCCCAGTTAAAAACTCAGCCATAGAAAACACCATAGAGAACATGTATCTACAAGATCTGGATAATAGTACAAAACTGTATGGGAAAACTGGTGCAGGATTCACAGCAAATAGAACCTTACAAAACGGATGGTTTGAAGGGTTTATTATAAGCAAATCAGGACATAAATATGTTTTTGTGTCCGCACTTACAGGAAACTTGGGGTCGAATTTAACATCAAGCATAAAAGCCAAGAAAAATGCGATCACCATTCTAAACACACTAAATTTATAA	
7932	CARD	prokka_00115	contig_1	971478	85	123112	124237	-1	111	Klebsiella pneumoniae OmpK37	3004122.0	751.51	700.0	Strict	99.47	100.0	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFGFKGETQINDMLTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDMLPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGISTDNIVALGLVYQF	ATGAAAAGAAAAGTACTGGCCCTCGTTATTCCGGCTTTATTAGCCGCCGGTGCCGCGCATGCGGCGGAAATTTATAATAAAGACGGGAATAAATTAGATCTCTATGGCAAGGTAGATGGTCTGCATTATTTCTCCAGCGACTCGAAAAAAGACGGCGATCAAACTTATTTACGTTTTGGCTTTAAAGGCGAAACCCAGATCAACGATATGCTTACCGGCTATGGCCAGTGGGAATATAACGTTCAGGCCAACAACACCGAGACCTCCAGCGATCAGGCGTGGACCCGTCTGGCATTCGCCGGTATCAAAGTGGGCGATTACGGCTCCTTCGACTACGGTCGTAACTACGGCGTGCTGTACGACGTTGAAGGCTGGACCGATATGCTGCCGGAGTTCGGCGGCGACTCCTACACCTATGCGGATAACTTTATGGCAGGCCGCGCCAACGGCGTCGCAACCTACCGTAACAGCGATTTCTTCGGTCTGGTGGAGGGTCTGAACTTCGCCCTGCAGTATCAGGGTAAAAACGAAGGCCAGAACGCGCAGGATATCAACGTCGGCACCAATAACCGCAGCAGCGACAGCGATGTTCGCTTCGACAATGGCGATGGTTTCGGCCTCTCCACTTCCTACGACTTCGGCATGGGTATCAGCGCGGCGGCAGCTTACACCTCGTCTGACCGTACTAACGATCAGATGACCCAGACCAACGCGCGCGGCGATAAAGCGGAAGCATGGACCGCCGGCCTGAAGTACGACGCCAACGATATCTACCTGGCGACCATGTACTCTGAAACCCGCAATATGACCCCGTACGGCAATGACGGCGTGGCCAATAAAACGCAAAACTTCGAAGTCACCGCGCAGTATCAGTTCGACTTCGGCCTGCGTCCGGCCATCTCCTACCTGCAGTCCAAAGGCAAAGATCTGTACAATAACGGCCGCTATGCCGATAAAGATCTGGTCAAATATATGGACGTTGGCGCGACCTATTACTTCAACCGTAATATGTCCACCTATGTTGATTACAAAATCAACCTGCTGGATGGTAACGACAAATTCTACGAAGACAACGGTATCTCTACCGATAACATCGTCGCCCTGGGCCTGGTTTACCAGTTCTGA	
7932	CARD	prokka_00229	contig_1	971478	85	254625	254988	1	82	Klebsiella pneumoniae KpnE	3004580.0	223.402	150.0	Strict	99.17	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSKQEVAHAAV	ATGTTTTATTGGATTTTATTAGCTTTAGCAATTATTGCTGAAATTACCGGCACCTTGTCTATGAAATGGGCAAGCGTGAGCGGCGGGCACACCGGCTTTATTTTAATGCTGGCCATGATTGCCCTGTCATATATTTTTCTTGCCTTTGCGGTTAAAAAGATTGCCCTCGGTGTGGCCTATGCGTTGTGGGAAGGGATCGGTATTTTACTGATTACCCTGTTCAGCGTGCTGCTGTTTGATGAGAGTCTGTCCCTGCTGAAAATAGCCGGCTTGACCACCCTGGTGATAGGGATCGTCTTAATTAAGTCCGGCACCCAGAAAAAAGCGTCTTCCAAGCAGGAGGTGGCCCATGCAGCAGTTTGA	
7932	CARD	prokka_00230	contig_1	971478	85	254974	255304	1	56	Klebsiella pneumoniae KpnF	3004583.0	206.453	150.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGCTGGCAATCGCCATTGTGCTGGAAATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGCTTCCGCCGCAAGATCTACGGCATCCTGTCCCTGGCGGCAGTATTGGGCGCGTTCAGCGCCCTGTCGCAGGCGGTTAAAGGGATCGATCTCTCGGTCGCCTATGCGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGTCAGCGTCTGAATAACAAAGGCTGGGCGGGGGTTATCCTGCTGGTAGCCGGCATGGTGTTAATTAAACTCGCCTGA	
7932	CARD	prokka_00291	contig_1	971478	85	316299	316674	-1	108	marA	3000263.0	243.432	230.0	Strict	92.74	97.64	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN	ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCCGGTTACTCTAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACCGGCCATTCCCTCGGCCAGTACATCCGCAGCCGCAAGCTGACGGAGATTGCGCAGAAGCTCAAGCAGAGTAATGAGCCAATCCTGTACCTGGCGGAACGCTATGGTTTCGAGTCGCAGCAGACCCTGACGCGAACGTTCAAGAACTATTTCGATGTTCCGCCCCACAAGTATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTACATCCGCTAAATAACTGA	
7932	CARD	prokka_01324	contig_2	488878	92	426454	427687	1	92	Escherichia coli mdfA	3001328.0	705.671	700.0	Strict	85.37	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVLAAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG	ATGCAAAATTATTCGCTTTCAGGCCGCCGCCTCGGAAGGCAGGCGCTGTTGTTCCCGTTATGTCTGGTGCTGTACGAGTTTTCCACTTATATCGGCAACGATATGATTCAGCCGGGCATGTTAGCCGTGGTGCAGGAATTTCAGGTGGGTAACGAATGGGTACCTACCTCAATGACTGCCTATCTGGCAGGCGGCATGTTTTTACAGTGGCTGCTGGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCAGTGATGTTGACCGGCGTAGTATGGTTCATCGTTACCTGCCTGGCGACGCTGCTGGCGCAGACCATTGAGCAGTTTACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGCTTTATCGGCGCGGTGGGCTATGCGGCGATACAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCCCTGATGGCTAACGTGGCGCTGATAGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATATCCTGCCGTGGGAGATGATGTTTGTCCTGTTCGCCGTGCTGGCGGCCATCTCGTTCTTCGGCCTGCAGCGGGCGATGCCGGAGACCGCGACGCGGCTGGGCGAAAAGCTGTCGGTGAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTGAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCCACCGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCCACCAGCTATGAGTACGGCATGCTGCAGGTGCCGATTTTCGGGGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTGCGCGCCGGACCGTGCGCTCGCTGATTATCATGGGCGGTTGGCCGATCATGTTTGGCCTGATCCTCTCTGCGGCGGCGACCGTGGTCTCTTCCCACGCTTATCTGTGGATGACGGCCGGTCTGAGCTTCTACGCCTTCGGGATTGGCCTCGCGAACGCCGGCCTGGTGCGTTTAACCCTGTTCGCCAGCGAGATGAGTAAAGGCACGGTCTCGGCGGCGATGGGAATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTGGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGCTGGGTGGGGTACTATGGCTGGGGCTGATGATTTACTTTCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGGTAG	
7932	CARD	prokka_01382	contig_3	447420	95	9176	10352	1	82	oqxA	3003922.0	798.1189999999998	670.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	ATGAGCCTGCAAAAAACCTGGGGAAACATTCACCTGACCGCGCTCGGCGCGATGATGCTCTCCTTTCTGCTCGTCGGCTGCGACGACAGCGTCGCGCAGAATGCTGCGCCTCCCGCCCCGACGGTCAGCGCCGCTAAGGTGCTGGTGAAGTCGATCAGTCAGTGGGATAGTTTTAACGGTCGCATTGAAGCGGTGGAGAGCGTTCAGCTTCGCCCTCGCGTCTCGGGATACATTGATAAAGTGAATTACACCGACGGCCAGGAGGTGAAAAAGGGCCAGGTGCTGTTCACGATAGATGACAGAACCTATCGCGCCGCGCTGGAGCAGGCGCAGGCGGCGTTGGCAAGAGCCAAAACGCAGGCCAGCCTGGCGCAAAGCGAGGCGAACCGCACCGATAAATTAGTCCATACCAACCTCGTCTCCCGTGAAGAGTGGGAGCAGCGCCGGTCAGCCGCGGTTCAGGCGCAGGCCGACATTCGCGCCGCGCAGGCGGCGGTGGATGCCGCGCAGCTTAACCTCGACTTCACCAAAGTGACCGCCCCTATTGACGGCCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTCACCGCGGGCGACACCGCCAGCGTGCTCACCACCCTGGTCTCGCAGAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTCCACTATCAAAACCTCGCCCGCCGCGGGCAAGGCGCGTCCAGCGATAATCAGGCGCTCCCGGTGGAGATTGGCCTGGTTGGCGAGGAAGGTTACCCCCACCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGTACCGGCACCATCCGCATGCGTGCGCTGCTGGATAACTCGCAGCGTCTGTTCACACCGGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCAGAGTTCAAAGCCACGCTGATCGACGACAAAGCGGTACTGACCGATCAGGATCGTAAATACGTCTATATCGTTGATAAAGATGGTAAAGCACAGCGCCGCGACATTACCCCAGGGCGGCTGGCAGACGGTTTACGCATCGTTCAGAAGGGGTTGAATCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCCAAAACCGTTGCCATGACCTCCAGCGCCACCCTTAACTGA	
7932	CARD	prokka_01383	contig_3	447420	95	10375	13528	1	101	oqxB	3003923.0	2111.65	2000.0	Strict	99.71	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPKGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILNLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTELFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCGCTGCTGCCGGTGAGCGAATATCCGGACGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTATATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTTTCGCCAAAGGGTAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGTCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCGGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGCTGATCGCGGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCAATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCGATTGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTACCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGCTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCCATCCTGCCGCCGCCGATTTTAGGACTGGGTCAGGGTTCCGGCTACTCTCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAAACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCACAGGGGGTATCGCTAACCGAGCTATTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCCGATGGGCCATACCGCGAGAGCGTGGAAGATATCGCCAACCTGCGCACCCGCAATAATCAGGGCGAAATGGTGCCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCACAGGCGATGACGCATCTGGAGGAGCTGTCGAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCGTTCCTCGTGCTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTACCGATGACGATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGTCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATCCAGGGGAAAGGCATCATGGAAGCGGCGCTGGAGGCATGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTATTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTGCGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG	
7932	CARD	prokka_01428	contig_3	447420	95	57806	58337	1	92	emrR	3000516.0	338.961	280.0	Strict	92.57	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR	ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTTCGCGCCAGCCGCCATGAAGATTTCCCTTTTCAGGAGATCCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCACAGGAAAACCACAGCATCCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCACGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAGCGCCGCGAGAGCGATAACGATCGTCGCTGTTTGCATCTGCAACTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTTAGCACCAGCGAAAAAGATCAGCTCGAACACATCACCCGCAAACTCCTGAGCCGCCTTGATCAGATGGAAGAAGAAGGCGTGCTAGCGGACTCTCTACGCTAA	
7932	CARD	prokka_01429	contig_3	447420	95	58462	59635	1	112	Klebsiella pneumoniae KpnG	3004588.0	788.875	700.0	Strict	99.74	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	ATGAGTGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGAAAGCGTAAAGGCGCCCTTCTGTTGCTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTGGCAGGGAATCAGGTACAAATTATGGCTCAGGTCGCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACTCTCGATCGGACCGATGCCCAACAGGCGTTTGAAAAGGCTAAGACCCAACTGGCCGCCAGCGTCCGTCAGACCCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCAAATATCGACGTCAAAAAAACCGCCCTCGCCCAGGCGCAGGCTGACCTGAACCGCCGCATCCCGCTGGGCGCCGCGAACCTCATTGGCCGCGAAGAGCTGCAGCACGCCCGCGATACCGTCGCCAGCGCACAGGCCGAACTCGACGTGGCAATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGCACCAGGCTGGAACAGCAGCCGGCGGTGCTCCAGGCGGCCACTGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATCGGCACCACCACGCCGCTGATGGCGGTGGTCCCGGCGACCAACCTGTGGATCGATGCTAACTTTAAAGAGACTCAGCTGGCGCATATGCGTATCGGCCAGCCGGCCACCGTGATCAGCGATATCTATGGCGATGACGTGAAATACACCGGTAAAGTGGTCGGTCTGGATATGGGCACCGGCAGCGCCTTCTCTCTGCTGCCGGCGCAGAATGCTACCGGCAACTGGATCAAAGTGGTACAGCGTCTGCCGGTTCGTATCGAGCTGGATGAAAAACAACTAGCGGAACACCCGCTGCGCATCGGCCTCTCGACGCTGGTGGAAGTCAACACCACCGATCGCGATGGTGAAATGCTGGCCAGCCAGGTGCGGAGCTCCCCGGTTTACGAGAGCAATGCCCGTGAAATCGCTCTCGATCCGGTTAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA	
7932	CARD	prokka_01430	contig_3	447420	95	59650	61189	1	122	Klebsiella pneumoniae KpnH	3004597.0	937.947	700.0	Strict	94.02	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATTGCCGGCAACCTTGGCTCGTCGCTGAGCCAGGGGACCTGGGTCATCACCTCGTTCGGGGTCGCTAACGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGCGTCGGCGAGGTGAAGCTGTTCCTGTGGTCAACCACCGCTTTCGCCATTGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTCATTCAGGGGATCGTCGCCGGACCGCTGATCCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCCCCGGCGAAGCGCTCTATCGCTCTGGCGCTGTGGTCAATGACGGTGATTGTCGCGCCCATCTGCGGTCCGATCCTCGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGGATCGACGGTGTCGGTCTGGCGCTGCTGATCATCGGTATCGGTAGCCTGCAGGTGATGCTGGACCGGGGTAAAGAGCTGGACTGGTTCTCCTCCAATGAGATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTAACCGACGATAACCCGATTGTCGATCTGTCGCTATTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGTATCAGTCTGGCCTATATGCTCTACTTCGGCGCCATCGTACTGCTGCCGCAGCTGTTGCAGGAGGTCTACGGCTACACCGCGACCTGGGCCGGCCTGGCGTCGGCGCCGGTGGGGGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTCGCGCATAAGCTCGACATGCGGCGGCTGGTCACCTTCAGCTTTATTATGTACGCGGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCACAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTCTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCCTGTCGAACTTCACCCGTACCCTTGCCGGCTCCATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCATCATGCGCAGCTCACCGAATCGGTGACCCCCTTTAACCCCAACGCGCAGCAGATATACGATCAGCTGCAGGGCATGGGAATGACGCAGCAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACCAACCAGGGGCTGATTATCTCCGCCAACGAAATCTTCTGGATTTCTGCGGCTATTTTCATCCTGCTGTTGGGGCTGGTGTGGTTCGCCAGACCACCGTTCAGCGCCGGCGGAGGCGGCGGCGGCGCGCACTAA	
7932	CARD	prokka_01443	contig_3	447420	95	69048	69234	-1	117	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTGTCTGTTCACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	
7932	CARD	prokka_01819	contig_4	347019	101	14075	14495	1	60	FosA6	3004111.0	283.108	280.0	Strict	97.84	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEVAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFDQ	ATGCTGAGTGGACTGAATCACCTGACCCTGGCAGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTGCTGGGCATGACGCTGCACGCCCGCTGGGACAGTGGGGCCTATCTCTCCTGCGGCGATTTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTTACTCCGCCGGAAGAGAGCGACTACACCCATTATGCGTTTAGCATTAGCGAGGCGGATTTCGCTAGCTTCGCCGCCCGCCTTGAGGTTGCCGGCGTAGCGGTCTGGAAGCTGAACCGTAGCGAAGGCGCTTCGCACTACTTTCTCGACCCCGACGGCCACAAGCTGGAGCTGCACGTCGGCAGTCTTGCCCAGCGGCTGGCCGCCTGCCGCGAACAGCCGTATAAGGGGATGGTGTTTTTTGATCAGTGA	
7932	CARD	prokka_01951	contig_4	347019	101	147584	148064	1	108	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.9138	32.0	Strict	28.0	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVVMGRLTWESIGRPLPGRKNIVISSKPGSDDRVQWVSSVEEAIAACGDVEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSHSYCFEILERR	ATGATCAGTCTGATTGCGGCGTTAGCGGTAGATCGCGTCATTGGTATGGAAAACGCCATGCCATGGAACCTGCCTGCCGATCTCGCCTGGTTCAAACGCAACACGTTAAATAAGCCGGTGGTGATGGGGCGTCTGACCTGGGAATCCATTGGGCGCCCATTGCCGGGGCGTAAAAATATCGTGATCAGCAGCAAACCCGGCAGCGACGATCGCGTGCAGTGGGTCTCCTCCGTAGAAGAAGCAATTGCCGCCTGCGGCGATGTGGAAGAGATTATGGTGATCGGCGGCGGCCGGGTGTATGAGCAGTTCCTGCCGAAAGCGCAGAAGCTCTACTTGACCCATATTGATGCGGAAGTGGAAGGCGATACCCATTTCCCGGATTACGATCCGGACGAATGGGAGTCGGTGTTCAGCGAGTTTCATGACGCCGACGCGCAGAACTCCCATAGCTACTGCTTTGAGATCCTCGAACGCCGTTAA	
7932	CARD	prokka_01957	contig_4	347019	101	152874	155223	-1	131	LptD	3005059.0	1619.75	1500.0	Perfect	100.0	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		carbapenem; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTATGATCGTCCGCTCGTGGAAGGTCGTCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAACTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATTAACCAGGGGAATAGTCGCCTCCGCGCCGACGAAGTTCAGCTGCACCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGGCCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAAATGGTCGGACGCCAGGGACGCGGCACCGCCGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTCGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTCGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTTGCCGAGATCTGGAACGCCCGCTTCAAGCTTGGCTCTGTGCCGATTTTCTATAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATTACTCCGCACTATATGAACAAACGCGGCGGCGTGATGTGGGAAAACGAGTTCCGCTATCTGACCCAGCTCGGCAGCGGCTTAACTGAATTCGACTACCTGCCGTCGGATAAAGTCTACGAAGACGACCACTCGAGCGACAGCAACAGCCGCCGCTGGCTGTTCTACTGGAACCACTCAGGGGTTATCGATCAGGTATGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGACTTCAGCTCGAAATATGGTTCCAGTACCGACGGCTATGCGACGCAGAAATTCAGCGCCGGTTACGTCAACCAGAACTTTGACGCCACGGTATCGACCAAACAGTTCCAGGTCTTTGACCGCGAATCGAGCAACTCCTATTCGGCTGAGCCGCAGCTCGACGTCAACTACTACCAGAATGATGTCGGTCCGTTCGATACCCATCTCTATGGACAGGTTGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCCAACGGTTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACTCACTACCAGCAGAGCAACCTCGATAAGTACAATGCCGCCAACGGCACTGACTATAAAGAGTCCGTCAGCCGCGTAATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTTGAACGCGACCTACAGGAGGGATTCACCCAAACGCTGGAACCGCGCGTGCAGTATCTGTACGTGCCGTACCGCGATCAGAGTGAAATCGGCAACTACGACTCCACGCTGTTGCAGTCGGATTACACCGGTCTGTTCCGCGACCGTACCTATAGCGGTCTGGACCGCATCGCGTCGGCTAATCAGGTCACCACCGGCCTCACCTCGCGCGTGTATGATGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACGCACCGGTGATGACAACATCAACTGGGAGAACAACGATACCACGGGTTCACTGGTCTGGGCCGGCGATACCTACTGGCGCATTGCCGATGAATGGGGTCTGCGCGGAGGGATCCAGTACGATACGCGTCTGGATAACGTTGCCACTGGTAACGGCACCATTGAATACCGTCGCGATGAGAACCGCTTAGTTCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACGCTGCCGTCATATTCCACCGCGGCACAATATAAACAGGGTATTTCGCAGGTGGGGATGACCGCCAGTTGGCCGATTGTCGATCGCTGGTCCGTGGTCGGGGCCTACTACTACGATACTAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTGCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGTAAAGTCAACGGCTGGAACAGCAACGACAACGGCGGCGAGAGCAAATACGATAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGCTCGAACATTTTACCGTACCAGAGCTCCCTGTGA	
7932	CARD	prokka_02286	contig_5	302412	95	176568	179682	1	88	acrD	3000491.0	1956.03	1900.0	Strict	91.13	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGTLAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQPASGLGIKLASGANEMATAERVINRLNELAQFFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPVKPGESHERKGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLIYVVLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGTSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAGKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ	ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCATGGGTGCTGGCAATCCTGTTATGCCTGACGGGCACCCTTGCCATTTTGTCGCTGCCGGTTGAACAGTATCCCGACCTCGCCCCGCCGAATGTGCGGATCACCGCCAACTATCCCGGCGCTTCCGCGCAAACCCTGGAGAATACCGTCACTCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCCTCCCAGAGCAGCGCCACCGGCCAGGCGACGATCACCCTCAGCTTTACCGCCGGTACCGACCCGGATGAAGCCGTGCAGCAGGTTCAGAACCAGCTACAGTCGGCGATGCGTAAGCTGCCGCAGGCGGTGCAAAACCAGGGGGTGACGGTACGCAAGACCGGTGATACCAATATCCTGACGCTCGCCTTCGTCTCCACTGACGGCAGTATGGATAAACAAGATATCGCCGACTACGTCGCCAGTAACATCCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGTTCGCAATACTCAATGCGCATCTGGCTCGACCCGGCGAAGCTCAACAGCTACCAGATGACCACCAAGGATGTTACCGACGCCATCAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTTGGCGGGACGCCTTCGGTCGATAAGCAAGCGCTGAACGCCACCATCAACTCGCAATCTCTGCTGCAAACCCCGGAGCAGTTCCGCAATATCACTCTGCGCGTCAATCAGGATGGTTCAGAGGTGACGCTGGGCGATGTCGCCACCGTCGAGATGGGGGCGGAGAAGTACGACTATCTTAGCCGCTACAACCGCCAGCCGGCCTCAGGCCTCGGGATCAAGCTGGCTTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCAATCGCCTCAATGAGCTGGCGCAGTTTTTCCCCCACGGTCTGGAATATAAGGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCCATCACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCGACCATCGCCGTGCCGGTGGTGCTGATGGGCACTTTCGCGGTGCTGTATGCCTGTGGCTACAGCATCAACACCCTGACGATGTTCGCGATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGAGCGAGGAGGGCCTGTCGCCACGCGAGGCGACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTATTCGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCAATCACTATCGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCTGCCCTTTGCGCCACGCTGCTTAAGCCGGTTAAGCCAGGTGAATCCCATGAAAGAAAAGGCTTCTTCGGCTGGTTCAACCGCACCTTCAACCGCAGCGCCAGCCGCTACGAAACCTTCGTCGGCAAAATACTGCACCGCTCGCTGCGCTGGATGCTGATCTACGTCGTCCTGCTCGGCGGGATGGTGTTCCTGTTTCTGCATTTGCCGACCTCGTTCCTGCCGCTGGAGGATCGCGGGATGTTCACCACCTCGGTCCAGTTGCCGAGCGGCAGCACCCAGCAGCAGACGCTGAAGGTGGTGCAGAAGGCGGAAGATTACTTCCTCAATAACGAGAAGCAGAACGTCGAGTCGGTGTTCGCTACCGTTGGCTCCGGCCCCGGCGGCAATGGGCAGAACGTGGCCCGTATGTTCGTTCGTCTCAAAGACTGGGACCAGCGCGACCCGCAAACCGGCACCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATTAACGAAGCGCGGGTTATCGCCAGCAGCCCGCCGGCGATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGATATGGAGCTGGAGGATCATGCAGGGAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTGCTTGAGCTGGCCGGGAAAAATCCGCTGTTGACCCGCGTCCGGCATAACGGGCTCGATGACAGCCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCGCAGGCGCTTGGCGTCTCCATTGACGACATCAACGATACGCTGCAAACCGCATGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGCCGGGTAAAGAAAGTCTACGTCCAGGCGGCGGCGAAATACCGGATGCTGCCTGACGATATCAATCTTTGGTACGTGCGCAATAGCAGCGGCACGATGGTGCCATTCTCGGCCTTCGCCACCTCGCGCTGGGAGACCGGCTCGCCGCGGCTGGAGCGCTACAATGGCTACTCAGCGGTGGAGATCGTCGGTGAGGCGGCGCCGGGTATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGTTACCCACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCTCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCGGTGCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATTGGCGCCCTGCTGGCGACCTGGATGCGCGGGCTGGAGAATGACGTGTACTTCCAGGTGGGTCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAATTCGCCAATGAGCTCAACGAGAAGGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCTTGCCGTCAGCGCCTGCGCCCCATCCTGATGACCTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGAGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCGATCTTTTTCGTGCCGCTGTTCTTTGTGCTGGTGCGTCGCCGTTTTCCGCTAAAGGAGCGTCCGCAATAA	
7932	CARD	prokka_02493	contig_6	295974	98	102075	103236	-1	69	Escherichia coli ampH beta-lactamase	3004612.0	690.263	500.0	Strict	85.71	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKAAPGSQAAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ	TTGAAACGTAGTTTGCTCATTTTTGCTGCGCTGTGCGCGGCGTCGTGGACCTCGGTGCAGGCCGCACAGCCTACCGTTGACCCGGTTTTCGCCTCGGATGTGGTCGATCGTTACGCCAATCATATCTACTACGGCAGCGGCGCCACCGGCATGGCGCTGGTGGTTATCGATGGCAATCAGCGTGTTTTTCGCAGCTTTGGCGAAACCCGCCCGGGGAATAATCAGCACCCGCAGCTCGACTCGGTGATCCGTATCGCCTCCCTCAGCAAACTGATGACCAGCGAGATGCTGGTGAAGCTGCTCGACCAGGGGGTGGTGAAACTCAACGATCCGCTGAGCAAATACGCCCCGCCGGGCGCCCGGGTGCCTGACTGGCAGGGAAAACCAATCACCCTGGTTAACCTCGCGACCCATACCAGCGCCCTGCCGCGCGAGCAGCCTGGCGGCGCCGCTCATCGTCCGGTGTTTGTCTGGCCGACCCGCCAGCAGCGCTGGAACTGGCTCTCTACCGCGACCCTGAAAGCCGCGCCGGGCTCGCAGGCGGCCTACTCCAATCTGGCCTTCGATTTACTGGCGGACGCGCTCGCCACCGCTGCCGGCAAACCGTATCCGCAGCTGTTTGAAGAGCAGATCACCCGGCCGCTGGGGATGAAGGACACCACCTTTACCCCGTCACCGGATCAGTGCCAGCGGCTGATGATCCCGGAAAAAGGCGCCAGCCCGTGCAACAACACCCTGGCGGCGATCGGCAGCGGCGGAGTCTACTCGACGCCGGGGGATATGATGCGCTGGATGCAGCAGTTCCTGTCATCCGATTTCTATACCCGCAGCCAGCAGGCCGACCGGATGCAGACGCTGATTTATCAGCGTAACCAGCTGACCCGGGTGATTGGTATGGACGTGCCGGGCCGCGCAGACGCGCTGGGCCTCGGCTGGGTGTATATGAAGCCGAAGAACGGCCATCCGGGGATTATTCAGAAAACCGGCGGCGGCGGCGGGTTTATCACCTATATGGCGATGAATCCGCAGGCTAACGTTGGCGCCTTTGTGGTGGTAACCCGCTCGCCGTTAACCCGCTTCAACAATATGAGCGATGGCATCAACGACCTGGTCAGCGAGTTGAGCGGCGCACAGCCCAACATGCAGACGGCCAGCCAGTAA	
7932	CARD	prokka_02620	contig_6	295974	98	228794	231941	-1	122	acrB	3000216.0	1941.39	1900.0	Strict	91.52	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAMALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKSEDIEHSHQVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATTATCATCATGCTGGCTGGGGGATTATCGATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACGGTGCAGAACACCGTAACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCAAATGGCGACTCCACCGGTACGGCAACCATTACGCTGACCTTCGAATCCGGTACCGATCCGGATATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCGCTGGCGACGCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATTAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTCATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGATCCGATTAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTATTCGGTTCCCAGTATGCGATGCGTATCTGGATGGATCCAAACAAACTGAACAACTTCCAGCTTACGCCGGTGGATGTGATCAGCGCCCTGAAAGCGCAGAACGCCCAGGTGGCCGCGGGCCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCCTCGATCATCGCGCAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGACGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGCGGCGAAAGCTATGACGTAGTGGCGAAGTTTAACGGCCAGCCGGCATCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCTATTCGCGCTGAACTGGCGAAGATGGAGCCGTTTTTCCCGTCGGGGATGAAGATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATTTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCCACCATCGCGGTACCGGTGGTCCTGTTAGGCACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTGGTGGTAGAGAACGTCGAGCGCGTGATGGCGGAAGAGGGTCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGACAGATTCAGGGCGCGCTGGTTGGTATCGCTATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTCTTCGGCGGCTCAACCGGGGCCATCTATCGCCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTGGCGTTAATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAACCCATTCAGAAAGGCAGCCATGGCGCGACCACCGGCTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGTTATCTGGTGCTGTATCTGATCATCGTGGTGGGTATGGCATGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCGGACGAGGACCAGGGTGTATTCCTGAGTATGGCGCAGCTGCCTGCCGGCGCCACCCAGGAGCGTACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGTTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTTTCGCTGAAAGACTGGAGCCAGCGTCCGGGTGAGGAAAACAAAGTTGAAGCGATCACCGCGAGAGCAATGGGCTACTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCGAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACCCAGGCGCGTAACCAACTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGCCCTAACGGTCTGGAAGATACACCGCAGTTTAAAATCGATATCGATCAGGAGAAAGCTCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTGGGCGCAGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATCATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATCGGCAAGTGGTATGTTCGCGGCAGCGATGGTCAGATGGTGCCGTTCTCTGCTTTCTCGACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCGTCACTGGAAATCCTCGGTCAGGCCGCGCCAGGCAAGAGTACCGGTGAGGCGATGGCGCTGATGGAAGAGCTGGCGGGTAAACTGCCTTCCGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGACTGTCCGGCAACCAGGCCCCTGCCCTGTATGCCATCTCGCTGATTGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTTATGCTGGTCGTCCCCTTGGGTGTGGTCGGTGCGCTGTTAGCCGCCACCTTCCGCGGGCTAACCAACGACGTTTACTTCCAGGTGGGTCTGCTGACCACCATCGGCCTGTCGGCGAAGAACGCAATATTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCAGTACGTATGCGTCTACGTCCAATCCTGATGACATCTCTGGCGTTCATCCTCGGGGTAATGCCGCTAGTTATCAGCTCCGGCGCCGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCGATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGCAAAAAATCGGAAGATATAGAGCACAGCCATCAGGTTGAGCATCATTAA	
7932	CARD	prokka_02621	contig_6	295974	98	231963	233157	-1	128	Klebsiella pneumoniae acrA	3004041.0	738.413	770.0	Strict	95.24	99.75	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAGGGAGCCCAGCACATGCCGGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGCACCAGCGCCTATCGCATTGCGGAAGTCCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTCTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTGGGCACCAAATATATTAGTCAACAAGACTACGATACCGCCGTTGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCGGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATCAGCGGCCGGATCGGTAAATCCGCCGTGACCGAAGGGGCGCTGGTACAGAATGGTCAAACGACCGCCCTGGCAACCGTTCAGCAGCTGGATCCGATCTATGTTGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAGCAGGAGCTAGCCGACGGCCGCCTGAAACAGGAAAACGGCAAAGCGAAAGTGGAGCTGGTGACTAATGACGGTCTTAAGTATCCACAGTCCGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCAATCACGCTACGCGCTATTTTCCCGAACCCGGATCACACCCTGCTACCGGGGATGTTCGTCCGTGCCCGTCTGGAAGAAGGGATTAACCCTGACGCCCTGCTGGTACCGCAACAGGGTGTTACCCGTACGCCACGCGGCGACGCCAGCGTCATGGTAGTGGGGGAAGGCGATAAAGTCGAAGTCCGCCAGGTCACTGCTTCTCAGGCGATCGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACCGGCCTGCAAAAAATCAAACCAGGTGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA	loose hit with at least 95 percent identity pushed strict
7932	CARD	prokka_03227	contig_8	278008	104	273612	276723	1	131	adeF	3000777.0	750.355	750.0	Strict	41.66	97.83	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MSKFFIHRPVFAWVLAIIMMIAGGLAILQLPIAQYPTIAPPAVAISATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFKSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSFLLVAGFISDNPTTTQDDISDYVASNVKDPISRLNGVGDVQLFGAQYAMRVWLDGNLLNKYNLTPVDVINALQVQNDQIAAGQLGGTPALKGQQLNASIIAQTRLKDPQEFGKVTLRVNADGSVVHLKDVARIELGGENYNVVARINGKPASGLGIKLATGANALDTATAIKAKLAELQPYFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAVLSMFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEEKLSPKEATEKSMSQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALVLTPALCATLLKPASAEHHEKKGFFGWFNARFDQSVNHYTNSVSGILRGTGRYLVIYLLIVVGMAVLFMRLPTSFLPDEDQGVFLTMIQLPSGATQERTQKVLDTVTDYYLHNEKANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEARSGDENSVESIIKRATVAFSQIKDAMVFPFNMPAIIELGTATGFDFELIDQGGLGHTALTQARNQLLGMVKQHPDQLVRVRPNGLEDTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADAHFRMLPSDINNMYVRSANGEMVPFSAFVTSRWIYGSPRLERYNGLPSMEILGEASPGKSTGEAMALMETLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISHGAGSGAQNAVGTGVMGGMLTATLLAIFFVPVFFVVVRRRFTRHAE	ATGTCTAAGTTTTTTATTCATCGACCGGTCTTCGCCTGGGTGCTGGCTATCATTATGATGATTGCCGGCGGCCTGGCCATCCTGCAGCTGCCGATAGCTCAGTACCCGACAATCGCCCCTCCTGCGGTCGCGATCTCCGCCACCTACCCCGGTGCAGATGCCCAGACCGTACAGGATACGGTCACTCAGGTTATCGAGCAGAATATGAACGGCATCGACAATCTGATGTATATGTCGTCGACCAGCGACTCTGCCGGTTCGGTAACCATTACGCTCACCTTTAAATCAGGTACCGATCCCGATATTGCCCAGGTACAGGTGCAAAACAAACTGCAGCTGGCCACGCCGCTGCTGCCCCAGGAAGTACAGCAGCAGGGGATTAGCGTCGAGAAATCCAGTAGCAGCTTCCTGTTGGTCGCCGGCTTTATCTCTGATAACCCGACCACCACCCAGGACGATATTTCTGACTATGTTGCCTCCAATGTCAAAGATCCTATTAGCCGCCTCAACGGCGTGGGCGATGTGCAGCTGTTCGGCGCGCAGTACGCCATGCGCGTCTGGCTGGATGGCAACCTGCTGAATAAATACAACCTGACGCCGGTGGACGTCATCAATGCGCTGCAGGTCCAGAACGATCAGATCGCCGCGGGTCAGCTCGGCGGTACGCCAGCGCTGAAAGGCCAGCAGTTGAACGCGTCAATCATCGCTCAGACGCGGCTCAAAGATCCGCAGGAGTTTGGCAAGGTCACGCTGCGGGTCAACGCCGATGGCTCTGTCGTCCATCTGAAAGACGTCGCCCGCATTGAGCTGGGGGGAGAGAACTATAACGTTGTCGCCAGAATTAACGGTAAACCTGCCTCTGGTCTGGGTATTAAGCTTGCGACCGGCGCCAACGCCCTGGATACCGCCACCGCGATTAAAGCGAAGCTGGCCGAGCTGCAGCCCTACTTCCCTCAGGGGATGAAGGTGGTTTATCCGTATGATACGACCCCTTTCGTCAAAATCTCCATTCACGAAGTGGTCAAAACGCTTTTTGAAGCAATTATTCTCGTCTTTCTTGTCATGTATCTGTTCCTGCAGAACATGCGCGCAACGCTCATTCCAACCATTGCCGTACCCGTGGTGCTGTTGGGAACCTTCGCGGTATTGTCGATGTTTGGCTACTCCATCAACACGCTGACAATGTTTGGCATGGTGTTGGCGATAGGTCTGCTGGTCGATGACGCTATCGTAGTAGTGGAAAACGTCGAACGTGTGATGGTTGAGGAGAAGCTCTCGCCAAAAGAAGCGACGGAAAAATCTATGTCGCAGATCCAGGGAGCGCTGGTGGGTATCGCCATGGTGCTCTCCGCAGTATTTGTCCCGATGGCCTTTTTCGGCGGCTCAACCGGCGCGATTTATCGTCAGTTTTCAATCACCATCGTCTCCGCCATGGCGCTCTCCGTGCTGGTTGCGCTGGTACTGACTCCGGCGCTCTGCGCCACGTTGTTGAAGCCAGCCTCAGCTGAACACCATGAGAAAAAAGGATTTTTCGGCTGGTTTAACGCCCGCTTCGACCAGAGCGTTAACCACTATACCAACAGCGTCAGCGGTATTTTACGTGGAACTGGCCGTTATCTGGTGATCTACCTGCTGATCGTCGTGGGGATGGCCGTGCTGTTCATGCGCTTGCCCACGTCCTTTCTGCCCGACGAAGACCAGGGCGTCTTCCTGACCATGATCCAGCTGCCGTCCGGTGCTACCCAGGAGCGCACGCAGAAGGTCCTGGATACGGTGACAGACTACTACCTGCATAACGAGAAGGCCAACGTCGAAAGCGTCTTTACCGTTAACGGCTTCAGCTTCAGCGGCCAGGGACAAAACTCCGGTATGGCGTTTGTCAGCCTGAAGCCCTGGGAAGCGCGCAGCGGCGATGAAAACAGCGTGGAGTCCATCATCAAGCGGGCCACCGTAGCCTTTAGCCAGATCAAAGACGCCATGGTTTTCCCGTTCAACATGCCAGCCATTATTGAGCTGGGTACCGCCACCGGCTTCGACTTTGAACTGATCGACCAGGGCGGACTCGGTCATACCGCTCTGACCCAGGCGCGCAATCAACTGCTGGGCATGGTGAAACAGCATCCTGATCAGCTGGTTCGGGTACGCCCTAATGGGCTTGAAGATACCCCTCAGTTCAAACTGGATGTCGATCAGGAAAAAGCGCAGGCGCTGGGCGTATCGCTCTCCGATATCAATGAAACGATATCAGCCGCGCTGGGCGGATACTACGTCAATGACTTTATTGACCGCGGCCGCGTGAAAAAAGTGTACGTTCAGGCTGATGCCCACTTCCGTATGCTGCCGAGCGACATTAACAACATGTATGTTCGTAGCGCCAACGGCGAAATGGTGCCGTTCTCCGCCTTTGTCACTTCACGCTGGATATATGGCTCGCCGCGCCTGGAGCGCTACAACGGGTTGCCATCTATGGAGATCCTCGGTGAAGCTTCGCCAGGCAAAAGTACCGGGGAAGCCATGGCGCTGATGGAAACGCTGGCCAGTAAACTGCCGAGCGGCATCGGTTATGACTGGACCGGGATGTCTTACCAGGAACGGCTCTCCGGCAACCAGGCGCCTGCGCTCTATGCCATCTCGCTGATCGTCGTATTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATCCCCTTCTCAGTCATGTTAGTGGTTCCGCTGGGGGTCATTGGCGCGCTGTTAGCCGCCACGCTGCGTGGGCTGAATAATGACGTTTACTTCCAGGTCGGACTCTTGACCACGATCGGTTTGTCGGCCAAGAATGCGATCCTGATCGTCGAGTTCGCCAAGGATCTGATGGAGAAAGAAGGGAAAGGGATCATTGAGGCCACGCTGGAGGCATCGCGGATGCGCCTGCGGCCTATTCTGATGACCTCTCTGGCCTTTATTCTCGGGGTCATGCCGCTGGTGATTAGCCATGGTGCCGGCAGCGGGGCGCAAAATGCGGTTGGCACCGGCGTGATGGGCGGGATGCTGACCGCGACGCTGCTGGCAATCTTCTTTGTTCCGGTGTTCTTCGTGGTCGTTAGACGACGCTTTACCCGGCACGCTGAATAA	
7932	CARD	prokka_03495	contig_10	224642	100	28398	28821	-1	108	FosA7	3004113.0	278.87	250.0	Strict	95.0	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAPQESDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLASRLVQCREKLYFGMRFGPGK	ATGCTTCAATCTCTGAACCACTTAACGCTTGCTGTCAGTAATTTGCAAACTAGCCTGACATTCTGGCGCGATTTGCTGGGGTTGCAGCTTCATGCTGAGTGGGATACTGGTGCTTATCTTACCTGTGGCGACCTTTGGATCTGTCTTTCTTACGACGTATCCCGAAACTACGTAGCCCCGCAGGAAAGCGACTACACCCACTACGCATTCAGTATCGCGCCAGAAGATTTTGAGCCGTTCTCATATAAGCTGAAACAGTCGGGAGTGACGGTCTGGAAAGACAATAAAAGCGAAGGGCAATCTTTCTATTTTCTTGACCCGGATGGTCACAAGCTGGAGTTGCATGTGGGAGATTTAGCATCTCGACTGGTGCAATGCCGTGAGAAGCTTTACTTTGGAATGCGTTTCGGACCTGGAAAATAA	
7932	CARD	prokka_03911	contig_12	156034	92	23970	27093	1	85	mdtB	3000793.0	1833.15	1800.0	Strict	90.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFERVIAVYGRWLSRVLNHPWLTLGVALSTLALSIILWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAERQRQVASIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVDGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEQDTEATPGLAALENIRLTSSDGGIVPLTAIATVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILAAEQSLDFPTDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGIELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA	ATGCAGGTGTTACCTCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCTATCCTGCTGGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCCCTGCCGGAGGTCGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAGCGCCAGTTCGGCCAGATGTCCGGCCTTAAGCAGATGTCGTCGCAAAGCTCCGGCGGCGCCTCGGTAGTCACGCTGCAGTTCCAGCTGACCCTGCCGCTGGACGTCGCCGAGCAGGAAGTGCAGGCGGCCATTAACGCCGCCACCAACCTGCTGCCGAGCGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACTCTCGCCGTCACCTCATCCGCCATCCCGATGACCCAGGTTGAGGACATGGTGGAGACCCGGGTGGCGCAGAAGATCTCCCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCTATCACCAGCGCCAACGTTAACTCCGCGAAAGGCAGCCTCGACGGTCCGGCCCGCGCGGTGACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTATCGCCGGCTGATTATCGCTTATCAGAACGGGGCGCCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTCGGGGCGTGGGCCAACCAGCAGCGGGCCATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATCATCGACACCGCCGACAGCATTCGCCAGATGCTGCCGCAGCTCACCGAGAGCCTGCCGAAATCGGTGAAGGTGCAGGTCCTCTCCGACCGGACCACCAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTACCTGTTTCTGCGCAACGTGCCGGCGACCATTATTCCCGGCGTCGCGGTGCCGCTATCGCTGGTGGGCACTTTCGCGGTGATGGTGTTCCTCGACTTTTCGATCAATAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCCATCGTGGTGATTGAGAACATCTCGCGCTATATCGAAAAAGGCGAGAAGCCGCTGGCCGCCGCGCTGAAGGGCGCGGGGGAGATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGCCTGTTCCGCGAATTCGCCGTCACCCTTGCCGTCGCTATTCTTATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGCATGTTAAGCCACGAATCGCTGCGTAAGCAGAACCGATTCTCGCGGGCCAGCGAGCGTTTCTTCGAACGGGTGATCGCCGTCTATGGCCGCTGGCTGAGCCGGGTGCTGAACCATCCGTGGCTGACGCTCGGCGTTGCCCTGAGCACCCTGGCGCTGTCGATTATCCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGCACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGCATGGCCGAGCGCCAGCGGCAGGTGGCCAGCATTATCCTTAAGGATCCGGCGGTGGAGAGTCTGACCTCCTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGTCTGCAGATCAACCTCAAGCCGCTGGATGAACGCGACGACCGCGTCCAGACGGTGATAAGCCGCCTGCAGCAGGCGGTGGACGGCGTCCCCGGCGTGGCGCTCTACCTGCAGCCGACCCAGGACCTGACCATCGACACCACGGTGAGCCGTACCCAGTATCAGTTCACCCTGCAGGCAAACTCCCTCGAGGCGCTGAGCACCTGGGTGCCGCCGCTGCTCAGCCGTCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGATCGCGACAGCGCCAGCCGCCTCGGTATCTCAATGGCCGATGTCGATAATGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACTATTTACACTCAGGCGAATCAGTATCGCGTGGTGCTCGAGCAGGATACCGAGGCGACGCCGGGCCTGGCGGCGCTGGAGAATATCCGCCTCACCAGCAGCGACGGCGGCATCGTGCCGTTGACCGCCATCGCCACGGTGGAGCAGCGCTTTACCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTCCCGGACAACTACTCGCTGGGCGAAGCGGTGGAGGCGATCCTCGCCGCCGAACAGTCGCTGGATTTCCCGACCGATATTCGCACCCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTCGGCAGCACCGTCTGGCTGGTGGTCGCCGCGGTGGTGGCGATGTATATCGTGCTGGGGGTGCTGTACGAGAGCTTTATCCATCCGATCACGATCCTCTCCACCCTGCCCACCGCCGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCATCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCTGAGCGCGAGCAGGGCATGCCGCCGCGGGAGGCGATCTACCAGGCCTGTCTGCTGCGTTTTCGGCCGATCCTGATGACCACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTCGGCGCCGAGCTGCGGCGTCCGCTGGGGATCGGCATGGTCGGCGGTCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA	
7932	CARD	prokka_03912	contig_12	156034	92	27093	30171	1	80	mdtC	3000794.0	1865.12	1800.0	Strict	91.61	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVQTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVLGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSDGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSSQPVSE	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTACTGCCGGTGGCCCCGCTGCCGCAGGTGGACTTCCCGGTGATCATGGTTAGCGCCTCGCTGCCGGGAGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGCTCTCTCGGCAGCACCCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGACGTTCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGGATGCCCAGCCGGCCGACCTATCGCAAAGCCAATCCGTCGGATGCGCCGATCATGATCCTGACGCTGACCTCGGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATCGACGGCGTGGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCGCAGGCGCTGTTCAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAACCGCAGGGGGCGCTGGAGGACAGCGCGCACCGCTGGCAGGTGCAGACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCGCTGATCGTCCACTATCAAAATGGCGCCGCGGTGCGGCTGGGAGATGTCGCCACCGTCTCGGATTCGGTGCAGGACGTACGCAACGCCGGGATGACCAACGCCAAACCGGCGATCCTGCTGATGATCCGCAAACTGCCGGAAGCCAATATTATCCAGACGGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATTCCGGCGGCTATCGACCTGCAGATCGCCCAGGACCGCTCGCCGACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACACTGGTGATTTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCCGTCGCCGTCCCGGTATCCTTAATCGGCACCTTCGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGATGCTATCGTGGTGCTGGAGAATATCTCCCGCCATCTGGAGGCGGGGATGAAACCGCTGCAGGCGGCGCTGCAGGGGAGCCGCGAGGTCGGCTTTACCGTGCTGTCGATGAGCCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTGCCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAGCCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTGCAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCATAGCCGGCTGACCGGCCTGGTGGTGCTGGGCACCATCGCCCTCAGCGTCTGGCTCTACATTTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAGATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCCAACCTGTTCCTGATGGCGGTGCAGGATATCCGCGTCGGCGGCCGGCAGTCGAACGCCAGCTATCAGTACACCCTGCTGTCCGACGACCTGTCGGCGCTGCGCGAGTGGGAGCCGAAGATCCGCAAAGCGCTGGCGGCGCTGCCGGAGCTGGCGGACGTCAACTCGGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATCAGCGTCCAGGACGCCAACAACCTGCTGAACAACGCCTTTGGCCAGCGGCAGATCTCTACCATCTACCAGCCGCTCAACCAGTATAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTCGTCATTAACAGCGACGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAATGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCATCCACTATCTCCTTTAACCTGCCCACCGGCCGCTCACTGTCGGAAGCCAGCGAGGCCATTGACCGCGCGATGACCCAGCTCGGGGTGCCGTCGAGCGTGCGCGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTCGCAGCTATCGCCACGGTCTATATCGTGCTGGGGGTGCTATATGAGAGCTATGTGCATCCGTTGACCATCCTCTCGACGCTGCCCTCCGCCGGGGTGGGCGCTCTGCTGGCGCTGGAGATCTTCGATGCCCCGTTCAGCCTAATCGCCCTGATTGGGATTATGTTATTAATTGGCATCGTTAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTGGAGGCGCAGCGTAACGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTGCCGCTGGTGCTCTCCGGGGGCGATGGCTCTGAGCTGCGCCAGCCGCTGGGGATCACCATCGTCGGCGGTCTGGTGATGAGCCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTCTGCGGCTGCGTTTTTCGCGTCACTCCTCTCAACCGGTAAGCGAATAA	
7932	CARD	prokka_03915	contig_12	156034	92	33059	33782	1	89	baeR	3000828.0	455.677	450.0	Strict	91.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPVDENTPRILIVEDEPKLGQLLIDYLQAAGYAPALINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA	ATGACTGAATTGCCTGTAGATGAAAACACCCCACGCATCCTTATCGTGGAAGATGAACCGAAGCTCGGCCAACTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTGCGTTGATTAACCACGGCGACAAGGTCCTGCCCTACGTCCGCCAGACGCCGCCGCACCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGTCTGACGCTGTGCCGGGAAATTCGCCGCTTCTCCGATGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATTGACCGTTTGCTGGGGCTGGAAATAGGCGCCGACGACTATATCTGCAAGCCCTACAGCCCGCGGGAAGTGGTCGCCCGGGTAAAAACCATCCTCCGCCGCTGCAAACCGCAGCGCGATCTGCAGGCGCTGGACGCCCAGAGCCCGCTGATTGTCGACGAAGGTCGTTTTCAGGCCTCCTGGCGCGACAAGCTGCTGGACCTCACTCCCGCCGAGTTCCGGCTGCTGAAAACCCTCTCCCAGGAGCCGGGCAAAGTGTTCTCCCGCGAACAGCTACTCAACCATCTGTATGACGATTATCGGGTAGTCACCGATCGCACCATCGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAGCAGTCGTTTATCCGCGCGGTGTATGGCGTTGGCTACCGCTGGGAAGCGGACGCCTGCCGGCTGGCGTAG	
7932	CARD	prokka_04154	contig_14	119716	99	17838	19512	1	119	eptB	3005047.0	1160.98	1000.0	Strict	99.46	97.04	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELEKEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATTATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGCGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTGATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGACTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGGCTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTCGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAACCCCCAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCGCGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCCGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA	
7932	CARD	prokka_04211	contig_14	119716	99	94019	95003	1	109	PmrF	3003578.0	577.785	550.0	Strict	83.69	101.55	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS	ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATCCCGGTTTATAACGAACAGGATAGCCTGCCGGAACTGCTTCGTCGTACGGATGCCGCCTGCGCCACCCTGGGGCGGCAATATGAAATTCTGTTGATCGACGATGGCAGCAGCGACGATTCCGCGCGCATGCTCACCGAAGCCGCCGAGGCGGAAGGCAGCCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGCCAGCACTCGGCGATCATGGCCGGCTTCAGCCATGTAACCGGCGATCTGATTATTACCCTCGACGCCGACCTGCAAAACCCGCCGGAGGAGATCCCGCGGCTGGTGGCGAAGGCTGATGAAGGTTACGACGTGGTGGGCACCGTCCGCCAGAACCGTCAGGACAGCATCTTCCGTAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTCATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATTGCCCTGCTGGGCTTCGCCTTCGGCCTGCTGCTGGTGGTGCTGCGTCTGGCCTTTGGCCCGCAGTGGGCGGCGGAAGGGGTGTTTATGCTCTTCGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCCCGCCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA	
7932	CARD	prokka_04214	contig_14	119716	99	97883	99539	1	108	ArnT	3005053.0	1093.95	1000.0	Strict	99.27	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSPIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAAQAHSRSGKILSYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVEIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTCTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGATCAACAGTATTGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCTATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCCTGTCGCCGATTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGCGCGGCGCAGGCGCACAGCCGCAGCGGCAAAATACTGAGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAAGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCCCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTAATCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCTCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCGCTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGTATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCCGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAAGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTCGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTTGTGGAGATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA	
7932	CARD	prokka_04314	contig_15	106113	107	90202	90835	-1	130	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAGCGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTCACGTCTGAGAAAGTGGGCAACCTGGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCGGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGCCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCGCACGGTAAAACCATCGTCGTCTACGGCACCCGTTAA	
7932	CARD	prokka_04378	contig_16	93174	106	46751	46976	1	108	CBP-1	3004764.0	21.557	600.0	Strict	100.0	24.03	CBP beta-lactamase	protein homolog model	antibiotic inactivation		penam	MNHGQLSMKNVFPTLAVLFAIFSLTGCGLKGPLYFPPADKTAPPPTKPVNPGIQSATPDRNDRGDTGGPSQVNY	ATGAATCACGGGCAACTATCAATGAAAAACGTTTTTCCTACGCTTGCCGTTTTGTTTGCGATCTTCAGCCTGACCGGCTGTGGTCTGAAAGGGCCTCTCTATTTCCCACCGGCGGACAAAACCGCGCCGCCGCCGACCAAACCGGTTAACCCTGGCATTCAGAGCGCAACGCCGGATCGTAACGATCGTGGCGATACCGGTGGTCCGAGCCAGGTCAATTACTAA	loose hit with at least 95 percent identity pushed strict
7932	CARD	prokka_04519	contig_18	77940	97	7882	8953	1	109	OmpA	3005044.0	729.169	700.0	Strict	99.72	95.19	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTCGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA	
7932	CARD	prokka_04560	contig_18	77940	97	58324	60073	-1	118	msbA	3003950.0	1126.69	1000.0	Strict	92.78	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE	ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATCGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTGGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGCCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATTTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGTATGCCGGTGGCCTTCTTTGACAAGCAGTCTACCGGAACGCTGCTGTCACGCATCACCTATGATTCTGAGCAGGTCGCCTCCTCCTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGGGCATCGATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTGATCGTACTGGCGCCGATTGTGTCGGTGGCGATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCCGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAAGTCAGCAATAAAATGCGTCTGCAGGGGATGAAGATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCCGGGACCATTACCGTGGTCTTCTCCTCGATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAGCGTGGGATGGCGGCGTGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAAAAAGACGAAGGTACGCGGGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTACCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATACCGGAAGGGAAAACCGTGGCGCTGGTGGGGCGCTCAGGGTCGGGTAAATCGACCATTGCCAGCCTGATCACCCGCTTCTACGATGTCGACGAGGGGCAGATCCTGCTGGATGGCCACGACCTGCGCGAGTACAAGCTGAGCTCGCTGCGCGACCAGGTGGCGCTGGTTTCACAAAACGTGCATCTGTTCAACGATACCGTCGCCAACAATATCGCCTATGCCCGTACCGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCCGCGCGCATGGCCTACGCCATGGATTTCATCAACAAGATGGATAATGGTCTGGATACCATCATCGGCGAGAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATTGCCCGCGCGCTGCTGCGTAACAGCCCGATCCTGATCCTCGATGAAGCCACCTCGGCGCTGGATACCGAGTCCGAGCGTGCCATTCAGGCGGCGCTGGATGAGCTGCAGAAAAACCGTACCTCGCTGGTTATCGCTCACCGTCTGTCGACCATTGAGCAGGCTGATGAAATCGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCATGACCTGCTGGAGCATAAGGGCGTGTACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA	
7932	CARD	prokka_04864	contig_28	18996	69	5148	5646	1	96	dfrA12	3002858.0	339.732	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG	ATGAACTCGGAATCAGTACGCATTTATCTCGTTGCTGCGATGGGAGCCAATCGGGTTATTGGCAATGGTCCTAATATCCCCTGGAAAATTCCGGGTGAGCAGAAGATTTTTCGCAGACTCACTGAGGGAAAAGTCGTTGTCATGGGGCGAAAGACCTTTGAGTCTATCGGCAAGCCTCTACCGAACCGTCACACATTGGTAATCTCACGCCAAGCTAACTACCGCGCCACTGGCTGCGTAGTTGTTTCAACGCTGTCGCACGCTATCGCTTTGGCATCCGAACTCGGCAATGAACTCTACGTCGCGGGCGGAGCTGAGATATACACTCTGGCACTACCTCACGCCCACGGCGTGTTTCTATCTGAGGTACATCAAACCTTCGAGGGTGACGCCTTCTTCCCAATGCTCAACGAAACAGAATTCGAGCTTGTCTCAACCGAAACCATTCAAGCTGTAATTCCGTACACCCACTCCGTTTATGCGCGTCGAAACGGCTAA	
7932	CARD	prokka_04865	contig_28	18996	69	6065	6845	1	74	aadA2	3002602.0	522.316	450.0	Perfect	100.0	100.0	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	GTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTGATTTGTTGGTTACTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGATCTTATGGAGGCTTCGGCTTTCCCTGGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATAAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGA	
7932	CARD	prokka_04866	contig_28	18996	69	7008	7356	1	84	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
7932	CARD	prokka_04867	contig_28	18996	69	7349	8189	1	56	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
7932	CARD	prokka_04871	contig_28	18996	69	11533	12307	1	17	armA	3000858.0	516.924	450.0	Perfect	100.0	100.0	16S rRNA methyltransferase (G1405)	protein homolog model	antibiotic target alteration		aminoglycoside antibiotic	MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYPNWDKLLKKYNQGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPLALYQWNENEKIIYHAYDIDRAEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLKMLPVLKQQDVNILDFLQLFHTQNFVISFPIKSLSGKEKGMEENYQLWFESFTKGWIKILDSKVIGNELVYITSGFQK	ATGGATAAGAATGATGTTGTTAAGAAGATACTTGAATCAAAAAAGTACGAAAACCTTGATTCAGATATTGTTGAAAAGGTTGTTTCCATTTCTGAGAAGAAATATAAATTAAAGGAAGTTGAGAATTATTCTAAAAAGAAATTGCATCAAATATGGGGGTCTTACTATTCTGCCTATCCTAATTGGGATAAATTATTAAAAAAGTACAATCAGGGGCAGTTATCAATAGAAGATTTACTAAAGATTCATTCTTCGACGAATGAAAGAGTCGCAACATTAAATGACTTTTACACTTATGTATTTGGAAATATCAAACATGTCTCATCTATTTTAGATTTTGGTTGTGGCTTCAATCCATTAGCTTTATACCAATGGAATGAAAATGAAAAAATAATATATCATGCATACGATATTGATAGAGCTGAGATAGCTTTTTTGAGTAGCATTATTGGGAAGTTAAAGACGACGATAAAGTATAGGTTTTTGAATAAAGAGAGTGATGTCTACAAAGGTACTTATGATGTAGTATTCCTTTTAAAGATGCTTCCTGTGCTAAAACAGCAAGATGTAAATATCTTGGATTTCCTACAGCTTTTTCATACTCAAAACTTTGTAATATCTTTTCCAATAAAGTCTTTATCTGGAAAGGAGAAGGGAATGGAAGAGAATTACCAGCTATGGTTTGAATCTTTTACAAAAGGTTGGATAAAAATCCTTGATTCGAAGGTTATAGGGAATGAGTTAGTATATATTACTAGTGGATTTCAGAAATAA	
7932	CARD	prokka_04874	contig_28	18996	69	14605	16081	1	78	msrE	3003109.0	1000.73	950.0	Perfect	100.0	100.0	ABC-F ATP-binding cassette ribosomal protection protein	protein homolog model	antibiotic target protection		macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	ATGAGTTTAATTATTAAAGCGAGAAACATACGCTTGGATTATGCTGGGCGTGATGTTTTGGATATTGATGAATTGGAAATTCACTCTTATGACCGTATTGGTCTTGTGGGTGATAACGGAGCAGGAAAGAGTAGTTTACTCAAAGTACTTAATGGCGAAATTGTTTTAGCCGAAGCGACATTACAGCGTTTTGGTGATTTTGCACATATCAGCCAACTGGGCGGAATCGAAATAGAAACGGTCGAAGACCGGGCAATGTTATCTCGCCTTGGTGTTTCCAATGTACAAAACGACACAATGAGTGGCGGAGAGGAAACTCGTGCAAAAATTGCTGCCGCATTTTCCCAACAAGTACATGGCATTCTAGCGGATGAACCAACCAGCCACCTTGATCTCAATGGAATAGATCTACTTATTGGTCAACTTAAAGCATTTGATGGAGCATTACTTGTTATCAGTCATGACCGATATTTTCTTGATATGGTTGTAGACAAGATATGGGAGTTAAAAGACGGTAAAATTACGGAATATTGGGGTGGTTACTCGGATTACTTGCGTCAAAAAGAAGAAGAGCGACAACACCAAGCCGTAGAATATGAGCTGATGATGAAGGAACGGGAGCGATTAGAATCTGCTGTGCAAGAAAAACGCCAGCAAGCTAATCGATTAGACAATAAGAAAAAAGGAGAAAAATCCAAAAACTCTACCGAAAGTGCTGGACGACTTGGGCATGCAAAAATGACTGGCACCAAGCAAAGAAAACTGTATCAGGCAGCTAAGAGTATGGAAAAGCGTTTGGCTGCATTAGAAGATATTCAAGCACCAGAGCATTTGCGTTCTATTCGTTTTCGTCAAAGTTCAGCCCTAGAACTGCACAATAAGTTCCCGATTACGGCAGATGGTCTGAGCTTAAAATTTGGTAGCCGTACTATCTTTGATGACGCTAACTTTATAATACCGCTTGGCGCTAAAGTCGCTATAACTGGATCGAATGGAACAGGGAAAACGTCCTTGTTAAAAATGATATCAGAACGTGCTGATGGATTAACCATATCTCCAAAAGCTGAAATTGGCTACTTTACACAAACAGGATATAAATTTAACACGCATAAATCTGTGCTCTCCTTTATGCAGGAAGAGTGCGAGTACACAGTTGCGGAAATTCGTGCAGTATTGGCTTCAATGGGGATCGGAGCGAATGATATTCAAAAAAACTTATCCGACTTATCGGGAGGTGAAATCATCAAACTGCTTTTATCCAAAATGCTTTTAGGAAAATATAATATTTTGCTTATGGATGAACCAGGAAACTATCTTGACCTAAAAAGTATTGCCGCATTAGAAACAATGATGAAGTCCTATGCAGGAACTATTATCTTCGTATCTCATGACAAGCAATTGGTCGATAATATTGCTGACATTATCTACGAGATCAAAGACCACAAAATCATCAAGACTTTTGAGAGAGATTGTTAA	
7932	CARD	prokka_04875	contig_28	18996	69	16136	17021	1	33	mphE	3003741.0	600.127	500.0	Perfect	100.0	100.0	macrolide phosphotransferase (MPH)	protein homolog model	antibiotic inactivation		macrolide antibiotic	MTIQDIQSLAEAHGLLLTDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKEKRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITSLAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDNDVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKTLIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGVI	ATGACAATTCAAGATATTCAATCACTTGCTGAAGCACACGGCTTGTTGCTTACGGACAAAATGAATTTCAATGAAATGGGCATTGATTTTAAGGTCGTTTTTGCTCTTGATACAAAGGGGCAACAATGGTTGCTGCGTATTCCTCGTCGTGATGGCATGAGGGAACAAATCAAGAAAGAAAAACGCATTTTAGAATTGGTAAAAAAACATCTTTCTGTAGAGGTTCCTGATTGGAGAATTTCATCTACAGAATTAGTGGCTTATCCCATACTTAAAGATAATCCTGTTTTAAATTTGGATGCTGAAACCTATGAAATAATTTGGAATATGGACAAAGATAGCCCGAAATACATAACATCTTTGGCAAAAACCTTATTTGAAATCCATAGTATTCCTGAAAAAGAAGTTCGGGAAAATGATTTGAAAATTATGAAACCTTCAGATTTAAGACCTGAAATAGCAAACAATTTGCAGTTAGTAAAATCTGAAATTGGTATAAGTGAGCAATTGGAAACCCGCTACAGAAAATGGTTGGATAATGATGTTCTATGGGCAGATTTCACCCAATTTATACATGGCGATTTATATGCTGGGCATGTACTAGCTTCAAAGGATGGAGCTGTTTCAGGCGTTATTGATTGGTCAACAGCCCATATAGATGACCCAGCGATTGATTTTGCTGGGCATGTAACTTTGTTTGGAGAAGAAAGCCTCAAAACTCTAATCATCGAGTATGAAAAACTAGGGGGTAAAGTTTGGAATAAACTATATGAACAGACTTTAGAAAGAGCAGCGGCCTCTCCTTTGATGTATGGTTTATTTGCCTTAGAAACTCAAAATGAAAGCCTTATCGTTGGAGCAAAAGCTCAGTTGGGAGTTATATAA	
7932	CARD	prokka_04960	contig_36	5937	60	3945	4311	-1	77	BRP(MBL)	3001205.0	251.136	200.0	Perfect	100.0	100.0	Bleomycin resistant protein	protein homolog model	antibiotic inactivation		glycopeptide antibiotic	MADHVTPNLPSRDFDVTEAFYAKLGFATSWKDRGWMILQRGGLQLEFFPYPDLDPATSSFGCCLRLDDLDAMVALVNAAGAEEKSTGWPRFKAPQLEASGLRIGYLIDPDCTLVRLIQNPD	ATGGCTGACCACGTCACCCCCAATCTGCCATCGCGCGATTTCGATGTGACAGAGGCGTTTTATGCGAAGCTGGGCTTTGCGACGAGTTGGAAGGATCGCGGCTGGATGATCCTGCAGCGCGGCGGTTTGCAGCTCGAATTCTTCCCCTATCCTGACCTCGACCCAGCTACGAGCTCGTTCGGCTGTTGCCTGCGGTTGGATGATCTCGATGCCATGGTGGCATTGGTGAACGCGGCGGGAGCCGAGGAAAAAAGCACCGGCTGGCCGCGCTTCAAAGCTCCGCAACTGGAGGCGAGCGGCCTGAGGATCGGCTACCTGATCGATCCCGACTGCACGCTGGTGCGGCTGATCCAGAACCCCGACTGA	
7932	CARD	prokka_04996	contig_47	2438	158	171	771	1	267	AAC(6')-Ib-cr6	3005116.0	407.142	300.0	Strict	98.99	100.0	AAC(6')-Ib-cr	protein homolog model	antibiotic inactivation		fluoroquinolone antibiotic; aminoglycoside antibiotic	MSNAKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERTRSDA	ATGAGCAACGCAAAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGACGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCATATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	
7932	CARD	prokka_04998	contig_47	2438	158	1869	2418	1	232	catB3	3002676.0	308.145	350.0	Strict	100.0	86.67	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIGSFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIGSEAMVMPGIKIGHGAVIGSRSLVTKDVGHCCKVSDEAAFCLIQRPYISKTLLTRRISPRGSP	ATGACCAACTACTTTGATAGCCCCTTCAAAGGCAAGCTGCTTTCTGAGCAAGTGAAGAACCCCAATATCAAAGTTGGGCGGTACAGCTATTACTCTGGCTACTATCATGGGCACTCATTCGATGACTGCGCACGGTATCTGTTTCCGGACCGTGATGACGTTGATAAGTTGATCATCGGTAGTTTCTGCTCTATCGGGAGTGGGGCTTCCTTTATCATGGCTGGCAATCAGGGGCATCGGTACGACTGGGCATCATCTTTCCCGTTCTTTTATATGCAGGAAGAACCTGCATTCTCAAGCGCACTCGATGCCTTCCAAAAAGCAGGTAATACTGTCATTGGCAATGACGTTTGGATCGGCTCTGAGGCAATGGTCATGCCCGGAATCAAGATCGGGCACGGTGCGGTGATAGGCAGCCGCTCGTTGGTGACAAAAGATGTGGGGCACTGTTGCAAAGTTAGCGATGAGGCAGCCTTTTGTCTTATTCAAAGGCCTTACATTTCAAAAACTCTGCTTACCAGGCGCATTTCGCCCAGGGGATCACCATAA	loose hit with at least 95 percent identity pushed strict
7932	CARD	prokka_05001	contig_49	2210	76	619	1264	1	66	QnrB1	3002714.0	437.573	400.0	Perfect	100.0	100.0	quinolone resistance protein (qnr)	protein homolog model	antibiotic target protection		fluoroquinolone antibiotic	MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG	ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG	
7932	CARD	prokka_01994	contig_4	347019	101	200922	202689	1	127	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	595.89	500.0	Strict	52.37	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTGCTGGCGCTGGCTTTTCTGCTGGGTCGCGTCGCCTGGCTACAGGTGATCAGCCCCGATATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTGTCCACCGCGCGCGGGATGATTACCGATCGCTCCGGACGTCCGCTGGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGACCCGAAAGAGCTCCATGACGCCGGTGGGGTTACCCTGGATACGCGCTGGAAAGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGGTTTATCTATCTGGCGCGTCAGGTTAATCCTGACATGGCCGATTACATCAAGAAGCTGAAGCTGCCGGGCATTCATCTGCGCGAAGAATCCCGTCGGTACTACCCTTCCGGGGAAGTAACCGCTCACCTCATCGGCTTTACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAGAAAAGCTTTGATAAATGGCTTACCGGTCAGCCGGGCGAGCGTATCGTACGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCTACCGATAGCCAGGCAGCGCACAACCTGGCGCTGAGTATCGACGAACGCCTGCAGGCGCTGGTCTATCGCGAGCTGAACAACGCCGTGGCCTTTAACAAAGCCGAGTCGGGCAGCGCCGTGTTAGTGGATGTTAACACCGGTGAAGTGCTGGCGATGGCCAACAGCCCATCCTATAACCCGAACAACTTCGCCGGTACGGCAAAAGACACCATGCGTAACCGTGCGATTACCGACGTGTTTGAGCCGGGTTCGACGGTGAAACCGATGGTGGTCATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTATGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCGTTGTCGATTACCAAGGTTGATCCTCCGGTTCCGGGCGAGCGCGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGTGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTATATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
7932	CARD	prokka_02124	contig_5	302412	95	7177	9811	-1	104	Salmonella enterica gyrA with mutation conferring resistance to triclosan	3004334.0	1705.26	1500.0	Strict	96.2	99.89	triclosan resistant gyrA	protein variant model	antibiotic target alteration	S83F	triclosan	MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDFAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMATNIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATGVRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERNGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTCAACATTGAGGAAGAGCTTAAGAACTCTTATCTGGATTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGATGTCCGAGATGGCCTGAAGCCGGTACACCGTCGCGTACTTTACGCCATGAACGTATTGGGCAATGACTGGAACAAAGCCTATAAAAAATCAGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCACCCGCACGGCGACTTCGCGGTATACGACACCATCGTGCGTATGGCGCAGCCGTTCTCGCTGCGTTACATGCTGGTGGACGGCCAGGGTAACTTTGGTTCCATCGACGGCGACTCCGCCGCGGCGATGCGTTATACCGAAATTCGTCTGGCGAAAATCGCTCATGAGCTGATGGCCGATCTTGAAAAAGAGACGGTCGATTTCGTCGACAACTATGACGGTACGGAGCGTATTCCGGACGTCATGCCGACCAAAATTCCTAACCTGCTGGTGAACGGCGCCTCCGGGATCGCCGTAGGGATGGCCACCAACATACCGCCGCATAACCTGACGGAAGTGATTAACGGCTGTCTGGCGTATGTTGACGATGAAGACATCAGCATTGAAGGGCTGATGGCGCATATTCCTGGCCCTGATTTCCCGACCGCCGCCATTATCAATGGCCGTCGCGGCATCGAAGAGGCCTACCGCACCGGTCGCGGTAAAGTGTACATCCGCGCGCGCGCGGAAGTGGAAGTGGACGCGAAATCCGGCCGCGAAACCATCATCGTGCACGAAATTCCGTATCAGGTGAACAAAGCGCGCCTGATCGAGAAAATCGCCGAGCTGGTCAAAGAAAAACGCGTGGAAGGCATCAGCGCGCTGCGTGACGAGTCTGATAAAGACGGGATGCGCATCGTGATTGAAGTGAAGCGCGATGCGGTAGGGGAAGTGGTGCTTAACAACCTCTATTCCCAGACCCAGCTGCAGGTCTCCTTCGGCATCAACATGGTAGCTCTGCACCATGGTCAGCCGAAGATCATGAACCTGAAGGACATCATCGCCGCGTTTGTACGCCACCGCCGTGAAGTGGTGACCCGTCGTACGATTTTCGAACTGCGCAAAGCGCGCGACCGGGCGCATATCCTCGAAGCGCTGGCCGTTGCGCTGGCCAACATCGACCCGATTATCGAACTGATCCGTCGCGCGCCGACCCCGGCAGAAGCGAAAACGGCGCTGGTTGCCCAGGCGTGGGATCTTGGTAACGTCGCGGCGATGCTGGAGCGCGCCGGGGATGACGCCGCGCGTCCGGAATGGCTGGAGCCAGAGTTCGGCGTACGCGACGGTAAATACTATCTGACCGAGCAGCAGGCTCAGGCGATTCTGGATCTGCGTCTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAATATAAAGAGCTGCTGGAGCAGATCGCAGAGCTGCTGCACATTCTCGGCAGCGCCGACCGTCTGATGGAAGTGATTCGCGAAGAGCTGGAGCTGATCCGCGACCAGTTCGGCGACGAACGTCGTACCGAAATCACCGCCAACAGCGCTGATATTAACATCGAAGATCTGATCAACCAGGAAGATGTGGTGGTCACCCTGTCGCATCAGGGGTATGTGAAGTATCAGCCGCTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGCAAATCGGCAGCGCGCATTAAAGAAGAAGACTTTATCGACCGCCTGCTGGTGGCCAACACCCATGACACCATCCTCTGCTTCTCAAGCCGCGGCCGTCTGTACTGGATGAAGGTCTATCAGCTGCCGGAAGCCAGCCGCGGCGCGCGCGGTCGGCCGATCGTCAACCTGCTGCCGCTGGAAGCCGATGAGCGCATCACCGCCATCCTGCCGGTCCGCGAGTACGAAGAGGGCGTCAACGTCTTTATGGCGACCGCCAGCGGTACCGTGAAGAAAACCGCGCTGACCGAGTTCAGCCGTCCGCGTTCCGCCGGTATCATCGCGGTCAACCTGAACGAAGGCGATGAGCTGATCGGCGTCGATCTGACCTCTGGTCAGGATGAAGTGATGCTGTTCTCCGCGGCCGGTAAGGTTGTACGCTTCAAGGAAGACGCCGTTCGCGCCATGGGCCGTACCGCCACCGGCGTACGCGGTATTAAGCTTGCGGAAAACGACAGCGTCGTCTCGCTGATTATTCCACGCGGCGAAGGCGCGATCCTGACGGTGACGCAAAACGGTTACGGTAAACGTACCGCGGCGGCGGAGTATCCGACCAAGTCGCGTGCCACCCAGGGCGTTATTTCGATCAAAGTCACCGAGCGTAACGGTTCCGTGGTCGGCGCCGTGCAGGTGGATGACTGCGATCAGATCATGATGATCACCGACGCCGGGACGCTGGTGCGTACCCGCGTTTCCGAGGTGAGCATCGTGGGTCGTAACACCCAGGGCGTGATCCTCATCCGCACCGCGGAAGATGAAAACGTGGTGGGTCTGCAGCGCGTGGCTGAGCCGGTGGATGATGAAGAGCTGGATGCCATCGACGGTAGCGCGGCGGAAGGCGATGACGATATCGCCCCGGAAGCGGATACCGATGACGACATCGCCGAAGACGAAGAATAA	
7932	CARD	prokka_03314	contig_9	253960	102	89425	90817	1	111	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	861.677	850.0	Strict	94.6	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYMVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLIGWAGTFAALDAAAVGCICLMAIVAIFEERKIRREKKNRILQTA	ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATATGGTGGTTTTCATCGGCTACCTGACCATGTACCTGATCCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGTTGAGCATGACGCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAGACGCTGGTCTCTTATTATGCCGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCTACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACTTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTTGGCTTTATCGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCGAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAGGTCGGCGCGCTGGTCGGCACGCTGCTGTGGGGCTGGCTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACGCTTGGGGTTTACCAACACGCCAGCAACCAGTACGTCTATCTGGCCTCGTTATTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGGATCAAGGGCACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAACTGGGTCTCGGGATGATCGCCGACGGCACCCCGGTCTTCGGCCTGATCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCGTCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTTGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACCGCCTGA	
7932	CARD	prokka_00292	contig_1	971478	85	316694	317129	-1	110	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	253.447	210.0	Strict	84.03	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIERLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP	ATGAAAAGTACCAGCGACCTGTTTAATGAAATGATCCCGCTGGGCCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTACCTCTCACCTATGGATATTACCGCGACCCAGTTTCGCGTGCTCTGCTCCATTCGTTGCGAAGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGACCCGGGCGCGATGACGCGCATGCTCGACCGCCTGGCGTGCAAAGGCTGGATTGAACGGTTACCCAACCCCGCTGACAAGCGCGGCGTGCTGGTGCAGTTGACGCCGGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACGAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTGCTCAAGAAGGTCCTGCCGTAA	
8052	BLDB	prokka_03438	contig_14	130127	53	27986	28847	-1	52	SHV-11		79.3		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase SHV-11	protein homolog model			Beta-Lactam	MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGCGTTATATTCGCCTGTGTATTATCTCCCTGTTAGCCACCCTGCCGCTGGCGGTACACGCCAGCCCGCAGCCGCTTGAGCAAATTAAACAAAGCGAAAGCCAGCTGTCGGGCCGCGTAGGCATGATAGAAATGGATCTGGCCAGCGGCCGCACGCTGACCGCCTGGCGCGCCGATGAACGCTTTCCCATGATGAGCACCTTTAAAGTAGTGCTCTGCGGCGCAGTGCTGGCGCGGGTGGATGCCGGTGACGAACAGCTGGAGCGAAAGATCCACTATCGCCAGCAGGATCTGGTGGACTACTCGCCGGTCAGCGAAAAACATCTTGCCGACGGCATGACGGTCGGCGAACTCTGCGCCGCCGCCATTACCATGAGCGATAACAGCGCCGCCAATCTGCTGCTGGCCACCGTCGGCGGCCCCGCAGGATTGACTGCCTTTTTGCGCCAGATCGGCGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTGAATGAGGCGCTTCCCGGCGACGCCCGCGACACCACTACCCCGGCCAGCATGGCCGCGACCCTGCGCAAGCTGCTGACCAGCCAGCGTCTGAGCGCCCGTTCGCAACGGCAGCTGCTGCAGTGGATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAGCGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATTTATCTGCGGGATACCCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAACACTGGCAACGCTAA	
8052	BLDB	prokka_05151	contig_45	18682	99	8797	9679	-1	95	KPC-2		92.8		Perfect	100.0	99.66	carbapenem-hydrolyzing class A beta-lactamase KPC-2	protein homolog model			Beta-Lactam	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA	
8052	BLDB	prokka_05305	contig_59	8347	83	5669	6530	-1	105	TEM-1		80.1		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase TEM-1	protein homolog model			Beta-Lactam	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	ATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCTGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	
8052	BLDB	prokka_05307	contig_59	8347	83	7718	8054	-1	142	OXA-9		146.9		Strict	100.0	40.15	oxacillin-hydrolyzing class D beta-lactamase OXA-9	protein homolog model			Beta-Lactam	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVV	ATGAAAAAAATTTTGCTGCTGCATATGTTGGTGTTCGTTTCCGCCACTCTCCCAATCAGTTCCGTGGCTTCTGATGAGGTTGAAACGCTTAAATGCACCATCATCGCAGACGCCATTACCGGAAATACCTTATATGAGACCGGAGAATGTGCCCGTCGTGTGTCTCCGTGCTCGTCTTTTAAACTTCCATTGGCAATCATGGGGTTTGATAGTGGAATCTTGCAGTCGCCAAAATCACCTACGTGGGAATTGAAGCCGGAATACAACCCGTCTCCGAGAGATCGCACATACAAACAAGTCTATCCGGCGCTATGGCAAAGCGACTCTGTTGTCTAG	
8052	CARD	prokka_00378	contig_1	674575	57	405189	406422	1	51	Escherichia coli mdfA	3001328.0	706.057	700.0	Strict	85.61	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVLAAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG	ATGCAAAATTATTCGCTTTCAGGCCGCCGCCTCGGAAGGCAGGCGCTGTTGTTCCCGTTATGTCTGGTGCTGTACGAGTTTTCCACTTATATCGGCAACGATATGATTCAGCCGGGCATGTTAGCCGTGGTGCAGGAATTTCAGGTGGGCAACGAATGGGTACCTACCTCAATGACTGCCTATCTGGCAGGCGGCATGTTTTTACAGTGGCTGCTGGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGTTGACCGGCGTAGTATGGTTCATCGTCACCTGCCTGGCGACGCTGCTGGCGCAGACCATTGAGCAGTTTACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGCTTTATTGGCGCGGTGGGCTATGCGGCGATACAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCCCTGATGGCTAACGTGGCGCTGATTGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATGTCCTGCCGTGGGAGATGATGTTTGTCCTGTTCGCCGTGCTGGCGGCCATCTCGTTCTTCGGCCTGCAGCGGGCGATGCCGGAGACCGCGACGCGGCTGGGCGAAAAGCTGTCGGTGAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTGAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCCACCGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCCACCAGCTATGAGTACGGCATGCTGCAGGTGCCGATTTTCGGGGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTGCGCGCCGGACCGTGCGCTCGCTGATTATCATGGGCGGTTGGCCGATCATGTTTGGCCTGATCCTCTCTGCGGCGGCGACCGTGGTCTCTTCCCACGCTTATCTGTGGATGACGGCCGGTTTGAGCTTCTACGCCTTCGGGATTGGCCTCGCGAACGCCGGCCTGGTGCGTTTAACCCTGTTCGCCAGCGAGATGAGTAAAGGCACGGTCTCGGCGGCGATGGGAATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTGGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGCTGGGTGGGGTACTATGGCTGGGGCTGATGATTTACTTTCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGGTAG	
8052	CARD	prokka_00446	contig_1	674575	57	485793	487542	1	79	msbA	3003950.0	1126.69	1000.0	Strict	92.78	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE	ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATCGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTGGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGCCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATTTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGTATGCCGGTGGCCTTCTTTGACAAGCAGTCTACCGGAACGCTGCTGTCACGCATCACCTATGATTCTGAGCAGGTCGCCTCCTCCTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGGGCATCGATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTGATCGTACTGGCGCCGATTGTGTCGGTGGCGATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCCGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAAGTCAGCAATAAAATGCGTCTGCAGGGGATGAAGATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCCGGGACCATTACCGTGGTCTTCTCCTCGATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAGCGTGGGATGGCGGCGTGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAAAAAGACGAAGGTACGCGGGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTACCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATCCCGGAAGGGAAAACCGTGGCGCTGGTGGGGCGCTCAGGGTCGGGTAAATCGACCATTGCCAGCCTGATCACCCGCTTCTACGATGTCGACGAGGGGCAGATCCTGCTGGATGGCCACGACCTGCGCGAGTACAAGCTGAGCTCACTGCGCGATCAGGTGGCGCTGGTTTCACAGAACGTGCATCTGTTCAACGATACCGTCGCCAACAATATCGCCTATGCCCGTACCGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCCGCGCGCATGGCCTACGCCATGGATTTCATTAACAAGATGGATAATGGTCTGGATACCATCATCGGCGAGAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATTGCCCGCGCGCTGCTGCGTAACAGCCCGATCCTGATCCTTGATGAAGCCACCTCGGCGCTGGATACCGAGTCCGAGCGTGCCATTCAGGCGGCGCTGGATGAGCTGCAGAAAAACCGTACCTCGCTGGTTATCGCTCACCGTCTGTCGACCATTGAGCAGGCTGATGAAATCGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCATGACCTGCTGGAGCATAAGGGCGTGTACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA	
8052	CARD	prokka_00488	contig_1	674575	57	536913	537984	-1	74	OmpA	3005044.0	729.169	700.0	Strict	99.72	95.19	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTCGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA	
8052	CARD	prokka_00636	contig_2	405777	54	11772	12102	-1	44	Klebsiella pneumoniae KpnF	3004583.0	206.453	150.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGCTGGCAATCGCCATTGTGCTGGAAATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGCTTCCGCCGCAAGATCTACGGCATCCTGTCCCTGGCGGCAGTATTGGGCGCGTTCAGCGCCCTGTCGCAGGCGGTTAAAGGGATCGATCTCTCGGTCGCCTATGCGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGTCAGCGTCTGAATAACAAAGGCTGGGCGGGGGTTATCCTGCTGGTAGCCGGCATGGTGTTAATTAAACTCGCCTGA	
8052	CARD	prokka_00637	contig_2	405777	54	12088	12451	-1	61	Klebsiella pneumoniae KpnE	3004580.0	223.402	150.0	Strict	99.17	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSKQEVAHAAV	ATGTTTTATTGGATTTTATTAGCTTTAGCAATTATTGCTGAAATTACCGGCACCTTGTCTATGAAATGGGCAAGCGTGAGCGGCGGGCACACCGGCTTTATTTTAATGCTGGCCATGATTGCCCTGTCATATATTTTTCTTGCCTTTGCGGTTAAAAAGATTGCCCTCGGTGTGGCCTATGCGTTGTGGGAAGGGATCGGTATTTTACTGATTACCCTGTTCAGCGTGCTGCTGTTTGATGAGAGTCTGTCCCTGCTGAAAATAGCCGGCTTGACCACCCTGGTGATAGGGATCGTCTTAATTAAGTCCGGCACCCAGAAAAAAGCGTCTTCCAAGCAGGAGGTGGCCCATGCAGCAGTTTGA	
8052	CARD	prokka_00760	contig_2	405777	54	151971	153096	1	65	Klebsiella pneumoniae OmpK37	3004122.0	751.51	700.0	Strict	99.47	100.0	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFGFKGETQINDMLTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDMLPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGISTDNIVALGLVYQF	ATGAAAAGAAAAGTACTGGCCCTCGTTATTCCGGCTTTATTAGCCGCCGGTGCCGCGCATGCGGCGGAAATTTATAATAAAGACGGGAATAAATTAGATCTCTATGGCAAGGTAGATGGTCTGCATTATTTCTCCAGCGACTCGAAAAAAGACGGCGATCAAACTTATTTACGTTTTGGCTTTAAAGGCGAAACCCAGATCAACGATATGCTTACCGGCTATGGCCAGTGGGAATATAACGTTCAGGCCAACAACACCGAGACCTCCAGCGATCAGGCGTGGACCCGTCTGGCATTCGCCGGTATCAAAGTGGGCGATTACGGCTCCTTCGACTACGGTCGTAACTACGGCGTGCTGTACGACGTTGAAGGCTGGACCGATATGCTGCCGGAGTTCGGCGGCGACTCCTACACCTATGCGGATAACTTTATGGCAGGCCGCGCCAACGGCGTCGCAACCTACCGTAACAGCGATTTCTTCGGTCTGGTGGAGGGTCTGAACTTCGCCCTGCAGTATCAGGGTAAAAACGAAGGCCAGAACGCGCAGGATATCAACGTCGGCACCAATAACCGCAGCAGCGACAGCGATGTTCGCTTCGACAATGGCGATGGTTTCGGCCTCTCTACTTCCTACGACTTCGGCATGGGCATCAGCGCGGCGGCAGCTTACACCTCGTCTGACCGTACTAACGATCAGATGACCCAGACCAACGCGCGCGGCGATAAAGCGGAAGCCTGGACCGCCGGCCTGAAGTACGACGCCAACGATATCTACCTGGCGACCATGTACTCTGAAACCCGCAATATGACCCCGTACGGCAATGACGGCGTGGCCAATAAAACACAAAACTTCGAAGTCACCGCGCAGTATCAGTTCGACTTCGGCCTGCGTCCGGCCATCTCCTACCTGCAGTCCAAAGGCAAAGATCTGTACAATAACGGCCGCTATGCCGATAAAGATCTGGTCAAATATATGGACGTTGGCGCGACCTATTACTTCAACCGTAATATGTCCACCTATGTTGATTACAAAATCAACCTGCTGGATGGTAACGACAAATTCTACGAAGACAACGGTATCTCTACCGATAACATCGTCGCCCTGGGCCTGGTTTACCAGTTCTGA	
8052	CARD	prokka_01251	contig_3	358352	55	271594	271780	1	70	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTGTCTGTTCACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	
8052	CARD	prokka_01264	contig_3	358352	55	279638	281177	-1	47	Klebsiella pneumoniae KpnH	3004597.0	937.947	700.0	Strict	94.02	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAACTGGTCATTATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATTGCCGGCAACCTTGGCTCGTCGCTGAGCCAGGGGACCTGGGTCATCACCTCGTTCGGGGTCGCTAACGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGCGTCGGCGAGGTGAAGCTGTTCCTGTGGTCAACCACCGCCTTCGCCATTGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTCATTCAGGGGATCGTCGCCGGGCCGCTGATCCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCCCCGGCGAAGCGCTCTATCGCTCTGGCGCTGTGGTCAATGACGGTGATTGTCGCGCCCATCTGCGGTCCGATCCTCGGCGGCTATATCAGCGATAATTATCACTGGGGCTGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGGATCGACGGCGTCGGTCTGGCGCTGCTGATCATTGGTATCGGTAGCCTGCAGGTGATGCTGGACCGGGGTAAAGAGCTGGACTGGTTCTCCTCCAATGAGATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTAACCGACGATAACCCGATTGTCGATCTATCGCTATTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGTATCAGTCTGGCCTATATGCTCTACTTCGGCGCCATCGTGCTGCTGCCGCAGCTGTTGCAGGAGGTCTACGGCTACACCGCGACCTGGGCCGGCCTGGCGTCGGCGCCGGTGGGGGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTCGCGCATAAGCTCGACATGCGGCGGCTGGTCACCTTCAGCTTTATTATGTACGCGGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCACAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTCTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCCTGTCGAACTTCACCCGTACCCTTGCCGGCTCAATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCATCATGCGCAGCTCACCGAATCGGTGACCCCCTTTAACCCCAACGCGCAGCAGATATACGATCAGCTGCAGGGCATGGGAATGACGCAGCAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACCAACCAGGGGCTGATTATCTCCGCCAACGAAATCTTCTGGATTTCTGCGGCTATTTTCATCCTGCTGTTGGGGCTGGTGTGGTTCGCCAGACCACCGTTCAGCGCCGGCGGAGGCGGCGGCGGCGCGCACTAA	
8052	CARD	prokka_01265	contig_3	358352	55	281192	282365	-1	65	Klebsiella pneumoniae KpnG	3004588.0	788.875	700.0	Strict	99.74	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	ATGAGTGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGAAAGCGTAAAGGCGCCCTTCTGTTGCTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTAGCAGGGAATCAGGTACAAATTATGGCTCAGGTCGCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACGCTCGATCGGACCGATGCCCAACAGGCGTTTGAAAAGGCTAAGACCCAACTGGCCGCCAGCGTCCGTCAGACCCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCAAATATCGACGTCAAAAAAACCGCCCTTGCCCAGGCGCAGGCTGACCTGAACCGCCGCATCCCGCTGGGCGCCGCGAACCTCATTGGCCGCGAAGAGCTGCAGCACGCCCGCGATACCGTCGCCAGCGCACAGGCCGAACTCGACGTGGCAATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGCACCAGGCTGGAACAGCAGCCGGCGGTGCTCCAGGCGGCCACTGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATTGGCACCACCACGCCGCTGATGGCGGTGGTCCCGGCGACCAACCTGTGGATCGATGCTAACTTTAAAGAGACTCAGCTGGCGCATATGCGTATCGGCCAGCCGGCCACCGTGATCAGCGATATCTATGGCGATGACGTGAAATACACCGGTAAAGTGGTCGGTCTGGATATGGGCACCGGCAGCGCCTTCTCTCTGCTGCCGGCGCAGAATGCCACCGGCAACTGGATCAAAGTGGTACAACGCCTGCCGGTTCGTATCGAGCTGGATGAAAAACAACTAGCGGAACACCCGCTGCGTATCGGTCTCTCGACGCTGGTGGAAGTCAACACCACCGATCGCGATGGTGAAATGCTGGCCAGCCAGGTGCGGAGCTCCCCGGTTTACGAGAGCAATGCCCGCGAAATCGCTCTCGATCCGGTTAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA	
8052	CARD	prokka_01266	contig_3	358352	55	282490	283021	-1	62	emrR	3000516.0	338.961	280.0	Strict	92.57	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR	ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTTCGCGCCAGCCGCCATGAAGATTTCCCGTTTCAGGAGATCCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCACAGGAAAACCACAGCATCCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCACGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAGCGCCGCGAGAGCGATAACGATCGTCGCTGTTTGCATCTGCAACTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTTAGCACCAGCGAAAAAGATCAGCTCGAACACATCACCCGCAAACTCCTGAGCCGCCTTGATCAGATGGAAGAAGAAGGCGTGCTAGCGGACTCTCTACGCTAA	
8052	CARD	prokka_01308	contig_3	358352	55	323079	326232	-1	61	oqxB	3003923.0	2110.49	2000.0	Strict	99.62	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPNGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSISAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTELFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEMQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCGCTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCGGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTTTCGCCAAACGGTAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCGGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCTCCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGCTGATCGCGGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCGATTGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCACCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGTTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCCATCCTGCCGCCGCCGATTTTAGGACTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAAACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGAGCTATTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCCGATGGGCCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTGCCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAGGAGCTGTCAAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCGTTCCTCGTGCTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTGCCGATGACGATGCTCTCCGCGCTATTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGGCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGTGAGCTGGAGATGCAGGGCAAAGGCATCATGGAGGCCGCGCTGGAGGCGTGCCGCCTGCGTCTGCGCCCGATTGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTTGGCCACGGCGCAGGAGCGGAAGTTCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTGCGAAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG	
8052	CARD	prokka_01309	contig_3	358352	55	326255	327431	-1	48	oqxA	3003922.0	798.1189999999998	670.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	ATGAGCCTGCAAAAAACCTGGGGAAACATTCACCTGACCGCGCTCGGCGCGATGATGCTCTCCTTTCTGCTCGTCGGCTGCGACGACAGCGTCGCGCAGAATGCTGCGCCTCCCGCCCCGACGGTCAGCGCCGCTAAGGTGCTGGTGAAGTCGATCAGTCAGTGGGATAGTTTTAACGGTCGCATTGAAGCGGTGGAGAGCGTTCAGCTTCGCCCTCGCGTCTCGGGATACATTGATAAAGTGAATTACACCGACGGCCAGGAGGTGAAAAAGGGCCAGGTGCTGTTCACGATAGATGACAGAACCTATCGCGCCGCGCTGGAGCAGGCGCAGGCGGCGTTGGCAAGAGCCAAAACGCAGGCCAGCCTGGCGCAAAGCGAGGCGAACCGCACCGATAAATTAGTCCATACCAACCTCGTCTCCCGTGAAGAGTGGGAGCAGCGCCGGTCAGCCGCGGTTCAGGCGCAGGCCGACATTCGCGCCGCGCAGGCGGCGGTGGATGCCGCGCAGCTTAACCTCGACTTCACCAAAGTGACCGCCCCTATTGACGGCCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTCACCGCGGGCGACACCGCCAGCGTGCTCACCACCCTGGTCTCGCAGAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTCCACTATCAAAACCTCGCCCGCCGCGGGCAAGGCGCGTCCAGCGATAATCAGGCGCTCCCGGTGGAGATTGGCCTGGTTGGCGAGGAGGGTTACCCCCACCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGTACCGGCACCATCCGCATGCGTGCGCTGCTGGATAACTCGCAGCGTCTGTTCACACCGGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCAGAGTTCAAAGCCACGCTGATCGACGACAAAGCGGTACTGACCGATCAGGATCGTAAATACGTCTATATCGTTGATAAAGATGGTAAAGCACAGCGCCGCGACATTACCCCAGGGCGGCTGGCAGACGGTTTACGCATCGTTCAGAAGGGGTTGAATCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCCAAAACCGTTGCCATGACCTCCAGCGCCACCCTTAACTGA	
8052	CARD	prokka_01361	contig_4	335560	59	15278	15911	1	76	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAGCGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTCACGTCTGAGAAAGTGGGCAACCTCGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCGGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGCCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCGCACGGTAAAACCATCGTCGTCTACGGCACCCGTTAA	
8052	CARD	prokka_01461	contig_4	335560	59	125900	127556	-1	67	ArnT	3005053.0	1093.95	1000.0	Strict	99.09	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAIMSPVIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAAQAQSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTCTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGATCAACAGTATCGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCATGTCGCCGGTTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGTGCGGCGCAGGCGCAGAGCCGCAGCGGCAAAATACTGGGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAGGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCCCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTAATCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCTCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCACTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGGATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCCGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAAGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTTGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGATATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA	
8052	CARD	prokka_01464	contig_4	335560	59	130436	131420	-1	59	PmrF	3003578.0	577.785	550.0	Strict	83.69	101.55	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS	ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATCCCGGTTTATAATGAACAGGATAGCCTGCCGGAGCTGCTTCGTCGTACGGATGCCGCCTGCGCCACCCTGGGGCGGCAATATGAAATTCTGTTGATCGACGATGGCAGCAGCGACGATTCGGCGCGCATGCTCACCGAAGCCGCCGAGGCGGAAGGCAGCCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGCCAGCACTCGGCGATCATGGCCGGCTTCAGCCATGTAACCGGCGATCTGATTATTACCCTCGACGCCGACCTGCAAAACCCGCCGGAGGAGATCCCGCGGCTGGTGGCGAAGGCTGATGAAGGTTACGACGTGGTGGGCACTGTCCGCCAGAACCGTCAGGACAGCATCTTCCGTAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTTATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATTGCCCTGCTGGGCTTCGCCTTCGGCCTGCTGCTGGTGGTGCTGCGTCTGGCCTTTGGCCCGCAGTGGGCGGCGGAAGGGGTGTTTATGCTCTTCGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCCCGCCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA	
8052	CARD	prokka_01521	contig_4	335560	59	206076	207750	-1	73	eptB	3005047.0	1160.98	1000.0	Strict	99.46	97.04	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELEKEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATTATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGCGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTAATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGTCTGTACGCTTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGGCTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTCGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAATCCACAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCACGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCTGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA	
8052	CARD	prokka_02211	contig_7	214923	60	15701	16181	1	58	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.9138	32.0	Strict	28.0	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVVMGRLTWESIGRPLPGRKNIVISSKPGSDDRVQWVSSVEEAIAACGDVEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSNSYCFEILERR	ATGATCAGTCTGATTGCGGCGTTAGCGGTAGATCGCGTCATTGGTATGGAAAACGCCATGCCATGGAACCTGCCTGCCGATCTCGCCTGGTTCAAACGCAACACGTTAAATAAGCCGGTGGTGATGGGGCGTCTGACCTGGGAATCCATTGGGCGCCCATTGCCGGGGCGTAAAAATATCGTGATCAGCAGCAAACCCGGCAGCGACGATCGCGTGCAGTGGGTCTCCTCCGTAGAAGAAGCAATTGCCGCCTGCGGCGATGTGGAAGAGATTATGGTGATCGGCGGCGGCCGGGTGTATGAGCAGTTCCTGCCGAAAGCGCAGAAGCTCTACTTGACCCATATTGATGCGGAAGTGGAAGGCGATACCCATTTCCCGGATTACGATCCGGACGAATGGGAGTCGGTGTTCAGCGAGTTTCATGACGCCGACGCGCAGAACTCCAATAGCTACTGCTTTGAGATCCTCGAACGCCGTTAA	
8052	CARD	prokka_02217	contig_7	214923	60	20820	23169	-1	70	LptD	3005059.0	1617.82	1500.0	Strict	99.87	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		carbapenem; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESHTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTATGATCGTCCGCTCGTGGAAGGTCGTCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAACTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATTAACCAGGGGAATAGTCGCCTCCGCGCCGACGAAGTTCAGCTGCACCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGGCCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAAATGGTCGGACGCCAGGGACGCGGCACCGCCGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTCGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTCGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTTGCCGAGATCTGGAACGCCCGCTTCAAGCTTGGCTCTGTGCCGATTTTCTATAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATTACTCCGCACTATATGAACAAACGCGGCGGCGTGATGTGGGAAAACGAGTTCCGCTATCTGACCCAGCTCGGCAGCGGCTTAACTGAATTCGACTACCTGCCGTCGGATAAAGTCTACGAAGACGACCACTCGAGCGACAGCAACAGCCGCCGCTGGCTGTTCTACTGGAACCACTCGGGGGTTATCGATCAGGTATGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGACTTCAGCTCGAAATATGGTTCCAGTACCGACGGCTATGCGACGCAGAAATTCAGCGCCGGTTACGTCAACCAGAACTTTGACGCCACGGTATCGACCAAACAGTTCCAGGTCTTTGACCGCGAATCGAGCAACTCCTATTCGGCTGAGCCGCAGCTCGACGTCAACTACTACCAGAATGATGTCGGTCCGTTCGATACCCATCTCTATGGACAGGTTGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCCAACGGTTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACTCACTACCAGCAGAGCAACCTCGATAAGTACAATGCCGCCAACGGCACTGACTATAAAGAGTCCGTCAGCCGCGTAATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTTGAACGCGACCTGCAGGAGGGATTCACCCAAACGCTGGAACCGCGCGTGCAGTATCTGTACGTGCCGTACCGCGATCAGAGTGAAATCGGCAACTACGACTCCACGCTGTTGCAGTCGGATTACACCGGTCTGTTCCGCGACCGTACCTATAGCGGTCTGGACCGCATCGCGTCGGCTAATCAGGTCACCACCGGCCTCACCTCGCGCGTGTATGATGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACACACCGGTGATGACAACATCAACTGGGAGAACAACGATACCACGGGTTCACTGGTCTGGGCCGGCGATACCTACTGGCGCATTGCCGATGAATGGGGTCTGCGCGGGGGGATCCAGTACGATACGCGTCTGGATAACGTTGCCACTGGTAACGGCACCATTGAATACCGTCGCGATGAGAACCGCTTAGTCCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACGCTGCCGTCATATTCCACCGCGGCACAATATAAACAGGGTATTTCGCAGGTGGGGATGACCGCCAGTTGGCCGATTGTCGATCGCTGGTCCGTGGTCGGGGCCTACTACTACGATACTAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTGCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGTAAAGTCAACGGCTGGAACAGCAACGACAACGGCGGCGAGAGCAAATACGATAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGCTCGAACATTTTACCGTACCAGAGCTCCCTGTGA	
8052	CARD	prokka_02400	contig_8	213600	55	26039	29162	1	46	mdtB	3000793.0	1832.38	1800.0	Strict	90.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSICQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFERVIAVYGRWLSRVLNHPWLTLGVALSTLALSIILWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAERQRQVASIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVDGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEQDTEATPGLAALENIRLTSSDGGIVPLTAIATVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILAAEQSLDFPTDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA	ATGCAGGTGTTACCCCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCGATCCTGCTGGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCCCTGCCGGAGGTCGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAGCGCCAGTTCGGCCAGATGTCCGGCCTCAAGCAGATGTCGTCGCAAAGCTCTGGCGGCGCCTCGGTAGTCACGCTGCAGTTCCAGCTGACCCTGCCGCTGGACGTCGCCGAGCAGGAAGTGCAGGCGGCCATTAACGCCGCCACCAACCTGCTGCCGAGCGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACCCTCGCCGTCACCTCCTCCGCCATCCCGATGACCCAGGTTGAGGACATGGTGGAGACCCGGGTGGCGCAGAAGATCTCCCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCTATCACCAGCGCCAACGTTAACTCCGCGAAAGGCAGCCTCGACGGTCCGGCCCGCGCGGTGACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTATCGCCGGCTGATTATCGCTTATCAGAACGGGGCACCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTCGGGGCGTGGGCCAACCAGCAGCGGGCCATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATCATCGACACCGCCGACAGCATTTGCCAGATGCTGCCGCAGCTCACCGAGAGCCTGCCGAAATCGGTGAAGGTGCAGGTCCTCTCCGACCGGACCACCAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTACCTGTTTCTGCGCAACGTGCCGGCGACCATTATTCCCGGCGTCGCGGTGCCGCTGTCGCTGGTGGGCACTTTCGCGGTGATGGTGTTCCTCGACTTTTCGATCAATAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCCATCGTGGTGATCGAGAACATCTCGCGCTATATCGAAAAAGGCGAGAAGCCGCTGGCCGCCGCGCTGAAGGGCGCGGGGGAGATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGCCTGTTCCGCGAATTCGCCGTCACCCTTGCCGTCGCTATTCTTATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGCATGTTAAGCCACGAATCGCTGCGTAAGCAGAACCGATTCTCGCGGGCCAGCGAGCGTTTCTTCGAACGGGTGATCGCCGTCTATGGCCGCTGGCTGAGCCGGGTGCTGAACCATCCGTGGCTGACGCTCGGCGTCGCCCTGAGCACCCTGGCGCTGTCGATTATCCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGTACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGCATGGCCGAGCGCCAGCGGCAGGTGGCCAGCATTATCCTTAAGGATCCGGCAGTTGAGAGTCTGACCTCCTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGCCTGCAGATCAACCTCAAGCCGCTGGATGAACGCGACGATCGCGTCCAGACGGTGATAAGCCGCCTGCAGCAGGCGGTGGACGGCGTCCCCGGCGTGGCGCTCTACCTGCAGCCGACCCAGGACCTGACCATCGACACCACGGTGAGCCGCACCCAGTACCAGTTCACCCTGCAGGCAAACTCCCTCGAGGCGCTGAGCACCTGGGTGCCGCCGCTGCTCAGCCGCCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGATCGCGACAGCGCCAGCCGCCTCGGCATCTCAATGGCCGATGTCGATAATGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACTATTTACACTCAGGCGAATCAGTATCGCGTGGTGCTCGAGCAGGATACCGAGGCGACGCCGGGCCTGGCGGCGCTGGAGAATATCCGCCTCACCAGCAGCGACGGCGGCATCGTGCCGTTGACCGCCATCGCCACGGTGGAGCAGCGCTTTACCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTCCCGGACAACTACTCGCTGGGCGAAGCGGTGGAGGCGATCCTCGCCGCCGAACAGTCGCTGGATTTCCCGACCGATATTCGCACCCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTCGGCAGCACCGTCTGGCTGGTGGTCGCCGCGGTGGTGGCGATGTATATCGTGCTGGGGGTGCTGTACGAGAGCTTTATCCACCCGATCACGATTCTCTCCACCCTGCCCACCGCCGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCAGCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCTGAGCGCGAGCAGGGCATGCCGCCGCGGGAGGCGATCTACCAGGCCTGTCTGCTGCGTTTTCGGCCGATCCTGATGACTACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTCGGCGCCGAGCTGCGGCGTCCGCTGGGGATCGGCATGGTCGGCGGTCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA	
8052	CARD	prokka_02401	contig_8	213600	55	29162	32240	1	47	mdtC	3000794.0	1865.12	1800.0	Strict	91.61	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVQTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVLGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSDGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSSQPVSE	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTGCTGCCGGTAGCCCCGCTGCCGCAGGTGGACTTCCCGGTGATCATGGTTAGCGCCTCGCTGCCGGGAGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGCTCGCTCGGCAGCACCCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGACGTTCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGAATGCCCAGCCGGCCGACCTATCGCAAAGCCAATCCGTCGGATGCGCCGATCATGATCCTGACGCTGACCTCGGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATCGACGGCGTGGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCGCAGGCGCTGTTCAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAACCGCAGGGGGCGCTGGAGGACAGCGCGCACCGCTGGCAGGTGCAGACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCGCTGATCGTCCACTACCAGAATGGCGCCGCGGTGCGGCTGGGAGATGTCGCCACCGTCTCGGATTCGGTGCAGGACGTACGCAACGCCGGGATGACCAACGCCAAACCGGCGATCCTGCTGATGATCCGCAAACTGCCGGAAGCCAATATTATCCAGACGGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATTCCGGCGGCTATCGACCTGCAGATCGCCCAGGACCGCTCGCCGACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACGCTGGTGATTTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCCGTCGCCGTCCCGGTATCCTTAATCGGCACCTTCGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCTATCGTGGTGCTGGAGAATATCTCCCGCCATCTGGAGGCGGGGATGAAACCCCTGCAGGCGGCGCTGCAGGGGAGCCGCGAGGTCGGCTTTACCGTGCTGTCGATGAGCCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTGCCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAGCCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTGCAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCATAGCCGCCTGACCGGCCTGGTGGTGCTGGGCACCATCGCCCTCAGCGTCTGGCTCTACATTTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAGATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCCAACCTGTTCCTGATGGCGGTGCAGGATATCCGCGTCGGCGGCCGGCAGTCGAACGCCAGCTATCAGTACACCCTGCTGTCCGACGACCTGTCGGCGCTGCGCGAGTGGGAGCCGAAGATCCGCAAAGCGCTGGCGGCGCTGCCGGAGCTGGCGGACGTCAACTCCGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATCAGCGTCCAGGACGCCAACAACCTGCTGAACAACGCCTTTGGCCAGCGGCAGATCTCTACCATCTACCAGCCGCTCAACCAGTATAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTCGTCATTAACAGCGACGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAATGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCATCCACTATCTCCTTTAACCTGCCCACCGGCCGCTCGCTGTCGGAAGCCAGCGAGGCCATTGACCGCGCGATGACCCAGCTCGGGGTACCGTCGAGCGTGCGCGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTCGCGGCTATCGCCACGGTCTATATCGTGCTGGGGGTGCTATATGAGAGCTATGTGCATCCGTTGACCATCCTCTCGACGCTGCCCTCCGCCGGGGTGGGCGCTCTGCTGGCGCTGGAGATCTTCGATGCCCCGTTCAGCCTAATCGCCCTGATTGGGATTATGTTATTAATTGGCATCGTTAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTGGAGGCGCAGCGCAACGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTGCCGCTGGTGCTCTCCGGGGGCGATGGCTCTGAGCTGCGCCAGCCGCTGGGGATCACCATCGTCGGCGGTCTGGTGATGAGCCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTCTGCGGCTGCGTTTTTCGCGTCACTCCTCTCAACCGGTAAGCGAATAA	
8052	CARD	prokka_02404	contig_8	213600	55	35128	35851	1	43	baeR	3000828.0	455.677	450.0	Strict	91.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPVDENTPRILIVEDEPKLGQLLIDYLQAAGYAPALINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA	ATGACTGAATTGCCTGTAGATGAAAACACCCCACGCATCCTTATCGTGGAAGATGAACCGAAGCTCGGCCAGCTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTGCCTTGATTAACCACGGCGACAAGGTCCTGCCCTACGTCCGCCAGACGCCGCCGCATCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGTCTGACGCTGTGCCGGGAAATTCGCCGCTTCTCCGATGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATCGACCGTTTGCTGGGGCTGGAAATAGGCGCCGACGACTATATCTGCAAGCCCTACAGCCCGCGGGAAGTGGTCGCCCGGGTAAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGCGATCTGCAGGCGCTGGACGCCCAGAGCCCGCTGATTGTCGACGAAGGTCGTTTTCAGGCCTCCTGGCGCGACAAGCTGCTGGACCTCACTCCCGCCGAGTTCCGGCTGCTGAAAACCCTCTCCCAGGAGCCGGGCAAAGTGTTCTCCCGCGAACAGCTACTCAACCATCTGTATGACGATTATCGGGTAGTCACCGATCGCACCATCGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAGCAGTCGTTTATCCGCGCGGTGTATGGCGTTGGCTACCGCTGGGAAGCGGACGCCTGCCGGCTGGCGTAG	
8052	CARD	prokka_02853	contig_10	198101	57	121342	124456	-1	60	acrD	3000491.0	1956.03	1900.0	Strict	91.13	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGTLAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQPASGLGIKLASGANEMATAERVINRLNELAQFFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPVKPGESHERKGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLIYVVLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGTSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAGKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ	ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCATGGGTGCTGGCAATCCTGTTATGCCTGACGGGCACCCTTGCCATTTTGTCGCTGCCGGTTGAACAGTATCCCGACCTCGCCCCGCCGAATGTGCGGATCACCGCCAACTATCCCGGCGCCTCCGCGCAAACCCTGGAGAATACCGTCACTCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCCTCCCAGAGCAGCGCCACCGGCCAGGCGACGATCACCCTCAGCTTTACCGCCGGTACCGACCCGGATGAAGCCGTGCAGCAGGTTCAGAACCAGCTACAGTCGGCGATGCGTAAGCTGCCGCAGGCGGTGCAAAACCAGGGGGTGACGGTGCGCAAGACCGGTGATACCAATATCCTGACGCTCGCCTTCGTCTCCACTGACGGCAGTATGGATAAACAAGATATCGCCGACTACGTCGCCAGTAACATCCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGTTCGCAATACTCAATGCGCATCTGGCTCGACCCGGCGAAGCTCAACAGCTACCAGATGACCACCAAGGATGTTACCGACGCCATCAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTTGGCGGGACGCCTTCGGTCGATAAGCAAGCGCTGAACGCCACCATCAACTCGCAATCTCTGCTGCAAACCCCGGAGCAGTTCCGCAATATCACTCTGCGCGTCAATCAGGATGGTTCAGAGGTGACGCTGGGCGATGTCGCCACCGTCGAGATGGGGGCGGAGAAGTACGACTATCTTAGCCGCTACAACCGCCAGCCGGCCTCAGGCCTCGGGATCAAGCTGGCTTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCAATCGCCTCAATGAGCTGGCGCAGTTTTTCCCCCACGGTCTGGAATATAAGGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCCATCACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCGACCATCGCCGTGCCGGTGGTGCTGATGGGCACTTTCGCGGTGCTGTATGCCTGTGGCTACAGCATCAACACCCTGACGATGTTCGCGATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGAGCGAGGAGGGCCTGTCGCCACGCGAGGCGACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTATTCGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCAATCACTATCGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCTGCCCTTTGCGCCACGCTGCTTAAGCCTGTTAAGCCAGGTGAATCCCATGAAAGAAAAGGCTTCTTCGGCTGGTTCAACCGCACCTTCAACCGCAGCGCCAGCCGCTACGAAACCTTCGTCGGCAAAATACTGCACCGCTCGCTGCGCTGGATGCTGATCTACGTCGTCCTGCTCGGCGGGATGGTGTTCCTGTTTCTGCATTTGCCGACCTCGTTCCTGCCGCTGGAGGATCGCGGGATGTTCACCACCTCGGTCCAGTTGCCGAGCGGCAGCACCCAGCAGCAGACGCTGAAGGTGGTGCAGAAGGCGGAAGATTACTTCCTCAATAACGAGAAGCAGAACGTCGAGTCGGTGTTCGCTACCGTTGGCTCCGGCCCCGGCGGCAATGGGCAGAACGTGGCCCGTATGTTCGTTCGTCTCAAAGACTGGGACCAGCGCGACCCGCAAACCGGCACCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATTAACGAAGCGCGGGTTATCGCCAGCAGCCCGCCGGCGATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGATATGGAGCTGGAGGATCATGCCGGGAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTACTTGAGCTGGCCGGGAAAAATCCGCTGTTGACCCGCGTCCGGCATAACGGGCTCGATGACAGTCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCGCAGGCGCTTGGCGTCTCCATTGACGACATCAACGATACGCTGCAAACCGCGTGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGCCGGGTAAAGAAAGTCTACGTCCAGGCGGCGGCGAAATACCGGATGCTGCCTGACGATATCAATCTTTGGTACGTGCGCAACAGCAGCGGCACGATGGTGCCATTCTCGGCCTTCGCCACCTCGCGCTGGGAGACCGGCTCGCCGCGGCTGGAACGCTACAATGGCTACTCAGCGGTCGAGATCGTCGGTGAGGCGGCGCCGGGTATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGTTACCCACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCTCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCGGTGCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATTGGCGCCCTGCTGGCGACCTGGATGCGCGGGCTGGAGAATGACGTGTACTTCCAGGTGGGTCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTCAACGAGAAGGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCTTGCCGTCAGCGCCTGCGCCCCATCCTGATGACCTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGAGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCGATCTTTTTCGTGCCGCTGTTCTTTGTGCTGGTGCGTCGCCGTTTTCCGCTAAAGGAGCGTCCGCAATAA	
8052	CARD	prokka_02959	contig_11	192552	58	34475	35636	-1	49	Escherichia coli ampH beta-lactamase	3004612.0	687.567	500.0	Strict	85.19	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKTAPGSQAAYSNLAFDLLADALSTAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ	TTGAAACGTAGTTTGCTCATTTTTGCTGCGCTGTGCGCGGCGTCGTGGACCTCGGTGCAGGCCGCACAGCCTACCGTTGACCCGGTTTTCGCCTCGGATGTGGTCGATCGTTACGCCAATCATATCTACTACGGCAGCGGCGCCACCGGCATGGCGCTGGTGGTTATCGATGGCAATCAGCGTGTTTTTCGCAGCTTTGGCGAAACCCGCCCGGGGAATAATCAGCACCCGCAGCTCGACTCGGTGATCCGTATCGCCTCCCTCAGCAAACTGATGACCAGCGAGATGCTGGTGAAGCTGCTCGACCAGGGGGTGGTGAAACTCAACGATCCGCTGAGTAAATACGCCCCGCCGGGCGCCCGGGTGCCTGACTGGCAGGGAAAACCAATCACCCTGGTTAACCTCGCGACCCATACCAGCGCCCTGCCGCGCGAGCAGCCTGGCGGCGCCGCTCATCGTCCGGTGTTTGTCTGGCCGACCCGCCAGCAGCGCTGGAACTGGCTCTCTACCGCGACCCTGAAGACCGCGCCGGGCTCGCAGGCGGCCTACTCCAACCTGGCCTTCGATTTACTGGCGGACGCGCTCTCCACCGCCGCCGGCAAACCGTATCCGCAGCTGTTTGAAGAGCAGATCACCCGGCCGCTGGGGATGAAGGACACCACCTTTACCCCGTCACCGGATCAGTGCCAGCGGCTGATGATCCCGGAAAAAGGCGCCAGCCCATGCAACAACACCCTGGCGGCGATCGGCAGCGGCGGAGTCTACTCGACGCCGGGGGATATGATGCGCTGGATGCAGCAGTTCCTGTCATCCGATTTCTATACCCGCAGCCAGCAGGCCGACCGGATGCAGACGCTGATTTATCAGCGTAACCAGCTGACCCGGGTGATTGGTATGGACGTGCCGGGCCGCGCAGACGCGCTGGGCCTCGGCTGGGTGTATATGAAGCCGAAGAACGGCCATCCGGGGATTATTCAGAAAACCGGCGGCGGCGGCGGGTTTATCACCTATATGGCGATGAATCCGCAGGCTAACGTTGGCGCCTTTGTGGTGGTAACCCGCTCGCCGTTAACCCGCTTCAACAATATGAGCGATGGCATCAACGACCTGGTCAGCGAGTTGAGCGGCGCACAGCCCAACATGCAGACGGCCAGCCAGTAA	
8052	CARD	prokka_03085	contig_11	192552	58	161224	164371	-1	71	acrB	3000216.0	1941.39	1900.0	Strict	91.52	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAMALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKSEDIEHSHQVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATTATCATCATGCTGGCTGGGGGATTATCGATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACGGTGCAGAACACCGTAACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCAAATGGCGACTCCACCGGTACGGCAACCATTACGCTGACCTTCGAATCCGGTACCGATCCGGATATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCGCTGGCGACGCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATTAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTCATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGATCCGATTAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTATTCGGTTCCCAGTATGCGATGCGTATCTGGATGGATCCAAACAAACTGAACAACTTCCAGCTTACGCCGGTGGATGTGATCAGCGCCCTGAAAGCGCAGAACGCCCAGGTGGCCGCGGGCCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCCTCGATCATCGCGCAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGACGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGCGGCGAAAGCTATGACGTGGTGGCGAAGTTTAACGGCCAGCCGGCATCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCTATTCGCGCTGAACTGGCGAAGATGGAGCCGTTTTTCCCGTCGGGGATGAAGATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATTTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCCACCATCGCGGTACCGGTGGTCCTGTTAGGCACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTGGTGGTAGAGAACGTCGAGCGCGTGATGGCGGAAGAGGGTCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGACAGATTCAGGGCGCGCTGGTAGGTATCGCGATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTCTTCGGCGGCTCAACCGGGGCCATCTATCGCCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTGGCGTTAATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAACCCATTCAGAAAGGCAGCCATGGCGCGACCACCGGCTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGTTATCTGGTGCTGTATCTGATCATCGTGGTGGGTATGGCATGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCGGACGAGGACCAGGGTGTATTCCTGAGTATGGCGCAGCTGCCTGCCGGCGCCACCCAGGAGCGTACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGTTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTTTCGCTGAAAGACTGGAGCCAGCGTCCGGGTGAGGAAAACAAAGTTGAAGCGATCACCGCGAGAGCAATGGGCTACTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCGAGCTGATTGACCAGGGCGGTCTCGGCCACGAAAAACTGACCCAGGCGCGTAACCAACTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGCCCTAACGGTCTGGAAGATACACCGCAGTTTAAAATCGATATCGATCAGGAGAAAGCTCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTGGGCGCAGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATCATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATCGGCAAGTGGTATGTTCGCGGCAGCGATGGTCAGATGGTGCCGTTCTCTGCTTTCTCGACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCGTCACTGGAAATCCTCGGTCAGGCCGCGCCAGGCAAGAGTACCGGTGAGGCGATGGCGCTGATGGAAGAGCTGGCGGGTAAACTGCCTTCCGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGACTGTCCGGCAACCAGGCCCCTGCCCTGTATGCCATCTCGCTGATTGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTTATGCTGGTCGTCCCCTTGGGTGTGGTCGGTGCGCTGTTAGCCGCCACCTTCCGCGGGCTAACCAACGACGTTTACTTCCAGGTGGGTCTGCTGACCACCATCGGCCTGTCGGCGAAGAACGCAATATTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCAGTACGTATGCGTCTACGTCCAATCCTGATGACATCTCTGGCGTTCATCCTCGGGGTAATGCCGCTAGTTATCAGCTCCGGCGCCGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCGATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGCAAAAAATCGGAAGATATAGAGCACAGCCATCAGGTTGAGCATCATTAA	
8052	CARD	prokka_03086	contig_11	192552	58	164393	165587	-1	76	Klebsiella pneumoniae acrA	3004041.0	738.413	770.0	Strict	95.24	99.75	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAGGGAGCCCAGCACATGCCAGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGCACCAGCGCCTATCGCATTGCGGAAGTCCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTCTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTGGGCACCAAATATATTAGTCAACAAGACTACGATACCGCCGTTGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCTGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATCAGCGGCCGGATCGGTAAATCCGCCGTGACCGAAGGGGCGCTGGTACAGAATGGTCAAACGACCGCCCTGGCAACCGTACAGCAGCTGGATCCGATCTATGTTGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAGCAGGAGCTAGCCGACGGCCGCCTGAAACAGGAAAACGGCAAAGCGAAAGTGGAGCTGGTGACTAATGACGGTCTTAAGTATCCGCAGTCCGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCAATCACGCTACGCGCTATTTTCCCGAACCCGGATCACACCCTGCTACCGGGGATGTTCGTCCGTGCCCGTCTGGAAGAAGGGATTAACCCTGACGCCCTGCTGGTACCGCAACAGGGTGTTACCCGTACGCCGCGCGGCGACGCCAGCGTCATGGTAGTGGGGGAAGGCGATAAAGTCGAAGTCCGCCAGGTCACTGCTTCTCAGGCGATCGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACCGGCCTGCAAAAAATCAAACCAGGTGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA	loose hit with at least 95 percent identity pushed strict
8052	CARD	prokka_03123	contig_12	159039	59	14063	14486	1	45	FosA6	3004111.0	281.952	280.0	Strict	98.55	100.72	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFEDE	ATGCTGAGTGGACTGAATCACCTGACCCTGGCAGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTGCTGGGCATGACGCTGCATGCCCGCTGGGACAGCGGGGCTTATCTCTCCTGCGGCGATTTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTTACCCCGCCGGAGGAGAGCGACTACACCCATTATGCGTTTAGCATTAGCGAAGCCGATTTTGCTAGCTTCGCCGCCCGCCTTGAGGCTGCCGGCGTGGCGATCTGGAAGCTGAACCGTAGCGAAGGTGCCTCGCACTACTTTCTCGACCCCGACGGCCACAAGCTGGAGCTGCACGTCGGCAGTCTTGCCCAGCGGCTGGCCGCCTGCCGCGAACAGCCGTATAAGGGGATGGTGTTTTTTGAGGATGAGTAA	
8052	CARD	prokka_03458	contig_14	130127	53	48950	49325	-1	66	marA	3000263.0	243.432	230.0	Strict	92.74	97.64	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN	ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCAGGTTACTCCAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACTGGCCATTCCCTCGGCCAGTACATCCGCAGCCGTAAGCTGACGGAGATTGCGCAAAAGCTCAAGCAGAGCAATGAGCCAATCCTGTACCTGGCGGAACGCTACGGTTTCGAATCGCAGCAGACCTTGACGCGAACATTTAAAAACTATTTTGATGTTCCGCCCCACAAATATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTGCATCCGCTAAATAACTGA	
8052	CARD	prokka_04171	contig_21	86822	62	46802	47027	1	82	CBP-1	3004764.0	21.557	600.0	Strict	100.0	24.03	CBP beta-lactamase	protein homolog model	antibiotic inactivation		penam	MNHGQLSMKNVFPTLAVLFAIFSLTGCGLKGPLYFPPADKTAPPPTKPVNPGIQSATPDRNDRGDTGGPSQVNY	ATGAATCACGGGCAACTATCAATGAAAAACGTTTTTCCTACGCTTGCCGTTTTGTTTGCGATCTTCAGCCTGACCGGCTGCGGTCTGAAAGGGCCTCTCTATTTCCCACCGGCGGACAAAACCGCGCCGCCGCCGACCAAACCGGTTAACCCTGGCATTCAGAGCGCAACGCCGGATCGTAACGATCGTGGCGATACCGGTGGTCCGAGCCAGGTCAATTACTAA	loose hit with at least 95 percent identity pushed strict
8052	CARD	prokka_05403	contig_76	3594	53	333	681	1	64	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8052	CARD	prokka_05404	contig_76	3594	53	674	1514	1	52	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8052	CARD	prokka_05433	contig_88	2443	70	113	746	1	68	AAC(6')-Ib10	3002581.0	412.92	275.0	Strict	96.67	103.45	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MLRSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	ATGTTACGCAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	
8052	CARD	prokka_05434	contig_88	2443	70	821	1286	1	77	AAC(3)-Ia	3002528.0	311.997	300.0	Strict	98.7	100.0	AAC(3)	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQHQPDSDYLGNLLRSKTFIALAAFDQEAVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQGIATALINLLKHEANALGAYVIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT	ATGGGCATCATTCGCACATGTAGGCTCGGCCCTGACCAAGTCAAATCCATGAGGGCTGCTCTTGATCTTTTCGGTCGTGAGTTCGGAGACGTAGCCACCTACTCCCAACATCAGCCGGACTCCGATTACCTCGGGAACTTGCTCCGTAGTAAGACATTCATCGCGCTTGCTGCCTTCGACCAAGAAGCGGTTGTTGGCGCTCTCGCGGCTTACGTTCTGCCAAAGTTTGAGCAGGCGCGTAGTGAGATCTATATCTATGATCTCGCAGTCTCCGGCGAGCACCGGAGGCAAGGCATTGCCACCGCGCTCATCAATCTCCTCAAGCATGAGGCCAACGCGCTTGGTGCTTATGTGATCTACGTGCAAGCAGATTACGGTGACGATCCCGCAGTGGCTCTCTATACAAAGTTGGGCATACGGGAAGAAGTGATGCACTTTGATATCGACCCAAGTACCGCCACCTAA	
8052	CARD	prokka_05457	contig_102	1228	53	219	1035	-1	58	APH(3')-Ia	3002641.0	565.4590000000002	500.0	Perfect	100.0	100.0	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACCTGGATGCTGATTTATATGGGTATAGATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCAATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGCATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCTAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTGA	
8052	CARD	prokka_01710	contig_5	295825	59	71159	73418	-1	64	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1468.37	1400.0	Strict	94.28	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAELLLSELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTTLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVRMRAVWSKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSSRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQSELEKERDQLQAILASERKMNNLLKKELQADADAFGDDRRSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAQGLSYKAGDSWKASAKGKSNQPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALITLPDNAHVMPPLVIEDESDMLLAITAAGRMLMFPVSDLPQLSKGKGNKIISIPAAEAAAGQDGLAHLFVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGSLMRGLQKIDRVEIDSPRRAAAGDSEE	ATGAGCGATATGGCAGAGCGCCTTGCGCTGCATGAATTTACGGAAAATGCTTACCTGAACTACTCCATGTACGTGATCATGGACAGGGCATTACCGTTTATTGGCGATGGCTTAAAACCGGTCCAGCGTCGCATCGTCTATGCGATGTCCGAGCTGGGGCTGAACGCCAGCGCGAAATTCAAAAAGTCCGCCCGCACCGTCGGCGACGTGTTGGGTAAATATCACCCGCACGGCGACATTGCCTGCTATGAAGCGATGGTGCTGATGGCGCAGCCGTTCTCTTACCGCTATCCGCTGGTGGATGGTCAGGGAAACTGGGGGGCGCCGGACGATCCCAAATCTTTCGCCGCCATGCGTTACACCGAATCCCGCCTGTCGAAGTATGCCGAGCTGCTGCTCAGCGAGCTGGGGCAGGGGACGGTCGACTGGGTGCCAAACTTTGACGGCACGCTGCAGGAGCCGAAAATGCTGCCAGCGCGTCTGCCGAACATCCTGCTGAACGGTACCACCGGCATCGCGGTAGGCATGGCGACCGATATTCCTCCGCACAACCTGCGGGAAGTGGCCAAAGCGGCGATTACGCTGATTGAGCAGCCGAAAACCACCCTCGACGAACTGCTGGATATCGTACAGGGGCCGGATTTCCCGACCGAGGCGGAGATCATCACCTCGCGGGCGGAAATTCGCAAAATCTACCAGAACGGGCGCGGCTCAGTGCGCATGCGCGCGGTGTGGAGTAAAGAGGACGGCGCGGTGGTGATCAGTGCGCTGCCGCATCAGGTCTCTGGCGCCAAAGTGCTGGAGCAGATTGCGGCGCAGATGCGCAATAAAAAGCTGCCGATGGTTGACGATCTGCGCGACGAATCGGACCACGAAAACCCGACCCGTCTGGTGATTGTCCCGCGCTCCAGCCGGGTGGATATGGAACAGGTGATGAACCACCTGTTCGCCACCACCGATCTGGAGAAGAGCTACCGCATCAACCTCAATATGATCGGCCTTGACGGCCGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCAGCGAGTGGCTGGTGTTCCGTCGCGATACCGTGCGTCGCCGTCTAAACCATCGGTTAGAGAAAGTGCTGAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTTCTTAATATCGATGAAGTGATTGAGATCATCCGCACTGAAGATGAACCGAAGCCGGCCCTGATGTCGCGCTTTGGCATCAGCGAAACCCAGGCGGAAGCGATTCTGGAATTAAAACTGCGCCACCTCGCCAAACTGGAAGAGATGAAGATCCGCGGCGAGCAGAGCGAGCTGGAAAAAGAGCGCGACCAGCTGCAGGCGATTCTGGCGTCTGAACGTAAGATGAACAACCTGCTGAAAAAAGAGCTGCAGGCCGATGCCGATGCCTTCGGCGACGACCGTCGCTCGCCGCTTCACGAGCGTGAAGAAGCGAAAGCGATGAGCGAGCATGACATGCTGCCGTCTGAGCCGGTGACTATCGTTCTGTCGCAGATGGGCTGGGTGCGCAGCGCCAAAGGACACGACATTGACGCCCAGGGCTTGAGCTATAAGGCGGGCGACAGCTGGAAAGCCTCGGCGAAGGGCAAGAGCAACCAGCCGGTGGTGTTTATCGATACCACCGGACGCAGCTATGCCATCGATCCGATTACTCTGCCTTCCGCGCGTGGCCAGGGTGAACCGCTTACCGGCAAACTGACCCTGCCGCCGGGCGCGACCGTGGAGCATATGCTAATGGAAAGCGACGATCAGAAACTGCTGATGGCTTCCGACGCGGGCTACGGTTTCGTCTGTACCTTCAACGATCTGGTGGCGCGCAACCGTGCCGGGAAAGCGCTAATCACCCTGCCTGACAACGCGCACGTGATGCCGCCGCTGGTGATTGAGGATGAGTCCGATATGCTGCTGGCCATCACCGCCGCCGGGCGGATGCTGATGTTCCCGGTCAGCGATCTGCCGCAGCTGTCGAAAGGCAAGGGCAACAAAATTATCAGCATTCCGGCGGCGGAAGCCGCAGCCGGCCAGGACGGTCTGGCACATCTGTTTGTTCTGCCGCCGCAGAGTACGCTGACCATTCACGTCGGCAAACGGAAGATCAAACTGCGTCCGGAAGAGCTGCAAAAAGTCACCGGCGAGCGCGGCCGCCGCGGTTCGCTGATGCGCGGGCTGCAGAAAATTGACCGCGTGGAAATTGACTCGCCGCGTCGTGCCGCGGCAGGCGATAGCGAAGAGTAA	
8052	CARD	prokka_02254	contig_7	214923	60	68806	70573	1	78	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	595.89	500.0	Strict	52.37	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTGCTGGCGCTGGCTTTTCTGCTGGGGCGCGTCGCCTGGCTACAGGTGATCAGCCCCGATATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTGTCCACCGCGCGCGGGATGATTACCGATCGCTCCGGACGTCCGCTGGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGACCCGAAAGAGCTCCATGACGCCGGCGGGGTTACCCTGGATACGCGCTGGAAGGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGGTTTATCTATCTGGCGCGTCAGGTTAACCCTGACATGGCCGATTACATCAAGAAGCTGAAGCTGCCGGGCATTCATCTGCGCGAAGAATCCCGTCGTTACTACCCTTCCGGGGAAGTAACCGCTCACCTCATCGGCTTTACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAGAAAAGCTTTGATAAATGGCTTACCGGTCAGCCGGGCGAGCGTATCGTGCGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCTACCGATAGCCAGGCAGCGCACAACCTGGCGCTGAGTATCGACGAACGCCTGCAGGCGCTGGTCTATCGCGAGCTAAACAACGCCGTGGCCTTTAACAAAGCCGAGTCGGGCAGCGCCGTGTTAGTGGATGTTAACACCGGTGAAGTGCTGGCGATGGCCAACAGTCCATCCTATAACCCGAACAACTTCGCCGGTACGGCAAAAGACACCATGCGTAACCGTGCGATTACCGACGTGTTTGAGCCGGGTTCGACGGTGAAACCGATGGTGGTCATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTATGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCGTTGTCGATTACCAAGGTTGATCCTCCGGTTCCGGGCGAGCGCGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGTGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTATATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
8052	CARD	prokka_02513	contig_8	213600	55	165028	167662	-1	58	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1642.48	1500.0	Strict	92.23	100.23	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMATNIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATGVRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERNGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTCAACATTGAGGAAGAGCTTAAGAACTCTTATCTGGATTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGATGTCCGAGATGGCCTGAAGCCGGTACACCGTCGCGTACTTTACGCCATGAACGTATTGGGCAATGACTGGAACAAAGCCTATAAAAAATCAGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCACCCGCACGGCGACATCGCGGTATACGACACCATCGTGCGTATGGCGCAGCCGTTCTCGCTGCGTTACATGCTGGTGGACGGCCAGGGTAACTTTGGTTCCATCGACGGCGACTCCGCCGCGGCGATGCGTTATACCGAAATTCGTCTGGCGAAAATCGCTCATGAGCTGATGGCCGATCTTGAAAAAGAGACGGTCGATTTCGTCGACAACTATGACGGTACGGAGCGTATTCCGGACGTCATGCCGACCAAAATTCCTAACCTGCTGGTGAACGGCGCCTCCGGGATCGCCGTAGGGATGGCCACCAACATACCGCCGCATAACCTGACGGAAGTGATTAACGGCTGTCTGGCGTATGTTGACGATGAAGACATCAGCATTGAAGGGCTGATGGCGCATATTCCTGGCCCTGATTTCCCGACCGCCGCCATTATCAATGGCCGTCGCGGCATCGAAGAGGCCTACCGCACCGGTCGCGGTAAAGTGTACATCCGCGCGCGCGCGGAAGTGGAAGTGGACGCGAAATCCGGCCGCGAAACCATCATCGTGCACGAAATTCCGTATCAGGTGAACAAAGCGCGCCTGATCGAGAAAATCGCCGAGCTGGTCAAAGAAAAACGCGTGGAAGGCATCAGCGCGCTGCGTGACGAGTCTGATAAAGACGGGATGCGCATCGTGATTGAAGTGAAGCGCGATGCGGTAGGGGAAGTGGTGCTTAACAACCTCTATTCCCAGACCCAGCTGCAGGTCTCCTTCGGCATCAACATGGTAGCTCTGCACCATGGTCAGCCGAAGATCATGAACCTGAAGGACATCATCGCCGCGTTTGTACGCCACCGCCGTGAAGTGGTGACCCGTCGTACGATTTTCGAACTGCGCAAAGCGCGCGACCGGGCGCATATCCTCGAAGCGCTGGCCGTTGCGCTGGCCAACATCGACCCGATTATCGAACTGATCCGTCGCGCGCCGACCCCGGCAGAAGCGAAAACGGCGCTGGTTGCCCAGGCGTGGGATCTTGGTAACGTCGCGGCGATGCTGGAGCGCGCCGGGGATGACGCCGCGCGTCCGGAATGGCTGGAGCCAGAGTTCGGCGTACGCGACGGTAAATACTATCTGACCGAGCAGCAGGCTCAGGCGATTCTGGATCTGCGTCTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAATATAAAGAGCTGCTGGAGCAGATCGCGGAGCTGCTGCACATTCTCGGCAGCGCCGACCGTCTGATGGAAGTGATTCGCGAAGAGCTGGAGCTGATCCGCGACCAGTTCGGCGACGAACGTCGTACCGAAATCACCGCCAACAGCGCTGATATTAACATCGAAGATCTGATCAACCAGGAAGATGTGGTGGTCACCCTGTCGCATCAGGGGTATGTGAAGTATCAGCCGCTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGCAAATCGGCAGCGCGCATTAAAGAAGAAGACTTTATCGACCGCCTGCTGGTGGCCAACACCCATGACACCATCCTCTGCTTCTCAAGCCGCGGCCGTCTGTACTGGATGAAGGTCTATCAGCTGCCGGAAGCCAGCCGCGGCGCGCGCGGTCGGCCGATCGTCAACCTGCTGCCGCTGGAAGCCGATGAGCGCATCACCGCCATCCTGCCGGTCCGCGAGTACGAAGAGGGCGTCAACGTCTTTATGGCGACCGCCAGCGGTACCGTGAAGAAAACCGCGCTGACCGAGTTCAGCCGTCCGCGTTCCGCCGGTATCATCGCGGTCAACCTGAACGAAGGCGATGAGCTGATCGGCGTCGATCTGACCTCTGGTCAGGATGAAGTGATGCTGTTCTCCGCGGCCGGTAAGGTTGTACGCTTCAAGGAAGACGCCGTTCGCGCCATGGGCCGTACCGCCACCGGCGTACGCGGTATTAAGCTTGCGGAAAACGACAGCGTCGTCTCGCTGATTATTCCACGCGGCGAAGGCGCGATCCTGACGGTGACGCAAAACGGTTACGGTAAACGTACCGCGGCGGCGGAGTATCCGACCAAGTCGCGCGCCACCCAGGGCGTTATTTCGATCAAAGTCACCGAGCGTAACGGTTCCGTGGTCGGCGCCGTGCAGGTGGATGACTGCGATCAGATCATGATGATCACCGACGCCGGGACGCTGGTGCGTACCCGCGTTTCCGAGGTGAGCATCGTGGGCCGTAACACCCAGGGCGTGATCCTCATCCGCACCGCGGAAGATGAAAACGTGGTGGGTCTGCAGCGCGTGGCTGAGCCGGTGGATGATGAAGAGCTGGATGCCATCGACGGTAGCGCGGCGGAAGGCGATGACGATATCGCCCCGGAAGCGGATACCGATGACGACATCGCCGAAGACGAAGAATAA	
8052	CARD	prokka_03807	contig_17	103110	55	52905	54297	1	69	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	864.3739999999998	850.0	Strict	95.03	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAVGCICLMAIVAIFEERKIRREKKNRILQTA	ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACCATGTACCTGATCCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGCTGAGCATGACCCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAGACGCTGGTCTCTTATTATGCCGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCTACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACTTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTTGGCTTTATCGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCGAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAGGTCGGCGCGCTGGTCGGCACGCTGCTGTGGGGCTGGTTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACCCTTGGGGTTTACCAACACGCCAGCAACCAGTACGTCTATCTGGCCTCGTTATTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGAATCAAGGGCACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAACTGGGTCTCGGGATGATCGCCGACGGCACCCCGGTCTTCGGCCTGACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCGTCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTTGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACCGCCTGA	
8052	CARD	prokka_03459	contig_14	130127	53	49345	49780	-1	67	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	252.292	210.0	Strict	83.33	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux	S3N	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKNTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIERLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP	ATGAAAAATACCAGCGACCTGTTCAACGAGATGATTCCGCTGGGCCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAACGACTACCTCTCACCCATGGATATTACCGCGACCCAGTTTCGGGTGCTCTGTTCCATTCGTTGCGAGGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGACCCGGGCGCGATGACGCGTATGCTCGACCGCCTGGCGTGTAAAGGCTGGATTGAACGGTTACCCAACCCCGCTGACAAGCGCGGTGTGCTGGTGCAGTTGACGCCAGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACAAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTCCTCAAGAAGGTCCTGCCGTAA	
8083	BLDB	prokka_04733	contig_25	67797	154	58115	58997	1	145	KPC-2		92.8		Perfect	100.0	99.66	carbapenem-hydrolyzing class A beta-lactamase KPC-2	protein homolog model			Beta-Lactam	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA	
8083	BLDB	prokka_04965	contig_30	34776	164	33807	34668	-1	192	TEM-1		80.1		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase TEM-1	protein homolog model			Beta-Lactam	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	ATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCTGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	
8083	BLDB	prokka_05446	contig_67	1443	164	293	629	1	183	OXA-9		146.9		Strict	100.0	40.15	oxacillin-hydrolyzing class D beta-lactamase OXA-9	protein homolog model			Beta-Lactam	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVV	ATGAAAAAAATTTTGCTGCTGCATATGTTGGTGTTCGTTTCCGCCACTCTCCCAATCAGTTCCGTGGCTTCTGATGAGGTTGAAACGCTTAAATGCACCATCATCGCAGACGCCATTACCGGAAATACCTTATATGAGACCGGAGAATGTGCCCGTCGTGTGTCTCCGTGCTCGTCTTTTAAACTTCCATTGGCAATCATGGGGTTTGATAGTGGAATCTTGCAGTCGCCAAAATCACCTACGTGGGAATTGAAGCCGGAATACAACCCGTCTCCGAGAGATCGCACATACAAACAAGTCTATCCGGCGCTATGGCAAAGCGACTCTGTTGTCTAG	
8083	CARD	prokka_00163	contig_1	499605	102	162102	165216	-1	100	acrD	3000491.0	1951.79	1900.0	Strict	91.03	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGALAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQPASGLGIKLASGANEMATAERVINRLNELAQFFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPVKPGESHERTGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLIYVLLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGTSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAGKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ	ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCATGGGTGCTGGCAATCCTGTTATGCCTGACGGGCGCCCTTGCCATTTTGTCGCTGCCGGTTGAACAGTATCCCGACCTCGCCCCGCCGAATGTGCGGATCACCGCCAACTATCCCGGCGCTTCCGCGCAAACCCTGGAGAATACCGTCACTCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCCTCCCAGAGCAGCGCCACCGGCCAGGCGACGATCACCCTCAGCTTTACCGCCGGTACCGACCCGGATGAAGCCGTGCAGCAGGTTCAGAACCAGCTACAGTCGGCGATGCGTAAGCTGCCGCAGGCGGTGCAAAACCAGGGGGTGACGGTGCGCAAGACCGGTGATACCAATATCCTGACGCTCGCCTTCGTCTCCACTGACGGCAGTATGGATAAACAAGATATCGCCGACTACGTCGCCAGTAACATCCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGTTCGCAATACTCAATGCGCATCTGGCTCGACCCGGCGAAGCTCAACAGCTACCAGATGACCACCAAGGATGTTACCGACGCCATCAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTTGGCGGGACGCCTTCGGTCGATAAGCAAGCGCTGAACGCCACCATCAACTCGCAATCTCTGCTGCAAACCCCGGAGCAGTTCCGCAATATCACTCTGCGCGTCAATCAGGATGGTTCAGAGGTGACGCTGGGCGATGTCGCCACCGTCGAGATGGGGGCGGAGAAGTACGACTATCTTAGCCGCTACAACCGCCAGCCGGCCTCAGGCCTCGGGATCAAGCTGGCTTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCAATCGCCTCAATGAGCTGGCGCAGTTTTTCCCCCACGGTCTGGAATATAAGGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCCATCACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCGACCATCGCCGTGCCGGTGGTGCTGATGGGCACTTTCGCGGTGCTGTATGCCTGTGGCTACAGCATCAACACCCTGACGATGTTCGCGATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGAGCGAGGAGGGCCTGTCGCCACGCGAGGCGACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTATTTGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCAATCACTATCGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCTGCCCTTTGCGCCACGCTGCTTAAGCCTGTTAAGCCAGGTGAATCCCATGAAAGAACAGGCTTCTTCGGCTGGTTCAACCGCACCTTCAACCGCAGCGCCAGCCGCTACGAAACCTTCGTCGGCAAAATACTGCACCGCTCGCTGCGCTGGATGCTGATCTACGTCCTCCTGCTCGGCGGGATGGTGTTCCTGTTTCTGCATTTGCCGACCTCGTTCCTGCCGCTGGAGGATCGCGGGATGTTCACCACCTCGGTCCAGTTGCCGAGCGGCAGCACCCAGCAGCAGACGCTGAAGGTGGTGCAGAAGGCGGAAGATTACTTCCTCAATAACGAGAAGCAGAACGTCGAGTCGGTGTTCGCTACCGTTGGCTCCGGCCCCGGCGGCAATGGGCAGAACGTGGCCCGCATGTTCGTTCGTCTCAAAGACTGGGACCAGCGCGACCCGCAAACCGGCACCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATTAACGAAGCGCGGGTTATCGCCAGCAGCCCGCCGGCGATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGATATGGAGCTGGAGGATCATGCCGGGAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTACTTGAGCTGGCCGGGAAAAATCCGCTGTTGACCCGCGTCCGGCATAACGGGCTCGATGACAGTCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCGCAGGCGCTGGGCGTCTCCATTGACGACATCAACGATACGCTGCAAACCGCGTGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGCCGGGTAAAGAAAGTCTACGTCCAGGCGGCGGCGAAATACCGGATGCTGCCTGACGATATCAATCTTTGGTACGTGCGCAACAGCAGCGGCACGATGGTGCCATTCTCGGCCTTCGCCACCTCGCGCTGGGAGACCGGCTCGCCGCGGCTGGAGCGCTACAATGGCTACTCAGCGGTGGAGATCGTCGGTGAGGCGGCGCCGGGTATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGTTACCCACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCTCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCAGTGCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATTGGCGCCCTGCTGGCGACCTGGATGCGCGGGCTGGAGAATGACGTGTACTTCCAGGTGGGTCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTCAACGAGAAGGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCTTGCCGTCAGCGCCTGCGCCCCATCCTGATGACCTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGAGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCGATCTTTTTCGTGCCGCTGTTCTTTGTGCTGGTGCGTCGCCGTTTTCCGCTAAAGGAGCGTCCGCAATAA	
8083	CARD	prokka_00436	contig_1	499605	102	463494	464217	-1	102	baeR	3000828.0	452.981	450.0	Strict	91.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPGDENTPRILIVEDEPKLGQLLIDYLQAAGYAPALINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA	ATGACTGAATTGCCTGGAGATGAAAACACCCCACGCATCCTTATCGTGGAAGATGAACCGAAGCTCGGCCAGCTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTGCCTTGATTAACCACGGCGACAAGGTCCTGCCCTACGTCCGCCAGACGCCGCCGCACCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGTCTGACGCTGTGCCGGGAAATTCGCCGCTTCTCCGATGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATCGACCGTTTGCTGGGGCTGGAAATAGGCGCCGACGACTATATCTGCAAGCCCTACAGCCCCCGGGAAGTGGTCGCCCGGGTAAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGCGATCTGCAGGCGCTGGACGCCCAGAGCCCGCTGATTGTCGACGAAGGTCGTTTTCAGGCCTCCTGGCGCGACAAGCTGCTGGACCTCACTCCCGCCGAGTTCCGGCTGCTGAAAACCCTCTCCCAGGAGCCGGGCAAAGTGTTCTCCCGCGAACAGCTACTCAACCATCTGTATGACGATTATCGGGTAGTCACCGATCGCACCATCGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAGCAGTCGTTTATCCGCGCGGTGTATGGCGTTGGCTACCGCTGGGAAGCGGACGCCTGCCGGCTGGCGTAG	
8083	CARD	prokka_00439	contig_1	499605	102	467105	470183	-1	88	mdtC	3000794.0	1865.12	1800.0	Strict	91.61	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVQTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVLGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSDGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSSQPVSE	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTACTGCCGGTGGCCCCGCTGCCGCAGGTGGACTTCCCGGTGATCATGGTTAGCGCCTCGCTGCCGGGAGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGCTCGCTCGGCAGCACCCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGACGTTCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGAATGCCCAGCCGGCCGACCTATCGCAAAGCCAATCCGTCAGATGCGCCGATCATGATCCTGACGCTGACCTCGGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATCGACGGCGTGGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCACAGGCGCTGTTTAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAACCGCAGGGGGCGCTGGAGGACAGCGCGCACCGCTGGCAGGTGCAGACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCACTGATCGTCCACTATCAAAATGGCGCCGCGGTGCGGCTGGGAGATGTCGCTACCGTCTCGGATTCGGTGCAGGACGTACGCAACGCCGGGATGACCAACGCCAAACCGGCGATCCTGCTGATGATCCGCAAACTGCCGGAAGCCAATATCATTCAGACAGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATTCCGGCGGCTATCGACCTGCAGATCGCCCAGGACCGCTCGCCTACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACGCTGGTGATTTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCCGTCGCCGTCCCGGTTTCCTTAATCGGCACCTTCGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCTATCGTGGTGCTGGAGAATATCTCCCGCCATCTGGAAGCGGGGATGAAACCGCTGCAGGCGGCGCTGCAGGGGAGCCGTGAGGTCGGCTTTACCGTGCTCTCGATGAGCCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTACCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAGCCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTGCAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCATAGCCGCCTGACCGGCCTGGTGGTGCTGGGCACCATCGCCCTCAGCGTCTGGCTCTACATTTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAGATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCCAACCTGTTCCTGATGGCGGTGCAGGATATCCGCGTCGGCGGCCGGCAGTCGAACGCCAGCTATCAGTACACCCTGCTGTCCGACGACCTGTCGGCGCTGCGCGAGTGGGAGCCGAAGATCCGCAAAGCGCTGGCGGCGCTGCCGGAGCTGGCGGACGTCAACTCGGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATCAGCGTCCAGGACGCCAACAACCTGCTGAACAACGCCTTTGGCCAGCGGCAGATCTCTACCATCTACCAGCCGCTCAACCAGTATAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTCGTCATTAACAGCGACGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAATGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCATCCACTATCTCCTTTAACCTGCCCACCGGCCGCTCGCTGTCGGAAGCCAGCGAGGCCATTGACCGCGCGATGACCCAGCTCGGGGTGCCGTCGAGCGTGCGCGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTTGCGGCTATCGCCACGGTCTATATCGTGCTGGGGGTGCTATATGAGAGCTATGTGCATCCGTTGACCATCCTCTCGACGCTGCCCTCCGCCGGGGTGGGCGCTCTGCTGGCGCTGGAGATCTTCGATGCCCCGTTCAGCCTAATCGCCCTGATTGGGATTATGTTATTAATTGGCATCGTTAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTGGAGGCGCAGCGCAACGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTGCCGCTGGTGCTCTCCGGGGGCGATGGCTCTGAGCTGCGCCAGCCGCTGGGGATCACCATCGTCGGCGGTCTGGTGATGAGTCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTCTGCGGCTGCGTTTTTCGCGTCACTCCTCTCAACCGGTAAGCGAATAA	
8083	CARD	prokka_00440	contig_1	499605	102	470183	473306	-1	87	mdtB	3000793.0	1832.0	1800.0	Strict	89.9	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSQASERFFERVIAVYGRWLSRVLNHPWLTLGVALSTLALSIILWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAERQRQVASIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVDGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANHYRVVLEQDTEATPGLAALENIRLTSSDGGIVPLTAIATVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILAAEQSLDFPTDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA	ATGCAGGTGTTACCCCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCGATCCTGCTGGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCCCTGCCGGAGGTCGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAGCGCCAGTTCGGCCAGATGTCCGGCCTCAAGCAGATGTCGTCGCAAAGCTCCGGCGGCGCCTCGGTAGTCACGCTGCAGTTCCAGCTGACCCTGCCGCTGGACGTCGCCGAGCAGGAAGTGCAGGCGGCCATTAACGCCGCCACCAACCTGCTGCCGAGCGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACCCTCGCCGTCACCTCCTCCGCCATCCCGATGACCCAGGTTGAGGACATGGTGGAGACCCGGGTGGCGCAGAAGATCTCCCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCTATCACCAGCGCCAACGTTAACTCCGCGAAAGGCAGCCTCGACGGCCCGGCCCGCGCGGTGACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTATCGCCGGCTGATTATCGCTTATCAGAACGGGGCGCCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTCGGGGCGTGGGCCAACCAGCAGCGGGCCATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATCATCGACACCGCCGACAGCATTCGCCAGATGCTGCCGCAGCTCACCGAGAGCCTACCGAAATCGGTGAAGGTGCAGGTCCTCTCCGACCGGACCACCAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTACCTGTTTCTGCGCAACGTGCCGGCGACCATTATTCCCGGCGTCGCGGTGCCGCTATCGCTGGTGGGCACTTTCGCGGTGATGGTATTCCTCGACTTCTCGATCAATAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCCATCGTGGTGATCGAGAACATCTCGCGCTATATCGAAAAAGGCGAGAAGCCGCTGGCCGCCGCGCTGAAGGGCGCGGGGGAGATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGCCTGTTCCGCGAATTCGCCGTCACCCTTGCCGTCGCTATTCTTATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGCATGTTAAGCCACGAATCGCTGCGTAAGCAGAACCGATTCTCGCAGGCCAGCGAGCGTTTCTTCGAACGGGTGATCGCCGTCTACGGCCGCTGGCTGAGCCGGGTGCTGAATCATCCGTGGCTGACGCTCGGCGTCGCCCTGAGCACCCTGGCGCTGTCGATTATCCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGTACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGCATGGCCGAGCGCCAGCGGCAGGTGGCCAGCATTATCCTTAAGGATCCGGCGGTGGAGAGTCTGACCTCCTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGCCTGCAGATCAACCTCAAGCCGCTGGACGAACGCGACGACCGCGTCCAGACGGTGATTAGCCGCCTGCAGCAGGCGGTGGACGGCGTCCCCGGCGTGGCGCTCTACCTGCAGCCGACCCAGGACCTGACCATCGACACCACGGTGAGCCGCACCCAGTATCAGTTCACCCTGCAGGCAAACTCCCTCGAGGCGCTGAGCACCTGGGTGCCGCCGCTGCTCAGCCGCCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGATCGCGACAGCGCCAGCCGCCTCGGTATCTCAATGGCCGATGTCGATAATGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACTATTTACACTCAGGCGAATCATTATCGCGTGGTGCTCGAGCAGGATACCGAGGCGACGCCGGGCCTGGCGGCGCTGGAGAATATCCGTCTCACCAGCAGCGACGGCGGCATCGTGCCGTTGACCGCCATCGCCACGGTGGAGCAGCGCTTTACCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTCCCGGACAACTACTCGCTGGGCGAAGCGGTGGAGGCGATCCTCGCCGCCGAACAGTCGCTCGATTTTCCGACCGATATTCGCACCCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTCGGCAGCACCGTCTGGCTGGTGGTCGCCGCGGTGGTGGCGATGTATATCGTGCTGGGGGTGCTGTACGAGAGCTTTATCCATCCGATCACGATTCTCTCCACCCTGCCCACCGCCGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCAGCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCTGAGCGCGAGCAGGGCATGCCGCCGCGGGAGGCGATCTACCAGGCCTGTCTGCTGCGTTTTCGGCCGATCCTGATGACCACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTCGGCGCCGAGCTGCGGCGTCCGCTGGGGATCGGCATGGTCGGCGGTCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA	
8083	CARD	prokka_01133	contig_3	375298	98	283981	284167	1	134	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTGTCTGTTCACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	
8083	CARD	prokka_01146	contig_3	375298	98	292026	293565	-1	110	Klebsiella pneumoniae KpnH	3004597.0	937.947	700.0	Strict	94.02	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATTGCCGGCAACCTTGGCTCGTCGCTGAGCCAGGGGACCTGGGTCATCACCTCGTTCGGGGTCGCTAACGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGCGTCGGCGAGGTGAAGCTGTTCCTGTGGTCAACCACCGCTTTCGCCATTGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTCATTCAGGGGATCGTCGCCGGACCGCTGATCCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCCCCGGCGAAGCGCTCTATCGCTCTGGCGCTGTGGTCAATGACGGTGATTGTCGCGCCCATCTGCGGTCCGATCCTCGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGGATCGACGGTGTCGGTCTGGCGCTGCTGATCATCGGTATCGGTAGCCTGCAGGTGATGCTGGACCGGGGTAAAGAGCTGGACTGGTTCTCCTCCAATGAGATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTAACCGACGATAACCCGATTGTCGATCTGTCGCTATTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGTATCAGTCTGGCCTATATGCTCTACTTCGGCGCCATCGTACTGCTGCCGCAGCTGTTGCAGGAGGTCTACGGCTACACCGCGACCTGGGCCGGCCTGGCGTCGGCGCCGGTGGGGGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTCGCGCATAAGCTCGACATGCGGCGGCTGGTCACCTTCAGCTTTATTATGTACGCGGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCACAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTCTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCCTGTCGAACTTCACCCGTACCCTTGCCGGCTCCATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCATCATGCGCAGCTCACCGAATCGGTGACCCCCTTTAACCCCAACGCGCAGCAGATATACGATCAGCTGCAGGGCATGGGAATGACGCAGCAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACCAACCAGGGGCTGATTATCTCCGCCAACGAAATCTTCTGGATTTCTGCGGCTATTTTCATCCTGCTGTTGGGGCTGGTGTGGTTCGCCAGACCACCGTTCAGCGCCGGCGGAGGCGGCGGCGGCGCGCACTAA	
8083	CARD	prokka_01147	contig_3	375298	98	293580	294753	-1	104	Klebsiella pneumoniae KpnG	3004588.0	788.875	700.0	Strict	99.74	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	ATGAGTGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGAAAGCGTAAAGGCGCCCTTCTGTTGCTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTGGCAGGGAATCAGGTACAAATTATGGCTCAGGTCGCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACTCTCGATCGGACCGATGCCCAACAGGCGTTTGAAAAGGCTAAGACCCAACTGGCCGCCAGCGTCCGTCAGACCCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCAAATATCGACGTCAAAAAAACCGCCCTCGCCCAGGCGCAGGCTGACCTGAACCGCCGCATCCCGCTGGGCGCCGCGAACCTCATTGGCCGCGAAGAGCTGCAGCACGCCCGCGATACCGTCGCCAGCGCACAGGCCGAACTCGACGTGGCAATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGCACCAGGCTGGAACAGCAGCCGGCGGTGCTCCAGGCGGCCACTGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATCGGCACCACCACGCCGCTGATGGCGGTGGTCCCGGCGACCAACCTGTGGATCGATGCTAACTTTAAAGAGACTCAGCTGGCGCATATGCGTATCGGCCAGCCGGCCACCGTGATCAGCGATATCTATGGCGATGACGTGAAATACACCGGTAAAGTGGTCGGTCTGGATATGGGCACCGGCAGCGCCTTCTCTCTGCTGCCGGCGCAGAATGCTACCGGCAACTGGATCAAAGTGGTACAGCGTCTGCCGGTTCGTATCGAGCTGGATGAAAAACAACTAGCGGAACACCCGCTGCGCATCGGCCTCTCGACGCTGGTGGAAGTCAACACCACCGATCGCGATGGTGAAATGCTGGCCAGCCAGGTGCGGAGCTCCCCGGTTTACGAGAGCAATGCCCGTGAAATCGCTCTCGATCCGGTTAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA	
8083	CARD	prokka_01148	contig_3	375298	98	294878	295409	-1	137	emrR	3000516.0	338.961	280.0	Strict	92.57	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR	ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTCCGCGCCAGCCGCCATGAAGATTTCCCGTTTCAGGAGATCCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCACAGGAAAACCACAGCATCCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCACGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAGCGCCGCGAGAGCGATAACGATCGTCGCTGTTTGCATCTGCAACTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTTAGCACCAGCGAAAAAGATCAGCTCGAACACATCACCCGCAAACTCCTGAGCCGCCTTGATCAGATGGAAGAAGAAGGCGTGCTAGCGGACTCTCTACGCTAA	
8083	CARD	prokka_01193	contig_3	375298	98	339678	342831	-1	105	oqxB	3003923.0	2118.2	2000.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCACTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTCTCCCCCGGCGGGAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCTGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGTTGATCGCTGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCTATCGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGCTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTTTCCATCCTGCCGCCGCCGATTTTAGGTCTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAGACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGATCTGTTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCTGACGGACCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTACCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAAGAGCTGTCGAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCATTCCTCGTACTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTACCGATGACGATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGTCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATCCAGGGGAAAGGCATCATGGAAGCGGCGCTGGAGGCATGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTACGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG	
8083	CARD	prokka_01194	contig_3	375298	98	342854	344030	-1	90	oqxA	3003922.0	798.1189999999998	670.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	ATGAGCCTGCAAAAAACCTGGGGAAACATTCACCTGACCGCGCTCGGCGCGATGATGCTCTCCTTTCTGCTCGTCGGCTGCGACGACAGCGTCGCACAGAATGCTGCGCCTCCCGCCCCGACGGTCAGCGCCGCTAAGGTGCTGGTGAAGTCGATCAGTCAGTGGGATAGTTTTAACGGTCGCATTGAAGCGGTGGAGAGCGTTCAGCTTCGCCCTCGCGTCTCGGGATACATTGATAAAGTGAATTACACTGACGGCCAGGAGGTGAAAAAGGGCCAGGTGCTGTTCACGATAGATGACAGAACCTATCGCGCCGCGCTGGAGCAGGCGCAGGCGGCGTTGGCAAGAGCCAAAACGCAGGCCAGCCTCGCGCAAAGCGAGGCGAACCGCACCGATAAATTAGTCCATACCAACCTCGTCTCCCGTGAAGAGTGGGAGCAGCGCCGGTCAGCCGCGGTTCAGGCGCAGGCCGACATTCGCGCCGCGCAGGCGGCGGTGGATGCCGCGCAGCTTAACCTCGACTTCACCAAAGTGACCGCCCCTATTGACGGCCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTCACCGCGGGCGACACCGCCAGCGTGCTCACCACCCTGGTCTCGCAAAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTCCACTATCAAAACCTCGCCCGCCGCGGGCAAGGCGCGTCCAGCGATAATCAGGCGCTCCCGGTGGAGATTGGCCTGGTGGGCGAGGAGGGTTACCCCCACCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGTACCGGCACCATCCGCATGCGTGCGCTGCTGGATAACTCGCAGCGTCTGTTCACGCCGGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCAGAGTTCAAAGCCACGCTGATCGACGACAAAGCGGTACTGACCGATCAGGATCGTAAATACGTCTATATCGTTGATAAAGATGGTAAAGCACAGCGCCGCGACATTACCCCAGGGCGGCTGGCAGACGGTTTACGCATCGTTCAGAAGGGGTTGAATCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCCAAAACCGTTGCCATGACCTCCAGCGCCACCCTTAACTGA	
8083	CARD	prokka_01536	contig_4	329026	101	323746	324979	1	91	Escherichia coli mdfA	3001328.0	706.057	700.0	Strict	85.61	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVLAAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG	ATGCAAAATTATTCGCTTTCAGGCCGCCGCCTCGGAAGGCAGGCGCTGTTGTTCCCGTTATGTCTGGTGCTGTACGAGTTTTCCACTTATATCGGCAACGATATGATTCAGCCGGGCATGTTAGCCGTGGTGCAGGAATTTCAGGTGGGCAACGAATGGGTACCTACTTCAATGACTGCCTATCTGGCAGGCGGCATGTTTTTACAGTGGCTGCTGGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGTTGACCGGCGTAGTATGGTTTATCGTCACCTGCCTGGCGACGCTGCTGGCGCAGACCATTGAGCAGTTTACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGCTTTATCGGCGCGGTGGGCTATGCGGCGATACAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCCCTGATGGCTAACGTGGCGCTGATTGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATGTCCTGCCGTGGGAGATGATGTTTGTCCTGTTCGCCGTGCTGGCGGCCATCTCGTTCTTCGGCCTGCAGCGGGCGATGCCGGAGACCGCGACGCGGCTGGGCGAAAAGCTGTCGGTGAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTGAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCCACTGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCCACCAGCTATGAGTACGGCATGCTGCAGGTGCCGATTTTCGGGGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTGCGCGTCGGACCGTGCGCTCGCTGATTATCATGGGCGGTTGGCCGATCATGTTTGGCCTGATCCTCTCTGCGGCGGCGACCGTGGTCTCTTCCCACGCTTATCTGTGGATGACGGCCGGTCTGAGCTTCTACGCCTTCGGGATTGGCCTCGCGAACGCCGGCCTGGTGCGTTTAACCCTGTTCGCCAGCGAGATGAGTAAAGGCACGGTCTCGGCGGCGATGGGAATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTGGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGCTGGGTGGGGTACTATGGCTGGGGCTGATGATTTACTTTCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGGTAG	
8083	CARD	prokka_01645	contig_5	324604	106	86143	87337	1	139	Klebsiella pneumoniae acrA	3004041.0	738.028	770.0	Strict	95.24	99.75	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSTVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAGGGAGCCCAGCACATGCCGGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGCACCAGCGCCTATCGCATTGCGGAAGTCCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTCTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTGGGCACCAAATATATTAGTCAACAAGACTACGATACCGCCGTTGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCGGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATCAGCGGCCGGATTGGTAAATCCACCGTGACCGAAGGGGCGCTGGTACAGAATGGTCAAACGACCGCCCTGGCAACCGTTCAGCAGCTGGATCCGATCTATGTTGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAGCAGGAGCTAGCCGACGGCCGCCTGAAACAGGAAAACGGCAAAGCGAAAGTGGAGCTAGTGACTAATGACGGTCTTAAGTATCCGCAGTCCGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCAATCACGCTACGCGCTATTTTCCCGAACCCGGATCACACCCTGCTACCGGGGATGTTCGTCCGTGCCCGTCTGGAAGAAGGGATTAACCCTGACGCCCTGCTGGTACCGCAACAGGGTGTTACCCGTACGCCGCGCGGCGACGCCAGCGTCATGGTAGTGGGGGAAGGCGATAAAGTCGAAGTCCGCCAGGTCACTGCTTCTCAGGCGATCGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACCGGCCTGCAAAAAATCAAACCAGGTGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA	loose hit with at least 95 percent identity pushed strict
8083	CARD	prokka_01646	contig_5	324604	106	87359	90506	1	121	acrB	3000216.0	1941.39	1900.0	Strict	91.52	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAMALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKSEDIEHSHQVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATTATCATCATGCTGGCTGGGGGATTATCGATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACGGTGCAGAACACCGTAACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCAAATGGCGACTCCACCGGTACGGCAACCATTACGCTGACCTTCGAATCCGGTACCGATCCGGATATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCGCTGGCGACGCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATTAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTCATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGATCCGATTAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTATTCGGTTCCCAGTATGCGATGCGTATCTGGATGGATCCAAACAAACTGAACAACTTCCAGCTTACGCCGGTGGATGTGATCAGCGCCCTGAAAGCGCAGAACGCCCAGGTGGCCGCGGGCCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCCTCGATCATCGCGCAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGACGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGCGGCGAAAGCTATGACGTAGTGGCGAAGTTTAACGGCCAGCCGGCATCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCTATTCGCGCTGAACTGGCGAAGATGGAGCCGTTTTTCCCGTCGGGGATGAAGATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATTTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCCACCATCGCGGTACCGGTGGTCCTGTTAGGCACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTGGTGGTAGAGAACGTCGAGCGCGTGATGGCGGAAGAGGGTCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGACAGATTCAGGGCGCGCTGGTTGGTATCGCTATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTCTTCGGCGGCTCAACCGGGGCCATCTATCGCCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTGGCGTTAATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAACCCATTCAGAAAGGCAGCCATGGCGCGACCACCGGCTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGTTATCTGGTGCTGTATCTGATCATCGTGGTGGGTATGGCATGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCGGACGAGGACCAGGGTGTATTCCTGAGTATGGCGCAGCTGCCTGCCGGCGCCACCCAGGAGCGTACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGTTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTTTCGCTGAAAGACTGGAGCCAGCGTCCGGGTGAGGAAAACAAAGTTGAAGCGATCACCGCGAGAGCAATGGGCTACTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCGAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACCCAGGCGCGTAACCAACTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGCCCTAACGGTCTGGAAGATACACCGCAGTTTAAAATCGATATCGATCAGGAGAAAGCTCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTGGGCGCAGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATCATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATCGGCAAGTGGTATGTTCGCGGCAGCGATGGTCAGATGGTGCCGTTCTCTGCTTTCTCGACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCGTCACTGGAAATCCTCGGTCAGGCCGCGCCAGGCAAGAGTACCGGTGAGGCGATGGCGCTGATGGAAGAGCTGGCGGGTAAACTGCCTTCCGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGACTGTCCGGCAACCAGGCCCCTGCCCTGTATGCCATCTCGCTGATTGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTTATGCTGGTCGTCCCCTTGGGTGTGGTTGGTGCGCTGTTAGCCGCCACCTTCCGCGGGCTAACCAACGACGTTTACTTCCAGGTGGGTCTGCTGACCACCATCGGCCTGTCGGCGAAGAACGCAATATTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCAGTACGTATGCGTCTACGTCCAATCCTGATGACATCTCTGGCGTTCATCCTCGGGGTAATGCCGCTAGTTATCAGCTCCGGCGCCGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCGATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGCAAAAAATCGGAAGATATAGAGCACAGCCATCAGGTTGAGCATCATTAA	
8083	CARD	prokka_01773	contig_5	324604	106	216089	217250	1	76	Escherichia coli ampH beta-lactamase	3004612.0	689.493	500.0	Strict	85.71	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTAPLKAAPGSQAAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ	TTGAAACGTAGTTTGCTCATTTTTGCTGCGCTGTGCGCGGCGTCGTGGACCTCGGTGCAGGCCGCACAGCCTACCGTTGACCCGGTTTTCGCCTCGGATGTGGTCGATCGTTACGCCAATCATATCTACTACGGCAGCGGCGCCACCGGCATGGCGCTGGTGGTTATCGATGGCAATCAGCGTGTTTTTCGCAGCTTTGGCGAAACCCGCCCGGGGAATAATCAGCACCCGCAGCTCGACTCGGTGATCCGTATCGCCTCCCTCAGCAAACTGATGACCAGCGAGATGCTGGTGAAGCTGCTCGACCAGGGGGTGGTGAAACTCAACGATCCGCTGAGTAAATACGCCCCGCCGGGCGCCCGGGTGCCTGACTGGCAGGGAAAACCAATCACCCTGGTGAATCTCGCGACCCATACCAGCGCCCTGCCGCGCGAGCAGCCTGGTGGCGCCGCTCATCGTCCGGTGTTTGTCTGGCCGACCCGCCAGCAGCGCTGGAACTGGCTCTCTACCGCGCCCCTGAAAGCCGCGCCGGGCTCGCAGGCGGCCTACTCCAACCTGGCCTTCGATTTACTGGCAGACGCGCTCGCCACCGCCGCCGGCAAACCGTATCCGCAGCTGTTTGAAGAGCAGATCACCCGGCCGCTGGGGATGAAGGACACCACCTTTACCCCGTCACCGGATCAGTGCCAGCGGCTGATGATCCCGGAAAAAGGCGCCAGCCCATGCAACAACACCCTGGCGGCGATCGGCAGCGGCGGAGTCTACTCGACGCCGGGGGATATGATGCGCTGGATGCAGCAGTTCCTGTCATCCGATTTCTATACCCGCAGCCAGCAGGCCGACCGGATGCAGACGCTGATTTATCAGCGTAACCAGCTGACCCGGGTGATTGGTATGGACGTGCCGGGCCGCGCCGACGCGCTGGGCCTCGGCTGGGTGTATATGAAGCCGAAGAACGGCCATCCGGGGATTATTCAGAAAACCGGCGGCGGCGGCGGGTTTATCACCTATATGGCGATGAATCCGCAGGCTAACGTTGGCGCCTTTGTGGTGGTAACCCGCTCGCCGTTGACCCGCTTCAACAATATGAGCGATGGCATCAACGACCTGGTCAGCGAGCTGAGCGGCGCACAGCCCAACATGCAGACGGCCAGCCAGTAA	
8083	CARD	prokka_02035	contig_6	319249	104	155934	157005	1	130	OmpA	3005044.0	729.169	700.0	Strict	99.72	95.19	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTTGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA	
8083	CARD	prokka_02076	contig_6	319249	104	206398	208147	-1	127	msbA	3003950.0	1126.69	1000.0	Strict	92.78	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE	ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATCGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTGGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGCCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATTTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGTATGCCGGTGGCCTTCTTTGACAAGCAGTCTACCGGAACGCTGCTGTCACGCATCACCTATGATTCTGAGCAGGTCGCCTCCTCTTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGAGCATCGATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTGATCGTACTGGCGCCGATTGTGTCGGTGGCGATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCCGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAAGTCAGCAATAAAATGCGTCTGCAGGGGATGAAGATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCCGGGACCATTACCGTGGTCTTCTCCTCGATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAGCGCGGGATGGCGGCGTGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAAAAAGACGAAGGTACGCGGGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTACCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATCCCGGAAGGGAAAACAGTGGCGCTGGTGGGGCGCTCAGGGTCGGGTAAATCGACCATTGCCAGCCTGATCACCCGCTTCTACGATGTCGACGAGGGGCAGATCCTGCTGGATGGCCACGACCTGCGCGAGTACAAGCTGAGCTCGCTGCGCGACCAGGTGGCGCTGGTTTCACAAAACGTGCATCTGTTCAACGATACCGTCGCCAACAATATCGCCTATGCCCGTACCGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCCGCGCGCATGGCCTACGCCATGGATTTCATTAACAAGATGGATAATGGTCTGGATACCATCATCGGCGAGAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATTGCCCGCGCGCTGCTGCGTAACAGCCCGATCCTGATCCTCGATGAAGCCACCTCGGCGCTGGATACCGAGTCCGAGCGTGCTATTCAGGCGGCGCTGGATGAGCTGCAGAAAAACCGTACCTCGCTGGTTATCGCTCACCGTCTGTCGACCATTGAGCAGGCTGATGAAATCGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCATGACCTGCTGGAGCATAAGGGCGTGTACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA	
8083	CARD	prokka_02553	contig_8	270450	105	96162	98511	1	134	LptD	3005059.0	1619.75	1500.0	Perfect	100.0	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		carbapenem; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTATGATCGTCCGCTCGTGGAAGGTCGTCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAACTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATTAACCAGGGGAATAGTCGCCTCCGCGCCGACGAAGTTCAGCTGCACCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGGCCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAAATGGTCGGACGCCAGGGACGCGGCACCGCCGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTCGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTCGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTTGCCGAGATCTGGAACGCCCGCTTCAAGCTTGGCTCTGTGCCGATTTTCTATAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATTACTCCGCACTATATGAACAAACGCGGCGGCGTGATGTGGGAAAACGAGTTCCGCTATCTGACCCAGCTCGGCAGCGGCTTAACTGAATTCGACTACCTGCCGTCGGATAAAGTCTACGAAGACGACCACTCGAGCGACAGCAACAGCCGCCGCTGGCTGTTCTACTGGAACCACTCAGGGGTTATCGATCAGGTATGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGACTTCAGCTCGAAATATGGTTCCAGTACCGATGGCTATGCGACGCAGAAATTCAGCGCCGGTTACGTCAACCAGAACTTTGACGCCACGGTATCGACCAAACAGTTCCAGGTCTTTGACCGCGAATCGAGCAACTCCTATTCGGCTGAGCCGCAGCTCGACGTCAACTACTACCAGAATGATGTCGGTCCGTTCGATACCCATCTCTATGGACAGGTTGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCCAACGGTTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACTCACTACCAGCAGAGCAACCTCGATAAGTACAATGCCGCCAACGGCACTGACTATAAAGAGTCCGTCAGCCGCGTAATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTTGAACGCGACCTGCAGGAGGGATTCACCCAAACGCTGGAACCGCGCGTGCAGTATCTGTACGTGCCGTACCGCGATCAGAGTGAAATCGGCAACTACGACTCCACGCTGTTGCAGTCGGATTACACCGGTCTGTTCCGCGACCGTACCTATAGCGGTCTGGACCGCATCGCGTCGGCTAATCAGGTCACCACCGGGCTCACCTCGCGCGTGTATGATGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACGCACCGGTGATGACAACATCAACTGGGAGAACAACGATACCACGGGTTCACTGGTCTGGGCCGGCGATACCTACTGGCGCATTGCCGATGAATGGGGTCTGCGCGGAGGGATCCAGTACGATACGCGTCTGGATAACGTTGCCACTGGTAACGGCACCATTGAATACCGTCGCGATGAGAACCGCTTAGTTCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACGCTGCCGTCATATTCCACCGCGGCACAATATAAACAGGGTATTTCGCAGGTGGGGATGACCGCCAGTTGGCCGATTGTCGATCGCTGGTCCGTGGTCGGGGCCTACTACTACGATACTAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTGCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGTAAAGTCAACGGCTGGAACAGCAACGACAACGGCGGCGAGAGCAAATACGATAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGCTCGAACATTTTACCGTACCAGAGCTCCCTGTGA	
8083	CARD	prokka_02559	contig_8	270450	105	103153	103633	-1	113	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.9138	32.0	Strict	28.0	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVVMGRLTWESIGRPLPGRKNIVISSKPGSDDRVQWVSSVEEAIAACGDVEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSHSYCFEILERR	ATGATCAGTCTGATTGCGGCGTTAGCGGTAGATCGCGTCATTGGTATGGAAAACGCCATGCCATGGAACCTGCCTGCCGATCTCGCCTGGTTCAAACGCAACACGTTAAATAAGCCGGTGGTGATGGGGCGTCTGACCTGGGAATCCATTGGGCGCCCATTGCCGGGGCGTAAAAATATCGTGATCAGCAGCAAACCCGGCAGCGACGATCGCGTGCAGTGGGTCTCCTCCGTAGAAGAAGCAATTGCCGCCTGCGGCGATGTGGAAGAGATTATGGTGATCGGCGGCGGCCGGGTGTATGAGCAGTTCCTGCCGAAAGCGCAGAAGCTCTACTTGACCCATATTGATGCGGAAGTGGAAGGCGATACCCATTTCCCGGATTACGATCCGGACGAATGGGAGTCGGTGTTCAGCGAGTTTCATGACGCCGACGCGCAGAACTCCCATAGCTACTGCTTTGAGATCCTCGAACGCCGTTAA	
8083	CARD	prokka_02709	contig_8	270450	105	255954	256374	-1	67	FosA6	3004111.0	283.108	280.0	Strict	97.84	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFEQ	ATGCTGAGTGGACTGAATCACCTGACCCTGGCAGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTGCTGGGCATGACGCTGCATGCCCGCTGGGACAGCGGGGCTTATCTCTCCTGCGGCGATTTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTTACTCCGCCGGAAGAGAGCGACTACACCCATTATGCGTTTAGTATTAGCGAAGCCGATTTTGCTAGCTTCGCCGCCCGCCTTGAGGCTGCCGGCGTGGCGGTCTGGAAGCTGAACCGTAGCGAAGGTGCCTCGCACTATTTCCTCGATCCCGATGGCCATAAGCTGGAGCTGCACGTCGGCAGTCTCGCCCAGCGGCTGGCCGCCTGCCGCGAGCAGCCGTATAAGGGGATGGTGTTTTTTGAACAGTGA	
8083	CARD	prokka_02986	contig_10	203931	104	72731	73715	1	102	PmrF	3003578.0	577.785	550.0	Strict	83.69	101.55	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS	ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATCCCGGTTTATAACGAACAGGATAGCCTGCCGGAACTGCTTCGTCGTACGGATGCCGCCTGCGCCACCCTGGGGCGGCAATATGAAATTCTGTTGATCGACGATGGCAGCAGCGACGATTCCGCGCGCATGCTCACCGAAGCCGCCGAGGCGGAAGGCAGCCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGCCAGCACTCGGCGATCATGGCCGGCTTCAGCCATGTAACCGGCGATCTGATTATTACCCTCGACGCCGACCTGCAAAACCCGCCGGAGGAGATCCCGCGGCTGGTGGCGAAGGCTGATGAAGGTTACGACGTGGTGGGCACCGTCCGCCAGAACCGTCAGGACAGCATCTTCCGTAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTTATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATTGCCCTGCTGGGCTTCGCCTTCGGCCTGCTGCTGGTGGTGCTGCGTCTGGCCTTTGGCCCGCAGTGGGCGGCGGAAGGGGTGTTTATGCTCTTCGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCCCGCCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA	
8083	CARD	prokka_02989	contig_10	203931	104	76595	78251	1	120	ArnT	3005053.0	1097.03	1000.0	Strict	99.64	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSPIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAAQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTCTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGATCAACAGTATCGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCCTGTCGCCGATTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGCGCGGCGCAGGCGCACAGCCGCAGCGGCAAAATACTGGGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAGGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCTCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTAATCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCTCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCGCTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGGATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCCGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAAGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTCGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGATATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA	
8083	CARD	prokka_03089	contig_10	203931	104	187996	188629	-1	129	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAACGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTCACGTCTGAGAAAGTGGGCAACCTGGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCGGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGCCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCGCACGGTAAAACCATCGTCGTCTACGGCACCCGTTAA	
8083	CARD	prokka_03534	contig_13	149744	100	129163	129538	1	141	marA	3000263.0	243.432	230.0	Strict	92.74	97.64	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN	ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCCGGTTACTCTAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACCGGCCATTCCCTCGGCCAGTACATCCGCAGCCGCAAGCTGACGGAGATTGCGCAGAAGCTCAAGCAGAGTAATGAGCCAATCCTGTACCTGGCGGAACGCTATGGTTTCGAGTCGCAGCAGACCCTGACGCGAACGTTCAAGAACTATTTCGATGTTCCGCCCCACAAGTATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTACATCCGCTAAATAACTGA	
8083	CARD	prokka_04634	contig_24	69371	106	29560	29785	1	110	CBP-1	3004764.0	21.557	600.0	Strict	100.0	24.03	CBP beta-lactamase	protein homolog model	antibiotic inactivation		penam	MNHGQLSMKNVFPTLAVLFAIFSLTGCGLKGPLYFPPADKTAPPPTKPVNPGIQSATPDRNDRGDTGGPSQVNY	ATGAATCACGGGCAACTATCAATGAAAAACGTTTTTCCTACGCTTGCCGTTTTGTTTGCGATCTTCAGCCTGACCGGCTGCGGTCTGAAAGGGCCTCTCTATTTCCCACCGGCGGACAAAACCGCGCCGCCGCCGACCAAACCGGTTAACCCTGGCATTCAGAGCGCAACGCCGGATCGTAACGATCGTGGCGATACCGGTGGTCCGAGCCAGGTCAATTACTAA	loose hit with at least 95 percent identity pushed strict
8083	CARD	prokka_04759	contig_26	53656	100	25310	25673	1	86	Klebsiella pneumoniae KpnE	3004580.0	223.402	150.0	Strict	99.17	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSKQEVAHAAV	ATGTTTTATTGGATTTTATTAGCTTTAGCAATTATTGCTGAAATTACCGGCACCTTGTCTATGAAATGGGCAAGCGTGAGCGGCGGGCACACCGGCTTTATTTTAATGCTGGCCATGATTGCCCTGTCATATATTTTTCTTGCCTTTGCGGTTAAAAAGATTGCCCTCGGTGTGGCCTATGCGTTGTGGGAAGGGATCGGTATTTTACTGATTACCCTGTTCAGCGTGCTGCTGTTTGATGAGAGTCTGTCCCTGCTGAAAATAGCCGGCTTGACCACCCTGGTGATAGGGATCGTCTTAATTAAGTCCGGCACCCAGAAAAAAGCGTCTTCCAAGCAGGAGGTGGCCCATGCAGCAGTTTGA	
8083	CARD	prokka_04760	contig_26	53656	100	25659	25989	1	70	Klebsiella pneumoniae KpnF	3004583.0	206.453	150.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGCTGGCAATCGCCATTGTGCTGGAAATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGCTTCCGCCGCAAGATCTACGGCATCCTGTCCCTGGCGGCAGTATTGGGCGCGTTCAGCGCCCTGTCGCAGGCGGTTAAAGGGATCGATCTCTCGGTCGCCTATGCGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGTCAGCGTCTGAATAACAAAGGCTGGGCGGGGGTTATCCTGCTGGTAGCCGGCATGGTGTTAATTAAACTCGCCTGA	
8083	CARD	prokka_04868	contig_28	43600	157	27477	28137	1	184	catI	3002683.0	465.692	400.0	Perfect	100.0	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA	
8083	CARD	prokka_04874	contig_28	43600	157	34147	34645	1	195	dfrA12	3002858.0	339.732	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG	ATGAACTCGGAATCAGTACGCATTTATCTCGTTGCTGCGATGGGAGCCAATCGGGTTATTGGCAATGGTCCTAATATCCCCTGGAAAATTCCGGGTGAGCAGAAGATTTTTCGCAGACTCACTGAGGGAAAAGTCGTTGTCATGGGGCGAAAGACCTTTGAGTCTATCGGCAAGCCTCTACCGAACCGTCACACATTGGTAATCTCACGCCAAGCTAACTACCGCGCCACTGGCTGCGTAGTTGTTTCAACGCTGTCGCACGCTATCGCTTTGGCATCCGAACTCGGCAATGAACTCTACGTCGCGGGCGGAGCTGAGATATACACTCTGGCACTACCTCACGCCCACGGCGTGTTTCTATCTGAGGTACATCAAACCTTCGAGGGTGACGCCTTCTTCCCAATGCTCAACGAAACAGAATTCGAGCTTGTCTCAACCGAAACCATTCAAGCTGTAATTCCGTACACCCACTCCGTTTATGCGCGTCGAAACGGCTAA	
8083	CARD	prokka_04875	contig_28	43600	157	35064	35844	1	174	aadA2	3002602.0	522.316	450.0	Perfect	100.0	100.0	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	GTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTGATTTGTTGGTTACTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGATCTTATGGAGGCTTCGGCTTTCCCTGGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATAAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGA	
8083	CARD	prokka_04876	contig_28	43600	157	36007	36355	1	161	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8083	CARD	prokka_04877	contig_28	43600	157	36348	37188	1	144	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8083	CARD	prokka_04884	contig_28	43600	157	42498	43404	-1	168	mphA	3000316.0	604.364	500.0	Perfect	100.0	100.0	macrolide phosphotransferase (MPH)	protein homolog model	antibiotic inactivation		macrolide antibiotic	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	ATGACCGTAGTCACGACCGCCGATACCTCCCAACTGTACGCACTTGCAGCCCGACATGGGCTCAAGCTCCATGGCCCGCTGACTGTCAATGAGCTTGGGCTCGACTATAGGATCGTGATCGCCACCGTCGACGATGGACGTCGGTGGGTGCTGCGCATCCCGCGCCGAGCCGAGGTAAGCGCGAAGGTCGAACCAGAGGCGCGGGTGCTGGCAATGCTCAAGAATCGCCTGCCGTTCGCGGTGCCGGACTGGCGCGTGGCCAACGCCGAGCTCGTTGCCTATCCCATGCTCGAAGACTCGACTGCGATGGTCATCCAGCCTGGTTCGTCCACGCCCGACTGGGTCGTGCCGCAGGACTCGGAGGTCTTCGCGGAGAGCTTCGCGACCGCGCTCGCCGCCCTGCATGCCGTCCCCATTTCCGCCGCCGTGGATGCGGGGATGCTCATCCGTACACCGACGCAGGCCCGTCAGAAGGTGGCCGACGACGTTGACCGCGTCCGACGCGAGTTCGTGGTGAACGACAAGCGCCTCCACCGGTGGCAGCGCTGGCTCGACGACGATTCGTCGTGGCCAGATTTCTCCGTGGTGGTGCATGGCGATCTCTACGTGGGCCATGTGCTCATCGACAACACGGAGCGCGTCAGCGGGATGATCGACTGGAGCGAGGCCCGCGTTGATGACCCTGCCATCGACATGGCCGCGCACCTTATGGTCTTTGGTGAAGAGGGGCTCGCGAAGCTCCTCCTCACGTATGAAGCGGCCGGTGGCCGGGTGTGGCCGCGGCTCGCCCACCACATCGCGGAGCGCCTTGCGTTCGGGGCGGTCACCTACGCACTCTTCGCCCTCGACTCGGGTAACGAAGAGTACCTCGCTGCGGCGAAGGCGCAGCTCGCCGCAGCGGAATGA	
8083	CARD	prokka_05178	contig_38	21679	97	2169	3843	-1	136	eptB	3005047.0	1160.98	1000.0	Strict	99.46	97.04	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELEKEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATCATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGCGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTGATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGTCTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGGCTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTCGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAACCCACAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCGCGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCTGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA	
8083	CARD	prokka_05451	contig_70	1292	161	213	1029	1	175	APH(3')-Ia	3002641.0	560.066	500.0	Strict	98.52	100.0	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAA	
8083	CARD	prokka_05455	contig_74	1128	147	108	714	1	171	AAC(6')-Ib10	3002581.0	399.4380000000001	275.0	Strict	98.97	99.01	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSIQHFQTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA	ATGAGTATTCAACATTTCCAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGTTGCCTAA	
8083	CARD	prokka_05456	contig_74	1128	147	795	1053	1	144	ANT(3'')-IIa	3004089.0	135.961	450.0	Strict	97.14	26.32	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETALLQIVGGDKLIIPFC	GTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACGGCACTGTTGCAAATAGTCGGTGGTGATAAACTTATCATCCCCTTTTGCTGA	loose hit with at least 95 percent identity pushed strict
8083	CARD	prokka_05459	contig_82	656	77	46	289	1	65	SHV-51	3001108.0	165.236	550.0	Strict	100.0	27.97	SHV beta-lactamase	protein homolog model	antibiotic inactivation		carbapenem; cephalosporin; penam	MVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAACGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATTTATCTGCGGGATACGCCGGCGAGTATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA	loose hit with at least 95 percent identity pushed strict
8083	CARD	prokka_05462	contig_83	656	73	367	610	-1	74	SHV-105	3001154.0	164.851	550.0	Strict	100.0	27.97	SHV beta-lactamase	protein homolog model	antibiotic inactivation		carbapenem; cephalosporin; penam	MVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTAGCAAGCGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATTTATCTGCGGGATACGCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA	loose hit with at least 95 percent identity pushed strict
8083	CARD	prokka_00327	contig_1	499605	102	331811	334445	1	115	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1642.48	1500.0	Strict	92.23	100.23	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMATNIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATGVRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERNGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTCAACATTGAGGAAGAGCTTAAGAACTCTTATCTGGATTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGATGTCCGAGATGGCCTGAAGCCGGTACACCGTCGCGTACTTTACGCCATGAACGTATTGGGCAATGACTGGAACAAAGCCTATAAAAAATCAGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCACCCGCACGGCGACATCGCGGTATACGACACCATCGTGCGTATGGCGCAGCCGTTCTCGCTGCGTTACATGCTGGTGGACGGCCAGGGTAACTTTGGTTCCATCGACGGCGACTCCGCCGCGGCGATGCGTTATACCGAAATTCGTCTGGCGAAAATCGCTCATGAGCTGATGGCCGATCTTGAAAAAGAGACGGTCGATTTCGTCGACAACTATGACGGTACGGAGCGTATTCCGGACGTCATGCCGACCAAAATTCCTAACCTGCTGGTGAACGGCGCCTCCGGGATCGCCGTAGGGATGGCCACCAACATACCGCCGCATAACCTGACGGAAGTGATTAACGGCTGTCTGGCGTATGTTGACGATGAAGACATCAGCATTGAAGGGCTGATGGCGCATATTCCTGGCCCTGATTTCCCGACCGCCGCCATTATCAATGGCCGTCGCGGCATCGAAGAGGCCTATCGCACCGGTCGCGGTAAAGTGTACATCCGCGCGCGCGCGGAAGTGGAAGTGGACGCGAAATCCGGCCGCGAAACCATCATCGTGCACGAAATTCCGTATCAGGTGAACAAAGCGCGCCTGATCGAGAAAATCGCCGAGCTGGTCAAAGAAAAACGCGTGGAAGGCATCAGCGCGCTGCGTGACGAGTCTGATAAAGACGGGATGCGCATCGTGATTGAAGTGAAGCGCGATGCGGTAGGGGAAGTGGTGCTTAACAACCTCTATTCCCAGACCCAGCTGCAGGTCTCCTTCGGCATCAACATGGTAGCTCTGCACCATGGTCAGCCGAAGATCATGAACCTGAAGGACATCATCGCCGCGTTTGTACGCCACCGCCGTGAAGTGGTGACCCGTCGTACGATTTTCGAACTGCGCAAAGCGCGCGACCGGGCGCATATCCTCGAAGCGCTGGCCGTTGCGCTGGCCAACATCGACCCGATTATCGAACTGATCCGTCGCGCGCCGACCCCGGCAGAAGCGAAAACGGCGCTGGTTGCCCAGGCGTGGGATCTCGGTAACGTCGCGGCGATGCTGGAGCGCGCCGGGGATGACGCCGCGCGTCCGGAATGGCTGGAGCCAGAGTTCGGCGTGCGCGACGGTAAATACTATCTGACCGAGCAGCAGGCTCAGGCGATTCTGGATCTGCGTCTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAATATAAAGAGCTGCTGGAGCAGATCGCGGAGCTGCTGCACATTCTCGGCAGCGCCGACCGTCTGATGGAAGTGATTCGCGAAGAGCTGGAGCTGATCCGCGATCAGTTCGGCGACGAACGTCGTACCGAAATCACCGCCAACAGCGCTGATATTAACATCGAAGATCTGATCAACCAGGAAGATGTGGTGGTCACCCTGTCGCATCAGGGGTATGTGAAGTATCAGCCGCTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGCAAATCGGCAGCGCGCATTAAAGAAGAAGACTTTATCGACCGCCTGCTGGTGGCTAACACCCATGACACCATCCTCTGCTTCTCAAGCCGCGGCCGTCTGTACTGGATGAAGGTCTATCAGCTGCCGGAAGCCAGCCGCGGCGCGCGCGGTCGGCCGATCGTCAACCTGCTGCCGCTGGAAGCCGATGAGCGCATCACCGCCATCCTGCCGGTCCGCGAGTACGAAGAGGGCGTCAACGTCTTTATGGCGACCGCCAGCGGTACCGTGAAGAAAACCGCGCTGACCGAGTTCAGCCGTCCGCGTTCCGCCGGTATCATCGCGGTCAACCTGAACGAAGGCGATGAGCTGATCGGCGTCGATCTGACCTCTGGTCAGGATGAAGTGATGCTGTTCTCCGCGGCCGGTAAGGTTGTACGCTTCAAGGAAGACGCCGTTCGCGCCATGGGCCGTACCGCCACCGGCGTACGCGGTATTAAGCTTGCGGAAAACGACAGCGTCGTCTCGCTGATTATTCCACGCGGCGAAGGCGCGATCCTGACGGTGACGCAAAACGGTTACGGTAAACGTACCGCGGCGGCGGAGTATCCGACCAAGTCGCGTGCCACCCAGGGCGTTATTTCGATCAAAGTCACCGAGCGTAACGGTTCCGTGGTCGGCGCCGTGCAGGTGGATGACTGCGATCAGATCATGATGATCACCGACGCCGGGACGCTGGTGCGTACCCGCGTTTCCGAAGTGAGCATCGTGGGCCGTAACACCCAGGGCGTGATCCTCATCCGCACCGCGGAAGATGAAAACGTGGTGGGTCTGCAGCGCGTGGCTGAGCCGGTGGATGATGAAGAGCTGGATGCCATCGATGGTAGCGCGGCGGAAGGCGATGACGATATCGCCCCGGAAGCGGATACCGATGACGACATCGCCGAAGACGAAGAATAA	
8083	CARD	prokka_02443	contig_7	284035	106	250012	252271	1	109	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1470.29	1400.0	Strict	94.41	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAELLLSELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTTLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVRMRAVWSKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQSELEKERDQLQAILASERKMNNLLKKELQADADAFGDDRRSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAQGLSYKAGDSWKASAKGKSNQPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALITLPDNAHVMPPLVIEDESDMLLAITAAGRMLMFPVSDLPQLSKGKGNKIISIPAAEAAAGQDGLAHLFVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGSLMRGLQKIDRVEIDSPRRAAAGDSEE	ATGAGCGATATGGCAGAGCGCCTTGCGCTGCATGAATTTACGGAAAATGCTTACCTGAACTACTCCATGTACGTGATCATGGACAGGGCATTACCGTTTATTGGCGATGGCTTAAAACCGGTCCAGCGTCGCATCGTCTATGCGATGTCCGAGCTGGGGCTGAACGCCAGCGCGAAATTCAAAAAGTCCGCCCGCACCGTCGGCGACGTGTTGGGTAAATATCACCCGCACGGCGACATCGCCTGCTATGAAGCGATGGTGCTGATGGCGCAGCCGTTCTCTTACCGCTATCCGCTGGTGGATGGTCAGGGAAACTGGGGGGCGCCGGACGATCCCAAATCTTTCGCCGCCATGCGTTACACCGAATCCCGCCTGTCGAAGTATGCCGAGCTGCTGCTCAGCGAGCTGGGGCAGGGGACGGTCGACTGGGTGCCAAACTTTGACGGCACGCTGCAGGAGCCGAAAATGCTGCCAGCGCGTCTGCCGAACATCCTGCTGAACGGCACCACCGGCATCGCGGTAGGCATGGCGACCGATATTCCTCCGCACAACCTGCGGGAAGTGGCCAAAGCGGCGATTACGCTGATTGAGCAGCCGAAAACCACCCTCGACGAACTGCTGGATATCGTACAGGGGCCGGATTTCCCGACCGAGGCGGAGATCATCACCTCGCGGGCGGAAATTCGCAAAATCTACCAGAACGGGCGCGGCTCAGTGCGCATGCGTGCGGTGTGGAGTAAAGAGGACGGCGCGGTGGTGATCAGTGCGCTGCCGCATCAGGTCTCCGGCGCCAAAGTGCTGGAGCAGATTGCGGCGCAGATGCGCAATAAAAAGCTGCCGATGGTTGACGATCTGCGCGACGAATCGGACCACGAAAACCCGACCCGTCTGGTGATTGTCCCGCGCTCCAACCGGGTGGATATGGAACAGGTGATGAACCACCTGTTCGCCACCACCGATCTGGAGAAGAGCTACCGCATCAACCTCAATATGATCGGCCTTGACGGCCGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCAGCGAGTGGCTGGTGTTCCGTCGCGATACCGTGCGTCGCCGTCTAAACCATCGGTTAGAGAAAGTGCTGAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTTCTTAATATCGATGAAGTGATTGAGATCATCCGCACTGAAGATGAACCGAAGCCGGCCCTGATGTCGCGCTTTGGCATCAGCGAAACCCAGGCGGAAGCGATTCTGGAATTAAAACTGCGCCACCTCGCCAAACTGGAAGAGATGAAGATCCGCGGCGAGCAGAGCGAGCTGGAAAAAGAGCGCGACCAGCTGCAGGCGATTCTGGCGTCTGAACGTAAGATGAACAACCTGCTGAAAAAAGAGCTGCAGGCCGATGCCGATGCCTTCGGCGACGACCGTCGCTCGCCGCTTCACGAGCGTGAAGAAGCGAAAGCGATGAGCGAGCATGACATGCTGCCGTCTGAGCCGGTGACTATCGTTCTGTCGCAGATGGGCTGGGTGCGCAGCGCCAAAGGACACGACATTGACGCCCAGGGCTTGAGCTATAAGGCGGGCGACAGCTGGAAAGCCTCGGCGAAGGGCAAGAGCAACCAGCCGGTGGTGTTTATCGATACCACCGGACGCAGCTATGCCATCGATCCGATTACTCTGCCTTCCGCGCGTGGCCAGGGTGAACCGCTTACCGGCAAACTGACCCTGCCGCCGGGCGCGACCGTGGAGCATATGCTAATGGAAAGCGACGATCAGAAACTGCTGATGGCTTCCGACGCGGGCTACGGTTTCGTCTGTACCTTCAACGATCTGGTGGCGCGCAACCGTGCCGGTAAAGCGCTAATCACCCTGCCTGACAACGCGCACGTGATGCCGCCGCTGGTGATTGAGGATGAGTCCGATATGCTGCTGGCCATCACCGCCGCCGGGCGGATGCTGATGTTCCCGGTCAGCGATCTGCCGCAGCTGTCGAAAGGCAAGGGCAACAAAATTATCAGCATTCCGGCGGCGGAAGCCGCAGCCGGCCAGGACGGTCTGGCACATCTGTTTGTTCTGCCGCCGCAGAGTACGCTGACCATTCACGTCGGCAAACGGAAGATCAAACTGCGTCCGGAAGAGCTGCAAAAAGTCACCGGCGAGCGCGGCCGCCGCGGTTCGCTGATGCGCGGGCTGCAGAAAATTGACCGCGTGGAAATTGACTCGCCGCGTCGTGCCGCGGCAGGCGATAGCGAAGAGTAA	
8083	CARD	prokka_02516	contig_8	270450	105	48696	50463	-1	124	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	595.89	500.0	Strict	52.37	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTGCTGGCGCTGGCTTTTCTGCTGGGTCGCGTCGCCTGGCTACAGGTGATCAGCCCCGATATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTGTCCACCGCGCGCGGGATGATTACCGATCGCTCCGGACGTCCGCTGGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGACCCGAAAGAGCTCCATGACGCCGGCGGGGTTACCCTGGATACGCGCTGGAAAGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGGTTTATCTATCTGGCGCGTCAGGTTAACCCTGACATGGCCGATTACATCAAGAAGCTGAAGCTGCCGGGCATTCATCTGCGCGAAGAATCCCGTCGGTACTACCCTTCCGGGGAAGTAACCGCTCACCTCATCGGCTTTACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAAAAAAGCTTTGATAAATGGCTTACCGGTCAGCCGGGCGAGCGTATCGTGCGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCTACCGATAGCCAGGCAGCGCACAACCTGGCGCTGAGTATCGACGAACGCCTGCAGGCGCTGGTCTATCGCGAGCTAAACAACGCCGTGGCCTTTAACAAAGCCGAGTCGGGCAGCGCCGTGTTAGTAGATGTTAACACCGGTGAAGTGCTGGCGATGGCCAACAGCCCATCCTATAACCCGAACAACTTCGCCGGTACGGCAAAAGACACCATGCGTAACCGTGCGATTACCGACGTGTTTGAGCCGGGTTCGACGGTGAAACCGATGGTGGTCATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTATGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCGTTGTCGATTACCAAAGTTGATCCTCCGGTTCCGGGCGAGCGCGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGTGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTATATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
8083	CARD	prokka_04172	contig_19	101300	107	10493	11885	-1	123	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	864.3739999999998	850.0	Strict	95.03	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAVGCICLMAIVAIFEERKIRREKKNRILQTA	ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCTTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTTTTCATCGGCTACCTGACCATGTACTTGATCCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGCTGAGCATGACCCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAGACGCTGGTCTCTTATTATGCCGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCTACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACTTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTTGGCTTTATCGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCGAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAGGTCGGCGCGCTGGTCGGCACGCTGCTGTGGGGCTGGCTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACCCTCGGGGTTTACCAACACGCCAGCAACCAGTACGTCTATCTGGCCTCGTTATTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGGATCAAGGGCACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAACTGGGTCTCGGGATGATCGCCGACGGCACCCCGGTCTTCGGCCTGACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCGTCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTTGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACCGCCTGA	
8083	CARD	prokka_04206	contig_19	101300	107	44623	47038	-1	122	Salmonella serovars gyrB conferring resistance to fluoroquinolones	3003307.0	1568.52	1200.0	Strict	94.78	100.0	fluoroquinolone resistant gyrB	protein variant model	antibiotic target alteration	E466D	fluoroquinolone antibiotic	MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGYCKDIVVTIHSDNSVSVQDDGRGIPTGIHPEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGVSVVNALSQKLELVIQRDNKVHKQMYEHGVPQAPLAVTGETDKTGTMVRFWPSLETFTNVTEFEYDILAKRLRELSFLNSGVSIRLRDKRDGKEDHFHYEGGIKAFVEYLNKNKTPIHPNIFYFSTEKDGIGVEVALQWNDGFQENIYCFTNNIPQRDGGTHLAGFRAAMTRTLNAYMDKEGYSKKAKVSATGDDAREGLIAVVSVKVPDPKFSSQTKDKLVSSEVKSAVEQQMNELLSEYLLENPSDAKIVVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPALSELYLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLSSQDVATLITALGCGIGRDEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIVERGHVYIAQPPLYKVKKGKQEQYIKDDEAMDQYQISIALDGATLHTNANAPALAGEPLEKLVAEFNATQKMIGRMERRFPKALLKELIYQPTLTEADLADEQKVTRWVNTLVSELNEKEQHGSQWKFDLHENKELQHFEPVIRVRTHGVDTDYPLDNEFIMGPEYRRICALGEKLRGLMEEDAYIERGERRQPVASFEQALDWLVKESRRGLSIQRYKGLGEMNPDQLWETTMDPDSRRMLRVTVKDAIAADQLFTTLMGDAVEPRRAFIEENALKAANIDI	ATGTCGAATTCTTATGACTCCTCCAGTATCAAAGTCCTGAAAGGGCTGGATGCGGTGCGTAAGCGCCCGGGTATGTATATCGGCGACACGGATGACGGCACCGGTCTGCACCACATGGTATTCGAGGTTGTGGATAACGCTATCGACGAAGCGCTCGCGGGTTACTGCAAAGATATCGTTGTCACCATCCACAGCGATAACTCCGTCTCCGTCCAGGATGACGGCCGCGGCATCCCGACCGGCATTCACCCGGAAGAGGGCGTCTCCGCAGCGGAAGTTATCATGACCGTCCTGCACGCTGGCGGTAAATTCGATGATAACTCCTATAAAGTTTCCGGCGGTCTGCACGGCGTAGGCGTCTCGGTGGTTAACGCCCTGTCGCAGAAGCTGGAGCTGGTTATCCAGCGCGATAACAAAGTTCACAAGCAGATGTACGAACACGGTGTGCCGCAGGCACCGCTGGCCGTGACTGGCGAAACCGACAAAACCGGCACCATGGTGCGTTTCTGGCCAAGCCTGGAAACCTTCACCAATGTCACCGAATTTGAATATGACATCCTGGCGAAACGCCTGCGCGAGCTGTCGTTCCTGAACTCCGGCGTCTCTATCCGCCTGCGCGATAAGCGCGACGGCAAAGAAGACCATTTCCACTACGAAGGCGGCATCAAGGCGTTCGTTGAGTATCTCAACAAGAACAAAACGCCGATCCACCCGAATATTTTCTATTTCTCCACCGAAAAAGACGGTATCGGCGTGGAAGTGGCCCTGCAGTGGAACGACGGCTTCCAGGAAAACATCTACTGCTTTACCAACAACATTCCGCAGCGTGACGGCGGTACTCACCTCGCCGGCTTCCGCGCGGCGATGACCCGTACTCTTAACGCCTATATGGACAAAGAGGGCTATAGCAAAAAAGCGAAAGTCAGCGCCACCGGCGACGATGCGCGTGAAGGCCTGATTGCCGTGGTATCCGTGAAGGTGCCGGATCCGAAATTCTCCTCGCAGACCAAAGACAAGCTGGTCTCCTCCGAGGTGAAATCGGCGGTGGAGCAGCAGATGAACGAACTGCTGAGCGAATACCTGCTGGAAAATCCATCCGATGCGAAAATCGTGGTCGGCAAAATTATTGACGCCGCGCGCGCCCGTGAGGCCGCACGTCGCGCTCGTGAGATGACTCGTCGTAAAGGCGCGCTGGATCTGGCAGGCCTGCCGGGCAAACTGGCGGATTGCCAGGAGCGCGACCCGGCGCTGTCCGAACTGTACCTGGTGGAAGGGGACTCCGCGGGCGGCTCTGCTAAACAGGGTCGTAACCGCAAGAACCAGGCGATCCTGCCGCTGAAGGGTAAAATCCTTAACGTTGAGAAAGCCCGCTTCGATAAAATGCTCTCTTCCCAGGACGTGGCGACGCTGATCACCGCGCTGGGCTGCGGTATCGGTCGCGATGAGTACAATCCGGATAAACTGCGCTACCACAGCATCATCATCATGACCGATGCGGACGTCGACGGCTCGCACATTCGTACCCTGCTGTTGACCTTCTTCTATCGTCAGATGCCGGAGATCGTCGAGCGCGGCCACGTCTACATTGCCCAGCCGCCGCTGTACAAAGTGAAGAAAGGCAAGCAGGAACAGTACATTAAAGACGACGAAGCGATGGATCAGTATCAGATCTCCATCGCGCTCGACGGTGCGACCCTGCACACCAACGCCAATGCGCCGGCGCTGGCGGGCGAACCGCTGGAAAAACTGGTTGCCGAGTTCAATGCCACCCAGAAAATGATTGGCCGCATGGAGCGCCGCTTCCCGAAAGCGCTGCTGAAAGAGCTTATCTATCAGCCGACCCTGACCGAGGCCGACCTGGCGGACGAGCAGAAGGTGACCCGCTGGGTGAACACCCTGGTCTCCGAGCTGAACGAGAAAGAACAGCACGGCAGCCAGTGGAAATTCGATCTCCACGAGAACAAAGAACTGCAGCATTTTGAGCCGGTTATTCGCGTACGTACCCACGGCGTGGATACCGACTATCCGCTGGATAACGAGTTCATTATGGGGCCGGAATATCGTCGTATTTGTGCCCTGGGCGAGAAACTGCGCGGCCTGATGGAAGAAGATGCTTACATCGAGCGCGGCGAACGTCGTCAGCCGGTAGCCAGCTTCGAGCAGGCCCTGGACTGGCTGGTGAAAGAGTCCCGTCGCGGTCTCTCCATCCAGCGCTATAAAGGTCTGGGCGAGATGAACCCGGATCAGCTGTGGGAAACCACCATGGATCCGGACAGCCGTCGCATGCTGCGCGTGACCGTCAAGGATGCCATCGCTGCCGATCAGCTGTTCACCACCCTGATGGGTGATGCCGTTGAGCCGCGTCGCGCGTTTATCGAAGAGAATGCCCTGAAAGCGGCGAATATCGATATTTAA	
8083	CARD	prokka_03533	contig_13	149744	100	128708	129143	1	142	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	251.906	210.0	Strict	83.33	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIKRLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP	ATGAAAAGTACCAGCGACCTGTTTAATGAAATGATCCCGCTGGGTCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTACCTCTCACCTATGGATATTACCGCGACCCAGTTTCGCGTGCTCTGCTCCATTCGTTGCGAAGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGACCCGGGCGCAATGACGCGCATGCTCGACCGCCTGGCGTGCAAAGGCTGGATTAAACGGTTACCCAACCCCGCTGACAAGCGCGGCGTGCTGGTGCAGTTGACGCCGGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACGAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTGCTCAAGAAGGTCCTGCCGTAA	
8090	BLDB	prokka_01105	contig_2	739929	77	276431	277292	-1	68	SHV-11		79.3		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase SHV-11	protein homolog model			Beta-Lactam	MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGCGTTATATTCGCCTGTGTATTATCTCCCTGTTAGCCACCCTGCCGCTGGCGGTACACGCCAGCCCGCAGCCGCTTGAGCAAATTAAACAAAGCGAAAGCCAGCTGTCGGGCCGCGTAGGCATGATAGAAATGGATCTGGCCAGCGGCCGCACGCTGACCGCCTGGCGCGCCGATGAACGCTTTCCCATGATGAGCACCTTTAAAGTAGTGCTCTGCGGCGCAGTGCTGGCGCGGGTGGATGCCGGTGACGAACAGCTGGAGCGAAAGATCCACTATCGCCAGCAGGATCTGGTGGACTACTCGCCGGTCAGCGAAAAACATCTTGCCGACGGCATGACGGTCGGCGAACTCTGCGCCGCCGCCATTACCATGAGCGATAACAGCGCCGCCAATCTGCTGCTGGCCACCGTCGGCGGCCCCGCAGGATTGACTGCCTTTTTGCGCCAGATCGGCGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTGAATGAGGCGCTTCCCGGCGACGCCCGCGACACCACTACCCCGGCCAGCATGGCCGCGACCCTGCGCAAGCTGCTGACCAGCCAGCGTCTGAGCGCCCGTTCGCAACGGCAGCTGCTGCAGTGGATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAGCGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATTTATCTGCGGGATACCCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAACACTGGCAACGCTAA	
8090	BLDB	prokka_05244	contig_53	2186	132	776	1607	1	77	OXA-1		238.9		Perfect	100.0	99.64	oxacillin-hydrolyzing class D beta-lactamase OXA-1	protein homolog model			Beta-Lactam	MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL	ATGAAAAACACAATACATATCAACTTCGCTATTTTTTTAATAATTGCAAATATTATCTACAGCAGCGCCAGTGCATCAACAGATATCTCTACTGTTGCATCTCCATTATTTGAAGGAACTGAAGGTTGTTTTTTACTTTACGATGCATCCACAAACGCTGAAATTGCTCAATTCAATAAAGCAAAGTGTGCAACGCAAATGGCACCAGATTCAACTTTCAAGATCGCATTATCACTTATGGCATTTGATGCGGAAATAATAGATCAGAAAACCATATTCAAATGGGATAAAACCCCCAAAGGAATGGAGATCTGGAACAGCAATCATACACCAAAGACGTGGATGCAATTTTCTGTTGTTTGGGTTTCGCAAGAAATAACCCAAAAAATTGGATTAAATAAAATCAAGAATTATCTCAAAGATTTTGATTATGGAAATCAAGACTTCTCTGGAGATAAAGAAAGAAACAACGGATTAACAGAAGCATGGCTCGAAAGTAGCTTAAAAATTTCACCAGAAGAACAAATTCAATTCCTGCGTAAAATTATTAATCACAATCTCCCAGTTAAAAACTCAGCCATAGAAAACACCATAGAGAACATGTATCTACAAGATCTGGATAATAGTACAAAACTGTATGGGAAAACTGGTGCAGGATTCACAGCAAATAGAACCTTACAAAACGGATGGTTTGAAGGGTTTATTATAAGCAAATCAGGACATAAATATGTTTTTGTGTCCGCACTTACAGGAAACTTGGGGTCGAATTTAACATCAAGCATAAAAGCCAAGAAAAATGCGATCACCATTCTAAACACACTAAATTTATAA	
8090	BLDB	prokka_05245	contig_55	1975	97	396	1272	1	107	CTX-M-15		90.0		Perfect	100.0	99.66	class A extended-spectrum beta-lactamase CTX-M-15	protein homolog model			Beta-Lactam	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	ATGGTTAAAAAATCACTGCGCCAGTTCACGCTGATGGCGACGGCAACCGTCACGCTGTTGTTAGGAAGTGTGCCGCTGTATGCGCAAACGGCGGACGTACAGCAAAAACTTGCCGAATTAGAGCGGCAGTCGGGAGGCAGACTGGGTGTGGCATTGATTAACACAGCAGATAATTCGCAAATACTTTATCGTGCTGATGAGCGCTTTGCGATGTGCAGCACCAGTAAAGTGATGGCCGCGGCCGCGGTGCTGAAGAAAAGTGAAAGCGAACCGAATCTGTTAAATCAGCGAGTTGAGATCAAAAAATCTGACCTTGTTAACTATAATCCGATTGCGGAAAAGCACGTCAATGGGACGATGTCACTGGCTGAGCTTAGCGCGGCCGCGCTACAGTACAGCGATAACGTGGCGATGAATAAGCTGATTGCTCACGTTGGCGGCCCGGCTAGCGTCACCGCGTTCGCCCGACAGCTGGGAGACGAAACGTTCCGTCTCGACCGTACCGAGCCGACGTTAAACACCGCCATTCCGGGCGATCCGCGTGATACCACTTCACCTCGGGCAATGGCGCAAACTCTGCGGAATCTGACGCTGGGTAAAGCATTGGGCGACAGCCAACGGGCGCAGCTGGTGACATGGATGAAAGGCAATACCACCGGTGCAGCGAGCATTCAGGCTGGACTGCCTGCTTCCTGGGTTGTGGGGGATAAAACCGGCAGCGGTGGCTATGGCACCACCAACGATATCGCGGTGATCTGGCCAAAAGATCGTGCGCCGCTGATTCTGGTCACTTACTTCACCCAGCCTCAACCTAAGGCAGAAAGCCGTCGCGATGTATTAGCGTCGGCGGCTAAAATCGTCACCGACGGTTTGTAA	
8090	CARD	prokka_00033	contig_1	915801	84	34475	35636	-1	73	Escherichia coli ampH beta-lactamase	3004612.0	687.567	500.0	Strict	85.19	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKTAPGSQAAYSNLAFDLLADALSTAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ	TTGAAACGTAGTTTGCTCATTTTTGCTGCGCTGTGCGCGGCGTCGTGGACCTCGGTGCAGGCCGCACAGCCTACCGTTGACCCGGTTTTCGCCTCGGATGTGGTCGATCGTTACGCCAATCATATCTACTACGGCAGCGGCGCCACCGGCATGGCGCTGGTGGTTATCGATGGCAATCAGCGTGTTTTTCGCAGCTTTGGCGAAACCCGCCCGGGGAATAATCAGCACCCGCAGCTCGACTCGGTGATCCGTATCGCCTCCCTCAGCAAACTGATGACCAGCGAGATGCTGGTGAAGCTGCTCGACCAGGGGGTGGTGAAACTCAACGATCCGCTGAGTAAATACGCCCCGCCGGGCGCCCGGGTGCCTGACTGGCAGGGAAAACCAATCACCCTGGTTAACCTCGCGACCCATACCAGCGCCCTGCCGCGCGAGCAGCCTGGCGGCGCCGCTCATCGTCCGGTGTTTGTCTGGCCGACCCGCCAGCAGCGCTGGAACTGGCTCTCTACCGCGACCCTGAAGACCGCGCCGGGCTCGCAGGCGGCCTACTCCAACCTGGCCTTCGATTTACTGGCGGACGCGCTCTCCACCGCCGCCGGCAAACCGTATCCGCAGCTGTTTGAAGAGCAGATCACCCGGCCGCTGGGGATGAAGGACACCACCTTTACCCCGTCACCGGATCAGTGCCAGCGGCTGATGATCCCGGAAAAAGGCGCCAGCCCATGCAACAACACCCTGGCGGCGATCGGCAGCGGCGGAGTCTACTCGACGCCGGGGGATATGATGCGCTGGATGCAGCAGTTCCTGTCATCCGATTTCTATACCCGCAGCCAGCAGGCCGACCGGATGCAGACGCTGATTTATCAGCGTAACCAGCTGACCCGGGTGATTGGTATGGACGTGCCGGGCCGCGCAGACGCGCTGGGCCTCGGCTGGGTGTATATGAAGCCGAAGAACGGCCATCCGGGGATTATTCAGAAAACCGGCGGCGGCGGCGGGTTTATCACCTATATGGCGATGAATCCGCAGGCTAACGTTGGCGCCTTTGTGGTGGTAACCCGCTCGCCGTTAACCCGCTTCAACAATATGAGCGATGGCATCAACGACCTGGTCAGCGAGTTGAGCGGCGCACAGCCCAACATGCAGACGGCCAGCCAGTAA	
8090	CARD	prokka_00159	contig_1	915801	84	161224	164371	-1	102	acrB	3000216.0	1941.39	1900.0	Strict	91.52	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAMALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKSEDIEHSHQVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATTATCATCATGCTGGCTGGGGGATTATCGATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACGGTGCAGAACACCGTAACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCAAATGGCGACTCCACCGGTACGGCAACCATTACGCTGACCTTCGAATCCGGTACCGATCCGGATATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCGCTGGCGACGCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATTAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTCATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGATCCGATTAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTATTCGGTTCCCAGTATGCGATGCGTATCTGGATGGATCCAAACAAACTGAACAACTTCCAGCTTACGCCGGTGGATGTGATCAGCGCCCTGAAAGCGCAGAACGCCCAGGTGGCCGCGGGCCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCCTCGATCATCGCGCAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGACGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGCGGCGAAAGCTATGACGTGGTGGCGAAGTTTAACGGCCAGCCGGCATCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCTATTCGCGCTGAACTGGCGAAGATGGAGCCGTTTTTCCCGTCGGGGATGAAGATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATTTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCCACCATCGCGGTACCGGTGGTCCTGTTAGGCACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTGGTGGTAGAGAACGTCGAGCGCGTGATGGCGGAAGAGGGTCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGACAGATTCAGGGCGCGCTGGTAGGTATCGCGATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTCTTCGGCGGCTCAACCGGGGCCATCTATCGCCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTGGCGTTAATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAACCCATTCAGAAAGGCAGCCATGGCGCGACCACCGGCTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGTTATCTGGTGCTGTATCTGATCATCGTGGTGGGTATGGCATGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCGGACGAGGACCAGGGTGTATTCCTGAGTATGGCGCAGCTGCCTGCCGGCGCCACCCAGGAGCGTACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGTTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTTTCGCTGAAAGACTGGAGCCAGCGTCCGGGTGAGGAAAACAAAGTTGAAGCGATCACCGCGAGAGCAATGGGCTACTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCGAGCTGATTGACCAGGGCGGTCTCGGCCACGAAAAACTGACCCAGGCGCGTAACCAACTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGCCCTAACGGTCTGGAAGATACACCGCAGTTTAAAATCGATATCGATCAGGAGAAAGCTCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTGGGCGCAGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATCATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATCGGCAAGTGGTATGTTCGCGGCAGCGATGGTCAGATGGTGCCGTTCTCTGCTTTCTCGACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCGTCACTGGAAATCCTCGGTCAGGCCGCGCCAGGCAAGAGTACCGGTGAGGCGATGGCGCTGATGGAAGAGCTGGCGGGTAAACTGCCTTCCGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGACTGTCCGGCAACCAGGCCCCTGCCCTGTATGCCATCTCGCTGATTGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTTATGCTGGTCGTCCCCTTGGGTGTGGTCGGTGCGCTGTTAGCCGCCACCTTCCGCGGGCTAACCAACGACGTTTACTTCCAGGTGGGTCTGCTGACCACCATCGGCCTGTCGGCGAAGAACGCAATATTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCAGTACGTATGCGTCTACGTCCAATCCTGATGACATCTCTGGCGTTCATCCTCGGGGTAATGCCGCTAGTTATCAGCTCCGGCGCCGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCGATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGCAAAAAATCGGAAGATATAGAGCACAGCCATCAGGTTGAGCATCATTAA	
8090	CARD	prokka_00160	contig_1	915801	84	164393	165587	-1	102	Klebsiella pneumoniae acrA	3004041.0	738.413	770.0	Strict	95.24	99.75	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAGGGAGCCCAGCACATGCCAGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGCACCAGCGCCTATCGCATTGCGGAAGTCCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTCTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTGGGCACCAAATATATTAGTCAACAAGACTACGATACCGCCGTTGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCTGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATCAGCGGCCGGATCGGTAAATCCGCCGTGACCGAAGGGGCGCTGGTACAGAATGGTCAAACGACCGCCCTGGCAACCGTACAGCAGCTGGATCCGATCTATGTTGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAGCAGGAGCTAGCCGACGGCCGCCTGAAACAGGAAAACGGCAAAGCGAAAGTGGAGCTGGTGACTAATGACGGTCTTAAGTATCCGCAGTCCGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCAATCACGCTACGCGCTATTTTCCCGAACCCGGATCACACCCTGCTACCGGGGATGTTCGTCCGTGCCCGTCTGGAAGAAGGGATTAACCCTGACGCCCTGCTGGTACCGCAACAGGGTGTTACCCGTACGCCGCGCGGCGACGCCAGCGTCATGGTAGTGGGGGAAGGCGATAAAGTCGAAGTCCGCCAGGTCACTGCTTCTCAGGCGATCGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACCGGCCTGCAAAAAATCAAACCAGGTGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA	loose hit with at least 95 percent identity pushed strict
8090	CARD	prokka_00603	contig_1	915801	84	646414	647647	1	103	Escherichia coli mdfA	3001328.0	706.057	700.0	Strict	85.61	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVLAAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG	ATGCAAAATTATTCGCTTTCAGGCCGCCGCCTCGGAAGGCAGGCGCTGTTGTTCCCGTTATGTCTGGTGCTGTACGAGTTTTCCACTTATATCGGCAACGATATGATTCAGCCGGGCATGTTAGCCGTGGTGCAGGAATTTCAGGTGGGCAACGAATGGGTACCTACCTCAATGACTGCCTATCTGGCAGGCGGCATGTTTTTACAGTGGCTGCTGGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGTTGACCGGCGTAGTATGGTTCATCGTCACCTGCCTGGCGACGCTGCTGGCGCAGACCATTGAGCAGTTTACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGCTTTATTGGCGCGGTGGGCTATGCGGCGATACAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCCCTGATGGCTAACGTGGCGCTGATTGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATGTCCTGCCGTGGGAGATGATGTTTGTCCTGTTCGCCGTGCTGGCGGCCATCTCGTTCTTCGGCCTGCAGCGGGCGATGCCGGAGACCGCGACGCGGCTGGGCGAAAAGCTGTCGGTGAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTGAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCCACCGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCCACCAGCTATGAGTACGGCATGCTGCAGGTGCCGATTTTCGGGGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTGCGCGCCGGACCGTGCGCTCGCTGATTATCATGGGCGGTTGGCCGATCATGTTTGGCCTGATCCTCTCTGCGGCGGCGACCGTGGTCTCTTCCCACGCTTATCTGTGGATGACGGCCGGTTTGAGCTTCTACGCCTTCGGGATTGGCCTCGCGAACGCCGGCCTGGTGCGTTTAACCCTGTTCGCCAGCGAGATGAGTAAAGGCACGGTCTCGGCGGCGATGGGAATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTGGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGCTGGGTGGGGTACTATGGCTGGGGCTGATGATTTACTTTCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGGTAG	
8090	CARD	prokka_00671	contig_1	915801	84	727018	728767	1	102	msbA	3003950.0	1126.69	1000.0	Strict	92.78	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE	ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATCGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTGGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGCCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATTTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGTATGCCGGTGGCCTTCTTTGACAAGCAGTCTACCGGAACGCTGCTGTCACGCATCACCTATGATTCTGAGCAGGTCGCCTCCTCCTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGGGCATCGATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTGATCGTACTGGCGCCGATTGTGTCGGTGGCGATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCCGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAAGTCAGCAATAAAATGCGTCTGCAGGGGATGAAGATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCCGGGACCATTACCGTGGTCTTCTCCTCGATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAGCGTGGGATGGCGGCGTGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAAAAAGACGAAGGTACGCGGGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTACCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATCCCGGAAGGGAAAACCGTGGCGCTGGTGGGGCGCTCAGGGTCGGGTAAATCGACCATTGCCAGCCTGATCACCCGCTTCTACGATGTCGACGAGGGGCAGATCCTGCTGGATGGCCACGACCTGCGCGAGTACAAGCTGAGCTCACTGCGCGATCAGGTGGCGCTGGTTTCACAGAACGTGCATCTGTTCAACGATACCGTCGCCAACAATATCGCCTATGCCCGTACCGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCCGCGCGCATGGCCTACGCCATGGATTTCATTAACAAGATGGATAATGGTCTGGATACCATCATCGGCGAGAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATTGCCCGCGCGCTGCTGCGTAACAGCCCGATCCTGATCCTTGATGAAGCCACCTCGGCGCTGGATACCGAGTCCGAGCGTGCCATTCAGGCGGCGCTGGATGAGCTGCAGAAAAACCGTACCTCGCTGGTTATCGCTCACCGTCTGTCGACCATTGAGCAGGCTGATGAAATCGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCATGACCTGCTGGAGCATAAGGGCGTGTACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA	
8090	CARD	prokka_00713	contig_1	915801	84	778139	779210	-1	108	OmpA	3005044.0	729.169	700.0	Strict	99.72	95.19	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTCGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA	
8090	CARD	prokka_00938	contig_2	739929	77	95077	96202	-1	84	Klebsiella pneumoniae OmpK37	3004122.0	751.51	700.0	Strict	99.47	100.0	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFGFKGETQINDMLTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDMLPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGISTDNIVALGLVYQF	ATGAAAAGAAAAGTACTGGCCCTCGTTATTCCGGCTTTATTAGCCGCCGGTGCCGCGCATGCGGCGGAAATTTATAATAAAGACGGGAATAAATTAGATCTCTATGGCAAGGTAGATGGTCTGCATTATTTCTCCAGCGACTCGAAAAAAGACGGCGATCAAACTTATTTACGTTTTGGCTTTAAAGGCGAAACCCAGATCAACGATATGCTTACCGGCTATGGCCAGTGGGAATATAACGTTCAGGCCAACAACACCGAGACCTCCAGCGATCAGGCGTGGACCCGTCTGGCATTCGCCGGTATCAAAGTGGGCGATTACGGCTCCTTCGACTACGGTCGTAACTACGGCGTGCTGTACGACGTTGAAGGCTGGACCGATATGCTGCCGGAGTTCGGCGGCGACTCCTACACCTATGCGGATAACTTTATGGCAGGCCGCGCCAACGGCGTCGCAACCTACCGTAACAGCGATTTCTTCGGTCTGGTGGAGGGTCTGAACTTCGCCCTGCAGTATCAGGGTAAAAACGAAGGCCAGAACGCGCAGGATATCAACGTCGGCACCAATAACCGCAGCAGCGACAGCGATGTTCGCTTCGACAATGGCGATGGTTTCGGCCTCTCTACTTCCTACGACTTCGGCATGGGCATCAGCGCGGCGGCAGCTTACACCTCGTCTGACCGTACTAACGATCAGATGACCCAGACCAACGCGCGCGGCGATAAAGCGGAAGCCTGGACCGCCGGCCTGAAGTACGACGCCAACGATATCTACCTGGCGACCATGTACTCTGAAACCCGCAATATGACCCCGTACGGCAATGACGGCGTGGCCAATAAAACACAAAACTTCGAAGTCACCGCGCAGTATCAGTTCGACTTCGGCCTGCGTCCGGCCATCTCCTACCTGCAGTCCAAAGGCAAAGATCTGTACAATAACGGCCGCTATGCCGATAAAGATCTGGTCAAATATATGGACGTTGGCGCGACCTATTACTTCAACCGTAATATGTCCACCTATGTTGATTACAAAATCAACCTGCTGGATGGTAACGACAAATTCTACGAAGACAACGGTATCTCTACCGATAACATCGTCGCCCTGGGCCTGGTTTACCAGTTCTGA	
8090	CARD	prokka_01061	contig_2	739929	77	235722	236085	1	93	Klebsiella pneumoniae KpnE	3004580.0	223.402	150.0	Strict	99.17	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSKQEVAHAAV	ATGTTTTATTGGATTTTATTAGCTTTAGCAATTATTGCTGAAATTACCGGCACCTTGTCTATGAAATGGGCAAGCGTGAGCGGCGGGCACACCGGCTTTATTTTAATGCTGGCCATGATTGCCCTGTCATATATTTTTCTTGCCTTTGCGGTTAAAAAGATTGCCCTCGGTGTGGCCTATGCGTTGTGGGAAGGGATCGGTATTTTACTGATTACCCTGTTCAGCGTGCTGCTGTTTGATGAGAGTCTGTCCCTGCTGAAAATAGCCGGCTTGACCACCCTGGTGATAGGGATCGTCTTAATTAAGTCCGGCACCCAGAAAAAAGCGTCTTCCAAGCAGGAGGTGGCCCATGCAGCAGTTTGA	
8090	CARD	prokka_01062	contig_2	739929	77	236071	236401	1	75	Klebsiella pneumoniae KpnF	3004583.0	206.453	150.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGCTGGCAATCGCCATTGTGCTGGAAATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGCTTCCGCCGCAAGATCTACGGCATCCTGTCCCTGGCGGCAGTATTGGGCGCGTTCAGCGCCCTGTCGCAGGCGGTTAAAGGGATCGATCTCTCGGTCGCCTATGCGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGTCAGCGTCTGAATAACAAAGGCTGGGCGGGGGTTATCCTGCTGGTAGCCGGCATGGTGTTAATTAAACTCGCCTGA	
8090	CARD	prokka_01126	contig_2	739929	77	297384	297759	-1	104	marA	3000263.0	243.432	230.0	Strict	92.74	97.64	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN	ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCAGGTTACTCCAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACTGGCCATTCCCTCGGCCAGTACATCCGCAGCCGTAAGCTGACGGAGATTGCGCAAAAGCTCAAGCAGAGCAATGAGCCAATCCTGTACCTGGCGGAACGCTACGGTTTCGAATCGCAGCAGACCTTGACGCGAACATTTAAAAACTATTTTGATGTTCCGCCCCACAAATATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTGCATCCGCTAAATAACTGA	
8090	CARD	prokka_01889	contig_3	431684	87	344926	345112	1	105	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTGTCTGTTCACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	
8090	CARD	prokka_01902	contig_3	431684	87	352970	354509	-1	95	Klebsiella pneumoniae KpnH	3004597.0	937.947	700.0	Strict	94.02	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAACTGGTCATTATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATTGCCGGCAACCTTGGCTCGTCGCTGAGCCAGGGGACCTGGGTCATCACCTCGTTCGGGGTCGCTAACGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGCGTCGGCGAGGTGAAGCTGTTCCTGTGGTCAACCACCGCCTTCGCCATTGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTCATTCAGGGGATCGTCGCCGGGCCGCTGATCCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCCCCGGCGAAGCGCTCTATCGCTCTGGCGCTGTGGTCAATGACGGTGATTGTCGCGCCCATCTGCGGTCCGATCCTCGGCGGCTATATCAGCGATAATTATCACTGGGGCTGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGGATCGACGGCGTCGGTCTGGCGCTGCTGATCATTGGTATCGGTAGCCTGCAGGTGATGCTGGACCGGGGTAAAGAGCTGGACTGGTTCTCCTCCAATGAGATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTAACCGACGATAACCCGATTGTCGATCTATCGCTATTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGTATCAGTCTGGCCTATATGCTCTACTTCGGCGCCATCGTGCTGCTGCCGCAGCTGTTGCAGGAGGTCTACGGCTACACCGCGACCTGGGCCGGCCTGGCGTCGGCGCCGGTGGGGGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTCGCGCATAAGCTCGACATGCGGCGGCTGGTCACCTTCAGCTTTATTATGTACGCGGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCACAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTCTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCCTGTCGAACTTCACCCGTACCCTTGCCGGCTCAATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCATCATGCGCAGCTCACCGAATCGGTGACCCCCTTTAACCCCAACGCGCAGCAGATATACGATCAGCTGCAGGGCATGGGAATGACGCAGCAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACCAACCAGGGGCTGATTATCTCCGCCAACGAAATCTTCTGGATTTCTGCGGCTATTTTCATCCTGCTGTTGGGGCTGGTGTGGTTCGCCAGACCACCGTTCAGCGCCGGCGGAGGCGGCGGCGGCGCGCACTAA	
8090	CARD	prokka_01903	contig_3	431684	87	354524	355697	-1	84	Klebsiella pneumoniae KpnG	3004588.0	788.875	700.0	Strict	99.74	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	ATGAGTGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGAAAGCGTAAAGGCGCCCTTCTGTTGCTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTAGCAGGGAATCAGGTACAAATTATGGCTCAGGTCGCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACGCTCGATCGGACCGATGCCCAACAGGCGTTTGAAAAGGCTAAGACCCAACTGGCCGCCAGCGTCCGTCAGACCCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCAAATATCGACGTCAAAAAAACCGCCCTTGCCCAGGCGCAGGCTGACCTGAACCGCCGCATCCCGCTGGGCGCCGCGAACCTCATTGGCCGCGAAGAGCTGCAGCACGCCCGCGATACCGTCGCCAGCGCACAGGCCGAACTCGACGTGGCAATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGCACCAGGCTGGAACAGCAGCCGGCGGTGCTCCAGGCGGCCACTGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATTGGCACCACCACGCCGCTGATGGCGGTGGTCCCGGCGACCAACCTGTGGATCGATGCTAACTTTAAAGAGACTCAGCTGGCGCATATGCGTATCGGCCAGCCGGCCACCGTGATCAGCGATATCTATGGCGATGACGTGAAATACACCGGTAAAGTGGTCGGTCTGGATATGGGCACCGGCAGCGCCTTCTCTCTGCTGCCGGCGCAGAATGCCACCGGCAACTGGATCAAAGTGGTACAACGCCTGCCGGTTCGTATCGAGCTGGATGAAAAACAACTAGCGGAACACCCGCTGCGTATCGGTCTCTCGACGCTGGTGGAAGTCAACACCACCGATCGCGATGGTGAAATGCTGGCCAGCCAGGTGCGGAGCTCCCCGGTTTACGAGAGCAATGCCCGCGAAATCGCTCTCGATCCGGTTAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA	
8090	CARD	prokka_01904	contig_3	431684	87	355822	356353	-1	95	emrR	3000516.0	338.961	280.0	Strict	92.57	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR	ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTTCGCGCCAGCCGCCATGAAGATTTCCCGTTTCAGGAGATCCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCACAGGAAAACCACAGCATCCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCACGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAGCGCCGCGAGAGCGATAACGATCGTCGCTGTTTGCATCTGCAACTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTTAGCACCAGCGAAAAAGATCAGCTCGAACACATCACCCGCAAACTCCTGAGCCGCCTTGATCAGATGGAAGAAGAAGGCGTGCTAGCGGACTCTCTACGCTAA	
8090	CARD	prokka_01946	contig_3	431684	87	396411	399564	-1	95	oqxB	3003923.0	2110.49	2000.0	Strict	99.62	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPNGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSISAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTELFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEMQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCGCTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCGGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTTTCGCCAAACGGTAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCGGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCTCCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGCTGATCGCGGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCGATTGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCACCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGTTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCCATCCTGCCGCCGCCGATTTTAGGACTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAAACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGAGCTATTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCCGATGGGCCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTGCCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAGGAGCTGTCAAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCGTTCCTCGTGCTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTGCCGATGACGATGCTCTCCGCGCTATTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGGCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGTGAGCTGGAGATGCAGGGCAAAGGCATCATGGAGGCCGCGCTGGAGGCGTGCCGCCTGCGTCTGCGCCCGATTGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTTGGCCACGGCGCAGGAGCGGAAGTTCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTGCGAAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG	
8090	CARD	prokka_01947	contig_3	431684	87	399587	400763	-1	72	oqxA	3003922.0	798.1189999999998	670.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	ATGAGCCTGCAAAAAACCTGGGGAAACATTCACCTGACCGCGCTCGGCGCGATGATGCTCTCCTTTCTGCTCGTCGGCTGCGACGACAGCGTCGCGCAGAATGCTGCGCCTCCCGCCCCGACGGTCAGCGCCGCTAAGGTGCTGGTGAAGTCGATCAGTCAGTGGGATAGTTTTAACGGTCGCATTGAAGCGGTGGAGAGCGTTCAGCTTCGCCCTCGCGTCTCGGGATACATTGATAAAGTGAATTACACCGACGGCCAGGAGGTGAAAAAGGGCCAGGTGCTGTTCACGATAGATGACAGAACCTATCGCGCCGCGCTGGAGCAGGCGCAGGCGGCGTTGGCAAGAGCCAAAACGCAGGCCAGCCTGGCGCAAAGCGAGGCGAACCGCACCGATAAATTAGTCCATACCAACCTCGTCTCCCGTGAAGAGTGGGAGCAGCGCCGGTCAGCCGCGGTTCAGGCGCAGGCCGACATTCGCGCCGCGCAGGCGGCGGTGGATGCCGCGCAGCTTAACCTCGACTTCACCAAAGTGACCGCCCCTATTGACGGCCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTCACCGCGGGCGACACCGCCAGCGTGCTCACCACCCTGGTCTCGCAGAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTCCACTATCAAAACCTCGCCCGCCGCGGGCAAGGCGCGTCCAGCGATAATCAGGCGCTCCCGGTGGAGATTGGCCTGGTTGGCGAGGAGGGTTACCCCCACCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGTACCGGCACCATCCGCATGCGTGCGCTGCTGGATAACTCGCAGCGTCTGTTCACACCGGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCAGAGTTCAAAGCCACGCTGATCGACGACAAAGCGGTACTGACCGATCAGGATCGTAAATACGTCTATATCGTTGATAAAGATGGTAAAGCACAGCGCCGCGACATTACCCCAGGGCGGCTGGCAGACGGTTTACGCATCGTTCAGAAGGGGTTGAATCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCCAAAACCGTTGCCATGACCTCCAGCGCCACCCTTAACTGA	
8090	CARD	prokka_02068	contig_4	298863	94	90989	92663	1	120	eptB	3005047.0	1160.98	1000.0	Strict	99.46	97.04	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELEKEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATTATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGCGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTAATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGTCTGTACGCTTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGGCTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTCGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAATCCACAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCACGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCTGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA	
8090	CARD	prokka_02125	contig_4	298863	94	167319	168303	1	95	PmrF	3003578.0	577.785	550.0	Strict	83.69	101.55	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS	ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATCCCGGTTTATAATGAACAGGATAGCCTGCCGGAGCTGCTTCGTCGTACGGATGCCGCCTGCGCCACCCTGGGGCGGCAATATGAAATTCTGTTGATCGACGATGGCAGCAGCGACGATTCGGCGCGCATGCTCACCGAAGCCGCCGAGGCGGAAGGCAGCCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGCCAGCACTCGGCGATCATGGCCGGCTTCAGCCATGTAACCGGCGATCTGATTATTACCCTCGACGCCGACCTGCAAAACCCGCCGGAGGAGATCCCGCGGCTGGTGGCGAAGGCTGATGAAGGTTACGACGTGGTGGGCACTGTCCGCCAGAACCGTCAGGACAGCATCTTCCGTAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTTATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATTGCCCTGCTGGGCTTCGCCTTCGGCCTGCTGCTGGTGGTGCTGCGTCTGGCCTTTGGCCCGCAGTGGGCGGCGGAAGGGGTGTTTATGCTCTTCGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCCCGCCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA	
8090	CARD	prokka_02128	contig_4	298863	94	171183	172839	1	106	ArnT	3005053.0	1093.95	1000.0	Strict	99.09	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAIMSPVIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAAQAQSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTCTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGATCAACAGTATCGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCATGTCGCCGGTTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGTGCGGCGCAGGCGCAGAGCCGCAGCGGCAAAATACTGGGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAGGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCCCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTAATCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCTCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCACTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGGATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCCGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAAGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTTGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGATATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA	
8090	CARD	prokka_02228	contig_4	298863	94	282952	283585	-1	103	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAGCGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTCACGTCTGAGAAAGTGGGCAACCTCGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCGGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGCCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCGCACGGTAAAACCATCGTCGTCTACGGCACCCGTTAA	
8090	CARD	prokka_02873	contig_7	238469	87	121342	124456	-1	89	acrD	3000491.0	1956.03	1900.0	Strict	91.13	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGTLAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQPASGLGIKLASGANEMATAERVINRLNELAQFFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPVKPGESHERKGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLIYVVLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGTSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAGKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ	ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCATGGGTGCTGGCAATCCTGTTATGCCTGACGGGCACCCTTGCCATTTTGTCGCTGCCGGTTGAACAGTATCCCGACCTCGCCCCGCCGAATGTGCGGATCACCGCCAACTATCCCGGCGCCTCCGCGCAAACCCTGGAGAATACCGTCACTCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCCTCCCAGAGCAGCGCCACCGGCCAGGCGACGATCACCCTCAGCTTTACCGCCGGTACCGACCCGGATGAAGCCGTGCAGCAGGTTCAGAACCAGCTACAGTCGGCGATGCGTAAGCTGCCGCAGGCGGTGCAAAACCAGGGGGTGACGGTGCGCAAGACCGGTGATACCAATATCCTGACGCTCGCCTTCGTCTCCACTGACGGCAGTATGGATAAACAAGATATCGCCGACTACGTCGCCAGTAACATCCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGTTCGCAATACTCAATGCGCATCTGGCTCGACCCGGCGAAGCTCAACAGCTACCAGATGACCACCAAGGATGTTACCGACGCCATCAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTTGGCGGGACGCCTTCGGTCGATAAGCAAGCGCTGAACGCCACCATCAACTCGCAATCTCTGCTGCAAACCCCGGAGCAGTTCCGCAATATCACTCTGCGCGTCAATCAGGATGGTTCAGAGGTGACGCTGGGCGATGTCGCCACCGTCGAGATGGGGGCGGAGAAGTACGACTATCTTAGCCGCTACAACCGCCAGCCGGCCTCAGGCCTCGGGATCAAGCTGGCTTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCAATCGCCTCAATGAGCTGGCGCAGTTTTTCCCCCACGGTCTGGAATATAAGGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCCATCACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCGACCATCGCCGTGCCGGTGGTGCTGATGGGCACTTTCGCGGTGCTGTATGCCTGTGGCTACAGCATCAACACCCTGACGATGTTCGCGATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGAGCGAGGAGGGCCTGTCGCCACGCGAGGCGACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTATTCGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCAATCACTATCGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCTGCCCTTTGCGCCACGCTGCTTAAGCCTGTTAAGCCAGGTGAATCCCATGAAAGAAAAGGCTTCTTCGGCTGGTTCAACCGCACCTTCAACCGCAGCGCCAGCCGCTACGAAACCTTCGTCGGCAAAATACTGCACCGCTCGCTGCGCTGGATGCTGATCTACGTCGTCCTGCTCGGCGGGATGGTGTTCCTGTTTCTGCATTTGCCGACCTCGTTCCTGCCGCTGGAGGATCGCGGGATGTTCACCACCTCGGTCCAGTTGCCGAGCGGCAGCACCCAGCAGCAGACGCTGAAGGTGGTGCAGAAGGCGGAAGATTACTTCCTCAATAACGAGAAGCAGAACGTCGAGTCGGTGTTCGCTACCGTTGGCTCCGGCCCCGGCGGCAATGGGCAGAACGTGGCCCGTATGTTCGTTCGTCTCAAAGACTGGGACCAGCGCGACCCGCAAACCGGCACCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATTAACGAAGCGCGGGTTATCGCCAGCAGCCCGCCGGCGATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGATATGGAGCTGGAGGATCATGCCGGGAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTACTTGAGCTGGCCGGGAAAAATCCGCTGTTGACCCGCGTCCGGCATAACGGGCTCGATGACAGTCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCGCAGGCGCTTGGCGTCTCCATTGACGACATCAACGATACGCTGCAAACCGCGTGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGCCGGGTAAAGAAAGTCTACGTCCAGGCGGCGGCGAAATACCGGATGCTGCCTGACGATATCAATCTTTGGTACGTGCGCAACAGCAGCGGCACGATGGTGCCATTCTCGGCCTTCGCCACCTCGCGCTGGGAGACCGGCTCGCCGCGGCTGGAACGCTACAATGGCTACTCAGCGGTCGAGATCGTCGGTGAGGCGGCGCCGGGTATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGTTACCCACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCTCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCGGTGCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATTGGCGCCCTGCTGGCGACCTGGATGCGCGGGCTGGAGAATGACGTGTACTTCCAGGTGGGTCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTCAACGAGAAGGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCTTGCCGTCAGCGCCTGCGCCCCATCCTGATGACCTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGAGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCGATCTTTTTCGTGCCGCTGTTCTTTGTGCTGGTGCGTCGCCGTTTTCCGCTAAAGGAGCGTCCGCAATAA	
8090	CARD	prokka_03155	contig_8	214923	92	191754	194103	1	104	LptD	3005059.0	1617.82	1500.0	Strict	99.87	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		carbapenem; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESHTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTATGATCGTCCGCTCGTGGAAGGTCGTCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAACTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATTAACCAGGGGAATAGTCGCCTCCGCGCCGACGAAGTTCAGCTGCACCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGGCCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAAATGGTCGGACGCCAGGGACGCGGCACCGCCGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTCGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTCGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTTGCCGAGATCTGGAACGCCCGCTTCAAGCTTGGCTCTGTGCCGATTTTCTATAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATTACTCCGCACTATATGAACAAACGCGGCGGCGTGATGTGGGAAAACGAGTTCCGCTATCTGACCCAGCTCGGCAGCGGCTTAACTGAATTCGACTACCTGCCGTCGGATAAAGTCTACGAAGACGACCACTCGAGCGACAGCAACAGCCGCCGCTGGCTGTTCTACTGGAACCACTCGGGGGTTATCGATCAGGTATGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGACTTCAGCTCGAAATATGGTTCCAGTACCGACGGCTATGCGACGCAGAAATTCAGCGCCGGTTACGTCAACCAGAACTTTGACGCCACGGTATCGACCAAACAGTTCCAGGTCTTTGACCGCGAATCGAGCAACTCCTATTCGGCTGAGCCGCAGCTCGACGTCAACTACTACCAGAATGATGTCGGTCCGTTCGATACCCATCTCTATGGACAGGTTGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCCAACGGTTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACTCACTACCAGCAGAGCAACCTCGATAAGTACAATGCCGCCAACGGCACTGACTATAAAGAGTCCGTCAGCCGCGTAATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTTGAACGCGACCTGCAGGAGGGATTCACCCAAACGCTGGAACCGCGCGTGCAGTATCTGTACGTGCCGTACCGCGATCAGAGTGAAATCGGCAACTACGACTCCACGCTGTTGCAGTCGGATTACACCGGTCTGTTCCGCGACCGTACCTATAGCGGTCTGGACCGCATCGCGTCGGCTAATCAGGTCACCACCGGCCTCACCTCGCGCGTGTATGATGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACACACCGGTGATGACAACATCAACTGGGAGAACAACGATACCACGGGTTCACTGGTCTGGGCCGGCGATACCTACTGGCGCATTGCCGATGAATGGGGTCTGCGCGGGGGGATCCAGTACGATACGCGTCTGGATAACGTTGCCACTGGTAACGGCACCATTGAATACCGTCGCGATGAGAACCGCTTAGTCCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACGCTGCCGTCATATTCCACCGCGGCACAATATAAACAGGGTATTTCGCAGGTGGGGATGACCGCCAGTTGGCCGATTGTCGATCGCTGGTCCGTGGTCGGGGCCTACTACTACGATACTAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTGCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGTAAAGTCAACGGCTGGAACAGCAACGACAACGGCGGCGAGAGCAAATACGATAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGCTCGAACATTTTACCGTACCAGAGCTCCCTGTGA	
8090	CARD	prokka_03161	contig_8	214923	92	198742	199222	-1	107	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.9138	32.0	Strict	28.0	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVVMGRLTWESIGRPLPGRKNIVISSKPGSDDRVQWVSSVEEAIAACGDVEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSNSYCFEILERR	ATGATCAGTCTGATTGCGGCGTTAGCGGTAGATCGCGTCATTGGTATGGAAAACGCCATGCCATGGAACCTGCCTGCCGATCTCGCCTGGTTCAAACGCAACACGTTAAATAAGCCGGTGGTGATGGGGCGTCTGACCTGGGAATCCATTGGGCGCCCATTGCCGGGGCGTAAAAATATCGTGATCAGCAGCAAACCCGGCAGCGACGATCGCGTGCAGTGGGTCTCCTCCGTAGAAGAAGCAATTGCCGCCTGCGGCGATGTGGAAGAGATTATGGTGATCGGCGGCGGCCGGGTGTATGAGCAGTTCCTGCCGAAAGCGCAGAAGCTCTACTTGACCCATATTGATGCGGAAGTGGAAGGCGATACCCATTTCCCGGATTACGATCCGGACGAATGGGAGTCGGTGTTCAGCGAGTTTCATGACGCCGACGCGCAGAACTCCAATAGCTACTGCTTTGAGATCCTCGAACGCCGTTAA	
8090	CARD	prokka_03455	contig_10	168674	87	123804	123960	-1	87	AAC(6')-Iai	3002575.0	20.4014	275.0	Strict	100.0	27.13	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MQKKCGYCRKAIEGKPVVSTLLYLQGNQLARKEKEYCSERCASYDQMAHES	ATGCAGAAGAAATGCGGTTACTGCCGTAAAGCGATCGAGGGAAAACCAGTGGTGAGCACCCTGTTGTACCTCCAGGGGAACCAGCTCGCACGGAAAGAAAAAGAGTACTGCTCTGAACGCTGCGCCTCTTACGACCAGATGGCGCACGAGAGCTAA	loose hit with at least 95 percent identity pushed strict
8090	CARD	prokka_03521	contig_11	161899	91	14063	14486	1	62	FosA6	3004111.0	281.952	280.0	Strict	98.55	100.72	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFEDE	ATGCTGAGTGGACTGAATCACCTGACCCTGGCAGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTGCTGGGCATGACGCTGCATGCCCGCTGGGACAGCGGGGCTTATCTCTCCTGCGGCGATTTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTTACCCCGCCGGAGGAGAGCGACTACACCCATTATGCGTTTAGCATTAGCGAAGCCGATTTTGCTAGCTTCGCCGCCCGCCTTGAGGCTGCCGGCGTGGCGATCTGGAAGCTGAACCGTAGCGAAGGTGCCTCGCACTACTTTCTCGACCCCGACGGCCACAAGCTGGAGCTGCACGTCGGCAGTCTTGCCCAGCGGCTGGCCGCCTGCCGCGAACAGCCGTATAAGGGGATGGTGTTTTTTGAGGATGAGTAA	
8090	CARD	prokka_04293	contig_17	86822	99	39795	40020	-1	92	CBP-1	3004764.0	21.557	600.0	Strict	100.0	24.03	CBP beta-lactamase	protein homolog model	antibiotic inactivation		penam	MNHGQLSMKNVFPTLAVLFAIFSLTGCGLKGPLYFPPADKTAPPPTKPVNPGIQSATPDRNDRGDTGGPSQVNY	ATGAATCACGGGCAACTATCAATGAAAAACGTTTTTCCTACGCTTGCCGTTTTGTTTGCGATCTTCAGCCTGACCGGCTGCGGTCTGAAAGGGCCTCTCTATTTCCCACCGGCGGACAAAACCGCGCCGCCGCCGACCAAACCGGTTAACCCTGGCATTCAGAGCGCAACGCCGGATCGTAACGATCGTGGCGATACCGGTGGTCCGAGCCAGGTCAATTACTAA	loose hit with at least 95 percent identity pushed strict
8090	CARD	prokka_04460	contig_19	72302	82	39505	40228	-1	83	baeR	3000828.0	455.677	450.0	Strict	91.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPVDENTPRILIVEDEPKLGQLLIDYLQAAGYAPALINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA	ATGACTGAATTGCCTGTAGATGAAAACACCCCACGCATCCTTATCGTGGAAGATGAACCGAAGCTCGGCCAGCTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTGCGTTGATTAACCACGGCGACAAGGTCCTGCCCTACGTCCGCCAGACGCCGCCGCACCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGTCTGACGCTGTGCCGGGAAATTCGCCGCTTCTCCGATGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATCGACCGTTTGCTGGGGCTGGAAATAGGCGCCGACGACTATATCTGCAAGCCCTACAGCCCGCGGGAAGTGGTCGCCCGGGTAAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGCGATCTGCAGGCGCTGGACGCCCAGAGCCCGCTGATTGTCGACGAAGGTCGTTTTCAGGCCTCCTGGCGCGACAAGCTGCTGGACCTCACTCCCGCCGAGTTCCGGCTGCTGAAAACCCTCTCCCAGGAGCCGGGCAAAGTGTTCTCCCGCGAACAGCTACTCAACCATCTGTATGACGATTATCGGGTAGTCACCGATCGCACCATCGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAGCAGTCGTTTATCCGCGCGGTGTATGGCGTTGGCTACCGCTGGGAAGCGGACGCCTGCCGGCTGGCGTAG	
8090	CARD	prokka_04463	contig_19	72302	82	43116	46194	-1	75	mdtC	3000794.0	1865.12	1800.0	Strict	91.61	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVQTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVLGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSDGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSSQPVSE	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTGCTGCCGGTAGCCCCGCTGCCGCAGGTGGACTTCCCGGTGATCATGGTTAGCGCCTCGCTGCCGGGAGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGCTCGCTCGGCAGCACCCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGACGTTCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGGATGCCGAGCCGGCCGACCTATCGCAAAGCCAATCCGTCGGATGCGCCGATCATGATCCTGACGCTGACCTCGGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATCGACGGCGTGGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCGCAGGCGCTGTTCAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAACCGCAGGGGGCGCTGGAGGACAGCGCGCACCGCTGGCAGGTGCAGACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCGCTGATCGTCCACTACCAGAATGGCGCCGCGGTGCGGCTGGGAGATGTCGCCACCGTCTCGGATTCGGTGCAGGACGTACGCAACGCCGGGATGACCAACGCCAAACCGGCGATCCTGCTGATGATCCGCAAACTGCCGGAAGCCAATATTATCCAGACGGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATTCCGGCGGCTATCGACCTGCAGATCGCCCAGGACCGCTCGCCGACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACGCTGGTGATTTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACACTGATCCCGGCCGTCGCCGTCCCGGTATCCTTAATCGGCACCTTCGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCTATCGTGGTGCTGGAGAATATCTCCCGCCATCTTGAGGCGGGGATGAAACCTCTGCAGGCGGCGCTGCAGGGGAGCCGTGAGGTCGGCTTTACCGTGCTGTCGATGAGTCTGTCGCTGGTGGCAGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTGCCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAGCCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTGCAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCATAGCCGGCTGACCGGCCTGGTGGTGCTCGGCACCATCGCCCTCAGCGTCTGGCTCTACATTTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAGATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCCAACCTGTTCCTGATGGCGGTGCAGGATATCCGCGTCGGCGGCCGGCAGTCGAACGCCAGCTATCAGTACACCCTGCTGTCCGACGACCTGTCGGCGCTGCGCGAGTGGGAGCCGAAGATCCGCAAAGCGCTGGCGGCGCTGCCGGAGCTGGCGGACGTCAACTCGGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATCAGCGTCCAGGACGCCAACAACCTGCTGAACAACGCCTTTGGCCAGCGGCAGATCTCTACCATCTACCAGCCGCTCAACCAGTATAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTCGTCATTAACAGCGACGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAATGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCATCCACTATCTCCTTTAACCTGCCCACCGGCCGCTCGCTGTCGGAAGCCAGCGAGGCCATTGACCGCGCGATGACCCAGCTCGGGGTGCCGTCGAGCGTGCGCGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTCGCAGCTATCGCCACGGTCTATATCGTGCTGGGGGTGCTATATGAGAGCTATGTGCATCCGTTGACCATCCTCTCGACGCTGCCCTCCGCCGGGGTGGGCGCTCTGCTGGCGCTGGAGATCTTCGATGCCCCGTTCAGCCTAATCGCCCTGATTGGGATTATGTTATTAATTGGCATCGTTAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTGGAGGCGCAGCGCAACGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTCCCGCTGGTGCTCTCCGGGGGCGATGGCTCTGAGCTGCGCCAGCCTCTGGGGATCACCATCGTCGGCGGTCTGGTGATGAGCCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTCTGCGGCTGCGTTTTTCGCGTCACTCCTCTCAACCGGTAAGCGAATAA	
8090	CARD	prokka_04464	contig_19	72302	82	46194	49317	-1	78	mdtB	3000793.0	1835.46	1800.0	Strict	90.1	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFERVIAVYGRWLSRVLNHPWLTLGVALSTLALSIILWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAERQRQVASIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVDGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEQDTEATPGLAALENIRLTSSDGGIVPLTAIATVEQRFIPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILAAEQSLDFPTDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA	ATGCAGGTGTTACCCCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCGATCCTGCTGGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCCCTGCCGGAGGTCGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAGCGCCAGTTCGGCCAGATGTCCGGCCTCAAGCAGATGTCGTCGCAAAGCTCCGGCGGCGCCTCGGTAGTCACGCTGCAGTTCCAGCTGACCCTGCCGCTGGACGTCGCCGAGCAGGAAGTGCAGGCGGCCATTAACGCCGCCACCAACCTGCTGCCGAGCGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACTCTCGCCGTCACCTCCTCCGCCATCCCGATGACCCAGGTTGAGGACATGGTGGAGACCCGGGTGGCGCAGAAGATCTCCCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCTATCACCAGCGCCAACGTTAACTCCGCGAAAGGCAGCCTCGACGGTCCGGCCCGCGCGGTGACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTATCGCCGGCTGATTATCGCTTATCAGAACGGGGCGCCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTCGGGGCGTGGGCCAACCAGCAGCGGGCCATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATCATCGACACCGCCGACAGCATTCGCCAGATGCTGCCGCAGCTCACCGAGAGCCTGCCGAAATCGGTGAAGGTGCAGGTCCTCTCCGACCGGACCACTAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTACCTGTTTCTGCGCAACGTGCCGGCGACCATTATTCCCGGCGTCGCGGTGCCGCTGTCGCTGGTGGGCACTTTCGCGGTGATGGTGTTCCTCGACTTCTCGATCAACAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCCATCGTGGTGATCGAGAACATCTCGCGCTATATCGAAAAAGGCGAGAAGCCGCTGGCCGCCGCGCTGAAGGGTGCGGGGGAGATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGCCTGTTCCGCGAATTCGCCGTCACCCTTGCCGTCGCTATTCTTATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGCATGTTAAGCCACGAATCGCTGCGTAAGCAGAACCGATTCTCGCGGGCCAGCGAGCGTTTCTTCGAACGGGTGATCGCCGTCTATGGCCGCTGGCTGAGCCGGGTGCTGAACCATCCGTGGCTGACGCTCGGCGTCGCCCTGAGCACCCTGGCGCTGTCGATTATCCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGTACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGCATGGCCGAGCGCCAGCGGCAGGTGGCCAGCATTATCCTTAAGGATCCGGCGGTGGAGAGTCTGACCTCCTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGTCTGCAGATCAACCTCAAGCCGCTGGATGAACGCGACGACCGCGTCCAGACGGTGATAAGCCGCCTGCAGCAGGCGGTGGACGGCGTCCCCGGCGTGGCGCTCTACCTGCAGCCGACCCAGGACCTGACCATCGACACCACGGTGAGCCGCACCCAGTATCAGTTCACCCTGCAGGCAAACTCCCTCGAGGCGCTGAGCACCTGGGTGCCGCCGCTGCTCAGCCGCCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGATCGCGACAGCGCCAGCCGCCTCGGCATCTCAATGGCCGATGTCGATAACGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACTATTTACACTCAGGCGAATCAGTATCGCGTGGTGCTCGAGCAGGATACCGAGGCGACGCCGGGCCTGGCGGCGCTGGAGAATATCCGCCTCACCAGCAGCGACGGCGGCATCGTGCCGTTGACCGCCATCGCCACGGTGGAGCAGCGCTTTATCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTCCCGGACAACTACTCGCTGGGCGAAGCGGTGGAGGCGATCCTCGCCGCCGAACAGTCGCTGGATTTCCCGACCGATATTCGCACCCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTCGGTAGCACCGTCTGGCTGGTGGTCGCCGCGGTGGTGGCGATGTATATCGTGCTGGGGGTGCTGTACGAGAGCTTTATCCATCCGATCACGATTCTCTCCACCCTGCCCACCGCCGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCAGCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCTGAGCGCGAGCAGGGCATGCCGCCGCGGGAAGCGATCTACCAGGCCTGTCTGCTGCGTTTTCGGCCGATCCTGATGACTACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTTGGCGCCGAGCTGCGGCGTCCGCTGGGGATCGGTATGGTCGGCGGTCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA	
8090	CARD	prokka_05199	contig_40	9181	112	7682	8327	1	79	QnrB1	3002714.0	437.573	400.0	Perfect	100.0	100.0	quinolone resistance protein (qnr)	protein homolog model	antibiotic target protection		fluoroquinolone antibiotic	MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG	ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG	
8090	CARD	prokka_05228	contig_47	3335	94	60	318	1	120	catB3	3002676.0	176.792	350.0	Strict	100.0	40.48	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWNWSLEKIKAAMPMLCSSNIVGLHKYWLEFAV	ATGCCCGGAATCAAGATCGGGCACGGTGCGGTGATAGGCAGCCGCTCGTTGGTGACAAAAGATGTGGAGCCTTACGCTATCGTTGGCGGCAATCCCGCTAAGAAGATTAAGAAACGCTTCACCGATGAGGAAATTTCATTGCTTCTGGAGATGGAGTGGTGGAATTGGTCACTGGAGAAGATCAAAGCGGCAATGCCCATGCTGTGCTCGTCTAATATTGTTGGCCTGCACAAGTATTGGCTCGAGTTTGCCGTCTAA	loose hit with at least 95 percent identity pushed strict
8090	CARD	prokka_05229	contig_47	3335	94	402	855	1	126	arr-3	3002848.0	311.997	250.0	Perfect	100.0	100.0	rifampin ADP-ribosyltransferase (Arr)	protein homolog model	antibiotic inactivation		rifamycin antibiotic	MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED	ATGGTAAAAGATTGGATTCCCATCTCTCATGATAATTACAAGCAGGTGCAAGGACCGTTCTATCATGGAACCAAAGCCAATTTGGCGATTGGTGACTTGCTAACCACAGGGTTCATCTCTCATTTCGAGGACGGTCGTATTCTTAAGCACATCTACTTTTCAGCCTTGATGGAGCCAGCAGTTTGGGGAGCTGAACTTGCTATGTCACTGTCTGGCCTCGAGGGTCGCGGCTACATATACATAGTTGAGCCAACAGGACCGTTCGAAGACGATCCGAATCTTACGAACAAAAGATTTCCCGGTAATCCAACACAGTCCTATAGAACCTGCGAACCCTTGAGAATTGTTGGCGTTGTTGAAGACTGGGAGGGGCATCCTGTTGAATTAATAAGGGGAATGTTGGATTCGTTGGAGGACTTAAAGCGCCGTGGTTTACACGTCATTGAAGACTAG	
8090	CARD	prokka_05230	contig_47	3335	94	1077	1425	1	98	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8090	CARD	prokka_05231	contig_47	3335	94	1418	2258	1	82	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8090	CARD	prokka_05238	contig_50	2850	607	1377	2178	1	626	tet(A)	3000165.0	506.138	700.0	Strict	98.08	62.74	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MAMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR	ATGGCGATGAGCGCCTGTTTCGGGTTCGGGATGGTCGCGGGACCTGTGCTCGGTGGGCTGATGGGCGGTTTCTCCCCCCACGCTCCGTTCTTCGCCGCGGCAGCCTTGAACGGCCTCAATTTCCTGACGGGCTGTTTCCTTTTGCCGGAGTCGCACAAAGGCGAACGCCGGCCGTTACGCCGGGAGGCTCTCAACCCGCTCGCTTCGTTCCGGTGGGCCCGGGGCATGACCGTCGTCGCCGCCCTGATGGCGGTCTTCTTCATCATGCAACTTGTCGGACAGGTGCCGGCCGCGCTTTGGGTCATTTTCGGCGAGGATCGCTTTCACTGGGACGCGACCACGATCGGCATTTCGCTTGCCGCATTTGGCATTCTGCATTCACTCGCCCAGGCAATGATCACCGGCCCTGTAGCCGCCCGGCTCGGCGAAAGGCGGGCACTCATGCTCGGAATGATTGCCGACGGCACAGGCTACATCCTGCTTGCCTTCGCGACACGGGGATGGATGGCGTTCCCGATCATGGTCCTGCTTGCTTCGGGTGGCATCGGAATGCCGGCGCTGCAAGCAATGTTGTCCAGGCAGGTGGATGAGGAACGTCAGGGGCAGCTGCAAGGCTCACTGGCGGCGCTCACCAGCCTGACCTCGATCGTCGGACCCCTCCTCTTCACGGCGATCTATGCGGCTTCTATAACAACGTGGAACGGGTGGGCATGGATTGCAGGCGCTGCCCTCTACTTGCTCTGCCTGCCGGCGCTGCGTCGCGGGCTTTGGAGCGGCGCAGGGCAACGAGCCGATCGCTGA	loose hit with at least 95 percent identity pushed strict
8090	CARD	prokka_05243	contig_53	2186	132	46	646	1	303	AAC(6')-Ib-cr6	3005116.0	407.142	300.0	Strict	98.99	100.0	AAC(6')-Ib-cr	protein homolog model	antibiotic inactivation		fluoroquinolone antibiotic; aminoglycoside antibiotic	MSNAKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERTRSDA	ATGAGCAACGCAAAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGACGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCATATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	
8090	CARD	prokka_03118	contig_8	214923	92	144350	146117	-1	119	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	595.89	500.0	Strict	52.37	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTGCTGGCGCTGGCTTTTCTGCTGGGGCGCGTCGCCTGGCTACAGGTGATCAGCCCCGATATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTGTCCACCGCGCGCGGGATGATTACCGATCGCTCCGGACGTCCGCTGGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGACCCGAAAGAGCTCCATGACGCCGGCGGGGTTACCCTGGATACGCGCTGGAAGGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGGTTTATCTATCTGGCGCGTCAGGTTAACCCTGACATGGCCGATTACATCAAGAAGCTGAAGCTGCCGGGCATTCATCTGCGCGAAGAATCCCGTCGTTACTACCCTTCCGGGGAAGTAACCGCTCACCTCATCGGCTTTACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAGAAAAGCTTTGATAAATGGCTTACCGGTCAGCCGGGCGAGCGTATCGTGCGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCTACCGATAGCCAGGCAGCGCACAACCTGGCGCTGAGTATCGACGAACGCCTGCAGGCGCTGGTCTATCGCGAGCTAAACAACGCCGTGGCCTTTAACAAAGCCGAGTCGGGCAGCGCCGTGTTAGTGGATGTTAACACCGGTGAAGTGCTGGCGATGGCCAACAGTCCATCCTATAACCCGAACAACTTCGCCGGTACGGCAAAAGACACCATGCGTAACCGTGCGATTACCGACGTGTTTGAGCCGGGTTCGACGGTGAAACCGATGGTGGTCATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTATGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCGTTGTCGATTACCAAGGTTGATCCTCCGGTTCCGGGCGAGCGCGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGTGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTATATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
8090	CARD	prokka_03269	contig_9	190517	90	104691	107325	1	98	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1642.48	1500.0	Strict	92.23	100.23	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMATNIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATGVRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERNGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTCAACATTGAGGAAGAGCTTAAGAACTCTTATCTGGATTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGATGTCCGAGATGGCCTGAAGCCGGTACACCGTCGCGTACTTTACGCCATGAACGTATTGGGCAATGACTGGAACAAAGCCTATAAAAAATCAGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCACCCGCACGGCGACATCGCGGTATACGACACCATCGTGCGTATGGCGCAGCCGTTCTCGCTGCGTTACATGCTGGTGGACGGCCAGGGTAACTTTGGTTCCATCGACGGCGACTCCGCCGCGGCGATGCGTTATACCGAAATTCGTCTGGCGAAAATCGCTCATGAGCTGATGGCCGATCTTGAAAAAGAGACGGTCGATTTCGTCGACAACTATGACGGTACGGAGCGTATTCCGGACGTCATGCCGACCAAAATTCCTAACCTGCTGGTGAACGGCGCCTCCGGGATCGCCGTAGGGATGGCCACCAACATACCGCCGCATAACCTGACGGAAGTGATTAACGGCTGTCTGGCGTATGTTGACGATGAAGACATCAGCATTGAAGGGCTGATGGCGCATATTCCTGGCCCTGATTTCCCGACCGCCGCCATTATCAATGGCCGTCGCGGCATCGAAGAGGCCTACCGCACCGGTCGCGGTAAAGTGTACATCCGCGCGCGCGCGGAAGTGGAAGTGGACGCGAAATCCGGCCGCGAAACCATCATCGTGCACGAAATTCCGTATCAGGTGAACAAAGCGCGCCTGATCGAGAAAATCGCCGAGCTGGTCAAAGAAAAACGCGTGGAAGGCATCAGCGCGCTGCGTGACGAGTCTGATAAAGACGGGATGCGCATCGTGATTGAAGTGAAGCGCGATGCGGTAGGGGAAGTGGTGCTTAACAACCTCTATTCCCAGACCCAGCTGCAGGTCTCCTTCGGCATCAACATGGTAGCTCTGCACCATGGTCAGCCGAAGATCATGAACCTGAAGGACATCATCGCCGCGTTTGTACGCCACCGCCGTGAAGTGGTGACCCGTCGTACGATTTTCGAACTGCGCAAAGCGCGCGACCGGGCGCATATCCTCGAAGCGCTGGCCGTTGCGCTGGCCAACATCGACCCGATTATCGAACTGATCCGTCGCGCGCCGACCCCGGCAGAAGCGAAAACGGCGCTGGTTGCCCAGGCGTGGGATCTTGGTAACGTCGCGGCGATGCTGGAGCGCGCCGGGGATGACGCCGCGCGTCCGGAATGGCTGGAGCCAGAGTTCGGCGTACGCGACGGTAAATACTATCTGACCGAGCAGCAGGCTCAGGCGATTCTGGATCTGCGTCTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAATATAAAGAGCTGCTGGAGCAGATCGCGGAGCTGCTGCACATTCTCGGCAGCGCCGACCGTCTGATGGAAGTGATTCGCGAAGAGCTGGAGCTGATCCGCGACCAGTTCGGCGACGAACGTCGTACCGAAATCACCGCCAACAGCGCTGATATTAACATCGAAGATCTGATCAACCAGGAAGATGTGGTGGTCACCCTGTCGCATCAGGGGTATGTGAAGTATCAGCCGCTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGCAAATCGGCAGCGCGCATTAAAGAAGAAGACTTTATCGACCGCCTGCTGGTGGCCAACACCCATGACACCATCCTCTGCTTCTCAAGCCGCGGCCGTCTGTACTGGATGAAGGTCTATCAGCTGCCGGAAGCCAGCCGCGGCGCGCGCGGTCGGCCGATCGTCAACCTGCTGCCGCTGGAAGCCGATGAGCGCATCACCGCCATCCTGCCGGTCCGCGAGTACGAAGAGGGCGTCAACGTCTTTATGGCGACCGCCAGCGGTACCGTGAAGAAAACCGCGCTGACCGAGTTCAGCCGTCCGCGTTCCGCCGGTATCATCGCGGTCAACCTGAACGAAGGCGATGAGCTGATCGGCGTCGATCTGACCTCTGGTCAGGATGAAGTGATGCTGTTCTCCGCGGCCGGTAAGGTTGTACGCTTCAAGGAAGACGCCGTTCGCGCCATGGGCCGTACCGCCACCGGCGTACGCGGTATTAAGCTTGCGGAAAACGACAGCGTCGTCTCGCTGATTATTCCACGCGGCGAAGGCGCGATCCTGACGGTGACGCAAAACGGTTACGGTAAACGTACCGCGGCGGCGGAGTATCCGACCAAGTCGCGCGCCACCCAGGGCGTTATTTCGATCAAAGTCACCGAGCGTAACGGTTCCGTGGTCGGCGCCGTGCAGGTGGATGACTGCGATCAGATCATGATGATCACCGACGCCGGGACGCTGGTGCGTACCCGCGTTTCCGAGGTGAGCATCGTGGGCCGTAACACCCAGGGCGTGATCCTCATCCGCACCGCGGAAGATGAAAACGTGGTGGGTCTGCAGCGCGTGGCTGAGCCGGTGGATGATGAAGAGCTGGATGCCATCGACGGTAGCGCGGCGGAAGGCGATGACGATATCGCCCCGGAAGCGGATACCGATGACGACATCGCCGAAGACGAAGAATAA	
8090	CARD	prokka_03901	contig_13	141211	92	67793	70052	1	102	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1468.37	1400.0	Strict	94.28	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAELLLSELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTTLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVRMRAVWSKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSSRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQSELEKERDQLQAILASERKMNNLLKKELQADADAFGDDRRSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAQGLSYKAGDSWKASAKGKSNQPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALITLPDNAHVMPPLVIEDESDMLLAITAAGRMLMFPVSDLPQLSKGKGNKIISIPAAEAAAGQDGLAHLFVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGSLMRGLQKIDRVEIDSPRRAAAGDSEE	ATGAGCGATATGGCAGAGCGCCTTGCGCTGCATGAATTTACGGAAAATGCTTACCTGAACTACTCCATGTACGTGATCATGGACAGGGCATTACCGTTTATTGGCGATGGCTTAAAACCGGTCCAGCGTCGCATCGTCTATGCGATGTCCGAGCTGGGGCTGAACGCCAGCGCGAAATTCAAAAAGTCCGCCCGCACCGTCGGCGACGTGTTGGGTAAATATCACCCGCACGGCGACATTGCCTGCTATGAAGCGATGGTGCTGATGGCGCAGCCGTTCTCTTACCGCTATCCGCTGGTGGATGGTCAGGGAAACTGGGGGGCGCCGGACGATCCCAAATCTTTCGCCGCCATGCGTTACACCGAATCCCGCCTGTCGAAGTATGCCGAGCTGCTGCTCAGCGAGCTGGGGCAGGGGACGGTCGACTGGGTGCCAAACTTTGACGGCACGCTGCAGGAGCCGAAAATGCTGCCAGCGCGTCTGCCGAACATCCTGCTGAACGGTACCACCGGCATCGCGGTAGGCATGGCGACCGATATTCCTCCGCACAACCTGCGGGAAGTGGCCAAAGCGGCGATTACGCTGATTGAGCAGCCGAAAACCACCCTCGACGAACTGCTGGATATCGTACAGGGGCCGGATTTCCCGACCGAGGCGGAGATCATCACCTCGCGGGCGGAAATTCGCAAAATCTACCAGAACGGGCGCGGCTCAGTGCGCATGCGCGCGGTGTGGAGTAAAGAGGACGGCGCGGTGGTGATCAGTGCGCTGCCGCATCAGGTCTCTGGCGCCAAAGTGCTGGAGCAGATTGCGGCGCAGATGCGCAATAAAAAGCTGCCGATGGTTGACGATCTGCGCGACGAATCGGACCACGAAAACCCGACCCGTCTGGTGATTGTCCCGCGCTCCAGCCGGGTGGATATGGAACAGGTGATGAACCACCTGTTCGCCACCACCGATCTGGAGAAGAGCTACCGCATCAACCTCAATATGATCGGCCTTGACGGCCGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCAGCGAGTGGCTGGTGTTCCGTCGCGATACCGTGCGTCGCCGTCTAAACCATCGGTTAGAGAAAGTGCTGAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTTCTTAATATCGATGAAGTGATTGAGATCATCCGCACTGAAGATGAACCGAAGCCGGCCCTGATGTCGCGCTTTGGCATCAGCGAAACCCAGGCGGAAGCGATTCTGGAATTAAAACTGCGCCACCTCGCCAAACTGGAAGAGATGAAGATCCGCGGCGAGCAGAGCGAGCTGGAAAAAGAGCGCGACCAGCTGCAGGCGATTCTGGCGTCTGAACGTAAGATGAACAACCTGCTGAAAAAAGAGCTGCAGGCCGATGCCGATGCCTTCGGCGACGACCGTCGCTCGCCGCTTCACGAGCGTGAAGAAGCGAAAGCGATGAGCGAGCATGACATGCTGCCGTCTGAGCCGGTGACTATCGTTCTGTCGCAGATGGGCTGGGTGCGCAGCGCCAAAGGACACGACATTGACGCCCAGGGCTTGAGCTATAAGGCGGGCGACAGCTGGAAAGCCTCGGCGAAGGGCAAGAGCAACCAGCCGGTGGTGTTTATCGATACCACCGGACGCAGCTATGCCATCGATCCGATTACTCTGCCTTCCGCGCGTGGCCAGGGTGAACCGCTTACCGGCAAACTGACCCTGCCGCCGGGCGCGACCGTGGAGCATATGCTAATGGAAAGCGACGATCAGAAACTGCTGATGGCTTCCGACGCGGGCTACGGTTTCGTCTGTACCTTCAACGATCTGGTGGCGCGCAACCGTGCCGGGAAAGCGCTAATCACCCTGCCTGACAACGCGCACGTGATGCCGCCGCTGGTGATTGAGGATGAGTCCGATATGCTGCTGGCCATCACCGCCGCCGGGCGGATGCTGATGTTCCCGGTCAGCGATCTGCCGCAGCTGTCGAAAGGCAAGGGCAACAAAATTATCAGCATTCCGGCGGCGGAAGCCGCAGCCGGCCAGGACGGTCTGGCACATCTGTTTGTTCTGCCGCCGCAGAGTACGCTGACCATTCACGTCGGCAAACGGAAGATCAAACTGCGTCCGGAAGAGCTGCAAAAAGTCACCGGCGAGCGCGGCCGCCGCGGTTCGCTGATGCGCGGGCTGCAGAAAATTGACCGCGTGGAAATTGACTCGCCGCGTCGTGCCGCGGCAGGCGATAGCGAAGAGTAA	
8090	CARD	prokka_04119	contig_15	97648	89	48812	50204	-1	96	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	864.3739999999998	850.0	Strict	95.03	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAVGCICLMAIVAIFEERKIRREKKNRILQTA	ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACCATGTACCTGATCCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGCTGAGCATGACCCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAGACGCTGGTCTCTTATTATGCCGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCTACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACTTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTTGGCTTTATCGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCGAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAGGTCGGCGCGCTGGTCGGCACGCTGCTGTGGGGCTGGTTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACCCTTGGGGTTTACCAACACGCCAGCAACCAGTACGTCTATCTGGCCTCGTTATTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGAATCAAGGGCACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAACTGGGTCTCGGGATGATCGCCGACGGCACCCCGGTCTTCGGCCTGACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCGTCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTTGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACCGCCTGA	
8090	CARD	prokka_01127	contig_2	739929	77	297779	298214	-1	102	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	252.292	210.0	Strict	83.33	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux	S3N	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKNTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIERLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP	ATGAAAAATACCAGCGACCTGTTCAACGAGATGATTCCGCTGGGCCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAACGACTACCTCTCACCCATGGATATTACCGCGACCCAGTTTCGGGTGCTCTGTTCCATTCGTTGCGAGGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGACCCGGGCGCGATGACGCGTATGCTCGACCGCCTGGCGTGTAAAGGCTGGATTGAACGGTTACCCAACCCCGCTGACAAGCGCGGTGTGCTGGTGCAGTTGACGCCAGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACAAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTCCTCAAGAAGGTCCTGCCGTAA	
7877	BLDB	prokka_03185	contig_12	182054	75	62592	63453	-1	68	SHV-1		79.2		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase SHV-1	protein homolog model			Beta-Lactam	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGCGTTATATTCGCCTGTGTATTATCTCCCTGTTAGCCACCCTGCCGCTGGCGGTACACGCCAGCCCGCAGCCGCTTGAGCAAATTAAACTAAGCGAAAGCCAGCTGTCGGGCCGCGTAGGCATGATAGAAATGGATCTGGCCAGCGGCCGCACGCTGACCGCCTGGCGCGCCGATGAACGCTTTCCCATGATGAGCACCTTTAAAGTAGTGCTCTGCGGCGCAGTGCTGGCGCGGGTGGATGCCGGTGACGAACAGCTGGAGCGAAAGATCCACTATCGCCAGCAGGATCTGGTGGACTACTCGCCGGTCAGCGAAAAACATCTTGCCGACGGCATGACGGTCGGCGAACTCTGCGCCGCCGCCATTACCATGAGCGATAACAGCGCCGCCAATCTGCTGCTGGCCACCGTCGGCGGCCCCGCAGGATTGACTGCCTTTTTGCGCCAGATCGGCGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTGAATGAGGCGCTTCCCGGCGACGCCCGCGACACCACTACCCCGGCCAGCATGGCCGCGACCCTGCGCAAGCTGCTGACCAGCCAGCGTCTGAGCGCCCGTTCGCAACGGCAGCTGCTGCAGTGGATGGTGGACGATCGAGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAACGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATCGTGGTGATTTATCTGCGGGATACCCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA	
7877	BLDB	prokka_04648	contig_28	44589	112	41354	42167	1	130	NDM-7		260.4		Perfect	100.0	99.63	subclass B1 metallo-beta-lactamase NDM-7	protein homolog model			Beta-Lactam	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMNALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	ATGGAATTGCCCAATATTATGCACCCGGTCGCGAAGCTGAGCACCGCATTAGCCGCTGCATTGATGCTGAGCGGGTGCATGCCCGGTGAAATCCGCCCGACGATTGGCCAGCAAATGGAAACTGGCGACCAACGGTTTGGCGATCTGGTTTTCCGCCAGCTCGCACCGAATGTCTGGCAGCACACTTCCTATCTCGACATGCCGGGTTTCGGGGCAGTCGCTTCCAACGGTTTGATCGTCAGGGATGGCGGCCGCGTGCTGGTGGTCGATACCGCCTGGACCGATGACCAGACCGCCCAGATCCTCAACTGGATCAAGCAGGAGATCAACCTGCCGGTCGCGCTGGCGGTGGTGACTCACGCGCATCAGGACAAGATGGGCGGTATGAACGCGCTGCATGCGGCGGGGATTGCGACTTATGCCAATGCGTTGTCGAACCAGCTTGCCCCGCAAGAGGGGCTGGTTGCGGCGCAACACAGCCTGACTTTCGCCGCCAATGGCTGGGTCGAACCAGCAACCGCGCCCAACTTTGGCCCGCTCAAGGTATTTTACCCCGGCCCCGGCCACACCAGTGACAATATCACCGTTGGGATCGACGGCACCGACATCGCTTTTGGTGGCTGCCTGATCAAGGACAGCAAGGCCAAGTCGCTCGGCAATCTCGGTGATGCCGACACTGAGCACTACGCCGCGTCAGCGCGCGCGTTTGGTGCGGCGTTCCCCAAGGCCAGCATGATCGTGATGAGCCATTCCGCCCCCGATAGCCGCGCCGCAATCACTCATACGGCCCGCATGGCCGACAAGCTGCGCTGA	
7877	BLDB	prokka_05074	contig_44	17632	165	2763	3639	-1	160	CTX-M-15		90.0		Perfect	100.0	99.66	class A extended-spectrum beta-lactamase CTX-M-15	protein homolog model			Beta-Lactam	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	ATGGTTAAAAAATCACTGCGCCAGTTCACGCTGATGGCGACGGCAACCGTCACGCTGTTGTTAGGAAGTGTGCCGCTGTATGCGCAAACGGCGGACGTACAGCAAAAACTTGCCGAATTAGAGCGGCAGTCGGGAGGCAGACTGGGTGTGGCATTGATTAACACAGCAGATAATTCGCAAATACTTTATCGTGCTGATGAGCGCTTTGCGATGTGCAGCACCAGTAAAGTGATGGCCGCGGCCGCGGTGCTGAAGAAAAGTGAAAGCGAACCGAATCTGTTAAATCAGCGAGTTGAGATCAAAAAATCTGACCTTGTTAACTATAATCCGATTGCGGAAAAGCACGTCAATGGGACGATGTCACTGGCTGAGCTTAGCGCGGCCGCGCTACAGTACAGCGATAACGTGGCGATGAATAAGCTGATTGCTCACGTTGGCGGCCCGGCTAGCGTCACCGCGTTCGCCCGACAGCTGGGAGACGAAACGTTCCGTCTCGACCGTACCGAGCCGACGTTAAACACCGCCATTCCGGGCGATCCGCGTGATACCACTTCACCTCGGGCAATGGCGCAAACTCTGCGGAATCTGACGCTGGGTAAAGCATTGGGCGACAGCCAACGGGCGCAGCTGGTGACATGGATGAAAGGCAATACCACCGGTGCAGCGAGCATTCAGGCTGGACTGCCTGCTTCCTGGGTTGTGGGGGATAAAACCGGCAGCGGTGGCTATGGCACCACCAACGATATCGCGGTGATCTGGCCAAAAGATCGTGCGCCGCTGATTCTGGTCACTTACTTCACCCAGCCTCAACCTAAGGCAGAAAGCCGTCGCGATGTATTAGCGTCGGCGGCTAAAATCGTCACCGACGGTTTGTAA	
7877	BLDB	prokka_05079	contig_44	17632	165	6460	7321	1	194	TEM-1		80.1		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase TEM-1	protein homolog model			Beta-Lactam	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	ATGAGTATTCAACATTTTCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGTGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCTGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	
7877	BLDB	prokka_05263	contig_73	2439	66	903	1734	1	23	OXA-1		238.9		Perfect	100.0	99.64	oxacillin-hydrolyzing class D beta-lactamase OXA-1	protein homolog model			Beta-Lactam	MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL	ATGAAAAACACAATACATATCAACTTCGCTATTTTTTTAATAATTGCAAATATTATCTACAGCAGCGCCAGTGCATCAACAGATATCTCTACTGTTGCATCTCCATTATTTGAAGGAACTGAAGGTTGTTTTTTACTTTACGATGCATCCACAAACGCTGAAATTGCTCAATTCAATAAAGCAAAGTGTGCAACGCAAATGGCACCAGATTCAACTTTCAAGATCGCATTATCACTTATGGCATTTGATGCGGAAATAATAGATCAGAAAACCATATTCAAATGGGATAAAACCCCCAAAGGAATGGAGATCTGGAACAGCAATCATACACCAAAGACGTGGATGCAATTTTCTGTTGTTTGGGTTTCGCAAGAAATAACCCAAAAAATTGGATTAAATAAAATCAAGAATTATCTCAAAGATTTTGATTATGGAAATCAAGACTTCTCTGGAGATAAAGAAAGAAACAACGGATTAACAGAAGCATGGCTCGAAAGTAGCTTAAAAATTTCACCAGAAGAACAAATTCAATTCCTGCGTAAAATTATTAATCACAATCTCCCAGTTAAAAACTCAGCCATAGAAAACACCATAGAGAACATGTATCTACAAGATCTGGATAATAGTACAAAACTGTATGGGAAAACTGGTGCAGGATTCACAGCAAATAGAACCTTACAAAACGGATGGTTTGAAGGGTTTATTATAAGCAAATCAGGACATAAATATGTTTTTGTGTCCGCACTTACAGGAAACTTGGGGTCGAATTTAACATCAAGCATAAAAGCCAAGAAAAATGCGATCACCATTCTAAACACACTAAATTTATAA	
7877	CARD	prokka_00431	contig_1	629086	83	463789	464983	1	115	Klebsiella pneumoniae acrA	3004041.0	738.413	770.0	Strict	95.24	99.75	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAGGGAGCCCAGCACATGCCGGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGCACCAGCGCCTATCGCATTGCGGAAGTCCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTCTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTGGGCACCAAATATATTAGTCAACAAGACTACGATACCGCCGTTGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCGGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATCAGCGGCCGGATTGGTAAATCCGCCGTGACCGAAGGGGCGCTGGTACAGAATGGTCAAACGACCGCCCTGGCAACCGTACAGCAGCTGGATCCGATCTATGTTGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAGCAGGAGCTAGCCGATGGCCGCCTGAAACAGGAAAACGGCAAAGCGAAAGTGGAGCTGGTGACTAATGACGGTCTTAAGTATCCGCAGTCCGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCAATCACGCTACGCGCTATTTTCCCGAACCCGGATCACACCCTGCTACCGGGGATGTTCGTCCGTGCCCGTCTGGAAGAAGGGATTAACCCTGACGCCCTGCTGGTACCGCAACAGGGTGTTACCCGTACGCCGCGCGGCGACGCCAGCGTCATGGTAGTGGGGGAAGGCGATAAAGTCGAAGTCCGCCAGGTCACTGCTTCTCAGGCGATCGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACCGGCCTGCAAAAAATCAAACCAGGTGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA	loose hit with at least 95 percent identity pushed strict
7877	CARD	prokka_00432	contig_1	629086	83	465005	468152	1	108	acrB	3000216.0	1941.39	1900.0	Strict	91.52	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAMALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKSEDIEHSHQVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATTATCATCATGCTGGCTGGGGGATTATCGATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACGGTGCAGAACACCGTAACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCAAATGGCGACTCCACCGGTACGGCAACCATTACGCTGACCTTCGAATCCGGTACCGATCCGGATATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCGCTGGCGACGCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATTAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTCATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGATCCGATTAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTATTCGGTTCCCAGTATGCGATGCGTATCTGGATGGATCCAAACAAACTGAACAACTTCCAGCTTACGCCGGTGGATGTGATCAGCGCCCTGAAAGCGCAGAACGCCCAGGTGGCCGCGGGCCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCCTCGATCATCGCGCAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGACGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGCGGCGAAAGCTATGACGTAGTGGCGAAGTTTAACGGCCAGCCGGCATCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCTATTCGCGCTGAACTGGCGAAGATGGAGCCGTTTTTCCCGTCGGGGATGAAGATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATTTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCCACCATCGCGGTACCGGTGGTCCTGTTAGGCACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTGGTGGTAGAGAACGTCGAGCGCGTGATGGCGGAAGAGGGTCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGACAGATTCAGGGCGCGCTGGTTGGTATCGCTATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTCTTCGGCGGCTCAACCGGGGCCATCTATCGCCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTGGCGTTAATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAACCAATTCAGAAAGGCAGCCATGGCGCGACCACCGGCTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGTTATCTGGTGCTGTATCTGATCATCGTGGTGGGTATGGCATGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCGGACGAGGACCAGGGTGTATTCCTGAGTATGGCGCAGCTGCCTGCCGGCGCCACCCAGGAGCGTACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGTTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTTTCGCTGAAAGACTGGAGCCAGCGTCCGGGTGAGGAAAACAAAGTTGAAGCGATCACCGCGAGAGCAATGGGCTACTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCGAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACCCAGGCGCGTAACCAACTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGCCCTAACGGTCTGGAAGATACACCGCAGTTTAAAATCGATATCGATCAGGAGAAAGCTCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTGGGCGCAGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATTATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATCGGCAAGTGGTATGTTCGCGGCAGCGATGGTCAGATGGTGCCGTTCTCTGCTTTCTCGACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCGTCACTGGAAATCCTCGGTCAGGCCGCGCCAGGCAAGAGTACCGGTGAGGCGATGGCGCTGATGGAAGAGCTGGCGGGTAAACTGCCTTCCGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGACTGTCCGGCAACCAGGCCCCTGCCCTGTATGCCATCTCGCTGATTGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTTATGCTGGTCGTCCCCTTGGGTGTGGTCGGTGCGCTGTTAGCCGCCACCTTCCGCGGGCTAACCAACGACGTTTACTTCCAGGTGGGTCTGCTGACCACCATCGGCCTGTCGGCGAAGAACGCAATATTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCAGTACGTATGCGTCTACGTCCAATCCTGATGACATCTCTGGCGTTCATCCTCGGGGTAATGCCGCTAGTTATCAGCTCCGGCGCCGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCGATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGCAAAAAATCGGAAGATATAGAGCACAGCCATCAGGTTGAGCATCATTAA	
7877	CARD	prokka_00559	contig_1	629086	83	593774	594935	1	74	Escherichia coli ampH beta-lactamase	3004612.0	688.337	500.0	Strict	85.45	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKAEPGSQAAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ	TTGAAACGTAGTTTGCTCATTTTTGCTGCGCTGTGCGCGGCGTCGTGGACCTCGGTGCAGGCCGCACAGCCTACCGTTGACCCGGTTTTCGCCTCGGATGTGGTCGATCGTTACGCCAATCATATCTACTACGGCAGCGGCGCCACCGGCATGGCGCTGGTGGTTATCGATGGCAATCAGCGTGTTTTTCGCAGCTTTGGCGAAACCCGCCCGGGGAATAATCAGCACCCGCAGCTCGACTCGGTGATCCGTATCGCCTCCCTCAGCAAACTGATGACCAGCGAGATGCTGGTGAAGCTGCTCGACCAGGGGGTGGTGAAACTCAACGATCCGCTGAGCAAATACGCCCCGCCGGGCGCCCGGGTGCCTGACTGGCAGGGAAAACCAATCACCCTGGTTAACCTCGCGACCCATACCAGCGCCCTGCCGCGCGAGCAGCCTGGCGGCGCCGCTCATCGTCCGGTGTTTGTCTGGCCGACCCGCCAGCAGCGCTGGAACTGGCTCTCTACCGCGACCCTGAAAGCCGAGCCGGGCTCACAGGCGGCCTACTCCAACCTGGCCTTCGATTTACTGGCGGACGCGCTCGCCACCGCCGCCGGAAAACCGTATCCGCAGCTGTTTGAAGAGCAGATCACCCGGCCGCTGGGGATGAAGGACACCACCTTTACCCCGTCACCGGATCAGTGCCAGCGGCTGATGATCCCGGAAAAAGGCGCCAGCCCGTGCAACAACACCCTGGCGGCGATCGGCAGCGGCGGAGTCTACTCGACGCCGGGGGATATGATGCGCTGGATGCAGCAGTTCCTGTCATCCGATTTCTATACCCGCAGCCAGCAGGCCGACCGGATGCAGACGCTGATTTATCAGCGTAACCAGCTGACCCGGGTGATTGGTATGGACGTGCCGGGCCGCGCCGACGCGCTGGGCCTCGGCTGGGTGTATATGAAGCCGAAGAACGGCCATCCGGGGATTATTCAGAAAACCGGCGGCGGCGGCGGGTTTATCACCTATATGGCGATGAATCCGCAGGCTAACGTTGGCGCCTTTGTGGTGGTAACCCGCTCGCCGTTAACCCGCTTCAACAATATGAGCGATGGCATCAACGACCTGGTCAGCGAGCTGAGCGGCGCACAGCCCAACATGCAGACGGCCAGCCAGTAA	
7877	CARD	prokka_00626	contig_2	420396	86	30789	31965	1	67	oqxA	3003922.0	798.1189999999998	670.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	ATGAGCCTGCAAAAAACCTGGGGAAACATTCACCTGACCGCGCTCGGCGCGATGATGCTCTCCTTTCTGCTCGTCGGCTGCGACGACAGCGTCGCGCAGAATGCTGCGCCTCCCGCCCCGACGGTCAGCGCCGCTAAGGTGCTGGTGAAGTCGATCAGTCAGTGGGATAGTTTTAACGGTCGCATTGAAGCGGTGGAGAGCGTTCAGCTTCGCCCTCGCGTCTCGGGATACATTGATAAAGTGAATTACACTGACGGCCAGGAGGTGAAAAAGGGCCAGGTGCTGTTCACGATAGATGACAGAACCTATCGCGCCGCGCTGGAGCAGGCGCAGGCGGCGTTGGCAAGAGCCAAAACGCAGGCCAGCCTGGCGCAAAGCGAGGCGAACCGCACCGATAAATTAGTCCATACCAACCTCGTCTCCCGTGAAGAGTGGGAGCAGCGCCGGTCAGCCGCGGTTCAGGCACAGGCCGACATTCGCGCCGCGCAGGCGGCGGTGGATGCCGCGCAGCTTAACCTCGACTTCACCAAAGTGACCGCCCCTATTGACGGCCGTGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTCACCGCGGGCGACACCGCCAGCGTGCTCACCACCCTGGTCTCGCAGAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTCCACTATCAAAACCTCGCCCGCCGCGGGCAAGGCGCGTCCAGCGATAATCAGGCGCTTCCGGTGGAGATTGGCCTGGTTGGCGAGGAGGGTTACCCCCACCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGTACCGGCACCATCCGCATGCGTGCGCTGCTGGATAACTCGCAGCGTCTGTTCACGCCGGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCAGAGTTCAAAGCCACGCTGATCGACGACAAAGCGGTACTGACCGATCAGGATCGTAAATACGTCTATATCGTTGATAAAGATGGTAAAGCACAGCGCCGCGACATTACCCCAGGGCGGCTGGCAGACGGTTTACGCATCGTTCAGAAGGGGTTGAATCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCCAAAACCGTTGCCATGACCTCCAGCGCCACCCTTAACTGA	
7877	CARD	prokka_00627	contig_2	420396	86	31988	35141	1	86	oqxB	3003923.0	2112.42	2000.0	Strict	99.71	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPNGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVSKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTELFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCACTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTTTCGCCAAACGGGAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCGGCCCGCGGTCTGACGGCTTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGACGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAATGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGTTGATCGCTGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCTATCGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGTCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGGCTGGTGAGCAAAACCCTCGGACGCCGTGGCGCGGTGTTTGCGGTGTATCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGCTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACATACGGCGGCGGAAATTAACGCGGAGATCAACGCTAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCCATCCTGCCGCCGCCGATTTTAGGACTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAGACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGAGCTATTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCTGACGGACCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTACCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCTCAGGCGATGACGCATCTGGAGGAGCTGTCGAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCGTTCCTCGTGCTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTACCGATGACGATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGTCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGTTGGAGATCCAGGGGAAAGGCATCATGGAAGCCGCGCTGGAGGCGTGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTATTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTGCGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG	
7877	CARD	prokka_00673	contig_2	420396	86	79409	79940	1	102	emrR	3000516.0	338.961	280.0	Strict	92.57	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR	ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTCCGCGCCAGCCGCCATGAAGATTTCCCGTTTCAGGAGATCCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCACAGGAAAACCACAGCATCCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCACGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAGCGCCGCGAGAGCGATAACGATCGTCGCTGTTTGCATCTGCAACTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTTAGCACCAGCGAAAAAGATCAGCTCGAACACATCACCCGCAAACTCCTGAGCCGCCTTGATCAGATGGAAGAAGAAGGCGTGCTAGCGGACTCTCTACGCTAA	
7877	CARD	prokka_00674	contig_2	420396	86	80065	81238	1	98	Klebsiella pneumoniae KpnG	3004588.0	788.875	700.0	Strict	99.74	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	ATGAGTGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGAAAGCGTAAAGGCGCCCTTCTGTTGCTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTAGCAGGGAATCAGGTACAAATTATGGCTCAGGTCGCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACTCTCGATCGGACCGATGCCCAACAGGCGTTTGAAAAGGCTAAGACCCAACTGGCCGCCAGCGTCCGTCAGACCCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCAAATATCGACGTCAAAAAAACCGCCCTCGCCCAGGCGCAGGCTGACCTGAACCGCCGCATCCCGCTGGGCGCCGCGAACCTCATTGGCCGCGAAGAGCTGCAGCACGCCCGCGATACCGTCGCCAGCGCACAGGCCGAACTCGACGTGGCAATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGCACCAGGCTGGAACAGCAGCCGGCGGTGCTCCAGGCGGCCACTGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATCGGCACCACCACGCCGCTGATGGCGGTGGTCCCGGCGACCAACCTGTGGATCGATGCTAACTTTAAAGAGACTCAGCTGGCGCATATGCGTATCGGCCAGCCGGCCACCGTGATCAGCGATATCTATGGCGATGACGTGAAATACACCGGTAAAGTGGTCGGTCTGGATATGGGCACCGGCAGCGCCTTCTCTCTGCTGCCGGCGCAGAATGCCACCGGCAACTGGATCAAAGTGGTACAGCGTCTGCCGGTTCGTATCGAGCTGGATGAAAAACAACTAGCGGAACACCCGCTGCGCATCGGCCTCTCGACGCTGGTGGAAGTCAACACCACCGATCGCGATGGTGAAATGCTGGCCAGCCAGGTGCGGAGCTCCCCGGTTTACGAGAGCAATGCCCGCGAAATCGCTCTCGATCCGGTTAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA	
7877	CARD	prokka_00675	contig_2	420396	86	81253	82792	1	97	Klebsiella pneumoniae KpnH	3004597.0	937.947	700.0	Strict	94.02	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATTGCCGGCAACCTTGGCTCGTCGCTGAGCCAGGGGACCTGGGTCATCACCTCGTTCGGGGTCGCTAACGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGCGTCGGCGAGGTGAAGCTGTTCCTGTGGTCAACCACCGCCTTCGCCATTGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTCATTCAGGGGATCGTCGCCGGACCGCTGATCCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCCCCGGCGAAGCGCTCTATCGCTCTGGCGCTGTGGTCAATGACGGTGATTGTCGCGCCCATCTGCGGTCCGATCCTCGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGGATCGACGGTGTCGGTCTGGCGCTGCTGATCATCGGTATCGGTAGCCTGCAGGTGATGCTGGACCGGGGTAAAGAGCTGGACTGGTTCTCCTCCAATGAGATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTAACCGACGATAACCCGATTGTCGATCTATCGCTATTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGTATCAGTCTGGCCTATATGCTCTACTTCGGCGCCATCGTGCTGCTGCCGCAGCTGTTGCAGGAGGTCTACGGCTACACCGCGACCTGGGCCGGCCTGGCGTCGGCGCCGGTGGGAGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTCGCGCATAAGCTCGACATGCGGCGGCTGGTCACCTTCAGCTTTATTATGTACGCGGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCACAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTCTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCCTGTCGAACTTCACCCGTACCCTTGCCGGCTCCATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCATCATGCGCAGCTCACCGAATCGGTGACCCCCTTTAACCCCAACGCGCAGCAGATATACGATCAGCTGCAGGGCATGGGAATGACGCAGCAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACCAACCAGGGGCTGATTATCTCCGCCAACGAAATCTTCTGGATTTCTGCGGCTATTTTCATCCTGCTGTTGGGGCTGGTGTGGTTCGCCAGACCACCGTTCAGCGCCGGCGGAGGCGGCGGCGGCGCGCACTAA	
7877	CARD	prokka_00688	contig_2	420396	86	90649	90835	-1	92	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTGTCTGTTCACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	
7877	CARD	prokka_01016	contig_3	355316	91	15540	15960	1	59	FosA6	3004111.0	283.108	280.0	Strict	97.84	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEVAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFDQ	ATGCTGAGTGGACTGAATCACCTGACCCTGGCAGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTGCTGGGCATGACGCTGCACGCCCGCTGGGACAGTGGGGCCTATCTCTCCTGCGGCGATTTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTTACTCCGCCGGAAGAGAGCGACTACACCCATTATGCGTTTAGCATTAGCGAGGCGGATTTCGCTAGCTTCGCCGCCCGCCTTGAGGTTGCCGGCGTAGCGGTCTGGAAGCTGAACCGTAGCGAAGGCGCTTCGCACTACTTTCTCGACCCCGACGGCCACAAGCTGGAGCTGCACGTCGGCAGTCTTGCCCAGCGGCTGGCCGCCTGCCGCGAACAGCCGTATAAGGGGATGGTGTTTTTTGATCAGTGA	
7877	CARD	prokka_01156	contig_3	355316	91	156075	156555	1	108	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.9138	32.0	Strict	28.0	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVVMGRLTWESIGRPLPGRKNIVISSKPGSDDRVQWVSSVEEAIAACGDVEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSHSYCFEILERR	ATGATCAGTCTGATTGCGGCGTTAGCGGTAGATCGCGTCATTGGTATGGAAAACGCCATGCCATGGAACCTGCCTGCCGATCTCGCCTGGTTCAAACGCAACACGTTAAATAAGCCGGTGGTGATGGGGCGTCTGACCTGGGAATCCATTGGGCGCCCATTGCCGGGGCGTAAAAATATCGTGATCAGCAGCAAACCCGGCAGCGACGATCGCGTGCAGTGGGTCTCCTCCGTAGAAGAAGCAATTGCCGCCTGCGGCGATGTGGAAGAGATTATGGTGATCGGCGGCGGCCGGGTGTATGAGCAGTTCCTGCCGAAAGCGCAGAAGCTCTACTTGACCCATATTGATGCGGAAGTGGAAGGCGATACCCATTTCCCGGATTACGATCCGGACGAATGGGAGTCGGTGTTCAGCGAGTTTCATGACGCCGACGCGCAGAACTCCCATAGCTACTGCTTTGAGATCCTCGAACGCCGTTAA	
7877	CARD	prokka_01162	contig_3	355316	91	161193	163542	-1	112	LptD	3005059.0	1619.75	1500.0	Perfect	100.0	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		carbapenem; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTATGATCGTCCGCTCGTGGAAGGTCGTCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAACTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATTAACCAGGGGAATAGTCGCCTCCGCGCCGACGAAGTTCAGCTGCATCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGGCCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAAATGGTCGGACGCCAGGGACGCGGCACCGCCGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTCGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTCGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTTGCCGAGATCTGGAACGCCCGCTTCAAGCTTGGCTCTGTGCCGATTTTCTATAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATTACTCCGCACTATATGAACAAACGCGGCGGCGTGATGTGGGAAAACGAGTTCCGCTATCTGACCCAGCTCGGCAGCGGCTTAACTGAATTCGACTACCTGCCGTCGGATAAAGTCTACGAAGACGACCACTCGAGCGACAGCAACAGCCGCCGCTGGCTGTTCTACTGGAACCACTCGGGGGTTATCGATCAGGTATGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGACTTCAGCTCGAAATATGGTTCCAGTACCGACGGCTATGCGACGCAGAAATTCAGCGCCGGTTACGTCAACCAGAACTTTGACGCCACGGTATCGACCAAACAGTTCCAGGTCTTTGACCGCGAATCGAGCAACTCCTATTCGGCTGAGCCGCAGCTCGACGTCAACTACTACCAGAATGATGTCGGTCCGTTCGATACCCATCTCTATGGACAGGTTGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCCAACGGTTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACTCACTACCAGCAAAGCAACCTCGATAAGTACAATGCCGCCAACGGCACTGACTATAAAGAGTCCGTCAGCCGCGTAATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTTGAACGCGACCTGCAGGAGGGATTCACCCAAACGCTGGAACCGCGCGTGCAGTATCTGTACGTGCCGTACCGCGATCAGAGTGAAATCGGCAACTACGACTCCACGCTGTTGCAGTCGGATTACACCGGTCTGTTCCGCGACCGTACCTATAGCGGTCTGGACCGCATCGCGTCGGCTAATCAGGTCACCACCGGGCTCACCTCGCGCGTGTATGATGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACGCACCGGTGATGACAACATCAACTGGGAGAACAACGATACCACGGGTTCACTGGTCTGGGCCGGCGATACCTACTGGCGCATTGCCGATGAATGGGGTCTGCGCGGGGGGATCCAGTACGATACGCGTCTGGATAACGTTGCCACTGGTAACGGCACCATTGAATACCGTCGCGATGAGAACCGCTTAGTCCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACGCTGCCGTCATATTCCACCGCGGCACAATATAAACAGGGTATTTCGCAGGTGGGGATGACCGCCAGTTGGCCGATTGTCGATCGCTGGTCCGTGGTCGGGGCCTACTACTACGATACTAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTGCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGTAAAGTCAACGGCTGGAACAGCAACGACAACGGCGGCGAGAGCAAATACGATAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGCTCGAACATTTTACCGTACCAGAGCTCCCTGTGA	
7877	CARD	prokka_01442	contig_4	334445	92	126590	128264	1	118	eptB	3005047.0	1160.98	1000.0	Strict	99.46	97.04	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELEKEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATTATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGCGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTGATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGTGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGTCTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGGCTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTCGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAACCCACAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCACGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCTGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA	
7877	CARD	prokka_01500	contig_4	334445	92	203548	204532	1	106	PmrF	3003578.0	577.785	550.0	Strict	83.69	101.55	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS	ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATCCCGGTTTATAACGAACAGGATAGCCTGCCGGAACTGCTTCGTCGTACGGATGCCGCCTGCGCCACCCTGGGGCGGCAATATGAAATTCTGTTGATCGACGATGGCAGCAGCGACGATTCCGCGCGCATGCTCACCGAAGCCGCCGAGGCGGAAGGCAGCCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGCCAGCACTCGGCGATCATGGCCGGCTTCAGCCATGTAACCGGCGATCTGATTATTACCCTCGACGCCGACCTGCAAAACCCGCCGGAGGAGATCCCGCGGCTGGTGGCGAAGGCTGATGAAGGTTACGACGTGGTGGGCACCGTCCGCCAGAACCGTCAGGACAGCATCTTCCGTAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTTATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATTGCCCTGCTGGGCTTCGCCTTCGGCCTGCTGCTGGTGGTGCTGCGCCTGGCCTTCGGCCCACAGTGGGCGGCGGAAGGGGTGTTTATGCTCTTCGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCCCGCCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA	
7877	CARD	prokka_01503	contig_4	334445	92	207412	209068	1	103	ArnT	3005053.0	1093.57	1000.0	Strict	99.27	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSPIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAAQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHRPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDINMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTTTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGATCAACAGTATCGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCCTGTCGCCGATTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGCGCGGCGCAGGCGCACAGCCGCAGCGGCAAAATACTGGGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAGGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCCCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTAATCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCTCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCGCTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGGATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCCGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAGGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTCGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGATATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTAATATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTATTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA	
7877	CARD	prokka_01601	contig_4	334445	92	318429	319062	-1	102	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAGCGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTCACGTCTGAGAAAGTGGGCAACCTTGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCGGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGCCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCGCACGGTAAAACCATCGTCGTCTACGGCACCCGTTAA	
7877	CARD	prokka_01907	contig_5	292385	93	287987	291098	1	111	adeF	3000777.0	750.355	750.0	Strict	41.66	97.83	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MSKFFIHRPVFAWVLAIIMMIAGGLAILQLPIAQYPTIAPPAVAISATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFKSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSFLLVAGFISDNPTTTQDDISDYVASNVKDPISRLNGVGDVQLFGAQYAMRVWLDGNLLNKYNLTPVDVINALQVQNDQIAAGQLGGTPALKGQQLNASIIAQTRLKDPQEFGKVTLRVNADGSVVHLKDVARIELGGENYNVVARINGKPASGLGIKLATGANALDTATAIKAKLAELQPYFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAVLSMFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEEKLSPKEATEKSMSQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALVLTPALCATLLKPASAEHHEKKGFFGWFNARFDQSVNHYTNSVSGILRGTGRYLVIYLLIVVGMAVLFMRLPTSFLPDEDQGVFLTMIQLPSGATQERTQKVLDTVTDYYLHNEKANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEARSGDENSVESIIKRATVAFSQIKDAMVFPFNMPAIIELGTATGFDFELIDQGGLGHTALTQARNQLLGMVKQHPDQLVRVRPNGLEDTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADAHFRMLPSDINNMYVRSANGEMVPFSAFVTSRWIYGSPRLERYNGLPSMEILGEASPGKSTGEAMALMETLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISHGAGSGAQNAVGTGVMGGMLTATLLAIFFVPVFFVVVRRRFTRHAE	ATGTCTAAGTTTTTTATTCATCGACCGGTCTTCGCCTGGGTGCTGGCCATCATTATGATGATTGCCGGCGGCCTGGCCATCCTGCAGCTGCCGATAGCTCAGTACCCGACAATCGCCCCTCCTGCGGTAGCGATCTCCGCCACCTACCCCGGTGCAGATGCCCAGACCGTACAGGATACGGTCACTCAGGTTATCGAGCAGAATATGAACGGCATCGACAATCTGATGTATATGTCGTCGACCAGCGACTCTGCCGGTTCGGTAACCATTACGCTCACCTTTAAATCGGGTACCGATCCCGATATTGCCCAGGTACAGGTGCAAAACAAACTGCAGCTGGCCACGCCGCTGCTGCCCCAGGAAGTACAGCAGCAAGGGATTAGCGTCGAGAAATCCAGTAGCAGCTTCCTGTTGGTCGCCGGCTTTATCTCTGATAACCCGACCACCACCCAGGACGATATTTCTGACTATGTTGCCTCCAATGTCAAAGATCCTATTAGCCGCCTCAACGGCGTGGGCGATGTGCAGCTGTTCGGCGCGCAGTACGCTATGCGCGTCTGGCTGGATGGCAACCTGCTGAATAAATACAACCTGACGCCGGTGGACGTCATCAATGCGCTGCAGGTCCAGAACGATCAGATCGCCGCGGGTCAGCTCGGGGGTACGCCAGCGCTGAAAGGCCAGCAGTTGAACGCGTCAATCATCGCTCAGACGCGGCTCAAAGATCCGCAGGAGTTTGGCAAGGTCACGCTGCGGGTCAATGCCGATGGCTCTGTCGTCCATCTGAAAGACGTCGCCCGCATTGAGCTGGGGGGAGAGAACTATAACGTCGTCGCCAGAATTAACGGTAAACCTGCCTCTGGTCTGGGTATTAAGCTTGCGACCGGCGCCAACGCCCTGGATACCGCCACCGCGATTAAAGCGAAGCTGGCCGAGCTGCAGCCCTACTTCCCTCAGGGGATGAAGGTGGTCTATCCGTATGATACGACCCCTTTCGTCAAAATCTCCATTCACGAAGTGGTCAAAACGCTTTTTGAAGCAATTATTCTCGTCTTTCTTGTCATGTATCTGTTCCTGCAGAACATGCGCGCAACGCTCATTCCAACCATTGCCGTACCCGTGGTGCTGTTGGGAACCTTCGCGGTATTGTCGATGTTTGGCTACTCCATCAACACGCTGACAATGTTTGGCATGGTGTTGGCGATAGGTCTGCTGGTCGATGACGCTATCGTAGTAGTGGAAAACGTCGAACGTGTGATGGTTGAGGAGAAGCTCTCGCCAAAAGAAGCGACGGAAAAATCTATGTCGCAGATCCAGGGAGCGCTGGTGGGTATCGCCATGGTGCTCTCCGCAGTATTTGTCCCGATGGCCTTTTTCGGCGGCTCAACCGGCGCGATTTATCGTCAGTTTTCAATCACCATCGTCTCCGCCATGGCGCTCTCCGTGCTGGTTGCGCTGGTACTGACGCCGGCGCTCTGCGCCACGTTGTTGAAGCCAGCCTCAGCTGAACACCATGAGAAAAAAGGATTTTTCGGCTGGTTTAACGCCCGCTTCGACCAGAGCGTTAACCACTATACCAACAGCGTCAGCGGTATTTTACGTGGAACTGGCCGTTATCTGGTGATCTACCTGCTGATCGTCGTGGGGATGGCCGTGCTGTTCATGCGCTTGCCCACGTCCTTTCTGCCCGACGAAGACCAGGGCGTCTTCCTGACCATGATCCAGCTGCCGTCCGGTGCTACCCAGGAGCGCACGCAGAAGGTCCTGGATACGGTGACAGACTACTACCTGCATAACGAGAAGGCCAACGTCGAAAGCGTCTTTACCGTTAACGGCTTCAGCTTCAGCGGCCAGGGACAAAACTCCGGTATGGCGTTTGTCAGCCTGAAGCCTTGGGAAGCGCGCAGCGGCGATGAAAACAGCGTGGAGTCCATCATCAAGCGGGCCACCGTAGCCTTTAGCCAGATCAAAGACGCCATGGTTTTCCCGTTCAACATGCCAGCCATTATTGAGCTGGGTACCGCCACCGGCTTCGACTTTGAACTGATCGACCAGGGCGGACTCGGTCATACCGCTCTGACCCAGGCGCGCAATCAACTGCTGGGCATGGTGAAACAGCATCCGGATCAGCTGGTTCGGGTACGCCCTAATGGGCTGGAAGATACCCCTCAGTTCAAACTGGATGTCGATCAGGAAAAAGCGCAGGCGCTGGGCGTATCGCTCTCCGATATCAATGAAACGATATCAGCCGCGCTGGGCGGATACTACGTCAATGACTTTATTGACCGCGGCCGCGTGAAAAAAGTGTACGTTCAGGCTGATGCCCACTTCCGTATGCTGCCGAGCGACATTAACAACATGTATGTTCGTAGCGCCAACGGCGAAATGGTGCCGTTCTCCGCCTTTGTCACTTCACGCTGGATATATGGCTCGCCGCGCCTGGAGCGCTACAACGGGTTGCCATCTATGGAGATCCTCGGTGAAGCTTCGCCAGGCAAAAGTACCGGGGAAGCCATGGCGCTGATGGAAACGCTGGCCAGTAAACTGCCGAGCGGCATCGGTTATGACTGGACCGGGATGTCTTACCAGGAACGGCTCTCCGGCAACCAGGCGCCTGCGCTCTATGCCATCTCGCTGATCGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATCCCCTTCTCAGTCATGTTAGTGGTTCCGCTAGGGGTCATTGGCGCGCTGTTAGCCGCCACGCTGCGTGGGCTGAATAATGACGTTTACTTCCAGGTCGGACTCTTGACCACGATCGGTTTGTCGGCCAAGAATGCGATCCTGATCGTCGAGTTCGCCAAGGATCTGATGGAGAAAGAAGGGAAAGGGATCATTGAGGCCACGCTGGAGGCATCGCGGATGCGCCTGCGGCCTATTCTGATGACCTCTCTGGCCTTTATTCTCGGGGTCATGCCGCTGGTGATTAGCCATGGTGCCGGCAGCGGGGCGCAGAATGCGGTTGGCACCGGCGTGATGGGCGGGATGCTGACCGCGACGCTGCTGGCGATCTTCTTTGTTCCGGTGTTCTTCGTAGTCGTTAGACGACGCTTTACCCGGCACGCTGAATAA	
7877	CARD	prokka_02133	contig_6	283880	85	250229	250952	-1	75	baeR	3000828.0	455.677	450.0	Strict	91.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPVDENTPRILIVEDEPKLGQLLIDYLQAAGYAPALINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA	ATGACTGAATTGCCTGTAGATGAAAACACCCCACGCATCCTTATCGTGGAAGATGAACCGAAGCTCGGCCAGCTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTGCGTTGATTAACCACGGCGACAAGGTCCTGCCCTACGTCCGCCAGACGCCGCCGCATCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGTCTGACGCTGTGCCGGGAAATTCGCCGCTTCTCCGATGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATCGACCGTTTGCTGGGGCTGGAAATAGGCGCCGACGACTATATCTGCAAGCCCTACAGCCCGCGGGAAGTGGTCGCCCGGGTAAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGCGATCTGCAGGCGCTGGACGCCCAGAGCCCGCTGATTGTCGACGAAGGTCGTTTTCAGGCCTCCTGGCGCGACAAGCTGCTGGACCTCACTCCCGCCGAGTTCCGGCTGCTGAAAACCCTCTCCCAGGAGCCGGGCAAAGTGTTCTCCCGCGAACAGCTACTCAACCATCTGTATGACGATTATCGGGTAGTCACCGATCGCACCATCGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAGCAGTCGTTTATCCGCGCGGTGTATGGCGTTGGCTACCGCTGGGAAGCGGACGCCTGCCGGCTGGCGTAG	
7877	CARD	prokka_02136	contig_6	283880	85	253840	256918	-1	73	mdtC	3000794.0	1861.27	1800.0	Strict	91.51	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVQTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVPGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSDGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSSQPVSE	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTGCTGCCGGTAGCCCCGCTGCCGCAGGTGGACTTCCCGGTGATCATGGTTAGCGCCTCGCTGCCGGGAGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGCTCGCTGGGCAGTACGCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGACGTTCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGGATGCCCAGCCGGCCGACCTATCGCAAAGCCAATCCGTCGGATGCGCCGATCATGATCCTGACGCTGACCTCGGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATCGACGGCGTGGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCGCAGGCGCTGTTCAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAACCGCAGGGGGCGCTGGAGGACAGCGCGCACCGCTGGCAGGTGCAGACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCGCTGATCGTCCACTACCAGAATGGCGCCGCGGTGCGGCTGGGAGATGTCGCCACCGTCTCGGATTCGGTGCAGGACGTACGCAACGCCGGGATGACCAACGCCAAACCGGCGATCCTGCTGATGATCCGCAAACTGCCGGAAGCCAATATTATCCAGACAGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATTCCGGCGGCTATCGACCTACAGATCGCCCAGGACCGCTCGCCGACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACGCTGGTGATTTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCCGTCGCCGTCCCGGTTTCCTTAATCGGCACCTTCGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCTATCGTGGTGCTGGAGAATATCTCCCGCCATCTGGAGGCGGGGATGAAACCGCTGCAGGCGGCGCTGCAGGGGAGCCGCGAGGTGGGCTTTACCGTGCTGTCGATGAGTCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTGCCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAGCCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTGCAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCATAGCCGCCTGACCGGCCTGGTGGTGCCGGGCACCATCGCCCTCAGCGTCTGGCTCTACATTTCGATCCCGAAAACCTTCTTCCCGGAACAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAGATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCCAACCTGTTTCTGATGGCGGTGCAGGATATCCGCGTCGGCGGCCGGCAGTCGAACGCCAGCTATCAGTACACCCTGCTGTCCGACGACCTGTCGGCGCTGCGCGAGTGGGAGCCGAAGATCCGCAAAGCGCTGGCGGCGCTGCCGGAGCTGGCGGACGTCAACTCCGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATTAGCGTCCAGGACGCCAACAACCTGCTGAACAACGCCTTTGGCCAGCGGCAGATCTCTACCATCTACCAGCCGCTCAACCAGTATAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTCGTCATTAACAGCGACGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAATGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCATCCACTATCTCCTTTAACCTGCCCACCGGCCGCTCGCTGTCGGAAGCCAGCGAGGCCATTGACCGCGCGATGACCCAGCTCGGGGTGCCGTCGAGCGTGCGCGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTCGCGGCTATCGCCACGGTCTATATCGTGCTGGGGGTGCTATATGAGAGCTATGTGCATCCGTTGACCATCCTCTCGACGCTGCCCTCCGCCGGGGTGGGCGCTCTGCTGGCGCTGGAGATCTTCGATGCCCCGTTCAGCCTAATCGCCCTGATTGGGATTATGTTATTAATTGGCATCGTTAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTGGAGGCGCAGCGTAACGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTGCCGCTGGTGCTCTCCGGGGGCGATGGCTCTGAGCTGCGCCAGCCGCTGGGGATCACCATCGTCGGCGGTCTGGTGATGAGCCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTCTGCGGCTGCGTTTTTCGCGTCACTCCTCTCAACCGGTAAGCGAATAA	
7877	CARD	prokka_02137	contig_6	283880	85	256918	260041	-1	77	mdtB	3000793.0	1831.22	1800.0	Strict	90.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFERVIAVYGRWLSRVLNHPWLTLGVALSTLALSIILWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAERQRQVASIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVDGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEQDTEATPGLAALENILLTSSDGGIVPLTAIATVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILAAEQSLDFPTDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA	ATGCAGGTGTTACCTCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCTATCCTACTGGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCCCTGCCGGAGGTCGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAGCGCCAGTTCGGCCAGATGTCAGGCCTCAAGCAGATGTCGTCGCAAAGCTCCGGCGGCGCCTCGGTAGTCACGCTGCAGTTCCAGCTGACCCTGCCGCTGGACGTCGCCGAGCAGGAAGTGCAGGCGGCCATTAACGCCGCCACCAACCTGCTGCCGAGCGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACTCTCGCCGTCACCTCCTCCGCCATCCCGATGACCCAGGTTGAGGACATGGTGGAGACCCGGGTGGCGCAGAAGATCTCCCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCTATCACCAGCGCCAACGTTAATTCAGCGAAAGGCAGCCTCGACGGCCCGGCCCGCGCAGTGACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTATCGCCGGCTGATTATCGCTTATCAGAACGGGGCGCCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTCGGGGCGTGGGCCAACCAGCAGCGGGCCATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATCATCGACACCGCCGACAGCATTCGCCAGATGCTGCCGCAGCTCACCGAGAGCCTGCCGAAATCGGTGAAGGTGCAGGTCCTCTCCGACCGGACCACTAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTACCTGTTTCTGCGCAACGTGCCGGCGACCATTATTCCCGGCGTCGCGGTGCCGCTGTCGCTGGTGGGCACTTTCGCGGTGATGGTGTTCCTCGACTTCTCGATCAACAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCCATCGTGGTGATCGAGAACATCTCGCGCTATATCGAAAAAGGCGAGAAGCCGCTGGCCGCCGCGCTGAAGGGCGCGGGGGAGATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGCCTGTTCCGCGAATTCGCCGTCACCCTTGCCGTCGCTATTCTTATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGTATGCTAAGCCACGAATCGCTGCGTAAGCAGAACCGATTCTCGCGGGCCAGCGAGCGTTTCTTCGAACGGGTGATCGCCGTCTATGGCCGCTGGCTGAGCCGGGTGCTGAACCATCCGTGGCTGACGCTCGGCGTCGCCCTGAGCACCCTGGCGCTGTCGATTATCCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGCACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGCATGGCCGAGCGCCAGCGGCAGGTGGCCAGCATTATCCTTAAGGATCCGGCGGTGGAGAGTCTGACCTCCTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGTCTGCAGATCAACCTCAAGCCGCTGGATGAACGCGACGACCGCGTCCAGACGGTGATAAGCCGCCTGCAGCAGGCGGTGGACGGCGTCCCCGGCGTGGCGCTCTACCTGCAGCCGACCCAGGACCTGACCATCGACACCACGGTGAGCCGCACCCAGTATCAGTTCACCCTGCAGGCAAACTCCCTCGAGGCGCTGAGCACCTGGGTGCCGCCGCTGCTCAGCCGCCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGATCGCGACAGCGCCAGCCGCCTCGGTATCTCAATGGCCGATGTCGATAATGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACTATTTACACTCAGGCGAATCAGTATCGCGTGGTGCTCGAGCAGGATACCGAGGCGACGCCGGGCCTGGCGGCGCTGGAGAATATCCTCCTCACCAGCAGCGACGGCGGCATCGTGCCGTTGACCGCCATCGCCACGGTGGAGCAGCGCTTTACCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTCCCGGACAACTACTCGCTGGGCGAAGCGGTGGAGGCGATCCTTGCCGCCGAACAGTCGCTGGATTTCCCGACCGATATTCGCACCCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTCGGCAGCACCGTCTGGCTGGTGGTCGCCGCGGTGGTGGCGATGTATATCGTGCTGGGGGTGCTGTACGAGAGCTTTATCCATCCGATCACGATTCTCTCCACCCTGCCCACCGCCGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCAGCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCTGAGCGCGAGCAGGGCATGCCGCCGCGGGAAGCGATCTACCAGGCCTGTCTGCTGCGTTTTCGGCCGATCCTGATGACTACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTCGGCGCCGAGCTGCGGCGTCCGCTGGGGATCGGCATGGTCGGCGGTCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA	
7877	CARD	prokka_02791	contig_10	192452	84	10954	12703	1	98	msbA	3003950.0	1126.69	1000.0	Strict	92.78	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE	ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATCGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTGGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGCCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATTTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGTATGCCGGTGGCCTTCTTTGACAAGCAGTCTACCGGAACGCTGCTGTCACGCATCACCTATGATTCTGAGCAGGTCGCCTCCTCCTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGGGCATCGATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTGATCGTACTGGCGCCGATTGTGTCGGTGGCGATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCCGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAAGTCAGCAATAAAATGCGTCTGCAGGGGATGAAGATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCCGGGACCATTACCGTGGTCTTCTCCTCGATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAGCGCGGGATGGCGGCGTGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAAAAAGACGAAGGTACGCGGGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTACCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATCCCGGAAGGGAAAACCGTGGCGCTGGTGGGGCGCTCAGGGTCGGGTAAATCGACCATTGCCAGCCTGATCACCCGCTTCTACGATGTCGACGAGGGGCAGATCCTGCTGGATGGCCACGACCTGCGCGAGTACAAGCTGAGCTCGCTGCGCGACCAGGTGGCGCTGGTTTCACAAAACGTGCATCTGTTCAACGATACCGTCGCCAACAATATCGCCTATGCCCGTACCGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCCGCGCGCATGGCCTACGCCATGGATTTCATCAACAAGATGGATAATGGTCTGGATACCATCATCGGCGAGAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATTGCCCGCGCGCTGCTGCGTAACAGCCCGATCCTGATCCTCGATGAAGCCACCTCGGCGCTGGATACCGAGTCCGAGCGTGCCATTCAGGCGGCGCTGGATGAGCTGCAGAAAAACCGTACCTCGCTGGTTATTGCTCACCGTCTGTCGACCATTGAGCAGGCTGATGAAATCGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCATGATCTGCTGGAGCATAAGGGCGTGTACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA	
7877	CARD	prokka_02832	contig_10	192452	84	62074	63145	-1	110	OmpA	3005044.0	729.169	700.0	Strict	99.72	95.19	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTTGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCTGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCTGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA	
7877	CARD	prokka_03074	contig_11	182432	84	130862	133976	-1	98	acrD	3000491.0	1953.33	1900.0	Strict	91.13	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGTLAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQPASGLGIKLASGANEMATAERVINRLNELAQFFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPVKPGESHERTGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLIYVLLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGTSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAGKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ	ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCATGGGTGCTGGCAATCCTGTTATGCCTGACGGGCACCCTTGCCATTTTGTCGCTGCCGGTTGAACAGTATCCCGACCTCGCCCCGCCGAATGTGCGGATCACCGCCAACTATCCCGGCGCTTCCGCGCAAACCCTGGAGAATACCGTCACTCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCCTCCCAGAGCAGCGCCACCGGCCAGGCGACGATCACCCTCAGCTTTACCGCCGGTACCGACCCGGATGAAGCCGTGCAGCAGGTTCAGAACCAGCTACAGTCGGCGATGCGTAAGCTGCCGCAGGCGGTGCAAAACCAGGGGGTGACGGTGCGCAAGACCGGTGATACCAATATCCTGACGCTCGCCTTCGTCTCCACTGACGGCAGTATGGATAAACAAGATATCGCCGACTACGTCGCCAGTAACATCCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGTTCGCAATACTCAATGCGCATCTGGCTCGACCCGGCGAAGCTCAACAGCTACCAGATGACCACCAAGGATGTTACCGACGCCATCAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTTGGCGGGACGCCTTCGGTCGATAAGCAAGCGCTGAACGCCACCATCAACTCGCAATCTCTGCTGCAAACCCCGGAGCAGTTCCGCAATATCACTCTGCGCGTCAATCAGGATGGTTCAGAGGTGACGCTGGGCGATGTCGCCACCGTCGAGATGGGGGCGGAGAAGTACGACTATCTTAGCCGCTACAACCGCCAGCCGGCCTCAGGCCTCGGGATCAAGCTGGCTTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCAATCGCCTCAATGAGCTGGCGCAGTTTTTCCCCCACGGTCTGGAATATAAGGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCTATCACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCGACCATCGCCGTGCCGGTGGTGCTGATGGGCACTTTCGCGGTGCTGTATGCCTGTGGTTACAGCATTAACACCCTGACGATGTTCGCGATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGAGCGAGGAGGGCCTGTCGCCACGCGAGGCGACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTATTTGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCAATCACTATCGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCTGCCCTTTGCGCCACGCTGCTTAAGCCGGTTAAGCCAGGTGAATCCCATGAAAGAACAGGCTTCTTCGGCTGGTTCAACCGCACCTTCAACCGCAGCGCCAGCCGCTACGAAACCTTCGTCGGCAAAATACTGCACCGCTCGCTGCGCTGGATGCTGATCTACGTCCTCCTGCTCGGCGGGATGGTGTTCCTGTTTCTGCATTTGCCGACCTCGTTCCTGCCGCTGGAGGATCGCGGGATGTTCACCACCTCGGTCCAGTTGCCGAGCGGCAGCACCCAGCAGCAGACGCTGAAGGTGGTGCAGAAGGCGGAAGATTACTTCCTCAATAACGAGAAGCAGAACGTCGAGTCGGTGTTCGCTACCGTTGGCTCCGGCCCCGGCGGCAATGGGCAGAACGTGGCCCGTATGTTCGTTCGTCTCAAAGACTGGGACCAGCGCGACCCGCAAACCGGCACCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATTAACGAAGCGCGGGTTATCGCCAGCAGCCCGCCGGCGATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGATATGGAGCTGGAGGATCATGCCGGGAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTACTTGAGCTGGCCGGGAAAAATCCGCTGTTGACCCGCGTCCGGCATAACGGGCTCGATGACAGTCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCGCAGGCGCTTGGCGTCTCCATTGACGACATCAACGATACGCTGCAAACCGCGTGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGCCGGGTAAAGAAAGTCTACGTCCAGGCGGCGGCGAAATACCGGATGCTGCCTGACGATATCAATCTTTGGTACGTGCGCAACAGCAGCGGTACGATGGTGCCATTCTCGGCCTTCGCCACCTCGCGCTGGGAGACCGGCTCGCCGCGGCTGGAGCGCTACAATGGCTACTCAGCGGTCGAGATCGTCGGTGAGGCGGCGCCGGGTATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGTTACCCACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCTCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCAGTGCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATTGGCGCCCTGCTGGCGACCTGGATGCGCGGGCTGGAGAATGACGTGTACTTCCAGGTGGGTCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTCAACGAGAAGGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCTTGCCGTCAGCGCCTGCGCCCCATCCTGATGACCTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGAGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCGATCTTTTTCGTGCCGCTGTTCTTTGTGCTGGTGCGTCGCCGTTTTCCGCTAAAGGAGCGTCCGCAATAA	
7877	CARD	prokka_03142	contig_12	182054	75	21884	22247	1	63	Klebsiella pneumoniae KpnE	3004580.0	223.402	150.0	Strict	99.17	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSKQEVAHAAV	ATGTTTTATTGGATTTTATTAGCTTTAGCAATTATTGCTGAAATTACCGGCACCTTGTCTATGAAATGGGCAAGCGTGAGCGGCGGGCACACCGGCTTTATTTTAATGCTGGCCATGATTGCCCTGTCATATATTTTTCTTGCCTTTGCGGTTAAAAAGATTGCCCTCGGTGTGGCCTATGCGTTGTGGGAAGGGATCGGTATTTTACTGATTACCCTGTTTAGCGTGCTGCTGTTTGATGAGAGTCTGTCCCTGCTGAAAATAGCCGGCTTGACCACCCTGGTGATAGGGATCGTCTTAATTAAGTCCGGCACCCAGAAAAAAGCGTCTTCCAAGCAGGAGGTGGCCCATGCAGCAGTTTGA	
7877	CARD	prokka_03143	contig_12	182054	75	22233	22563	1	68	Klebsiella pneumoniae KpnF	3004583.0	206.453	150.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGCTGGCAATCGCCATTGTGCTGGAAATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGCTTCCGCCGCAAGATCTACGGCATCCTGTCCCTGGCGGCAGTATTGGGCGCGTTCAGCGCCCTGTCGCAGGCGGTTAAAGGGATCGATCTCTCGGTCGCCTATGCGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGTCAGCGTCTGAATAACAAAGGCTGGGCGGGGGTTATCCTGCTGGTAGCCGGCATGGTGTTAATTAAACTCGCCTGA	
7877	CARD	prokka_03205	contig_12	182054	75	83555	83930	-1	102	marA	3000263.0	243.432	230.0	Strict	92.74	97.64	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN	ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCCGGTTACTCTAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACCGGCCATTCCCTCGGCCAGTACATCCGCAGCCGCAAGCTGACGGAGATTGCGCAGAAGCTCAAGCAGAGTAATGAGCCAATCCTGTACCTGGCGGAACGCTATGGTTTCGAGTCGCAGCAGACCCTGACGCGAACGTTCAAGAACTATTTCGATGTTCCGCCCCATAAGTATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTACATCCGCTAAATAACTGA	
7877	CARD	prokka_04209	contig_21	86706	95	46882	47107	1	88	CBP-1	3004764.0	21.557	600.0	Strict	100.0	24.03	CBP beta-lactamase	protein homolog model	antibiotic inactivation		penam	MNHGQLSMKNVFPTLAVLFAIFSLTGCGLKGPLYFPPADKTAPPPTKPVNPGIQSATPDRNDRGDTGGPSQVNY	ATGAATCACGGGCAACTATCAATGAAAAACGTTTTTCCTACGCTTGCCGTTTTGTTTGCGATCTTCAGCCTGACCGGCTGCGGTCTGAAAGGGCCTCTCTATTTCCCACCGGCGGACAAAACCGCGCCGCCGCCGACCAAACCGGTTAACCCTGGCATTCAGAGCGCAACGCCGGATCGTAACGATCGTGGCGATACCGGTGGTCCGAGCCAGGTCAATTACTAA	loose hit with at least 95 percent identity pushed strict
7877	CARD	prokka_04649	contig_28	44589	112	42170	42536	1	131	BRP(MBL)	3001205.0	251.136	200.0	Perfect	100.0	100.0	Bleomycin resistant protein	protein homolog model	antibiotic inactivation		glycopeptide antibiotic	MADHVTPNLPSRDFDVTEAFYAKLGFATSWKDRGWMILQRGGLQLEFFPYPDLDPATSSFGCCLRLDDLDAMVALVNAAGAEEKSTGWPRFKAPQLEASGLRIGYLIDPDCTLVRLIQNPD	ATGGCTGACCACGTCACCCCCAATCTGCCATCGCGCGATTTCGATGTGACAGAGGCGTTTTATGCGAAGCTGGGCTTTGCGACGAGTTGGAAGGATCGCGGCTGGATGATCCTGCAGCGCGGCGGTTTGCAGCTCGAATTCTTCCCCTATCCTGACCTCGACCCAGCTACGAGCTCGTTCGGCTGTTGCCTGCGGTTGGATGATCTCGATGCCATGGTGGCATTGGTGAACGCGGCGGGAGCCGAGGAAAAAAGCACCGGCTGGCCGCGCTTCAAAGCTCCGCAACTGGAGGCGAGCGGCCTGAGGATCGGCTACCTGATCGATCCCGACTGCACGCTGGTGCGGCTGATCCAGAACCCCGACTGA	
7877	CARD	prokka_05063	contig_43	18099	82	5528	6761	-1	97	Escherichia coli mdfA	3001328.0	705.671	700.0	Strict	85.37	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVLAAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG	ATGCAAAATTATTCGCTTTCAGGCCGCCGCCTCGGAAGGCAGGCGCTGTTGTTCCCGTTATGTCTGGTGCTGTACGAGTTTTCCACTTATATCGGCAACGATATGATTCAGCCGGGCATGTTAGCCGTGGTGCAGGAATTTCAGGTGGGTAACGAATGGGTACCTACCTCAATGACTGCCTATCTGGCAGGCGGCATGTTTTTACAGTGGCTGCTGGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGTTGACCGGCGTAGTATGGTTCATCGTTACCTGCCTGGCGACGCTGCTGGCGCAGACCATTGAGCAGTTTACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGCTTTATCGGCGCGGTGGGCTATGCGGCGATACAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCCCTGATGGCTAACGTGGCGCTGATAGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATATCCTGCCGTGGGAGATGATGTTTGTCCTGTTCGCCGTGCTGGCGGCCATCTCGTTCTTCGGCCTGCAGCGGGCGATGCCGGAGACCGCGACGCGGCTGGGCGAAAAGCTGTCGGTGAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTGAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCCACTGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCCACCAGCTATGAGTACGGCATGCTGCAGGTGCCGATTTTCGGGGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTGCGCGCCGGACCGTGCGCTCGCTGATTATCATGGGCGGTTGGCCGATCATGTTTGGTCTGATCCTCTCTGCGGCGGCGACCGTGGTCTCTTCCCACGCTTATCTGTGGATGACGGCCGGTCTGAGCTTCTACGCCTTCGGGATTGGCCTCGCGAACGCCGGCCTGGTGCGTTTAACCCTGTTCGCCAGCGAGATGAGTAAAGGCACGGTCTCGGCGGCGATGGGAATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTGGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGCTGGGTGGGGTACTATGGCTGGGGCTGATGATTTACTTTCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGGTAG	
7877	CARD	prokka_05083	contig_44	17632	165	8566	9223	1	185	QnrS1	3002790.0	455.292	400.0	Perfect	100.0	100.0	quinolone resistance protein (qnr)	protein homolog model	antibiotic target protection		fluoroquinolone antibiotic	METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD	ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA	
7877	CARD	prokka_05111	contig_47	12408	82	1630	2128	1	104	dfrA12	3002858.0	339.732	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG	ATGAACTCGGAATCAGTACGCATTTATCTCGTTGCTGCGATGGGAGCCAATCGGGTTATTGGCAATGGTCCTAATATCCCCTGGAAAATTCCGGGTGAGCAGAAGATTTTTCGCAGACTCACTGAGGGAAAAGTCGTTGTCATGGGGCGAAAGACCTTTGAGTCTATCGGCAAGCCTCTACCGAACCGTCACACATTGGTAATCTCACGCCAAGCTAACTACCGCGCCACTGGCTGCGTAGTTGTTTCAACGCTGTCGCACGCTATCGCTTTGGCATCCGAACTCGGCAATGAACTCTACGTCGCGGGCGGAGCTGAGATATACACTCTGGCACTACCTCACGCCCACGGCGTGTTTCTATCTGAGGTACATCAAACCTTCGAGGGTGACGCCTTCTTCCCAATGCTCAACGAAACAGAATTCGAGCTTGTCTCAACCGAAACCATTCAAGCTGTAATTCCGTACACCCACTCCGTTTATGCGCGTCGAAACGGCTAA	
7877	CARD	prokka_05112	contig_47	12408	82	2547	3327	1	80	aadA2	3002602.0	522.316	450.0	Perfect	100.0	100.0	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	GTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTGATTTGTTGGTTACTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGATCTTATGGAGGCTTCGGCTTTCCCTGGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATAAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGA	
7877	CARD	prokka_05113	contig_47	12408	82	3490	3838	1	74	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
7877	CARD	prokka_05114	contig_47	12408	82	3831	4671	1	66	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
7877	CARD	prokka_05122	contig_47	12408	82	11308	12214	-1	67	mphA	3000316.0	604.364	500.0	Perfect	100.0	100.0	macrolide phosphotransferase (MPH)	protein homolog model	antibiotic inactivation		macrolide antibiotic	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	ATGACCGTAGTCACGACCGCCGATACCTCCCAACTGTACGCACTTGCAGCCCGACATGGGCTCAAGCTCCATGGCCCGCTGACTGTCAATGAGCTTGGGCTCGACTATAGGATCGTGATCGCCACCGTCGACGATGGACGTCGGTGGGTGCTGCGCATCCCGCGCCGAGCCGAGGTAAGCGCGAAGGTCGAACCAGAGGCGCGGGTGCTGGCAATGCTCAAGAATCGCCTGCCGTTCGCGGTGCCGGACTGGCGCGTGGCCAACGCCGAGCTCGTTGCCTATCCCATGCTCGAAGACTCGACTGCGATGGTCATCCAGCCTGGTTCGTCCACGCCCGACTGGGTCGTGCCGCAGGACTCGGAGGTCTTCGCGGAGAGCTTCGCGACCGCGCTCGCCGCCCTGCATGCCGTCCCCATTTCCGCCGCCGTGGATGCGGGGATGCTCATCCGTACACCGACGCAGGCCCGTCAGAAGGTGGCCGACGACGTTGACCGCGTCCGACGCGAGTTCGTGGTGAACGACAAGCGCCTCCACCGGTGGCAGCGCTGGCTCGACGACGATTCGTCGTGGCCAGATTTCTCCGTGGTGGTGCATGGCGATCTCTACGTGGGCCATGTGCTCATCGACAACACGGAGCGCGTCAGCGGGATGATCGACTGGAGCGAGGCCCGCGTTGATGACCCTGCCATCGACATGGCCGCGCACCTTATGGTCTTTGGTGAAGAGGGGCTCGCGAAGCTCCTCCTCACGTATGAAGCGGCCGGTGGCCGGGTGTGGCCGCGGCTCGCCCACCACATCGCGGAGCGCCTTGCGTTCGGGGCGGTCACCTACGCACTCTTCGCCCTCGACTCGGGTAACGAAGAGTACCTCGCTGCGGCGAAGGCGCAGCTCGCCGCAGCGGAATGA	
7877	CARD	prokka_05171	contig_53	5958	89	193	853	-1	105	catI	3002683.0	465.692	400.0	Perfect	100.0	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA	
7877	CARD	prokka_05256	contig_69	2853	99	1822	2683	-1	101	AAC(3)-IIe	3004621.0	582.408	565.0	Strict	98.95	100.0	AAC(3)	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MHTRKAITEAIRKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAHEAAQRSCEPSG	ATGCATACGCGGAAGGCAATAACGGAGGCAATTCGAAAATTAGGAGTCCAAACCGGTGACCTGTTGATGGTGCATGCCTCACTTAAAGCGATTGGTCCGGTCGAAGGAGGAGCGGAGACGGTCGTTGCCGCGTTACGCTCCGCGGTTGGGCCGACTGGCACTGTGATGGGATACGCGTCGTGGGACCGATCACCCTACGAGGAGACTCTGAATGGCGCTCGGTTGGATGACAAAGCCCGCCGTACCTGGCCGCCGTTCGATCCCGCAACGGCCGGGACTTACCGTGGGTTCGGCCTGCTGAATCAATTTCTGGTTCAAGCCCCCGGCGCGCGGCGCAGCGCGCACCCCGATGCATCGATGGTCGCGGTTGGTCCGCTAGCTGAAACGCTGACGGAGCCTCACGAACTCGGTCACGCCTTGGGGGAAGGGTCGCCCGTCGAGCGGTTCGTCCGCCTTGGCGGGAAGGCCCTGCTGTTGGGTGCGCCGCTAAACTCCGTTACCGCATTGCACTACGCCGAGGCGGTTGCGGATATCCCCAACAAACGATGGGTGACGTATGAGATGCCGATGCTTGGAAGAAACGGTGAAGTCGCCTGGAAAACGGCATCAGAATACGATTCAAACGGCATTCTCGATTGCTTTGCTATCGAAGGAAAGCCGGATGCGGTCGAAACTATAGCAAATGCTTACGTGAAGCTCGGTCGCCATCGAGAAGGTGTCGTGGGCTTTGCTCAGTGCTACCTGTTCGACGCGCAGGACATCGTGACGTTCGGCGTCACCTATCTTGAGAAGCACTTCGGAGCCACTCCGATCGTGCCAGCACACGAAGCCGCCCAGCGCTCTTGCGAGCCTTCCGGTTAG	
7877	CARD	prokka_05262	contig_73	2439	66	173	773	1	127	AAC(6')-Ib-cr6	3005116.0	407.142	300.0	Strict	98.99	100.0	AAC(6')-Ib-cr	protein homolog model	antibiotic inactivation		fluoroquinolone antibiotic; aminoglycoside antibiotic	MSNAKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERTRSDA	ATGAGCAACGCAAAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGACGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCATATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	
7877	CARD	prokka_05264	contig_73	2439	66	1871	2420	1	95	catB3	3002676.0	308.145	350.0	Strict	100.0	86.67	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIGSFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIGSEAMVMPGIKIGHGAVIGSRSLVTKDVGHCCKVSDEAAFCLIQRPYISKTLLTRRISPRGSP	ATGACCAACTACTTTGATAGCCCCTTCAAAGGCAAGCTGCTTTCTGAGCAAGTGAAGAACCCCAATATCAAAGTTGGGCGGTACAGCTATTACTCTGGCTACTATCATGGGCACTCATTCGATGACTGCGCACGGTATCTGTTTCCGGACCGTGATGACGTTGATAAGTTGATCATCGGTAGTTTCTGCTCTATCGGGAGTGGGGCTTCCTTTATCATGGCTGGCAATCAGGGGCATCGGTACGACTGGGCATCATCTTTCCCGTTCTTTTATATGCAGGAAGAACCTGCATTCTCAAGCGCACTCGATGCCTTCCAAAAAGCAGGTAATACTGTCATTGGCAATGACGTTTGGATCGGCTCTGAGGCAATGGTCATGCCCGGAATCAAGATCGGGCACGGTGCGGTGATAGGCAGCCGCTCGTTGGTGACAAAAGATGTGGGGCACTGTTGCAAAGTTAGCGATGAGGCAGCCTTTTGTCTTATTCAAAGGCCTTACATTTCAAAAACTCTGCTTACCAGGCGCATTTCGCCCAGGGGATCACCATAA	loose hit with at least 95 percent identity pushed strict
7877	CARD	prokka_01200	contig_3	355316	91	209240	211007	1	113	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	595.89	500.0	Strict	52.37	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTGCTGGCGCTGGCTTTTCTGCTGGGTCGCGTCGCCTGGCTACAGGTGATCAGCCCCGATATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTGTCCACCGCGCGCGGGATGATTACCGATCGCTCCGGACGTCCGCTGGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGACCCGAAAGAGCTCCATGACGCCGGCGGGGTTACCCTGGATACACGCTGGAAGGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGGTTTATCTATCTGGCGCGTCAGGTTAACCCTGACATGGCCGATTACATCAAGAAGCTGAAGCTGCCGGGCATTCATCTGCGCGAAGAATCCCGTCGGTACTACCCTTCCGGGGAAGTAACCGCTCACCTCATCGGCTTTACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAGAAAAGCTTTGATAAATGGCTTACCGGCCAGCCGGGCGAGCGTATCGTACGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCTACCGATAGCCAGGCAGCGCACAACCTGGCGCTGAGTATCGACGAACGCCTGCAGGCGCTGGTCTATCGCGAGCTAAACAACGCCGTGGCCTTTAACAAAGCCGAGTCGGGCAGCGCCGTGTTAGTGGATGTTAACACCGGTGAAGTGCTGGCGATGGCCAACAGCCCATCCTATAACCCGAACAACTTCGCCGGTACGGCAAAAGACACTATGCGTAACCGTGCGATTACCGACGTGTTTGAGCCGGGTTCGACGGTGAAACCGATGGTGGTCATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTATGGGCTAATGGTAACCCCGTTACAGTTAGCGCGTGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCGTTGTCGATTACCAAGGTTGATCCTCCGGTTCCGGGCGAGCGCGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGTGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTATATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
7877	CARD	prokka_01675	contig_5	292385	93	55348	57607	-1	98	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1470.29	1400.0	Strict	94.41	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAELLLSELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTTLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVRMRAVWSKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQSELEKERDQLQAILASERKMNNLLKKELQADADAFGDDRRSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAQGLSYKAGDSWKASAKGKSNQPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALITLPDNAHVMPPLVIEDESDMLLAITAAGRMLMFPVSDLPQLSKGKGNKIISIPAAEAAAGQDGLAHLFVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGSLMRGLQKIDRVEIDSPRRAAAGDSEE	ATGAGCGATATGGCAGAGCGCCTTGCGCTGCATGAATTTACGGAAAATGCTTACCTGAACTACTCCATGTACGTGATCATGGACAGGGCATTACCGTTTATTGGCGATGGCTTAAAACCGGTCCAGCGTCGCATCGTCTATGCGATGTCCGAGCTGGGGCTGAACGCCAGCGCGAAATTCAAAAAGTCCGCCCGCACTGTCGGCGACGTGTTGGGTAAATATCACCCGCACGGCGACATCGCCTGCTATGAAGCGATGGTGCTGATGGCGCAGCCGTTCTCTTACCGCTATCCGCTGGTGGATGGTCAGGGAAACTGGGGGGCGCCGGACGATCCCAAATCTTTCGCCGCCATGCGTTACACCGAATCCCGCCTGTCGAAGTATGCCGAGCTGCTGCTCAGCGAGCTGGGGCAGGGGACGGTCGACTGGGTGCCAAACTTTGACGGCACGCTGCAGGAGCCGAAAATGCTGCCAGCGCGTTTGCCGAACATCCTGCTGAACGGCACCACCGGCATCGCGGTAGGCATGGCGACCGATATTCCTCCGCACAACCTGCGGGAAGTGGCCAAAGCGGCGATTACGCTGATTGAGCAGCCGAAAACCACTCTCGACGAACTGCTGGATATCGTACAGGGGCCGGATTTCCCGACCGAGGCGGAGATCATCACCTCGCGGGCGGAAATTCGCAAAATCTACCAGAACGGGCGCGGCTCAGTGCGCATGCGCGCGGTGTGGAGTAAAGAGGACGGCGCGGTGGTGATCAGCGCGCTGCCGCATCAGGTCTCCGGCGCCAAAGTGCTGGAGCAGATTGCGGCGCAGATGCGCAATAAAAAGCTGCCGATGGTTGACGATCTGCGCGACGAATCGGACCACGAAAACCCGACCCGTCTGGTAATTGTCCCGCGCTCCAACCGGGTGGACATGGAACAGGTGATGAACCACCTGTTCGCCACCACCGATCTGGAGAAGAGCTACCGCATCAACCTCAATATGATCGGCCTTGACGGCCGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCAGCGAGTGGCTGGTGTTCCGTCGCGATACCGTGCGTCGCCGTCTAAACCATCGGTTAGAGAAAGTGCTGAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTTCTTAATATCGATGAAGTGATTGAGATCATCCGCACTGAAGATGAACCGAAGCCGGCCTTGATGTCGCGCTTTGGCATCAGCGAAACCCAGGCGGAGGCGATTCTGGAATTAAAACTGCGCCACCTCGCCAAACTGGAAGAGATGAAGATCCGCGGCGAGCAGAGCGAGCTGGAAAAAGAGCGCGACCAGCTGCAGGCGATTCTGGCGTCTGAACGTAAGATGAACAACCTGCTGAAAAAAGAGCTGCAGGCCGATGCCGATGCCTTCGGCGACGACCGTCGCTCGCCGCTTCACGAGCGTGAAGAAGCGAAAGCGATGAGCGAGCATGACATGCTGCCGTCTGAGCCGGTGACTATCGTTCTGTCGCAGATGGGCTGGGTGCGCAGCGCCAAAGGACACGACATTGACGCCCAGGGCTTGAGCTATAAGGCGGGCGACAGCTGGAAAGCCTCGGCGAAGGGCAAGAGCAACCAGCCGGTGGTGTTTATCGATACCACCGGACGCAGCTATGCCATCGATCCGATTACTCTGCCTTCCGCGCGTGGCCAGGGTGAACCGCTTACCGGCAAACTGACCCTGCCGCCGGGCGCGACCGTGGAGCATATGCTAATGGAAAGCGACGATCAGAAACTGCTGATGGCTTCCGACGCGGGCTACGGTTTCGTCTGTACCTTCAACGATCTGGTGGCGCGCAACCGTGCCGGGAAAGCGCTAATCACCCTGCCTGACAACGCGCACGTGATGCCGCCGCTGGTGATTGAGGATGAGTCCGATATGCTGCTGGCCATCACCGCCGCCGGGCGGATGCTGATGTTCCCGGTCAGCGATCTGCCGCAGCTGTCGAAAGGCAAGGGCAACAAAATTATCAGCATTCCGGCGGCGGAAGCCGCAGCCGGCCAGGACGGTCTGGCACATCTGTTTGTTCTGCCGCCGCAGAGTACGCTGACCATTCACGTCGGCAAACGGAAGATCAAACTGCGTCCGGAAGAGCTGCAAAAAGTCACCGGCGAGCGCGGCCGCCGCGGTTCGCTGATGCGCGGGCTGCAGAAAATTGACCGCGTGGAAATTGACTCGCCGCGTCGTGCCGCGGCAGGCGATAGCGAAGAGTAA	
7877	CARD	prokka_02025	contig_6	283880	85	118483	121117	1	105	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1642.48	1500.0	Strict	92.23	100.23	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMATNIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATGVRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERNGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTCAACATTGAGGAAGAGCTTAAGAACTCTTATCTGGATTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGATGTCCGAGATGGCCTGAAGCCGGTACACCGTCGCGTACTTTACGCCATGAACGTATTGGGCAATGACTGGAACAAAGCCTATAAAAAATCAGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCACCCGCACGGCGACATCGCGGTATACGACACCATCGTGCGTATGGCGCAGCCGTTCTCGCTGCGTTACATGCTGGTGGACGGCCAGGGTAACTTTGGTTCCATCGACGGCGACTCCGCCGCGGCGATGCGTTATACCGAAATTCGTCTGGCGAAAATCGCTCATGAGCTGATGGCCGATCTTGAAAAAGAGACGGTCGATTTCGTCGACAACTATGACGGTACGGAGCGTATTCCGGACGTCATGCCGACCAAAATTCCTAACCTGCTGGTGAACGGCGCCTCCGGGATCGCCGTAGGGATGGCCACCAACATACCGCCGCATAACCTGACGGAAGTGATTAACGGCTGTCTGGCGTATGTTGACGATGAAGACATCAGCATTGAAGGGCTGATGGCGCATATTCCTGGCCCTGATTTCCCGACCGCCGCCATTATCAATGGCCGTCGCGGCATCGAAGAGGCCTACCGCACCGGTCGCGGTAAAGTGTACATTCGCGCGCGCGCGGAAGTGGAAGTGGACGCGAAATCCGGCCGCGAAACCATCATCGTGCACGAAATTCCGTATCAGGTGAACAAAGCGCGCCTGATCGAGAAAATCGCCGAGCTGGTCAAAGAAAAACGCGTGGAAGGCATCAGCGCGCTGCGTGACGAGTCTGATAAAGACGGGATGCGCATCGTGATTGAAGTGAAGCGCGATGCGGTAGGGGAAGTGGTGCTTAACAACCTCTATTCCCAGACCCAGCTGCAGGTCTCCTTCGGCATCAACATGGTAGCTCTGCACCATGGTCAGCCGAAGATCATGAACCTGAAGGACATTATCGCCGCGTTTGTACGCCACCGCCGTGAAGTGGTGACCCGTCGTACGATTTTCGAACTGCGCAAAGCGCGCGACCGGGCGCATATCCTCGAAGCGCTGGCCGTTGCGCTGGCCAATATCGACCCGATTATCGAACTGATCCGTCGCGCGCCGACCCCGGCAGAAGCGAAAACGGCGCTGGTTGCCCAGGCGTGGGATCTCGGTAACGTTGCGGCGATGCTGGAGCGCGCCGGGGATGACGCCGCGCGTCCGGAATGGCTGGAGCCAGAGTTCGGCGTGCGCGACGGTAAATACTACCTGACCGAGCAGCAGGCTCAGGCGATTCTGGATCTGCGTCTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAATATAAAGAGCTGCTGGAGCAGATCGCAGAGCTGCTGCACATTCTCGGCAGCGCCGACCGTCTGATGGAAGTGATTCGCGAAGAGCTGGAGCTGATCCGCGACCAGTTCGGCGACGAACGTCGTACCGAAATCACCGCCAACAGCGCTGATATTAACATCGAAGATCTGATCAACCAGGAAGATGTGGTGGTCACCCTGTCGCATCAGGGGTATGTGAAGTATCAGCCGCTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGCAAATCGGCAGCGCGCATTAAAGAAGAAGACTTTATCGACCGCCTGCTGGTGGCTAACACCCATGACACCATCCTCTGCTTCTCAAGCCGCGGCCGTCTGTACTGGATGAAGGTCTATCAGCTGCCGGAAGCCAGCCGCGGCGCGCGCGGTCGGCCGATCGTCAACCTGCTGCCGCTGGAAGCCGATGAGCGCATCACCGCCATCCTGCCGGTCCGCGAGTACGAAGAGGGCGTCAACGTCTTTATGGCGACCGCCAGCGGTACCGTGAAGAAAACCGCGCTGACCGAGTTCAGCCGTCCGCGTTCCGCCGGTATCATCGCGGTCAACCTGAACGAAGGCGATGAGCTGATCGGCGTCGATCTGACCTCTGGTCAGGATGAAGTGATGCTGTTCTCCGCGGCCGGTAAGGTTGTACGCTTCAAGGAAGACGCCGTTCGCGCCATGGGCCGTACCGCCACCGGCGTACGCGGTATTAAGCTTGCGGAAAACGACAGCGTCGTCTCGCTGATTATTCCACGCGGCGAAGGCGCGATCCTGACGGTGACGCAAAACGGTTACGGTAAACGTACCGCGGCGGCGGAGTATCCGACCAAGTCGCGTGCCACCCAGGGCGTTATTTCGATCAAAGTCACCGAGCGTAACGGTTCCGTGGTCGGCGCCGTGCAGGTGGATGACTGCGATCAGATCATGATGATCACCGACGCCGGGACGCTGGTGCGTACCCGCGTTTCCGAAGTGAGCATCGTGGGCCGTAACACCCAGGGCGTGATCCTCATCCGCACCGCGGAAGATGAAAACGTGGTGGGTCTGCAGCGCGTGGCTGAGCCGGTGGATGATGAAGAGCTGGATGCCATCGACGGTAGCGCGGCGGAAGGCGATGACGATATCGCCCCGGAAGCGGATACCGATGACGACATCGCCGAAGACGAAGAATAA	
7877	CARD	prokka_03818	contig_17	101298	95	10422	11814	-1	104	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	864.7589999999999	850.0	Strict	95.25	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAIGCICLMAIVAIFEERKIRREKKNRILQTA	ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACCATGTACCTGATCCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGCTGAGCATGACCCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAGACGCTGGTCTCTTATTATGCCGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCTACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACTTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTTGGCTTTATCGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCTAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAGGTCGGCGCGCTGGTCGGCACGCTGCTGTGGGGCTGGTTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACCCTCGGGGTTTACCAACACGCCAGCAACCAGTACGTCTATCTGGCCTCGTTATTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGGATCAAGGGCACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAACTGGGTCTCGGGATGATCGCCGACGGCACCCCGGTCTTCGGCCTGACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCATCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTTGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACCGCCTGA	
7877	CARD	prokka_03206	contig_12	182054	75	83950	84385	-1	80	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	253.447	210.0	Strict	84.03	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIERLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP	ATGAAAAGTACCAGCGACCTGTTTAATGAAATGATCCCGCTGGGTCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTACCTCTCACCTATGGATATTACCGCGACCCAGTTTCGCGTGCTCTGCTCCATTCGTTGCGAAGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGACCCGGGCGCGATGACGCGCATGCTCGACCGCCTGGCGTGCAAAGGCTGGATTGAACGGTTACCCAACCCCGCTGACAAGCGCGGCGTGCTGGTGCAGTTGACGCCGGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACGAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTGCTCAAGAAGGTCCTGCCGTAA	
7845	BLDB	prokka_04412	contig_24	74567	118	55752	56898	1	112	CMH-19		486.3		Perfect	100.0	99.74	Enterobacter sp. 50793107	protein homolog model			Beta-Lactam	MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDNVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEESHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPPSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDVKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILETLQ	ATGATGAAAAAATCCCTAAGCTGCGCCCTGCTGCTCAGCGTTGCTTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGTATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAACTGGGCTCCGTCAGTAAAACCTTTACTGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCTCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATAATGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGTCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTTCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCCGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGTCAAAACCGTGGTGGATGGCAGCGACAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATTCTCGAGACGCTACAGTAA	
7845	BLDB	prokka_04740	contig_32	30305	191	9280	10111	1	79	OXA-1		238.9		Perfect	100.0	99.64	oxacillin-hydrolyzing class D beta-lactamase OXA-1	protein homolog model			Beta-Lactam	MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL	ATGAAAAACACAATACATATCAACTTCGCTATTTTTTTAATAATTGCAAATATTATCTACAGCAGCGCCAGTGCATCAACAGATATCTCTACTGTTGCATCTCCATTATTTGAAGGAACTGAAGGTTGTTTTTTACTTTACGATGCATCCACAAACGCTGAAATTGCTCAATTCAATAAAGCAAAGTGTGCAACGCAAATGGCACCAGATTCAACTTTCAAGATCGCATTATCACTTATGGCATTTGATGCGGAAATAATAGATCAGAAAACCATATTCAAATGGGATAAAACCCCCAAAGGAATGGAGATCTGGAACAGCAATCATACACCAAAGACGTGGATGCAATTTTCTGTTGTTTGGGTTTCGCAAGAAATAACCCAAAAAATTGGATTAAATAAAATCAAGAATTATCTCAAAGATTTTGATTATGGAAATCAAGACTTCTCTGGAGATAAAGAAAGAAACAACGGATTAACAGAAGCATGGCTCGAAAGTAGCTTAAAAATTTCACCAGAAGAACAAATTCAATTCCTGCGTAAAATTATTAATCACAATCTCCCAGTTAAAAACTCAGCCATAGAAAACACCATAGAGAACATGTATCTACAAGATCTGGATAATAGTACAAAACTGTATGGGAAAACTGGTGCAGGATTCACAGCAAATAGAACCTTACAAAACGGATGGTTTGAAGGGTTTATTATAAGCAAATCAGGACATAAATATGTTTTTGTGTCCGCACTTACAGGAAACTTGGGGTCGAATTTAACATCAAGCATAAAAGCCAAGAAAAATGCGATCACCATTCTAAACACACTAAATTTATAA	
7845	BLDB	prokka_04761	contig_32	30305	191	26306	27446	-1	186	DHA-1		580.1		Perfect	100.0	99.74	class C beta-lactamase DHA-1	protein homolog model			Beta-Lactam	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA	
7845	CARD	prokka_00113	contig_1	683717	109	120367	120760	1	106	Klebsiella pneumoniae KpnE	3004580.0	199.519	150.0	Strict	85.0	108.33	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MDYILKQEKNMFYWILLALAILAEITGTLSMKWASVSDGNTGFILMLVMISLSYIFLSFAVKKIALGVAYALWEGIGILLITLFSVLLFDETLSTMKIAGLTTLVVGIVLIKSGTRKPTKPQKEQTHAAV	ATGGATTATATTCTCAAGCAGGAGAAAAACATGTTTTACTGGATTTTATTAGCCCTGGCTATTCTCGCTGAAATTACCGGCACGCTGTCTATGAAATGGGCAAGCGTCAGCGATGGCAATACCGGTTTTATTTTAATGCTGGTGATGATTTCGCTTTCCTATATTTTCCTCTCGTTTGCGGTGAAGAAAATCGCGCTGGGAGTGGCTTATGCCCTCTGGGAAGGTATCGGTATTTTGTTGATTACGCTGTTCAGCGTTTTGTTATTTGACGAAACCTTATCAACAATGAAGATCGCCGGATTGACGACGCTGGTAGTCGGGATTGTGCTGATTAAATCGGGTACACGTAAACCGACAAAACCGCAGAAGGAGCAGACCCATGCAGCAGTTTGA	
7845	CARD	prokka_00114	contig_1	683717	109	120746	121076	1	105	Klebsiella pneumoniae KpnF	3004583.0	191.815	150.0	Strict	87.16	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLGFAIVLEILANVFLKFSDGFRRKVYGLMSIAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWVLFGQRLNNKGWIGLVLLLAGMIMIKLA	ATGCAGCAGTTTGAATGGATCCACGCGGCCTGGTTGGGGTTCGCCATTGTTCTGGAAATTCTGGCGAACGTGTTTCTGAAATTCTCTGATGGTTTTCGCCGTAAAGTTTACGGTCTGATGTCGATTGCCGCTGTGCTGGGGGCGTTTAGCGCCCTGTCTCAGGCGGTCAAAGGTATCGATCTGTCTGTAGCCTATGCCCTGTGGGGCGGGTTTGGTATTGCCGCGACCCTGGCAGCAGGGTGGGTGCTCTTCGGCCAACGGTTAAATAATAAAGGCTGGATCGGCCTGGTATTGCTGCTGGCCGGTATGATTATGATAAAACTCGCCTGA	
7845	CARD	prokka_00233	contig_1	683717	109	245349	248502	-1	97	oqxB	3003923.0	2072.74	2000.0	Strict	97.71	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVSQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPKESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELSTRFPEDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSVLYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAPKDLPTRLIDRLFGWIFRPFNRFFHRSSNGYQGLVGKTLGRRGAVFVVYVLLLCAAGVMFKAVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRAGLGYGALQNAVNTMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRDSVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSTQAMTQLEGMSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKFVTRGKVEREVLPA	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATCTTCGCCGCGGTGTTGTCGATACTGATTTTTATCACAGGATTAATCGCCATCCCGCTGTTGCCGGTGAGCGAATACCCTGACGTTGTGCCGCCAAGCGTGCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAGGTGATTGCAGAGACCGTGGCGACGCCGCTGGAAGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAGTCTGTCGCCGGCTCCGACGGCGTACTGGTGACCACCGTCACGTTCCGCCCAGGAACCGACCCGGATCAGGCCCAGGTTCAGGTACAAAACCGCGTGTCACAGGCCGAAGCGCGCCTGCCGGAAGACGTTCGCCGTCTGGGTATCACCACCCAGAAGCAGTCGCCGACACTGACGCTGGTGGTGCATCTGTTTTCGCCCGGCGGTAAGTACGATTCACTCTATATGCGTAACTACGCCACGCTGAAAGTGAAGGATGAACTGGCGCGTCTGCCCGGCGTCGGCCAAATCCAGATTTTTGGCTCGGGCGAATACGCGATGCGCGTCTGGCTGGATCCGAATAAGGTGGCGGCACGCGGCCTGACCGCCTCGGACGTGGTAACGGCAATGCAGGAACAAAACGTGCAGGTGTCCGCCGGACAGCTGGGCGCCGAGCCGCTGCCGAAAGAGAGCGATTTCCTGATCTCCATTAACGCGCAGGGTCGTCTGCATACTGAAGAAGAGTTTGGCAATATTATCCTGAAAACCGCGCAGGACGGCTCGCTGGTGCGCCTGCGCGATGTGGCGCGCATTGAAATGGGCTCCGGCAGCTATGCGCTGCGTTCGCAGCTCAACAATAAAGACGCGGTCGGGATTGGTATCTTCCAGTCGCCGGGAGCGAACGCCATCGATCTGTCTAACGCGGTGCGCGCTAAAATGGCAGAACTGTCTACCCGTTTCCCGGAAGACATGAAATGGGCGGCACCGTACGATCCGACGGTATTCGTGCGTGACTCCATTCGCGCGGTCGTGCAGACGCTGCTGGAAGCGGTGGTGCTGGTTGTACTGGTGGTCATTCTGTTCCTGCAAACCTGGCGTGCGTCGATCATTCCGCTGATCGCGGTGCCGGTCTCGGTGGTGGGCACGTTCAGCGTTCTTTATCTGCTGGGCTTTTCGCTTAACACCCTGAGTTTGTTCGGGCTGGTGCTGGCGATCGGTATCGTCGTGGACGATGCCATTGTGGTGGTGGAAAACGTCGAGCGAAACATCGAAGAGGGGCTGGCTCCGCTGGCGGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCCATTATCGCGATTGCGCTGGTTCTGTGCGCGGTGTTCGTGCCGATGGCGTTTCTTTCGGGGGTTACGGGTCAGTTCTACAAGCAGTTTGCGGTGACGATTGCGATATCAACGGTGATCTCCGCCATTAACTCGCTGACGCTTTCGCCTGCGCTGGCCGCCCTGCTCCTGAAGCCGCACGGCGCGCCGAAAGACCTCCCTACCCGGCTTATCGATCGCCTGTTCGGCTGGATTTTCCGTCCGTTTAACCGCTTCTTCCACCGTAGCTCGAACGGTTATCAGGGGCTGGTGGGCAAAACGCTCGGACGACGCGGTGCGGTGTTTGTGGTCTATGTGCTGCTGCTCTGTGCCGCAGGCGTGATGTTTAAAGCCGTACCCGGCGGGTTTATTCCCACTCAGGATAAGCTGTACCTGATTGGCGGCGTGAAAATGCCGGAAGGCTCATCGCTGGCACGTACCGATGCGGTGATCCGCAAAATGAGCGAAATCGGTATGAACACCGAGGGCGTGGATTATGCGGTCGCCTTCCCGGGGCTGAATGCGCTGCAGTTCACCAATACGCCGAATACCGGGACGGTCTTCTTTGGCCTGAAACCGTTTGACCAGCGTAAACACACGGCGGCGGAAATTAACGCCGAGATCAATGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCCATTCTGCCGCCGCCTATTCTGGGGCTGGGTCAGGGGTCGGGTTACTCGCTGTACATCCAGGATCGGGCCGGTCTGGGATACGGTGCGTTGCAAAATGCGGTGAACACCATGTCGGGCGCAATTATGCAGACGCCGGGAATGCACTTCCCTATCTCCACCTACCAGGCGAACGTTCCGCAGCTGGATGTGCAGGTCGACAGGGATAAGGCCAAAGCCCAGGGCGTGTCGCTGACCGATCTGTTCGGGACGCTGCAAACCTATCTGGGATCGTCTTATGTGAATGACTTTAACCAGTTCGGGCGCACCTGGCGCGTGATGGCGCAGGCCGACGGGCCGTATCGCGACAGCGTGGAAGATATTGCGAATCTGCGCACCCGTAATAACCAGGGTGAGATGGTGCCGATTGGCAGTATGGTCAATATCAGTACCACTTACGGGCCCGATCCGGTGATCCGCTACAACGGCTATCCGGCGGCGGACCTGATTGGCGATGCCGACCCGCGCGTCCTCTCCTCTACCCAGGCAATGACGCAACTGGAGGGGATGTCTAAGCAGATCCTGCCGAACGGGATGAATATCGAGTGGACGGATCTGAGCTTCCAGCAGGCCACTCAGGGGAACACGGCGTTAATCGTCTTCCCGGTCGCGGTTCTGCTGGCGTTCCTGGTCCTGGCGGCACTGTACGAAAGCTGGACGCTGCCGCTGGCGGTGATCCTTATCGTGCCGATGACGATGCTCTCTGCCCTGTTTGGCGTCTGGCTGACCGGCGGTGATAACAACGTGTTCGTGCAGGTGGGGCTGGTAGTATTGATGGGGCTGGCGTGTAAAAACGCGATTCTTATCGTGGAGTTCGCCCGCGAGCTGGAAATCCAGGGCAAAGGTATAATGGAAGCGGCGCTCGAAGCGTGCCGCCTGCGTTTACGCCCGATTGTGATGACCTCCATCGCCTTTATCGCCGGGACCATCCCGCTCATCCTCGGCCACGGTGCGGGTGCAGAAGTGCGCGGCGTCACCGGGATCACCGTATTCTCCGGTATGCTGGGCGTAACGCTGTTTGGCCTGTTCCTGACGCCGGTGTTTTACGTGACGCTGCGTAAATTTGTCACGCGCGGCAAAGTGGAAAGAGAGGTCTTGCCCGCGTAA	
7845	CARD	prokka_00234	contig_1	683717	109	248525	249701	-1	101	oqxA	3003922.0	691.034	670.0	Strict	91.3	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGNFHLNALGAVLLSALLVGCDEGVAQNAAPQAPTVSAADVVVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRATLEQAQAALARAKTQASLAQSEANRTDKLVNTHLVSREEWEQRRAAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDSASVLTTLVSQKTVYVYFDVDESTYLHYQKLALSGQGAASNHQALPVEIGLVGEDGYPHQGKVDFLDNQLTPSTGTIRMRALLDNTQRQFTPGLFARVRLPGSAEFQATLIDDKAVLTDQDRKYVYVVDKESKAQRRDITPGRLADGLRIVQQGLKPGDKVIVDGLQKVFMPGMPVNAKTVAMTTRAALN	ATGAGCCTGCAAAAAACCTGGGGTAATTTTCATCTGAACGCGTTGGGCGCGGTGTTACTCTCCGCCCTGCTCGTCGGGTGTGACGAGGGTGTCGCGCAAAATGCCGCGCCACAAGCGCCCACCGTCAGCGCCGCTGACGTGGTCGTCAAATCCATTAGCCAGTGGGATAGCTTTAATGGCCGGATCGAAGCGGTGGAAAGCGTACAGCTCCGCCCTCGCGTCTCCGGCTACATTGATAAAGTGAATTACACCGACGGTCAGGAGGTCAAAAAAGGCCAGGTATTGTTCACGATCGATGACAGAACCTATCGCGCCACGCTGGAACAGGCGCAGGCAGCGCTGGCAAGAGCCAAAACGCAGGCCAGTCTGGCGCAAAGCGAGGCAAACCGTACCGATAAACTGGTCAATACCCATCTGGTCTCACGTGAAGAGTGGGAGCAGCGCCGCGCTGCTGCCGTCCAGGCCCAGGCCGACATTCGCGCCGCACAGGCGGCGGTGGATGCCGCGCAACTGAACCTGGATTTCACTAAAGTGACCGCCCCTATCGACGGGCGCGCCAGCCGCGCGTTGATCACCAGCGGGAACCTCGTTACCGCCGGTGATAGCGCCAGCGTGCTCACCACGCTGGTTTCGCAGAAGACGGTTTACGTCTACTTTGACGTGGATGAGTCAACCTACCTTCACTATCAAAAACTCGCCCTCAGCGGGCAAGGTGCCGCCAGCAATCACCAGGCGCTACCGGTTGAGATTGGGCTGGTGGGCGAAGACGGCTATCCCCATCAGGGCAAAGTCGATTTTCTTGATAATCAGTTAACACCCAGTACCGGCACCATCCGCATGCGCGCGCTGCTGGATAACACACAGCGTCAGTTCACGCCGGGACTGTTTGCCCGCGTCCGCCTGCCGGGCAGCGCGGAGTTCCAGGCCACGCTAATTGACGACAAAGCGGTGCTGACCGATCAGGATCGTAAGTATGTCTATGTCGTTGATAAAGAGAGTAAAGCGCAGCGACGTGATATTACGCCAGGGCGTCTGGCCGACGGTTTACGTATCGTCCAGCAGGGGCTGAAGCCTGGCGATAAAGTCATCGTCGACGGTTTACAAAAAGTGTTTATGCCGGGCATGCCGGTAAACGCGAAAACCGTTGCCATGACCACCCGCGCCGCCCTTAACTGA	
7845	CARD	prokka_00350	contig_1	683717	109	379386	379767	-1	107	marA	3000263.0	245.743	230.0	Strict	93.55	99.21	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITSVPGESRYLYPLKHCS	ATGTCCAGACGCAATACTGACGCTATCACTATTCATAGCATTTTGGACTGGATCGAAGATAACCTGGAATCGCCGCTCTCCCTTGAAAAAGTGTCAGAGCGTTCAGGTTACTCCAAATGGCACCTGCAACGGATGTTTAAAAAAGAGACCGGTCATTCATTAGGTCAATATATTCGCAGCCGCAAGCTGACGGAAATTGCCCAAAAACTGAAAGAAAGTAATGAACCGATCCTTTATCTGGCGGAGCGATACGGGTTTGAATCGCAACAGACCCTGACGCGTACGTTTAAGAACTACTTCGACGTGCCGCCTCATAAGTATCGTATCACCAGCGTGCCGGGTGAATCCCGATACCTTTATCCGCTAAAACATTGTAGTTAA	
7845	CARD	prokka_00533	contig_1	683717	109	568556	570314	-1	139	msbA	3003950.0	1063.91	1000.0	Strict	87.09	100.52	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MQTDKDLSTWLTFRRLWPIISPFKKGLLVAALALMINAACDPFMLSLLKPLMDDGVGKMDRSVMLWMPVVVIGLMTLRGITSFISSYCVSWVSGKVVMDVRRKLFRHLMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGTLITVIREGASIIGLFAMMFYYSWQLSIILIVLAPVISVTIRMVSKRFRTISKSMQNTMGQVTASAEQMLKGHKEVLIFGGQDVETKRFDKVSNKMRLQGMKMMSASSIYDPVIQLIASLALAFVLYAASFPSVMATLTAGTISVVFTSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGQRVLERAKAEVAFRNVTFTYPGREAPALRNITLNIPAGKTVALVGRSGSGKSTIASLMTRFYDIDEGEILLDGHDLREYTLQSLRNQVALVSQNVHLFNDTVANNIAYGRTEQYTRDQIENAARMANAMDFINKMDNGLDTIIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQSALEELQKNRTSLVIAHRLSTIEKADEIIVVEDGVIVERGSHAELLTHNGVYAQLHKMQFGASNS	ATGCAAACTGACAAAGACCTTTCCACCTGGCTTACGTTTCGCCGTCTTTGGCCTATAATATCGCCTTTTAAGAAAGGGCTATTGGTTGCGGCATTAGCATTAATGATAAATGCCGCCTGCGATCCTTTTATGCTGTCTTTGCTAAAGCCGTTAATGGATGATGGCGTGGGCAAAATGGACCGCTCTGTCATGTTATGGATGCCGGTTGTGGTTATCGGATTGATGACGCTACGCGGTATTACCAGCTTCATTTCCAGTTATTGTGTCTCCTGGGTCTCGGGCAAAGTGGTGATGGATGTGCGCCGGAAATTGTTCCGCCATTTGATGGGCATGCCTGTGTCGTTTTTTGACAAACAGTCAACCGGGACGTTGCTGTCGCGGATTACCTATGATTCCGAACAAGTCGCATCTTCGTCATCAGGTACGCTGATAACGGTCATCCGTGAGGGCGCGTCAATCATCGGCTTGTTCGCAATGATGTTCTACTATAGCTGGCAGCTCTCAATCATCCTGATTGTACTGGCACCTGTTATATCCGTGACTATTCGTATGGTGTCCAAACGCTTTCGCACTATCAGTAAAAGCATGCAGAATACGATGGGGCAGGTCACGGCGAGTGCTGAGCAGATGCTTAAAGGCCATAAAGAAGTATTAATTTTCGGCGGTCAGGACGTTGAAACAAAACGCTTTGATAAGGTCAGCAATAAGATGCGTTTGCAGGGAATGAAAATGATGTCCGCATCGTCAATCTACGATCCTGTTATTCAGCTTATTGCCTCCCTGGCACTCGCGTTTGTTCTTTATGCTGCCAGCTTCCCGAGTGTTATGGCGACCCTGACGGCGGGAACGATTAGCGTCGTTTTCACATCGATGATTGCATTGATGCGGCCTCTTAAATCCCTGACCAATGTGAACGCACAGTTCCAGCGCGGGATGGCCGCTTGCCAGACGCTGTTCACTATTCTTGATTCCGAACAGGAAAAAGATGAAGGTCAGCGCGTACTTGAACGCGCAAAAGCGGAGGTTGCATTTCGCAATGTGACGTTTACCTATCCGGGACGTGAGGCCCCAGCGCTACGCAATATCACCCTGAACATACCTGCCGGTAAGACCGTTGCCCTTGTCGGACGTTCCGGCTCGGGTAAATCAACCATCGCCAGCCTGATGACGCGATTTTATGATATTGATGAAGGTGAAATTCTGCTGGACGGCCACGACCTGCGAGAATATACCCTTCAGTCGCTTCGTAACCAGGTGGCGCTCGTGTCGCAAAATGTCCACCTGTTCAACGACACGGTTGCCAACAACATCGCCTACGGTCGTACGGAGCAGTACACCCGTGACCAGATCGAGAATGCCGCGCGTATGGCAAATGCGATGGACTTTATCAACAAGATGGATAACGGTCTTGATACCATCATCGGTGAAAACGGGGTACTGCTTTCTGGTGGGCAACGGCAACGTATCGCTATTGCACGCGCACTGTTGCGGGACAGTCCAATACTCATCCTTGATGAAGCAACGTCAGCCCTGGATACGGAATCGGAACGCGCTATACAGTCTGCGCTCGAGGAACTGCAAAAGAACCGTACATCACTGGTGATTGCGCATCGTCTGTCGACTATCGAAAAAGCTGACGAAATCATTGTTGTTGAAGATGGCGTTATCGTTGAACGCGGAAGCCATGCGGAATTGCTGACGCACAATGGGGTGTACGCACAGCTTCACAAAATGCAATTCGGTGCGTCAAACAGTTAA	
7845	CARD	prokka_00634	contig_2	399393	112	1737	4860	1	97	mdtB	3000793.0	1847.4	1800.0	Strict	89.81	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVMPPGATGGPSRLFILRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLSLSLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAMPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETIRTAISNANVNSAKGSLDGPTRAVTLSANDQMQSADEYRQLIIAYQNGAPVRLGDVATVEQGAENSWLGAWANKQQAIVMNVQRQPGANIIETADSIRTMLPQLIESLPKSVTVKVLSDRTTNIRASVTDTQFELMLAIALVVMIIYLFLRNVPATIIPAVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERMFERIIAAYGRVLAKVLNHPWATLGVALGTLALSVMLWIVIPKGFFPIQDNGIIQGTLQAPQSVSFASMAQRQQQVSDIIMKDPAVESLTAYVGVDGTNPSLNSARLQINLKPLDDRDDRVNAVIERLQTAVARVPGIELYLQPIQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLVNKLKALPQLSDVSSDWQDKGLAAYVNVNRDTASRLGITMSDVDNALYNAFGQRLISTIYTQANQYRVVLEHNTDNTPGLAALDSVRLTSKDGGIVPLSAIASVEERYTPLSINHLDQFPSTTISFNVPDNYSLGEAVEAILGAEKELNFPSDIQTQFQGSTLAFQAALGNTIWLIVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALMLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPRDAIFQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLLVSQVLTLFTTPVIYLLFDQLALWTKSRFPKREEEA	ATGCAGGTCATGCCGCCAGGCGCAACAGGTGGGCCATCACGCCTGTTTATTCTGCGCCCTGTTGCCACCACGCTGCTGATGGTGGCGATCCTGCTCGCCGGGATTATTGGCTATCGCTTCCTGCCCGTCTCGGCGCTGCCGGAAGTGGATTACCCCACCATTCAGGTCGTTACCCTCTATCCTGGCGCCAGCCCGGATGTGGTGACCTCCGCCATTACCGCTCCGCTGGAACGCCAGTTTGGTCAGATGTCGGGCCTGAAACAGATGTCATCGCAAAGCTCCGGTGGGGCGTCGGTGGTAACGCTGCAGTTCCAGCTCTCGCTGTCGCTGGACGTGGCCGAGCAGGAGGTGCAGGCTGCGATCAACGCCGCCACCAACCTGCTGCCGTCAGACCTGCCTAACCCGCCGGTCTACAGCAAAGTAAACCCGGCGGATCCGCCGATCATGACCCTTGCTGTCACCTCTTCCGCCATGCCAATGACGCAGGTGGAAGACATGGTCGAAACCCGCGTGGCGCAGAAAATTTCCCAGGTCTCCGGCGTCGGGCTGGTAACGCTGGCGGGCGGACAACGCCCGGCGGTGCGCGTGAAGCTTAATGCGCAGGCCATCGCTGCGCTGGGGCTGACCAGCGAAACCATCCGCACCGCCATCAGCAACGCCAACGTCAACTCGGCGAAAGGCTCGCTGGACGGCCCCACCCGCGCCGTGACGCTCTCGGCCAACGATCAGATGCAGTCTGCCGATGAGTACCGTCAGCTGATTATTGCCTACCAGAACGGTGCGCCGGTACGTCTGGGTGACGTCGCCACCGTTGAACAAGGCGCGGAAAACAGCTGGCTGGGTGCGTGGGCCAACAAACAGCAGGCGATTGTGATGAACGTGCAGCGCCAGCCGGGCGCTAACATCATTGAAACCGCCGACAGCATTCGCACCATGCTCCCGCAGCTTATTGAAAGCCTGCCAAAATCGGTCACGGTGAAGGTGCTTTCCGACCGCACCACCAACATTCGCGCGTCGGTTACCGATACCCAGTTTGAGCTGATGCTGGCGATTGCGCTGGTGGTGATGATCATCTATCTGTTCCTGCGCAACGTACCGGCAACCATCATTCCCGCCGTTGCCGTGCCGCTCTCGCTGGTGGGAACATTTGCCGTGATGGTGTTCCTCGATTTTTCGATCAACAACCTGACGCTGATGGCGCTCACCATCGCCACCGGCTTCGTGGTGGATGATGCCATCGTTGTGATCGAGAACATCTCGCGCTATATCGAGAAAGGCGAAAAACCGCTGGCCGCTGCGCTGAAAGGTGCGGGCGAGATCGGATTTACCATTATCTCGCTGACCTTCTCGCTGATTGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGGCGACTGTTCCGCGAGTTTGCCGTCACGCTGGCGGTCGCCATTCTGATCTCTGCCGTGGTGTCGCTGACCCTGACGCCAATGATGTGCGCCCGCATGCTGAGCCATGAATCCCTGCGCAAGCAAAACCGTTTCTCTCGCGCCTCTGAGCGGATGTTCGAACGGATCATTGCCGCTTACGGCCGGGTGCTGGCAAAAGTGCTTAACCACCCGTGGGCGACGCTCGGCGTGGCACTCGGCACGCTGGCACTCAGCGTCATGCTGTGGATCGTTATCCCGAAAGGCTTTTTCCCCATCCAGGACAACGGCATTATTCAGGGCACGCTTCAGGCGCCCCAGTCGGTCTCCTTCGCCAGTATGGCGCAGCGTCAGCAGCAGGTCTCTGACATCATCATGAAAGATCCGGCGGTGGAAAGCCTGACCGCGTACGTGGGCGTCGATGGCACCAACCCGTCGCTGAACAGTGCGCGTCTGCAAATCAACCTCAAGCCGCTGGATGACCGCGACGATCGGGTCAACGCCGTCATTGAGCGGCTGCAAACTGCCGTGGCGCGCGTGCCGGGGATTGAACTTTACCTGCAGCCAATTCAGGATTTGACCATCGATACCCAGGTCAGCCGCACGCAGTACCAGTTCACGCTTCAGGCGACCAGCCTTGATGCGCTGAGCACGTGGGTACCGCAACTGGTCAACAAACTCAAGGCGCTGCCGCAGCTTTCTGACGTCAGCAGCGACTGGCAGGACAAAGGGCTGGCGGCATATGTGAACGTCAATCGCGATACTGCCAGCCGGCTGGGCATCACCATGTCCGACGTGGACAACGCGCTCTATAACGCCTTTGGTCAGCGCCTCATCTCCACCATTTATACCCAGGCGAATCAGTATCGCGTGGTGCTGGAACACAACACCGATAACACGCCCGGCCTGGCCGCGCTGGACTCGGTGCGCCTGACCAGCAAAGACGGTGGTATTGTGCCGTTAAGCGCCATAGCCAGCGTAGAGGAGCGTTATACGCCGCTGTCGATTAACCATCTCGATCAGTTCCCGTCCACCACCATCTCGTTCAACGTACCGGACAACTATTCGCTGGGTGAAGCGGTCGAGGCCATTCTGGGCGCGGAGAAAGAACTCAACTTCCCGTCTGATATTCAGACCCAGTTCCAGGGCAGCACCCTGGCGTTCCAGGCTGCGCTGGGCAATACCATCTGGCTGATCGTGGCTGCGGTGGTGGCGATGTACATCGTCCTCGGGGTGCTGTACGAAAGCTTTATCCACCCAATCACCATCCTCTCCACCCTGCCGACCGCCGGGGTGGGTGCGCTACTGGCCCTGATGCTGGCGGGCAGCGAACTGGACGTCATCGCCATTATCGGCATCATTCTGCTTATCGGGATCGTGAAGAAAAACGCCATCATGATGATCGACTTCGCCCTTGCCGCCGAGCGCGAGCAGGGCATGTCGCCGCGAGACGCCATCTTCCAGGCCTGTCTGTTGCGTTTTCGTCCGATCCTGATGACCACGCTCGCGGCCCTGCTGGGCGCGCTGCCGCTGATGCTCAGCACCGGCGTCGGTGCGGAGCTGCGTCGTCCGCTGGGTATCGGCATGGTCGGCGGCCTGTTGGTGAGCCAGGTGCTGACGCTGTTCACCACGCCGGTGATTTACCTGCTGTTTGACCAACTGGCCCTGTGGACTAAAAGCCGCTTCCCGAAACGTGAAGAGGAGGCGTAA	
7845	CARD	prokka_00635	contig_2	399393	112	4860	7938	1	88	mdtC	3000794.0	1877.83	1800.0	Strict	92.09	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILISLAITLCGVLGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFSFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGQLYDFASTQLAQTISQINGVGDVSVGGSSLPAVRVGLNPQALFNQGVSLDDVRSAISSANVRRPQGAIESNSHRWQIQTNDELKTAAEYQPLIIHYNNGAAVRLSDVASVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIETVNSIRARLPELQKTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVGLVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGVKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLIISLTLTPMMCGWMLKRSKPHSQPRRKGFGRFLLAMQEGYGKSLKWVLNHTRLVGLVLVGTIALNVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDRAVDNVTGFTGGSRVNSGMMFITLKPRGERNETAQQVIDRLRMKLAKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLAALREWEPKIRKALAALPQLADVNSDQQDNGAEMALTYDRETMSRLGINVEAANSLLNNAFGQREISTIYQPMNQYKVVMEVDPRYTQDISALDKMFVINNDGKAIPLSYFASWRPANAPLSVNHQGLSAASTISFNLPTGSSLSEASEAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALELFGAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVISGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKNRTTVTG	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATTTTAATCTCGCTCGCCATTACGCTGTGCGGCGTGCTGGGCTTCCGCCTGCTGCCGGTGGCCCCCCTGCCGCAGGTGGATTTTCCGGTGATCATGGTCAGCGCATCGCTGCCGGGCGCGTCGCCGGAGACCATGGCCTCGTCGGTTGCCACGCCACTGGAACGCTCGCTCGGGCGAATTGCGGGGGTCAACGAGATGACCTCCAGCAGCTCGCTCGGCAGCACGCGCATCATTCTGGAGTTCAGCTTCGACCGGGATATTAACGGTGCGGCGCGCGACGTGCAGGCCGCCATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGAATGCCAAGCCGCCCGACCTACCGTAAAGCCAACCCGTCCGACGCGCCGATCATGATCCTGACGCTGACCTCGGATACCTATTCCCAGGGGCAGCTCTACGACTTTGCGTCGACCCAGTTGGCGCAGACGATCTCACAAATAAACGGCGTGGGTGACGTGAGCGTTGGCGGTAGCTCCCTGCCCGCCGTGCGCGTCGGCCTGAACCCGCAGGCGCTGTTTAACCAGGGCGTGTCGTTGGATGACGTGCGCTCCGCCATCAGCAGCGCCAACGTGCGCAGGCCGCAGGGGGCGATAGAGAGCAACAGCCACCGCTGGCAGATCCAGACCAACGACGAGCTCAAAACCGCCGCCGAATATCAGCCGCTCATCATCCACTACAATAACGGCGCGGCGGTACGTTTAAGCGACGTAGCCAGCGTCACCGACTCGGTGCAGGACGTGCGCAACGCCGGGATGACCAACGCCAAACCGGCCATCTTGCTGATGATCCGCAAGCTGCCGGAAGCCAATATTATTGAAACGGTAAACAGCATTCGCGCGCGTCTGCCGGAGTTACAGAAGACCATTCCGGCCGCTATTGATCTGCAGATTGCCCAGGATCGTTCGCCGACCATTCGCGCCTCGCTTGAAGAGGTGGAACAGACGCTGGTGATCTCCGTCGGGCTGGTGATCCTGGTGGTGTTCCTGTTTCTGCGCTCGGGCCGCGCAACGCTTATTCCCGCCGTTGCGGTACCGGTGTCGCTGATTGGTACCTTCGCCGCCATGTACCTGTGCGGCTTTAGCCTGAACAACCTGTCGCTGATGGCGCTGACCATCGCCACCGGCTTTGTGGTGGATGACGCCATCGTGGTGCTGGAGAATATTTCCCGCCATCTGGAAGCCGGGGTAAAACCGCTGCAGGCCGCCCTGCAGGGCACGCGCGAAGTGGGCTTTACGGTGCTCTCCATGAGCCTGTCGCTGGTGGCGGTCTTCCTGCCGCTGCTGTTGATGGGCGGGCTGCCGGGGCGACTGCTGCGCGAATTTGCCGTCACCCTTTCGGTGGCTATCGGCATCTCGCTGATTATCTCGCTAACGCTCACGCCAATGATGTGCGGCTGGATGCTTAAGCGCAGCAAACCGCACTCGCAGCCGCGTCGTAAAGGGTTTGGCCGTTTCCTGTTGGCAATGCAGGAAGGGTACGGAAAATCACTGAAGTGGGTGCTCAACCACACGCGGCTGGTTGGTCTGGTGCTTGTCGGCACCATCGCGCTCAACGTCTGGCTGTATATCTCCATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGCGTGCTGATGGGCGGCATCCAGGCTGACCAGAGTATTTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGATTTTATGAAGATCATCCGCGAAGACAGGGCGGTGGATAACGTTACCGGCTTTACCGGCGGGTCACGCGTTAACAGCGGGATGATGTTTATCACCCTTAAGCCGCGCGGCGAGCGCAATGAAACGGCGCAGCAGGTGATAGACCGGCTGCGAATGAAGCTCGCCAAAGAGCCAGGCGCCAACCTGTTTTTGATGGCCGTTCAGGATATCCGCGTGGGCGGACGTCAGGCGAACGCCAGCTACCAGTACACCCTGCTCTCTGACGATCTGGCCGCGCTGCGCGAGTGGGAGCCCAAAATCCGTAAAGCGCTGGCCGCCCTGCCGCAGCTGGCGGACGTTAACTCCGATCAGCAGGACAACGGGGCAGAGATGGCGTTGACCTACGATCGTGAAACCATGTCGCGGCTGGGCATTAACGTTGAAGCCGCCAACAGTCTGCTGAACAACGCCTTTGGCCAGCGCGAGATTTCCACCATCTATCAGCCAATGAACCAGTACAAGGTGGTGATGGAAGTGGACCCGCGCTATACCCAGGACATCAGCGCGCTGGATAAAATGTTTGTCATTAACAACGACGGTAAAGCGATCCCGCTCTCTTACTTCGCCAGCTGGCGGCCCGCTAACGCGCCGCTCTCTGTGAACCATCAGGGGTTGTCGGCAGCGTCCACGATCTCCTTTAACCTGCCCACCGGCTCGTCGCTTTCCGAGGCCAGCGAGGCCATCGACCGTGCCATGACCCAGCTCGGCGTGCCCTCGACCGTGCGCGGCAGTTTTGCCGGGACCGCACAGGTCTTCCAGGAGACGATGAATTCGCAGGTGATTTTGATTCTGGCGGCCATTGCCACGGTCTATATCGTGCTTGGCGTGCTGTATGAGAGCTATGTTCATCCGCTGACCATTCTCTCGACGCTGCCGTCGGCAGGCGTGGGGGCGTTGCTGGCGCTGGAGCTGTTTGGCGCGCCCTTTAGCCTCATCGCCTTAATCGGGATCATGCTGTTAATTGGTATTGTGAAGAAAAACGCCATCATGATGGTGGATTTTGCGCTGGAGGCTCAGCGTAACGGCAACCTGACGCCAGAAGAGGCAATTTTCCAGGCCTGCCTGCTGCGTTTTCGTCCGATCATGATGACCACGCTGGCGGCGCTGTTTGGCGCGCTGCCGCTGGTGATCTCCGGTGGCGATGGTTCAGAGCTGCGCCAGCCGCTGGGGATCACTATTGTCGGTGGGCTGGTGATGAGTCAGCTCCTGACGCTCTACACCACGCCGGTGGTCTATCTGTTCTTTGACCGCCTGCGGCTGCGTTTTTCACGTAAAAACAGAACCACGGTGACCGGGTAA	
7845	CARD	prokka_00639	contig_2	399393	112	10749	11472	1	103	baeR	3000828.0	470.315	450.0	Strict	95.83	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPSLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDVPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQVLDAESPLIVDESRFQASWRSKLLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRIA	ATGACCGAATTACCGATTGACGAAAACACGCCACGCATTTTGATTGTGGAAGACGAGCCTAAGCTTGGGCAGTTACTGATCGACTATTTACGTGCGGCCAGCTACGCCCCGTCGCTTATCAGCCATGGCGATCAGGTGTTACCGTACGTGCGCCAGACGCCGCCGGATCTGATCCTGCTGGATCTGATGCTCCCCGGCACCGATGGCCTGACCCTGTGCCGGGAAATTCGTCGCTTCTCCGACGTGCCGATCGTCATGGTGACGGCAAAAATCGAAGAGATCGACCGCCTGCTGGGACTCGAAATTGGCGCGGACGATTACATCTGCAAACCCTACAGCCCGCGTGAAGTGGTCGCCCGCGTGAAAACCATTCTGCGCCGCTGTAAACCGCAGCGCGAGCTTCAGGTGCTGGACGCCGAAAGCCCGCTGATTGTTGATGAGAGCCGCTTCCAGGCCAGCTGGCGCAGCAAGCTTCTCGATCTCACGCCTGCTGAGTTCCGCCTGCTGAAAACCCTTTCCCACGAGCCGGGGAAAGTGTTCTCTCGCGAGCAGCTGCTCAACCACCTGTATGACGATTACCGCGTGGTGACAGACCGCACCATCGACAGCCACATCAAAAACCTGCGCCGTAAGCTGGAGGCGCTCGACGCCGAACAGTCATTTATTCGCGCGGTGTATGGCGTGGGATACCGCTGGGAAGCGGATGCGTGCAGGATTGCATAG	
7845	CARD	prokka_00896	contig_2	399393	112	293528	296642	1	125	acrD	3000491.0	1968.36	1900.0	Strict	91.32	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGVLAITSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATVTLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRINGVGDIDAYGSQYSMRIWLDPNKLNSFQMTATDVTDAIKSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGNPASGLGVKLASGANEMATAQLVLDRLDELSHYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLYAFGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPRQATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGTTGAIYRQFSITIVSAMVLSVLVALILTPALCATLLKPLHKGEQHGQKGFFGWFNRMFNRSAARYETAVGKVLHRSLRWMMIYVVLLGGMVWLFLHLPTSFLPQEDRGMFITSVQLPSGSTQQQTLKVVQKVEQYFFTKEKDNVVSVFSTVGSGPGGNGQNVARMFVRLKDWDARDTKTGTSFAIIERATKAFSRIKEARVFASSPPAISGLGSSAGFDMELQDHAGAGHTALMAARDKLLELAGKDPGLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQSAAPYRMLPDDINRWYVRNNAGGMVPFSAFASSHWESGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDTMEKLVQQLPAGFGLQWTAMSYQERLSGAQAPALYALSLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNAKGHELMASTLHACRQRLRPILMTSLAFVFGVLPMATSSGAGSSSQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKERPE	ATGGCGAATTTTTTTATCGATCGCCCCATTTTTGCCTGGGTACTTGCCATACTGTTGTGTCTGACAGGTGTCCTGGCCATTACTTCACTTCCTGTTGAGCAATATCCCGACCTGGCACCACCAAACGTGCGCGTCACGGCAAATTACCCCGGAGCTTCAGCACAAACGCTGGAAAATACCGTCACGCAGGTTATCGAGCAGAACATGACGGGTCTGGATAACCTGATGTACATGTCCTCGCAGAGTAGCGCCACGGGCCAGGCGACCGTCACCCTGAGCTTTACCGCCGGTACGGATCCGGACGAAGCCGTACAGCAGGTGCAAAACCAGCTGCAGTCGGCGATGCGTAAACTGCCTCAGGCGGTGCAGAATCAGGGGGTTACCGTACGTAAAACCGGTGACACCAACATCCTGACTATTGCGTTTGTCTCTACCGACGGTTCCATGGATAAGCAGGACATTGCGGACTACGTCGCCAGTAATATTCAGGATCCCCTCAGCCGTATTAACGGCGTCGGTGATATCGATGCTTACGGCTCTCAGTATTCAATGCGTATCTGGCTTGATCCGAATAAGCTGAACAGCTTCCAGATGACGGCAACCGACGTGACGGATGCCATTAAATCCCAGAACGCCCAGATTGCGGTGGGACAACTGGGGGGAACGCCCTCCGTCGATAAACAAGCGTTGAATGCCACCATTAACTCACAGTCGCTGCTTCAGACCCCGGAGCAGTTTCGCAACATTACCCTGCGCGTAAATCAGGATGGTTCAGAGGTCCGCCTGGGCGATGTCGCCACAGTAGAAATGGGGGCAGAGAAATATGATTATCTCAGCCGCTTTAACGGTAACCCGGCCTCCGGTCTGGGGGTAAAACTGGCCTCCGGGGCCAATGAAATGGCCACCGCGCAGCTGGTGCTGGATCGTCTGGATGAGCTGTCGCACTATTTTCCCCACGGGCTGGAATATAAAGTCGCCTACGAAACCACCTCCTTCGTTAAAGCCTCTATTGAAGATGTGGTGAAAACGCTGCTGGAAGCGATCGCGCTGGTCTTCCTGGTCATGTACCTGTTCCTGCAAAACTTCCGCGCAACGCTGATCCCGACCATTGCCGTTCCGGTGGTGTTGCTGGGTACCTTCGCGGTGCTTTACGCGTTTGGTTACAGCATTAACACCCTGACGATGTTTGCAATGGTGCTGGCGATTGGCCTGCTGGTGGACGATGCCATCGTGGTGGTCGAAAACGTCGAGCGCATCATGAGCGAGGAAGGGCTTTCCCCCCGTCAGGCCACGCGTAAATCGATGGGACAAATTCAGGGGGCGTTAGTTGGCATCGCGATGGTGCTCTCGGCGGTCTTTATCCCGATGGCGTTTTTCGGCGGCACAACCGGCGCCATTTATCGTCAGTTCTCAATCACCATCGTCTCCGCAATGGTGCTCTCGGTGCTGGTGGCGCTGATCCTCACGCCTGCCCTCTGCGCCACCCTCCTCAAGCCGCTACATAAAGGGGAGCAGCACGGTCAGAAAGGCTTTTTTGGCTGGTTTAACCGCATGTTCAACCGCAGTGCCGCGCGTTATGAAACTGCCGTCGGCAAGGTGCTGCACCGCAGCCTGCGCTGGATGATGATTTATGTTGTGCTGTTGGGCGGTATGGTATGGCTGTTCCTGCATCTGCCGACTTCGTTCCTGCCGCAGGAAGACCGGGGGATGTTCATCACTTCGGTGCAGCTCCCGAGCGGGTCAACGCAGCAGCAAACGCTGAAGGTAGTTCAGAAGGTGGAGCAGTACTTCTTTACCAAAGAGAAAGATAACGTGGTGTCGGTCTTCTCCACCGTCGGCTCCGGCCCGGGCGGGAACGGGCAGAACGTTGCACGTATGTTTGTGCGCCTGAAAGACTGGGACGCACGCGATACGAAAACGGGCACCTCGTTTGCCATTATCGAACGCGCGACCAAAGCCTTCTCCCGTATCAAAGAGGCTCGCGTTTTTGCCAGCAGCCCACCGGCCATCAGCGGTCTCGGCAGTTCTGCCGGGTTTGACATGGAGTTGCAGGACCATGCCGGTGCGGGCCACACGGCGCTGATGGCGGCACGCGACAAGCTGTTAGAGCTGGCCGGTAAAGATCCGGGTCTGACCCGCGTCCGTCACAACGGTCTGGATGACAGCCCGCAGCTGCAGGTGGATATTGATCAGCGTAAGGCGCAGGCGCTGGGCGTTTCCATCGACGATATTAACGACACCCTGCAAACGGCGTGGGGTTCAAGCTATGTGAATGACTTTATGGATCGCGGTCGCGTTAAAAAAGTGTATGTGCAATCCGCCGCGCCATACCGCATGCTGCCGGACGATATTAACCGCTGGTATGTCCGCAACAATGCGGGCGGCATGGTGCCGTTCTCCGCCTTCGCCTCCTCGCACTGGGAGAGCGGTTCTCCGCGTCTGGAGCGCTATAACGGCTATTCCGCCGTTGAGATCGTCGGTGAAGCCGCGCCGGGCGTCAGCACCGGTACGGCGATGGACACCATGGAAAAGCTGGTGCAACAGCTGCCCGCTGGCTTTGGTCTGCAGTGGACGGCCATGTCTTATCAGGAGCGGCTCTCCGGGGCGCAGGCTCCCGCGCTTTACGCGCTTTCGCTGCTGGTGGTCTTCCTCTGTCTTGCGGCGCTGTATGAAAGCTGGTCAGTCCCGTTCTCGGTCATGCTGGTGGTACCGCTTGGCGTGATCGGCGCGCTGCTCGCCACCTGGATGCGCGGTCTGGAGAACGACGTTTACTTTCAGGTGGGGCTGCTCACCGTGATTGGGTTGTCGGCGAAAAACGCCATCCTGATTGTTGAGTTTGCCAATGAGATGAATGCGAAAGGCCATGAACTGATGGCTTCCACGCTGCATGCCTGCCGTCAGCGCTTACGTCCAATCCTGATGACCTCGCTGGCGTTTGTCTTCGGGGTGTTACCGATGGCAACCAGCTCAGGTGCAGGCTCCAGCAGCCAGCATGCGGTAGGTACAGGCGTCATGGGAGGAATGATTTCAGCCACGATCCTGGCCATTTATTTTGTGCCGCTGTTCTTCGTGCTGGTGCGTCGCCGCTTCCCGCTCAAGGAACGGCCTGAATAA	
7845	CARD	prokka_01298	contig_3	341052	113	328795	328981	1	133	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGGGATGAGGTCACCGTGACAGTTTTAGGGGTAAAGGGTAACCAGGTACGTATTGGTGTTAACGCTCCTAAAGAAGTATCTGTCCACCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTGA	
7845	CARD	prokka_01311	contig_3	341052	113	335883	337431	-1	120	emrB	3000074.0	932.939	900.0	Strict	92.87	100.59	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MQQQKPQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTVAFVLASWACGMSSSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSVALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGAVVVLMTLQSLRGRETRTEQRRIDSIGLALLILGIGSLQIMLDRGKELDWFNSQEIIILTIVAVVSLSFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVLLSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNRESMHHAQLTEAVNPYNPNAQQMYSQLQGMGMTEQQASGWIAQQITNQGLIISANEIFWISAGIFIVLLGLVWFARPPFGAGGGGGGAH	ATGCAACAGCAAAAGCCGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATAATGACCATTGCGTTGTCGCTGGCGACATTCATGCAGGTGCTGGACTCCACCATCGCAAACGTGGCGATCCCGACGATCGCCGGGAACCTTGGCTCATCATTGAGCCAGGGAACCTGGGTCATTACCTCGTTCGGGGTGGCAAACGCCATCTCCATTCCGATTACCGGCTGGCTGGCGAAGCGCGTCGGTGAGGTGAAGTTGTTCCTGTGGTCAACAGTGGCGTTTGTGCTGGCCTCCTGGGCGTGCGGGATGTCCAGCAGCCTGACGATGCTGATTTTCTTCCGCGTCATCCAGGGGATTGTCGCCGGGCCGCTGATCCCCCTTTCGCAAAGTTTGCTGCTGAGTAACTACCCGCCTGCAAAACGCTCCGTCGCGCTGGCGCTGTGGTCAATGACCGTGATCGTCGCGCCTATCTGCGGACCGATTCTCGGCGGGTACATCAGCGATAACTACCACTGGGGCTGGATCTTCTTCATCAACGTTCCGATTGGAGCGGTTGTGGTTCTGATGACGCTGCAATCCCTGCGCGGTCGTGAGACCCGTACCGAACAGCGGCGAATCGACAGCATTGGTCTGGCGCTGCTGATCCTCGGTATCGGCAGTCTGCAGATCATGCTCGACCGGGGTAAGGAGCTGGACTGGTTCAACTCGCAGGAGATCATCATCCTGACCATTGTCGCGGTGGTGTCGCTGAGCTTCCTGATTGTCTGGGAGCTGACGGACGACAACCCGATAGTCGATCTCTCGCTGTTTAAGTCGCGAAATTTCACCATCGGCTGTCTGTGTATCAGCCTCGCCTATATGCTCTACTTCGGCGCGATTGTTCTGCTGCCGCAGCTGCTGCAGGAGGTGTATGGCTATACCGCGACCTGGGCGGGTCTGGCCTCTGCGCCTGTTGGGGTGATCCCGGTGCTGCTATCGCCGATCATTGGCCGCTTTGCCCATAAGCTCGACATGCGTCGGCTGGTGACCTTCAGCTTCATTATGTATGCGGTGTGCTTCTACTGGCGTGCGTATACCTTTGAACCGGGGATGGACTTTGGCGCCTCTGCGTGGCCGCAGTTTATTCAGGGCTTCGCGGTAGCGTGCTTCTTTATGCCGCTGACCACCATCACGCTGTCTGGCTTACCGCCTGAGCGTCTGGCGGCCGCGTCGAGCCTGTCGAACTTTACCCGTACATTAGCGGGCTCCATCGGGACATCGATCACCACCACGCTGTGGACAAACCGGGAATCGATGCACCATGCGCAGCTGACCGAAGCGGTAAATCCGTACAACCCGAATGCGCAGCAGATGTATAGCCAGCTTCAGGGGATGGGCATGACGGAACAGCAGGCGTCCGGCTGGATTGCCCAGCAGATCACCAACCAGGGGCTGATTATCTCGGCTAACGAGATTTTCTGGATATCCGCGGGGATCTTCATCGTCCTGCTGGGGCTGGTGTGGTTTGCCAGACCGCCGTTTGGTGCCGGCGGTGGAGGGGGTGGCGCGCACTAG	
7845	CARD	prokka_01312	contig_3	341052	113	337447	338620	-1	100	emrA	3000027.0	677.1669999999998	675.0	Strict	86.67	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MSANAENTTPQQPANKKGKRKSALLLLTLLFIIIAVAYGIYWFLVLRHAEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVQKGDVLVTLDPTDAQQAFEKAQTALASSVRQTRQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGTANLIGREELQHARDAVASAQAQLDVAIQQYNANQAMILGTSLENQPAVQQAATEVRNAWLALQRTKIVSPMTGYVSRRSVQPGAQISPTTPLMAVVPADNLWVDANFKETQLAHMRIGQTATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDPKQLADHPLRIGLSTLVTVDTANRDGQILASQVRSTPAYESNAREISLDPVNKLIDDIVKANAG	ATGAGCGCAAATGCGGAGAACACAACCCCGCAGCAACCGGCCAACAAGAAAGGCAAACGTAAGAGCGCCCTTCTTCTGTTGACCTTGCTCTTTATCATTATTGCCGTGGCATATGGGATCTATTGGTTTTTAGTATTGCGTCATGCAGAAGAGACAGACGACGCATACGTGGCAGGGAATCAGGTACAAATTATGGCGCAGGTGTCGGGCAGCGTGACGAAAGTCTGGGCTGACAATACCGACTTTGTGCAAAAAGGGGATGTGCTGGTCACGCTGGATCCGACCGACGCTCAACAGGCGTTTGAAAAAGCACAGACCGCGCTGGCCTCCAGCGTGCGTCAGACCCGTCAGCTGATGATCAACAGTAAGCAGCTGCAGGCCAACATCGACGTGCAGAAAACCGCACTCGCCCAGGCACAGAGCGACCTGAACCGTCGCGTGCCGCTCGGTACCGCCAATCTGATTGGCCGTGAAGAGCTGCAGCACGCCCGCGATGCCGTTGCCAGCGCCCAGGCGCAGCTGGATGTGGCTATTCAGCAGTACAACGCTAACCAGGCGATGATTCTCGGTACCAGCCTTGAAAACCAGCCTGCGGTACAACAGGCGGCGACCGAAGTGCGTAACGCGTGGCTTGCCCTGCAGCGTACCAAAATCGTCAGCCCGATGACCGGCTACGTCTCCCGTCGTTCCGTACAGCCAGGCGCGCAGATCAGCCCAACCACGCCGCTGATGGCGGTCGTGCCGGCGGACAATCTGTGGGTTGATGCGAACTTCAAAGAGACGCAGCTTGCCCATATGCGTATCGGCCAGACCGCAACTGTTATCAGCGACATTTACGGCGACGACGTGAAGTACACCGGTAAAGTGGTGGGTCTGGATATGGGTACCGGCAGCGCCTTCTCGCTGCTGCCTGCGCAAAACGCCACCGGTAACTGGATCAAAGTGGTGCAGCGTCTGCCTGTGCGTATCGAGCTTGATCCTAAGCAGCTGGCAGACCATCCGCTGCGTATTGGCCTCTCCACGCTGGTGACGGTGGATACCGCTAACCGCGACGGCCAGATCCTGGCAAGCCAGGTACGCAGCACTCCGGCTTATGAAAGTAACGCCCGTGAAATTAGCCTCGATCCGGTCAACAAGCTGATCGATGACATCGTGAAGGCAAACGCCGGTTAA	
7845	CARD	prokka_01313	contig_3	341052	113	338749	339280	-1	100	emrR	3000516.0	338.961	280.0	Strict	91.43	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQGKLLDNRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTDKGHQFLREVLPPQHNCLHKLWSVLSTSERDQLEHITRKLLTRLDQMDEDGAILEALR	ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTTAAATTCCGCGCCAGTCGTCATGAGGACTTCCCGTATCAGGAAATCCTGCTGACCCGCCTGTGCATGCACATGCAGGGGAAACTGCTGGATAATCGTAATAAGATGCTGAAAGCTCAGGGGATTAACGAGACGTTATTTATGGCGTTGATTACGCTGGAGTCTCAGGAAAACCACAGTATTCAGCCGTCTGAGCTGAGCTGCGCGCTGGGTTCGTCCCGTACGAACGCCACCCGTATCGCTGATGAGCTGGAAAAGCGCGGCTGGATTGAACGCCGTGAAAGCGATAACGACCGCCGTTGCCTGCATCTGCAACTGACCGACAAAGGTCACCAATTCCTGCGTGAGGTCCTGCCACCTCAGCACAACTGCCTGCACAAACTCTGGTCTGTCCTCAGCACAAGCGAGCGCGACCAGCTTGAGCACATCACTCGCAAGCTGCTCACCCGTCTGGATCAGATGGATGAAGATGGCGCCATCCTTGAGGCGCTGCGCTAA	
7845	CARD	prokka_01402	contig_4	335301	113	96241	96667	1	100	FosA2	3002804.0	284.648	200.0	Strict	96.45	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLQSLNHLTLAVSDLQKSVTFWHELLGLALHARWNTGAYLTCGDLWVCLSYDEARQYVPPQESDYTHYAFTVAEEDFEPFSHRLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGSLAARLAACREKPYAGMVFTSDGA	ATGCTGCAATCTCTCAACCATCTGACCCTCGCGGTCAGCGACCTGCAAAAAAGCGTTACCTTCTGGCACGAGCTGCTGGGGTTAGCGCTGCATGCCCGCTGGAATACCGGGGCCTATCTCACCTGCGGCGATCTGTGGGTCTGCCTGTCGTACGACGAGGCGCGCCAGTATGTCCCGCCGCAGGAGAGCGACTACACCCACTACGCGTTTACCGTGGCGGAAGAGGATTTTGAACCGTTCTCGCACAGGCTGGAGCAGGCGGGCGTCACCGTCTGGAAGCAGAATAAAAGCGAGGGGGCGTCGTTCTATTTTCTCGACCCGGACGGGCACAAGCTGGAGCTGCACGTGGGCAGCCTCGCCGCGCGGCTGGCGGCGTGTCGCGAGAAGCCCTATGCGGGCATGGTGTTTACCTCAGACGGGGCTTGA	
7845	CARD	prokka_01533	contig_4	335301	113	234001	234481	1	108	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	51.6026	32.0	Strict	27.4	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRTTLNKPVVMGRLTWESIGRPLPGRKNIVISSQPGTDDRVEWVKSVDEAIAACGNAEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSHSYCFEILERR	ATGATCAGTCTGATTGCAGCGCTGGCGGTGGACCGTGTTATCGGTATGGAAAATGCCATGCCGTGGAACCTGCCTGCCGATCTCGCATGGTTTAAACGTACGACGTTAAACAAGCCGGTAGTGATGGGCCGCCTGACCTGGGAGTCGATTGGTCGCCCATTGCCGGGCCGTAAGAATATCGTGATCAGTAGCCAGCCAGGCACTGACGATCGCGTCGAATGGGTGAAATCCGTGGACGAGGCGATTGCCGCGTGCGGTAACGCCGAAGAGATCATGGTGATTGGTGGTGGGCGTGTATATGAGCAGTTCCTGCCAAAAGCGCAAAAGCTCTATCTGACGCATATTGATGCGGAAGTGGAAGGCGATACCCATTTCCCGGACTACGATCCGGACGAGTGGGAATCGGTATTCAGCGAATTTCACGACGCGGATGCGCAGAACTCACACAGCTACTGCTTCGAGATTCTGGAACGTCGCTAG	
7845	CARD	prokka_01665	contig_5	315871	112	43129	43543	1	123	H-NS	3000676.0	233.032	240.0	Strict	95.59	100.0	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; cephamycin; penam; tetracycline antibiotic	MSEALKILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEIEERTRKLQQYREMLIADGIDPNELLNSMAAAKTGTKAKRAARPAKYSYVDENGETKTWTGQGRTPAVIKKAMDEQGKQLDDFLIKD	ATGAGCGAAGCACTTAAAATTCTGAACAACATCCGTACTCTTCGTGCGCAGGCAAGAGAATGCACCCTGGAAACGCTTGAAGAAATGCTGGAAAAATTAGAAGTTGTAGTTAATGAACGTCGCGAAGAAGAAAGCGCTGCTGCTGCTGAAATCGAAGAGCGTACGCGTAAACTGCAGCAATATCGTGAAATGCTGATTGCTGATGGTATCGATCCAAATGAATTGCTGAACAGCATGGCTGCAGCGAAGACCGGTACTAAAGCAAAACGCGCTGCTCGTCCTGCTAAATATAGCTATGTAGACGAGAACGGCGAAACTAAAACCTGGACTGGCCAGGGTCGTACGCCTGCTGTTATCAAAAAAGCCATGGATGAGCAAGGTAAACAGCTGGACGACTTCCTGATCAAGGATTAA	loose hit with at least 95 percent identity pushed strict
7845	CARD	prokka_01935	contig_6	307716	115	19350	19692	-1	113	ramA	3000823.0	238.039	230.0	Strict	99.12	91.13	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MTISAQVIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	ATGACCATTTCCGCTCAAGTCATCGACACTATCGTCGAGTGGATCGACGATAACCTGCACCAGCCATTACGTATCGAAGAGATTGCCCGCCATGCGGGTTACTCGAAATGGCACCTGCAGCGGCTGTTTATGCAATACAAAGGGGAGAGTCTGGGGCGCTATATCCGTGAACGCAAACTGCTGCTGGCGGCGCGGGATCTGCGCGAATCAGACGCCCGGGTGTACGACATCTGCCTGCGTTACGGGTTTGACTCGCAGCAGACCTTCACCCGCATCTTCACCCGCACGTTCAACCAGCCACCTGGGGCGTATCGTAAAGAGAACCACAGCAGGGCACACTGA	
7845	CARD	prokka_02012	contig_6	307716	115	99177	100371	1	131	Enterobacter cloacae acrA	3004042.0	715.301	760.0	Strict	95.72	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGLTPLAVVLMLSGSLALTGCDDKQAQQGAQQMPEVGVVTLKSEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFTEGGDVQAGESLYQIDPATYQASYESAKGDLAKAEAAAKISQLTLNRYKKLLGTQYISQQDYDTALADAQQANAAVVAAKAAVETARINLAYTKVTSPISGRIGKSSVTEGALVQNGQATAMATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVELVTNDGIKYPQAGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGTNPTALLVPQQGVTRTPRGDASALVVGAGDKVEMRNITATQAIGDKWLVTDGLKDGDRVIVTGLQKVRPGAQVKAQEVKSDDKQQASAAGQSEQTKS	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTTACAGGATGTGACGACAAACAGGCTCAACAAGGAGCGCAGCAGATGCCAGAAGTTGGCGTTGTGACGCTCAAATCCGAACCTCTTCAGATCACCACCGAATTGCCTGGCCGCACAAGTGCTTATCGCATTGCAGAAGTTCGTCCTCAGGTGAGCGGCATTATCCTGAAACGTAACTTTACCGAAGGCGGCGATGTGCAAGCCGGTGAGTCTCTTTATCAGATTGATCCCGCAACGTATCAGGCGTCGTATGAAAGCGCGAAAGGCGACCTGGCGAAAGCGGAAGCGGCGGCCAAAATCTCTCAGCTGACGTTGAATCGTTACAAAAAACTGCTCGGTACGCAGTACATCAGCCAACAGGACTACGACACAGCCCTGGCGGATGCACAGCAGGCTAACGCGGCCGTTGTGGCAGCAAAAGCGGCTGTCGAAACCGCGCGCATCAACCTGGCCTATACCAAAGTGACCTCCCCTATCAGCGGTCGTATTGGTAAATCCTCCGTGACGGAAGGGGCACTGGTGCAAAACGGTCAGGCCACAGCGATGGCAACCGTGCAGCAGCTTGATCCGATCTACGTTGACGTGACGCAGTCCAGCAACGATTTCCTGCGACTGAAACAAGAGCTGGCAAACGGCACCCTGAAGCAGGAGAACGGCAAAGCCAAAGTGGAGCTGGTCACTAACGACGGCATCAAATATCCACAGGCGGGTACGCTGGAATTCTCTGACGTAACGGTCGACCAGACCACCGGTTCCATCACCTTACGTGCGATCTTCCCGAACCCTGACCACACCCTGTTGCCAGGTATGTTCGTTCGCGCACGTCTGGAAGAAGGCACTAACCCAACCGCACTTCTGGTTCCACAGCAGGGTGTGACCCGTACGCCACGCGGCGATGCGAGCGCACTGGTTGTTGGCGCTGGTGACAAAGTCGAAATGCGCAATATCACTGCTACGCAGGCGATTGGCGATAAATGGCTGGTGACGGACGGTCTGAAAGATGGCGATCGCGTGATTGTTACTGGTTTGCAAAAAGTTCGTCCTGGCGCGCAGGTTAAAGCACAGGAAGTGAAGTCTGACGATAAACAACAAGCTTCGGCCGCTGGCCAGTCAGAACAAACCAAGTCTTAA	loose hit with at least 95 percent identity pushed strict
7845	CARD	prokka_02013	contig_6	307716	115	100393	103540	1	128	acrB	3000216.0	1967.97	1900.0	Strict	93.14	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGKPASGLGIKLATGANALDTATAIRAELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAILAIFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLLLYIIIVVGMAYLFVRLPSSFLPDEDQGVFLTMAQLPAGASQERTQKVLDEVTDYYLTKEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGEENKVEAITGRAMGTFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGLEDTPQYKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAQYRMLPNDINNWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAMNLMEELASKLPAGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHSVEPH	ATGCCTAATTTCTTTATCGATCGCCCCATATTCGCATGGGTGATCGCCATTATTATCATGCTGGCCGGGGGACTTGCGATCCTGAAGCTGCCTGTTGCGCAATATCCGACCATTGCGCCACCGGCGGTGACGATCTCCGCAACCTACCCGGGGGCGGATGCGAAAACGGTGCAGGATACCGTTACGCAGGTTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCAAACAGTGACTCCACCGGTACGGTTCAGATCACCCTGACCTTCGAGTCTGGTACTGATGCTGACATCGCGCAGGTTCAGGTGCAGAACAAACTGCAGCTGGCGATGCCGCTGCTGCCGCAGGAAGTACAACAGCAGGGTGTGAGCGTCGAGAAATCGTCCAGTAGCTTCCTGATGGTTGTTGGCGTTATCAACACCAACGGCACCATGACGCAGGAGGATATTTCCGACTACGTGGGCGCCAACATGAAGGACGCTATTAGCCGTACTTCAGGTGTGGGTGACGTTCAGCTGTTTGGTTCCCAGTACGCGATGCGTATCTGGATGGACCCGAATAAACTGAACAACTTCCAGCTGACGCCGGTTGACGTCATCAACGCCATTAAAGCACAGAACGCCCAGGTTGCAGCCGGTCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCGTCCATCATCGCGCAAACCCGTCTGACCTCCGCCGATGAATTCAGCAAAATTCTGCTGAAAGTGAATCAGGACGGTTCGCAGGTTCGCCTGCGTGACGTGGCAAAAGTGGAGCTGGGTGGCGAAAACTACGACATCATTGCGAAGTTTAACGGCAAACCAGCTTCTGGTCTGGGTATCAAACTGGCGACCGGTGCTAACGCCCTGGACACCGCAACGGCTATCCGTGCAGAACTGAAGAAGATGGAACCGTTCTTCCCGTCAGGTCTGAAGATCGTTTATCCGTATGACACCACGCCATTCGTTAAAATTTCGATTCACGAAGTGGTTAAAACCCTGGTAGAAGCGATCATCCTGGTCTTCCTGGTGATGTATCTGTTCCTGCAGAACTTCCGCGCGACGCTGATTCCAACCATCGCCGTACCGGTCGTCTTGCTCGGAACCTTCGCCATACTGGCAATATTTGGCTACTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCTTGCTGGTGGATGACGCCATCGTGGTGGTAGAAAACGTCGAGCGCGTCATGGCGGAAGAAGGTCTGCCGCCGAAGGAAGCAACCCGTAAATCCATGGGCCAGATCCAGGGCGCGCTGGTCGGTATCGCGATGGTGCTGTCCGCCGTATTTATTCCGATGGCGTTCTTCGGGGGCTCTACCGGTGCGATTTACCGTCAGTTCTCCATCACTATCGTTTCTGCGATGGCGCTGTCGGTGCTGGTGGCGTTGATCCTGACGCCTGCGCTGTGTGCAACCATGCTGAAACCGATTCAGAAAGGCGGTCACGGCGAGCACAAAGGGTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGTACGCACCACTATACCGACAGCGTAGGGAACATTCTGCGCAGCACCGGTCGTTATCTGCTGCTCTATATCATCATCGTGGTGGGCATGGCCTATCTGTTCGTTCGTCTGCCAAGCTCGTTCCTGCCAGATGAAGACCAGGGCGTATTCCTGACGATGGCGCAGCTTCCGGCGGGTGCATCGCAAGAACGTACCCAGAAAGTGCTGGATGAAGTGACGGACTACTACCTCACCAAAGAAAAAGCGAACGTTGAATCCGTGTTTGCGGTTAACGGCTTTGGCTTTGCGGGTCGTGGCCAGAACACCGGTATCGCCTTCGTTTCACTGAAAGACTGGTCTGAACGTCCGGGCGAAGAGAACAAGGTTGAAGCGATCACCGGCCGTGCAATGGGCACCTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCAGCGATCGTTGAACTGGGTACGGCGACCGGTTTCGACTTCCAGCTGATTGACCAGGGCGGTCTGGGCCATGAGAAACTGACTCAGGCGCGTAACCAGCTGTTTGGCGAAGTGGCTAAACACCCTGACCTGCTGGTCGGCGTGCGTCCTAACGGCCTGGAAGATACGCCGCAGTACAAGATCGACATCGACCAGGAGAAAGCGCAGGCGCTGGGTGTATCCATCAGCGACATCAATACCACACTGGGCGCAGCCTGGGGCGGTAGCTACGTTAACGACTTCATCGACCGCGGTCGTGTGAAGAAAGTGTACGTGATGTCTGAAGCGCAATACCGTATGTTGCCGAACGATATCAACAACTGGTACGTTCGCGGCAGCGATGGCCAGATGGTGCCGTTCTCAGCCTTCTCGACGTCGCGCTGGGAATACGGTTCACCGCGTCTGGAACGTTATAACGGGCTGCCATCCATGGAAATTCTGGGTCAGGCCGCGCCGGGTCGAAGCACCGGTGAAGCCATGAACCTGATGGAAGAGTTAGCCAGCAAGCTGCCTGCGGGTATTGGCTATGACTGGACCGGTATGTCCTATCAGGAACGTCTGTCCGGTAACCAGGCCCCTGCCCTGTACGCCATTTCACTGATTGTGGTGTTCCTGTGTCTGGCGGCACTGTATGAGAGCTGGTCAATTCCGTTCTCCGTTATGCTGGTGGTGCCATTGGGGGTTATCGGTGCGCTGCTGGCTGCAACGTTCCGTGGGCTGACCAACGACGTGTACTTCCAGGTAGGCCTGCTGACAACCATTGGCTTGTCGGCGAAGAACGCGATACTTATCGTCGAATTCGCCAAAGATCTGATGGAGAAAGAAGGTAAAGGCCTGATCGAAGCCACGCTTGAAGCTGTTCGTATGCGTCTGCGCCCTATTCTGATGACCTCACTGGCATTTATCCTCGGGGTACTGCCGCTGGTTATCAGCTCTGGTGCGGGTTCCGGCGCACAGAACGCGGTAGGTACCGGGGTAATGGGCGGTATGATCACCGCGACCGTACTGGCTATCTTCTTCGTACCGGTGTTCTTTGTGGTGGTTCGCCGCCGCTTCAGCCGGAAGAATGAAGATATTGAACACAGTCATTCGGTAGAACCTCACTGA	
7845	CARD	prokka_02112	contig_6	307716	115	200567	201734	1	114	Escherichia coli ampH beta-lactamase	3004612.0	692.96	500.0	Strict	85.71	100.78	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRCLLFFAALCAVSFSTAQAAQPLTAPVLASDIADRYANLIYYGSGATGMAMVVIDGNQRVFRSFGETRPGNNVHPQLDSVIRIASLTKLMTSEMLVKLLDQGVVKLDDPLSKYAPPGARVPTYQGTPIRLVNLATHTSALPREQPGGAAHRDVFVWPTREQRWNYLSKATLKSAPGSQASYSNLAFDLLADALSTAAGKPYTQLFEEQITRPLGMKDTTFTPSPDQCRRLMVAEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYSRSHQADRMQTLIYQRSQLHRVIGMDVPGKADALGLGWVYMAPKNGRPGIIQKTGGGGGFITYMAMIPQSNVGAFVVVTRSPNTRFVNMSDGINNLVAELSANKAQVLTASVQP	TTGAAACGTTGTCTGCTCTTTTTCGCCGCGCTGTGTGCGGTGAGCTTCTCAACCGCCCAGGCAGCCCAACCGCTGACGGCGCCCGTTCTGGCATCAGATATTGCCGATCGCTACGCGAACCTGATTTATTACGGCAGCGGCGCGACGGGAATGGCGATGGTCGTCATCGACGGTAATCAGCGCGTGTTTCGCAGTTTCGGTGAAACGCGTCCCGGTAATAATGTTCATCCGCAGCTGGATTCCGTCATCCGCATCGCGTCCCTGACCAAGCTGATGACCAGCGAAATGCTGGTGAAATTGCTGGACCAGGGCGTGGTGAAACTCGACGATCCGCTCAGCAAGTATGCTCCGCCGGGCGCACGTGTCCCGACGTATCAGGGGACGCCGATAAGGCTGGTCAACCTGGCAACGCATACCAGCGCCCTGCCTCGCGAACAGCCAGGGGGTGCGGCGCATCGCGACGTTTTTGTCTGGCCAACGCGTGAACAGCGCTGGAACTACCTGAGCAAAGCCACGTTGAAGTCCGCGCCCGGTTCTCAGGCCTCTTACTCCAACCTGGCGTTTGACCTGCTGGCCGATGCGCTGTCGACGGCAGCGGGCAAACCGTATACGCAGCTGTTTGAAGAGCAGATCACGCGCCCGCTGGGCATGAAGGACACCACCTTCACCCCATCACCGGATCAGTGCCGCCGTCTGATGGTCGCCGAAAAAGGTGCCAGCCCGTGTAACAACACGCTGGCAGCCATCGGCAGCGGCGGGGTTTATTCCACCCCTGGCGACATGATGCGCTGGATGCAGCAGTTCCTCTCATCAGACTTCTACTCACGCAGCCATCAGGCCGACCGAATGCAGACGCTGATTTACCAGCGCAGCCAGTTGCACCGCGTGATCGGTATGGACGTGCCGGGCAAAGCCGACGCCCTCGGTCTGGGCTGGGTATATATGGCACCTAAAAATGGCCGTCCGGGCATTATTCAGAAAACGGGGGGTGGTGGAGGATTCATTACCTATATGGCAATGATCCCCCAGTCCAACGTAGGCGCTTTTGTGGTGGTCACCCGCTCGCCAAATACCCGTTTCGTCAATATGAGCGATGGGATCAATAACTTAGTGGCTGAGCTCAGCGCCAATAAAGCCCAGGTGCTTACCGCCTCCGTCCAGCCTTAA	
7845	CARD	prokka_02454	contig_7	263761	114	261751	262225	1	127	dfrA1	3002854.0	321.627	300.0	Strict	99.36	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG	GTGAAACTATCACTAATGGTAGCTATATCGAAGAATGGAGTTATCGGGAATGGCCCTGATATTCCATGGAGTGCCAAAGGTGAACAGCTCCTGTTTAAAGCTATTACCTATAACCAATGGCTGTTGGTTGGACGCAAGACTTTTGAATCAATGGGAGCATTACCCAACCGAAAGTATGCGGTCGTAACACGTTCAAGTTTTACATCTGACAATGAGAACGTATTGATCTTTCCATCAATTAAAGATGCTTTAACCAACCTAAAGAAAATAACGGATCATGTCATTGTTTCAGGTGGTGGGGAGATATACAAAAGCCTGATCGATCAAGTAGATACACTACATATATCTACAATAGACATCGAGCCGGAAGGTGATGTTTACTTTCCTGAAATCCCCAGCAATTTTAGGCCAGTTTTTACCCAAGACTTCGCCTCTAACATAAATTATAGTTACCAAATCTGGCAAAAGGGTTAA	
7845	CARD	prokka_02455	contig_7	263761	114	262319	262844	1	123	SAT-2	3002895.0	365.925	300.0	Perfect	100.0	100.0	streptothricin acetyltransferase (SAT)	protein homolog model	antibiotic inactivation		nucleoside antibiotic	MKISVIPEQVAETLDAENHFIVREVFDVHLSDQGFELSTRSVSPYRKDYISDDDSDEDSACYGAFIDQELVGKIELNSTWNDLASIEHIVVSHTHRGKGVAHSLIEFAKKWALSRQLLGIRLETQTNNVPACNLYAKCGFTLGGIDLFTYKTRPQVSNETAMYWYWFSGAQDDA	ATGAAGATTTCGGTGATCCCTGAGCAGGTGGCGGAAACATTGGATGCTGAGAACCATTTCATTGTTCGTGAAGTGTTCGATGTGCACCTATCCGACCAAGGCTTTGAACTATCTACCAGAAGTGTGAGCCCCTACCGGAAGGATTACATCTCGGATGATGACTCTGATGAAGACTCTGCTTGCTATGGCGCATTCATCGACCAAGAGCTTGTCGGGAAGATTGAACTCAACTCAACATGGAACGATCTAGCCTCTATCGAACACATTGTTGTGTCGCACACGCACCGAGGCAAAGGAGTCGCGCACAGTCTCATCGAATTTGCGAAAAAGTGGGCACTAAGCAGACAGCTCCTTGGCATACGATTAGAGACACAAACGAACAATGTACCTGCCTGCAATTTGTACGCAAAATGTGGCTTTACTCTCGGCGGCATTGACCTGTTCACGTATAAAACTAGACCTCAAGTCTCGAACGAAACAGCGATGTACTGGTACTGGTTCTCGGGAGCACAGGATGACGCCTAA	
7845	CARD	prokka_02456	contig_7	263761	114	262901	263654	1	118	ANT(3'')-IIa	3004089.0	486.878	450.0	Strict	99.19	77.4	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLASRADQFESPRV	ATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGGCAGGCTTATCTTGGACAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTTGAATCGCCACGCGTTTAA	
7845	CARD	prokka_02465	contig_8	248372	118	5613	8727	-1	123	adeF	3000777.0	760.37	750.0	Strict	40.82	97.92	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MANFFIQRPVFAWVLAIILMIAGGLAILKLPVAQYPTIAPPAVAITATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGNVTITLTFESGTDPDIAQVQVQNKLQLAMPLLPQEVQQQGIGVEKSSSSFLLVAGFVSDNKSLSQDDISDYVASNVKDAISRTTGVGDVQLFGAQYAMRIWLDSNAMNKYQLTPLDIINQLKTQNDQIAAGQLGGTPSVPGQQLNASIIAQTRLKSPEEFGRVTLKVNQDGSMVHLKDVARIELGGENYNMVTKINGQAATGLGIKLATGANALDTAAAIKSKLAQLQQFFPQGLKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQNLRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEDKLPPKEATQKSMEQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSLTIVSAMALSVLVALILTPALCATLLKPVSGDHHEKKGGFFGWFNALFDRSVEHYSNSVSGILRKTGRYLVVYIIIVGGMAVLFLRLPTSFLPEEDQGVFMTMVQLPAGATQTRTQQVLDQVQNYYLKNEKANVESVFTVNGFSFSGQGQNAGIAFISLKPWEARPGAENSVEAIVGRATKAFSQIKDGLVFPFNLPAIIELGTATGFDFELIDQANLGHTSLTQARNELLGMVKSHPDMLVRVRPNGLEDTPQFKLDVDQEKAQALGISLSDVNQTISTALGGTYVNDFIDHGRVKKVYVQADARFRMLPGDISNLYVRSANGEMVPFSAFSTSHWVYGSPRLERYNGMPSMEIIGESAPGKSTGEAMALMESLAAKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALFAAALRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISHGAGSGAQNAVGTGVMGGMLSATLLAIFFVPVFFVVVRRRFTRHKE	ATGGCTAATTTCTTTATCCAGAGGCCGGTTTTCGCCTGGGTACTCGCCATCATTTTGATGATTGCAGGTGGGCTGGCGATCCTCAAACTGCCCGTCGCGCAGTATCCGACTATCGCCCCACCCGCGGTTGCTATAACCGCAACCTACCCTGGCGCAGATGCGCAGACGGTGCAGGATACCGTGACGCAGGTTATCGAACAGAATATGAACGGCATCGATAACCTGATGTATATGTCATCCACCAGCGATTCTGCAGGTAATGTCACCATCACCCTGACCTTTGAGTCTGGTACAGACCCGGATATCGCCCAGGTTCAGGTTCAGAATAAACTTCAGCTCGCCATGCCGCTGCTGCCGCAGGAAGTGCAGCAACAAGGGATCGGCGTTGAGAAGTCCAGCAGCAGCTTCCTGCTGGTGGCTGGCTTTGTTTCAGACAATAAAAGCCTCTCGCAGGATGACATTTCCGACTACGTCGCCTCGAATGTGAAAGATGCCATTAGTCGAACCACAGGGGTGGGTGATGTTCAGCTGTTTGGTGCCCAGTATGCAATGCGCATCTGGCTCGACAGTAACGCGATGAATAAATACCAGCTGACGCCGCTGGACATTATTAATCAACTGAAAACCCAGAATGACCAGATAGCGGCAGGCCAGCTAGGCGGAACGCCGTCCGTGCCGGGCCAGCAATTGAACGCCTCGATCATTGCGCAAACCCGCCTGAAATCACCGGAAGAGTTTGGCCGCGTGACGCTGAAGGTGAACCAGGACGGCTCGATGGTGCACCTGAAGGATGTCGCACGCATTGAACTGGGCGGTGAAAACTACAATATGGTGACCAAAATCAACGGGCAGGCCGCAACCGGCCTGGGGATTAAGCTGGCGACCGGTGCAAATGCGCTGGATACGGCGGCGGCCATCAAGAGCAAGCTGGCGCAACTGCAGCAATTCTTCCCACAGGGTCTGAAGGTGGTTTATCCGTACGACACCACGCCGTTTGTGAAGATCTCTATTCACGAAGTGGTAAAAACCCTGTTTGAAGCGATCATTCTCGTCTTCCTGGTGATGTATCTGTTCCTGCAAAACCTGCGCGCGACGCTTATCCCCACTATCGCGGTGCCGGTTGTTTTGCTGGGTACCTTCGCGGTGCTGGCGGCGTTCGGGTTCTCCATCAATACCCTGACGATGTTCGGGATGGTGCTGGCAATAGGCTTGCTGGTTGATGATGCCATCGTGGTCGTTGAGAACGTCGAACGCGTGATGGTAGAAGACAAACTGCCGCCGAAAGAGGCGACGCAGAAGTCGATGGAACAGATTCAGGGCGCACTGGTGGGTATAGCCATGGTGCTGTCGGCGGTCTTTATCCCGATGGCATTTTTCGGTGGCTCGACCGGGGCCATCTATCGCCAGTTTTCACTGACCATCGTTTCGGCAATGGCACTCTCCGTGTTGGTCGCCCTGATCCTGACCCCCGCGCTGTGCGCAACCCTGCTTAAACCGGTATCCGGCGATCACCACGAAAAGAAAGGCGGTTTCTTTGGCTGGTTTAATGCGCTTTTTGACCGCAGCGTGGAGCACTACAGCAACAGCGTGAGCGGCATTTTACGCAAGACCGGACGCTACCTGGTGGTGTACATCATCATTGTGGGTGGTATGGCGGTGCTATTCCTGCGCTTGCCCACCTCCTTCCTGCCCGAAGAGGACCAGGGGGTATTTATGACGATGGTGCAACTTCCGGCCGGTGCGACCCAGACGCGTACACAGCAGGTCCTCGATCAGGTCCAGAACTATTATCTGAAAAACGAGAAGGCCAATGTTGAATCTGTCTTTACCGTTAATGGCTTTAGTTTTAGCGGCCAGGGCCAGAACGCCGGGATTGCCTTTATCAGCCTGAAGCCCTGGGAAGCACGACCGGGGGCGGAAAATAGCGTTGAGGCGATTGTTGGCCGCGCGACAAAAGCCTTCAGTCAGATAAAAGATGGGCTCGTATTTCCATTTAACCTGCCTGCAATTATCGAACTGGGAACCGCAACGGGTTTCGACTTCGAACTGATTGATCAGGCAAACCTGGGGCATACCTCGCTGACGCAGGCGCGGAACGAGCTGCTCGGAATGGTGAAATCGCACCCTGACATGCTGGTGCGCGTGCGGCCAAATGGTCTGGAAGATACCCCGCAGTTTAAACTGGATGTCGACCAGGAGAAGGCTCAGGCGCTGGGCATCAGTCTTTCTGACGTCAACCAGACCATCTCGACGGCCCTGGGTGGAACTTATGTAAATGACTTTATCGATCATGGCCGCGTGAAAAAGGTCTATGTCCAGGCCGATGCGCGCTTCCGTATGCTGCCTGGTGACATCAGCAACCTGTATGTACGCAGCGCAAATGGTGAGATGGTACCTTTCTCCGCCTTTAGCACCTCGCACTGGGTGTACGGTTCACCTCGCCTGGAGCGCTATAACGGGATGCCATCCATGGAGATCATCGGTGAGTCCGCCCCCGGTAAAAGTACCGGTGAGGCCATGGCGCTGATGGAAAGTCTTGCTGCAAAACTGCCTTCCGGCATCGGGTATGACTGGACAGGAATGTCTTATCAGGAGCGACTTTCCGGAAATCAGGCGCCTGCGTTGTACGCTATTTCACTGATTGTGGTGTTTCTGTGTCTGGCTGCTCTTTACGAAAGCTGGTCCATTCCCTTCTCAGTGATGCTGGTGGTCCCGCTGGGAGTCATTGGGGCGCTGTTTGCAGCAGCGTTACGTGGTTTGAACAATGACGTCTATTTCCAGGTGGGTTTGCTGACAACGATTGGTTTGTCGGCTAAAAACGCCATTCTGATCGTTGAGTTTGCCAAAGATCTGATGGAAAAAGAGGGTAAAGGCATCATTGAAGCCACGCTGGAAGCATCGAGAATGCGCCTTCGACCGATCCTGATGACCTCGCTCGCCTTTATTCTTGGCGTCATGCCGCTGGTGATCAGCCATGGCGCCGGGAGCGGTGCGCAAAATGCGGTCGGGACAGGGGTCATGGGGGGCATGCTTTCCGCAACGCTTCTGGCTATCTTCTTCGTGCCCGTTTTCTTTGTGGTCGTCCGGCGACGCTTTACGCGCCATAAAGAGTAA	
7845	CARD	prokka_02789	contig_9	169166	116	106544	108293	1	139	msbA	3003950.0	1144.41	1000.0	Strict	94.16	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MHNDKDLSTWQTFRRLWPMIAPFKAGLIVAGIALVLNAASDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMILRGITSYISSYCISWVSGKVVMTMRRRLFSHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPVVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMETLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFSILDSEQEKDEGTRVIERAKGDVEFRNVTFTYPGREVPALRNINLTIPAGKTVALVGRSGSGKSTIASLITRFYDIDQGEILLDGHDLREYTLQSLRNQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVLLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQSALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGIIVERGSHTDLLAQRGVYAQLHKMQFGE	ATGCATAACGACAAAGATCTCTCCACGTGGCAAACCTTCCGCCGACTCTGGCCGATGATTGCACCTTTTAAAGCAGGTTTAATCGTGGCGGGTATAGCGTTAGTTCTCAACGCAGCCAGCGATACTTTTATGTTATCGCTCCTCAAACCGTTACTGGATGACGGTTTTGGTAAAACGGATCGCTCAGTGTTGCTATGGATGCCTCTGGTGGTGATCGGACTGATGATCTTACGCGGTATCACCAGCTATATTTCCAGTTATTGCATCTCCTGGGTGTCAGGAAAAGTGGTCATGACAATGCGCCGTCGGCTGTTCAGCCACATGATGGGCATGCCGGTGGCCTTCTTTGACAAACAATCGACAGGTACGTTGTTGTCACGTATCACCTATGACTCAGAACAGGTGGCATCCTCTTCCTCCAGCGCACTGATTACCGTTGTGCGTGAAGGTGCGTCAATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTCATCGTGCTGGCTCCGGTTGTTTCTGTCGCGATCCGCGTCGTCTCAAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAATACGATGGGGCAGGTGACCACCAGCGCTGAACAGATGCTGAAAGGACATAAAGAGGTGTTGATTTTCGGCGGGCAGGAGGTCGAAACAAAACGCTTCGATAAAGTCAGCAACAAAATGCGTCTGCAGGGGATGAAAATGGTCTCGGCCTCTTCAATCTCTGATCCCATTATTCAGCTGATTGCCTCTCTGGCTCTGGCATTCGTCCTGTATGCGGCAAGCTTCCCGAGCGTAATGGAAACGCTGACGGCGGGAACCATCACCGTTGTGTTCTCTTCCATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTTAACGCCCAGTTCCAGCGCGGGATGGCAGCATGCCAGACGCTGTTCAGCATCCTGGATTCTGAGCAAGAGAAAGACGAAGGTACTCGCGTCATTGAGCGCGCAAAGGGCGATGTCGAATTCCGCAACGTGACCTTCACTTACCCTGGCCGTGAAGTTCCAGCATTACGTAACATCAACCTGACCATTCCGGCAGGCAAAACCGTTGCGCTGGTCGGCCGTTCCGGTTCGGGTAAATCGACGATTGCCAGCCTGATTACCCGTTTCTACGACATCGATCAGGGTGAAATTCTGTTAGACGGTCACGACCTGCGGGAATACACCCTGCAGTCGCTGCGTAACCAGGTTGCGCTGGTGTCTCAGAACGTGCATCTGTTCAACGATACTGTTGCGAACAATATTGCCTATGCGCGCACTGAAGAGTACAGCCGCGAGCAGATTGAAGAAGCCGCTCGCATGGCCTATGCCATGGACTTTATTAACAAGATGGACAACGGCCTGGATACCATCATCGGTGAGAATGGAGTTCTGCTCTCCGGTGGTCAACGCCAGCGTATCGCCATCGCCCGTGCACTGCTGCGTAACAGCCCTATTCTGATCCTTGACGAAGCAACCTCTGCTTTGGATACAGAATCTGAACGTGCAATTCAGTCTGCGCTGGATGAACTGCAAAAGAACCGTACATCACTGGTGATTGCACACCGCCTGTCAACGATTGAACAGGCTGACGAAATCGTTGTTGTGGAGGATGGGATCATTGTAGAACGCGGTAGCCATACCGATTTACTGGCACAGCGTGGTGTTTACGCTCAGCTCCATAAGATGCAGTTCGGCGAATGA	
7845	CARD	prokka_03254	contig_12	163674	116	23547	24180	1	123	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCGAAGAGCACGCTGATTCACCAGGGTGAAAAAGCGGAAACGTTGTATTACATCGTCAAAGGCTCGGTGGCAGTGCTGATCAAAGATGAAGAAGGGAAAGAGATGATCCTTTCTTATCTGAACCAGGGCGATTTTATCGGTGAACTGGGCCTGTTTGAAGAAGGCCAGGAACGTAGCGCCTGGGTTCGTGCAAAGACAGCATGTGAAGTGGCTGAAATTTCCTACAAGAAATTCCGTCAGTTGATTCAGGTTAACCCTGACATCCTGATGCGTCTTTCTTCGCAGATGGCTCGCCGTCTGCAGGTGACATCAGAGAAAGTGGGTAACCTCGCCTTCCTGGACGTGACCGGCCGTATCGCGCAGACCCTGCTGAACCTGGCGAAACAGCCAGACGCTATGACCCACCCTGACGGCATGCAAATTAAAATTACCCGCCAGGAAATTGGCCAGATCGTCGGTTGCTCCCGTGAAACAGTGGGCCGTATCCTGAAAATGCTGGAAGATCAGAACCTGATCTCCGCCCACGGTAAAACCATCGTGGTTTACGGAACCCGTTAA	
7845	CARD	prokka_03371	contig_12	163674	116	152758	153742	-1	112	PmrF	3003578.0	584.3340000000002	550.0	Strict	85.4	101.55	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYEILLVDDGSSDNSALMLTEAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFGSIIALAGFTLSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHKVSQEEKHP	ATGTTCAGTGCGCCGCCTGTACAAAAAGTTTCTGTGGTGATCCCCGTTTATAACGAGCAGGAGAGCCTGCCCGAACTGATCCGCCGCACCACCGCCGCCTGCGAGACGCTGGGCAAAGCCTACGAAATCCTGCTGGTGGATGACGGCAGCAGCGATAACTCCGCCCTGATGTTGACCGAGGCTGCGCAGGCCGAAGGCAGCCATATCGTCGCGGTGCTGCTTAACCGCAACTATGGCCAGCACTCGGCCATTATGGCCGGGTTCAGCCACGTGACGGGGGATTTGGTCATCACGCTGGATGCCGATCTGCAAAACCCGCCGGAGGAGATCCCCCGGCTGGTCGCCAAAGCCGACGAAGGGTACGACGTGGTGGGTACGGTACGGCAGAATCGTCAGGATAGCCTGTTCCGCAAGCTGGCTTCCCGCACCATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGATTACGGCTGCATGCTGCGCGCCTATCGCCGCCATATTGTCGACGCCATGCTGCACTGCCATGAACGCAGCACCTTCATTCCGATTCTGGCGAATACCTTTGCCCGTAAGGCGACGGAGATCCCGGTGCTGCACGCCGAGCGTGAGCACGGGGAGTCGAAGTACAGCTTTATGCGTCTTATCAACCTGATGTACGACCTCATCACCTGCCTGACCACCACGCCGCTGCGCCTGCTGAGCGTCTTTGGCAGCATTATCGCGCTGGCCGGGTTCACGCTTTCCGTTTTGCTGGTCGTCCTGCGTCTGGTCTTTGGCCCCCAGTGGGCGGCGGAAGGGGTGTTCATGCTCTTTGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGGATGGGCCTGCTCGGTGAGTACATTGGCCGTATCTATAACGATGTTCGCGCACGTCCGCGCTACTTTATTCAACGTGTTGTCCGCCAGGAACACAAAGTCTCTCAAGAGGAAAAACACCCATGA	
7845	CARD	prokka_03638	contig_15	100788	116	56474	57848	1	93	cpxA	3000830.0	825.4689999999998	890.0	Strict	95.4	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGVMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTSEGRVIGADRNEMQIIRNFIGQADNADHPQKKKYGRVEMVGPFSVRDGEDNYQLYLIRPASNSQSDFINLLFDRPLLLLIVTMLVSSPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMITALERMMTTQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETVKANQLWHEVLDNAAFEAEQMGKSFTVNFPPGPWPLYGNPNTLESALENIVRNALRYSHTKIEVAFSVDKDGITIIVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAMQQHRGWVKADDSPLGGLRLTLWLPLYKRA	ATGATAGGAAGCTTAACCGCCCGCATCTTCGCCATCTTCTGGCTGACGCTGGCACTGGTTTTAATGCTGGTTTTGATGTTGCCAAAACTCGACTCACGCCAGATGACGGAGCTTCTCGACAGCGAGCAACGTCAGGGCGTGATGATCGAGCAGCACGTAGAAGCCGAGCTGGCAAACGATCCGCCAAACGATTTGATGTGGTGGCGCAGGCTGTTTCGCGCTATCGACAAATGGGCACCTCCCGGACAACGCCTGCTGCTGGTGACCAGCGAAGGCCGCGTGATTGGCGCGGATCGCAATGAAATGCAGATCATCCGCAACTTTATTGGCCAGGCGGATAACGCCGATCATCCGCAGAAGAAAAAATATGGTCGGGTTGAGATGGTGGGCCCTTTCTCAGTCAGGGATGGGGAAGATAACTACCAGCTTTATTTGATTCGCCCGGCGAGCAATTCCCAGTCCGATTTTATCAACCTGCTGTTTGACCGTCCGCTTCTGCTGCTGATTGTGACGATGCTGGTCAGTTCACCGCTGTTGCTTTGGCTGGCGTGGAGTCTGGCGAAACCGGCGCGTAAGCTGAAAAACGCCGCCGACGAAGTGGCGCAGGGTAACCTGCGACAGCACCCTGAGCTGGAAGCCGGACCGCAGGAGTTTCTTGCCGCCGGGGCCAGTTTCAACCAGATGATCACCGCTCTTGAGCGCATGATGACCACGCAGCAGCGGCTGCTGTCGGATATCTCGCACGAACTGCGTACGCCACTCACGCGACTCCAGCTGGGCACCGCGCTGCTGCGTCGCCGCAGCGGTGAGAGCAAAGAGCTGGAACGTATCGAAACCGAAGCCCAGCGTCTGGACAGCATGATCAACGATCTGCTGGTGATGTCGCGCAATCAGCAAAAAAACGCGCTGGTGAGCGAAACGGTGAAAGCCAATCAGCTGTGGCATGAAGTGTTAGACAACGCGGCGTTCGAAGCGGAACAGATGGGTAAATCGTTCACCGTCAACTTCCCGCCGGGGCCATGGCCGCTGTACGGTAACCCCAACACGCTGGAGAGCGCGCTGGAGAATATCGTGCGTAACGCCCTGCGTTACTCGCATACGAAGATTGAGGTGGCCTTCTCGGTGGATAAAGACGGTATCACCATCATTGTGGATGACGATGGTCCAGGCGTAAGCCCGGAAGATCGCGAGCAGATTTTCCGTCCGTTCTACCGCACCGACGAGGCGCGGGACCGTGAATCTGGCGGTACCGGGCTGGGTCTGGCGATTGTTGAAACCGCTATGCAGCAGCATCGCGGCTGGGTGAAAGCCGACGACAGTCCGTTGGGTGGGCTGCGGTTAACGCTGTGGCTACCGTTGTATAAGCGCGCGTAA	loose hit with at least 95 percent identity pushed strict
7845	CARD	prokka_03828	contig_17	98173	115	61136	61958	-1	107	bacA	3002986.0	514.998	500.0	Strict	95.24	100.0	undecaprenyl pyrophosphate related proteins	protein homolog model	antibiotic target alteration		peptide antibiotic	MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRLPQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF	ATGAGCGATATGCACTCGCTGCTGGTGGCGGCAATTCTGGGTGTGGTCGAAGGATTGACGGAGTTTTTGCCGGTTTCCAGTACGGGCCATATGATTATTGTTGGCCACCTGCTGGGTTTTGAAGGCGATACCGCAAAGACGTTCGAGGTGGTCATTCAGTTGGGGTCCATTCTGGCTGTGGTCGTGATGTTCTGGCGTCGTCTGTTTGGGCTGATCGGCATCCACTTCGGGCGTTTGCCACAGCGTGAAGGAGAGAGCAAGGGCCGCCTGACGCTGATTCATATCCTGCTCGGGATGATCCCGGCTGTGGTGCTGGGGCTGGTTTTCCACGACACCATCAAATCGCTGTTTAACCCGATTAACGTGATGTACGCGCTGGTGGTCGGTGGTTTCCTGCTGATTGCGGCGGAAGTGCTGAAGCCAAAAACGCCGCGCGCAGAAGGTCTGGACGATATGACGTATCGCCAGGCCTTTATCATTGGCTGCTTCCAGTGTCTGGCGCTGTGGCCGGGCTTCTCCCGTTCAGGAGCAACGATTTCCGGCGGGATGCTGATGGGTGTAAGCCGTTACGCGGCATCTGAGTTCTCGTTCCTGCTGGCGGTGCCGATGATGATGGGCGCCACCGCGCTGGACCTCTACAAAAGCATTGGTTTTCTCACCACGGGCGATATTCCGATGTTCGCCGTGGGCTTTATCACCGCCTTTATCGTGGCGCTGATTGCCATTAAAACCTTCCTGCAACTGATTAAGCGTATCTCGTTTATCCCGTTCGCGATCTACCGCTTTATCGTCGCGGCTGCGGTTTACGTGGTCTTCTTCTGA	
7845	CARD	prokka_04720	contig_31	31284	103	20429	21662	1	120	Escherichia coli mdfA	3001328.0	712.605	700.0	Strict	86.98	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MLNRSSSGTRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVAQYNAGIEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAVLAAIAFFGLHRAMPETATRLGETLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIAQSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIIMGGWPIAAGLTVAAVATVVSSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIEVSKHAYALGGNGLFSLFNLANGVLWVILMVMFLKDKRVGNALQP	ATGTTAAACCGTTCTTCTTCGGGTACGCGTCTGGGTCGTCAGGCGTTACTTTTCCCTCTGTGTCTGGTGCTTTACGAGTTCTCTACCTATATCGGCAACGATATGATTCAGCCCGGTATGCTGGCCGTGGTGGCGCAATACAACGCAGGTATTGAATGGGTGCCGACCTCTATGACCGCCTATCTGGCTGGCGGCATGTTTTTACAGTGGCTGTTAGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGCTGACGGGCGTGGTGTGGTTTATCGTGACCTGTCTCGCCACGCTGCTGGCGCAAAACATTGAACAGTTCACCCTGCTGCGTTTCCTGCAGGGGGTAAGCCTGTGCTTTATCGGTGCCGTGGGGTATGCCGCCATTCAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCGCTGATGGCGAACGTGGCGCTGATTGCTCCGTTGCTGGGGCCGCTGGTGGGCGCCGCGTGGGTGCATGTGGCACCGTGGGAAGGCATGTTTGTGCTCTTCGCCGTGCTGGCCGCCATCGCGTTCTTTGGCCTGCACCGCGCAATGCCGGAAACGGCCACCCGACTGGGTGAGACGCTGTCGCTGAAAGAGCTGGGACGGGATTATAAAGCGGTGCTGAAAAACGGCCGCTTTGTGGCAGGCGCGCTGGCGACGGGCTTTGTTAGCCTGCCGCTACTGGCGTGGATCGCCCAGTCACCGGTCATTATCATCAGCGGTGAACAGCTCAGCAGCTACGAGTACGGGCTGCTGCAGGTGCCTATTTTTGGCGCACTGATTATCGGTAACCTGGTGCTGGCGCGTCTGACATCACGACGCACGGTGCGCTCGCTCATCATCATGGGCGGCTGGCCGATTGCGGCGGGCCTTACCGTGGCCGCGGTGGCGACGGTGGTATCATCTCATGCCTATCTGTGGATGACGGCGGGATTGAGTATTTACGCCTTCGGTATTGGCGTGGCGAATGCCGGGCTGGTGCGTCTGACGCTGTTTGCCAGCGAGATGAGTAAAGGCACCGTTTCGGCGGCGATGGGGATGCTGCAGATGCTGATTTTTACCGTCGGGATCGAGGTGAGCAAGCACGCTTATGCGCTCGGCGGCAACGGTCTGTTCAGCCTGTTTAACCTCGCCAACGGCGTGCTGTGGGTTATCCTGATGGTGATGTTCCTGAAAGACAAACGCGTCGGGAACGCCCTGCAGCCATAA	
7845	CARD	prokka_04739	contig_32	30305	191	8550	9150	1	272	AAC(6')-Ib-cr6	3005116.0	407.142	300.0	Strict	98.99	100.0	AAC(6')-Ib-cr	protein homolog model	antibiotic inactivation		fluoroquinolone antibiotic; aminoglycoside antibiotic	MSNAKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERTRSDA	ATGAGCAACGCAAAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGAAGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCATATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	
7845	CARD	prokka_04741	contig_32	30305	191	10248	10881	1	235	catB3	3002676.0	437.958	350.0	Perfect	100.0	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIGSFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIGSEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWNWSLEKIKAAMPMLCSSNIVGLHKYWLEFAV	ATGACCAACTACTTTGATAGCCCCTTCAAAGGCAAGCTGCTTTCTGAGCAAGTGAAGAACCCCAATATCAAAGTTGGGCGGTACAGCTATTACTCTGGCTACTATCATGGGCACTCATTCGATGACTGCGCACGGTATCTGTTTCCGGACCGTGATGACGTTGATAAGTTGATCATCGGTAGTTTCTGCTCTATCGGGAGTGGGGCTTCCTTTATCATGGCTGGCAATCAGGGGCATCGGTACGACTGGGCATCATCTTTCCCGTTCTTTTATATGCAGGAAGAACCTGCATTCTCAAGCGCACTCGATGCCTTCCAAAAAGCAGGTAATACTGTCATTGGCAATGACGTTTGGATCGGCTCTGAGGCAATGGTCATGCCCGGAATCAAGATCGGGCACGGTGCGGTGATAGGCAGCCGCTCGTTGGTGACAAAAGATGTGGAGCCTTACGCTATCGTTGGCGGCAATCCCGCTAAGAAGATTAAGAAACGCTTCACCGATGAGGAAATTTCATTGCTTCTGGAGATGGAGTGGTGGAATTGGTCACTGGAGAAGATCAAAGCGGCAATGCCCATGCTGTGCTCGTCTAATATTGTTGGCCTGCACAAGTATTGGCTCGAGTTTGCCGTCTAA	
7845	CARD	prokka_04742	contig_32	30305	191	10965	11418	1	227	arr-3	3002848.0	311.997	250.0	Perfect	100.0	100.0	rifampin ADP-ribosyltransferase (Arr)	protein homolog model	antibiotic inactivation		rifamycin antibiotic	MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED	ATGGTAAAAGATTGGATTCCCATCTCTCATGATAATTACAAGCAGGTGCAAGGACCGTTCTATCATGGAACCAAAGCCAATTTGGCGATTGGTGACTTGCTAACCACAGGGTTCATCTCTCATTTCGAGGACGGTCGTATTCTTAAGCACATCTACTTTTCAGCCTTGATGGAGCCAGCAGTTTGGGGAGCTGAACTTGCTATGTCACTGTCTGGCCTCGAGGGTCGCGGCTACATATACATAGTTGAGCCAACAGGACCGTTCGAAGACGATCCGAATCTTACGAACAAAAGATTTCCCGGTAATCCAACACAGTCCTATAGAACCTGCGAACCCTTGAGAATTGTTGGCGTTGTTGAAGACTGGGAGGGGCATCCTGTTGAATTAATAAGGGGAATGTTGGATTCGTTGGAGGACTTAAAGCGCCGTGGTTTACACGTCATTGAAGACTAG	
7845	CARD	prokka_04743	contig_32	30305	191	11640	11988	1	209	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
7845	CARD	prokka_04744	contig_32	30305	191	11981	12821	1	162	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
7845	CARD	prokka_04754	contig_32	30305	191	21538	22186	-1	196	QnrB4	3002718.0	440.654	400.0	Perfect	100.0	100.0	quinolone resistance protein (qnr)	protein homolog model	antibiotic target protection		fluoroquinolone antibiotic	MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG	ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA	
7845	CARD	prokka_04764	contig_32	30305	191	29022	29862	1	159	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
7845	CARD	prokka_04972	contig_44	8427	183	5109	6015	-1	191	mphA	3000316.0	604.364	500.0	Perfect	100.0	100.0	macrolide phosphotransferase (MPH)	protein homolog model	antibiotic inactivation		macrolide antibiotic	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	ATGACCGTAGTCACGACCGCCGATACCTCCCAACTGTACGCACTTGCAGCCCGACATGGGCTCAAGCTCCATGGCCCGCTGACTGTCAATGAGCTTGGGCTCGACTATAGGATCGTGATCGCCACCGTCGACGATGGACGTCGGTGGGTGCTGCGCATCCCGCGCCGAGCCGAGGTAAGCGCGAAGGTCGAACCAGAGGCGCGGGTGCTGGCAATGCTCAAGAATCGCCTGCCGTTCGCGGTGCCGGACTGGCGCGTGGCCAACGCCGAGCTCGTTGCCTATCCCATGCTCGAAGACTCGACTGCGATGGTCATCCAGCCTGGTTCGTCCACGCCCGACTGGGTCGTGCCGCAGGACTCGGAGGTCTTCGCGGAGAGCTTCGCGACCGCGCTCGCCGCCCTGCATGCCGTCCCCATTTCCGCCGCCGTGGATGCGGGGATGCTCATCCGTACACCGACGCAGGCCCGTCAGAAGGTGGCCGACGACGTTGACCGCGTCCGACGCGAGTTCGTGGTGAACGACAAGCGCCTCCACCGGTGGCAGCGCTGGCTCGACGACGATTCGTCGTGGCCAGATTTCTCCGTGGTGGTGCATGGCGATCTCTACGTGGGCCATGTGCTCATCGACAACACGGAGCGCGTCAGCGGGATGATCGACTGGAGCGAGGCCCGCGTTGATGACCCTGCCATCGACATGGCCGCGCACCTTATGGTCTTTGGTGAAGAGGGGCTCGCGAAGCTCCTCCTCACGTATGAAGCGGCCGGTGGCCGGGTGTGGCCGCGGCTCGCCCACCACATCGCGGAGCGCCTTGCGTTCGGGGCGGTCACCTACGCACTCTTCGCCCTCGACTCGGGTAACGAAGAGTACCTCGCTGCGGCGAAGGCGCAGCTCGCCGCAGCGGAATGA	
7845	CARD	prokka_00745	contig_2	399393	112	132982	135619	-1	128	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1626.68	1500.0	Strict	91.62	100.34	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMATNIPPHNITEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKIYIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEIKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKEILSAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALISRPWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSAERLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGKDEVMLFSAAGKVVRFKEDAVRAMGRTATGVRGIKLAGEDSVVSLIIPRGEGAILTVTQNGYGKRTAEGEYPTKSRGTQGVISIKVTERNGSVVGAVQVDDADQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDSIDGSVAEGDDDIAPEVDTDDDAADDADE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTTAACATCGAGGAAGAGCTGAAGAGCTCCTATCTGGACTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGACGTCCGCGATGGCCTGAAGCCGGTACACCGTCGCGTACTATACGCCATGAACGTATTGGGCAATGACTGGAATAAAGCCTACAAAAAATCTGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCATCCCCATGGTGATATCGCGGTGTACGACACCATCGTTCGTATGGCGCAGCCTTTCTCGCTGCGTTACATGCTGGTAGATGGTCAGGGTAACTTTGGTTCTATCGACGGCGACTCCGCCGCGGCAATGCGTTATACGGAAATCCGTCTGGCGAAAATTGCCCATGAGCTGATGGCCGACCTGGAAAAAGAGACGGTTGATTTCGTTGATAACTACGATGGCACGGAAAAAATTCCTGACGTCATGCCAACGAAGATCCCTAACCTGCTGGTGAACGGTTCGTCCGGTATCGCCGTAGGGATGGCGACCAACATTCCGCCGCACAACATCACCGAAGTGATCAACGGCTGCCTGGCCTATATCGACGATGAAGACATCAGCATTGAAGGGCTGATGGAACACATCCCGGGCCCGGACTTCCCGACGGCGGCCATCATCAACGGTCGTCGTGGTATTGAAGAAGCGTACCGCACCGGTCGCGGCAAGATTTACATCCGTGCCCGCGCCGAAGTGGAAGCAGATGCCAAAACCGGCCGTGAAACCATCATTGTTCACGAGATCCCGTATCAGGTGAACAAAGCGCGACTGATTGAAAAAATCGCCGAGCTGGTAAAAGAAAAACGTGTTGAAGGCATCAGCGCGCTGCGCGACGAGTCTGATAAAGACGGTATGCGCATCGTGATTGAAATCAAACGCGACGCGGTGGGCGAGGTTGTGCTGAACAACCTGTACTCCCAGACTCAGCTGCAGGTCTCCTTCGGTATCAACATGGTTGCACTGCACCATGGTCAGCCGAAGATCATGAACCTGAAAGAGATCCTGAGCGCGTTTGTCCGTCACCGCCGCGAAGTGGTGACCCGTCGTACCATTTTCGAACTGCGTAAAGCGCGTGACCGTGCCCACATCCTTGAGGCACTGGCTGTGGCGCTGGCCAACATCGACCCGATCATCGAGCTGATCCGTCGCGCGCCAACCCCGGCGGAAGCGAAAACCGCGCTGATTTCCCGTCCGTGGGATCTGGGCAACGTTGCGGCAATGCTGGAGCGTGCCGGTGATGACGCCGCGCGTCCTGAGTGGCTGGAACCTGAATTCGGCGTGCGTGATGGTCAGTACTACCTGACTGAACAGCAGGCCCAGGCGATTCTGGATCTGCGTCTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAATATAAAGAGCTGCTGGAGCAGATCGCTGAACTGCTGCACATTCTGGGCAGCGCAGAGCGCCTGATGGAAGTGATCCGCGAAGAGCTGGAGCTGATCCGCGATCAGTTCGGCGATGAGCGTCGCACCGAAATCACCGCCAACTCCGCAGATATCAACATCGAAGACCTGATCAACCAGGAAGACGTTGTTGTGACCCTGTCTCACCAGGGCTACGTGAAGTATCAGCCGTTAACTGACTACGAAGCACAGCGTCGTGGTGGTAAAGGCAAATCTGCGGCACGTATTAAAGAAGAAGACTTTATCGACCGTCTGCTGGTGGCGAACACCCATGACACCATCCTCTGCTTCTCCAGCCGGGGTCGTCTGTACTGGATGAAGGTCTACCAGTTGCCGGAAGCGAGCCGTGGTGCACGTGGTCGTCCGATCGTTAACCTGCTGCCCCTGGAAGCGAACGAACGTATCACTGCCATTCTGCCGGTACGCGAGTACGAAGAGGGCGTGAACGTCTTTATGGCGACCGCCAGCGGTACCGTGAAGAAAACCGCGCTGACCGAGTTCAGCCGTCCACGTTCTGCCGGTATCATCGCGGTGAACCTGAACGAAGGCGATGAGCTGATTGGCGTCGATCTGACTTCAGGCAAAGATGAAGTCATGCTCTTCTCCGCAGCCGGTAAAGTGGTGCGCTTCAAAGAAGACGCCGTCCGCGCAATGGGTCGTACCGCAACGGGCGTTCGCGGTATCAAACTGGCGGGCGAAGACAGCGTCGTTTCTCTGATTATTCCGCGCGGGGAAGGGGCTATCCTGACCGTGACGCAGAATGGTTACGGTAAACGTACCGCGGAAGGGGAATACCCAACCAAGTCGCGTGGCACGCAGGGCGTTATCTCTATCAAGGTGACCGAGCGCAACGGTTCCGTTGTGGGCGCGGTGCAGGTAGACGATGCCGACCAGATCATGATGATCACCGATGCCGGTACGCTGGTGCGTACCCGCGTGTCGGAGATTAGCGTGGTGGGTCGTAATACCCAGGGCGTTATCCTCATCCGTACGGCGGAAGATGAAAACGTGGTGGGTCTGCAACGTGTTGCTGAGCCAGTGGACGACGAAGAGCTCGACTCCATCGACGGTAGCGTCGCGGAAGGTGATGATGATATCGCACCGGAAGTGGACACCGACGATGATGCAGCGGATGATGCTGACGAGTAA	
7845	CARD	prokka_01567	contig_4	335301	113	274235	276002	1	121	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	595.504	500.0	Strict	52.74	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MRAAAKTLKPKRQEEQANFISWRFALLCGCILLALGFLLGRVAWLQIIAPDMLVRQGDMRSLRVQEVSTSRGMITDRSGRPLAVSVPVKAIWADPKELHDAGGITLDNRWKALSDALKMPLDQLASRVNANPKGRFIYLARQVNPDMADYIRKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVSTGEVLAMANSPSYNPNNFTGTAKDAMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVETYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERIFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASNPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNVEPDALATGEKSEFVINQGEGTGGRS	ATGAGAGCAGCGGCAAAAACGCTAAAACCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTTTGCGGCTGCATTTTACTCGCGCTGGGCTTCCTGCTGGGACGTGTGGCGTGGCTACAAATCATCGCGCCTGACATGCTGGTGCGCCAGGGCGATATGCGCTCTCTGCGCGTACAGGAAGTCTCCACATCTCGCGGGATGATCACCGATCGTTCCGGTCGTCCGCTGGCGGTGAGCGTACCGGTGAAGGCGATCTGGGCCGATCCGAAAGAGCTGCACGATGCCGGTGGTATCACGCTCGACAACCGCTGGAAAGCGCTGTCTGACGCCCTGAAAATGCCGCTGGATCAGCTTGCCTCCCGCGTTAATGCCAACCCGAAAGGGCGCTTTATCTATCTGGCGCGTCAGGTTAACCCTGACATGGCCGATTACATCAGAAAACTGAAGCTCCCGGGTATCCATCTGCGAGAAGAGTCTCGCCGTTACTACCCTTCCGGCGAAGTAACCGCTCACCTCATTGGCTTTACTAACGTCGACAGCCAGGGGATTGAAGGGGTTGAAAAAAGCTTCGATAAGTGGCTTACCGGTCAGCCGGGTGAGCGAATCGTGCGTAAAGACCGCTATGGTCGCGTGATTGAAGATATCTCTTCCACAGATAGCCAGGCCGCGCATAACCTGGCGTTGAGCATTGATGAACGCCTGCAGGCGCTGGTGTATCGCGAACTGAACAATGCCGTGGCCTTTAACAAAGCGGAGTCGGGCAGCGCCGTGCTGGTGGATGTCAGCACTGGCGAAGTGCTGGCGATGGCCAACAGCCCGTCCTACAACCCGAACAACTTTACTGGTACCGCAAAAGATGCAATGCGTAACCGGGCCATTACCGACGTGTTCGAACCTGGCTCCACGGTGAAGCCGATGGTGGTGATGACGGCGCTGCAACGCGGCATCGTCAATGAGAACACGGTTCTGAACACGATCCCTTACCGAATCAACGGCCACGAGATTAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTATTACAGAAGTCGAGTAACGTCGGTGTTTCAAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGAGACTTACTCACGTTTTGGGCTAGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCACTGTCGATTACCAAAGTTGATCCACCGGTTCCGGGCGAGCGTATCTTCCCGGAATCTATCGTTCGTACCGTTGTGCATATGATGGAAAGCGTGGCGCTACCTGGCGGTGGCGGCGTGAAGGCGGCGATCAAAGGCTATCGCATCGCCATTAAAACCGGTACGGCGAAAAAAGTGGGGCCAGACGGCCGCTACATCAACAAATACATTGCCTATACCGCAGGCGTTGCGCCTGCAAGCAATCCGCGTTTTGCGCTGGTGGTCGTCATTAACGATCCACAGGCGGGTAAATACTACGGCGGCGCCGTTTCAGCGCCTGTGTTCGGCGCCATTATGGGCGGCGTATTACGCACCATGAACGTTGAACCGGACGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGTACAGGTGGCAGATCGTAA	
7845	CARD	prokka_02401	contig_7	263761	114	207157	208549	-1	115	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	862.062	850.0	Strict	93.74	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTVVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGSYLGMWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRFGSDSPESYGLGKAEELFGEAISEEDKETEENEMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACVALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPIFGLTGWAGTFAALDAAAIGCIVLMAMVAVLEERKIRRENRVQKLKAA	ATGCTGGCCTTCCTTAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGACGTGCGGCGCAAAATGTGGTTCAAACCGTTCATGCAGTCCTATCTGGTGGTCTTTATCGGCTACCTGACCATGTACCTGATCCGCAAAAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGCTGAGCATGACGCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAAACCGTTGTCTCGTACTATGCAGACGGCAAAAACACCAAGCAATTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTCGGCTTCAGCGCCAGCATGGGCGCGGGCTCCGTCAGCCTGTTCCTGATGATCGCCTTCTACGCCCTGAGCGGTTTCTTCCAGAGTACCGGTGGGTCGTGCAGCTACTCCACCATTACCAAATGGACCCCGCGCCGTAAGCGTGGTTCATACCTTGGTATGTGGAACATCTCCCACAACCTCGGCGGGGCGGGTGCAGCAGGCGTGGCGCTGTTCGGTGCTAACTACCTGTTTGACGGTCACGTCATCGGCATGTTTATCTTCCCGTCGATTATCGCCCTGATTGTCGGCTTTATCGGTCTGCGTTTCGGCAGTGACTCTCCGGAATCTTACGGCCTCGGCAAAGCCGAAGAGCTGTTCGGCGAGGCGATCAGCGAAGAGGACAAAGAGACCGAAGAGAACGAGATGACAAAATGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTCTGCTTCTCCAACATTTTCCTGTACGTGGTGCGCATCGGTATTGACCAGTGGTCGACCGTGTATGCCTTCCAGGAGCTGAAGCTATCAAAAGAAGTCGCGATTCAGGGCTTCACCCTGTTTGAGGTGGGTGCGCTGGTCGGTACGCTGCTGTGGGGCTGGCTCTCTGACCTCGCCAACGGTCGTCGTGCGCTGGTGGCCTGCGTCGCGCTGGCGCTGATTATCGCTACCCTGGGCGTCTACCAGCACGCCAGCAACCAGTACGTTTACCTGGCGTCTCTGTTTGCGCTCGGCTTTCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTAGCGGCGGTAGGTTTTGTACCGAAAAAAGCGATCGGCGCCGCCGATGGTATTAAAGGCACCTTCGCTTACCTGATCGGCGACAGCTTCGCCAAGCTGGGTCTGGGGATGATTGCCGACGGCACGCCGATTTTCGGCCTCACCGGCTGGGCAGGCACCTTTGCGGCGCTGGATGCCGCCGCCATCGGCTGTATCGTCCTGATGGCGATGGTTGCGGTGCTCGAAGAACGTAAAATTCGCCGTGAAAATCGTGTGCAGAAATTAAAAGCAGCCTGA	
7845	CARD	prokka_03786	contig_17	98173	115	12332	14591	-1	117	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1449.88	1400.0	Strict	92.29	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNATAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAEVLLGELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTSLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVRMRAVWTKEDGAVVITALPHQVSGAKVLEQIASQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLTFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQNELEKERDQLQAILASERKMNTLLKKELQADADAFGDDRRSPLHEREEAKAMNEHDMQPSEPVTIVLSQSGWVRSAKGHDIDAPGLSYKAGDSFKAAVKGKSNQPVAFIDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMEADDQKLLLASDAGYGFICTFNDLVSRNRAGKAMISLPDNAHVMPPLVVENESDMLLAITSAGRMLMFPVSDLPELSKGKGNKIINIPSAEAAKGEDGLAHLFILPPQSTLTIHVGKRKIKLRPEELQKVVGERGRRGSLMRGLQRIDRVEIDSPARSNAGDSEE	ATGAGCGATATGGCAGAGCGCCTCGCGCTACATGAATTCACGGAAAACGCCTACCTGAACTACTCCATGTACGTCATCATGGACAGGGCATTGCCGTTTATCGGGGATGGCCTGAAGCCCGTTCAGCGTCGCATCGTCTATGCGATGTCCGAGCTGGGGCTGAACGCCACCGCCAAGTTCAAGAAATCCGCCCGTACCGTCGGTGACGTACTGGGTAAATACCATCCGCACGGCGACATCGCCTGCTATGAAGCGATGGTGCTGATGGCCCAGCCGTTCTCTTATCGTTACCCGCTGGTGGACGGTCAGGGGAACTGGGGGGCACCGGACGATCCGAAATCCTTCGCGGCGATGCGTTATACCGAATCCCGCCTGTCTAAATATGCCGAAGTGCTGCTGGGCGAACTCGGCCAGGGGACGGTGGACTGGGTGCCAAACTTCGACGGCACGCTGCAGGAGCCGAAAATGCTGCCTGCGCGTCTGCCGAATATCCTGCTGAACGGCACCACCGGTATCGCGGTCGGTATGGCGACGGACATCCCGCCACACAACCTGCGTGAAGTGGCGAAAGCCGCCATCACCCTGATTGAACAGCCGAAAACCTCGCTGGACGAGCTGCTGGATATCGTTCAGGGGCCGGACTTCCCGACCGAAGCTGAGATCATCACCTCGCGTGCGGAAATCCGCAAAATCTACCAGAACGGCCGTGGCTCCGTGCGCATGCGCGCGGTGTGGACCAAAGAGGACGGCGCCGTGGTGATCACCGCGCTGCCGCATCAGGTCTCTGGTGCCAAGGTGCTGGAGCAGATCGCCTCCCAGATGCGCAATAAAAAGCTGCCGATGGTGGACGACCTGCGCGATGAATCCGACCACGAAAACCCAACCCGTCTGGTGATCGTGCCGCGCTCTAACCGCGTGGACATGGAGCAGGTGATGAACCACCTGTTCGCCACCACCGACCTGGAAAAAAGCTACCGCATCAACCTGAACATGATCGGTCTGGACGGACGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCTCCGAATGGCTGACCTTCCGTCGCGATACGGTGCGCCGTCGTCTGAACCACCGTCTGGAGAAAGTGCTTAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTCCTCAATATTGATGAAGTCATTGAGATCATCCGTACCGAGGATGAGCCGAAGCCCGCGTTAATGTCGCGCTTTGGTATCAGTGAAACCCAGGCCGAAGCGATCCTCGAACTGAAGCTGCGCCATCTCGCTAAGCTGGAAGAGATGAAGATCCGCGGTGAGCAGAACGAGCTGGAAAAAGAGCGCGATCAGCTGCAGGCGATCCTCGCGTCCGAACGCAAGATGAACACCCTGCTGAAGAAAGAGTTGCAGGCCGATGCCGATGCCTTCGGCGACGACCGCCGTTCTCCGCTGCATGAGCGCGAAGAAGCGAAGGCGATGAACGAGCATGACATGCAGCCTTCAGAGCCGGTCACCATCGTCCTGTCCCAGAGCGGCTGGGTGCGTAGCGCCAAAGGCCATGATATCGATGCGCCGGGGCTGAGCTACAAAGCGGGCGACAGCTTCAAGGCGGCCGTGAAAGGCAAGAGCAACCAGCCGGTGGCGTTTATTGACTCCACGGGCCGCAGTTACGCCATCGATCCGATCACGTTGCCTTCCGCGCGTGGTCAAGGCGAACCGCTGACCGGCAAGCTGACGCTGCCGCCGGGGGCGACGGTTGACCACATGCTGATGGAAGCCGACGACCAGAAACTGCTGTTGGCCTCTGATGCGGGTTACGGCTTTATCTGTACCTTTAACGATCTCGTGTCACGTAACCGTGCCGGTAAAGCCATGATCAGCCTGCCGGATAACGCGCACGTTATGCCGCCGCTGGTGGTTGAGAACGAGAGCGACATGCTGCTGGCCATCACGTCTGCCGGGCGCATGCTGATGTTCCCGGTCAGCGACCTGCCGGAGTTGTCAAAAGGGAAGGGCAATAAGATCATCAACATCCCGTCGGCGGAAGCCGCGAAAGGTGAAGATGGCCTGGCGCATCTCTTCATTCTGCCGCCGCAGAGCACGCTGACCATTCATGTCGGCAAGCGTAAAATCAAGCTGCGTCCGGAAGAGTTGCAGAAGGTGGTGGGCGAGCGCGGACGCCGCGGTTCGCTGATGCGCGGCCTGCAGCGTATCGACCGCGTGGAGATCGATTCTCCTGCACGCAGCAACGCGGGCGACAGCGAAGAGTAA	
7845	CARD	prokka_00351	contig_1	683717	109	379787	380222	-1	144	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	261.536	210.0	Strict	86.11	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDIFNDVVPLGRLIHLVNQKKDRLLNDYLSPLDITATQFKVLCSIRCQVCITPVELKKVLSVDLGALTRMLDRLVCKGWIERSPNPNDKRGVLVTLTSDGADMCEQCHQLVGQTLHQELTKNLTAEEVATLELLLKKILP	GTGAAAAGCACCAGTGATATCTTCAACGACGTTGTTCCGCTGGGTCGTCTTATTCATCTGGTTAATCAGAAAAAAGACCGCCTGCTGAATGACTATCTGTCGCCGCTGGATATCACCGCAACGCAGTTTAAAGTGCTGTGCTCCATTCGCTGCCAGGTGTGTATCACCCCGGTTGAGTTAAAAAAGGTGCTCTCTGTCGATCTGGGCGCGCTGACCCGCATGCTGGATCGTCTCGTCTGTAAAGGATGGATAGAACGAAGCCCTAACCCGAATGACAAGCGCGGCGTCCTGGTGACACTCACCAGCGACGGTGCGGATATGTGTGAACAATGTCATCAATTAGTAGGACAAACACTGCATCAGGAACTAACAAAAAACTTAACGGCAGAGGAAGTGGCAACGCTTGAGCTTTTGCTTAAGAAAATACTGCCGTAA	
7845	CARD	prokka_03429	contig_13	110531	114	49039	49366	1	128	Escherichia coli soxS with mutation conferring antibiotic resistance	3003511.0	201.06	200.0	Strict	89.72	100.93	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein overexpression model	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSHQQIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVMHQTLGEYIRQRRLLLAAQALRSTQRPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHQLN	ATGTCGCATCAGCAAATTATTCAGACACTTATTGAATGGATTGATGAACATATCGACCAACCGTTGAACATTGATGTGGTCGCGAAAAAGTCGGGCTATTCGAAATGGTATTTACAGAGAATGTTCCGGACCGTAATGCACCAGACGCTGGGTGAGTACATTCGTCAGCGCAGGTTACTGCTGGCAGCGCAGGCGTTACGCTCTACGCAGCGGCCTATTTTTGATATCGCGATGGATCTGGGGTATGTGTCGCAACAAACCTTTTCCCGCGTGTTTCGCCGCGAGTTTGACCGCACGCCAAGCGATTACCGTCACCAGTTGAATTAA	
8088	BLDB	prokka_00594	contig_2	492734	103	17782	19030	-1	104	ACT-24		456.0		Perfect	100.0	99.74	cephalosporin-hydrolyzing class C beta-lactamase ACT-24	protein homolog model			Beta-Lactam	MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEANTVIDGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	ATGCTAAATTTAACCGTTTGTCAGGCACAGTCAAATCCAACAGACTACGCCTGTCTGACGGGCCCGGACATCCCCTTGACTCGCTATTACGGAAGATTACTGATGATGAAAAAATCTCTTTGCTGCGCCCTGCTGCTCGGCATCTCTTGCTCTGCTCTCGCCGCGCCAGTGTCAGAAAAACAGCTGGCGGAGGTGGTCGCGAATACGATTACCCCGCTGATGAAAGCCCAGTCGATTCCAGGCATGGCGGTGGCCGTTATTTATCAGGGTAAACCGCACTATTATACGTTTGGCAAAGCCGATATCGCGGCCAGCAAACCCGTTACGCCTCAGACTCTGTTCGAGCTGGGTTCTATAAGTAAAACCTTCACCGGGGTTTTAGGAGGGGATGCCATTGCTCGCGGTGAAATTTCGCTGGACGATCCGGTGACCAGATACTGGCCACAGCTGACGGGCAAGCAGTGGCAGGGGATTCGTATGCTGGATCTCGCAACCTACACCGCTGGCGGCCTGCCGCTACAGGTACCGGATGAGGTCACGGATAATGCCGCCCTGCTGCGCTTTTATCAAAACTGGCAGCCGCAGTGGAAGCCTGGCACAACGCGTCTTTACGCCAACGCCAGTATCGGTCTTTTTGGCGCGCTGGCGGTCAAACCTTCCGGCATGGGCTATGAGCAGGCCATGACGACGCGGGTCCTTAAGCCGCTCAAGCTGGACCATACCTGGATTAACGTTCCGAAAGCGGAAGAGGCGCATTACGCCTGGGGCTATCGTGACGGTAAAGCGGTGCGCGTTTCGCCGGGAATGCTGGATGCACAAGCCTATGGCGTGAAAACCAACGTGCAGGATATGGCGAACTGGGTCATGGCAAACATGGCGCCGGAGAACGTTGCTGATGCCTCACTTAAGCAGGGCATCTCGCTGGCGCAGTCGCGCTACTGGCGTATCGGGTCAATGTATCAGGGTCTGGGCTGGGAGATGCTCAACTGGCCCGTGGAGGCCAACACGGTGATCGACGGCAGCGACAGTAAGGTGGCGCTGGCACCGCTGCCCGTGGCAGAAGTGAATCCACCGGCTCCCCCGGTCAAAGCGTCCTGGGTCCATAAAACGGGCTCTACTGGCGGGTTTGGCAGCTACGTGGCCTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCGAATAAAAGCTATCCGAACCCGGCACGCGTTGAGGCGGCATACCATATCCTCGACGCGCTACAGTAA	
8088	BLDB	prokka_04556	contig_26	27356	129	964	1795	1	44	OXA-1		238.9		Perfect	100.0	99.64	oxacillin-hydrolyzing class D beta-lactamase OXA-1	protein homolog model			Beta-Lactam	MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL	ATGAAAAACACAATACATATCAACTTCGCTATTTTTTTAATAATTGCAAATATTATCTACAGCAGCGCCAGTGCATCAACAGATATCTCTACTGTTGCATCTCCATTATTTGAAGGAACTGAAGGTTGTTTTTTACTTTACGATGCATCCACAAACGCTGAAATTGCTCAATTCAATAAAGCAAAGTGTGCAACGCAAATGGCACCAGATTCAACTTTCAAGATCGCATTATCACTTATGGCATTTGATGCGGAAATAATAGATCAGAAAACCATATTCAAATGGGATAAAACCCCCAAAGGAATGGAGATCTGGAACAGCAATCATACACCAAAGACGTGGATGCAATTTTCTGTTGTTTGGGTTTCGCAAGAAATAACCCAAAAAATTGGATTAAATAAAATCAAGAATTATCTCAAAGATTTTGATTATGGAAATCAAGACTTCTCTGGAGATAAAGAAAGAAACAACGGATTAACAGAAGCATGGCTCGAAAGTAGCTTAAAAATTTCACCAGAAGAACAAATTCAATTCCTGCGTAAAATTATTAATCACAATCTCCCAGTTAAAAACTCAGCCATAGAAAACACCATAGAGAACATGTATCTACAAGATCTGGATAATAGTACAAAACTGTATGGGAAAACTGGTGCAGGATTCACAGCAAATAGAACCTTACAAAACGGATGGTTTGAAGGGTTTATTATAAGCAAATCAGGACATAAATATGTTTTTGTGTCCGCACTTACAGGAAACTTGGGGTCGAATTTAACATCAAGCATAAAAGCCAAGAAAAATGCGATCACCATTCTAAACACACTAAATTTATAA	
8088	BLDB	prokka_04576	contig_26	27356	129	16057	17197	-1	114	DHA-1		580.1		Perfect	100.0	99.74	class C beta-lactamase DHA-1	protein homolog model			Beta-Lactam	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA	
8088	BLDB	prokka_04662	contig_30	8022	187	1325	2123	-1	295	OXA-204		298.0		Perfect	100.0	99.62	OXA-48 family carbapenem-hydrolyzing class D beta-lactamase OXA-204	protein homolog model			Beta-Lactam	MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGHRRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP	ATGCGTGTATTAGCCTTATCGGCTGTGTTTTTGGTGGCATCGATTATCGGAATGCCTGCGGTAGCAAAAGAATGGCAAGAAAACAAAAGTTGGAATGCTCACTTTACTGAACATAAATCACAGGGCGTAGTTGTGCTCTGGAATGAGAATAAGCAGCAAGGATTTACCAATAATCTTAAACGGGCGAACCAAGCATTTTTACCCGCATCTACCTTTAAAATTCCCAATAGCTTGATCGCCCTCGATTTGGGCGTGGTTAAGGATGAACACCAAGTCTTTAAGTGGGATGGACATCGGCGCGATATCGCCACTTGGAATCGCGATCATAATCTAATCACCGCGATGAAATATTCAGTTGTGCCTGTTTATCAAGAATTTGCCCGCCAAATTGGCGAGGCACGTATGAGCAAGATGCTACATGCTTTCGATTATGGTAATGAGGACATTTCGGGCAATGTAGACAGTTTCTGGCTCGATGGTGGTATTCGAATTTCGGCCACTGAGCAAATCAGCTTTTTAAGAAAGCTGTATCACAATAAGTTACACGTATCGGAGCGCAGCCAGCGTATTGTCAAACAAGCCATGCTGACCGAAGCCAATGGCGACTATATTATTCGGGCTAAAACGGGATACTCGACTAGAATCGAACCTAAGATTGGCTGGTGGGTCGGTTGGGTTGAACTGGATGATAATGTGTGGTTTTTTGCGATGAATATGGATATGCCCACATCGGATGGTTTAGGGCTGCGCCAAGCCATCACAAAAGAAGTGCTCAAACAGGAAAAAATTATTCCCTAG	
8088	CARD	prokka_00753	contig_2	492734	103	182237	182663	1	71	FosA2	3002804.0	288.115	200.0	Strict	97.16	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARQYVPPQKSDYTHYAFTVAEEDFEPFSHRLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGSLAARLAACREKPYAGMVFTSDEA	ATGCTGCAATCTCTCAATCATCTGACCCTCGCGGTCAGCGACCTGCAAAAAAGCGTCACCTTCTGGCACGAGCTGCTGGGGCTGACGCTGCACGCCCGCTGGAATACCGGGGCCTATCTCACCTGTGGCGATCTCTGGGTCTGCCTGTCCTACGACGAGGCGCGCCAGTATGTGCCGCCGCAGAAGAGCGACTATACCCACTACGCGTTTACCGTGGCGGAAGAGGATTTTGAACCGTTCTCGCACAGGCTGGAGCAGGCGGGCGTCACCGTCTGGAAGCAGAATAAAAGCGAGGGGGCGTCGTTTTACTTTCTCGACCCGGACGGGCACAAGCTGGAGCTGCACGTGGGCAGCCTCGCCGCGCGGCTGGCGGCGTGTCGCGAGAAGCCCTATGCGGGCATGGTGTTTACCTCAGACGAGGCTTGA	
8088	CARD	prokka_00885	contig_2	492734	103	321435	321915	1	90	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.1434	32.0	Strict	27.33	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRTTLNKPVVMGRLTWESIGRPLPGRKNIVISSQPGTDDRVQWVKSVDEAIAACGDAEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSHSYCFEILERR	ATGATCAGTCTGATTGCAGCGCTGGCGGTAGACCGCGTTATCGGCATGGAAAACGCCATGCCGTGGAACCTGCCTGCCGATCTCGCATGGTTTAAACGTACTACGTTAAACAAGCCGGTAGTGATGGGCCGCCTGACCTGGGAGTCGATTGGTCGTCCATTGCCGGGTCGTAAGAATATTGTGATCAGTAGCCAGCCGGGCACTGACGATCGCGTGCAGTGGGTGAAATCCGTTGATGAAGCGATTGCCGCCTGCGGCGATGCCGAAGAGATCATGGTGATCGGTGGTGGTCGCGTGTATGAGCAGTTCCTGCCAAAAGCGCAGAAACTGTATCTGACGCACATTGATGCGGAAGTGGAAGGGGATACCCATTTTCCGGATTACGATCCGGACGAGTGGGAGTCCGTATTCAGTGAGTTTCACGATGCGGATGCGCAGAACTCGCACAGCTACTGCTTCGAAATTCTGGAACGTCGTTAA	
8088	CARD	prokka_01049	contig_3	459609	103	18287	20036	1	122	msbA	3003950.0	1139.79	1000.0	Strict	94.85	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MHNDKDLSTWQTFRRLWPMIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMILRGISSYVSSYCISWVSGKVVMTMRRRLFSHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFAMMFYYSWQLSLILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMETLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFSILDSEQEKDEGTRVIERAKGDLEFRNVTFTYPGREVPALRDISLSIPAGKTVALVGRSGSGKSTIASLITRFYDIDQGEILLDGHDLREYTLQSLRNQVALVSQNVHLFNDTVANNIAYARTEEYSREEIENAARMAYAMDFINKMDNGLDTIIGENGVLLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQSALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGVIVERGSHADLLEQRGVYAQLHKMQFGQ	ATGCATAACGACAAAGATCTCTCCACGTGGCAAACGTTCCGCCGGCTCTGGCCGATGATTGCACCTTTCAAAGCAGGCTTGATCGTGGCGGGCGTAGCGTTAATCCTCAACGCAGCCAGCGATACGTTTATGTTATCGCTTCTCAAACCGTTACTGGATGACGGTTTTGGTAAAACGGATCGTTCAGTGCTGCTATGGATGCCGCTGGTGGTTATTGGGCTGATGATCTTACGCGGAATCTCCAGCTATGTATCCAGCTACTGCATCTCCTGGGTATCCGGTAAAGTGGTGATGACCATGCGCCGTCGGTTATTCAGCCATATGATGGGGATGCCAGTCTCATTCTTTGACAAACAGTCAACCGGTACCCTGCTGTCGCGTATTACCTACGATTCAGAGCAGGTGGCGTCGTCCTCTTCCAGCGCACTGATTACCGTTGTGCGTGAAGGCGCATCCATCATCGGTCTTTTTGCGATGATGTTCTATTACAGCTGGCAACTGTCGCTGATCCTTATTGTGCTGGCGCCGATTGTCTCCATCGCGATCCGCGTGGTATCAAAGCGTTTTCGCAACATCAGTAAAAATATGCAGAATACGATGGGGCAGGTGACTACCAGCGCCGAGCAGATGCTGAAAGGCCATAAGGAAGTGTTGATCTTCGGCGGTCAGGAAGTCGAAACCAAACGCTTTGACAAGGTCAGCAACAGAATGCGCCTGCAAGGGATGAAAATGGTATCGGCCTCGTCGATTTCCGATCCGATCATTCAGCTGATTGCCTCTTTGGCCCTGGCCTTCGTCCTGTATGCAGCAAGCTTCCCGAGCGTCATGGAAACCCTGACTGCGGGTACCATTACCGTGGTGTTCTCATCCATGATTGCGCTGATGCGTCCGCTGAAATCGCTGACTAACGTCAACGCCCAGTTCCAGCGCGGGATGGCAGCCTGTCAGACGCTGTTCAGCATCCTCGATTCCGAACAGGAAAAAGATGAAGGTACACGCGTGATCGAGCGCGCTAAAGGTGACCTGGAATTCCGCAACGTGACCTTTACCTATCCAGGCCGTGAAGTGCCGGCGCTGCGTGATATCAGCCTGTCCATCCCGGCGGGTAAGACCGTTGCACTGGTCGGTCGTTCCGGTTCGGGCAAGTCGACTATTGCCAGCCTGATTACCCGTTTCTACGATATCGACCAGGGCGAAATCCTGCTTGATGGTCACGACCTGCGGGAATATACCCTACAGTCGTTGCGTAACCAGGTCGCGCTGGTTTCGCAAAACGTGCATCTGTTCAACGATACGGTGGCGAACAACATTGCGTATGCCCGTACCGAAGAGTACAGCCGTGAAGAGATCGAGAATGCGGCGCGTATGGCCTATGCGATGGACTTCATTAACAAAATGGATAACGGTCTGGATACGATCATTGGCGAAAACGGGGTGCTGCTCTCCGGTGGTCAGCGTCAACGTATCGCGATTGCCCGAGCGCTGCTGCGCAACAGCCCGATTCTGATCCTCGATGAAGCAACGTCCGCACTGGATACGGAATCTGAACGCGCTATCCAGTCGGCTCTGGATGAATTACAGAAAAACCGTACCTCGCTGGTTATCGCGCACCGTCTGTCGACCATCGAACAGGCTGACGAAATCGTGGTGGTGGAAGACGGCGTTATCGTTGAACGCGGCAGCCATGCGGACCTGCTGGAACAACGTGGTGTATACGCGCAGCTTCATAAAATGCAGTTCGGTCAATGA	
8088	CARD	prokka_01464	contig_3	459609	103	440411	440804	1	114	Klebsiella pneumoniae KpnE	3004580.0	196.052	150.0	Strict	82.5	108.33	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MDYILKQEKNMFYWILLALAIVAEITGTLSMKWASVSDGNTGFILMLVMITLSYIFLSFAVKKIALGVAYALWEGVGILLITLFSVMIFDETLTTMKIAGLTTLVAGIVLIKSGTRKPAKQQKEQTHAAV	ATGGATTATATTCTCAAGCAGGAGAAAAACATGTTTTACTGGATTTTATTAGCTCTGGCTATCGTTGCTGAAATTACCGGCACCTTGTCGATGAAATGGGCGAGCGTGAGTGACGGCAACACCGGATTTATTTTGATGCTGGTCATGATTACACTTTCCTATATATTCCTCTCTTTCGCGGTTAAAAAAATCGCGCTGGGCGTGGCATACGCTTTGTGGGAAGGTGTTGGTATTTTATTGATCACGCTGTTCAGCGTCATGATATTTGATGAAACCCTGACGACAATGAAAATTGCCGGGCTGACGACCCTGGTCGCAGGTATCGTGCTGATTAAATCGGGTACGCGCAAACCAGCCAAACAGCAGAAGGAGCAGACCCATGCAGCAGTTTGA	
8088	CARD	prokka_01465	contig_3	459609	103	440790	441120	1	87	Klebsiella pneumoniae KpnF	3004583.0	190.274	150.0	Strict	87.16	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAFAIVLEIIANVFLKFSDGFRRKAYGLLSIAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWIMFGQRLNHKGWIGLVLLLAGMIMIKLA	ATGCAGCAGTTTGAATGGATCCACGCGGCCTGGCTGGCTTTCGCCATCGTTCTGGAAATTATTGCGAACGTCTTTTTGAAGTTCTCCGACGGCTTTCGTCGCAAAGCCTACGGCCTGTTATCGATTGCCGCGGTTCTGGGGGCGTTTAGCGCCCTGTCGCAGGCGGTGAAAGGCATCGATCTTTCCGTGGCCTACGCGCTGTGGGGCGGCTTCGGTATTGCCGCCACCCTGGCGGCAGGCTGGATTATGTTCGGGCAGCGTTTAAACCATAAAGGCTGGATAGGGCTGGTATTACTGCTCGCTGGCATGATCATGATTAAACTGGCCTGA	
8088	CARD	prokka_01574	contig_4	349756	102	101474	104597	1	83	mdtB	3000793.0	1850.48	1800.0	Strict	90.1	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVMPPSSTGGPSRLFILRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLSLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAMPMTQVEDMVETRVAQKISQVTGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETIRTAISSANVNSAKGSLDGPTRAVTLSANDQMQSADEYRQLIVAYQNGAPIRLGDVATVEQGAENSWLGAWANKQQAIVMNVQRQPGANIIDTADSIRTMLPQLVESLPKSVSVKVLSDRTTNIRASVSDTQFELMLAIALVVMIIYLFLRNVPATIIPAVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERMFERIIAAYGRVLAKVLNHPWATLGVALGTLALSVMLWIFIPKGFFPIQDNGIIQGTLQAPQTVSFANMAQRQQQVSEIIMKDPAVESLTAYVGVDGTNPSLNSARLQINLKPLDDRDDRVNAVIERLQSAVARVPGIELYLQPIQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLVDKLKALPQVSDVSSDWQDKGLAAYVNVNRDTASRLGITMSDVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAVLDSIRLTSKDGGIVPLSAIASVEERHTPLSINHLDQFPSTTISFNVPDGYSLGEAVEAILGAEKELSFPSDIQTQFQGSTLAFQAALGSTVWLIVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALMLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMAPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLLVSQVLTLFTTPVIYLLFDRLALWTKSRFPKREEEA	ATGCAGGTGATGCCGCCGAGCTCTACAGGTGGGCCATCACGCCTGTTTATCTTACGTCCGGTTGCGACGACCCTGTTGATGGTGGCGATCCTGCTGGCCGGGATCATTGGCTACCGTTTTCTGCCCGTGTCGGCGCTGCCGGAAGTGGACTACCCGACCATTCAGGTTGTCACCCTCTATCCGGGCGCCAGTCCGGATGTGGTGACGTCCGCCATCACCGCCCCGCTGGAGCGTCAGTTTGGCCAGATGTCTGGCCTGAAGCAGATGTCCTCCCAGAGCTCCGGCGGCGCCTCGGTCGTCACGCTTCAGTTCCAGCTCACGCTGTCGCTGGACGTCGCCGAGCAGGAGGTGCAGGCCGCGATTAACGCCGCCACTAACCTGCTGCCGTCTGACCTGCCGAATCCACCGGTTTACAGCAAGGTGAACCCGGCAGACCCGCCGATCATGACGCTTGCCGTCACCTCCTCCGCCATGCCGATGACGCAGGTGGAAGACATGGTTGAAACCCGCGTGGCGCAGAAGATTTCGCAGGTGACCGGCGTGGGACTGGTGACGCTGGCGGGCGGTCAACGCCCCGCTGTGCGCGTTAAGCTCAATGCCCAGGCCATTGCCGCGCTGGGGTTAACCAGCGAAACCATTCGCACCGCCATCAGCAGCGCCAACGTTAACTCAGCGAAGGGCTCGCTGGACGGCCCAACCCGTGCGGTCACGCTCTCTGCCAACGACCAGATGCAGTCCGCCGATGAATACCGCCAGCTGATTGTGGCCTATCAAAACGGCGCGCCGATCCGCCTGGGCGACGTGGCAACCGTCGAACAAGGCGCGGAAAACAGCTGGCTCGGGGCGTGGGCCAATAAGCAGCAGGCGATTGTCATGAACGTTCAGCGCCAGCCAGGCGCGAACATTATTGATACCGCCGACAGCATTCGCACCATGCTGCCGCAGCTGGTGGAAAGCCTGCCAAAATCGGTGAGCGTGAAAGTGCTTTCTGACCGCACCACGAATATTCGCGCCTCGGTGTCAGACACCCAGTTCGAGCTGATGCTGGCGATTGCGCTGGTGGTGATGATCATCTACCTGTTCCTGCGCAACGTTCCGGCAACCATCATTCCCGCCGTCGCCGTGCCGCTCTCGCTGGTCGGGACGTTTGCGGTGATGGTGTTCCTCGACTTTTCGATTAATAACCTGACGCTGATGGCGCTCACCATCGCCACCGGGTTCGTGGTGGACGATGCCATCGTGGTCATCGAGAACATCTCGCGCTATATCGAAAAAGGTGAAAAGCCCTTAGCCGCCGCGCTGAAGGGCGCAGGAGAAATTGGCTTTACCATTATCTCGCTCACCTTCTCGCTGATTGCGGTGCTGATCCCGCTGCTGTTTATGGGGGATATCGTCGGGCGGCTGTTCCGCGAGTTTGCCGTGACGCTGGCGGTCGCCATTCTGATCTCTGCCGTGGTGTCGCTGACGCTAACGCCGATGATGTGCGCCCGCATGCTGAGCCACGAATCTTTGCGCAAGCAAAACCGCTTCTCGCGCGCCTCCGAGCGGATGTTCGAGCGCATTATCGCCGCCTACGGCCGCGTGCTGGCGAAAGTCCTGAACCATCCCTGGGCGACGCTCGGCGTGGCGCTCGGCACCCTGGCGCTCAGCGTGATGCTGTGGATTTTCATTCCGAAAGGCTTCTTCCCGATTCAGGACAACGGCATTATTCAGGGCACGCTTCAGGCGCCGCAGACGGTCTCCTTCGCCAACATGGCGCAGCGCCAGCAGCAGGTGTCTGAGATCATCATGAAAGATCCGGCGGTGGAAAGCCTGACCGCCTACGTGGGCGTGGACGGCACCAACCCGTCGCTCAACAGCGCGCGCCTGCAAATTAACCTTAAACCGCTTGATGACCGCGACGATCGCGTCAACGCGGTAATTGAGCGCCTGCAAAGCGCGGTGGCGCGCGTGCCGGGCATTGAGCTGTATCTGCAACCGATCCAGGATTTAACCATTGATACGCAGGTGAGCCGCACGCAGTACCAGTTTACGCTCCAGGCCACCTCGCTTGATGCACTCAGCACCTGGGTGCCGCAGCTGGTGGATAAGCTGAAAGCACTGCCGCAGGTTTCTGACGTCAGCAGCGACTGGCAGGATAAAGGGCTGGCGGCGTACGTGAACGTCAACCGCGACACCGCCAGCCGTCTGGGCATTACCATGTCCGATGTGGATAACGCCCTGTATAACGCCTTTGGTCAGCGACTGATCTCCACCATTTACACCCAGGCCAACCAGTATCGCGTGGTGCTGGAACATAACACCGAGAACACGCCCGGGCTTGCCGTGCTGGACTCAATACGCCTGACCAGCAAAGACGGCGGGATTGTGCCGCTCAGCGCCATTGCCAGCGTGGAAGAGCGCCACACCCCGCTGTCGATTAACCATCTCGATCAGTTCCCGTCCACCACCATTTCGTTCAACGTGCCGGATGGGTATTCGCTGGGCGAAGCGGTGGAGGCCATTCTGGGCGCGGAGAAAGAACTCAGCTTCCCGTCCGATATTCAGACCCAGTTCCAGGGCAGTACGCTGGCGTTCCAGGCCGCGCTGGGCAGCACCGTCTGGCTGATTGTCGCGGCGGTGGTGGCGATGTATATCGTGCTTGGCGTGCTGTATGAGAGTTTCATCCACCCGATCACCATCCTCTCCACCCTGCCGACGGCGGGCGTGGGGGCGCTGCTGGCGCTGATGCTGGCGGGGAGCGAACTGGACGTGATTGCGATAATTGGCATCATCCTGCTTATCGGCATCGTGAAGAAAAACGCCATCATGATGATCGACTTTGCGCTGGCCGCCGAGCGCGAGCAGGGTATGGCGCCGCGCGAGGCCATTTACCAGGCCTGTCTGCTGCGTTTTCGCCCGATCCTGATGACCACTCTCGCCGCCCTGCTGGGCGCGCTGCCGCTGATGCTGAGCACCGGCGTGGGGGCCGAACTGCGCCGTCCGCTGGGCATCGGCATGGTCGGCGGTCTGCTGGTGAGCCAGGTGCTGACGCTGTTTACCACGCCGGTTATCTACCTGCTGTTTGACCGTTTGGCCCTGTGGACAAAAAGCCGCTTCCCGAAACGTGAAGAGGAGGCGTAA	
8088	CARD	prokka_01575	contig_4	349756	102	104597	107675	1	96	mdtC	3000794.0	1873.6	1800.0	Strict	91.9	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILLSVAITLCGVLGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSETYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRSAISNANVRKPQGAIEDSSHRWQIQTNDELKTAAEYQPLIIHYNNGAAVRLSDVASVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVNSIRARLPELQETIPAAIVLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLVISLTLTPMMCGWMLKRSQPHSQPRRKGFGHVLMAMQSGYGKSLKWVLNHTRIVGLVLIATIGLNVWMYITIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRGERHETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLAALREWEPKIRKALAALPQLADVNSDSQNNGAEMALTYDRETMARLGINVEAANSLLNNAFGQREVSTIYQPMNQYKVVMEVDPRYTQDISALDKMFVINDDGKAIPLSYFASWQPSNAPLSVNHQGLSAASTVSFNLPTGSSLSEASDAINRAMTQLGVPSSVRGSFAGTAQVFQDTMNSQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALELFGAPFSLIALIGIMLLIGIVKKNAIMMVDFALDAQRNGNLTPDEAIFQACLLRFRPIMMTTLAALFGALPLVISGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKKRTTVTE	GTGAAGTTTTTCGCCCTCTTCATTTACCGTCCGGTGGCGACGATTTTACTCTCCGTCGCTATCACCCTGTGCGGCGTGCTCGGCTTCCGGCTGCTGCCGGTGGCCCCGCTACCGCAGGTCGATTTCCCGGTGATCATGGTCAGCGCCTCGCTGCCGGGCGCATCGCCGGAAACCATGGCCTCATCGGTGGCGACGCCGCTTGAGCGATCGCTTGGGCGGATTGCCGGGGTTAACGAGATGACCTCCAGCAGTTCGCTGGGCAGCACGCGCATCATTCTGGAATTTAACTTCGACCGGGATATCAACGGTGCGGCGCGCGACGTGCAGGCCGCGATTAACGCCGCCCAAAGCCTGCTGCCGAGCGGCATGCCGAGCCGTCCAACCTACCGCAAGGCCAACCCGTCCGATGCGCCGATCATGATCCTGACGCTTACGTCAGAGACCTACTCCCAGGGCGAGCTGTACGATTTTGCCTCCACCCAGCTGGCGCAAACCATCGCCCAGATTGACGGCGTGGGCGACGTGGACGTCGGCGGCAGCTCCTTGCCCGCCGTGCGCGTGGGGCTGAATCCGCAGGCGCTGTTTAATCAGGGCGTGTCGCTGGACGACGTGCGATCCGCCATCAGCAACGCCAACGTGCGTAAGCCGCAGGGCGCGATTGAGGACAGCAGCCACCGCTGGCAAATCCAGACCAACGACGAGCTGAAAACCGCCGCCGAGTATCAGCCGTTGATTATTCACTACAACAACGGCGCGGCGGTGCGCCTGAGCGACGTCGCCAGCGTCACCGATTCGGTGCAGGACGTGCGTAACGCCGGGATGACCAATGCCAAACCGGCGATTTTGCTGATGATCCGCAAGCTGCCGGAAGCCAACATCATTCAGACGGTGAACAGCATCCGCGCGCGGCTGCCGGAGCTTCAGGAAACCATTCCGGCGGCCATCGTTCTCCAGATTGCGCAGGACCGCTCCCCCACCATCCGCGCCTCGCTTGAAGAGGTAGAGCAAACGCTGATCATCTCCGTCGCGCTGGTAATTCTGGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCGGTAGCGGTCCCGGTATCGCTGATAGGCACCTTTGCCGCCATGTACCTGTGCGGGTTTAGCCTTAACAACCTGTCGCTGATGGCGCTGACGATTGCCACCGGGTTTGTGGTGGATGATGCCATCGTGGTGCTGGAGAATATCTCGCGTCATCTGGAAGCGGGCATGAAGCCGCTCCAGGCGGCGCTTCAGGGGACGCGCGAAGTGGGCTTCACGGTCCTGTCCATGAGCCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTGCCGGGGCGACTGCTGCGCGAATTTGCCGTCACGCTCTCCGTCGCCATTGGTATCTCACTGGTGATTTCGCTGACGCTAACGCCGATGATGTGCGGCTGGATGCTAAAGCGCAGCCAACCACACTCACAGCCGCGCAGGAAAGGCTTTGGCCACGTCCTGATGGCGATGCAGTCCGGCTACGGCAAATCGCTGAAATGGGTGCTGAACCACACGCGTATTGTCGGGCTGGTGCTTATCGCCACCATCGGGCTCAACGTCTGGATGTATATCACCATCCCGAAAACCTTCTTCCCGGAGCAGGATACCGGCGTGCTGATGGGCGGTATTCAGGCAGACCAGAGCATTTCGTTCCAGGCGATGCGCGGCAAGCTTCAGGACTTTATGAAAATCATCCGGGAAGATCCGGCCGTAGACAACGTTACCGGCTTTACCGGCGGCTCGCGCGTTAACAGCGGGATGATGTTTATTACCCTTAAGCCGCGCGGTGAACGTCACGAAACGGCGCAGCAGATCATTGACCGCTTGCGGGTGAAGCTCGCCAAAGAGCCGGGGGCGAACCTGTTTTTGATGGCCGTTCAGGATATCCGCGTCGGCGGACGACAGGCTAACGCCAGCTATCAGTACACCCTGCTCTCGGATGACTTAGCCGCCCTGCGCGAGTGGGAGCCGAAGATCCGTAAAGCGCTGGCCGCGCTGCCGCAGCTGGCGGACGTGAACTCCGACAGCCAGAACAACGGCGCGGAGATGGCGCTCACCTACGATCGTGAAACTATGGCCCGCCTGGGCATTAACGTGGAGGCGGCCAACAGCCTGCTTAACAACGCCTTCGGGCAGCGTGAAGTCTCCACCATCTATCAGCCGATGAACCAGTACAAGGTGGTAATGGAAGTTGATCCGCGCTACACCCAGGACATCAGCGCGCTGGACAAGATGTTTGTGATCAATGATGACGGCAAGGCGATCCCGCTGTCGTACTTCGCCAGCTGGCAGCCGTCGAACGCGCCGCTGTCGGTAAACCACCAGGGGCTTTCCGCCGCCTCGACCGTGTCGTTTAACCTGCCAACCGGCTCGTCGCTGTCTGAGGCCAGCGATGCCATTAACCGCGCCATGACCCAGCTTGGGGTGCCCTCCTCCGTGCGCGGCAGCTTTGCCGGTACGGCGCAGGTGTTCCAGGACACCATGAACTCGCAGGTCATTTTGATCCTGGCGGCCATTGCCACGGTGTACATCGTGCTGGGCGTGCTGTACGAAAGCTACGTGCACCCGTTGACCATTCTCTCCACGCTTCCCTCTGCGGGCGTGGGGGCGCTGCTGGCGCTGGAGCTGTTCGGTGCTCCATTCAGCCTCATCGCGCTCATTGGGATCATGCTATTAATAGGTATTGTGAAGAAAAACGCGATTATGATGGTCGACTTTGCCCTGGATGCCCAGCGTAACGGCAACCTGACGCCGGACGAGGCGATATTCCAGGCCTGTCTGCTGCGTTTTCGCCCGATCATGATGACTACGCTGGCCGCGCTGTTCGGCGCACTGCCGCTGGTCATATCCGGCGGTGACGGCTCTGAACTGCGCCAGCCGCTGGGGATCACGATCGTTGGCGGCCTGGTGATGAGCCAGTTGCTGACGCTCTACACCACGCCGGTAGTCTATCTGTTCTTTGACCGCCTGCGGCTGCGTTTTTCGCGTAAAAAGAGAACCACGGTGACCGAGTAA	
8088	CARD	prokka_01578	contig_4	349756	102	110487	111210	1	78	baeR	3000828.0	467.233	450.0	Strict	95.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPIDDNTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDVPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQVLDAQSPLIVDESRFQASWRSKLLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDADQSFIRAVYGVGYRWEADACRIA	ATGACCGAGTTACCGATTGACGACAACACACCGCGTATTTTGATCGTGGAAGACGAGCCTAAACTTGGGCAACTGCTGATCGACTATTTACGTGCCGCGAGCTATGCGCCAACGCTTATCAGCCACGGCGACCAGGTGCTGCCCTACGTGCGCCAGACGCCGCCGGATCTGATCCTGCTGGATCTGATGCTGCCGGGTACTGACGGCCTGACCCTGTGCCGGGAAATTCGTCGTTTCTCCGATGTGCCCATCGTGATGGTGACGGCCAAAATCGAAGAGATCGACCGTCTGCTGGGGCTCGAAATCGGCGCCGACGATTACATCTGCAAGCCTTACAGCCCGCGGGAGGTGGTCGCTCGCGTGAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGTGAATTGCAGGTGCTGGATGCACAAAGCCCACTGATCGTCGACGAAAGCCGCTTCCAGGCGAGCTGGCGCAGCAAACTATTGGATCTCACCCCCGCGGAGTTCCGCCTGCTGAAAACCCTCTCCCACGAGCCGGGAAAAGTGTTTTCCCGCGAGCAGCTGCTCAACCATCTGTATGACGATTACCGCGTGGTGACCGACCGCACCATCGACAGCCACATCAAAAACCTGCGCCGCAAGCTGGAGGCGCTGGACGCCGACCAGTCGTTTATTCGCGCGGTGTACGGCGTGGGGTATCGCTGGGAAGCGGATGCCTGCAGGATTGCCTGA	
8088	CARD	prokka_01870	contig_5	335564	101	86103	87336	-1	111	Escherichia coli mdfA	3001328.0	712.99	700.0	Strict	86.73	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MINRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQSIEQFTLLRFLQGVSLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAALAAISFFGLHRAMPETATRLGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIAQSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIILGGWPIAAGLIIAAVATVASSHAYLWMTAGLSVYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIEVSKHAYAFGGNGLFSLFNLANGVLWVGLMVVFLKDKRVGSALQP	ATGATAAACCGTTCTTCTTCCGGTAATCGTCTGGGTCGTCAGGCGTTACTTTTTCCTCTGTGTCTGGTGCTTTACGAATTCTCTACCTACATCGGCAACGACATGATCCAGCCCGGCATGCTGGCTGTGGTTGAGCAGTACAACGCAGGTATTGAGTGGGTGCCGACATCCATGACCGCCTATCTGGCGGGCGGCATGTTTTTACAGTGGCTGTTAGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGCTGACGGGCGTAGTGTGGTTTATCGTCACCTGTCTCGCCACGCTGCTGGCGCAGAGTATTGAGCAGTTCACGCTGCTGCGTTTCCTTCAGGGCGTGAGCCTGTGCTTTATTGGCGCCGTGGGCTATGCCGCTATTCAGGAGTCGTTTGAGGAGGCGGTGTGTATCAAAATTACCGCGCTGATGGCAAACGTGGCGCTGATTGCACCGCTTCTTGGGCCGCTGGTGGGAGCCGCATGGGTTCACGTCGCGCCGTGGGAGGGGATGTTCGTCCTCTTTGCCGCGCTTGCGGCTATCTCTTTCTTTGGCCTGCACCGTGCGATGCCGGAAACCGCCACCCGCCTGGGCGAAAAGCTCTCGCTTAAAGAGCTGGGGCGGGATTATAAGGCGGTGCTGAAAAATGGCCGTTTTGTCGCGGGCGCATTGGCGACGGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTCATTATCATCAGCGGCGAACAGCTTAGCAGCTATGAGTATGGCCTGTTACAGGTGCCGATTTTTGGCGCGCTGATTATCGGTAACCTGGTGCTGGCGCGTCTGACGTCGCGCCGTACCGTGCGTTCGCTGATTATTTTGGGCGGCTGGCCCATAGCGGCAGGGCTGATTATCGCGGCGGTGGCGACCGTAGCCTCGTCTCATGCGTACCTGTGGATGACGGCGGGGCTGAGTGTTTACGCGTTTGGTATCGGCGTGGCGAATGCTGGCCTGGTGCGCCTGACGCTGTTCGCCAGTGAAATGAGTAAAGGCACGGTGTCTGCCGCGATGGGGATGCTGCAAATGCTGATTTTCACCGTCGGTATTGAGGTGAGCAAACATGCCTATGCTTTCGGCGGTAACGGGCTGTTCAGCCTGTTCAACCTCGCAAACGGTGTGCTGTGGGTAGGGCTGATGGTGGTGTTCCTGAAGGACAAACGCGTCGGAAGCGCACTGCAACCGTAA	
8088	CARD	prokka_02167	contig_6	286506	105	66277	67099	-1	93	bacA	3002986.0	512.686	500.0	Strict	95.24	100.0	undecaprenyl pyrophosphate related proteins	protein homolog model	antibiotic target alteration		peptide antibiotic	MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRLPQREGEGKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTVGDIPMFAVGFITAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF	ATGAGCGATATGCACTCGCTGCTGGTGGCGGCAATTCTGGGTGTGGTCGAAGGATTGACGGAGTTTTTGCCGGTGTCCAGTACGGGCCATATGATTATCGTTGGCCATCTCCTGGGCTTTGAAGGCGATACCGCAAAGACGTTTGAGGTGGTGATTCAGCTGGGCTCTATTCTGGCGGTGGTCGTCATGTTCTGGCGTCGTCTGTTTGGTCTGATCGGCATCCACTTCGGGCGTCTACCGCAGCGTGAAGGAGAGGGCAAGGGGCGCCTGACGCTGATTCATATTCTGCTGGGGATGATCCCGGCGGTGGTGCTGGGGCTGGTGTTCCATGACACCATAAAATCGCTTTTCAACCCGATTAACGTGATGTACGCGCTGGTTGTCGGCGGCTTCCTGCTGATTGCCGCCGAAGTGCTGAAGCCAAAAACCCCGCGTGCAGAAGGTCTGGACGATATGACGTATCGCCAGGCGTTTATGATTGGCTGCTTCCAGTGTCTGGCGCTGTGGCCGGGCTTCTCCCGTTCAGGGGCAACCATTTCCGGCGGGATGCTGATGGGCGTGAGCCGTTACGCGGCGTCTGAGTTCTCGTTCCTGCTGGCGGTACCGATGATGATGGGCGCCACCGCACTGGATCTCTACAAAAGCATCGGCTTCCTGACCGTAGGCGACATTCCGATGTTCGCCGTGGGCTTTATCACCGCCTTTATCGTGGCGCTGATTGCCATCAAAACCTTCCTGCAACTGATTAAGCGTATCTCGTTTATTCCGTTCGCGATCTACCGCTTTATCGTCGCGGCTGCCGTGTACGTGGTCTTCTTCTGA	
8088	CARD	prokka_02371	contig_6	286506	105	282205	285319	1	116	adeF	3000777.0	755.747	750.0	Strict	40.63	97.92	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MANFFIQRPVFAWVLSIILMIAGGLAILKLPVAQYPTIAPPAVAVTATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGNVTITLTFESGTDPDIAQVQVQNKLQLAMPLLPQEVQQQGIGVEKSSSSFLLVAGFVSDNKNLTQDDISDYVASNVKDAISRTSGVGDVQLFGAQYAMRIWLDSNAMNKYQLTPLDVINQLKTQNDQIAAGQLGGTPSVPGQQLNASIIAQTRLKSPEEFGRVTLKVNQDGSMVHLKDVARIELGGENYNMVTKINGQAATGLGIKLATGANALDTAAAIKSKLAQLQPFFPQGLKVVYPYDTTPFVKISIHEVVKTLFEAIVLVFLVMYLFLQNLRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEDKLPPKEATQKSMEQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSLTIVSAMALSVLVALILTPALCATLLKPVSSDHHEKKGGFFGWFNALFDKSVEHYSNSVSGILRKTGRYLLVYVIIVGGMAVLFLRLPSSFLPEEDQGVFMTMVQLPAGATQMRTQQVLDQVQDYYLTKEKANVESVFTVNGFSFSGQGQNSGIAFVSLKPWEERPGKENGVEAIVSRATKAFSQIKDGLVFPFNLPAIIELGTATGFDFELIDQANLGHTQLTQARNQLLGMVREHPDLLVRVRPNGLEDTPQYKLDVDQEKAQALGVSISDVNQTISTALGGTYVNDFIDHGRVKKVYVQADARFRMLPGDINDLYVRSANGEMVPFSAFSSSHWVYGSPRLERYNGMPSMEILGESAPGKSTGEAMEMMESLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAASIRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMLSATLLAIFFVPVFFVVVRRRFTKHKD	ATGGCTAATTTCTTTATTCAACGGCCTGTTTTCGCCTGGGTGCTCTCCATCATTCTGATGATTGCGGGCGGGCTGGCCATTTTAAAACTGCCGGTGGCGCAATATCCAACCATTGCGCCGCCAGCAGTTGCGGTGACAGCGACCTACCCTGGCGCTGATGCCCAGACGGTCCAGGATACCGTGACGCAGGTTATCGAACAGAACATGAACGGAATCGACAATCTGATGTACATGTCGTCCACCAGTGATTCTGCCGGTAACGTCACCATCACCCTGACGTTCGAGTCGGGTACGGATCCTGACATCGCGCAGGTGCAGGTTCAGAACAAACTCCAGCTCGCTATGCCGCTGCTACCGCAAGAAGTACAGCAACAGGGGATCGGCGTGGAAAAATCCAGCAGCAGCTTCCTGCTGGTCGCGGGATTTGTGTCGGATAATAAAAACCTCACTCAGGATGATATCTCCGACTATGTCGCTTCTAACGTAAAAGATGCGATCAGCCGTACTTCCGGCGTCGGTGATGTGCAGCTGTTCGGTGCGCAGTATGCAATGCGCATCTGGCTGGACAGCAACGCGATGAATAAATATCAGCTCACGCCGTTGGATGTCATTAACCAACTGAAAACGCAGAACGACCAGATTGCTGCGGGCCAGTTGGGAGGTACGCCGTCCGTACCAGGGCAGCAACTGAACGCCTCAATTATTGCTCAAACGCGCCTGAAATCGCCGGAGGAGTTTGGCCGTGTGACGCTGAAGGTGAACCAGGACGGTTCAATGGTCCACCTGAAAGATGTGGCCCGCATTGAGCTGGGTGGCGAAAACTACAACATGGTCACCAAAATCAATGGCCAGGCAGCAACGGGGCTCGGGATCAAGCTGGCGACTGGCGCAAACGCGCTGGATACCGCTGCCGCCATTAAGAGTAAACTGGCGCAGTTGCAGCCCTTCTTCCCTCAGGGCCTGAAAGTCGTTTATCCGTACGACACCACACCTTTCGTGAAGATCTCAATCCATGAAGTGGTGAAGACGCTGTTTGAAGCGATCGTTCTCGTGTTCCTGGTGATGTACTTGTTCCTGCAAAACCTGCGGGCAACCCTTATTCCGACTATTGCCGTGCCCGTGGTGCTACTGGGTACCTTTGCAGTACTGGCTGCGTTTGGTTTCTCCATTAACACCCTGACGATGTTCGGGATGGTATTGGCGATAGGTTTGCTCGTCGATGATGCCATCGTGGTGGTTGAGAACGTAGAACGCGTCATGGTTGAGGACAAGCTGCCGCCAAAAGAGGCGACCCAGAAGTCGATGGAGCAAATCCAGGGCGCTCTGGTGGGCATTGCCATGGTGCTTTCAGCGGTGTTTATTCCGATGGCATTTTTTGGAGGTTCAACCGGGGCTATCTATCGCCAGTTCTCGCTGACCATTGTCTCCGCGATGGCCTTATCGGTGCTGGTGGCGTTGATATTAACGCCTGCTTTATGTGCAACGCTGCTCAAACCGGTTTCCAGCGACCATCATGAAAAGAAAGGTGGATTCTTCGGCTGGTTTAACGCGCTTTTTGATAAGAGCGTGGAGCACTACAGCAACAGCGTGAGCGGCATTTTACGTAAGACTGGACGCTATCTGCTGGTTTACGTCATCATCGTCGGCGGCATGGCAGTACTGTTCCTGCGCCTGCCTTCCTCCTTCCTGCCGGAAGAGGATCAGGGGGTGTTTATGACGATGGTTCAGCTGCCGGCAGGGGCGACGCAGATGCGTACCCAGCAGGTACTCGATCAGGTTCAGGACTATTATCTGACGAAAGAGAAAGCGAACGTTGAATCGGTCTTTACCGTAAACGGATTTAGCTTTAGCGGGCAGGGGCAGAACTCCGGTATCGCTTTCGTCAGCCTGAAGCCATGGGAAGAACGCCCGGGCAAGGAAAACGGCGTTGAGGCGATTGTCAGCCGCGCAACGAAAGCGTTTAGCCAGATCAAAGATGGTCTTGTATTTCCGTTTAACCTCCCTGCCATTATTGAACTGGGTACCGCAACAGGCTTTGACTTTGAACTGATTGACCAGGCAAACCTGGGACATACGCAGCTCACGCAGGCACGTAACCAACTGCTTGGCATGGTAAGGGAACATCCTGACTTACTGGTCCGCGTGCGTCCTAACGGACTGGAAGATACGCCACAGTACAAACTGGATGTCGACCAGGAGAAGGCCCAGGCGCTGGGTGTGAGCATATCTGATGTCAATCAGACCATCTCAACAGCATTGGGTGGCACTTATGTGAACGACTTTATCGATCATGGACGCGTGAAAAAAGTTTATGTCCAGGCTGATGCTCGCTTCCGTATGTTACCAGGAGATATTAACGACCTGTATGTGCGTAGTGCTAACGGCGAAATGGTGCCTTTCTCTGCCTTTAGCAGCTCTCACTGGGTGTACGGCTCACCTCGTCTGGAACGTTACAATGGGATGCCATCAATGGAGATCCTCGGTGAGTCTGCGCCAGGCAAAAGTACCGGTGAGGCAATGGAGATGATGGAAAGCCTTGCGTCGAAACTGCCTTCCGGAATTGGCTACGACTGGACGGGGATGTCTTATCAGGAACGTCTTTCCGGAAATCAGGCTCCAGCACTGTATGCCATTTCACTGATTGTGGTGTTCCTGTGTCTGGCGGCTCTCTATGAAAGCTGGTCAATTCCATTCTCGGTCATGCTGGTTGTGCCCCTGGGGGTGATCGGCGCGCTTCTGGCTGCATCAATACGTGGGCTGAACAATGACGTTTACTTCCAGGTTGGTCTGCTTACGACAATTGGTTTATCAGCCAAAAACGCCATACTGATCGTTGAGTTCGCCAAGGATCTTATGGATAAAGAAGGCAAAGGGATTATTGAAGCCACGCTGGAAGCCTCACGTATGCGTCTGCGCCCTATCCTGATGACCTCTCTGGCATTTATCCTTGGTGTTATGCCTCTGGTCATCAGTAGTGGCGCAGGTAGTGGGGCACAAAACGCTGTCGGGACGGGCGTGATGGGAGGGATGCTGTCAGCCACTCTGCTGGCCATTTTCTTTGTTCCTGTTTTCTTCGTTGTTGTCCGGAGACGGTTTACAAAGCATAAGGATTAA	
8088	CARD	prokka_02667	contig_8	241014	102	22048	22390	-1	99	ramA	3000823.0	232.261	230.0	Strict	95.58	91.13	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MTISAQVIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLMAARDLRESDERVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSQTH	ATGACGATTTCCGCTCAGGTCATTGATACGATTGTCGAATGGATCGATGACAACCTACACCAGCCGTTACGCATCGAAGAGATTGCCCGCCATGCGGGTTACTCAAAATGGCATTTACAGCGGCTGTTTATGCAGTACAAAGGCGAAAGTCTGGGGCGCTACATCCGCGAACGCAAGCTGCTGATGGCGGCGCGCGATCTGCGTGAGTCAGACGAGCGCGTATACGATATCTGCCTGCGCTACGGGTTTGACTCGCAGCAGACGTTTACCCGCATCTTTACCCGCACCTTCAACCAGCCGCCCGGGGCGTACCGCAAAGAGAACCATAGCCAGACACATTAA	
8088	CARD	prokka_02740	contig_8	241014	102	99253	102400	1	113	acrB	3000216.0	1971.05	1900.0	Strict	92.85	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDVIAKFNGKPASGLGIKLATGANALDTATAIRAELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAIFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIKKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLLLYIIIVVGMAFLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYFLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGDENKVEAITNRAMGTFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGLEDTPQYKIDIDQEKAQALGVTISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAQYRMLPNDINNWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAMNLMEELASKLPAGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDVEHNHSVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCGTGGGTGATCGCCATTATCATCATGCTGGCCGGGGGACTTGCGATCCTGAAGCTGCCTGTTGCGCAATATCCAACGATTGCGCCGCCGGCAGTGACGATCTCCGCAACCTACCCGGGCGCTGATGCCAAAACGGTGCAGGACACCGTTACGCAGGTTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCAAACAGTGACTCAACCGGTACAGTTCAGATTACCCTGACCTTTGAATCCGGTACGGATGCGGACATTGCGCAGGTTCAGGTGCAGAACAAACTGCAGCTGGCGATGCCCCTGCTGCCGCAGGAAGTGCAACAACAGGGTGTGAGCGTCGAGAAATCGTCCAGTAGCTTCCTGATGGTTGTCGGCGTGATTAACACCGATGGCACCATGACGCAGGAAGATATTTCCGACTACGTGGGCGCCAACATGAAGGACGCCATCAGCCGTACGTCTGGTGTGGGTGATGTTCAGCTGTTCGGTTCACAGTACGCGATGCGTATCTGGATGGATCCGAATAAGCTGAACAACTTCCAGCTAACCCCGGTTGACGTGATCAGCGCAATTAAAGCGCAAAACGCCCAGGTTGCAGCCGGTCAGTTAGGCGGCACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCGTCTATCATCGCGCAAACGCGTCTGACCTCGGCGGATGAGTTCAGTAAAATTCTGCTGAAGGTGAATCAGGACGGTTCGCAGGTTCGCCTGCGTGACGTGGCGAAAGTGGAGCTGGGTGGCGAGAACTACGACGTTATTGCGAAGTTCAACGGTAAACCGGCTTCCGGTTTAGGTATCAAACTGGCGACTGGTGCGAACGCCCTGGACACCGCGACGGCTATCCGTGCAGAACTGAAGAAGATGGAACCTTTCTTCCCGTCAGGTCTGAAAATTGTTTACCCGTATGACACCACGCCGTTCGTTAAAATTTCGATTCACGAAGTGGTTAAAACCCTGGTTGAGGCGATCATCCTCGTCTTCCTGGTAATGTACCTGTTCCTGCAAAACTTCCGCGCAACGCTGATCCCAACCATCGCCGTGCCGGTTGTACTGCTCGGCACCTTCGCGGTTCTGGCGATATTTGGCTATTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGCTGGTGGATGACGCCATCGTAGTGGTCGAAAACGTTGAGCGTGTGATGGCGGAAGAAGGCCTGCCGCCGAAGGAAGCAACCCGTAAATCAATGGGCCAGATCCAGGGCGCGCTGGTCGGTATCGCGATGGTTCTGTCTGCGGTATTTATCCCGATGGCCTTCTTCGGTGGTTCAACCGGTGCGATTTACCGTCAGTTCTCTATTACCATCGTTTCCGCGATGGCGCTGTCGGTGCTGGTAGCCCTGATCCTGACGCCAGCCCTGTGTGCGACCATGCTGAAGCCGATTAAGAAAGGTGGCCACGGCGAGCACAAAGGGTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGTACGCATCACTACACCGACAGCGTGGGGAACATCCTGCGCAGCACCGGTCGTTATCTGCTGCTCTATATCATCATCGTGGTGGGCATGGCTTTCCTGTTTGTTCGTCTGCCAAGCTCGTTCCTGCCAGATGAAGACCAGGGCGTGTTCCTGAGCATGGCTCAGCTTCCGGCGGGTGCGACGCAAGAACGTACGCAAAAAGTGCTGGATGAGATGACCGACTACTTCCTGACCAAAGAGAAAGACAACGTCGAATCCGTGTTTGCGGTTAACGGCTTTGGCTTCGCGGGTCGTGGTCAGAACACCGGTATTGCCTTCGTTTCTCTGAAAGACTGGTCCGAACGCCCGGGTGATGAGAACAAAGTTGAAGCCATTACCAACCGGGCCATGGGTACCTTCTCACAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCAGCGATTGTTGAACTGGGTACGGCGACCGGCTTCGACTTCCAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACTCAGGCGCGTAACCAGCTATTTGGCGAGGTGGCTAAACACCCTGACCTGCTGGTGGGCGTGCGTCCTAACGGTCTGGAAGATACGCCGCAGTACAAGATCGATATCGACCAGGAAAAAGCACAGGCGCTGGGTGTGACCATCAGTGACATCAATACCACGCTGGGTGCAGCCTGGGGTGGCAGCTACGTCAACGACTTCATCGACCGTGGTCGCGTGAAGAAAGTGTACGTCATGTCCGAAGCGCAATACCGTATGCTGCCGAACGATATCAACAACTGGTACGTTCGCGGCAGCGATGGCCAGATGGTGCCGTTCTCCGCCTTCTCAACTTCGCGCTGGGAATACGGTTCGCCGCGTCTGGAGCGTTATAACGGCTTGCCATCGATGGAGATTCTCGGTCAGGCGGCGCCGGGCCGAAGCACCGGTGAAGCCATGAACCTGATGGAAGAGTTGGCCAGCAAACTGCCTGCGGGTATTGGCTACGACTGGACCGGTATGTCCTATCAGGAACGTCTGTCCGGTAACCAGGCCCCTGCCCTGTACGCCATTTCACTGATTGTGGTGTTCCTGTGTCTGGCGGCATTGTATGAGAGCTGGTCGATTCCGTTCTCCGTTATGCTCGTGGTTCCGCTGGGGGTTATCGGTGCGCTGCTTGCCGCAACCTTCCGTGGGCTGACTAACGACGTTTACTTCCAGGTGGGCCTGCTGACAACCATTGGCTTGTCGGCGAAGAACGCGATACTTATCGTCGAATTCGCCAAAGATCTGATGGAGAAAGAAGGTAAAGGCCTGATTGAAGCAACGCTTGAAGCCGTTCGTATGCGTCTGCGTCCAATCCTGATGACGTCCCTGGCGTTTATCCTCGGCGTTATGCCGCTGGTTATCAGCTCAGGCGCAGGCTCCGGCGCACAGAACGCGGTAGGTACCGGTGTAATGGGTGGTATGGTCACTGCGACCGTTCTCGCCATCTTCTTTGTACCGGTGTTCTTCGTGGTGGTACGTCGCCGCTTTAGCCGCAAAAATGAAGATGTGGAGCACAATCATTCGGTAGAACATCACTGA	
8088	CARD	prokka_02844	contig_8	241014	102	211362	212523	1	125	Escherichia coli ampH beta-lactamase	3004612.0	697.197	500.0	Strict	86.23	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRCLLSFAALCAVSLSTAQAAQPLTAPVLASDIADRYANLIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNVRPQLDSVIRVASITKLMTSEMLVKLLDQGVVKLDDPLSKYAPPGARVPTYQGTPIRLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWNYLSTATLKSAPGSQAGYSNLAFDLLADALATASGKPYPQLFEEQITRPLGMKDTTYTPSPDQCKRLMVAEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYARSNQADRMQTLIYQRAQLRRVIGMDVPGKADALGMGWVYMAPKDGRPGIIQKTGGGGGFITYMAMIPQSNVGAFVVVTRSPNTRFVNMSDGVNNLVAELSANKAQVLTAAN	TTGAAACGTTGTCTGCTCTCTTTCGCCGCGCTGTGTGCGGTGAGCCTGTCCACCGCCCAGGCAGCACAGCCTCTGACGGCACCGGTTCTGGCCTCTGACATTGCCGATCGCTATGCGAACCTTATTTATTACGGCAGTGGTGCGACGGGAATGGCGCTGGTCGTGATCGACGGTAACCAGCGGGTGTTTCGCAGCTTCGGTGAAACACGACCGGGAAATAACGTTCGCCCGCAGCTGGATTCCGTTATCCGTGTCGCGTCGATAACTAAGCTGATGACCAGCGAAATGCTGGTGAAATTGCTCGATCAGGGCGTGGTAAAACTCGACGATCCACTTAGCAAATATGCGCCACCCGGCGCTCGCGTTCCGACATATCAGGGAACGCCGATCAGGCTGGTGAACCTGGCGACCCATACCAGCGCCCTGCCGCGAGAACAGCCCGGTGGCGCTGCGCATCGCCCTGTCTTTGTCTGGCCAACTCGCGAACAACGCTGGAACTACCTGAGCACCGCAACGCTGAAATCGGCTCCGGGTTCTCAGGCTGGCTATTCTAACCTGGCGTTTGATCTGCTGGCCGACGCGTTAGCAACGGCATCAGGTAAGCCTTACCCTCAGCTGTTTGAAGAGCAAATCACGCGTCCGCTCGGGATGAAAGATACTACTTACACCCCCTCCCCGGACCAGTGCAAGCGTCTGATGGTGGCGGAAAAAGGGGCCAGCCCGTGTAATAACACGCTGGCAGCCATTGGCAGCGGTGGGGTTTACTCTACGCCTGGCGACATGATGCGCTGGATGCAACAGTTCCTCTCATCGGATTTTTACGCGCGCAGTAATCAGGCCGACCGAATGCAGACGCTCATCTACCAGCGTGCTCAGTTACGTCGCGTCATTGGTATGGATGTTCCCGGTAAAGCCGATGCCCTCGGCATGGGCTGGGTATATATGGCGCCAAAAGATGGTCGCCCGGGTATTATTCAAAAAACCGGTGGGGGTGGCGGATTCATCACCTACATGGCGATGATTCCGCAATCAAACGTGGGCGCTTTTGTGGTGGTCACCCGGTCACCGAACACCCGCTTCGTGAATATGAGTGATGGCGTAAATAACCTTGTAGCCGAGCTGAGCGCCAATAAAGCGCAGGTACTTACGGCCGCTAACTGA	
8088	CARD	prokka_03098	contig_9	240616	104	239724	239910	1	149	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGGGATGAGGTCACCGTGACAGTTTTAGGGGTAAAGGGTAACCAGGTACGTATTGGTGTTAACGCTCCTAAAGAAGTATCTGTCCACCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTGA	
8088	CARD	prokka_03187	contig_10	226606	107	91584	92760	1	88	oqxA	3003922.0	695.6560000000002	670.0	Strict	92.07	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGYFHLSATGVVLLSALLVGCDDSVAQNAAPQAPVVSAADVVVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGEVLFTIDDRTYRAALEQAQANLARAKTQASLARSEANRTDKLVNTNVVSREEWEQRRSAATQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDSASVLTTLVSQKTVYVYFDVDESTYLHYQNLARSGQGASSHHTALPVEIGLTGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRQFTPGLFARVRLPGSAEFKATLVDDKAVLTDQDRKYVYVVDKDGKAQRRDITPGRLADGLRIVQQGLNPGDKVIVDGLQKVFMPGMPVNAKTVAMTASAALN	ATGAGCCTGCAAAAAACCTGGGGTTACTTTCATCTGAGCGCGACGGGGGTGGTTTTACTCTCCGCGCTTCTCGTCGGGTGCGATGACAGTGTCGCGCAAAATGCTGCACCGCAAGCGCCCGTCGTCAGCGCAGCTGACGTGGTGGTGAAATCCATTAGCCAGTGGGACAGCTTTAACGGTCGCATTGAAGCGGTGGAAAGCGTTCAGCTGCGCCCACGCGTCTCCGGCTACATTGATAAAGTGAATTACACCGACGGCCAGGAGGTGAAAAAGGGCGAGGTGCTGTTCACGATTGATGACCGAACCTATCGCGCGGCGCTGGAACAGGCGCAGGCGAACCTGGCGAGAGCCAAAACGCAGGCCAGCCTGGCGCGAAGCGAGGCTAACCGTACCGATAAATTAGTCAATACCAACGTGGTATCCCGTGAAGAGTGGGAGCAGCGCCGTTCCGCCGCTACCCAGGCGCAGGCCGATATTCGCGCGGCGCAGGCGGCGGTTGATGCCGCGCAGCTCAACCTCGACTTCACCAAAGTGACCGCGCCTATCGACGGTCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTGACTGCGGGTGACAGCGCCAGCGTGCTCACCACCCTGGTCTCACAGAAGACGGTTTACGTCTACTTCGACGTGGACGAGTCCACCTATCTTCACTATCAGAACCTGGCCCGCAGCGGGCAGGGGGCGTCCAGTCACCACACGGCGCTGCCGGTGGAGATTGGTCTGACGGGTGAGGAGGGCTATCCCCATCAGGGCAAAGTGGATTTCCTGGATAACCAGCTCACGCCGAGTACCGGTACAATCCGCATGCGCGCGCTGCTGGATAACTCACAGCGTCAGTTCACGCCGGGACTCTTCGCACGCGTGCGCCTGCCGGGCAGTGCGGAATTTAAAGCCACGCTTGTTGACGATAAGGCGGTGCTGACCGATCAGGATCGTAAGTATGTTTATGTCGTTGATAAAGACGGGAAAGCGCAGCGCCGCGATATTACGCCGGGGCGTCTGGCCGACGGTTTACGTATTGTACAGCAGGGGCTGAATCCCGGGGATAAAGTCATCGTCGATGGTTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCGAAAACCGTTGCCATGACCGCCAGCGCCGCCCTCAACTGA	
8088	CARD	prokka_03188	contig_10	226606	107	92783	95936	1	102	oqxB	3003923.0	2053.48	2000.0	Strict	96.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQISAGQLGAEPLPKESDFLISINAQGRLHTEEEFGNIVLKTTQDGTVVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMDELSTRFPDDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGFAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAPKDFPTRLIDRLFGWIFRPFNRFFHRSSTGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRAGLGYGALQNAVNTMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGQFRDSVEDIANLRTRNDQGEMVPIGSMVKITTTYGPDPVIRYNGYPAADLIGDADPRVLSSAQAMTQLDAMSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKFVTRGKAEREVLPA	ATGGACTTTTCCCGTTTTTTCATCGACAGGCCGATTTTTGCCGCCGTACTGTCGATTCTGATTTTTATCACAGGATTAATCGCCATCCCGCTGCTGCCGGTGAGCGAATATCCTGATGTCGTGCCGCCAAGCGTGCAGGTGCGCGCCGAGTACCCGGGCGCCAACCCGAAAGTGATTGCCGAAACCGTGGCGACGCCGCTGGAAGAGGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCCGTCGCGGGCTCCGACGGCGTGCTGGTGACTACCGTCACCTTCCGTCCGGGTACCGACCCGGATCAGGCGCAGGTACAGGTGCAAAACCGCGTCGCACAGGCCGAGGCACGTCTGCCGGAAGACGTTCGGCGTCTGGGCATTACGACTCAGAAACAGTCGCCAACGCTGACGCTGGTGGTGCATCTCTTTTCGCCTGGCGGTAAGTACGATTCACTGTATATGCGTAACTACGCCACGCTGAAGGTGAAGGACGAGCTGGCGCGTCTGCCCGGCGTGGGTCAGATCCAGATTTTCGGCTCGGGTGAATACGCGATGCGCGTCTGGCTGGATCCAAACAAGGTGGCGGCGCGCGGACTGACGGCCTCGGACGTGGTGACGGCGATGCAGGAGCAAAACGTACAGATATCCGCCGGGCAGCTTGGCGCCGAGCCGCTGCCGAAAGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATTGTCCTGAAAACAACGCAGGACGGTACGGTCGTCCGCCTGCGCGACGTGGCGCGTATCGAGATGGGTTCCGGCAGCTATGCGCTGCGCTCCCAGCTGAACAATAAAGACGCGGTCGGGATTGGTATCTTCCAGTCGCCGGGGGCAAACGCCATCGATCTGTCTAACGCGGTGCGCGCCAAAATGGACGAACTGTCCACCCGTTTCCCGGACGATATGAAGTGGGCGGCACCTTATGACCCAACGGTATTTGTGCGCGACTCGATCCGTGCGGTTGTACAAACGCTGCTGGAAGCGGTGGTGCTGGTCGTGCTGGTGGTGATCCTGTTCCTGCAAACCTGGCGCGCGTCGATCATCCCGCTGATCGCGGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTTTACCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTGCTGGCCATCGGTATCGTGGTGGATGATGCCATCGTGGTGGTGGAGAACGTCGAGCGAAATATCGAAGAGGGGTTCGCCCCGCTTGCGGCGGCGCATCAGGCGATGCGTGAAGTGTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCAGTGTTTGTGCCGATGGCGTTCCTCTCTGGCGTGACCGGCCAGTTCTACAAACAGTTTGCGGTAACGATAGCCATTTCCACGGTGATCTCCGCGATCAACTCGCTGACGCTTTCTCCGGCGCTGGCCGCGCTGCTGTTGAAGCCGCATGGTGCCCCGAAAGATTTCCCGACCCGGCTTATCGATCGTCTGTTCGGCTGGATTTTCCGCCCGTTTAACCGCTTTTTCCATCGCAGCTCGACCGGCTATCAGGGACTGGTAGGGAAAACGCTTGGCCGACGCGGTGCAGTGTTTGCGGTTTATTTGCTGCTGCTTTGTGCCGCGGGTGTGATGTTTAAAGTCGTACCCGGCGGGTTTATTCCGACGCAGGATAAGCTGTACCTGATCGGCGGCGTGAAAATGCCGGAAGGCTCGTCGCTGGCGCGTACCGATGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGTGTGGATTATGCGGTCGCGTTTCCTGGCCTGAACGCGCTCCAGTTCACCAATACGCCGAACACCGGGACGGTCTTCTTTGGCCTGAAGCCGTTCGACCAGCGTAAACATACTGCGGCGGAAATTAACGCGGAGATCAATGCGAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCGATTCTGCCGCCGCCGATTTTAGGGCTGGGTCAAGGGTCCGGTTATTCGCTGTACATTCAGGATCGTGCTGGTCTGGGCTATGGCGCGCTGCAAAACGCGGTGAACACCATGTCCGGGGCGATTATGCAGACGCCGGGGATGCATTTCCCCATCTCAACCTACCAGGCTAACGTTCCGCAGCTGGATGTGCAGGTTGACCGTGATAAAGCGAAAGCGCAGGGCGTATCGCTTACCGATCTTTTCGGCACGCTGCAAACCTATCTGGGCTCGTCATATGTAAACGACTTTAACCAGTTTGGACGGACCTGGCGCGTAATGGCACAGGCCGACGGGCAGTTCCGCGACAGCGTGGAAGATATCGCGAATTTACGCACACGCAATGACCAGGGCGAAATGGTGCCGATTGGCAGTATGGTGAAAATCACGACCACCTACGGGCCGGACCCGGTGATCCGCTATAATGGTTACCCGGCGGCGGATCTTATTGGTGATGCTGACCCGCGCGTGCTCTCTTCCGCGCAGGCGATGACGCAGCTGGACGCCATGTCTAAGCAGATCCTGCCGAACGGGATGAATATTGAATGGACGGACCTGAGTTTCCAGCAGGCCACCCAGGGCAATACGGCGCTGATCGTCTTCCCGGTCGCGGTGCTGCTGGCGTTCCTGGTGCTGGCGGCGCTGTATGAAAGCTGGACGCTGCCGCTGGCGGTGATCCTTATCGTGCCGATGACGATGCTCTCCGCGCTGTTCGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGGCTGGTCGTGCTGATGGGGCTGGCCTGTAAAAACGCGATACTTATCGTGGAGTTTGCCCGCGAGCTGGAAATTCAGGGCAAAGGCATCATGGAGGCTGCGCTGGAGGCGTGCCGCCTGCGTTTACGCCCGATTGTAATGACCTCTATCGCCTTTATTGCCGGGACCATTCCACTGATCCTAGGTCACGGGGCAGGGGCAGAAGTCCGCGGCGTCACCGGGATCACCGTCTTCTCCGGGATGCTGGGCGTGACGCTGTTTGGTCTGTTCCTGACGCCGGTCTTTTACGTGACGCTGCGTAAGTTCGTGACGCGCGGCAAAGCGGAAAGAGAGGTGTTGCCTGCGTAG	
8088	CARD	prokka_03224	contig_10	226606	107	132589	135703	-1	106	acrD	3000491.0	1981.84	1900.0	Strict	91.71	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGVLAITSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATVTLSFTAGTDPDEAVQQVQNQLQSALRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRINGVGDIDAYGSQYSMRIWLDPNKLNSVQMTAKDVTDAIESQNAQIAVGQLGGTPSVDNQALNATINSQSLLQTPEQFRNITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGNAASGLGVKLASGANEMATAQRVLERLDELSHYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLYAFGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCSTLLKPLHKGEHHGQKGFFGWFNRMFNRNAARYEAGVGKVLHRSVRWMVVYVLLLGGMVFLFLRLPTSFLPLEDRGMFITSVQLPSGSTQQQTLKVVQKVENYFHTQEKDNVVSVFSTVGSGPGGNGQNVARMFVRLKDWDQRDSDSGSSFAIIERATKAFNKIKEARVFASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARDKLLELAGKDPQLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQSAAKYRMLPDDINRWYVRNNTGGMVPFSAFATSRWETGSPRLERYNGYSALEIVGEAAPGVSTGTAMDIMEKLVQQLPTGFGLEWTAMSYQERLSGAQAPALYALSLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNAKGHELMAATLHACRQRLRPILMTSLAFVFGVLPMATSSGAGSSSQHAVGTGVMGGMISATILAIYFVPLFFVLIRRRFPLKDKPE	ATGGCGAATTTTTTCATCGATCGCCCCATTTTTGCCTGGGTGCTAGCAATCCTGTTGTGTCTGACGGGTGTCCTGGCGATTACTTCCCTTCCTGTTGAGCAATACCCCGACCTCGCCCCCCCTAACGTGCGTATCACGGCGAACTACCCTGGCGCCTCGGCACAGACGCTGGAAAATACCGTCACGCAGGTTATCGAGCAGAACATGACGGGTCTTGATAACCTGATGTACATGTCCTCGCAGAGCAGCGCCACGGGCCAGGCGACGGTAACCCTGAGCTTTACGGCGGGCACGGATCCGGACGAAGCGGTGCAGCAGGTGCAAAACCAGCTGCAATCGGCCCTGCGTAAACTGCCTCAGGCGGTGCAGAACCAGGGGGTGACCGTGCGTAAGACCGGTGACACCAATATTTTGACCATCGCGTTTGTTTCAACCGATGGCTCGATGGATAAGCAGGACATCGCGGACTACGTCGCCAGTAATATTCAGGACCCGCTCAGCCGTATCAACGGCGTGGGTGATATCGACGCCTACGGCTCGCAGTATTCCATGCGTATCTGGCTGGATCCCAACAAGCTGAACAGCGTGCAGATGACCGCCAAAGATGTCACCGACGCCATCGAATCGCAGAACGCTCAGATTGCCGTGGGGCAGCTCGGTGGTACGCCGTCCGTGGATAACCAGGCGCTTAACGCCACCATCAACTCCCAGTCGCTGCTCCAGACGCCTGAACAGTTCCGCAATATCACTCTGCGCGTGAATCAGGATGGTTCCGAAGTGCGTCTGGGGGATGTCGCCACAGTGGAAATGGGGGCGGAAAAATATGACTACCTGAGTCGCTTTAACGGCAATGCTGCGTCCGGCCTGGGGGTGAAACTGGCCTCCGGTGCCAACGAAATGGCGACCGCGCAGCGGGTGTTAGAGCGTCTGGATGAGCTGTCGCATTACTTCCCGCACGGACTGGAGTACAAAGTCGCCTACGAAACCACCTCATTCGTAAAAGCCTCCATCGAAGATGTGGTGAAAACTTTGCTCGAAGCTATCGCGCTGGTGTTCCTCGTGATGTACCTGTTCCTGCAAAACTTCCGCGCCACGCTGATCCCCACCATTGCGGTGCCGGTGGTGTTGCTGGGAACCTTTGCGGTGCTGTATGCCTTCGGTTACAGCATCAACACCCTGACCATGTTTGCCATGGTGCTGGCCATCGGCCTGCTGGTGGATGATGCCATCGTGGTGGTGGAAAACGTCGAGCGCATCATGAGCGAGGAAGGGCTTTCGCCCCGCGAGGCCACGCGTAAATCGATGGGGCAAATTCAGGGTGCGCTGGTCGGTATCGCCATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTTTTTGGCGGCACTACGGGCGCGATTTATCGCCAGTTCTCGATCACCATCGTCTCTGCGATGGTGCTCTCCGTACTGGTGGCGATGATCCTTACCCCTGCTCTGTGCTCGACGCTGCTCAAACCGCTGCATAAGGGCGAACACCACGGTCAAAAAGGCTTCTTCGGCTGGTTTAACCGCATGTTTAACCGAAATGCGGCGCGCTATGAAGCGGGCGTGGGTAAAGTACTGCACCGCAGCGTGCGCTGGATGGTGGTCTATGTCCTGCTGCTCGGCGGCATGGTCTTCTTATTCCTGCGGCTGCCAACCTCGTTCCTGCCGCTGGAAGATCGCGGCATGTTTATCACCTCCGTACAGTTACCGAGCGGCTCGACCCAGCAGCAGACCCTGAAAGTGGTGCAGAAGGTTGAGAACTACTTCCATACTCAGGAGAAGGATAACGTGGTCTCCGTCTTCTCCACCGTCGGCTCTGGCCCTGGCGGTAACGGGCAGAACGTGGCGCGTATGTTTGTGCGCCTGAAAGACTGGGACCAGCGCGACAGCGATAGCGGCTCCTCCTTTGCCATCATTGAACGTGCAACTAAAGCGTTCAACAAAATCAAGGAAGCGCGCGTTTTCGCCAGCAGCCCGCCCGCTATCAGTGGCCTGGGCAGCTCAGCCGGATTTGATATGGAGCTTCAGGATCACGCGGGTGCCGGGCATGACGCGTTGATGGCAGCTCGCGATAAACTGCTCGAGCTGGCCGGGAAAGATCCGCAGCTTACCCGCGTTCGTCATAACGGTCTGGATGACAGCCCTCAGCTACAGGTGGATATTGACCAGCGTAAAGCGCAGGCGCTGGGCGTCTCCATCGACGACATTAACGACACCCTGCAAACGGCATGGGGCTCAAGCTACGTGAATGACTTTATGGATCGCGGTCGCGTGAAAAAGGTCTACGTTCAGTCTGCTGCCAAATACCGCATGCTGCCGGACGATATCAACCGCTGGTATGTGCGCAATAACACCGGCGGCATGGTGCCGTTCTCGGCGTTTGCGACGTCACGCTGGGAGACCGGTTCGCCGCGTCTGGAGCGTTACAACGGCTATTCGGCGCTGGAGATTGTCGGTGAAGCCGCGCCTGGCGTTAGTACCGGTACTGCAATGGACATTATGGAAAAACTGGTTCAGCAGTTACCGACCGGCTTTGGCCTGGAGTGGACGGCGATGTCCTACCAGGAACGGCTTTCCGGCGCGCAGGCGCCTGCCCTGTATGCCCTTTCGCTGCTGGTGGTGTTCCTCTGCCTGGCGGCGCTGTATGAAAGCTGGTCAGTGCCGTTCTCGGTAATGCTGGTGGTGCCTCTCGGGGTCATCGGCGCGCTGCTGGCAACCTGGATGCGTGGCCTGGAAAACGATGTCTATTTCCAGGTCGGACTCCTCACCGTAATCGGATTGTCGGCGAAAAACGCCATTCTGATCGTCGAATTTGCCAATGAGATGAATGCCAAAGGTCACGAACTGATGGCCGCCACGCTGCACGCCTGTCGTCAGCGCCTGCGCCCGATCCTGATGACTTCTCTGGCGTTTGTATTTGGCGTCCTGCCGATGGCCACCAGCTCCGGCGCAGGCTCCAGCAGCCAGCACGCGGTGGGAACGGGCGTTATGGGGGGAATGATTTCCGCGACGATTCTGGCTATCTATTTCGTACCGCTGTTCTTTGTGCTGATACGCCGTCGTTTCCCGCTGAAGGATAAGCCGGAATAA	
8088	CARD	prokka_03480	contig_12	116829	105	189	1737	-1	83	emrB	3000074.0	932.939	900.0	Strict	93.47	100.59	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MQQQKPQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTILFVLASWACGMSSSLTMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGALVVLMTLQSLRGRETRTEQRRIDGIGLALLVVGIGSLQIMLDRGKELDWFASTEIIVLTVVAVVAISFLIVWELTDENPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGLIPVLLSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERMAAASSLSNFTRTLAGSIGTSITTTLWTNREAMHHAQLTEAVNPFNPNAQQMYSQLEGMGMTEQQASGWLAQQITNQGLIISANEIFWISAGIFIVLLGLVWFAKPPFGAGSGGGGAH	ATGCAACAGCAAAAGCCGCAAAAACCGCTTGAGGGGGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTGGCGACATTCATGCAGGTGCTGGACTCCACCATCGCAAACGTGGCGATCCCTACGATCGCCGGGAACCTTGGCTCATCGCTGAGCCAGGGGACCTGGGTCATTACCTCATTCGGGGTGGCGAACGCCATCTCTATTCCCATCACCGGCTGGCTGGCGAAGCGCGTCGGTGAAGTGAAGCTGTTCCTCTGGTCGACGATCCTGTTCGTGCTGGCCTCCTGGGCCTGCGGCATGTCCAGCAGCCTGACGATGCTGATTTTCTTCCGCGTCATCCAGGGGATTGTCGCCGGGCCGTTGATTCCGCTATCGCAGAGTTTACTGCTGAACAACTATCCGCCCGCCAAGCGCTCCATCGCGCTCGCGCTGTGGTCGATGACGGTGATTGTCGCCCCAATTTGCGGGCCAATCCTCGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTCATCAACGTACCCATCGGTGCGCTGGTGGTGCTGATGACGCTACAGTCTCTGCGTGGTCGCGAAACGCGGACCGAACAGCGGCGGATCGACGGCATCGGGCTGGCACTGCTGGTTGTCGGCATCGGCAGCCTGCAAATCATGCTCGACCGCGGCAAAGAGCTGGACTGGTTCGCCTCTACGGAAATCATCGTGCTGACGGTGGTCGCCGTGGTTGCCATTAGCTTCCTGATTGTCTGGGAGCTGACGGACGAAAATCCGATAGTCGACCTCTCGCTGTTTAAATCGCGAAACTTCACCATCGGCTGCCTCTGTATCAGCCTCGCCTATATGCTCTACTTCGGCGCGATTGTTCTGCTGCCGCAGCTGTTGCAGGAGGTGTACGGCTATACCGCAACCTGGGCGGGGCTGGCCTCCGCGCCGGTGGGGTTAATTCCGGTTCTGCTGTCGCCGATTATTGGCCGTTTCGCCCATAAGCTCGACATGCGCAGGCTGGTGACGTTCAGCTTCATCATGTACGCCGTGTGCTTCTACTGGCGCGCGTATACGTTTGAACCGGGAATGGACTTTGGCGCCTCCGCGTGGCCGCAGTTTATTCAGGGCTTTGCTGTGGCGTGCTTCTTTATGCCACTGACCACCATTACGCTTTCCGGCTTGCCGCCTGAGCGGATGGCGGCGGCATCGAGCCTGTCGAACTTCACCCGTACGCTGGCGGGCTCCATCGGGACATCGATCACCACCACGCTGTGGACCAACCGGGAAGCGATGCACCATGCCCAGCTGACCGAAGCGGTGAACCCGTTCAACCCTAACGCTCAGCAGATGTATAGCCAGCTTGAGGGGATGGGGATGACGGAGCAGCAGGCGTCCGGCTGGCTTGCCCAGCAGATCACCAACCAGGGGCTGATTATCTCGGCAAACGAGATTTTCTGGATATCGGCGGGGATCTTCATCGTCCTGCTGGGGCTGGTGTGGTTTGCCAAACCACCGTTTGGTGCCGGTAGCGGGGGCGGTGGAGCGCACTAG	
8088	CARD	prokka_03482	contig_12	116829	105	3054	3585	-1	108	emrR	3000516.0	347.051	280.0	Strict	94.86	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTAERDQLEHITRKLLTRLDQMDEDGVILEALR	ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTTAAGTTCCGCGCCAGTCGTCATGAGGACTTCCCGTATCAGGAGATCCTGCTGACCCGCCTGTGCATGCACATGCAGGGTAAGCTGCTGGAAAATCGTAACAAGATGCTGAAAGCGCAAGGGATTAACGAGACGTTGTTTATGGCGTTGATTACGCTTGAGTCTCAGGAAAACCACAGCATTCAGCCGTCTGAACTGAGCTGCGCGCTGGGTTCATCCCGTACCAATGCAACCCGTATTGCTGATGAGCTGGAGAAGCGCGGCTGGATAGAGCGCCGTGAGAGCGATAACGATCGCCGCTGCCTGCATCTGCAACTGACCGAGAAAGGTCACGAATTCCTGCGCGAAGTGTTGCCACCGCAGCATAACTGCCTGCACCAGCTTTGGTCTGCCCTCAGCACCGCCGAGCGCGACCAGCTTGAGCACATTACTCGCAAGCTGCTCACCCGTCTGGACCAGATGGATGAAGATGGCGTCATTCTTGAGGCGCTGCGCTAA	
8088	CARD	prokka_03865	contig_15	103619	109	65933	66410	-1	116	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	37.7354	32.0	Strict	27.21	89.27	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MKMIAAVGRNYEIGIGNELPWRCPTDLKLFKQLTKNATVVMGRKTMESLKRPLPERHNLVLTRSRGYIPNGFYPAGIDDVLRLPDPVWVIGGGQIYLLFMPHVEEIWLSHIGVDVPGADAFFPAPMMRSLGFVPVETAYTQRANEDEPGFLQIVYRRS	ATGAAGATGATTGCAGCTGTCGGCCGCAACTATGAAATCGGCATTGGCAACGAACTTCCCTGGCGTTGCCCGACCGATCTGAAACTGTTCAAACAACTCACCAAAAACGCCACTGTCGTGATGGGACGCAAGACGATGGAAAGTCTCAAGCGCCCGCTGCCAGAGCGCCATAACCTCGTTTTGACGCGCTCTCGTGGGTATATCCCCAATGGGTTCTACCCCGCTGGCATCGATGACGTTTTGAGACTGCCAGATCCGGTCTGGGTGATTGGTGGCGGGCAGATTTACTTGCTCTTTATGCCACACGTAGAAGAGATCTGGCTGTCGCATATTGGCGTGGATGTGCCGGGCGCGGATGCGTTCTTCCCGGCGCCAATGATGCGTTCTTTAGGGTTCGTACCAGTCGAAACGGCTTATACCCAACGTGCAAATGAGGATGAGCCTGGCTTTTTGCAGATCGTATACAGAAGGTCGTAA	
8088	CARD	prokka_04088	contig_17	87608	116	84490	85690	-1	104	tet(A)	3000165.0	768.459	700.0	Strict	98.48	94.1	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR	GTGAAACCCAACAGACCCCTGATCGTAATTCTGAGCACTGTCGCGCTCGACGCTGTCGGCATCGGCCTGATTATGCCGGTGCTGCCGGGCCTCCTGCGCGATCTGGTTCACTCGAACGACGTCACCGCCCACTATGGCATTCTGCTGGCGCTGTATGCGTTGATGCAATTTGCCTGCGCACCTGTGCTGGGCGCGCTGTCGGATCGTTTCGGGCGGCGGCCGGTCTTGCTCGTCTCGCTGGCCGGCGCTGCTGTCGACTACGCCATCATGGCGACGGCGCCTTTCCTTTGGGTTCTCTATATCGGGCGGATCGTGGCCGGCATCACCGGGGCGACTGGGGCGGTAGCCGGCGCTTATATTGCCGATATCACTGATGGCGATGAGCGCGCGCGGCACTTCGGCTTCATGAGCGCCTGTTTCGGGTTCGGGATGGTCGCGGGACCTGTGCTCGGTGGGCTGATGGGCGGTTTCTCCCCCCACGCTCCGTTCTTCGCCGCGGCAGCCTTGAACGGCCTCAATTTCCTGACGGGCTGTTTCCTTTTGCCGGAGTCGCACAAAGGCGAACGCCGGCCGTTACGCCGGGAGGCTCTCAACCCGCTCGCTTCGTTCCGGTGGGCCCGGGGCATGACCGTCGTCGCCGCCCTGATGGCGGTCTTCTTCATCATGCAACTTGTCGGACAGGTGCCGGCCGCGCTTTGGGTCATTTTCGGCGAGGATCGCTTTCACTGGGACGCGACCACGATCGGCATTTCGCTTGCCGCATTTGGCATTCTGCATTCACTCGCCCAGGCAATGATCACCGGCCCTGTAGCCGCCCGGCTCGGCGAAAGGCGGGCACTCATGCTCGGAATGATTGCCGACGGCACAGGCTACATCCTGCTTGCCTTCGCGACACGGGGATGGATGGCGTTCCCGATCATGGTCCTGCTTGCTTCGGGTGGCATCGGAATGCCGGCGCTGCAAGCAATGTTGTCCAGGCAGGTGGATGAGGAACGTCAGGGGCAGCTGCAAGGCTCACTGGCGGCGCTCACCAGCCTGACCTCGATCGTCGGACCCCTCCTCTTCACGGCGATCTATGCGGCTTCTATAACAACGTGGAACGGGTGGGCATGGATTGCAGGCGCTGCCCTCTACTTGCTCTGCCTGCCGGCGCTGCGTCGCGGGCTTTGGAGCGGCGCAGGGCAACGAGCCGATCGCTGA	
8088	CARD	prokka_04223	contig_19	82907	100	66373	66754	-1	130	marA	3000263.0	247.284	230.0	Strict	94.35	99.21	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITSMPGESRYLYPLKHCS	ATGTCCAGACGCAATACTGACGCTATCACCATTCATAGCATTTTGGACTGGATCGAAGATAACCTGGAATCTCCACTTTCCCTTGAGAAAGTGTCTGAGCGTTCAGGTTACTCAAAATGGCACCTGCAACGGATGTTTAAAAAAGAGACCGGCCATTCATTAGGACAATATATTCGCAGCCGTAAGCTGACGGAGATTGCCCAAAAACTGAAAGAAAGCAATGAGCCGATCCTCTATCTGGCGGAACGCTACGGATTTGAATCGCAACAAACCCTGACGCGTACGTTCAAGAACTACTTTGACGTGCCGCCTCATAAGTACCGTATTACCAGTATGCCGGGTGAATCCCGTTATCTGTATCCGCTAAAACATTGCAGTTAA	
8088	CARD	prokka_04326	contig_21	57756	102	33699	34332	-1	112	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATTCACCAGGGTGAAAAAGCGGAAACGTTGTATTACATCGTTAAAGGCTCGGTGGCCGTGCTGATCAAAGATGAAGAAGGGAAAGAGATGATCCTTTCTTATCTGAACCAGGGCGATTTTATCGGTGAACTGGGCCTGTTTGAAGAAGGCCAGGAACGTAGCGCCTGGGTTCGTGCAAAAACAGCATGTGAAGTGGCTGAAATTTCTTACAAGAAATTCCGTCAGCTGATTCAGGTCAACCCTGACATCCTGATGCGTCTTTCTTCCCAGATGGCACGCCGTCTGCAAGTGACCTCTGAGAAGGTGGGTAACCTCGCCTTCCTGGACGTGACCGGTCGTATCGCGCAGACTCTGTTGAACCTGGCGAAACAGCCAGACGCCATGACCCACCCTGACGGTATGCAAATTAAAATTACCCGCCAGGAAATCGGTCAGATCGTCGGCTGCTCCCGTGAAACAGTGGGCCGTATCCTGAAGATGCTGGAAGACCAGAACCTGATCTCCGCCCACGGTAAAACCATCGTGGTTTACGGGACCCGTTAA	
8088	CARD	prokka_04555	contig_26	27356	129	234	834	1	148	AAC(6')-Ib-cr6	3005116.0	407.142	300.0	Strict	98.99	100.0	AAC(6')-Ib-cr	protein homolog model	antibiotic inactivation		fluoroquinolone antibiotic; aminoglycoside antibiotic	MSNAKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERTRSDA	ATGAGCAACGCAAAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGAAGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCATATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	
8088	CARD	prokka_04557	contig_26	27356	129	1932	2565	1	143	catB3	3002676.0	437.958	350.0	Perfect	100.0	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIGSFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIGSEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWNWSLEKIKAAMPMLCSSNIVGLHKYWLEFAV	ATGACCAACTACTTTGATAGCCCCTTCAAAGGCAAGCTGCTTTCTGAGCAAGTGAAGAACCCCAATATCAAAGTTGGGCGGTACAGCTATTACTCTGGCTACTATCATGGGCACTCATTCGATGACTGCGCACGGTATCTGTTTCCGGACCGTGATGACGTTGATAAGTTGATCATCGGTAGTTTCTGCTCTATCGGGAGTGGGGCTTCCTTTATCATGGCTGGCAATCAGGGGCATCGGTACGACTGGGCATCATCTTTCCCGTTCTTTTATATGCAGGAAGAACCTGCATTCTCAAGCGCACTCGATGCCTTCCAAAAAGCAGGTAATACTGTCATTGGCAATGACGTTTGGATCGGCTCTGAGGCAATGGTCATGCCCGGAATCAAGATCGGGCACGGTGCGGTGATAGGCAGCCGCTCGTTGGTGACAAAAGATGTGGAGCCTTACGCTATCGTTGGCGGCAATCCCGCTAAGAAGATTAAGAAACGCTTCACCGATGAGGAAATTTCATTGCTTCTGGAGATGGAGTGGTGGAATTGGTCACTGGAGAAGATCAAAGCGGCAATGCCCATGCTGTGCTCGTCTAATATTGTTGGCCTGCACAAGTATTGGCTCGAGTTTGCCGTCTAA	
8088	CARD	prokka_04558	contig_26	27356	129	2649	3102	1	150	arr-3	3002848.0	311.997	250.0	Perfect	100.0	100.0	rifampin ADP-ribosyltransferase (Arr)	protein homolog model	antibiotic inactivation		rifamycin antibiotic	MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED	ATGGTAAAAGATTGGATTCCCATCTCTCATGATAATTACAAGCAGGTGCAAGGACCGTTCTATCATGGAACCAAAGCCAATTTGGCGATTGGTGACTTGCTAACCACAGGGTTCATCTCTCATTTCGAGGACGGTCGTATTCTTAAGCACATCTACTTTTCAGCCTTGATGGAGCCAGCAGTTTGGGGAGCTGAACTTGCTATGTCACTGTCTGGCCTCGAGGGTCGCGGCTACATATACATAGTTGAGCCAACAGGACCGTTCGAAGACGATCCGAATCTTACGAACAAAAGATTTCCCGGTAATCCAACACAGTCCTATAGAACCTGCGAACCCTTGAGAATTGTTGGCGTTGTTGAAGACTGGGAGGGGCATCCTGTTGAATTAATAAGGGGAATGTTGGATTCGTTGGAGGACTTAAAGCGCCGTGGTTTACACGTCATTGAAGACTAG	
8088	CARD	prokka_04559	contig_26	27356	129	3324	3672	1	178	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8088	CARD	prokka_04560	contig_26	27356	129	3665	4505	1	117	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8088	CARD	prokka_04568	contig_26	27356	129	11290	11938	-1	104	QnrB4	3002718.0	440.654	400.0	Perfect	100.0	100.0	quinolone resistance protein (qnr)	protein homolog model	antibiotic target protection		fluoroquinolone antibiotic	MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG	ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA	
8088	CARD	prokka_04579	contig_26	27356	129	18773	19613	1	125	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8088	CARD	prokka_04716	contig_45	833	76	144	618	1	104	dfrA15	3003013.0	322.783	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKVDTLHISTIDIEPEGDVYFPEIPSSFRPVFSQDFVSNINYSYQIWQKG	GTGAAACTATCACTAATGGCAGCAATTTCGAAGAATGGAGTTATCGGAAATGGCCCAGATATTCCATGGAGTGCCAAAGGGGAACAATTACTCTTCAAAGCGATTACCTATAATCAGTGGCTTTTGGTAGGCCGAAAGACTTTCGAGTCAATGGGGGCTTTACCCAACCGAAAATATGCCGTTGTAACTCGTTCAAGCTTCACTTCCAGTGATGAGAATGTATTGGTATTTCCATCTATCGATGAAGCGCTAAATCATCTGAAGACGATAACGGATCATGTGATTGTGTCTGGTGGTGGTGAAATATACAAAAGCCTGATCGATAAAGTTGATACTTTACATATTTCAACAATCGACATTGAGCCAGAAGGTGATGTCTATTTTCCAGAAATCCCCAGTAGTTTTAGGCCAGTTTTTAGCCAAGACTTCGTGTCTAACATAAATTATAGTTACCAAATCTGGCAAAAGGGTTAA	
8088	CARD	prokka_00920	contig_2	492734	103	361772	363539	1	113	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	593.193	500.0	Strict	52.57	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAAKTLKPKRQEEQANFISWRFALLCGCILLALGFLLGRVAWLQIIAPDMLVRQGDMRSLRVQEVSTSRGMITDRSGRPLAVSVPVKAIWADPKELHDAGGITLDNRWKALSDALKMPLDQLASRVNANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVATGEVLAMASSPSYNPNNFAGTAKDAMRNRSITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASNPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGGCAAAAACGCTAAAACCAAAACGCCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTTTGCGGCTGCATTTTACTGGCGCTGGGTTTCCTGCTGGGACGCGTGGCGTGGCTACAAATCATCGCGCCTGACATGCTGGTGCGTCAGGGGGATATGCGTTCTCTGCGCGTGCAGGAAGTTTCTACCTCTCGTGGGATGATCACCGACCGCTCCGGCCGCCCGCTGGCGGTGAGCGTACCGGTGAAGGCGATCTGGGCCGATCCTAAAGAGCTGCATGACGCAGGCGGGATCACCCTTGATAACCGCTGGAAGGCGCTCTCAGACGCGTTGAAAATGCCGCTGGATCAGCTGGCGTCACGCGTTAACGCCAACCCGAAAGGGCGCTTCATCTATCTTGCCCGTCAGGTGAACCCTGACATGGCTGATTACATTAAAAAACTTAAGCTGCCCGGCATTCATCTGCGGGAAGAATCCCGCCGTTATTATCCTTCCGGCGAAGTCACCGCGCACCTGATTGGCTTCACCAACGTGGATAGCCAGGGGATTGAAGGCGTTGAAAAAAGCTTCGACAAGTGGCTTACCGGCCAGCCTGGCGAGCGAATCGTGCGCAAAGACCGCTATGGTCGCGTCATTGAAGATATTTCCTCGACAGACAGCCAGGCCGCGCACAACCTGGCCCTGAGTATTGATGAGCGCTTGCAGGCGCTGGTCTATCGTGAGCTGAACAACGCCGTCGCGTTTAACAAGGCGGAATCGGGCAGTGCCGTGCTGGTGGATGTGGCGACAGGTGAAGTGCTGGCGATGGCCAGTAGTCCCTCATATAACCCGAATAATTTTGCCGGTACAGCAAAAGATGCGATGCGTAACCGCTCCATCACCGATGTGTTTGAACCCGGTTCAACCGTAAAACCTATGGTGGTGATGACGGCTCTACAGCGAGGCATCGTCAACGAAAATACCGTTCTGAATACGATCCCTTATCGAATTAACGGCCACGAAATAAAAGACGTGGCACGTTACAGCGAACTGACCCTGACCGGGGTCTTACAGAAGTCGAGTAACGTCGGTGTGTCAAAACTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTGGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACTCCCTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATTTATCGCCCGCTGTCGATCACCAAAGTTGATCCACCGGTACCGGGGGAACGTGTTTTCCCGGAATCTATCGTTCGTACCGTCGTACATATGATGGAAAGCGTCGCGCTGCCCGGTGGTGGTGGCGTGAAGGCCGCGATTAAGGGCTATCGTATCGCCATCAAAACCGGTACAGCGAAAAAAGTGGGGCCGGACGGCCGCTATATCAACAAATACATTGCCTATACCGCAGGCGTAGCGCCTGCAAGCAATCCGCGTTTTGCGCTGGTGGTCGTCATCAACGATCCGCAGGCGGGTAAATACTACGGCGGCGCCGTCTCCGCGCCTGTGTTCGGGGCTATTATGGGCGGCGTGTTGCGCACCATGAACATTGAACCGGATGCGCTGGCGACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
8088	CARD	prokka_01692	contig_4	349756	102	241284	243921	-1	106	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1624.37	1500.0	Strict	91.62	100.34	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMATNIPPHNITEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKIYIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEIKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKEILSAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKASLVARPWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSAERLMEVIREELELVRDQFGDERRTEITANSSDINIEDLINREDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGSDEVMLFSAAGKVVRFKENAVRAMGRTATGVRGIKLAGEDSVVSLIVPRGEGAILTVTQNGYGKRTAESEYPTKSRGTQGVISIKVTERNGSVVGAVQVDDADQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDSIDGSVAEGDDEIVPEADTDDEAADDADE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTTAACATCGAGGAAGAGCTGAAAAGCTCCTATCTGGACTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGACGTCCGCGATGGCCTTAAGCCGGTACACCGTCGCGTACTATACGCCATGAACGTATTGGGCAATGACTGGAATAAAGCCTACAAAAAATCTGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCATCCCCATGGTGATATCGCGGTGTACGACACCATTGTCCGTATGGCGCAGCCTTTCTCGCTGCGTTACATGCTGGTAGATGGTCAGGGTAACTTTGGTTCTATCGACGGCGACTCCGCCGCGGCAATGCGTTATACGGAAATCCGTCTGGCGAAGATTGCCCATGAGCTGATGGCTGACCTGGAAAAAGAGACGGTTGATTTCGTTGATAACTACGACGGCACGGAAAAAATTCCTGACGTTATGCCAACGAAGATCCCAAACCTGCTGGTGAACGGTTCGTCCGGTATCGCAGTGGGTATGGCGACCAATATTCCGCCGCACAACATCACGGAAGTGATTAACGGCTGCCTGGCCTACATCGACGATGAAGACATCAGCATTGAAGGGCTGATGGAACACATCCCGGGCCCGGACTTCCCGACGGCGGCAATCATCAACGGCCGTCGCGGTATTGAAGAAGCGTACCGTACCGGTCGCGGCAAGATTTACATCCGTGCCCGCGCCGAAGTGGAAGCGGACGCCAAAACCGGCCGTGAAACCATTATTGTTCACGAGATCCCGTATCAGGTGAACAAAGCGCGTCTGATTGAAAAAATCGCCGAGCTGGTAAAAGAAAAACGCGTTGAAGGCATCAGCGCGCTGCGCGACGAGTCTGACAAAGACGGTATGCGCATCGTGATTGAAATCAAGCGCGACGCGGTGGGTGAAGTTGTGCTGAACAACCTTTACTCCCAGACTCAGCTTCAGGTCTCCTTCGGTATCAACATGGTTGCGCTGCACCATGGCCAGCCGAAGATCATGAACCTGAAAGAGATCCTGAGCGCGTTTGTGCGTCACCGCCGTGAAGTGGTGACTCGCCGTACCATCTTTGAACTGCGCAAAGCGCGCGATCGTGCCCATATCCTTGAAGCACTGGCCGTTGCGCTGGCGAACATCGACCCGATAATCGAGCTGATCCGCCGTGCGCCGACGCCGGCAGAAGCGAAGGCGTCGCTGGTTGCGCGTCCATGGGATCTGGGCAACGTGGCGGCGATGCTGGAACGTGCCGGCGATGATGCTGCGCGTCCTGAGTGGCTGGAGCCGGAATTCGGCGTGCGTGACGGTCAGTACTATCTGACTGAACAGCAGGCCCAGGCGATTCTGGATCTGCGTTTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAGTACAAAGAGCTGCTGGAGCAGATTGCCGAGCTGCTGCATATCCTGGGTAGCGCAGAGCGCCTGATGGAAGTGATCCGTGAAGAGCTGGAGCTGGTTCGCGATCAGTTCGGCGACGAGCGTCGCACCGAAATCACGGCCAACAGCTCTGATATCAACATTGAAGATCTGATCAACCGCGAAGACGTGGTCGTGACGCTGTCTCACCAGGGTTACGTGAAGTATCAGCCGTTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGTAAATCTGCGGCGCGTATTAAAGAAGAAGACTTCATTGACCGTCTGCTGGTGGCCAACACCCACGACACGATCCTCTGCTTCTCCAGCCGGGGCCGTCTGTACTGGATGAAAGTCTATCAGCTGCCGGAAGCGAGCCGTGGCGCGCGGGGTCGACCTATCGTTAACCTGCTGCCGCTGGAAGCGAACGAACGTATCACCGCCATTCTGCCGGTACGCGAGTACGAAGAGGGCGTGAACGTCTTTATGGCAACCGCGAGCGGTACCGTGAAGAAAACCGCGCTGACCGAATTCAGCCGTCCACGTTCCGCCGGGATCATCGCGGTGAACCTGAACGAAGGCGACGAGCTGATCGGCGTGGATCTGACCTCCGGTTCTGATGAAGTGATGCTGTTCTCTGCGGCCGGTAAAGTGGTGCGCTTTAAAGAGAACGCCGTGCGCGCAATGGGTCGTACGGCGACCGGCGTGCGTGGTATCAAGCTGGCGGGTGAAGACAGCGTGGTTTCCCTGATCGTTCCGCGTGGCGAAGGCGCAATCCTGACCGTCACTCAGAACGGCTACGGTAAACGTACGGCGGAAAGCGAATACCCGACCAAGTCTCGCGGCACGCAGGGCGTTATCTCCATCAAAGTGACCGAGCGCAACGGTTCCGTTGTTGGCGCGGTACAGGTGGACGATGCGGACCAGATCATGATGATCACCGATGCCGGTACGCTGGTGCGTACCCGCGTGTCAGAGATCAGCGTGGTGGGTCGTAACACCCAGGGCGTTATCCTCATCCGTACTGCGGAAGATGAAAACGTCGTCGGTCTGCAACGCGTTGCTGAGCCGGTGGATGACGAAGAGCTCGACTCTATCGACGGCAGCGTCGCGGAAGGGGATGATGAAATCGTCCCGGAAGCGGACACCGATGATGAAGCAGCGGATGACGCTGACGAGTAA	
8088	CARD	prokka_02128	contig_6	286506	105	21691	23950	-1	106	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1444.1	1400.0	Strict	92.02	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNATAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAEVLLGELGQGTVDWVPNFDGTMQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTSLDDLLDIVQGPDYPTEAEIITSRAEIRKIYQNGRGSVRMRAVWTKEDGAVVITALPHQVSGAKVLEQIASQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLAFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQNELEKERDQLQAILASERKMNTLLKKELQADADAFGDDRRSPLHEREEAKAMNEHDMLPSEPVTIVLSQSGWVRSAKGHDIDAPGLSYKSGDSFKAAVKGKSNQPVAFIDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMEADDQKLLMASDAGYGFICTFNDLVSRNRAGKALISLPDNAHVMPPLIIENESDMLLAITAAGRMLMFPVSDLPELSKGKGNKIISIPSAEAAKGEDSLAHLFLLPPQSTLTIHVGKRKIKLRPEELQKVVGERGRRGSLMRGLQRIDRVEIDSPARSKADDSEE	ATGAGCGATATGGCAGAGCGCCTCGCGCTACATGAATTCACGGAAAACGCCTACCTGAACTACTCCATGTACGTCATCATGGACAGGGCGTTGCCGTTTATCGGGGATGGCCTGAAGCCCGTTCAGCGCCGCATCGTCTATGCGATGTCCGAACTGGGGCTGAATGCGACCGCCAAGTTCAAGAAATCCGCCCGTACCGTCGGCGACGTGCTGGGGAAATACCATCCGCACGGTGACATCGCCTGCTATGAAGCGATGGTGCTGATGGCCCAGCCGTTCTCTTACCGCTATCCGCTGGTGGATGGTCAGGGGAACTGGGGGGCGCCGGACGATCCGAAATCCTTCGCGGCAATGCGTTATACCGAATCCCGTCTGTCTAAATATGCCGAAGTGCTGTTGGGCGAACTGGGGCAGGGTACGGTCGACTGGGTGCCAAACTTCGACGGTACGATGCAGGAGCCGAAAATGCTGCCTGCGCGTCTGCCGAACATCCTGCTGAACGGCACGACCGGTATCGCCGTGGGCATGGCGACGGACATTCCGCCGCACAACCTGCGTGAAGTGGCGAAAGCGGCCATCACCCTGATTGAGCAGCCAAAAACCTCGCTGGACGATCTGCTGGATATCGTGCAGGGGCCGGACTATCCGACCGAAGCCGAGATCATCACCTCGCGTGCGGAAATCCGTAAAATCTACCAGAACGGCCGAGGCTCCGTGCGCATGCGCGCGGTATGGACCAAAGAGGATGGCGCCGTGGTGATCACCGCGCTGCCGCACCAGGTCTCCGGCGCGAAGGTGCTGGAGCAGATTGCCTCCCAGATGCGCAATAAAAAGCTGCCGATGGTGGACGACCTGCGTGACGAATCGGACCACGAAAACCCGACCCGTCTGGTGATTGTGCCGCGTTCTAACCGCGTGGATATGGAGCAGGTGATGAACCACCTGTTCGCCACTACCGATCTGGAAAAAAGCTACCGCATCAACCTGAACATGATTGGTCTGGATGGTCGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCACCGAATGGCTGGCCTTCCGCCGCGATACGGTGCGCCGCCGTCTGAACCATCGGCTGGAGAAAGTGCTTAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTCCTCAACATTGACGAAGTGATTGAGATCATTCGTACCGAGGACGAACCTAAGCCTGCCCTGATGTCGCGCTTTGGCATCAGCGAAACCCAGGCCGAAGCGATCCTCGAACTGAAGCTGCGCCATCTCGCTAAGCTGGAAGAGATGAAGATCCGCGGCGAGCAGAACGAGCTGGAAAAAGAGCGCGATCAGCTTCAGGCGATTCTGGCGTCCGAGCGCAAGATGAACACCCTGCTGAAGAAAGAGTTGCAGGCCGATGCCGACGCCTTTGGCGACGACCGTCGTTCTCCGCTGCATGAGCGCGAAGAAGCGAAGGCGATGAACGAGCACGACATGCTGCCGTCCGAGCCGGTGACCATCGTGCTTTCCCAGAGCGGCTGGGTGCGTAGCGCCAAAGGCCACGATATCGACGCGCCGGGTCTGAGCTACAAATCCGGTGACAGCTTCAAGGCGGCGGTGAAGGGCAAGAGCAACCAGCCGGTGGCGTTTATCGACTCCACGGGCCGCAGCTACGCTATTGATCCGATCACGCTGCCATCCGCGCGCGGGCAGGGCGAACCGCTGACCGGCAAGCTGACGCTGCCGCCGGGCGCCACGGTTGACCATATGCTGATGGAAGCCGACGATCAAAAACTGCTGATGGCGTCTGATGCTGGCTACGGCTTTATCTGCACCTTTAACGATCTGGTGTCGCGTAACCGCGCCGGTAAAGCGCTGATCAGCCTGCCGGATAACGCCCACGTCATGCCGCCGCTGATCATCGAGAACGAAAGCGATATGCTGCTGGCGATCACCGCTGCCGGACGCATGCTGATGTTCCCGGTCAGCGATCTGCCGGAGCTGTCGAAAGGGAAGGGCAACAAGATCATCAGTATCCCGTCAGCGGAAGCGGCAAAAGGCGAAGATAGCCTGGCGCATCTCTTCCTGCTGCCGCCGCAGAGCACGCTGACCATTCATGTCGGCAAACGTAAGATCAAACTGCGTCCGGAAGAGTTGCAGAAGGTGGTTGGCGAGCGCGGACGTCGCGGCTCACTGATGCGTGGCCTGCAGCGCATCGACCGCGTGGAGATCGACTCGCCGGCGCGCAGCAAAGCGGACGACAGCGAAGAGTAA	
8088	CARD	prokka_02571	contig_7	283485	104	198859	200251	-1	111	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	863.988	850.0	Strict	94.17	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTVVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGSYLGMWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETEENEMSKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACVALALIIATLGVYQHASNQYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPIFGLTGWAGTFAALDAAAIGCIVLMAMVAVLEERKIRRENRAQKLKAA	ATGCTGGCCTTCTTAAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCGTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACTATGTACCTGATCCGCAAAAACTTTAACATCGCGCAGAACGACATGATCTCGACCTACGGGCTGAGCATGACGCAGTTGGGGATGATTGGCCTGGGCTTCTCCATCACCTATGGCGTGGGGAAAACCGTCGTTTCCTACTATGCGGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCTGCCATCTGTATGCTCGGCTTCAGCGCCAGCATGGGCGCGGGCTCCGTCAGCCTGTTCCTGATGATCGCCTTTTACGCCCTGAGCGGTTTCTTCCAGAGCACCGGCGGGTCGTGCAGCTACTCCACCATCACCAAATGGACGCCGCGCCGCAAGCGGGGGTCGTACCTCGGCATGTGGAACATCTCCCACAACCTCGGCGGAGCGGGTGCGGCTGGCGTGGCGCTGTTCGGCGCGAACTACCTGTTCGACGGTCACGTCATCGGCATGTTTATCTTCCCGTCGATTATTGCCCTGATTGTTGGCTTTATCGGCCTGCGCTACGGCAGCGATTCCCCGGAATCGTACGGCCTCGGCAAAGCCGAAGAGCTGTTCGGGGAAGAGATCAGCGAAGAGGACAAAGAGACCGAAGAAAACGAGATGTCCAAATGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATTTGGCTGCTCTGTTTCTCGAACATCTTCCTGTACGTGGTGCGCATTGGTATCGACCAGTGGTCCACCGTGTATGCCTTCCAGGAGCTGAAGCTTTCTAAAGAAGTGGCGATTCAGGGCTTCACCCTGTTTGAAGTGGGCGCGCTGGTCGGCACGCTGCTGTGGGGATGGCTCTCCGACCTCGCCAATGGCCGCCGCGCGCTGGTGGCCTGCGTCGCGCTGGCGCTGATTATCGCCACCCTTGGCGTCTACCAGCACGCCAGCAACCAGTACATTTACCTGGCGTCCCTGTTCGCGCTCGGCTTCCTGGTGTTTGGTCCGCAATTACTGATCGGTGTGGCGGCAGTGGGCTTCGTCCCGAAAAAAGCGATCGGCGCCGCCGATGGGATTAAGGGCACCTTCGCCTACCTGATCGGCGACAGCTTCGCCAAGCTGGGTCTGGGGATGATCGCCGACGGCACGCCGATTTTCGGCCTTACCGGCTGGGCGGGCACCTTCGCCGCGCTGGATGCCGCCGCGATTGGCTGTATCGTCCTGATGGCGATGGTTGCGGTGCTGGAAGAGCGTAAGATCCGCCGTGAGAATCGTGCGCAGAAATTAAAAGCAGCCTGA	
8088	CARD	prokka_03737	contig_14	106312	102	58696	59023	-1	116	Escherichia coli soxS with mutation conferring antibiotic resistance	3003511.0	202.216	200.0	Strict	90.65	100.93	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein overexpression model	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSHQQIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVMHQTLGDYIRQRRLLLAAQALRSTQRPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHQLN	ATGTCGCATCAGCAAATTATTCAGACGCTTATTGAATGGATTGATGAACATATCGACCAGCCGTTGAACATTGATGTGGTCGCTAAGAAGTCGGGCTATTCGAAATGGTATTTACAGAGAATGTTCCGCACCGTAATGCATCAAACGCTGGGTGACTACATTCGCCAGCGCAGGCTCCTGCTGGCGGCGCAGGCGTTACGCTCAACGCAGCGGCCCATTTTTGATATCGCAATGGATCTGGGCTATGTGTCGCAGCAGACCTTTTCCCGCGTCTTCCGCCGCGAGTTTGACCGTACGCCGAGCGACTACCGCCATCAGCTCAATTAA	
8088	CARD	prokka_04224	contig_19	82907	100	66774	67209	-1	123	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	271.166	210.0	Strict	90.97	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDLFNDIIPLGRLIHMVNQKKDRLLNDYLSPLDITATQFKVLCSIRCEVCITPVELKKVLSVDLGALTRMLDRLVCKGWIERSPNPNDKRGVLVKLTSDGAAMCEQCHQLVGQTLHQELTKNLTADEVATLELLLKKILP	GTGAAAAGCACCAGTGACCTCTTTAACGACATAATCCCACTGGGTCGTCTTATTCATATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTACCTGTCACCGCTGGATATCACCGCAACACAGTTCAAAGTGCTGTGTTCCATTCGCTGCGAAGTGTGTATCACGCCGGTTGAGCTGAAAAAGGTGCTCTCTGTCGATCTGGGTGCGTTGACCCGCATGCTGGATCGTCTCGTCTGCAAAGGATGGATAGAACGAAGCCCTAACCCGAATGACAAACGTGGCGTACTGGTGAAACTGACCAGCGATGGCGCGGCCATGTGTGAGCAATGTCATCAATTAGTAGGACAAACACTGCACCAGGAACTGACAAAAAACTTAACGGCAGATGAAGTGGCAACGCTTGAGCTTTTACTCAAGAAAATCCTGCCGTAA	
8121	BLDB	prokka_03230	contig_12	160549	86	17782	19030	-1	96	ACT-24		456.0		Perfect	100.0	99.74	cephalosporin-hydrolyzing class C beta-lactamase ACT-24	protein homolog model			Beta-Lactam	MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEANTVIDGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	ATGCTAAATTTAACCGTTTGTCAGGCACAGTCAAATCCAACAGACTACGCCTGTCTGACGGGCCCGGACATCCCCTTGACTCGCTATTACGGAAGATTACTGATGATGAAAAAATCTCTTTGCTGCGCCCTGCTGCTCGGCATCTCTTGCTCTGCTCTCGCCGCGCCAGTGTCAGAAAAACAGCTGGCGGAGGTGGTCGCGAATACGATTACCCCGCTGATGAAAGCCCAGTCGATTCCAGGCATGGCGGTGGCCGTTATTTATCAGGGTAAACCGCACTATTATACGTTTGGCAAAGCCGATATCGCGGCCAGCAAACCCGTTACGCCTCAGACTCTGTTCGAGCTGGGTTCTATAAGTAAAACCTTCACCGGGGTTTTAGGAGGGGATGCCATTGCTCGCGGTGAAATTTCGCTGGACGATCCGGTGACCAGATACTGGCCACAGCTGACGGGCAAGCAGTGGCAGGGGATTCGTATGCTGGATCTCGCAACCTACACCGCTGGCGGCCTGCCGCTACAGGTACCGGATGAGGTCACGGATAATGCCGCCCTGCTGCGCTTTTATCAAAACTGGCAGCCGCAGTGGAAGCCTGGCACAACGCGTCTTTACGCCAACGCCAGTATCGGTCTTTTTGGCGCGCTGGCGGTCAAACCTTCCGGCATGGGCTATGAGCAGGCCATGACGACGCGGGTCCTTAAGCCGCTCAAGCTGGACCATACCTGGATTAACGTTCCGAAAGCGGAAGAGGCGCATTACGCCTGGGGCTATCGTGACGGTAAAGCGGTGCGCGTTTCGCCGGGAATGCTGGATGCACAAGCCTATGGCGTGAAAACCAACGTGCAGGATATGGCGAACTGGGTCATGGCAAACATGGCGCCGGAGAACGTTGCTGATGCCTCACTTAAGCAGGGCATCTCGCTGGCGCAGTCGCGCTACTGGCGTATCGGGTCAATGTATCAGGGTCTGGGCTGGGAGATGCTCAACTGGCCCGTGGAGGCCAACACGGTGATCGACGGCAGCGACAGTAAGGTGGCGCTGGCACCGCTGCCCGTGGCAGAAGTGAATCCACCGGCTCCCCCGGTCAAAGCGTCCTGGGTCCATAAAACGGGCTCTACTGGCGGGTTTGGCAGCTACGTGGCCTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCGAATAAAAGCTATCCGAACCCGGCACGCGTTGAGGCGGCATACCATATCCTCGACGCGCTACAGTAA	
8121	BLDB	prokka_05066	contig_51	4258	96	3303	4104	-1	90	VIM-1		236.9		Perfect	100.0	99.62	subclass B1 metallo-beta-lactamase VIM-1	protein homolog model			Beta-Lactam	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	ATGTTAAAAGTTATTAGTAGTTTATTGGTCTACATGACCGCGTCTGTCATGGCTGTCGCAAGTCCGTTAGCCCATTCCGGGGAGCCGAGTGGTGAGTATCCGACAGTCAACGAAATTCCGGTCGGAGAGGTCCGACTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCGGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAAAAGCAAATTGGACTTCCCGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGCAGAGGGGAACGAGATTCCCACGCATTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAGCTCTTCTATCCTGGTGCTGCGCATTCGACCGACAATCTGGTTGTATACGTCCCGTCAGCGAACGTGCTATACGGTGGTTGTGCCGTTCATGAGTTGTCAAGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCGTTGAGCGGATTCAAAAACACTACCCGGAAGCAGAGGTCGTCATTCCCGGGCACGGTCTACCGGGCGGTCTAGACTTGCTCCAGCACACAGCGAACGTTGTCAAAGCACACAAAAATCGCTCAGTCGCCGAGTAG	
8121	CARD	prokka_00539	contig_2	441920	86	17373	17703	-1	73	Klebsiella pneumoniae KpnF	3004583.0	190.274	150.0	Strict	87.16	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAFAIVLEIIANVFLKFSDGFRRKAYGLLSIAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWIMFGQRLNHKGWIGLVLLLAGMIMIKLA	ATGCAGCAGTTTGAATGGATCCACGCGGCCTGGCTGGCTTTCGCCATCGTTCTGGAAATTATTGCGAACGTCTTTTTGAAGTTCTCCGACGGCTTTCGTCGCAAAGCCTACGGCCTGTTATCGATTGCCGCGGTTCTGGGGGCGTTTAGCGCCCTGTCGCAGGCGGTGAAAGGCATCGATCTTTCCGTGGCCTACGCGCTGTGGGGCGGCTTCGGTATTGCCGCCACCCTGGCGGCAGGCTGGATTATGTTCGGGCAGCGTTTAAACCATAAAGGCTGGATAGGGCTGGTATTACTGCTCGCTGGCATGATCATGATTAAACTGGCCTGA	
8121	CARD	prokka_00540	contig_2	441920	86	17689	18082	-1	81	Klebsiella pneumoniae KpnE	3004580.0	196.052	150.0	Strict	82.5	108.33	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MDYILKQEKNMFYWILLALAIVAEITGTLSMKWASVSDGNTGFILMLVMITLSYIFLSFAVKKIALGVAYALWEGVGILLITLFSVMIFDETLTTMKIAGLTTLVAGIVLIKSGTRKPAKQQKEQTHAAV	ATGGATTATATTCTCAAGCAGGAGAAAAACATGTTTTACTGGATTTTATTAGCTCTGGCTATCGTTGCTGAAATTACCGGCACCTTGTCGATGAAATGGGCGAGCGTGAGTGACGGCAACACCGGATTTATTTTGATGCTGGTCATGATTACACTTTCCTATATATTCCTCTCTTTCGCGGTTAAAAAAATCGCGCTGGGCGTGGCATACGCTTTGTGGGAAGGTGTTGGTATTTTATTGATCACGCTGTTCAGCGTCATGATATTTGATGAAACCCTGACGACAATGAAAATTGCCGGGCTGACGACCCTGGTCGCAGGTATCGTGCTGATTAAATCGGGTACGCGCAAACCAGCCAAACAGCAGAAGGAGCAGACCCATGCAGCAGTTTGA	
8121	CARD	prokka_00954	contig_2	441920	86	438458	440207	-1	109	msbA	3003950.0	1139.79	1000.0	Strict	94.85	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MHNDKDLSTWQTFRRLWPMIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMILRGISSYVSSYCISWVSGKVVMTMRRRLFSHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFAMMFYYSWQLSLILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMETLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFSILDSEQEKDEGTRVIERAKGDLEFRNVTFTYPGREVPALRDISLSIPAGKTVALVGRSGSGKSTIASLITRFYDIDQGEILLDGHDLREYTLQSLRNQVALVSQNVHLFNDTVANNIAYARTEEYSREEIENAARMAYAMDFINKMDNGLDTIIGENGVLLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQSALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGVIVERGSHADLLEQRGVYAQLHKMQFGQ	ATGCATAACGACAAAGATCTCTCCACGTGGCAAACGTTCCGCCGGCTCTGGCCGATGATTGCACCTTTCAAAGCAGGCTTGATCGTGGCGGGCGTAGCGTTAATCCTCAACGCAGCCAGCGATACGTTTATGTTATCGCTTCTCAAACCGTTACTGGATGACGGTTTTGGTAAAACGGATCGTTCAGTGCTGCTATGGATGCCGCTGGTGGTTATTGGGCTGATGATCTTACGCGGAATCTCCAGCTATGTATCCAGCTACTGCATCTCCTGGGTATCCGGTAAAGTGGTGATGACCATGCGCCGTCGGTTATTCAGCCATATGATGGGGATGCCAGTCTCATTCTTTGACAAACAGTCAACCGGTACCCTGCTGTCGCGTATTACCTACGATTCAGAGCAGGTGGCGTCGTCCTCTTCCAGCGCACTGATTACCGTTGTGCGTGAAGGCGCATCCATCATCGGTCTTTTTGCGATGATGTTCTATTACAGCTGGCAACTGTCGCTGATCCTTATTGTGCTGGCGCCGATTGTCTCCATCGCGATCCGCGTGGTATCAAAGCGTTTTCGCAACATCAGTAAAAATATGCAGAATACGATGGGGCAGGTGACTACCAGCGCCGAGCAGATGCTGAAAGGCCATAAGGAAGTGTTGATCTTCGGCGGTCAGGAAGTCGAAACCAAACGCTTTGACAAGGTCAGCAACAGAATGCGCCTGCAAGGGATGAAAATGGTATCGGCCTCGTCGATTTCCGATCCGATCATTCAGCTGATTGCCTCTTTGGCCCTGGCCTTCGTCCTGTATGCAGCAAGCTTCCCGAGCGTCATGGAAACCCTGACTGCGGGTACCATTACCGTGGTGTTCTCATCCATGATTGCGCTGATGCGTCCGCTGAAATCGCTGACTAACGTCAACGCCCAGTTCCAGCGCGGGATGGCAGCCTGTCAGACGCTGTTCAGCATCCTCGATTCCGAACAGGAAAAAGATGAAGGTACACGCGTGATCGAGCGCGCTAAAGGTGACCTGGAATTCCGCAACGTGACCTTTACCTATCCAGGCCGTGAAGTGCCGGCGCTGCGTGATATCAGCCTGTCCATCCCGGCGGGTAAGACCGTTGCACTGGTCGGTCGTTCCGGTTCGGGCAAGTCGACTATTGCCAGCCTGATTACCCGTTTCTACGATATCGACCAGGGCGAAATCCTGCTTGATGGTCACGACCTGCGGGAATATACCCTACAGTCGTTGCGTAACCAGGTCGCGCTGGTTTCGCAAAACGTGCATCTGTTCAACGATACGGTGGCGAACAACATTGCGTATGCCCGTACCGAAGAGTACAGCCGTGAAGAGATCGAGAATGCGGCGCGTATGGCCTATGCGATGGACTTCATTAACAAAATGGATAACGGTCTGGATACGATCATTGGCGAAAACGGGGTGCTGCTCTCCGGTGGTCAGCGTCAACGTATCGCGATTGCCCGAGCGCTGCTGCGCAACAGCCCGATTCTGATCCTCGATGAAGCAACGTCCGCACTGGATACGGAATCTGAACGCGCTATCCAGTCGGCTCTGGATGAATTACAGAAAAACCGTACCTCGCTGGTTATCGCGCACCGTCTGTCGACCATCGAACAGGCTGACGAAATCGTGGTGGTGGAAGACGGCGTTATCGTTGAACGCGGCAGCCATGCGGACCTGCTGGAACAACGTGGTGTATACGCGCAGCTTCATAAAATGCAGTTCGGTCAATGA	
8121	CARD	prokka_01012	contig_3	343665	84	63365	63707	-1	96	ramA	3000823.0	232.261	230.0	Strict	95.58	91.13	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MTISAQVIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLMAARDLRESDERVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSQTH	ATGACGATTTCCGCTCAGGTCATTGATACGATTGTCGAATGGATCGATGACAACCTACACCAGCCGTTACGCATCGAAGAGATTGCCCGCCATGCGGGTTACTCAAAATGGCATTTACAGCGGCTGTTTATGCAGTACAAAGGCGAAAGTCTGGGGCGCTACATCCGCGAACGCAAGCTGCTGATGGCGGCGCGCGATCTGCGTGAGTCAGACGAGCGCGTATACGATATCTGCCTGCGCTACGGGTTTGACTCGCAGCAGACGTTTACCCGCATCTTTACCCGCACCTTCAACCAGCCGCCCGGGGCGTACCGCAAAGAGAACCATAGCCAGACACATTAA	
8121	CARD	prokka_01085	contig_3	343665	84	140570	143717	1	91	acrB	3000216.0	1971.05	1900.0	Strict	92.85	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDVIAKFNGKPASGLGIKLATGANALDTATAIRAELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAIFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIKKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLLLYIIIVVGMAFLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYFLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGDENKVEAITNRAMGTFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGLEDTPQYKIDIDQEKAQALGVTISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAQYRMLPNDINNWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAMNLMEELASKLPAGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDVEHNHSVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCGTGGGTGATCGCCATTATCATCATGCTGGCCGGGGGACTTGCGATCCTGAAGCTGCCTGTTGCGCAATATCCAACGATTGCGCCGCCGGCAGTGACGATCTCCGCAACCTACCCGGGCGCTGATGCCAAAACGGTGCAGGACACCGTTACGCAGGTTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCAAACAGTGACTCAACCGGTACAGTTCAGATTACCCTGACCTTTGAATCCGGTACGGATGCGGACATTGCGCAGGTTCAGGTGCAGAACAAACTGCAGCTGGCGATGCCCCTGCTGCCGCAGGAAGTGCAACAACAGGGTGTGAGCGTCGAGAAATCGTCCAGTAGCTTCCTGATGGTTGTCGGCGTGATTAACACCGATGGCACCATGACGCAGGAAGATATTTCCGACTACGTGGGCGCCAACATGAAGGACGCCATCAGCCGTACGTCTGGTGTGGGTGATGTTCAGCTGTTCGGTTCACAGTACGCGATGCGTATCTGGATGGATCCGAATAAGCTGAACAACTTCCAGCTAACCCCGGTTGACGTGATCAGCGCAATTAAAGCGCAAAACGCCCAGGTTGCAGCCGGTCAGTTAGGCGGCACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCGTCTATCATCGCGCAAACGCGTCTGACCTCGGCGGATGAGTTCAGTAAAATTCTGCTGAAGGTGAATCAGGACGGTTCGCAGGTTCGCCTGCGTGACGTGGCGAAAGTGGAGCTGGGTGGCGAGAACTACGACGTTATTGCGAAGTTCAACGGTAAACCGGCTTCCGGTTTAGGTATCAAACTGGCGACTGGTGCGAACGCCCTGGACACCGCGACGGCTATCCGTGCAGAACTGAAGAAGATGGAACCTTTCTTCCCGTCAGGTCTGAAAATTGTTTACCCGTATGACACCACGCCGTTCGTTAAAATTTCGATTCACGAAGTGGTTAAAACCCTGGTTGAGGCGATCATCCTCGTCTTCCTGGTAATGTACCTGTTCCTGCAAAACTTCCGCGCAACGCTGATCCCAACCATCGCCGTGCCGGTTGTACTGCTCGGCACCTTCGCGGTTCTGGCGATATTTGGCTATTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGCTGGTGGATGACGCCATCGTAGTGGTCGAAAACGTTGAGCGTGTGATGGCGGAAGAAGGCCTGCCGCCGAAGGAAGCAACCCGTAAATCAATGGGCCAGATCCAGGGCGCGCTGGTCGGTATCGCGATGGTTCTGTCTGCGGTATTTATCCCGATGGCCTTCTTCGGTGGTTCAACCGGTGCGATTTACCGTCAGTTCTCTATTACCATCGTTTCCGCGATGGCGCTGTCGGTGCTGGTAGCCCTGATCCTGACGCCAGCCCTGTGTGCGACCATGCTGAAGCCGATTAAGAAAGGTGGCCACGGCGAGCACAAAGGGTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGTACGCATCACTACACCGACAGCGTGGGGAACATCCTGCGCAGCACCGGTCGTTATCTGCTGCTCTATATCATCATCGTGGTGGGCATGGCTTTCCTGTTTGTTCGTCTGCCAAGCTCGTTCCTGCCAGATGAAGACCAGGGCGTGTTCCTGAGCATGGCTCAGCTTCCGGCGGGTGCGACGCAAGAACGTACGCAAAAAGTGCTGGATGAGATGACCGACTACTTCCTGACCAAAGAGAAAGACAACGTCGAATCCGTGTTTGCGGTTAACGGCTTTGGCTTCGCGGGTCGTGGTCAGAACACCGGTATTGCCTTCGTTTCTCTGAAAGACTGGTCCGAACGCCCGGGTGATGAGAACAAAGTTGAAGCCATTACCAACCGGGCCATGGGTACCTTCTCACAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCAGCGATTGTTGAACTGGGTACGGCGACCGGCTTCGACTTCCAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACTCAGGCGCGTAACCAGCTATTTGGCGAGGTGGCTAAACACCCTGACCTGCTGGTGGGCGTGCGTCCTAACGGTCTGGAAGATACGCCGCAGTACAAGATCGATATCGACCAGGAAAAAGCACAGGCGCTGGGTGTGACCATCAGTGACATCAATACCACGCTGGGTGCAGCCTGGGGTGGCAGCTACGTCAACGACTTCATCGACCGTGGTCGCGTGAAGAAAGTGTACGTCATGTCCGAAGCGCAATACCGTATGCTGCCGAACGATATCAACAACTGGTACGTTCGCGGCAGCGATGGCCAGATGGTGCCGTTCTCCGCCTTCTCAACTTCGCGCTGGGAATACGGTTCGCCGCGTCTGGAGCGTTATAACGGCTTGCCATCGATGGAGATTCTCGGTCAGGCGGCGCCGGGCCGAAGCACCGGTGAAGCCATGAACCTGATGGAAGAGTTGGCCAGCAAACTGCCTGCGGGTATTGGCTACGACTGGACCGGTATGTCCTATCAGGAACGTCTGTCCGGTAACCAGGCCCCTGCCCTGTACGCCATTTCACTGATTGTGGTGTTCCTGTGTCTGGCGGCATTGTATGAGAGCTGGTCGATTCCGTTCTCCGTTATGCTCGTGGTTCCGCTGGGGGTTATCGGTGCGCTGCTTGCCGCAACCTTCCGTGGGCTGACTAACGACGTTTACTTCCAGGTGGGCCTGCTGACAACCATTGGCTTGTCGGCGAAGAACGCGATACTTATCGTCGAATTCGCCAAAGATCTGATGGAGAAAGAAGGTAAAGGCCTGATTGAAGCAACGCTTGAAGCCGTTCGTATGCGTCTGCGTCCAATCCTGATGACGTCCCTGGCGTTTATCCTCGGCGTTATGCCGCTGGTTATCAGCTCAGGCGCAGGCTCCGGCGCACAGAACGCGGTAGGTACCGGTGTAATGGGTGGTATGGTCACTGCGACCGTTCTCGCCATCTTCTTTGTACCGGTGTTCTTCGTGGTGGTACGTCGCCGCTTTAGCCGCAAAAATGAAGATGTGGAGCACAATCATTCGGTAGAACATCACTGA	
8121	CARD	prokka_01189	contig_3	343665	84	252679	253840	1	115	Escherichia coli ampH beta-lactamase	3004612.0	697.197	500.0	Strict	86.23	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRCLLSFAALCAVSLSTAQAAQPLTAPVLASDIADRYANLIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNVRPQLDSVIRVASITKLMTSEMLVKLLDQGVVKLDDPLSKYAPPGARVPTYQGTPIRLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWNYLSTATLKSAPGSQAGYSNLAFDLLADALATASGKPYPQLFEEQITRPLGMKDTTYTPSPDQCKRLMVAEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYARSNQADRMQTLIYQRAQLRRVIGMDVPGKADALGMGWVYMAPKDGRPGIIQKTGGGGGFITYMAMIPQSNVGAFVVVTRSPNTRFVNMSDGVNNLVAELSANKAQVLTAAN	TTGAAACGTTGTCTGCTCTCTTTCGCCGCGCTGTGTGCGGTGAGCCTGTCCACCGCCCAGGCAGCACAGCCTCTGACGGCACCGGTTCTGGCCTCTGACATTGCCGATCGCTATGCGAACCTTATTTATTACGGCAGTGGTGCGACGGGAATGGCGCTGGTCGTGATCGACGGTAACCAGCGGGTGTTTCGCAGCTTCGGTGAAACACGACCGGGAAATAACGTTCGCCCGCAGCTGGATTCCGTTATCCGTGTCGCGTCGATAACTAAGCTGATGACCAGCGAAATGCTGGTGAAATTGCTCGATCAGGGCGTGGTAAAACTCGACGATCCACTTAGCAAATATGCGCCACCCGGCGCTCGCGTTCCGACATATCAGGGAACGCCGATCAGGCTGGTGAACCTGGCGACCCATACCAGCGCCCTGCCGCGAGAACAGCCCGGTGGCGCTGCGCATCGCCCTGTCTTTGTCTGGCCAACTCGCGAACAACGCTGGAACTACCTGAGCACCGCAACGCTGAAATCGGCTCCGGGTTCTCAGGCTGGCTATTCTAACCTGGCGTTTGATCTGCTGGCCGACGCGTTAGCAACGGCATCAGGTAAGCCTTACCCTCAGCTGTTTGAAGAGCAAATCACGCGTCCGCTCGGGATGAAAGATACTACTTACACCCCCTCCCCGGACCAGTGCAAGCGTCTGATGGTGGCGGAAAAAGGGGCCAGCCCGTGTAATAACACGCTGGCAGCCATTGGCAGCGGTGGGGTTTACTCTACGCCTGGCGACATGATGCGCTGGATGCAACAGTTCCTCTCATCGGATTTTTACGCGCGCAGTAATCAGGCCGACCGAATGCAGACGCTCATCTACCAGCGTGCTCAGTTACGTCGCGTCATTGGTATGGATGTTCCCGGTAAAGCCGATGCCCTCGGCATGGGCTGGGTATATATGGCGCCAAAAGATGGTCGCCCGGGTATTATTCAAAAAACCGGTGGGGGTGGCGGATTCATCACCTACATGGCGATGATTCCGCAATCAAACGTGGGCGCTTTTGTGGTGGTCACCCGGTCACCGAACACCCGCTTCGTGAATATGAGTGATGGCGTAAATAACCTTGTAGCCGAGCTGAGCGCCAATAAAGCGCAGGTACTTACGGCCGCTAACTGA	
8121	CARD	prokka_01303	contig_4	332469	90	21605	22031	1	86	FosA2	3002804.0	288.115	200.0	Strict	97.16	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARQYVPPQKSDYTHYAFTVAEEDFEPFSHRLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGSLAARLAACREKPYAGMVFTSDEA	ATGCTGCAATCTCTCAATCATCTGACCCTCGCGGTCAGCGACCTGCAAAAAAGCGTCACCTTCTGGCACGAGCTGCTGGGGCTGACGCTGCACGCCCGCTGGAATACCGGGGCCTATCTCACCTGTGGCGATCTCTGGGTCTGCCTGTCCTACGACGAGGCGCGCCAGTATGTGCCGCCGCAGAAGAGCGACTATACCCACTACGCGTTTACCGTGGCGGAAGAGGATTTTGAACCGTTCTCGCACAGGCTGGAGCAGGCGGGCGTCACCGTCTGGAAGCAGAATAAAAGCGAGGGGGCGTCGTTTTACTTTCTCGACCCGGACGGGCACAAGCTGGAGCTGCACGTGGGCAGCCTCGCCGCGCGGCTGGCGGCGTGTCGCGAGAAGCCCTATGCGGGCATGGTGTTTACCTCAGACGAGGCTTGA	
8121	CARD	prokka_01435	contig_4	332469	90	160803	161283	1	85	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.1434	32.0	Strict	27.33	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRTTLNKPVVMGRLTWESIGRPLPGRKNIVISSQPGTDDRVQWVKSVDEAIAACGDAEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSHSYCFEILERR	ATGATCAGTCTGATTGCAGCGCTGGCGGTAGACCGCGTTATCGGCATGGAAAACGCCATGCCGTGGAACCTGCCTGCCGATCTCGCATGGTTTAAACGTACTACGTTAAACAAGCCGGTAGTGATGGGCCGCCTGACCTGGGAGTCGATTGGTCGTCCATTGCCGGGTCGTAAGAATATTGTGATCAGTAGCCAGCCGGGCACTGACGATCGCGTGCAGTGGGTGAAATCCGTTGATGAAGCGATTGCCGCCTGCGGCGATGCCGAAGAGATCATGGTGATCGGTGGTGGTCGCGTGTATGAGCAGTTCCTGCCAAAAGCGCAGAAACTGTATCTGACGCACATTGATGCGGAAGTGGAAGGGGATACCCATTTTCCGGATTACGATCCGGACGAGTGGGAGTCCGTATTCAGTGAGTTTCACGATGCGGATGCGCAGAACTCGCACAGCTACTGCTTCGAAATTCTGGAACGTCGTTAA	
8121	CARD	prokka_01668	contig_5	287338	89	91584	92760	1	77	oqxA	3003922.0	695.6560000000002	670.0	Strict	92.07	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MSLQKTWGYFHLSATGVVLLSALLVGCDDSVAQNAAPQAPVVSAADVVVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGEVLFTIDDRTYRAALEQAQANLARAKTQASLARSEANRTDKLVNTNVVSREEWEQRRSAATQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDSASVLTTLVSQKTVYVYFDVDESTYLHYQNLARSGQGASSHHTALPVEIGLTGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRQFTPGLFARVRLPGSAEFKATLVDDKAVLTDQDRKYVYVVDKDGKAQRRDITPGRLADGLRIVQQGLNPGDKVIVDGLQKVFMPGMPVNAKTVAMTASAALN	ATGAGCCTGCAAAAAACCTGGGGTTACTTTCATCTGAGCGCGACGGGGGTGGTTTTACTCTCCGCGCTTCTCGTCGGGTGCGATGACAGTGTCGCGCAAAATGCTGCACCGCAAGCGCCCGTCGTCAGCGCAGCTGACGTGGTGGTGAAATCCATTAGCCAGTGGGACAGCTTTAACGGTCGCATTGAAGCGGTGGAAAGCGTTCAGCTGCGCCCACGCGTCTCCGGCTACATTGATAAAGTGAATTACACCGACGGCCAGGAGGTGAAAAAGGGCGAGGTGCTGTTCACGATTGATGACCGAACCTATCGCGCGGCGCTGGAACAGGCGCAGGCGAACCTGGCGAGAGCCAAAACGCAGGCCAGCCTGGCGCGAAGCGAGGCTAACCGTACCGATAAATTAGTCAATACCAACGTGGTATCCCGTGAAGAGTGGGAGCAGCGCCGTTCCGCCGCTACCCAGGCGCAGGCCGATATTCGCGCGGCGCAGGCGGCGGTTGATGCCGCGCAGCTCAACCTCGACTTCACCAAAGTGACCGCGCCTATCGACGGTCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTGACTGCGGGTGACAGCGCCAGCGTGCTCACCACCCTGGTCTCACAGAAGACGGTTTACGTCTACTTCGACGTGGACGAGTCCACCTATCTTCACTATCAGAACCTGGCCCGCAGCGGGCAGGGGGCGTCCAGTCACCACACGGCGCTGCCGGTGGAGATTGGTCTGACGGGTGAGGAGGGCTATCCCCATCAGGGCAAAGTGGATTTCCTGGATAACCAGCTCACGCCGAGTACCGGTACAATCCGCATGCGCGCGCTGCTGGATAACTCACAGCGTCAGTTCACGCCGGGACTCTTCGCACGCGTGCGCCTGCCGGGCAGTGCGGAATTTAAAGCCACGCTTGTTGACGATAAGGCGGTGCTGACCGATCAGGATCGTAAGTATGTTTATGTCGTTGATAAAGACGGGAAAGCGCAGCGCCGCGATATTACGCCGGGGCGTCTGGCCGACGGTTTACGTATTGTACAGCAGGGGCTGAATCCCGGGGATAAAGTCATCGTCGATGGTTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCGAAAACCGTTGCCATGACCGCCAGCGCCGCCCTCAACTGA	
8121	CARD	prokka_01669	contig_5	287338	89	92783	95936	1	81	oqxB	3003923.0	2053.48	2000.0	Strict	96.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQISAGQLGAEPLPKESDFLISINAQGRLHTEEEFGNIVLKTTQDGTVVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMDELSTRFPDDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGFAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAPKDFPTRLIDRLFGWIFRPFNRFFHRSSTGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRAGLGYGALQNAVNTMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGQFRDSVEDIANLRTRNDQGEMVPIGSMVKITTTYGPDPVIRYNGYPAADLIGDADPRVLSSAQAMTQLDAMSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKFVTRGKAEREVLPA	ATGGACTTTTCCCGTTTTTTCATCGACAGGCCGATTTTTGCCGCCGTACTGTCGATTCTGATTTTTATCACAGGATTAATCGCCATCCCGCTGCTGCCGGTGAGCGAATATCCTGATGTCGTGCCGCCAAGCGTGCAGGTGCGCGCCGAGTACCCGGGCGCCAACCCGAAAGTGATTGCCGAAACCGTGGCGACGCCGCTGGAAGAGGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCCGTCGCGGGCTCCGACGGCGTGCTGGTGACTACCGTCACCTTCCGTCCGGGTACCGACCCGGATCAGGCGCAGGTACAGGTGCAAAACCGCGTCGCACAGGCCGAGGCACGTCTGCCGGAAGACGTTCGGCGTCTGGGCATTACGACTCAGAAACAGTCGCCAACGCTGACGCTGGTGGTGCATCTCTTTTCGCCTGGCGGTAAGTACGATTCACTGTATATGCGTAACTACGCCACGCTGAAGGTGAAGGACGAGCTGGCGCGTCTGCCCGGCGTGGGTCAGATCCAGATTTTCGGCTCGGGTGAATACGCGATGCGCGTCTGGCTGGATCCAAACAAGGTGGCGGCGCGCGGACTGACGGCCTCGGACGTGGTGACGGCGATGCAGGAGCAAAACGTACAGATATCCGCCGGGCAGCTTGGCGCCGAGCCGCTGCCGAAAGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATTGTCCTGAAAACAACGCAGGACGGTACGGTCGTCCGCCTGCGCGACGTGGCGCGTATCGAGATGGGTTCCGGCAGCTATGCGCTGCGCTCCCAGCTGAACAATAAAGACGCGGTCGGGATTGGTATCTTCCAGTCGCCGGGGGCAAACGCCATCGATCTGTCTAACGCGGTGCGCGCCAAAATGGACGAACTGTCCACCCGTTTCCCGGACGATATGAAGTGGGCGGCACCTTATGACCCAACGGTATTTGTGCGCGACTCGATCCGTGCGGTTGTACAAACGCTGCTGGAAGCGGTGGTGCTGGTCGTGCTGGTGGTGATCCTGTTCCTGCAAACCTGGCGCGCGTCGATCATCCCGCTGATCGCGGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTTTACCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTGCTGGCCATCGGTATCGTGGTGGATGATGCCATCGTGGTGGTGGAGAACGTCGAGCGAAATATCGAAGAGGGGTTCGCCCCGCTTGCGGCGGCGCATCAGGCGATGCGTGAAGTGTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCAGTGTTTGTGCCGATGGCGTTCCTCTCTGGCGTGACCGGCCAGTTCTACAAACAGTTTGCGGTAACGATAGCCATTTCCACGGTGATCTCCGCGATCAACTCGCTGACGCTTTCTCCGGCGCTGGCCGCGCTGCTGTTGAAGCCGCATGGTGCCCCGAAAGATTTCCCGACCCGGCTTATCGATCGTCTGTTCGGCTGGATTTTCCGCCCGTTTAACCGCTTTTTCCATCGCAGCTCGACCGGCTATCAGGGACTGGTAGGGAAAACGCTTGGCCGACGCGGTGCAGTGTTTGCGGTTTATTTGCTGCTGCTTTGTGCCGCGGGTGTGATGTTTAAAGTCGTACCCGGCGGGTTTATTCCGACGCAGGATAAGCTGTACCTGATCGGCGGCGTGAAAATGCCGGAAGGCTCGTCGCTGGCGCGTACCGATGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGTGTGGATTATGCGGTCGCGTTTCCTGGCCTGAACGCGCTCCAGTTCACCAATACGCCGAACACCGGGACGGTCTTCTTTGGCCTGAAGCCGTTCGACCAGCGTAAACATACTGCGGCGGAAATTAACGCGGAGATCAATGCGAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCGATTCTGCCGCCGCCGATTTTAGGGCTGGGTCAAGGGTCCGGTTATTCGCTGTACATTCAGGATCGTGCTGGTCTGGGCTATGGCGCGCTGCAAAACGCGGTGAACACCATGTCCGGGGCGATTATGCAGACGCCGGGGATGCATTTCCCCATCTCAACCTACCAGGCTAACGTTCCGCAGCTGGATGTGCAGGTTGACCGTGATAAAGCGAAAGCGCAGGGCGTATCGCTTACCGATCTTTTCGGCACGCTGCAAACCTATCTGGGCTCGTCATATGTAAACGACTTTAACCAGTTTGGACGGACCTGGCGCGTAATGGCACAGGCCGACGGGCAGTTCCGCGACAGCGTGGAAGATATCGCGAATTTACGCACACGCAATGACCAGGGCGAAATGGTGCCGATTGGCAGTATGGTGAAAATCACGACCACCTACGGGCCGGACCCGGTGATCCGCTATAATGGTTACCCGGCGGCGGATCTTATTGGTGATGCTGACCCGCGCGTGCTCTCTTCCGCGCAGGCGATGACGCAGCTGGACGCCATGTCTAAGCAGATCCTGCCGAACGGGATGAATATTGAATGGACGGACCTGAGTTTCCAGCAGGCCACCCAGGGCAATACGGCGCTGATCGTCTTCCCGGTCGCGGTGCTGCTGGCGTTCCTGGTGCTGGCGGCGCTGTATGAAAGCTGGACGCTGCCGCTGGCGGTGATCCTTATCGTGCCGATGACGATGCTCTCCGCGCTGTTCGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGGCTGGTCGTGCTGATGGGGCTGGCCTGTAAAAACGCGATACTTATCGTGGAGTTTGCCCGCGAGCTGGAAATTCAGGGCAAAGGCATCATGGAGGCTGCGCTGGAGGCGTGCCGCCTGCGTTTACGCCCGATTGTAATGACCTCTATCGCCTTTATTGCCGGGACCATTCCACTGATCCTAGGTCACGGGGCAGGGGCAGAAGTCCGCGGCGTCACCGGGATCACCGTCTTCTCCGGGATGCTGGGCGTGACGCTGTTTGGTCTGTTCCTGACGCCGGTCTTTTACGTGACGCTGCGTAAGTTCGTGACGCGCGGCAAAGCGGAAAGAGAGGTGTTGCCTGCGTAG	
8121	CARD	prokka_01705	contig_5	287338	89	132589	135703	-1	91	acrD	3000491.0	1981.84	1900.0	Strict	91.71	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGVLAITSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATVTLSFTAGTDPDEAVQQVQNQLQSALRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRINGVGDIDAYGSQYSMRIWLDPNKLNSVQMTAKDVTDAIESQNAQIAVGQLGGTPSVDNQALNATINSQSLLQTPEQFRNITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGNAASGLGVKLASGANEMATAQRVLERLDELSHYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLYAFGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCSTLLKPLHKGEHHGQKGFFGWFNRMFNRNAARYEAGVGKVLHRSVRWMVVYVLLLGGMVFLFLRLPTSFLPLEDRGMFITSVQLPSGSTQQQTLKVVQKVENYFHTQEKDNVVSVFSTVGSGPGGNGQNVARMFVRLKDWDQRDSDSGSSFAIIERATKAFNKIKEARVFASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARDKLLELAGKDPQLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQSAAKYRMLPDDINRWYVRNNTGGMVPFSAFATSRWETGSPRLERYNGYSALEIVGEAAPGVSTGTAMDIMEKLVQQLPTGFGLEWTAMSYQERLSGAQAPALYALSLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNAKGHELMAATLHACRQRLRPILMTSLAFVFGVLPMATSSGAGSSSQHAVGTGVMGGMISATILAIYFVPLFFVLIRRRFPLKDKPE	ATGGCGAATTTTTTCATCGATCGCCCCATTTTTGCCTGGGTGCTAGCAATCCTGTTGTGTCTGACGGGTGTCCTGGCGATTACTTCCCTTCCTGTTGAGCAATACCCCGACCTCGCCCCCCCTAACGTGCGTATCACGGCGAACTACCCTGGCGCCTCGGCACAGACGCTGGAAAATACCGTCACGCAGGTTATCGAGCAGAACATGACGGGTCTTGATAACCTGATGTACATGTCCTCGCAGAGCAGCGCCACGGGCCAGGCGACGGTAACCCTGAGCTTTACGGCGGGCACGGATCCGGACGAAGCGGTGCAGCAGGTGCAAAACCAGCTGCAATCGGCCCTGCGTAAACTGCCTCAGGCGGTGCAGAACCAGGGGGTGACCGTGCGTAAGACCGGTGACACCAATATTTTGACCATCGCGTTTGTTTCAACCGATGGCTCGATGGATAAGCAGGACATCGCGGACTACGTCGCCAGTAATATTCAGGACCCGCTCAGCCGTATCAACGGCGTGGGTGATATCGACGCCTACGGCTCGCAGTATTCCATGCGTATCTGGCTGGATCCCAACAAGCTGAACAGCGTGCAGATGACCGCCAAAGATGTCACCGACGCCATCGAATCGCAGAACGCTCAGATTGCCGTGGGGCAGCTCGGTGGTACGCCGTCCGTGGATAACCAGGCGCTTAACGCCACCATCAACTCCCAGTCGCTGCTCCAGACGCCTGAACAGTTCCGCAATATCACTCTGCGCGTGAATCAGGATGGTTCCGAAGTGCGTCTGGGGGATGTCGCCACAGTGGAAATGGGGGCGGAAAAATATGACTACCTGAGTCGCTTTAACGGCAATGCTGCGTCCGGCCTGGGGGTGAAACTGGCCTCCGGTGCCAACGAAATGGCGACCGCGCAGCGGGTGTTAGAGCGTCTGGATGAGCTGTCGCATTACTTCCCGCACGGACTGGAGTACAAAGTCGCCTACGAAACCACCTCATTCGTAAAAGCCTCCATCGAAGATGTGGTGAAAACTTTGCTCGAAGCTATCGCGCTGGTGTTCCTCGTGATGTACCTGTTCCTGCAAAACTTCCGCGCCACGCTGATCCCCACCATTGCGGTGCCGGTGGTGTTGCTGGGAACCTTTGCGGTGCTGTATGCCTTCGGTTACAGCATCAACACCCTGACCATGTTTGCCATGGTGCTGGCCATCGGCCTGCTGGTGGATGATGCCATCGTGGTGGTGGAAAACGTCGAGCGCATCATGAGCGAGGAAGGGCTTTCGCCCCGCGAGGCCACGCGTAAATCGATGGGGCAAATTCAGGGTGCGCTGGTCGGTATCGCCATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTTTTTGGCGGCACTACGGGCGCGATTTATCGCCAGTTCTCGATCACCATCGTCTCTGCGATGGTGCTCTCCGTACTGGTGGCGATGATCCTTACCCCTGCTCTGTGCTCGACGCTGCTCAAACCGCTGCATAAGGGCGAACACCACGGTCAAAAAGGCTTCTTCGGCTGGTTTAACCGCATGTTTAACCGAAATGCGGCGCGCTATGAAGCGGGCGTGGGTAAAGTACTGCACCGCAGCGTGCGCTGGATGGTGGTCTATGTCCTGCTGCTCGGCGGCATGGTCTTCTTATTCCTGCGGCTGCCAACCTCGTTCCTGCCGCTGGAAGATCGCGGCATGTTTATCACCTCCGTACAGTTACCGAGCGGCTCGACCCAGCAGCAGACCCTGAAAGTGGTGCAGAAGGTTGAGAACTACTTCCATACTCAGGAGAAGGATAACGTGGTCTCCGTCTTCTCCACCGTCGGCTCTGGCCCTGGCGGTAACGGGCAGAACGTGGCGCGTATGTTTGTGCGCCTGAAAGACTGGGACCAGCGCGACAGCGATAGCGGCTCCTCCTTTGCCATCATTGAACGTGCAACTAAAGCGTTCAACAAAATCAAGGAAGCGCGCGTTTTCGCCAGCAGCCCGCCCGCTATCAGTGGCCTGGGCAGCTCAGCCGGATTTGATATGGAGCTTCAGGATCACGCGGGTGCCGGGCATGACGCGTTGATGGCAGCTCGCGATAAACTGCTCGAGCTGGCCGGGAAAGATCCGCAGCTTACCCGCGTTCGTCATAACGGTCTGGATGACAGCCCTCAGCTACAGGTGGATATTGACCAGCGTAAAGCGCAGGCGCTGGGCGTCTCCATCGACGACATTAACGACACCCTGCAAACGGCATGGGGCTCAAGCTACGTGAATGACTTTATGGATCGCGGTCGCGTGAAAAAGGTCTACGTTCAGTCTGCTGCCAAATACCGCATGCTGCCGGACGATATCAACCGCTGGTATGTGCGCAATAACACCGGCGGCATGGTGCCGTTCTCGGCGTTTGCGACGTCACGCTGGGAGACCGGTTCGCCGCGTCTGGAGCGTTACAACGGCTATTCGGCGCTGGAGATTGTCGGTGAAGCCGCGCCTGGCGTTAGTACCGGTACTGCAATGGACATTATGGAAAAACTGGTTCAGCAGTTACCGACCGGCTTTGGCCTGGAGTGGACGGCGATGTCCTACCAGGAACGGCTTTCCGGCGCGCAGGCGCCTGCCCTGTATGCCCTTTCGCTGCTGGTGGTGTTCCTCTGCCTGGCGGCGCTGTATGAAAGCTGGTCAGTGCCGTTCTCGGTAATGCTGGTGGTGCCTCTCGGGGTCATCGGCGCGCTGCTGGCAACCTGGATGCGTGGCCTGGAAAACGATGTCTATTTCCAGGTCGGACTCCTCACCGTAATCGGATTGTCGGCGAAAAACGCCATTCTGATCGTCGAATTTGCCAATGAGATGAATGCCAAAGGTCACGAACTGATGGCCGCCACGCTGCACGCCTGTCGTCAGCGCCTGCGCCCGATCCTGATGACTTCTCTGGCGTTTGTATTTGGCGTCCTGCCGATGGCCACCAGCTCCGGCGCAGGCTCCAGCAGCCAGCACGCGGTGGGAACGGGCGTTATGGGGGGAATGATTTCCGCGACGATTCTGGCTATCTATTTCGTACCGCTGTTCTTTGTGCTGATACGCCGTCGTTTCCCGCTGAAGGATAAGCCGGAATAA	
8121	CARD	prokka_02326	contig_7	278635	85	191299	192532	1	89	Escherichia coli mdfA	3001328.0	712.99	700.0	Strict	86.73	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MINRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQSIEQFTLLRFLQGVSLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAALAAISFFGLHRAMPETATRLGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIAQSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIILGGWPIAAGLIIAAVATVASSHAYLWMTAGLSVYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIEVSKHAYAFGGNGLFSLFNLANGVLWVGLMVVFLKDKRVGSALQP	ATGATAAACCGTTCTTCTTCCGGTAATCGTCTGGGTCGTCAGGCGTTACTTTTTCCTCTGTGTCTGGTGCTTTACGAATTCTCTACCTACATCGGCAACGACATGATCCAGCCCGGCATGCTGGCTGTGGTTGAGCAGTACAACGCAGGTATTGAGTGGGTGCCGACATCCATGACCGCCTATCTGGCGGGCGGCATGTTTTTACAGTGGCTGTTAGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGCTGACGGGCGTAGTGTGGTTTATCGTCACCTGTCTCGCCACGCTGCTGGCGCAGAGTATTGAGCAGTTCACGCTGCTGCGTTTCCTTCAGGGCGTGAGCCTGTGCTTTATTGGCGCCGTGGGCTATGCCGCTATTCAGGAGTCGTTTGAGGAGGCGGTGTGTATCAAAATTACCGCGCTGATGGCAAACGTGGCGCTGATTGCACCGCTTCTTGGGCCGCTGGTGGGAGCCGCATGGGTTCACGTCGCGCCGTGGGAGGGGATGTTCGTCCTCTTTGCCGCGCTTGCGGCTATCTCTTTCTTTGGCCTGCACCGTGCGATGCCGGAAACCGCCACCCGCCTGGGCGAAAAGCTCTCGCTTAAAGAGCTGGGGCGGGATTATAAGGCGGTGCTGAAAAATGGCCGTTTTGTCGCGGGCGCATTGGCGACGGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTCATTATCATCAGCGGCGAACAGCTTAGCAGCTATGAGTATGGCCTGTTACAGGTGCCGATTTTTGGCGCGCTGATTATCGGTAACCTGGTGCTGGCGCGTCTGACGTCGCGCCGTACCGTGCGTTCGCTGATTATTTTGGGCGGCTGGCCCATAGCGGCAGGGCTGATTATCGCGGCGGTGGCGACCGTAGCCTCGTCTCATGCGTACCTGTGGATGACGGCGGGGCTGAGTGTTTACGCGTTTGGTATCGGCGTGGCGAATGCTGGCCTGGTGCGCCTGACGCTGTTCGCCAGTGAAATGAGTAAAGGCACGGTGTCTGCCGCGATGGGGATGCTGCAAATGCTGATTTTCACCGTCGGTATTGAGGTGAGCAAACATGCCTATGCTTTCGGCGGTAACGGGCTGTTCAGCCTGTTCAACCTCGCAAACGGTGTGCTGTGGGTAGGGCTGATGGTGGTGTTCCTGAAGGACAAACGCGTCGGAAGCGCACTGCAACCGTAA	
8121	CARD	prokka_02644	contig_8	253020	88	252128	252314	1	111	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGGGATGAGGTCACCGTGACAGTTTTAGGGGTAAAGGGTAACCAGGTACGTATTGGTGTTAACGCTCCTAAAGAAGTATCTGTCCACCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTGA	
8121	CARD	prokka_02806	contig_9	232469	87	179185	179908	-1	77	baeR	3000828.0	467.233	450.0	Strict	95.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPIDDNTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDVPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQVLDAQSPLIVDESRFQASWRSKLLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDADQSFIRAVYGVGYRWEADACRIA	ATGACCGAGTTACCGATTGACGACAACACACCGCGTATTTTGATCGTGGAAGACGAGCCTAAACTTGGGCAACTGCTGATCGACTATTTACGTGCCGCGAGCTATGCGCCAACGCTTATCAGCCACGGCGACCAGGTGCTGCCCTACGTGCGCCAGACGCCGCCGGATCTGATCCTGCTGGATCTGATGCTGCCGGGTACTGACGGCCTGACCCTGTGCCGGGAAATTCGTCGTTTCTCCGATGTGCCCATCGTGATGGTGACGGCCAAAATCGAAGAGATCGACCGTCTGCTGGGGCTCGAAATCGGCGCCGACGATTACATCTGCAAGCCTTACAGCCCGCGGGAGGTGGTCGCTCGCGTGAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGTGAATTGCAGGTGCTGGATGCACAAAGCCCACTGATCGTCGACGAAAGCCGCTTCCAGGCGAGCTGGCGCAGCAAACTATTGGATCTCACCCCCGCGGAGTTCCGCCTGCTGAAAACCCTCTCCCACGAGCCGGGAAAAGTGTTTTCCCGCGAGCAGCTGCTCAACCATCTGTATGACGATTACCGCGTGGTGACCGACCGCACCATCGACAGCCACATCAAAAACCTGCGCCGCAAGCTGGAGGCGCTGGACGCCGACCAGTCGTTTATTCGCGCGGTGTACGGCGTGGGGTATCGCTGGGAAGCGGATGCCTGCAGGATTGCCTGA	
8121	CARD	prokka_02809	contig_9	232469	87	182720	185798	-1	75	mdtC	3000794.0	1876.68	1800.0	Strict	92.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILLSVAITLCGVLGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSETYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRSAISNANVRKPQGAIEDSSHRWQIQTNDELKTAAEYQPLIIHYNNGAAVRLSDVASVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVNSIRARLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLVISLTLTPMMCGWMLKRSQPHSQPRRKGFGHVLMAMQSGYGKSLKWVLNHTRIVGLVLIATIGLNVWMYITIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRGERHETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLAALREWEPKIRKALAALPQLADVNSDSQNNGAEMALTYDRETMARLGINVEAANSLLNNAFGQREVSTIYQPMNQYKVVMEVDPRYTQDISALDKMFVINDDGKAIPLSYFASWQPSNAPLSVNHQGLSAASTVSFNLPTGSSLSEASDAINRAMTQLGVPSSVRGSFAGTAQVFQDTMNSQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALELFGAPFSLIALIGIMLLIGIVKKNAIMMVDFALDAQRNGNLTPDEAIFQACLLRFRPIMMTTLAALFGALPLVISGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKKRTTVTE	GTGAAGTTTTTCGCCCTCTTCATTTACCGTCCGGTGGCGACGATTTTACTCTCCGTCGCTATCACCCTGTGCGGCGTGCTCGGCTTCCGGCTGCTGCCGGTGGCCCCGCTACCGCAGGTCGATTTCCCGGTGATCATGGTCAGCGCCTCGCTGCCGGGCGCATCGCCGGAAACCATGGCCTCATCGGTGGCGACGCCGCTTGAGCGATCGCTTGGGCGGATTGCCGGGGTTAACGAGATGACCTCCAGCAGTTCGCTGGGCAGCACGCGCATCATTCTGGAATTTAACTTCGACCGGGATATCAACGGTGCGGCGCGCGACGTGCAGGCCGCGATTAACGCCGCCCAAAGCCTGCTGCCGAGCGGCATGCCGAGCCGTCCAACCTACCGCAAGGCCAACCCGTCCGATGCGCCGATCATGATCCTGACGCTTACGTCAGAGACCTACTCCCAGGGCGAGCTGTACGATTTTGCCTCCACCCAGCTGGCGCAAACCATCGCCCAGATTGACGGCGTGGGCGACGTGGACGTCGGCGGCAGCTCCTTGCCCGCCGTGCGCGTGGGGCTGAATCCGCAGGCGCTGTTTAATCAGGGCGTGTCGCTGGACGACGTGCGATCCGCCATCAGCAACGCCAACGTGCGTAAGCCGCAGGGCGCGATTGAGGACAGCAGCCACCGCTGGCAAATCCAGACCAACGACGAGCTGAAAACCGCCGCCGAGTATCAGCCGTTGATTATTCACTACAACAACGGCGCGGCGGTGCGCCTGAGCGACGTCGCCAGCGTCACCGATTCGGTGCAGGACGTGCGTAACGCCGGGATGACCAATGCCAAACCGGCGATTTTGCTGATGATCCGCAAGCTGCCGGAAGCCAACATCATTCAGACGGTGAACAGCATCCGCGCGCGGCTGCCGGAGCTTCAGGAAACCATTCCGGCGGCCATCGATCTCCAGATTGCGCAGGACCGCTCCCCCACCATCCGCGCCTCGCTTGAAGAGGTAGAGCAAACGCTGATCATCTCCGTCGCGCTGGTAATTCTGGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCGGTAGCGGTCCCGGTATCGCTGATAGGCACCTTTGCCGCCATGTACCTGTGCGGGTTTAGCCTTAACAACCTGTCGCTGATGGCGCTGACGATTGCCACCGGGTTTGTGGTGGATGATGCCATCGTGGTGCTGGAGAATATCTCGCGTCATCTGGAAGCGGGCATGAAGCCGCTCCAGGCGGCGCTTCAGGGGACGCGCGAAGTGGGCTTCACGGTCCTGTCCATGAGCCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTGCCGGGGCGACTGCTGCGCGAATTTGCCGTCACGCTCTCCGTCGCCATTGGTATCTCACTGGTGATTTCGCTGACGCTAACGCCGATGATGTGCGGCTGGATGCTAAAGCGCAGCCAACCACACTCACAGCCGCGCAGGAAAGGCTTTGGCCACGTCCTGATGGCGATGCAGTCCGGCTACGGCAAATCGCTGAAATGGGTGCTGAACCACACGCGTATTGTCGGGCTGGTGCTTATCGCCACCATCGGGCTCAACGTCTGGATGTATATCACCATCCCGAAAACCTTCTTCCCGGAGCAGGATACCGGCGTGCTGATGGGCGGTATTCAGGCAGACCAGAGCATTTCGTTCCAGGCGATGCGCGGCAAGCTTCAGGACTTTATGAAAATCATCCGGGAAGATCCGGCCGTAGACAACGTTACCGGCTTTACCGGCGGCTCGCGCGTTAACAGCGGGATGATGTTTATTACCCTTAAGCCGCGCGGTGAACGTCACGAAACGGCGCAGCAGATCATTGACCGCTTGCGGGTGAAGCTCGCCAAAGAGCCGGGGGCGAACCTGTTTTTGATGGCCGTTCAGGATATCCGCGTCGGCGGACGACAGGCTAACGCCAGCTATCAGTACACCCTGCTCTCGGATGACTTAGCCGCCCTGCGCGAGTGGGAGCCGAAGATCCGTAAAGCGCTGGCCGCGCTGCCGCAGCTGGCGGACGTGAACTCCGACAGCCAGAACAACGGCGCGGAGATGGCGCTCACCTACGATCGTGAAACTATGGCCCGCCTGGGCATTAACGTGGAGGCGGCCAACAGCCTGCTTAACAACGCCTTCGGGCAGCGTGAAGTCTCCACCATCTATCAGCCGATGAACCAGTACAAGGTGGTAATGGAAGTTGATCCGCGCTACACCCAGGACATCAGCGCGCTGGACAAGATGTTTGTGATCAATGATGACGGCAAGGCGATCCCGCTGTCGTACTTCGCCAGCTGGCAGCCGTCGAACGCGCCGCTGTCGGTAAACCACCAGGGGCTTTCCGCCGCCTCGACCGTGTCGTTTAACCTGCCAACCGGCTCGTCGCTGTCTGAGGCCAGCGATGCCATTAACCGCGCCATGACCCAGCTTGGGGTGCCCTCCTCCGTGCGCGGCAGCTTTGCCGGTACGGCGCAGGTGTTCCAGGACACCATGAACTCGCAGGTCATTTTGATCCTGGCGGCCATTGCCACGGTGTACATCGTGCTGGGCGTGCTGTACGAAAGCTACGTGCACCCGTTGACCATTCTCTCCACGCTTCCCTCTGCGGGCGTGGGGGCGCTGCTGGCGCTGGAGCTGTTCGGTGCTCCATTCAGCCTCATCGCGCTCATTGGGATCATGCTATTAATAGGTATTGTGAAGAAAAACGCGATTATGATGGTCGACTTTGCCCTGGATGCCCAGCGTAACGGCAACCTGACGCCGGACGAGGCGATATTCCAGGCCTGTCTGCTGCGTTTTCGCCCGATCATGATGACTACGCTGGCCGCGCTGTTCGGCGCACTGCCGCTGGTCATATCCGGCGGTGACGGCTCTGAACTGCGCCAGCCGCTGGGGATCACGATCGTTGGCGGCCTGGTGATGAGCCAGTTGCTGACGCTCTACACCACGCCGGTAGTCTATCTGTTCTTTGACCGCCTGCGGCTGCGTTTTTCGCGTAAAAAGAGAACCACGGTGACCGAGTAA	
8121	CARD	prokka_02810	contig_9	232469	87	185798	188921	-1	77	mdtB	3000793.0	1850.48	1800.0	Strict	90.1	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVMPPSSTGGPSRLFILRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLSLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAMPMTQVEDMVETRVAQKISQVTGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETIRTAISSANVNSAKGSLDGPTRAVTLSANDQMQSADEYRQLIVAYQNGAPIRLGDVATVEQGAENSWLGAWANKQQAIVMNVQRQPGANIIDTADSIRTMLPQLVESLPKSVSVKVLSDRTTNIRASVSDTQFELMLAIALVVMIIYLFLRNVPATIIPAVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERMFERIIAAYGRVLAKVLNHPWATLGVALGTLALSVMLWIFIPKGFFPIQDNGIIQGTLQAPQTVSFANMAQRQQQVSEIIMKDPAVESLTAYVGVDGTNPSLNSARLQINLKPLDDRDDRVNAVIERLQSAVARVPGIELYLQPIQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLVDKLKALPQVSDVSSDWQDKGLAAYVNVNRDTASRLGITMSDVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAVLDSIRLTSKDGGIVPLSAIASVEERHTPLSINHLDQFPSTTISFNVPDGYSLGEAVEAILGAEKELSFPSDIQTQFQGSTLAFQAALGSTVWLIVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALMLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMAPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLLVSQVLTLFTTPVIYLLFDRLALWTKSRFPKREEEA	ATGCAGGTGATGCCGCCGAGCTCTACAGGTGGGCCATCACGCCTGTTTATCTTACGTCCGGTTGCGACGACCCTGTTGATGGTGGCGATCCTGCTGGCCGGGATCATTGGCTACCGTTTTCTGCCCGTGTCGGCGCTGCCGGAAGTGGACTACCCGACCATTCAGGTTGTCACCCTCTATCCGGGCGCCAGTCCGGATGTGGTGACGTCCGCCATCACCGCCCCGCTGGAGCGTCAGTTTGGCCAGATGTCTGGCCTGAAGCAGATGTCCTCCCAGAGCTCCGGCGGCGCCTCGGTCGTCACGCTTCAGTTCCAGCTCACGCTGTCGCTGGACGTCGCCGAGCAGGAGGTGCAGGCCGCGATTAACGCCGCCACTAACCTGCTGCCGTCTGACCTGCCGAATCCACCGGTTTACAGCAAGGTGAACCCGGCAGACCCGCCGATCATGACGCTTGCCGTCACCTCCTCCGCCATGCCGATGACGCAGGTGGAAGACATGGTTGAAACCCGCGTGGCGCAGAAGATTTCGCAGGTGACCGGCGTGGGACTGGTGACGCTGGCGGGCGGTCAACGCCCCGCTGTGCGCGTTAAGCTCAATGCCCAGGCCATTGCCGCGCTGGGGTTAACCAGCGAAACCATTCGCACCGCCATCAGCAGCGCCAACGTTAACTCAGCGAAGGGCTCGCTGGACGGCCCAACCCGTGCGGTCACGCTCTCTGCCAACGACCAGATGCAGTCCGCCGATGAATACCGCCAGCTGATTGTGGCCTATCAAAACGGCGCGCCGATCCGCCTGGGCGACGTGGCAACCGTCGAACAAGGCGCGGAAAACAGCTGGCTCGGGGCGTGGGCCAATAAGCAGCAGGCGATTGTCATGAACGTTCAGCGCCAGCCAGGCGCGAACATTATTGATACCGCCGACAGCATTCGCACCATGCTGCCGCAGCTGGTGGAAAGCCTGCCAAAATCGGTGAGCGTGAAAGTGCTTTCTGACCGCACCACGAATATTCGCGCCTCGGTGTCAGACACCCAGTTCGAGCTGATGCTGGCGATTGCGCTGGTGGTGATGATCATCTACCTGTTCCTGCGCAACGTTCCGGCAACCATCATTCCCGCCGTCGCCGTGCCGCTCTCGCTGGTCGGGACGTTTGCGGTGATGGTGTTCCTCGACTTTTCGATTAATAACCTGACGCTGATGGCGCTCACCATCGCCACCGGGTTCGTGGTGGACGATGCCATCGTGGTCATCGAGAACATCTCGCGCTATATCGAAAAAGGTGAAAAGCCCTTAGCCGCCGCGCTGAAGGGCGCAGGAGAAATTGGCTTTACCATTATCTCGCTCACCTTCTCGCTGATTGCGGTGCTGATCCCGCTGCTGTTTATGGGGGATATCGTCGGGCGGCTGTTCCGCGAGTTTGCCGTGACGCTGGCGGTCGCCATTCTGATCTCTGCCGTGGTGTCGCTGACGCTAACGCCGATGATGTGCGCCCGCATGCTGAGCCACGAATCTTTGCGCAAGCAAAACCGCTTCTCGCGCGCCTCCGAGCGGATGTTCGAGCGCATTATCGCCGCCTACGGCCGCGTGCTGGCGAAAGTCCTGAACCATCCCTGGGCGACGCTCGGCGTGGCGCTCGGCACCCTGGCGCTCAGCGTGATGCTGTGGATTTTCATTCCGAAAGGCTTCTTCCCGATTCAGGACAACGGCATTATTCAGGGCACGCTTCAGGCGCCGCAGACGGTCTCCTTCGCCAACATGGCGCAGCGCCAGCAGCAGGTGTCTGAGATCATCATGAAAGATCCGGCGGTGGAAAGCCTGACCGCCTACGTGGGCGTGGACGGCACCAACCCGTCGCTCAACAGCGCGCGCCTGCAAATTAACCTTAAACCGCTTGATGACCGCGACGATCGCGTCAACGCGGTAATTGAGCGCCTGCAAAGCGCGGTGGCGCGCGTGCCGGGCATTGAGCTGTATCTGCAACCGATCCAGGATTTAACCATTGATACGCAGGTGAGCCGCACGCAGTACCAGTTTACGCTCCAGGCCACCTCGCTTGATGCACTCAGCACCTGGGTGCCGCAGCTGGTGGATAAGCTGAAAGCACTGCCGCAGGTTTCTGACGTCAGCAGCGACTGGCAGGATAAAGGGCTGGCGGCGTACGTGAACGTCAACCGCGACACCGCCAGCCGTCTGGGCATTACCATGTCCGATGTGGATAACGCCCTGTATAACGCCTTTGGTCAGCGACTGATCTCCACCATTTACACCCAGGCCAACCAGTATCGCGTGGTGCTGGAACATAACACCGAGAACACGCCCGGGCTTGCCGTGCTGGACTCAATACGCCTGACCAGCAAAGACGGCGGGATTGTGCCGCTCAGCGCCATTGCCAGCGTGGAAGAGCGCCACACCCCGCTGTCGATTAACCATCTCGATCAGTTCCCGTCCACCACCATTTCGTTCAACGTGCCGGATGGGTATTCGCTGGGCGAAGCGGTGGAGGCCATTCTGGGCGCGGAGAAAGAACTCAGCTTCCCGTCCGATATTCAGACCCAGTTCCAGGGCAGTACGCTGGCGTTCCAGGCCGCGCTGGGCAGCACCGTCTGGCTGATTGTCGCGGCGGTGGTGGCGATGTATATCGTGCTTGGCGTGCTGTATGAGAGTTTCATCCACCCGATCACCATCCTCTCCACCCTGCCGACGGCGGGCGTGGGGGCGCTGCTGGCGCTGATGCTGGCGGGGAGCGAACTGGACGTGATTGCGATAATTGGCATCATCCTGCTTATCGGCATCGTGAAGAAAAACGCCATCATGATGATCGACTTTGCGCTGGCCGCCGAGCGCGAGCAGGGTATGGCGCCGCGCGAGGCCATTTACCAGGCCTGTCTGCTGCGTTTTCGCCCGATCCTGATGACCACTCTCGCCGCCCTGCTGGGCGCGCTGCCGCTGATGCTGAGCACCGGCGTGGGGGCCGAACTGCGCCGTCCGCTGGGCATCGGCATGGTCGGCGGTCTGCTGGTGAGCCAGGTGCTGACGCTGTTTACCACGCCGGTTATCTACCTGCTGTTTGACCGTTTGGCCCTGTGGACAAAAAGCCGCTTCCCGAAACGTGAAGAGGAGGCGTAA	
8121	CARD	prokka_02999	contig_10	207797	89	151279	152101	1	78	bacA	3002986.0	512.686	500.0	Strict	95.24	100.0	undecaprenyl pyrophosphate related proteins	protein homolog model	antibiotic target alteration		peptide antibiotic	MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRLPQREGEGKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTVGDIPMFAVGFITAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF	ATGAGCGATATGCACTCGCTGCTGGTGGCGGCAATTCTGGGTGTGGTCGAAGGATTGACGGAGTTTTTGCCGGTGTCCAGTACGGGCCATATGATTATCGTTGGCCATCTCCTGGGCTTTGAAGGCGATACCGCAAAGACGTTTGAGGTGGTGATTCAGCTGGGCTCTATTCTGGCGGTGGTCGTCATGTTCTGGCGTCGTCTGTTTGGTCTGATCGGCATCCACTTCGGGCGTCTACCGCAGCGTGAAGGAGAGGGCAAGGGGCGCCTGACGCTGATTCATATTCTGCTGGGGATGATCCCGGCGGTGGTGCTGGGGCTGGTGTTCCATGACACCATAAAATCGCTTTTCAACCCGATTAACGTGATGTACGCGCTGGTTGTCGGCGGCTTCCTGCTGATTGCCGCCGAAGTGCTGAAGCCAAAAACCCCGCGTGCAGAAGGTCTGGACGATATGACGTATCGCCAGGCGTTTATGATTGGCTGCTTCCAGTGTCTGGCGCTGTGGCCGGGCTTCTCCCGTTCAGGGGCAACCATTTCCGGCGGGATGCTGATGGGCGTGAGCCGTTACGCGGCGTCTGAGTTCTCGTTCCTGCTGGCGGTACCGATGATGATGGGCGCCACCGCACTGGATCTCTACAAAAGCATCGGCTTCCTGACCGTAGGCGACATTCCGATGTTCGCCGTGGGCTTTATCACCGCCTTTATCGTGGCGCTGATTGCCATCAAAACCTTCCTGCAACTGATTAAGCGTATCTCGTTTATTCCGTTCGCGATCTACCGCTTTATCGTCGCGGCTGCCGTGTACGTGGTCTTCTTCTGA	
8121	CARD	prokka_03068	contig_11	185017	83	20640	21021	1	99	marA	3000263.0	247.284	230.0	Strict	94.35	99.21	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITSMPGESRYLYPLKHCS	ATGTCCAGACGCAATACTGACGCTATCACCATTCATAGCATTTTGGACTGGATCGAAGATAACCTGGAATCTCCACTTTCCCTTGAGAAAGTGTCTGAGCGTTCAGGTTACTCAAAATGGCACCTGCAACGGATGTTTAAAAAAGAGACCGGCCATTCATTAGGACAATATATTCGCAGCCGTAAGCTGACGGAGATTGCCCAAAAACTGAAAGAAAGCAATGAGCCGATCCTCTATCTGGCGGAACGCTACGGATTTGAATCGCAACAAACCCTGACGCGTACGTTCAAGAACTACTTTGACGTGCCGCCTCATAAGTACCGTATTACCAGTATGCCGGGTGAATCCCGTTATCTGTATCCGCTAAAACATTGCAGTTAA	
8121	CARD	prokka_03393	contig_13	154643	85	23424	24057	1	84	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATTCACCAGGGTGAAAAAGCGGAAACGTTGTATTACATCGTTAAAGGCTCGGTGGCCGTGCTGATCAAAGATGAAGAAGGGAAAGAGATGATCCTTTCTTATCTGAACCAGGGCGATTTTATCGGTGAACTGGGCCTGTTTGAAGAAGGCCAGGAACGTAGCGCCTGGGTTCGTGCAAAAACAGCATGTGAAGTGGCTGAAATTTCTTACAAGAAATTCCGTCAGCTGATTCAGGTCAACCCTGACATCCTGATGCGTCTTTCTTCCCAGATGGCACGCCGTCTGCAAGTGACCTCTGAGAAGGTGGGTAACCTCGCCTTCCTGGACGTGACCGGTCGTATCGCGCAGACTCTGTTGAACCTGGCGAAACAGCCAGACGCCATGACCCACCCTGACGGTATGCAAATTAAAATTACCCGCCAGGAAATCGGTCAGATCGTCGGCTGCTCCCGTGAAACAGTGGGCCGTATCCTGAAGATGCTGGAAGACCAGAACCTGATCTCCGCCCACGGTAAAACCATCGTGGTTTACGGGACCCGTTAA	
8121	CARD	prokka_03707	contig_15	99128	90	94830	97944	1	101	adeF	3000777.0	755.747	750.0	Strict	40.63	97.92	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MANFFIQRPVFAWVLSIILMIAGGLAILKLPVAQYPTIAPPAVAVTATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGNVTITLTFESGTDPDIAQVQVQNKLQLAMPLLPQEVQQQGIGVEKSSSSFLLVAGFVSDNKNLTQDDISDYVASNVKDAISRTSGVGDVQLFGAQYAMRIWLDSNAMNKYQLTPLDVINQLKTQNDQIAAGQLGGTPSVPGQQLNASIIAQTRLKSPEEFGRVTLKVNQDGSMVHLKDVARIELGGENYNMVTKINGQAATGLGIKLATGANALDTAAAIKSKLAQLQPFFPQGLKVVYPYDTTPFVKISIHEVVKTLFEAIVLVFLVMYLFLQNLRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEDKLPPKEATQKSMEQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSLTIVSAMALSVLVALILTPALCATLLKPVSSDHHEKKGGFFGWFNALFDKSVEHYSNSVSGILRKTGRYLLVYVIIVGGMAVLFLRLPSSFLPEEDQGVFMTMVQLPAGATQMRTQQVLDQVQDYYLTKEKANVESVFTVNGFSFSGQGQNSGIAFVSLKPWEERPGKENGVEAIVSRATKAFSQIKDGLVFPFNLPAIIELGTATGFDFELIDQANLGHTQLTQARNQLLGMVREHPDLLVRVRPNGLEDTPQYKLDVDQEKAQALGVSISDVNQTISTALGGTYVNDFIDHGRVKKVYVQADARFRMLPGDINDLYVRSANGEMVPFSAFSSSHWVYGSPRLERYNGMPSMEILGESAPGKSTGEAMEMMESLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAASIRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMLSATLLAIFFVPVFFVVVRRRFTKHKD	ATGGCTAATTTCTTTATTCAACGGCCTGTTTTCGCCTGGGTGCTCTCCATCATTCTGATGATTGCGGGCGGGCTGGCCATTTTAAAACTGCCGGTGGCGCAATATCCAACCATTGCGCCGCCAGCAGTTGCGGTGACAGCGACCTACCCTGGCGCTGATGCCCAGACGGTCCAGGATACCGTGACGCAGGTTATCGAACAGAACATGAACGGAATCGACAATCTGATGTACATGTCGTCCACCAGTGATTCTGCCGGTAACGTCACCATCACCCTGACGTTCGAGTCGGGTACGGATCCTGACATCGCGCAGGTGCAGGTTCAGAACAAACTCCAGCTCGCTATGCCGCTGCTACCGCAAGAAGTACAGCAACAGGGGATCGGCGTGGAAAAATCCAGCAGCAGCTTCCTGCTGGTCGCGGGATTTGTGTCGGATAATAAAAACCTCACTCAGGATGATATCTCCGACTATGTCGCTTCTAACGTAAAAGATGCGATCAGCCGTACTTCCGGCGTCGGTGATGTGCAGCTGTTCGGTGCGCAGTATGCAATGCGCATCTGGCTGGACAGCAACGCGATGAATAAATATCAGCTCACGCCGTTGGATGTCATTAACCAACTGAAAACGCAGAACGACCAGATTGCTGCGGGCCAGTTGGGAGGTACGCCGTCCGTACCAGGGCAGCAACTGAACGCCTCAATTATTGCTCAAACGCGCCTGAAATCGCCGGAGGAGTTTGGCCGTGTGACGCTGAAGGTGAACCAGGACGGTTCAATGGTCCACCTGAAAGATGTGGCCCGCATTGAGCTGGGTGGCGAAAACTACAACATGGTCACCAAAATCAATGGCCAGGCAGCAACGGGGCTCGGGATCAAGCTGGCGACTGGCGCAAACGCGCTGGATACCGCTGCCGCCATTAAGAGTAAACTGGCGCAGTTGCAGCCCTTCTTCCCTCAGGGCCTGAAAGTCGTTTATCCGTACGACACCACACCTTTCGTGAAGATCTCAATCCATGAAGTGGTGAAGACGCTGTTTGAAGCGATCGTTCTCGTGTTCCTGGTGATGTACTTGTTCCTGCAAAACCTGCGGGCAACCCTTATTCCGACTATTGCCGTGCCCGTGGTGCTACTGGGTACCTTTGCAGTACTGGCTGCGTTTGGTTTCTCCATTAACACCCTGACGATGTTCGGGATGGTATTGGCGATAGGTTTGCTCGTCGATGATGCCATCGTGGTGGTTGAGAACGTAGAACGCGTCATGGTTGAGGACAAGCTGCCGCCAAAAGAGGCGACCCAGAAGTCGATGGAGCAAATCCAGGGCGCTCTGGTGGGCATTGCCATGGTGCTTTCAGCGGTGTTTATTCCGATGGCATTTTTTGGAGGTTCAACCGGGGCTATCTATCGCCAGTTCTCGCTGACCATTGTCTCCGCGATGGCCTTATCGGTGCTGGTGGCGTTGATATTAACGCCTGCTTTATGTGCAACGCTGCTCAAACCGGTTTCCAGCGACCATCATGAAAAGAAAGGTGGATTCTTCGGCTGGTTTAACGCGCTTTTTGATAAGAGCGTGGAGCACTACAGCAACAGCGTGAGCGGCATTTTACGTAAGACTGGACGCTATCTGCTGGTTTACGTCATCATCGTCGGCGGCATGGCAGTACTGTTCCTGCGCCTGCCTTCCTCCTTCCTGCCGGAAGAGGATCAGGGGGTGTTTATGACGATGGTTCAGCTGCCGGCAGGGGCGACGCAGATGCGTACCCAGCAGGTACTCGATCAGGTTCAGGACTATTATCTGACGAAAGAGAAAGCGAACGTTGAATCGGTCTTTACCGTAAACGGATTTAGCTTTAGCGGGCAGGGGCAGAACTCCGGTATCGCTTTCGTCAGCCTGAAGCCATGGGAAGAACGCCCGGGCAAGGAAAACGGCGTTGAGGCGATTGTCAGCCGCGCAACGAAAGCGTTTAGCCAGATCAAAGATGGTCTTGTATTTCCGTTTAACCTCCCTGCCATTATTGAACTGGGTACCGCAACAGGCTTTGACTTTGAACTGATTGACCAGGCAAACCTGGGACATACGCAGCTCACGCAGGCACGTAACCAACTGCTTGGCATGGTAAGGGAACATCCTGACTTACTGGTCCGCGTGCGTCCTAACGGACTGGAAGATACGCCACAGTACAAACTGGATGTCGACCAGGAGAAGGCCCAGGCGCTGGGTGTGAGCATATCTGATGTCAATCAGACCATCTCAACAGCATTGGGTGGCACTTATGTGAACGACTTTATCGATCATGGACGCGTGAAAAAAGTTTATGTCCAGGCTGATGCTCGCTTCCGTATGTTACCAGGAGATATTAACGACCTGTATGTGCGTAGTGCTAACGGCGAAATGGTGCCTTTCTCTGCCTTTAGCAGCTCTCACTGGGTGTACGGCTCACCTCGTCTGGAACGTTACAATGGGATGCCATCAATGGAGATCCTCGGTGAGTCTGCGCCAGGCAAAAGTACCGGTGAGGCAATGGAGATGATGGAAAGCCTTGCGTCGAAACTGCCTTCCGGAATTGGCTACGACTGGACGGGGATGTCTTATCAGGAACGTCTTTCCGGAAATCAGGCTCCAGCACTGTATGCCATTTCACTGATTGTGGTGTTCCTGTGTCTGGCGGCTCTCTATGAAAGCTGGTCAATTCCATTCTCGGTCATGCTGGTTGTGCCCCTGGGGGTGATCGGCGCGCTTCTGGCTGCATCAATACGTGGGCTGAACAATGACGTTTACTTCCAGGTTGGTCTGCTTACGACAATTGGTTTATCAGCCAAAAACGCCATACTGATCGTTGAGTTCGCCAAGGATCTTATGGATAAAGAAGGCAAAGGGATTATTGAAGCCACGCTGGAAGCCTCACGTATGCGTCTGCGCCCTATCCTGATGACCTCTCTGGCATTTATCCTTGGTGTTATGCCTCTGGTCATCAGTAGTGGCGCAGGTAGTGGGGCACAAAACGCTGTCGGGACGGGCGTGATGGGAGGGATGCTGTCAGCCACTCTGCTGGCCATTTTCTTTGTTCCTGTTTTCTTCGTTGTTGTCCGGAGACGGTTTACAAAGCATAAGGATTAA	
8121	CARD	prokka_03941	contig_18	75128	114	68699	69176	-1	139	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	37.7354	32.0	Strict	27.21	89.27	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MKMIAAVGRNYEIGIGNELPWRCPTDLKLFKQLTKNATVVMGRKTMESLKRPLPERHNLVLTRSRGYIPNGFYPAGIDDVLRLPDPVWVIGGGQIYLLFMPHVEEIWLSHIGVDVPGADAFFPAPMMRSLGFVPVETAYTQRANEDEPGFLQIVYRRS	ATGAAGATGATTGCAGCTGTCGGCCGCAACTATGAAATCGGCATTGGCAACGAACTTCCCTGGCGTTGCCCGACCGATCTGAAACTGTTCAAACAACTCACCAAAAACGCCACTGTCGTGATGGGACGCAAGACGATGGAAAGTCTCAAGCGCCCGCTGCCAGAGCGCCATAACCTCGTTTTGACGCGCTCTCGTGGGTATATCCCCAATGGGTTCTACCCCGCTGGCATCGATGACGTTTTGAGACTGCCAGATCCGGTCTGGGTGATTGGTGGCGGGCAGATTTACTTGCTCTTTATGCCACACGTAGAAGAGATCTGGCTGTCGCATATTGGCGTGGATGTGCCGGGCGCGGATGCGTTCTTCCCGGCGCCAATGATGCGTTCTTTAGGGTTCGTACCAGTCGAAACGGCTTATACCCAACGTGCAAATGAGGATGAGCCTGGCTTTTTGCAGATCGTATACAGAAGGTCGTAA	
8121	CARD	prokka_04295	contig_23	70611	80	67026	67557	1	81	emrR	3000516.0	347.051	280.0	Strict	94.86	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTAERDQLEHITRKLLTRLDQMDEDGVILEALR	ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTTAAGTTCCGCGCCAGTCGTCATGAGGACTTCCCGTATCAGGAGATCCTGCTGACCCGCCTGTGCATGCACATGCAGGGTAAGCTGCTGGAAAATCGTAACAAGATGCTGAAAGCGCAAGGGATTAACGAGACGTTGTTTATGGCGTTGATTACGCTTGAGTCTCAGGAAAACCACAGCATTCAGCCGTCTGAACTGAGCTGCGCGCTGGGTTCATCCCGTACCAATGCAACCCGTATTGCTGATGAGCTGGAGAAGCGCGGCTGGATAGAGCGCCGTGAGAGCGATAACGATCGCCGCTGCCTGCATCTGCAACTGACCGAGAAAGGTCACGAATTCCTGCGCGAAGTGTTGCCACCGCAGCATAACTGCCTGCACCAGCTTTGGTCTGCCCTCAGCACCGCCGAGCGCGACCAGCTTGAGCACATTACTCGCAAGCTGCTCACCCGTCTGGACCAGATGGATGAAGATGGCGTCATTCTTGAGGCGCTGCGCTAA	
8121	CARD	prokka_04297	contig_23	70611	80	68874	70422	1	73	emrB	3000074.0	932.939	900.0	Strict	93.47	100.59	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MQQQKPQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTILFVLASWACGMSSSLTMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGALVVLMTLQSLRGRETRTEQRRIDGIGLALLVVGIGSLQIMLDRGKELDWFASTEIIVLTVVAVVAISFLIVWELTDENPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGLIPVLLSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERMAAASSLSNFTRTLAGSIGTSITTTLWTNREAMHHAQLTEAVNPFNPNAQQMYSQLEGMGMTEQQASGWLAQQITNQGLIISANEIFWISAGIFIVLLGLVWFAKPPFGAGSGGGGAH	ATGCAACAGCAAAAGCCGCAAAAACCGCTTGAGGGGGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTGGCGACATTCATGCAGGTGCTGGACTCCACCATCGCAAACGTGGCGATCCCTACGATCGCCGGGAACCTTGGCTCATCGCTGAGCCAGGGGACCTGGGTCATTACCTCATTCGGGGTGGCGAACGCCATCTCTATTCCCATCACCGGCTGGCTGGCGAAGCGCGTCGGTGAAGTGAAGCTGTTCCTCTGGTCGACGATCCTGTTCGTGCTGGCCTCCTGGGCCTGCGGCATGTCCAGCAGCCTGACGATGCTGATTTTCTTCCGCGTCATCCAGGGGATTGTCGCCGGGCCGTTGATTCCGCTATCGCAGAGTTTACTGCTGAACAACTATCCGCCCGCCAAGCGCTCCATCGCGCTCGCGCTGTGGTCGATGACGGTGATTGTCGCCCCAATTTGCGGGCCAATCCTCGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTCATCAACGTACCCATCGGTGCGCTGGTGGTGCTGATGACGCTACAGTCTCTGCGTGGTCGCGAAACGCGGACCGAACAGCGGCGGATCGACGGCATCGGGCTGGCACTGCTGGTTGTCGGCATCGGCAGCCTGCAAATCATGCTCGACCGCGGCAAAGAGCTGGACTGGTTCGCCTCTACGGAAATCATCGTGCTGACGGTGGTCGCCGTGGTTGCCATTAGCTTCCTGATTGTCTGGGAGCTGACGGACGAAAATCCGATAGTCGACCTCTCGCTGTTTAAATCGCGAAACTTCACCATCGGCTGCCTCTGTATCAGCCTCGCCTATATGCTCTACTTCGGCGCGATTGTTCTGCTGCCGCAGCTGTTGCAGGAGGTGTACGGCTATACCGCAACCTGGGCGGGGCTGGCCTCCGCGCCGGTGGGGTTAATTCCGGTTCTGCTGTCGCCGATTATTGGCCGTTTCGCCCATAAGCTCGACATGCGCAGGCTGGTGACGTTCAGCTTCATCATGTACGCCGTGTGCTTCTACTGGCGCGCGTATACGTTTGAACCGGGAATGGACTTTGGCGCCTCCGCGTGGCCGCAGTTTATTCAGGGCTTTGCTGTGGCGTGCTTCTTTATGCCACTGACCACCATTACGCTTTCCGGCTTGCCGCCTGAGCGGATGGCGGCGGCATCGAGCCTGTCGAACTTCACCCGTACGCTGGCGGGCTCCATCGGGACATCGATCACCACCACGCTGTGGACCAACCGGGAAGCGATGCACCATGCCCAGCTGACCGAAGCGGTGAACCCGTTCAACCCTAACGCTCAGCAGATGTATAGCCAGCTTGAGGGGATGGGGATGACGGAGCAGCAGGCGTCCGGCTGGCTTGCCCAGCAGATCACCAACCAGGGGCTGATTATCTCGGCAAACGAGATTTTCTGGATATCGGCGGGGATCTTCATCGTCCTGCTGGGGCTGGTGTGGTTTGCCAAACCACCGTTTGGTGCCGGTAGCGGGGGCGGTGGAGCGCACTAG	
8121	CARD	prokka_04991	contig_42	13229	81	11716	11998	1	70	Brucella suis mprF	3003772.0	23.0978	1650.0	Strict	100.0	10.57	defensin resistant mprF	protein homolog model	antibiotic target alteration		peptide antibiotic	MKISQLESGMQVWSVTRTKMGNTTISTVIVHPVVIIEIHDNHVIARWNGNAPRRFGETAIRGWKKEKPLLVREPFGNVRLATRAEKTAMQEKE	ATGAAAATCAGCCAGCTGGAATCCGGGATGCAGGTTTGGTCTGTAACCCGTACCAAAATGGGAAATACCACCATTTCAACGGTCATTGTCCACCCCGTTGTCATTATTGAAATTCATGATAACCATGTGATTGCTCGCTGGAACGGCAATGCACCACGTCGGTTTGGAGAAACGGCTATCAGGGGCTGGAAGAAGGAGAAGCCACTGCTTGTCCGTGAGCCTTTCGGAAATGTTCGTCTGGCCACCCGGGCTGAAAAAACCGCTATGCAGGAAAAAGAGTAA	loose hit with at least 95 percent identity pushed strict
8121	CARD	prokka_05034	contig_47	7386	99	112	460	1	163	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8121	CARD	prokka_05035	contig_47	7386	99	453	1293	1	112	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8121	CARD	prokka_05037	contig_47	7386	99	3502	4159	1	86	QnrA1	3002707.0	446.047	400.0	Perfect	100.0	100.0	quinolone resistance protein (qnr)	protein homolog model	antibiotic target protection		fluoroquinolone antibiotic	MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD	ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG	
8121	CARD	prokka_05040	contig_47	7386	99	5810	6650	1	146	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8121	CARD	prokka_05062	contig_51	4258	96	183	816	-1	112	catB2	3002675.0	436.417	400.0	Strict	99.52	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MTNYFESPFKGKLLTEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDQLIIGSFCSIGSGAAFIMAGNQGHRYDWVSSFPFFYMNEEPAFAKSVDAFQRAGDTVIGSDVWIGSEAMIMPGIKIGHGAVIGSRALVAKDVEPYTIVGGNPAKSIRKRFSEEEISMLLDMAWWDWPLEQIKEAMPFLCSSGIASLYRRWQGTSA	ATGACGAATTATTTTGAGAGTCCCTTCAAAGGGAAGCTTCTGACTGAGCAGGTGAAGAATCCGAACATCAAGGTAGGGCGGTATAGCTACTATTCCGGCTATTACCATGGGCACTCGTTTGATGATTGTGCTCGCTACCTTCTACCAGACCGTGATGACGTTGATCAGCTGATTATCGGCAGCTTCTGCTCCATCGGATCAGGCGCAGCTTTTATTATGGCTGGGAATCAAGGCCACCGATATGATTGGGTCTCTTCTTTCCCTTTCTTCTACATGAACGAGGAGCCCGCGTTTGCAAAATCAGTCGATGCATTCCAGCGGGCTGGCGACACAGTTATAGGAAGTGATGTGTGGATCGGTTCGGAGGCCATGATCATGCCCGGGATCAAGATCGGGCATGGAGCGGTGATAGGTAGCCGCGCTTTGGTTGCCAAAGACGTGGAACCCTACACCATAGTGGGGGGAAACCCTGCAAAGTCGATTAGGAAGCGCTTTTCTGAAGAAGAAATTTCTATGCTTTTAGATATGGCTTGGTGGGATTGGCCGCTGGAACAAATCAAGGAAGCAATGCCTTTTCTTTGTTCGTCTGGCATTGCCAGCCTGTATCGTCGCTGGCAAGGCACAAGCGCCTAA	
8121	CARD	prokka_05063	contig_51	4258	96	868	1648	-1	80	ANT(3'')-IIa	3004089.0	518.0790000000002	450.0	Strict	99.23	80.19	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	GTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAGAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAA	
8121	CARD	prokka_05064	contig_51	4258	96	1776	2079	-1	73	aphA15	3004675.0	211.846	500.0	Strict	100.0	37.88	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MLARDVYEQLFIQMPGAEQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQFFIEYGEPNPNIAKIEYYRILDEFF	ATGCTGGCGCGGGATGTTTACGAGCAACTTTTTATACAAATGCCTGGAGCGGAGCAGCTGGTAGTCACACATGGCGACGCCTGTCCCGAGAACTTCATCTTCCAAGGTAATGCCTTCGTCGGCTTCATAGACTGCGGTCGGGTCGGGCTTGCCGATAAGTATCAAGACCTGGCGCTTGCATCGAGAAACATTGACGCGGTATTTGGACCAGAACTCACTAACCAGTTCTTCATCGAGTATGGAGAGCCAAATCCGAACATAGCTAAGATTGAGTACTACCGGATCTTGGATGAGTTCTTCTAA	loose hit with at least 95 percent identity pushed strict
8121	CARD	prokka_05065	contig_51	4258	96	2641	3268	-1	114	AAC(6')-Ib8	3002579.0	400.593	275.0	Strict	94.69	92.44	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MLRRLRLLRKSPSTQALGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	TTGCTACGCAGGCTGCGCCTACTCCGCAAAAGCCCCTCAACTCAGGCGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTCACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCACTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	
8121	CARD	prokka_05088	contig_57	1694	53	178	958	-1	65	aadA2	3002602.0	522.316	450.0	Perfect	100.0	100.0	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	GTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTGATTTGTTGGTTACTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGACCTTATGGAGGCTTCGGCTTTCCCTGGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATAAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGA	
8121	CARD	prokka_05089	contig_57	1694	53	1027	1624	-1	51	ANT(2'')-Ia	3000230.0	360.918	300.0	Strict	100.0	111.86	ANT(2'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MLWSSNDVTQQGSRPKTKLGRMDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA	ATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAGGCCGCATGGACACAACGCAGGTCACATTGATACACAAAATTCTAGCTGCGGCAGATGAGCGAAATCTGCCGCTCTGGATCGGTGGGGGCTGGGCGATCGATGCACGGCTAGGGCGTGTAACACGCAAGCACGATGATATTGATCTGACGTTTCCCGGCGAGAGGCGCGGCGAGCTCGAGGCAATAGTTGAAATGCTCGGCGGGCGCGTCATGGAGGAGTTGGACTATGGATTCTTAGCGGAGATCGGGGATGAGTTACTTGACTGCGAACCTGCTTGGTGGGCAGACGAAGCGTATGAAATCGCGGAGGCTCCGCAGGGCTCGTGCCCAGAGGCGGCTGAGGGCGTCATCGCCGGGCGGCCAGTCCGTTGTAACAGCTGGGAGGCGATCATCTGGGATTACTTTTACTATGCCGATGAAGTACCACCAGTGGACTGGCCTACAAAGCACATAGAGTCCTACAGGCTCGCATGCACCTCACTCGGGGCGGAAAAGGTTGAGGTCTTGCGTGCCGCTTTCAGGTCGCGATATGCGGCCTAA	
8121	CARD	prokka_05103	contig_69	833	77	215	689	-1	119	dfrA15	3003013.0	322.783	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKVDTLHISTIDIEPEGDVYFPEIPSSFRPVFSQDFVSNINYSYQIWQKG	GTGAAACTATCACTAATGGCAGCAATTTCGAAGAATGGAGTTATCGGAAATGGCCCAGATATTCCATGGAGTGCCAAAGGGGAACAATTACTCTTCAAAGCGATTACCTATAATCAGTGGCTTTTGGTAGGCCGAAAGACTTTCGAGTCAATGGGGGCTTTACCCAACCGAAAATATGCCGTTGTAACTCGTTCAAGCTTCACTTCCAGTGATGAGAATGTATTGGTATTTCCATCTATCGATGAAGCGCTAAATCATCTGAAGACGATAACGGATCATGTGATTGTGTCTGGTGGTGGTGAAATATACAAAAGCCTGATCGATAAAGTTGATACTTTACATATTTCAACAATCGACATTGAGCCAGAAGGTGATGTCTATTTTCCAGAAATCCCCAGTAGTTTTAGGCCAGTTTTTAGCCAAGACTTCGTGTCTAACATAAATTATAGTTACCAAATCTGGCAAAAGGGTTAA	
8121	CARD	prokka_01470	contig_4	332469	90	201140	202907	1	95	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	593.193	500.0	Strict	52.57	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAAKTLKPKRQEEQANFISWRFALLCGCILLALGFLLGRVAWLQIIAPDMLVRQGDMRSLRVQEVSTSRGMITDRSGRPLAVSVPVKAIWADPKELHDAGGITLDNRWKALSDALKMPLDQLASRVNANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVATGEVLAMASSPSYNPNNFAGTAKDAMRNRSITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASNPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGGCAAAAACGCTAAAACCAAAACGCCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTTTGCGGCTGCATTTTACTGGCGCTGGGTTTCCTGCTGGGACGCGTGGCGTGGCTACAAATCATCGCGCCTGACATGCTGGTGCGTCAGGGGGATATGCGTTCTCTGCGCGTGCAGGAAGTTTCTACCTCTCGTGGGATGATCACCGACCGCTCCGGCCGCCCGCTGGCGGTGAGCGTACCGGTGAAGGCGATCTGGGCCGATCCTAAAGAGCTGCATGACGCAGGCGGGATCACCCTTGATAACCGCTGGAAGGCGCTCTCAGACGCGTTGAAAATGCCGCTGGATCAGCTGGCGTCACGCGTTAACGCCAACCCGAAAGGGCGCTTCATCTATCTTGCCCGTCAGGTGAACCCTGACATGGCTGATTACATTAAAAAACTTAAGCTGCCCGGCATTCATCTGCGGGAAGAATCCCGCCGTTATTATCCTTCCGGCGAAGTCACCGCGCACCTGATTGGCTTCACCAACGTGGATAGCCAGGGGATTGAAGGCGTTGAAAAAAGCTTCGACAAGTGGCTTACCGGCCAGCCTGGCGAGCGAATCGTGCGCAAAGACCGCTATGGTCGCGTCATTGAAGATATTTCCTCGACAGACAGCCAGGCCGCGCACAACCTGGCCCTGAGTATTGATGAGCGCTTGCAGGCGCTGGTCTATCGTGAGCTGAACAACGCCGTCGCGTTTAACAAGGCGGAATCGGGCAGTGCCGTGCTGGTGGATGTGGCGACAGGTGAAGTGCTGGCGATGGCCAGTAGTCCCTCATATAACCCGAATAATTTTGCCGGTACAGCAAAAGATGCGATGCGTAACCGCTCCATCACCGATGTGTTTGAACCCGGTTCAACCGTAAAACCTATGGTGGTGATGACGGCTCTACAGCGAGGCATCGTCAACGAAAATACCGTTCTGAATACGATCCCTTATCGAATTAACGGCCACGAAATAAAAGACGTGGCACGTTACAGCGAACTGACCCTGACCGGGGTCTTACAGAAGTCGAGTAACGTCGGTGTGTCAAAACTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTGGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACTCCCTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATTTATCGCCCGCTGTCGATCACCAAAGTTGATCCACCGGTACCGGGGGAACGTGTTTTCCCGGAATCTATCGTTCGTACCGTCGTACATATGATGGAAAGCGTCGCGCTGCCCGGTGGTGGTGGCGTGAAGGCCGCGATTAAGGGCTATCGTATCGCCATCAAAACCGGTACAGCGAAAAAAGTGGGGCCGGACGGCCGCTATATCAACAAATACATTGCCTATACCGCAGGCGTAGCGCCTGCAAGCAATCCGCGTTTTGCGCTGGTGGTCGTCATCAACGATCCGCAGGCGGGTAAATACTACGGCGGCGCCGTCTCCGCGCCTGTGTTCGGGGCTATTATGGGCGGCGTGTTGCGCACCATGAACATTGAACCGGATGCGCTGGCGACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
8121	CARD	prokka_02066	contig_6	283485	90	198859	200251	-1	86	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	863.988	850.0	Strict	94.17	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTVVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGSYLGMWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETEENEMSKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACVALALIIATLGVYQHASNQYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPIFGLTGWAGTFAALDAAAIGCIVLMAMVAVLEERKIRRENRAQKLKAA	ATGCTGGCCTTCTTAAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCGTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACTATGTACCTGATCCGCAAAAACTTTAACATCGCGCAGAACGACATGATCTCGACCTACGGGCTGAGCATGACGCAGTTGGGGATGATTGGCCTGGGCTTCTCCATCACCTATGGCGTGGGGAAAACCGTCGTTTCCTACTATGCGGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCTGCCATCTGTATGCTCGGCTTCAGCGCCAGCATGGGCGCGGGCTCCGTCAGCCTGTTCCTGATGATCGCCTTTTACGCCCTGAGCGGTTTCTTCCAGAGCACCGGCGGGTCGTGCAGCTACTCCACCATCACCAAATGGACGCCGCGCCGCAAGCGGGGGTCGTACCTCGGCATGTGGAACATCTCCCACAACCTCGGCGGAGCGGGTGCGGCTGGCGTGGCGCTGTTCGGCGCGAACTACCTGTTCGACGGTCACGTCATCGGCATGTTTATCTTCCCGTCGATTATTGCCCTGATTGTTGGCTTTATCGGCCTGCGCTACGGCAGCGATTCCCCGGAATCGTACGGCCTCGGCAAAGCCGAAGAGCTGTTCGGGGAAGAGATCAGCGAAGAGGACAAAGAGACCGAAGAAAACGAGATGTCCAAATGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATTTGGCTGCTCTGTTTCTCGAACATCTTCCTGTACGTGGTGCGCATTGGTATCGACCAGTGGTCCACCGTGTATGCCTTCCAGGAGCTGAAGCTTTCTAAAGAAGTGGCGATTCAGGGCTTCACCCTGTTTGAAGTGGGCGCGCTGGTCGGCACGCTGCTGTGGGGATGGCTCTCCGACCTCGCCAATGGCCGCCGCGCGCTGGTGGCCTGCGTCGCGCTGGCGCTGATTATCGCCACCCTTGGCGTCTACCAGCACGCCAGCAACCAGTACATTTACCTGGCGTCCCTGTTCGCGCTCGGCTTCCTGGTGTTTGGTCCGCAATTACTGATCGGTGTGGCGGCAGTGGGCTTCGTCCCGAAAAAAGCGATCGGCGCCGCCGATGGGATTAAGGGCACCTTCGCCTACCTGATCGGCGACAGCTTCGCCAAGCTGGGTCTGGGGATGATCGCCGACGGCACGCCGATTTTCGGCCTTACCGGCTGGGCGGGCACCTTCGCCGCGCTGGATGCCGCCGCGATTGGCTGTATCGTCCTGATGGCGATGGTTGCGGTGCTGGAAGAGCGTAAGATCCGCCGTGAGAATCGTGCGCAGAAATTAAAAGCAGCCTGA	
8121	CARD	prokka_02691	contig_9	232469	87	46474	49111	1	95	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1624.37	1500.0	Strict	91.62	100.34	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMATNIPPHNITEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKIYIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEIKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKEILSAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKASLVARPWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSAERLMEVIREELELVRDQFGDERRTEITANSSDINIEDLINREDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGSDEVMLFSAAGKVVRFKENAVRAMGRTATGVRGIKLAGEDSVVSLIVPRGEGAILTVTQNGYGKRTAESEYPTKSRGTQGVISIKVTERNGSVVGAVQVDDADQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDSIDGSVAEGDDEIVPEADTDDEAADDADE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTTAACATCGAGGAAGAGCTGAAAAGCTCCTATCTGGACTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGACGTCCGCGATGGCCTTAAGCCGGTACACCGTCGCGTACTATACGCCATGAACGTATTGGGCAATGACTGGAATAAAGCCTACAAAAAATCTGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCATCCCCATGGTGATATCGCGGTGTACGACACCATTGTCCGTATGGCGCAGCCTTTCTCGCTGCGTTACATGCTGGTAGATGGTCAGGGTAACTTTGGTTCTATCGACGGCGACTCCGCCGCGGCAATGCGTTATACGGAAATCCGTCTGGCGAAGATTGCCCATGAGCTGATGGCTGACCTGGAAAAAGAGACGGTTGATTTCGTTGATAACTACGACGGCACGGAAAAAATTCCTGACGTTATGCCAACGAAGATCCCAAACCTGCTGGTGAACGGTTCGTCCGGTATCGCAGTGGGTATGGCGACCAATATTCCGCCGCACAACATCACGGAAGTGATTAACGGCTGCCTGGCCTACATCGACGATGAAGACATCAGCATTGAAGGGCTGATGGAACACATCCCGGGCCCGGACTTCCCGACGGCGGCAATCATCAACGGCCGTCGCGGTATTGAAGAAGCGTACCGTACCGGTCGCGGCAAGATTTACATCCGTGCCCGCGCCGAAGTGGAAGCGGACGCCAAAACCGGCCGTGAAACCATTATTGTTCACGAGATCCCGTATCAGGTGAACAAAGCGCGTCTGATTGAAAAAATCGCCGAGCTGGTAAAAGAAAAACGCGTTGAAGGCATCAGCGCGCTGCGCGACGAGTCTGACAAAGACGGTATGCGCATCGTGATTGAAATCAAGCGCGACGCGGTGGGTGAAGTTGTGCTGAACAACCTTTACTCCCAGACTCAGCTTCAGGTCTCCTTCGGTATCAACATGGTTGCGCTGCACCATGGCCAGCCGAAGATCATGAACCTGAAAGAGATCCTGAGCGCGTTTGTGCGTCACCGCCGTGAAGTGGTGACTCGCCGTACCATCTTTGAACTGCGCAAAGCGCGCGATCGTGCCCATATCCTTGAAGCACTGGCCGTTGCGCTGGCGAACATCGACCCGATAATCGAGCTGATCCGCCGTGCGCCGACGCCGGCAGAAGCGAAGGCGTCGCTGGTTGCGCGTCCATGGGATCTGGGCAACGTGGCGGCGATGCTGGAACGTGCCGGCGATGATGCTGCGCGTCCTGAGTGGCTGGAGCCGGAATTCGGCGTGCGTGACGGTCAGTACTATCTGACTGAACAGCAGGCCCAGGCGATTCTGGATCTGCGTTTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAGTACAAAGAGCTGCTGGAGCAGATTGCCGAGCTGCTGCATATCCTGGGTAGCGCAGAGCGCCTGATGGAAGTGATCCGTGAAGAGCTGGAGCTGGTTCGCGATCAGTTCGGCGACGAGCGTCGCACCGAAATCACGGCCAACAGCTCTGATATCAACATTGAAGATCTGATCAACCGCGAAGACGTGGTCGTGACGCTGTCTCACCAGGGTTACGTGAAGTATCAGCCGTTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGTAAATCTGCGGCGCGTATTAAAGAAGAAGACTTCATTGACCGTCTGCTGGTGGCCAACACCCACGACACGATCCTCTGCTTCTCCAGCCGGGGCCGTCTGTACTGGATGAAAGTCTATCAGCTGCCGGAAGCGAGCCGTGGCGCGCGGGGTCGACCTATCGTTAACCTGCTGCCGCTGGAAGCGAACGAACGTATCACCGCCATTCTGCCGGTACGCGAGTACGAAGAGGGCGTGAACGTCTTTATGGCAACCGCGAGCGGTACCGTGAAGAAAACCGCGCTGACCGAATTCAGCCGTCCACGTTCCGCCGGGATCATCGCGGTGAACCTGAACGAAGGCGACGAGCTGATCGGCGTGGATCTGACCTCCGGTTCTGATGAAGTGATGCTGTTCTCTGCGGCCGGTAAAGTGGTGCGCTTTAAAGAGAACGCCGTGCGCGCAATGGGTCGTACGGCGACCGGCGTGCGTGGTATCAAGCTGGCGGGTGAAGACAGCGTGGTTTCCCTGATCGTTCCGCGTGGCGAAGGCGCAATCCTGACCGTCACTCAGAACGGCTACGGTAAACGTACGGCGGAAAGCGAATACCCGACCAAGTCTCGCGGCACGCAGGGCGTTATCTCCATCAAAGTGACCGAGCGCAACGGTTCCGTTGTTGGCGCGGTACAGGTGGACGATGCGGACCAGATCATGATGATCACCGATGCCGGTACGCTGGTGCGTACCCGCGTGTCAGAGATCAGCGTGGTGGGTCGTAACACCCAGGGCGTTATCCTCATCCGTACTGCGGAAGATGAAAACGTCGTCGGTCTGCAACGCGTTGCTGAGCCGGTGGATGACGAAGAGCTCGACTCTATCGACGGCAGCGTCGCGGAAGGGGATGATGAAATCGTCCCGGAAGCGGACACCGATGATGAAGCAGCGGATGACGCTGACGAGTAA	
8121	CARD	prokka_03038	contig_10	207797	89	194428	196687	1	76	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1444.1	1400.0	Strict	92.02	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNATAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAEVLLGELGQGTVDWVPNFDGTMQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTSLDDLLDIVQGPDYPTEAEIITSRAEIRKIYQNGRGSVRMRAVWTKEDGAVVITALPHQVSGAKVLEQIASQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLAFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQNELEKERDQLQAILASERKMNTLLKKELQADADAFGDDRRSPLHEREEAKAMNEHDMLPSEPVTIVLSQSGWVRSAKGHDIDAPGLSYKSGDSFKAAVKGKSNQPVAFIDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMEADDQKLLMASDAGYGFICTFNDLVSRNRAGKALISLPDNAHVMPPLIIENESDMLLAITAAGRMLMFPVSDLPELSKGKGNKIISIPSAEAAKGEDSLAHLFLLPPQSTLTIHVGKRKIKLRPEELQKVVGERGRRGSLMRGLQRIDRVEIDSPARSKADDSEE	ATGAGCGATATGGCAGAGCGCCTCGCGCTACATGAATTCACGGAAAACGCCTACCTGAACTACTCCATGTACGTCATCATGGACAGGGCGTTGCCGTTTATCGGGGATGGCCTGAAGCCCGTTCAGCGCCGCATCGTCTATGCGATGTCCGAACTGGGGCTGAATGCGACCGCCAAGTTCAAGAAATCCGCCCGTACCGTCGGCGACGTGCTGGGGAAATACCATCCGCACGGTGACATCGCCTGCTATGAAGCGATGGTGCTGATGGCCCAGCCGTTCTCTTACCGCTATCCGCTGGTGGATGGTCAGGGGAACTGGGGGGCGCCGGACGATCCGAAATCCTTCGCGGCAATGCGTTATACCGAATCCCGTCTGTCTAAATATGCCGAAGTGCTGTTGGGCGAACTGGGGCAGGGTACGGTCGACTGGGTGCCAAACTTCGACGGTACGATGCAGGAGCCGAAAATGCTGCCTGCGCGTCTGCCGAACATCCTGCTGAACGGCACGACCGGTATCGCCGTGGGCATGGCGACGGACATTCCGCCGCACAACCTGCGTGAAGTGGCGAAAGCGGCCATCACCCTGATTGAGCAGCCAAAAACCTCGCTGGACGATCTGCTGGATATCGTGCAGGGGCCGGACTATCCGACCGAAGCCGAGATCATCACCTCGCGTGCGGAAATCCGTAAAATCTACCAGAACGGCCGAGGCTCCGTGCGCATGCGCGCGGTATGGACCAAAGAGGATGGCGCCGTGGTGATCACCGCGCTGCCGCACCAGGTCTCCGGCGCGAAGGTGCTGGAGCAGATTGCCTCCCAGATGCGCAATAAAAAGCTGCCGATGGTGGACGACCTGCGTGACGAATCGGACCACGAAAACCCGACCCGTCTGGTGATTGTGCCGCGTTCTAACCGCGTGGATATGGAGCAGGTGATGAACCACCTGTTCGCCACTACCGATCTGGAAAAAAGCTACCGCATCAACCTGAACATGATTGGTCTGGATGGTCGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCACCGAATGGCTGGCCTTCCGCCGCGATACGGTGCGCCGCCGTCTGAACCATCGGCTGGAGAAAGTGCTTAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTCCTCAACATTGACGAAGTGATTGAGATCATTCGTACCGAGGACGAACCTAAGCCTGCCCTGATGTCGCGCTTTGGCATCAGCGAAACCCAGGCCGAAGCGATCCTCGAACTGAAGCTGCGCCATCTCGCTAAGCTGGAAGAGATGAAGATCCGCGGCGAGCAGAACGAGCTGGAAAAAGAGCGCGATCAGCTTCAGGCGATTCTGGCGTCCGAGCGCAAGATGAACACCCTGCTGAAGAAAGAGTTGCAGGCCGATGCCGACGCCTTTGGCGACGACCGTCGTTCTCCGCTGCATGAGCGCGAAGAAGCGAAGGCGATGAACGAGCACGACATGCTGCCGTCCGAGCCGGTGACCATCGTGCTTTCCCAGAGCGGCTGGGTGCGTAGCGCCAAAGGCCACGATATCGACGCGCCGGGTCTGAGCTACAAATCCGGTGACAGCTTCAAGGCGGCGGTGAAGGGCAAGAGCAACCAGCCGGTGGCGTTTATCGACTCCACGGGCCGCAGCTACGCTATTGATCCGATCACGCTGCCATCCGCGCGCGGGCAGGGCGAACCGCTGACCGGCAAGCTGACGCTGCCGCCGGGCGCCACGGTTGACCATATGCTGATGGAAGCCGACGATCAAAAACTGCTGATGGCGTCTGATGCTGGCTACGGCTTTATCTGCACCTTTAACGATCTGGTGTCGCGTAACCGCGCCGGTAAAGCGCTGATCAGCCTGCCGGATAACGCCCACGTCATGCCGCCGCTGATCATCGAGAACGAAAGCGATATGCTGCTGGCGATCACCGCTGCCGGACGCATGCTGATGTTCCCGGTCAGCGATCTGCCGGAGCTGTCGAAAGGGAAGGGCAACAAGATCATCAGTATCCCGTCAGCGGAAGCGGCAAAAGGCGAAGATAGCCTGGCGCATCTCTTCCTGCTGCCGCCGCAGAGCACGCTGACCATTCATGTCGGCAAACGTAAGATCAAACTGCGTCCGGAAGAGTTGCAGAAGGTGGTTGGCGAGCGCGGACGTCGCGGCTCACTGATGCGTGGCCTGCAGCGCATCGACCGCGTGGAGATCGACTCGCCGGCGCGCAGCAAAGCGGACGACAGCGAAGAGTAA	
8121	CARD	prokka_03067	contig_11	185017	83	20185	20620	1	118	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	271.166	210.0	Strict	90.97	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDLFNDIIPLGRLIHMVNQKKDRLLNDYLSPLDITATQFKVLCSIRCEVCITPVELKKVLSVDLGALTRMLDRLVCKGWIERSPNPNDKRGVLVKLTSDGAAMCEQCHQLVGQTLHQELTKNLTADEVATLELLLKKILP	GTGAAAAGCACCAGTGACCTCTTTAACGACATAATCCCACTGGGTCGTCTTATTCATATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTACCTGTCACCGCTGGATATCACCGCAACACAGTTCAAAGTGCTGTGTTCCATTCGCTGCGAAGTGTGTATCACGCCGGTTGAGCTGAAAAAGGTGCTCTCTGTCGATCTGGGTGCGTTGACCCGCATGCTGGATCGTCTCGTCTGCAAAGGATGGATAGAACGAAGCCCTAACCCGAATGACAAACGTGGCGTACTGGTGAAACTGACCAGCGATGGCGCGGCCATGTGTGAGCAATGTCATCAATTAGTAGGACAAACACTGCACCAGGAACTGACAAAAAACTTAACGGCAGATGAAGTGGCAACGCTTGAGCTTTTACTCAAGAAAATCCTGCCGTAA	
8121	CARD	prokka_04084	contig_20	73662	89	58696	59023	-1	85	Escherichia coli soxS with mutation conferring antibiotic resistance	3003511.0	202.216	200.0	Strict	90.65	100.93	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein overexpression model	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSHQQIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVMHQTLGDYIRQRRLLLAAQALRSTQRPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHQLN	ATGTCGCATCAGCAAATTATTCAGACGCTTATTGAATGGATTGATGAACATATCGACCAGCCGTTGAACATTGATGTGGTCGCTAAGAAGTCGGGCTATTCGAAATGGTATTTACAGAGAATGTTCCGCACCGTAATGCATCAAACGCTGGGTGACTACATTCGCCAGCGCAGGCTCCTGCTGGCGGCGCAGGCGTTACGCTCAACGCAGCGGCCCATTTTTGATATCGCAATGGATCTGGGCTATGTGTCGCAGCAGACCTTTTCCCGCGTCTTCCGCCGCGAGTTTGACCGTACGCCGAGCGACTACCGCCATCAGCTCAATTAA	
8061	BLDB	prokka_00213	contig_1	467178	66	218820	219645	1	66	OXA-66		257.2		Perfect	100.0	99.64	OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-66	protein homolog model			Beta-Lactam	MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	ATGAACATTAAAGCACTCTTACTTATAACAAGCGCTATTTTTATTTCAGCCTGCTCACCTTATATAGTGACTGCTAATCCAAATCACAGCGCTTCAAAATCTGATGTAAAAGCAGAGAAAATTAAAAATTTATTTAACGAAGCACACACTACGGGTGTTTTAGTTATCCAACAAGGCCAAACTCAACAAAGCTATGGTAATGATCTTGCTCGTGCTTCGACCGAGTATGTACCTGCTTCGACCTTCAAAATGCTTAATGCTTTGATCGGCCTTGAGCACCATAAGGCAACCACCACAGAAGTATTTAAGTGGGATGGTAAAAAAAGGTTATTCCCAGAATGGGAAAAGGACATGACCCTAGGCGATGCCATGAAAGCTTCCGCTATTCCAGTTTATCAAGATTTAGCTCGTCGTATTGGACTTGAGCTCATGTCTAAGGAAGTGAAGCGTGTTGGTTATGGCAATGCAGATATCGGTACCCAAGTCGATAATTTTTGGCTGGTGGGTCCTTTAAAAATTACTCCTCAGCAAGAGGCACAGTTTGCTTACAAGCTAGCTAATAAAACGCTTCCATTTAGCCAAAAAGTCCAAGATGAAGTGCAATCCATGCTATTCATAGAAGAAAAGAATGGAAACAAAATATACGCAAAAAGTGGTTGGGGATGGGATGTAAACCCACAAGTAGGCTGGTTAACTGGATGGGTTGTTCAGCCTCAAGGGAATATTGTAGCGTTCTCCCTTAACTTAGAAATGAAAAAAGGAATACCTAGCTCTGTTCGAAAAGAGATTACTTATAAAAGCTTAGAACAATTAGGTATTTTATAG	
8061	BLDB	prokka_02599	contig_15	97265	67	135	1287	1	68	ADC-73		364.5		Perfect	100.0	99.74	class C extended-spectrum beta-lactamase ADC-73	protein homolog model			Beta-Lactam	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYSVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	ATGCGATTTAAAAAAATTTCTTGTCTACTTTTATCCCCGCTTTTTATTTTTAGTACCTCAATTTATGCGGGCAATACACCAAAAGACCAAGAAATTAAAAAACTGGTAGATCAAAACTTTAAACCGTTATTAGAAAAATATGATGTGCCAGGTATGGCTGTGGGTGTTATTCAAAATAATAAAAAGTATGAAATGTATTATGGTCTTCAATCTGTTCAAGATAAAAAAGCCGTAAATAGCAGTACTATTTTTGAGCTAGGTTCTGTCAGTAAATTATTTACCGCGACAGCAGGTGGATATGCAAAAAATAAAGGAAAAATCTCTTTTGACGATACGCCTGGTAAGTATTGGAAAGAACTAAAAAATACACCGATTGACCAAGTTAACTTACTTCAACTCGCGACGTATACAAGTGGTAACCTTGCCTTGCAATTTCCAGATGAAGTAAAAACAGATCAGCAAGTTTTAACATTTTTTAAAGACTGGAAACCTAAAAACTCAATCGGTGAATATCGACAATATTCAAACCCAAGCATTGGTTTATTTGGAAAAGTTGTAGCTTTGTCTATGAATAAACCTTTCGACCAAGTCTTAGAAAAAACAATTTTTCCGGCCCTTGGCTTAAAACATAGCTATGTAAATGTACCTAAGACCCAGATGCAAAACTATGCTTTTGGCTATAACCAAGAAAATCAGCCGATTCGAGTTAACCCCGGCCCACTCGATGCCCCAGCATATAGCGTCAAATCGACACTACCCGACATGTTGAGTTTTATTCATGCCAACCTAAATCCACAAAAATATCCAGCAGATATTCAACGGGCAATTAATGAAACACATCAGGGTCGCTATCAAGTAAATACCATGTATCAGGCACTCGGTTGGGAAGAGTTTTCTTATCCGGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTGATGAAACCTAATAAAGTGACTGCTATTTCAAAGGAACCTTCAGTTAAGATGTACCATAAAACTGGCTCAACTACCGGTTTCGGAACATATGTGGTGTTTATTCCTAAAGAAAATATTGGTTTAGTCATGTTAACCAATAAACGTATTCCAAATGAAGAGCGCATTAAGGCAGCTTATGCTGTGCTGAATGCAATAAAGAAATAA	
8061	BLDB	prokka_03764	contig_47	2445	137	34	856	1	126	OXA-23		256.7		Perfect	100.0	99.63	carbapenem-hydrolyzing class D beta-lactamase OXA-23	protein homolog model			Beta-Lactam	MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII	ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA	
8061	BLDB	prokka_03767	contig_48	1574	84	16	877	-1	91	TEM-1		80.1		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase TEM-1	protein homolog model			Beta-Lactam	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	ATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAGCTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGTGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACCCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGATCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	
8061	CARD	prokka_00439	contig_1	467178	66	456139	457429	1	70	Acinetobacter baumannii AbaF	3004573.0	863.2180000000002	700.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fosfomycin	MTTTLKKVVAASMVGSVAEWYEFFLYGTASALVFGELFFQQTGNAIDGILAAFALYAVGFLARPLGGLVFGHYGDKIGRKKLLQISLIIVGITTFLMGCIPTFHQIGYWAPTLLVILRLIQGFAFGGEWGGAVILVSEHSPDDRRGYWASWPQTGVPLGNLVATLVLLLLSKNLSPEQFLDWGWRCAFWFSAVVVLIGLWIRKNVDDAEVFKEAQAKQQLLEKQQLGIIEVLKYHKKSVIAGIGARFAENILYYMVVTFSISYLKLVVHKDTSQILLLMFGAHLIHFFIIPFMGHLSDIFGRKPIYLIGAVLTAFWGFVGFPLMDTGNDWLIMLAIVLGLFIESMTYSPYSALMTELFPTHIRYTALSFCYQVAPIMAGSLAPLIALTLLKEFNSSIPISLYLVAASLISIVSILLVKETKGRSLAFKD	ATGACGACAACATTAAAAAAGGTTGTAGCGGCCTCCATGGTTGGCTCCGTAGCAGAATGGTATGAATTTTTCCTTTATGGAACCGCTTCTGCCCTCGTCTTTGGCGAACTTTTCTTTCAACAAACCGGCAATGCTATAGATGGAATTTTGGCGGCCTTTGCCCTGTATGCCGTTGGCTTTTTAGCAAGACCTCTCGGTGGCCTCGTATTTGGTCACTACGGCGATAAAATTGGTCGCAAGAAATTATTGCAAATTAGCCTGATTATTGTCGGTATCACTACCTTTTTAATGGGCTGTATTCCGACCTTTCATCAAATTGGCTATTGGGCACCTACACTCCTAGTGATACTGCGTTTAATTCAAGGTTTTGCTTTTGGTGGTGAATGGGGCGGCGCAGTTATTTTAGTTTCAGAGCACAGTCCAGATGATCGCAGAGGTTATTGGGCAAGCTGGCCACAAACTGGCGTACCGCTCGGAAATTTAGTAGCCACACTGGTTTTATTATTACTTTCAAAAAACCTCTCACCCGAACAATTCCTAGATTGGGGATGGCGCTGTGCATTCTGGTTCTCAGCAGTCGTGGTACTGATTGGTTTATGGATCCGAAAAAATGTAGACGATGCCGAAGTGTTTAAAGAAGCACAGGCCAAACAACAGCTTCTTGAAAAGCAACAACTCGGGATTATTGAGGTTTTAAAATATCATAAGAAATCTGTTATTGCGGGTATCGGTGCCAGATTTGCAGAAAACATTTTGTACTATATGGTGGTTACTTTTTCGATCAGTTATTTAAAGTTAGTCGTCCATAAAGATACTTCACAGATCTTACTGCTCATGTTTGGCGCTCATCTGATCCATTTCTTTATTATTCCTTTTATGGGGCATTTAAGCGATATATTTGGCCGCAAACCTATTTATCTTATTGGAGCTGTACTTACTGCTTTTTGGGGTTTTGTCGGCTTTCCTTTAATGGATACAGGCAATGACTGGCTCATTATGTTAGCAATTGTGCTTGGTTTATTTATTGAGTCCATGACCTACTCGCCTTACTCTGCGTTAATGACTGAGTTATTTCCAACTCACATCCGCTATACGGCGCTTTCATTTTGTTATCAAGTCGCACCCATTATGGCAGGTTCGCTTGCTCCATTAATTGCCCTAACATTACTCAAAGAATTTAATAGTTCGATTCCGATTTCTTTATATTTGGTTGCCGCAAGTCTAATCTCTATTGTCTCGATTTTGCTAGTTAAAGAAACCAAAGGCCGATCTCTAGCTTTTAAAGATTAA	
8061	CARD	prokka_01103	contig_4	222439	75	123677	125024	-1	82	abeM	3000753.0	887.1	850.0	Strict	99.78	100.0	multidrug and toxic compound extrusion (MATE) transporter	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; acridine dye; triclosan; disinfecting agents and intercalating dyes	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKINLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	GTGTCGAATGTCACGTCGTTTCGGTCTGAATTAAAACAACTCTTCCATTTAATGTTACCTATTTTAATTACGCAGTTTGCTCAAGCAGGGTTCGGGTTAATTGATACCATTATGGCTGGGCATTTATCTGCTGCAGACTTAGCCGCGATTGCGGTAGGTGTAGGCTTATGGATTCCAGTCATGCTCTTGTTCAGTGGTATCATGATTGCAACCACACCATTAGTGGCTGAAGCAAAAGGCGCTAGAAATACAGAACAAATTCCAGTGATTGTCCGCCAATCATTATGGGTTGCAGTAATTCTAGGGGTATTGGCAATGCTCATTTTGCAGCTTATGCCATTTTTCTTACATGTGTTTGGCGTACCAGAAAGTTTACAACCTAAAGCCAGTTTATTCTTACATGCAATTGGTTTGGGTATGCCCGCTGTAACCATGTATGCAGCGCTCCGAGGCTATTCCGAAGCATTAGGCCATCCCCGCCCTGTCACGGTCATTAGCTTACTAGCCTTAGTGGTTTTAATCCCGCTTAACATGATTTTTATGTATGGCTTAGGACCAATACCTGCTTTGGGTAGCGCAGGCTGTGGTTTTGCAACATCTATTTTACAGTGGCTGATGCTCATTACGTTAGCAGGCTATATTTATAAGGCTTCGGCTTATCGAAACACATCTATTTTTAGCAGATTCGATAAAATTAACCTGACTTGGGTTAAAAGAATTTTACAGCTTGGCCTGCCAATTGGTTTAGCTGTGTTTTTTGAAGTGAGTATTTTTAGTACAGGGGCATTGGTCCTTAGCCCTCTAGGAGAAGTCTTTATTGCCGCACACCAAGTAGCGATTTCAGTCACTTCGGTATTATTTATGATTCCACTTTCTCTTGCCATTGCTTTAACTATTCGCGTGGGGACGTATTATGGTGAAAAGAACTGGGCTTCCATGTACCAAGTACAAAAAATTGGTCTAAGCACAGCAGTATTTTTTGCTCTATTGACCATGTCTTTTATTGCTCTAGGCCGTGAACAAATTGTCTCGGTTTATACTCAAGATATAAATGTTGTGCCGGTTGCCATGTATTTGCTCTGGTTTGCAATGGCATATCAATTAATGGATGCCCTACAAGTTAGCGCTGCCGGCTGTTTAAGAGGTATGCAAGATACTCAGGCACCGATGTGGATCACTTTAATGGCATATTGGGTAATTGCTTTTCCAATCGGTCTTTATTTAGCGCGTTATACCGATTGGGGCGTAGCTGGTGTGTGGTTAGGTTTAATTATTGGTTTAAGTATTGCCTGTGTTTTATTGCTCTCACGACTCTATTTGAATACCAAACGTTTAAGTCAAACCTAA	
8061	CARD	prokka_01142	contig_4	222439	75	166374	167475	-1	77	LpsB	3005051.0	741.11	700.0	Strict	97.81	100.0	Intrinsic peptide antibiotic resistant Lps	protein homolog model	reduced permeability to antibiotic		peptide antibiotic	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITDHYKNCPPQDIVRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQKLGEQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALVETVKNHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	ATGAAAGTGATGCAACTTCTCCCAGAACTTAATAGCGGTGGCGTAGAACGCGGCACACTGGAAATTGCACGTGCACTGGTTGCACAAGGTCATCAGTCTCTAGTTGTGTCTAATGGCGGGCGTTTGGTCTCACAACTTGAAGCTGAAGGTTCCACACACTTAACGCTGCCTATCCATAAAAAATCATTGTCAAGCTTGTGGCAAATCCGTCCATTACGTCAGCTGATTGAAGAGCACCAACCAGACATTGTACATGTGCGCTCTCGCGTACCTGCGTGGCTAACCCACTTCGCTTTAAGAAAAATACCAGCGAATAAACGCCCTCACCTCATTAGCACGGTACATGGTTTCTATTCAGTTAATCGTTATAGTGCGATCATGACTCAGGCAGAAAAAGTGATCGCTGTTTCTGACAGCGTAGTTAAATACATCACAGACCATTATAAAAACTGTCCACCACAAGATATTGTCCGTATTTATCGAGGCATTGACCCTGCTGCTTTTCCGCATAACTACCAACCTTCAGCACAGTGGTTTAACCAAGTTTTTAACGACTTTCCCGAACTCGAGAATAAATTTTTACTTTGCCTACCTGGCCGTATTACTCGTTTAAAAGGACATGAAAGTTTAATTGAACTGATGCAAAAACTAGGTGAACAATATCCTCAACTGCATGCTGTTGTTGTGGGTGGGGCTGATGTAAAAAAACAAGCCTATTTAAGTGAGTTGCAAAACACCATTCAAAGCAAAGGACTTGCAGATAAAATTACCTTTGTAGGACATCGCTCAGATATACGCGAATGGCTCGCTTTTAGCGATATAGTGCTCTCTCTATCCAATCAAGCAGAAACATTCGGTAGAACAGCATTAGAAGCCCTTTCGGTAGGCACGCCGGTCATTGGCTGGAACCGTGGCGGTGTTGCCGAGATTTTATCTCATGTATACCCACAAGGTCTTGTTGAAGCAGAAAATGAAAAAGCTTTAGTAGAAACAGTAAAGAATCATATTGAACAACCGCAAACAGTCGCTCCTGTGACAATGTTTAGTTTAAAAGATATGTGTGACCAAACCCTTGAGCTATATCAAAGTGTATTGAAATAA	
8061	CARD	prokka_01592	contig_7	177830	69	2001	2775	-1	55	armA	3000858.0	516.924	450.0	Perfect	100.0	100.0	16S rRNA methyltransferase (G1405)	protein homolog model	antibiotic target alteration		aminoglycoside antibiotic	MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYPNWDKLLKKYNQGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPLALYQWNENEKIIYHAYDIDRAEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLKMLPVLKQQDVNILDFLQLFHTQNFVISFPIKSLSGKEKGMEENYQLWFESFTKGWIKILDSKVIGNELVYITSGFQK	ATGGATAAGAATGATGTTGTTAAGAAGATACTTGAATCAAAAAAGTACGAAAACCTTGATTCAGATATTGTTGAAAAGGTTGTTTCCATTTCTGAGAAGAAATATAAATTAAAGGAAGTTGAGAATTATTCTAAAAAGAAATTGCATCAAATATGGGGGTCTTACTATTCTGCCTATCCTAATTGGGATAAATTATTAAAAAAGTACAATCAGGGGCAGTTATCAATAGAAGATTTACTAAAGATTCATTCTTCGACGAATGAAAGAGTCGCAACATTAAATGACTTTTACACTTATGTATTTGGAAATATCAAACATGTCTCATCTATTTTAGATTTTGGTTGTGGCTTCAATCCATTAGCTTTATACCAATGGAATGAAAATGAAAAAATAATATATCATGCATACGATATTGATAGAGCTGAGATAGCTTTTTTGAGTAGCATTATTGGGAAGTTAAAGACGACGATAAAGTATAGGTTTTTGAATAAAGAGAGTGATGTCTACAAAGGTACTTATGATGTAGTATTCCTTTTAAAGATGCTTCCTGTGCTAAAACAGCAAGATGTAAATATCTTGGATTTCCTACAGCTTTTTCATACTCAAAACTTTGTAATATCTTTTCCAATAAAGTCTTTATCTGGAAAGGAGAAGGGAATGGAAGAGAATTACCAGCTATGGTTTGAATCTTTTACAAAAGGTTGGATAAAAATCCTTGATTCGAAGGTTATAGGGAATGAGTTAGTATATATTACTAGTGGATTTCAGAAATAA	
8061	CARD	prokka_01690	contig_7	177830	69	99175	99505	1	72	abeS	3000768.0	209.92	175.0	Perfect	100.0	100.0	small multidrug resistance (SMR) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminocoumarin antibiotic	MSYLYLAIAIACEVIATSALKASQGFTVPIPSIITVVGYAVAFYLLSLTLKTIPIGIAYAIWSGAGIILISAIGWIFYKQHLDLAACIGLALMIAGIVIINVFSKNTHL	ATGTCTTATCTTTATTTAGCAATTGCGATTGCTTGTGAAGTTATTGCAACTTCAGCATTAAAAGCATCTCAAGGTTTTACTGTTCCAATTCCGTCTATTATTACGGTTGTGGGTTATGCAGTTGCTTTTTATTTATTATCTCTTACGCTCAAAACAATTCCGATCGGGATTGCCTATGCCATTTGGTCAGGCGCAGGTATTATTTTAATTTCTGCAATTGGCTGGATATTTTACAAACAGCATTTAGACTTGGCTGCCTGTATTGGTTTGGCTTTAATGATCGCAGGTATTGTGATTATTAATGTGTTTTCTAAAAACACCCATCTATAA	
8061	CARD	prokka_01695	contig_7	177830	69	102813	103845	-1	62	adeL	3000620.0	694.5010000000002	650.0	Strict	100.0	101.78	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MDLFHAMRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDAERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATAASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYMLTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTIRTLVEQHNIAEAYTLKT	GTGGATCTATTTCATGCCATGAGAGTATTCAACAAAGTTGTTGAAACAAATAGTTTCAGTTTAGCAGCTGATAGTTTGGGTCTACCGCGTGCTTCTGTGACCACAACCATTCAGGCTTTAGAGAAGCATTTGCAAGTTCGATTGCTTAATCGGACAACACGAAAAATTAGTCTCACACCGGATGGCGCCGTATATTATGATCGGACAGCCCGTATTTTAGCGGATGTTGCCGATATTGAATCTTCTTTTCATGATGCAGAGCGGGGGCCAAGAGGTCAGCTTCGTATTGATGTGCCTGTATCGATTGGACGTTTAATTTTAATTCCAAGGCTCCGCGATTTTCATGCACGCTATCCTGATATTGATTTAGTAATTGGTCTGAACGACCGACCTGTAGATTTGGTTGGAGAAGCTGTTGATTGTGCAATTCGGGTGGGTGAATTAAAAGATTCAAGCTTAATTGCGCGTCGTATCGGAACTTTCCAGTGTGCAACCGCTGCTTCACCGATTTATTTAGAAAAATATGGCGAACCTACCTCAATTGAAGATTTGCAAAAAAATCATAAAGCGATTCATTTCTTTTCAAGCCGTACCGGACGCAACTTCGATTGGGACTTTGTGGTTGATGATTTAATTAAAAGTGTGTCAGTACGTGGACGTGTTTCGGTAAATGACGGTGATGCTTATATCGACTTGGCTTTGCAAGGTTTTGGTATAATTCAAGGCCCACGTTATATGCTCACCAACCATTTAGAATCAGGTTTGTTAAAAGAGGTATTGCCTCAGTGGACGCCAGCACCGATGCCGATTTCAGCAGTTTATCTTCAAAATCGTCATTTATCGCTTAAAGTAAAAGTGTTTGTTGATTGGGTCGCTGAACTTTTTGCAGGCTGTCCATTACTTGGCGGTACAGCTTTACCTTTCGACCAGAAATGTGAATTTGCCTGTGATAAAGAAACTGGTCATGAATATACAATTCGTACTTTGGTCGAGCAGCATAATATTGCTGAAGCTTATACGCTCAAAACTTAA	
8061	CARD	prokka_01696	contig_7	177830	69	104042	105263	1	75	adeG	3000778.0	818.15	800.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MSFSRKQFALSAIFVAILATGGSFMLLHENADAKAAPTAAQQAATVDVAPVVSKTITDWQEYSGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFDNPNGVLLPGLYARIRLGGGQPRPAILISPTAVGVDQDKRFVVVVDAKNQTAYREVKLGAQQDGLQIVNSGLQAGDRIVVNGLQRIRPGDPVTPHLVPMPNSQITASATPPQPQPTDKTSTPAKG	ATGTCATTTTCCCGCAAACAGTTTGCACTGTCTGCCATCTTTGTCGCTATTTTAGCAACCGGTGGCAGTTTTATGTTGTTACATGAAAATGCCGATGCAAAAGCTGCACCAACCGCTGCCCAACAAGCTGCTACTGTTGATGTAGCCCCAGTAGTAAGCAAAACCATTACCGATTGGCAAGAATATTCCGGTCGTTTAGAAGCAATTGATCAAGTTGATATTCGGCCTCAAGTTTCAGGAAAACTCATTGCCGTACATTTCAAAGATGGAAGCCTCGTTAAAAAAGGTGATTTACTTTTCACAATCGACCCTCGTCCTTTTGAAGCAGAACTGAACCGTGCAAAAGCCCAGCTTGCTTCAGCTGAAGCACAGGTAACATATACCGCCAGCAATCTTTCGCGTATTCAACGTCTCATTCAGAGTAATGCTGTTTCTCGCCAAGAACTGGATTTAGCCGAAAATGATGCACGTTCAGCCAATGCTAACCTACAAGCCGCTAGAGCTGCTGTCCAATCTGCACGTTTAAATCTGGAATACACCCGTATTACTGCACCAGTCAGTGGCCGAATTTCACGAGCTGAAGTGACCGTGGGTAATGTCGTCTCTGCAGGTAATGGCGCACAGGTTTTAACAAGTTTAGTGTCTGTATCACGCCTATACGCATCTTTCGATGTTGATGAACAAACTTACCTGAAATATATCAGTAATCAGCGTAATTCAGCACAAGTACCTGTCTATATGGGACTTGCCAATGAAACAGGCTTTACTCGCGAAGGTACGATCAACTCAATCGATAACAACCTGAATACAACCTCAGGTACGATCCGTGTTCGCGCAACTTTTGATAATCCAAACGGTGTTTTATTACCAGGCCTATATGCACGAATTCGTTTAGGTGGAGGCCAACCTCGCCCAGCGATTCTGATTAGTCCAACCGCGGTTGGTGTCGACCAAGATAAACGTTTTGTCGTAGTAGTGGATGCGAAAAATCAAACTGCTTACCGCGAAGTAAAACTCGGTGCCCAACAAGATGGCTTGCAAATCGTAAATAGTGGATTACAAGCGGGTGATCGTATTGTAGTGAATGGTTTACAACGGATTCGTCCGGGTGACCCTGTTACACCGCATCTCGTTCCTATGCCAAATTCACAAATCACTGCTAGCGCTACTCCTCCTCAACCTCAGCCAACAGATAAAACATCAACTCCGGCAAAAGGTTAA	
8061	CARD	prokka_01697	contig_7	177830	69	105269	108449	1	78	adeF	3000777.0	2135.53	750.0	Strict	99.81	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAIALVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRLFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	ATGAATATTTCTAAATTTTTTATTGATCGGCCGATCTTTGCTGGTGTGCTATCAGTCTTGATTTTACTCGCCGGTCTCCTTTCGGTATTTCAGTTACCGATTTCTGAATATCCCGAGGTTGTTCCACCATCTGTGGTGGTACGTGCCCAATATCCGGGTGCAAACCCAAAAGTGATTGCTGAAACGGTTGCTTCTCCGCTCGAAGAGTCAATCAACGGCGTCGAAGACATGCTGTATATGCAATCTCAAGCAAACAGCGACGGTAATTTAACCATTACGGTGAACTTTAAACTCGGTATCGACCCAGACAAAGCCCAACAATTGGTTCAAAACCGTGTGTCTCAGGCCATGCCCCGTTTACCTGAAGATGTACAGCGCTTAGGTGTAACCACACTAAAAAGCTCACCTACTTTAACTATGGTAGTGCATCTGACCTCACCAGATAATCGCTATGACATGACCTACTTACGTAACTATGCGGTGCTCAACGTAAAAGACCGTTTGGCACGTTTACAAGGTGTAGGTGAAGTCGGTTTATTTGGATCTGGTGACTACGCGATGCGCGTATGGCTCGACCCGCAAAAAGTAGCGCAGCGTAACCTCACCGCGACCGAAATTGTGAATGCAATCCGTGAACAAAACATTCAGGTTGCAGCAGGTACAATCGGTGCATCACCAAGTAATTCACCTTTGCAACTTTCAGTGAATGCTCAAGGTCGTTTAACCACTGAGCAAGAATTTGCCGATATCATTTTAAAAACTGCCCCTGATGGCGCGGTTACCCGATTGGGTGATGTTGCACGTGTTGAACTCGCAGCCTCTCAATACGGCTTACGTTCATTACTTGATAATAAACAAGCGGTCGCGATTCCAATTTTCCAAGCACCAGGTGCGAATGCTTTACAAGTTTCCGATCAAGTGCGTAGCACAATGAAGGAGCTTTCAAAAGATTTTCCATCTTCAATTAAATACGACATTGTTTATGACCCGACTCAATTCGTACGGGCCAGTATTAAAGCGGTCGTTCATACCTTACTTGAAGCAATTGCACTGGTTGTTGTGGTTGTTATTTTATTTTTACAAACATGGCGTGCCTCAATCATTCCATTGCTTGCCGTACCAGTTTCAATTATTGGTACATTCGCACTCATGCTCGCTTTTGGTTACTCAATCAATGCGCTATCACTGTTCGGGATGGTACTTGCCATCGGTATTGTCGTCGATGACGCGATTGTGGTCGTCGAAAATGTCGAGAGGAATATTGAAGCAGGCTTAAACCCAAGGGAGGCGACTTACCGTGCCATGCGAGAAGTCAGTGGACCGATTATTGCCATTGCTTTAACACTTGTTGCAGTATTCGTACCTCTTGCCTTTATGACAGGCTTAACAGGGCAATTCTATAAACAATTTGCCATGACTATTGCCATTTCAACGGTTATTTCGGCATTTAACTCGCTTACCCTATCTCCTGCTTTGGCAGCGCTGTTACTGAAAGGACATGATGCTAAACCGGATGCCTTAACACGTATTATGAATCGTTTATTCGGTCGTTTCTTTGCACTGTTTAACCGTGTGTTTTCACGTGCTTCAGATCGTTATAGTCAAGGTGTCAGCCGTGTCATTTCCCATAAAGCTTCGGCAATGGGTGTCTATGCAGCACTTCTAGGTTTAACCGTTGGTATTTCCTATATTGTTCCAGGTGGTTTCGTTCCTGCGCAGGACAAACAATATTTAATTAGCTTTGCGCAGCTACCAAACGGCGCGTCATTAGATCGTACCGAAGCGGTCATTCGTAAAATGAGTGACACTGCGCTTAAACAACCTGGTGTAGAAAGTGCGGTTGCCTTTCCCGGCCTATCAATTAACGGTTTCACCAATAGCTCGAGTGCCGGTATTGTCTTTGTGACCTTAAAGCCATTCGATGAACGTAAGGCTAAAGACTTATCTGCAAATGCTATTGCAGGTGCACTCAACCAGAAATATTCAGCTATTCAAGATGCTTATATCGCTGTTTTCCCACCACCACCAGTGATGGGCTTAGGCACGATGGGCGGCTTTAAACTGCAACTTGAAGACCGAGGTGCCTTAGGCTATTCAGCCTTGAACGATGCTGCTCAAAACTTTATGAAAGCAGCACAATCAGCCCCTGAACTGGGTCCAATGTTCTCAAGTTATCAAATTAACGTACCTCAACTCAACGTAGATCTGGACCGTGTAAAAGCTAAACAGCAAGGCGTTGCTGTTACAGATGTTTTCAACACTATGCAGATTTATTTAGGTTCTCAGTACGTTAACGACTTTAACCGCTTTGGACGTGTTTATCAGGTTCGTGCACAAGCCGATGCGCCTTTCCGTGCTAACCCTGAAGATATTTTGCAGCTTAAAACCCGTAATAGTGCCGGACAAATGGTGCCATTATCTTCATTGGTGAATGTAACTCAAACCTATGGTCCTGAAATGGTCGTTCGTTATAACGGTTACACATCAGCAGATATTAACGGCGGCCCTGCCCCAGGTTATTCATCTAGCCAAGCAGAAGCTGCGGTTGAACGTATTGCTGCACAAACTCTACCGCGTGGTATCAAGTTTGAATGGACAGATTTAACTTACCAAAAAATCTTGGCTGGTAATGCTGGACTTTGGGTATTCCCTATTAGCGTATTACTCGTGTTCTTAGTATTAGCTGCTCAGTATGAAAGCTTAACCCTACCATTAGCAGTTATCTTAATTGTACCAATGGGAATCTTAGCGGCTCTGACAGGTGTCTGGTTGACAGCTGGAGATAACAACATCTTTACTCAAATCGGTCTAATGGTACTGGTCGGGCTAGCCTGTAAAAATGCCATCTTAATTGTTGAATTTGCGCGGGAACTTGAAATGCAAGGTGCGACTGCCTTTAAAGCAGCTGTTGAAGCAAGTCGTCTACGTTTACGCCCAATTTTAATGACCTCTATTGCATTTATTATGGGTGTAGTGCCACTGGTTACTTCAACTGGCGCAGGTTCTGAAATGCGACATGCGATGGGTGTTGCCGTATTCTTCGGCATGATCGGTGTAACATTCTTTGGTTTATTCCTCACCCCGGCCTTTTACGTTCTGATTCGTACCCTCAACAGCAAACATAAACTGCATTCTGCGGCAGTTCATGAAGCGCCGTTAGCTAGCCCACACGATCATTAA	
8061	CARD	prokka_01698	contig_7	177830	69	108461	109910	1	69	adeH	3000779.0	958.748	900.0	Strict	99.59	99.79	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLGSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	GTGATTACATCAAAACAAAATTGGTTGTTGTCCTCACTCATGGGAAGCCTGCTCCTTGCAGGCTGCTCATTGGCCCCAGAATATCAACCTGCAAAAGTTATAGTGCCAGTCAAATTCAAAGAATCTGACCCCAAACTTGAAGATAATAACTGGAAGATTGCCCAACCTGCCGATCAACAAACTCGTGGTGAATGGTGGCGCATTTACAATGATGCTCAACTGAATGAACTTGAACAGCAAGCTATCGCAGGCAATCAGAACCTAAAAGCGGTGGCAGCAAATATTCAGGCTTCACGTGCATTACGTTCGGCAGCTCAAGCTGAACGCTTACCAAGTATTGATGCCGGATTTGGGCCAACTCGCCAAAAGCCGTCTCCGGCTTCACTCGGTTTAGATGACAATGCACATACTTCGGCTCAAACCTTATGGCGCGCTCAAGCCAATGTTTCATATGAGCTCGATTTATTTGGTCGTGTAGCAAGTAGTGTCAACGCAGCAACAGCGGATCTACAGCAACAAGAGGCTCTATATCAGTCAGCACTTTTAGCTCTACAAGCGGATGTAGCTCAAGGTTATTTTCTGATACGTCAACTTGATACCGAACAAGCAATTTATAACCGAACAATCAAATTGCTAGGTGAAACACGAGATTTAATGCAGCTTCGTTTTAAAAACGGACTGGGCAGTGAATTAGATGTTTCTCGCGCACAAACCGAACTTGCTACCGCACAAACCACTGCCCTAAATATTGCTCGTAACAGAGCCAGTGCAGAACATGCGCTTGCAGTCTTATTAGGAAAACCACCAGCAGACTTTAACTTGGCAGTTCAACCTTTAACTGCAAATAGTATCCGTCTCCCTGCCGGTTTGCCGTCAACTTTACTTGAAAGACGACCCGATATTGCGGCTGCAGAGCGTGCAATGGCAGCAGATAATGCGCGTATTGGAATTGCTCGTGCAGCATTTTTCCCAAAACTCAGTCTTACAGGAGCTTTAGGTTATGAATCTTCAAGTTTAAGCGAGTTGGGTAAATGGTCGAGTCGGACTTTTTTACTAGGACCTGTCGCTGGTACTATTTTGTCGTTACCTTTATTTGATGGTGGACAACGTAAAGCAGGCGTTGCTCAAGCAAGAGCGGCTTATGAGGAAAGCGTCGCCAACTATAGACAAACTGTACTGAATGCATTTCGCGAAGTTGAAAATGGTTTATCTGATCAAAGAATTCTCGATCAGCAAATTCAGGCTCAAAACCAAGCACTCTCCTCTTCTCGTCATGCCAATCAACTTTCTCATTTACGTTATCGAGAAGGTGCTATTAGCTATCTTGATGTCATTGATTCTGACCGCACTATTTTGCAACAAGAACAATTAGCAGCTCAGCTGAAAGGCAGCCAAATCATTGCAAGCATCAATTTAATCCGTGCTTTAGGGGGCGGTTGGAGTAGTTAA	
8061	CARD	prokka_01954	contig_9	161085	76	35473	36262	-1	58	ANT(3'')-IIc	3004091.0	376.711	200.0	Strict	70.16	101.16	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSDFIQLEYLQEKLQQLLAESLFAIYLYGSAVDGGLGPESDLDVLVVVTQPLTSALREQLAQELLKISQPVGELQRPLEVTILLKDEIQSGNYPLSYEMQFGEWLREELKEGGTLSSQKDPDISILLRKARFHHAVLFGPALDQWAPEISDQELWQAMSDTYPEIVAHWDEDADERNQILALCRIYFSLVMKDIASKDNAARWVKSQLPPEQKFVLQRLIQEYRGEIGKQNWQEEHYALQPIVNFLSSKIEEQFEQKRNLIT	ATGTCTGATTTCATTCAGTTAGAATATCTACAAGAAAAATTACAGCAACTTTTAGCGGAATCATTATTTGCAATCTATCTTTATGGTTCAGCTGTTGATGGTGGCTTAGGGCCAGAAAGTGACCTTGATGTTCTGGTCGTGGTTACTCAACCATTAACATCTGCTTTACGCGAGCAGCTTGCACAAGAATTACTAAAAATTTCACAGCCTGTTGGAGAATTACAAAGACCATTAGAAGTTACTATTTTATTAAAAGACGAGATTCAGTCTGGAAATTATCCTTTAAGTTATGAAATGCAGTTTGGTGAATGGCTACGTGAAGAACTTAAAGAAGGTGGAACATTAAGTTCGCAGAAAGACCCAGATATTAGTATATTGCTTAGAAAAGCGAGATTTCATCATGCAGTTTTATTTGGTCCAGCTTTAGACCAATGGGCACCTGAAATTTCTGATCAAGAACTATGGCAAGCAATGTCTGACACTTACCCTGAAATTGTAGCGCATTGGGATGAAGATGCAGATGAAAGAAACCAGATTTTAGCTTTATGCCGGATCTATTTTAGTTTAGTCATGAAGGATATTGCTTCAAAAGACAATGCAGCACGATGGGTTAAGTCTCAGCTTCCTCCTGAGCAGAAATTCGTATTGCAGCGGCTTATACAGGAATATAGAGGGGAAATCGGCAAGCAAAATTGGCAAGAGGAACATTATGCTTTGCAGCCTATTGTTAATTTTCTGAGTTCAAAAATTGAAGAGCAGTTTGAGCAGAAAAGAAATTTGATCACATAA	
8061	CARD	prokka_02463	contig_13	105701	67	61706	62360	1	67	adeN	3000559.0	448.74300000000005	420.0	Strict	99.08	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	MHDPVLESHHLVCEKPQTRRGIERRLALLLSATELFLEKGYDAVSLDDIVNHAGGSKTSIYKYFGNKDGLFTAICDYRREMFFKDICIAFQPEQTSLKDYLIQTLIRFYKHIIQPEHIAFLRLVIEQTQCNATLSQYLYEKCALDVQNTIAQALLISHQSGEITCTSPDHSSLMYFGILRDIEWRMIMGMPLPPNETEVIDYINYCVDIFLKGHHKV	ATGCATGATCCAGTCCTTGAGTCACATCATCTCGTATGTGAAAAACCCCAAACACGCCGCGGTATAGAACGTCGTTTAGCTCTATTGCTAAGCGCAACCGAGCTGTTTTTGGAAAAAGGATATGATGCTGTCTCTCTTGACGACATCGTCAATCATGCTGGTGGTTCAAAAACCTCTATTTATAAATACTTCGGTAATAAAGATGGCTTATTTACTGCAATCTGCGATTATCGCCGTGAAATGTTTTTTAAAGATATCTGCATTGCATTTCAACCAGAGCAAACTTCTTTAAAAGATTATTTAATCCAAACTCTCATCCGTTTTTATAAACACATTATTCAACCTGAACACATTGCCTTTTTACGTTTGGTTATTGAACAAACTCAATGTAATGCAACTTTGAGCCAATACTTATATGAAAAATGTGCTCTGGATGTCCAAAATACAATTGCTCAAGCCTTACTCATATCTCATCAATCAGGTGAAATTACCTGTACATCTCCTGATCATTCCTCTCTTATGTATTTTGGAATTTTACGTGATATTGAATGGCGAATGATTATGGGAATGCCTCTTCCACCCAATGAGACAGAAGTTATTGATTATATTAACTATTGTGTTGATATTTTCTTAAAGGGCCATCATAAAGTCTAA	
8061	CARD	prokka_02548	contig_14	99756	73	44429	45680	1	92	adeI	3000780.0	832.7869999999998	800.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	MMSAKLWAPALTACALATSIALVGCSKGSDEKQQAAAAQKMPPAEVGVIVAQPQSVEQSVELSGRTSAYQISEVRPQTSGVILKRLFAEGSYVREGQALYELDSRTNRATLENAKASLLQQQANLASLRTKLNRYKQLVSSNAVSKQEYDDLLGQVNVAEAQVAAAKAQVTNANVDLGYSTIRSPISGQSGRSSVTAGALVTANQTDPLVTIQQLDPIYVDINQSSAELLRLRQQLSKGSLNNSNNTKVKLKLEDGSTYPIEGQLAFSDASVNQDTGTITLRAVFSNPNHLLLPGMYTTAQIVQGVVPNAYLIPQAAITRLPTGQAVAMLVNAKGVVESRPVETSGVQGQNWIVTNGLKAGDKVIVDGVAKVKEGQEVSAKPYQAQPANSQGAAPNAAKPAQSGKPQAEQKAASNA	ATGATGTCGGCTAAGCTTTGGGCACCAGCCCTTACTGCTTGCGCATTAGCAACAAGTATCGCGCTTGTTGGTTGTAGCAAAGGCTCCGATGAGAAACAGCAAGCTGCTGCTGCTCAGAAAATGCCGCCTGCAGAAGTAGGTGTTATTGTTGCTCAACCACAAAGTGTTGAACAAAGCGTTGAGCTTTCAGGCCGTACTTCAGCATATCAAATTTCTGAAGTTCGTCCTCAGACAAGTGGCGTGATTTTAAAACGCTTATTTGCTGAAGGAAGCTATGTTCGTGAAGGTCAGGCGCTTTATGAGCTCGACTCTAGAACGAACCGTGCAACGTTAGAAAATGCAAAAGCATCACTCCTACAACAACAGGCAAATCTAGCTTCACTACGTACCAAGTTAAATCGTTATAAACAACTTGTTTCTAGTAATGCTGTGTCTAAACAGGAATATGATGACTTACTTGGTCAAGTCAATGTTGCAGAAGCACAAGTTGCAGCAGCTAAGGCTCAAGTAACAAATGCAAATGTAGATCTTGGTTATTCTACAATTCGCTCTCCTATTTCTGGCCAATCTGGTCGTTCTTCAGTAACGGCTGGTGCTTTGGTTACTGCAAACCAGACTGACCCGTTGGTAACGATTCAACAGTTAGATCCTATCTATGTTGATATTAATCAGTCTAGTGCTGAGTTATTGCGTTTACGTCAACAACTAAGTAAAGGCAGTTTAAATAACAGTAACAACACGAAAGTAAAATTAAAGCTTGAAGATGGTTCTACCTATCCAATCGAAGGGCAACTTGCTTTCTCTGACGCTTCTGTAAACCAAGATACAGGAACAATTACATTACGTGCCGTATTCTCTAACCCGAATCATTTATTGCTTCCGGGTATGTATACCACTGCGCAAATTGTTCAGGGCGTTGTTCCAAATGCTTACCTGATTCCTCAAGCTGCCATTACTCGTTTACCTACAGGGCAAGCTGTAGCGATGCTTGTTAATGCTAAAGGGGTTGTTGAGAGTCGTCCTGTTGAAACCTCTGGTGTTCAAGGACAAAATTGGATTGTGACTAACGGCTTAAAAGCCGGCGATAAAGTCATTGTTGATGGTGTTGCCAAAGTTAAAGAAGGGCAAGAAGTATCAGCAAAACCTTATCAAGCTCAACCAGCAAACTCTCAAGGTGCAGCACCAAATGCTGCGAAACCGGCTCAATCAGGTAAACCTCAAGCAGAACAGAAAGCAGCTTCAAATGCATAA	
8061	CARD	prokka_02549	contig_14	99756	73	45692	48869	1	91	adeJ	3000781.0	2149.4	2000.0	Strict	99.91	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSIFKYKPKTINTQEHKS	ATGGCACAATTTTTTATTCATCGCCCCATATTTGCGTGGGTGATTGCATTAGTCATTATGTTGGCGGGTATTCTTACGCTAACAAAAATGCCTATTGCACAATATCCAACGATTGCACCACCAACCGTAACGATTGCTGCGACTTATCCTGGTGCATCGGCTGAAACAGTTGAAAATACTGTAACCCAGATCATTGAACAACAAATGAATGGTCTTGATGGCTTACGTTATATTTCATCTAACAGTGCTGGTAATGGTCAGGCATCTATTCAATTAAACTTTGAACAAGGTGTTGACCCTGATATTGCACAGGTTCAAGTTCAAAACAAATTGCAATCTGCAACTGCGCTTTTACCTGAAGATGTACAACGTCAAGGTGTAACAGTTACTAAATCTGGTGCGAGCTTCTTGCAAGTTATTGCATTCTATTCACCAGATAACAACCTGTCAGACTCTGACATTAAAGACTACGTAAACTCGTCAATTAAAGAACCGCTTAGCCGTGTTGCCGGTGTTGGTGAGGTACAGGTCTTCGGTGGCTCATACGCAATGCGTATCTGGCTTGATCCAGCTAAATTAACAAGCTATCAACTTACTCCTAGTGATATTGCAACTGCCTTACAAGCGCAGAACTCGCAAGTTGCCGTAGGTCAGTTAGGTGGTGCTCCGGCTGTACAAGGTCAAGTTCTTAACGCAACAGTAAATGCACAAAGCTTATTGCAGACTCCTGAACAGTTTAAAAATATCTTCTTAAAGAACACAGCATCAGGTGCTGAGGTTCGATTAAAAGATGTTGCTCGCGTAGAATTAGGTTCGGATAACTATCAATTCGACTCGAAGTTTAACGGTAAACCGGCAGCTGGTCTTGCAATTAAAATTGCAACAGGTGCTAACGCACTCGACACAGCCGAAGCAGTTGAACAACGTTTATCTGAACTACGTAAGAACTATCCAACAGGTCTTGCAGATAAACTGGCTTATGACACGACTCCATTTATCCGTCTTTCAATTGAAAGTGTAGTACACACATTAATTGAAGCCGTGATTTTGGTATTCATTGTCATGTTCCTATTCTTACAAAACTGGCGTGCAACGATTATTCCAACGCTTGCAGTTCCAGTAGTTGTATTAGGTACATTTGCGGTCATTAATATCTTTGGCTTCTCAATTAACACCTTAACCATGTTCGCTATGGTATTGGCAATCGGTCTTCTGGTCGACGACGCCATTGTTGTAGTCGAAAACGTTGAACGTGTGATGAGTGAAGACCATACCGATCCGGTTACGGCCACTTCTCGCTCAATGCAGCAGATTTCTGGTGCGTTAGTAGGTATTACCAGCGTATTGACAGCGGTATTCGTACCAATGGCTTTCTTTGGTGGTACAACAGGTGTAATTTACCGCCAGTTCTCGATTACCCTTGTAACTGCAATGGTTCTGTCGTTAATTGTAGCGTTGACGTTCACACCGGCACTTTGTGCAACTATCTTGAAACAGCATGATCCTAATAAAGAACCAAGCAATAATATCTTTGCGCGTTTCTTTAGAAGCTTTAACAATGGTTTTGACCGCATGTCGCATAGCTACCAAAATGGTGTTAGCCGCATGCTTAAAGGCAAAATCTTCTCTGGCGTGCTCTATGCTGTTGTAGTTGCCCTTTTAGTCTTCTTGTTCCAAAAACTCCCGTCTTCATTCTTACCAGAAGAAGATCAGGGTGTGGTCATGACACTTGTACAATTACCACCAAATGCAACGCTTGACCGTACCGGTAAAGTGATTGATACCATGACTAACTTCTTTATGAATGAAAAAGATACCGTGGAATCTATTTTCACTGTTTCTGGTTTCTCATTCACAGGTGTTGGTCAAAACGCGGGTATTGGCTTCGTTAAGTTGAAAGACTGGAGCAAACGTACGACACCAGAAACTCAAATTGGTTCATTGATTCAGCGTGGTATGGCATTAAATATGATCATTAAAGATGCATCATACGTTATGCCGTTACAGCTTCCAGCAATGCCTGAACTTGGTGTAACTGCCGGATTTAACTTGCAGCTTAAAGATTCAAGTGGTCAAGGCCATGAGAAACTGATTGCAGCTCGTAACACGATTTTAGGTTTGGCATCACAAGATAAACGTCTTGTAGGTGTGCGTCCAAATGGTCAGGAAGATACTCCTCAGTATCAAATTAATGTAGATCAGGCTCAAGCTGGTGCTATGGGCGTTAGTATTGCCGAAATCAACAATACAATGCGTATTGCATGGGGTGGCTCATACATTAACGATTTCGTTGACCGTGGTCGTGTGAAAAAAGTTTATGTTCAAGGTGATGCGGGCAGCCGTATGATGCCTGAAGACTTAAACAAATGGTATGTACGTAATAACAAAGGTGAGATGGTTCCATTCTCGGCATTTGCTACAGGCGAATGGACGTATGGTTCTCCACGTCTCGAACGTTATAACGGCGTGTCATCGGTTAACATTCAAGGTACACCTGCACCTGGCGTGAGCTCTGGTGATGCCATGAAAGCAATGGAAGAAATTATTGGTAAGTTACCATCTATGGGCTTACAAGGTTTCGACTATGAGTGGACAGGCTTATCACTTGAAGAACGTGAGTCTGGTGCTCAAGCGCCGTTCTTATACGCACTTTCATTGTTAATCGTATTCCTTTGCTTGGCTGCACTATATGAAAGCTGGTCAATTCCGTTCTCGGTTTTACTTGTGGTACCACTTGGTGTCATTGGTGCAATCGTATTGACCTACTTGGGCATGATTATTAAAGGAGATCCAAATCTCTCAAATAACATTTACTTCCAGGTAGCGATTATTGCGGTTATCGGTCTTTCTGCAAAAAATGCGATCTTGATTGTTGAATTCGCAAAAGAATTGCAGGAAAAAGGTGAAGATCTACTTGATGCAACCTTACATGCTGCAAAAATGCGTTTACGTCCAATTATCATGACCACCCTTGCCTTCGGTTTCGGTGTACTTCCACTTGCACTTTCAACAGGTGCCGGTGCAGGAAGTCAGCACTCTGTAGGCTTTGGTGTACTTGGTGGCGTACTCAGCGCGACGTTCTTAGGAATCTTCTTTATCCCTGTATTCTATGTGTGGATTCGTAGTATCTTTAAGTACAAACCAAAAACCATAAACACTCAGGAGCATAAATCGTGA	
8061	CARD	prokka_02550	contig_14	99756	73	48868	50323	1	73	adeK	3000782.0	974.926	950.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	MQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQFFADPRLLEVIDLALANNRDLRTATLNIERAQQQYQITQNNQLPTIGASGSAIRQVSQSRDPNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWLNYSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQIAQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAAGANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVKISETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFRAGIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSAELKKQ	ATGCAAAAAGTATGGTCTATTTCAGGTCGTAGCATTGCGGTGTCTGCACTTGCGCTTGCTTTGGCAGCTTGTCAAAGCATGCGCGGCCCAGAACCAGTCGTGAAAACCGATATACCACAAAGCTATGCATATAACAGCGCTTCTGGTACGTCTATTGCTGAACAGGGTTATAAACAGTTCTTTGCTGACCCGCGTTTGCTTGAAGTGATTGATTTGGCTCTTGCCAATAACCGTGACTTACGTACAGCAACGCTCAATATTGAACGTGCTCAACAGCAATATCAGATTACACAGAACAACCAGCTTCCAACAATCGGAGCAAGTGGTAGTGCAATTCGTCAGGTTTCTCAAAGCCGTGATCCGAATAACCCCTACTCTACTTATCAAGTAGGTTTGGGTGTAACTGCTTATGAGCTAGATTTCTGGGGTCGTGTTCGTAGCCTCAAAGATGCTGCTTTAGATAGTTATCTTGCAACACAAAGTGCTCGTGATTCGACTCAAATCAGTCTGATTAGCCAAGTTGCTCAAGCATGGTTAAATTATTCGTTTGCAACAGCAAACTTAAGACTGGCAGAGCAAACGCTTAAAGCACAGTTAGATTCTTACAATCTCAACAAAAAACGTTTTGATGTAGGTATTGACAGTGAAGTTCCATTACGTCAAGCACAGATTTCTGTAGAAACTGCGCGTAATGATGTAGCGAACTACAAAACTCAAATTGCTCAAGCACAAAACTTGTTGAACTTGCTTGTAGGCCAACCTGTTCCACAAAACTTGTTACCTACACAACCTGTAAAACGCATTGCTCAACAAAATGTGTTTACTGCCGGTTTACCAAGTGACTTGTTAAATAACCGTCCGGATGTAAAAGCTGCTGAATACAACTTAAGCGCTGCGGGTGCGAATATCGGTGCTGCAAAAGCACGTTTATTCCCAACCATTAGCTTAACGGGTTCGGCTGGTTATGCATCAACTGACTTAAGTGATCTATTTAAGTCTGGTGGTTTTGTATGGTCAGTTGGTCCAAGCTTAGATTTACCAATCTTTGACTGGGGTACACGCCGTGCCAATGTAAAAATTTCTGAAACCGATCAGAAAATTGCATTGTCTGATTATGAAAAATCAGTTCAGTCGGCGTTCCGTGAAGTTAATGACGCGCTTGCAACTCGTGCCAATATTGGTGAGCGTTTAACAGCACAACAACGTCTAGTAGAAGCAACTAACCGCAACTACACACTTTCAAATGCCCGCTTCCGTGCCGGTATTGATAGTTACTTGACTGTTCTTGATGCACAGCGTTCTTCATATGCAGCTGAACAAGGTTTGTTATTGCTTCAACAAGCAAACTTAAACAACCAAATCGAGTTATACAAAACTCTAGGTGGTGGTTTAAAAGCAAATACTTCAGATACAGTGGTTCACCAACCATCTAGTGCTGAACTTAAAAAGCAATAA	
8061	CARD	prokka_02779	contig_17	94215	71	1174	2479	-1	70	Acinetobacter baumannii AbaQ	3004574.0	864.7589999999999	600.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDFEKDVIRTVTFKLIPALVILYLVAYIDRAAVGFAHLHMGADVGIGDAAYGLGAGLFFIGYFLFEVPSNLLLDKFGARKWFTRILLTWGLITMAMALIQGPKSFYLLRFLLGVAEAGFFPGVLYLITQWYPVRHRGKIMGMFVLSQPIAMMIAGPLAGLLLGMDGIANLHGWQWLFVAVGLPAVLLALPTFLWLPDNIDKVKWLSIEQKQWLKNELVKDEAEYDQTRHANPLHALKDKRVLLLALYYLPVTLSIYGLNLWLPTIIKQFGGGSDIQIGFLSSIPYIFGIIGLLIIPRSTDRLNDRYGHLSFLYALGACAMFLSGWLNSPVMQLAALAVVAFCLFSSTAVFWTLPGRFLTGASAAAGIALINSVGNLGGYVGPFGIGLLKEYTGNMAAGLYFLSIVMLFGLILTYIVYAKLERQKTQTVNIQKPL	ATGGATTTCGAAAAGGATGTAATACGGACGGTCACGTTTAAGCTAATACCTGCATTAGTCATACTATATCTCGTGGCATACATTGATCGTGCCGCTGTTGGATTTGCCCATTTGCATATGGGTGCCGATGTAGGAATTGGTGATGCTGCCTATGGTCTAGGAGCTGGTTTATTTTTTATTGGATATTTTCTTTTTGAAGTCCCAAGTAATTTGCTTTTAGACAAATTTGGTGCTCGTAAATGGTTTACCCGCATTTTATTAACATGGGGCCTCATCACCATGGCCATGGCGCTTATTCAAGGCCCTAAAAGTTTTTATCTCTTAAGGTTTTTACTCGGTGTAGCAGAGGCGGGTTTTTTCCCTGGTGTTTTATACCTAATTACGCAGTGGTATCCGGTGCGGCATCGCGGAAAAATCATGGGAATGTTTGTGCTTTCACAACCAATTGCCATGATGATTGCAGGGCCTTTAGCTGGTCTATTACTTGGAATGGATGGCATTGCAAATTTACACGGCTGGCAATGGTTGTTTGTTGCAGTTGGCTTGCCCGCGGTTTTATTGGCTTTACCTACCTTTTTGTGGCTGCCCGATAACATTGATAAAGTAAAATGGTTAAGCATTGAACAAAAACAATGGCTTAAAAATGAACTCGTTAAAGATGAAGCCGAATATGACCAAACCCGACATGCCAATCCACTACATGCTTTAAAAGACAAACGCGTACTTTTATTAGCACTTTACTACTTACCGGTAACTTTAAGTATTTATGGTTTAAATCTCTGGCTTCCTACCATTATTAAGCAATTTGGCGGAGGTAGTGATATTCAAATTGGGTTCTTATCTAGCATTCCCTATATTTTTGGAATTATTGGACTCCTCATTATTCCGCGTAGTACTGACCGCCTAAATGATCGTTACGGACACTTAAGTTTTCTGTATGCACTAGGTGCTTGTGCAATGTTTTTAAGTGGTTGGCTAAATTCCCCAGTCATGCAGTTGGCAGCTTTGGCTGTAGTTGCGTTCTGTCTATTTTCATCGACTGCCGTGTTTTGGACACTACCGGGTCGTTTCTTAACGGGTGCAAGTGCAGCAGCTGGTATTGCCTTAATTAACTCTGTTGGAAATTTAGGTGGCTATGTCGGTCCATTTGGGATCGGACTGTTAAAAGAATACACGGGAAATATGGCTGCTGGTTTGTATTTCTTATCTATCGTCATGCTTTTTGGCTTGATTCTGACTTACATCGTCTATGCCAAGCTCGAACGTCAAAAAACACAAACAGTGAATATTCAAAAGCCTTTGTAA	
8061	CARD	prokka_02931	contig_18	79935	69	53927	55406	-1	86	Acinetobacter baumannii AmvA	3004577.0	964.14	600.0	Strict	98.98	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; acridine dye; disinfecting agents and intercalating dyes	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAVLGLGAAMLIPATLSGIRNAFTEEKQRNFALGLWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILVVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLVVVAQQAFSYAHSWVLTISAICFFLLTVFVWFSFPKKVN	ATGCAAAAAAAATGGTTAATCCTCACAATTATCGTCCTCATTTATTTACCTGTTACGATTGATGCAACGGTGATGCATGTTGCAACACCATCTTTAAGTGCAGCATTGAATTTAACTGCCAATCAGCTTTTATGGATTATTGATATTTATTCGCTGATTATGGCGGGTTTGATTTTACCGATGGGTGCACTCGGTGATCGTATTGGCTTTAAAAAATTATTATTTATTGGAACCGCAGTTTTTGGTGTTGGTTCTTTAGCTGCGGCTTTTTCTCCAACTGCCTATGCCTTAATTGCTTCTCGTGCTGTCTTAGGTCTAGGGGCAGCTATGCTTATTCCTGCCACTTTATCAGGTATCCGTAATGCTTTTACCGAAGAAAAACAGAGAAATTTTGCACTTGGTCTTTGGTCTACAGTAGGTGGAGGTGGAGCAGCTTTTGGTCCACTAGTTGGTGGTTTTGTATTAGAGCATTTCCACTGGGGAGCTGTATTCCTCATTAATATCCCGATCATTTTAGTGGTTCTAGTTATGATCGTGATGATCATTCCTAAACAACAAGAGAAAACTGATCAGCCAATTAACTTAGGGCAAGCTTTAGTTTTGGTTGTAGCAATTTTAAGCCTCATCTATTCAATCAAATCGGCTATGTATAACTTCTCGGTGCTCACGGTTGTGATGTTTGTGGTGGGTATAAGCACATTAATTCACTTCATTCGAAGCCAAAAAAGAGCTACGACACCAATGATTGATCTGGAATTGTTTAAACATCCTGTGATTTCTACCAGTATTGTTATGGCAGTTGTGTCCATGATTGCTTTGGTTGGCTTTGAATTATTACTGTCTCAAGAGTTGCAGTTTGTACACGGGTTTTCTCCATTACAGGCGGCGATGTTTATTATTCCATTTATGATTGCAATTAGTTTAGGTGGTCCATTAGCAGGTATTTGTTTAAATAAATGGGGTTTACGTAGAGTATCGAGCCTAGGTATTTTAGTGAGCGCGCTCAGTTTATGGGGGCTTGCTCAGCTCAACTTTTCAACCGACCACTTTTTAGCATGGACGTGTATGGTCTTTTTGGGCTTTAGTATTGAGATTGCCTTACTGGCCTCAACTGCTGCCATTATGTCATCTGTGCCCCCTCAAAAGGCGAGTGCAGCAGGTGCTATTGAGGGAATGGCCTATGAACTTGGCGCTGGTTTGGGCGTTGCTATATTTGGGTTAATGTTGTCTTGGTTTTATAGCCGCTCAATTATTTTGCCAGCCGAGCTTCCGTCAAACTTAATTGAAAAAGCGAGTATCTCGATTGGAGAAACCATGCAATTAGCCTCTAATCTTGAAAATCCTTTAGGAGGGCAATTAGTTGTAGTGGCGCAGCAAGCTTTTAGCTATGCACATAGTTGGGTACTTACCATCTCAGCGATCTGTTTCTTCCTTTTAACTGTATTTGTCTGGTTTAGTTTTCCGAAGAAAGTAAATTAA	
8061	CARD	prokka_03026	contig_20	72933	67	12311	13709	-1	62	adeC	3003811.0	952.97	850.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		glycylcycline; tetracycline antibiotic	MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKMIAEKSYKEFISDPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPNNPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYAFAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRVAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYKAGVDSYFTVLDAQRSAYAAQQGLLALEQIKLNNQIEIYKVLGGGISKV	ATGTCTAAATCGACAATCGTATCTCGTGGACTCATTCTTTCTACACTCTCAATTGCACTCGTTGCATGTGTCAATATGCAAGCGCCACAGCCTGCAATTACATCTCATATTCCTCAAAATTTTAGTCAAAATCATTCTGGAAAAATGATTGCAGAAAAAAGTTATAAAGAATTTATTTCTGATCCGAAATTATTACAGGTCATTGAAATCAGTTTAAATAACAACCGTGATTTACGGACTGCTACGCTTAATATTGAACGTGTACAGCAAGAATACCAAATCACAAAAAATAGCCAGCTCCCAACCATTGGTGTAACGGGAAATGCAGTGCGGCAGGTTAGCCCATCGATTAACCCCAATAACCCAGTTTCTACATTTCAAGTTGGCTTGGGAATGACTGCCTATGAGCTAGATTTTTGGGGCCGTGTTCAAAATTTAAAAGATGCTGCATTAAATAACTATCTTGCAACTCAAAGTGCAAAAGAAGCTGTACAAATTGGTTTAATCAGTAATATTACACAGGTCTGGTTAAATTATGCTTTTGCACAAGCAAATTTAAACCTTGCCGAGCAAACCTTAAAAGCACAAGTCGATGCTTATAACCTTAACAAGAAGCGCTTTGATGTTGGTATTGATAGTGAAGTGCCATTAAAACAAGCACAAATTTCGGTAGAGACTGCTCGAAATGATGTTGCAACTTATAAAACTCAAATTCAACAGGCAAAAAATTTACTGGATTTGTTAGCAGGTCATCCTGTTCCGCAAAATTTACTTCCGGATCATGCTATTCAAAATATTACCTTTGAGAAAAACTTTGCAGCCGGTTTACCAAGTGATTTATTAAATCATCGTCCAGACCTTAAAGCTGCCGAATATGAGTTACGTGTTGCAGGAGCAAATATTGGTGCTGCTAAAGCACGGATGTTCCCAACCATAAGCTTGACAGGCTCGACGGGTTATGCATCATCTGAACTGAAAGATTTATTTAAAACAGGCAATTTTGCATGGTCGATTGGACCTAATATCGATCTACCAATTTTTGATTGGGGAACAAGAAAAACTAATATTAAAATTGCGGAAACTGACCAGAAAATTGCTTTAGCTAAATATGAAAAAGCCATTCAATCAGCTTTTCGTGAAGTTAATGATGCACTTGCTACACATGCACATATTGGTGAACGATTAGACGCTCAGCGTCGCTTAGTCTCTGCGACTGCTGCAACCTATAAACTCTCAATGGCACGTTACAAAGCTGGAGTGGATAGTTATTTTACGGTTTTAGATGCTCAGCGTTCTGCTTATGCTGCACAACAAGGCTTACTTGCACTTGAACAAATAAAATTAAATAACCAAATTGAAATTTATAAAGTTTTAGGAGGAGGAATATCAAAAGTCTAA	
8061	CARD	prokka_03027	contig_20	72933	67	13785	16896	-1	73	adeB	3000775.0	2091.62	2000.0	Strict	100.0	100.1	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		glycylcycline; tetracycline antibiotic	MMSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	ATGATGTCACAATTTTTTATTCGTCGTCCCGTTTTTGCTTGGGTTATTGCGATCTTCATTATTATATTTGGATTGCTGAGCATTCCTAAACTGCCAATTGCACGTTTTCCAAGTGTGGCCCCGCCACAGGTGAATATTAGTGCGACTTATCCTGGTGCTACAGCTAAAACCATTAACGATAGCGTTGTAACCTTAATTGAGCGCGAATTATCGGGTGTAAAAAATCTACTCTACTATAGTGCGACAACAGATACCTCCGGTACAGCAGAGATTACGGCTACGTTTAAACCAGGCACAGATGTGGAAATGGCTCAGGTTGACGTTCAAAATAAAATCAAGGCTGTAGAAGCTCGCTTACCGCAAGTTGTACGTCAGCAAGGTTTACAGGTTGAGGCTTCATCGTCCGGATTTTTAATGCTGGTCGGGATTAACTCTCCAAATAATCAATATTCCGAAGTTGATTTGAGTGATTATTTGGTTCGAAATGTTGTAGAAGAGCTAAAACGTGTCGAAGGTGTAGGGAAGGTTCAATCTTTCGGTGCCGAGAAAGCTATGCGTATTTGGGTCGACCCGAATAAGCTTGTTTCTTACGGTTTATCGATTAGTGATGTGAATAATGCCATTCGTGAAAATAATGTCGAAATTGCACCCGGCCGACTTGGTGATTTACCAGCTGAAAAAGGCCAGCTCATTACTATTCCATTGTCTGCTCAAGGGCAATTGTCTAGTCTCGAGCAATTTAAAAATATTAGCTTAAAAAGTAAAACTAACGGTAGCGTAATTAAGTTATCTGATGTTGCCAATGTAGAAATAGGCTCACAGGCATATAACTTTGCCATTTTGGAAAATGGTAAGCCTGCTACCGCGGCAGCAATTCAATTAAGCCCGGGTGCTAACGCCGTGAAAACTGCCGAAGTTGTTCGAGCAAAAATTGAAGAGTTGAAGCTAAATTTACCGGAAGGCATGGAGTTTAGTATTCCTTACGACACCGCGCCGTTTGTCAAAATTTCAATTGAAAAGGTAATTCATACATTACTTGAAGCCATGGTTCTGGTTTTCATTGTGATGTATCTATTTTTACATAATGTCCGCTATACGCTTATTCCAGCGATTGTGGCGCCTATTGCCTTACTCGGTACTTTTACCGTGATGTTGCTTGCCGGCTTTTCAATTAACGTACTCACCATGTTCGGTATGGTGCTTGCCATCGGGATTATTGTCGACGATGCCATTGTCGTGGTTGAAAACGTCGAAAGGATTATGGCGACAGAAGGATTATCGCCTAAAGATGCAACCTCTAAAGCAATGAAAGAGATTACCAGCCCGATTATTGGTATTACGCTGGTATTGGCGGCAGTATTTTTACCTATGGCATTTGCGAGTGGTTCTGTAGGGGTAATCTATAAACAGTTTACCTTGACCATGTCGGTATCTATTTTATTTTCAGCGCTATTGGCACTTATTTTAACACCGGCACTTTGTGCCACGATTTTAAAACCAATCGATGGGCATCACCAGAAGAAGGGCTTCTTTGCATGGTTTGACCGTAGTTTCGATAAAGTCACTAAAAAGTATGAATTGATGCTGCTTAAAATCATCAAACATACAGTTCCAATGATGGTGATCTTTTTAGTAATTACCGGTATTACCTTTACCGGAATGAAATATTGGCCAACAGCATTTATGCCAGAGGAAGATCAAGGTTGGTTCATGACTTCGTTCCAGCTACCTTCAGATGCAACCGCTGAGCGTACTCGGAATGTAGTCAATCAATTTGAAAATAATTTGAAAGACAATCCCGATGTAAAAAGTAATACCACCATTTTGGGATGGGGTTTTAGTGGCGCAGGACAAAATGTAGCTGTGGCTTTTACGACACTTAAAGACTTCAAAGAGCGGACTAGCTCTGCATCTAAGATGACAAGCGACGTTAATTCTTCTATGGCGAACAGTACGGAAGGCGAGACTATGGCCGTATTACCACCCGCTATTGATGAGTTAGGTACTTTTTCAGGTTTCAGTTTACGTTTACAAGACCGCGCTAACTTAGGTATGCCTGCTTTACTGGCTGCTCAAGATGAACTTATGGCAATGGCAGCCAAGAATAAAAAGTTCTATATGGTTTGGAATGAAGGGTTGCCACAAGGTGACAATATTTCTTTAAAAATTGACCGTGAAAAGCTTAGTGCATTTGGTGTTAAGTTTTCTGATGTTTCAGACATCATTTCTACATCAATGGGTTCAATGTATATCAATGACTTCCCTAATCAAGGACGTATGCAACAAGTCATTGTACAAGTTGAGGCTAAATCACGTATGCAATTGAAAGATATCTTGAATCTGAAAGTCATGGGTTCAAGCGGTCAATTAGTCTCGTTATCAGAAGTTGTAACGCCACAATGGAATAAGGCACCACAACAATATAATCGTTATAACGGACGACCATCTTTGAGTATTGCTGGTATTCCTAACTTCGATACGTCATCGGGTGAAGCAATGCGTGAAATGGAACAACTGATTGCGAAATTACCGAAAGGTATTGGCTACGAGTGGACAGGTATTTCCTTACAGGAAAAGCAGTCTGAATCACAAATGGCCTTTTTACTTGGTTTATCCATGTTAGTTGTCTTCCTTGTCTTGGCTGCACTCTATGAAAGCTGGGCAATTCCACTTTCTGTGATGCTAGTTGTGCCACTCGGTATTTTTGGAGCAATCATTGCCATTATGTCTAGGGGGTTAATGAATGATGTGTTCTTCAAAATCGGGCTAATTACCATTATTGGTCTATCGGCAAAGAATGCGATTTTGATTGTTGAATTTGCGAAAATGCTGAAAGAAGAAGGCATGAGTTTGATTGAAGCCACTGTTGCCGCAGCCAAACTTCGCTTACGGCCAATTCTGATGACATCACTTGCATTTACGTGTGGTGTAATTCCTTTGGTGATTGCCTCAGGTGCAAGTTCAGAAACTCAACATGCTTTAGGCACAGGGGTTTTTGGCGGCATGATTTCAGCCACCATTCTGGCTATTTTCTTTGTTCCCGTGTTTTTTATCTTCATTTTGGGTGCAGTAGAAAAGCTATTTTCCTCTAAGAAAAAAATCTCATCTTAA	
8061	CARD	prokka_03028	contig_20	72933	67	16892	18083	-1	86	adeA	3000774.0	802.357	750.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		glycylcycline; tetracycline antibiotic	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	ATGCAAAAGCATCTTTTACTTCCTTTATTTTTATCTATTGGGCTGATATTACAGGGGTGTGATTCAAAAGAAGTCGCTCAAGCTGAGCCACCACCGGCTAAAGTCAGTGTATTAAGCATTCAACCGCAATCGGTAAATTTTAGTGAAAATCTTCCTGCACGTGTACATGCATTCCGTACGGCGGAAATCCGTCCGCAAGTCGGAGGTATCATTGAAAAGGTTCTATTTAAACAAGGTAGTGAAGTTAGAGCAGGGCAAGCCTTATATAAAATTAATTCCGAGACTTTTGAGGCCGATGTAAATAGCAATAGAGCTTCTCTCAATAAAGCTGAAGCTGAGGTGGCAAGACTCAAAGTTCAGTTAGAACGTTATGAGCAGTTATTACCAAGTAATGCAATTAGTAAGCAAGAAGTAAGTAATGCTCAAGCTCAGTATCGTCAGGCTCTAGCCGATGTCGCTCAAATGAAAGCATTGCTGGCCAGACAAAACTTGAATCTGCAATATGCAACAGTTCGAGCGCCTATTTCTGGGCGTATTGGGCAATCTTTTGTCACTGAAGGTGCATTGGTCGGTCAGGGCGATACCAATACGATGGCAACCATTCAACAGATTGATAAAGTCTATGTTGATGTAAAGCAATCGGTTAGTGAGTATGAACGCCTACAGGCTGCGCTACAAAGCGGCGAATTATCAGCAAATAGTGACAAAACCGTTCGTATTACCAATAGCCACGGACAGCCCTATAACGTCACAGCAAAAATGTTGTTTGAAGATATTAATGTTGACCCGGAAACAGGCGATGTCACATTCCGTATTGAAGTTAATAACACTGAACGAAAATTACTTCCGGGCATGTATGTGCGTGTCAATATTGATCGTGCTTCTATTCCTCAAGCGCTATTGGTTCCGGCGCAAGCGATCCAACGTAATATCAGTGGCGAGCCTCAGGTATATGTCATTAACGCCCAAGGGACAGCGGAAATTCGTCCTATCGAAATTGGACAGCAATATGAGCAGTTCTATATCGCTAACAAAGGCTTGAAAGTCGGTGACAGAGTCGTTGTTGAAGGTATTGAACGTATTAAGCCAAATCAAAAATTGGCATTGGCAGCATGGAAAGCACCAGCCGTCGCGAATCATGCTTCAAGTGTAGAAACCAAAACTTCTATAGCTGAAGGGGCACAACCATGA	
8061	CARD	prokka_03029	contig_20	72933	67	18228	18972	1	57	adeR	3000553.0	504.212	480.0	Strict	98.79	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		glycylcycline; tetracycline antibiotic	MFDHSFSFDCQDKVILVVEDDYDIGNIIENYLKREGMSVIRAMNGKQAIELHASQPIDLILLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVIARVQAVLRRTQFANKVTNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMIDQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNPLAVKDDA	ATGTTTGATCATTCTTTTTCTTTTGATTGCCAAGATAAAGTTATTCTTGTGGTAGAAGATGACTACGATATTGGCAACATTATTGAAAATTATTTAAAACGTGAAGGCATGAGTGTTATTCGGGCTATGAATGGAAAACAAGCGATTGAATTGCATGCGAGCCAACCCATCGATTTAATTTTACTTGATATTAAATTACCCGAATTAAACGGTTGGGAAGTATTAAATAAAATACGCCAAAAAGCTCAGACTCCCGTGATCATGTTGACGGCGCTAGATCAAGATATTGATAAAGTTATGGCATTACGCATAGGTGCAGATGACTTTGTGGTGAAGCCTTTTAACCCAAATGAAGTCATCGCTAGAGTTCAGGCAGTCTTAAGACGTACTCAGTTTGCAAACAAAGTAACTAATAAAAATAAACTCTATAAAAATATTGAAATTGATACCGACACTCATAGCGTTTATATACACTCTGAGAATAAGAAGATCTTGCTTAATCTGACGCTGACTGAATATAAAATTATTTCATTCATGATTGACCAACCTCATAAAGTTTTTACGCGCGGAGAACTTATGAATCACTGCATGAATGATAGCGATGCACTAGAGCGAACCGTAGATAGCCATGTAAGTAAGCTGAGAAAAAAACTAGAAGAACAAGGCATATTTCAAATGTTAATTAATGTGCGTGGCGTGGGATATAGGCTAGATAATCCCCTAGCTGTAAAAGATGACGCCTAA	
8061	CARD	prokka_03030	contig_20	72933	67	19003	20077	1	56	adeS	3000549.0	705.671	700.0	Strict	96.36	98.89	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		glycylcycline; tetracycline antibiotic	MKSKLGISKQLFIALTIVNLSVTLFSVVLGYVIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLAEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEVLSHLVEDLRTLSLVENQQLRLNYELFDFKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSHAGKLKISSEVVSQNWILKIEDEGPGIATEFQDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIQYSNQGSKSIFTIKISMNN	ATGAAAAGTAAGTTAGGAATTAGTAAGCAACTTTTTATTGCCTTAACTATTGTAAATTTAAGCGTTACGCTATTTTCTGTAGTACTGGGTTATGTCATTTATAACTATGCGATTGAAAAAGGCTGGATTAGTTTAAGCTCATTTCAACAAGAAGATTGGACCAGTTTTCATTTTGTAGACTGGATTTGGTTAGCCACTGTTATCTTTTGCGGCTGTATTATTTCATTAGTGATTGGCATGCGCCTCGCAAAGCGTTTTATTGTGCCAATTAACTTCTTAGCCGAAGCAGCAAAAAAAATTAGTCACGGCGACCTCTCTGCTAGAGCTTACGATAATAGAATTCACTCCGCCGAAATGTCGGAGCTTTTATATAATTTTAATGATATGGCTCAAAAGCTAGAGGTTTCTGTTAAAAATGCGCAGGTTTGGAATGCAGCCATCGCACATGAGTTAAGAACGCCTATAACGATATTACAAGGTCGTTTACAAGGCATCATCGACGGTGTTTTTAAACCTGATGAAGTCCTATTTAAAAGCCTTTTAAATCAAGTTGAAGTTTTATCTCACTTAGTCGAAGACTTACGGACTTTAAGCTTAGTAGAGAACCAGCAACTCCGGTTAAATTATGAATTGTTTGACTTTAAGGCGGTAGTTGAAAAAGTTCTTAAAGCATTTGAAGATCGTTTGGATCAAGCTAAGCTAGTACCAGAACTTGACCTAACTTCCACTCCTGTATATTGCGACCGCCGTCGTATTGAGCAAGTTTTAATTGCTTTAATTGATAATGCTATACGCTATTCACATGCAGGCAAACTTAAAATTTCCTCGGAAGTGGTATCACAAAACTGGATATTAAAAATTGAGGATGAAGGCCCCGGCATTGCAACCGAGTTCCAAGACGATTTATTTAAGCCTTTCTTTAGATTAGAAGAATCAAGGAATAAAGAATTTGGCGGCACAGGTTTAGGTCTTGCTGTTGTACATGCAATTATTGTGGCACTGAAAGGCACTATTCAATATAGCAATCAAGGCTCGAAAAGTATTTTCACCATAAAAATTTCTATGAATAACTAA	
8061	CARD	prokka_03089	contig_21	67943	75	2388	3606	-1	71	tet(B)	3000166.0	785.023	700.0	Strict	99.25	101.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSCQFHK	ATGAATAGTTCGACAAAGATCGCATTGGTAATTACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAACGTTATTACGTGAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTGCACTTTATGCGTTAATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGATTTGGTCGGCGCCCAGTGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATTGCTGGCTTTTTCAAGTGCGCTTTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCACAGGAGCTACTGGGGCTGTCGCGGCATCGGTCATTGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGTTTAATAGCGGGGCCTATTATTGGTGGTTTTGCAGGAGAGATTTCACCGCATAGTCCCTTTTTTATCGCTGCGTTGCTAAATATTGTCACTTTCCTTGTGGTTATGTTTTGGTTCCGTGAAACCAAAAATACACGTGATAATACAGATACCGAAGTAGGGGTTGAGACGCAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTTGATTATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATTTACCGAAAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGGTCTTTTACACTCAGTATTCCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGCGAAAAAACGGCAGTACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTTTATATCTGAAGGTTGGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTTACCTGCATTACAGGGAGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTACAGGGATTATTGGTGAGCCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGTTATTTATAATCATTCACTACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTTACTGTATTATTATCCTGCTATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAAACAGGAGACAAGTTGTCAGTTCCACAAATAA	
8061	CARD	prokka_03094	contig_21	67943	75	6978	7815	-1	70	APH(6)-Id	3002660.0	568.155	500.0	Strict	99.64	100.0	APH(6)	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	
8061	CARD	prokka_03095	contig_21	67943	75	7814	8660	-1	62	APH(3'')-Ib	3002639.0	540.036	500.0	Strict	99.25	105.24	APH(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MYLSDLNAQQREPPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	ATGTACTTATCTGATTTAAACGCACAACAAAGGGAACCTCCATTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTGATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	
8061	CARD	prokka_03655	contig_33	22168	73	10766	11021	-1	49	rsmA	3005069.0	102.064	100.0	Strict	89.09	137.7	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDQVSVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQHERAMHEHLQHLDQDYQVSYEDDNYAQKNFNR	ATGCTGATTCTGACCCGCCGTGTCGGGGAAACATTAATGATTGGGGATCAAGTCAGTGTTACTGTGCTTGGCGTCAAAGGAAACCAAGTTCGAATTGGTGTAAATGCACCAAAAGAGGTTTCTGTTCATCGCGAAGAAATTTATCAACGTATTCAACATGAACGTGCAATGCATGAACACCTTCAACATCTTGATCAAGATTATCAAGTTTCATATGAAGATGATAATTATGCACAGAAAAACTTCAATCGTTAG	
8061	CARD	prokka_03769	contig_49	1507	69	193	1009	1	84	APH(3')-Ia	3002641.0	565.4590000000002	500.0	Perfect	100.0	100.0	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACCTGGATGCTGATTTATATGGGTATAGATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCAATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGCATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCTAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTGA	
8061	CARD	prokka_03770	contig_50	1416	42	95	962	1	52	sul2	3000412.0	529.635	500.0	Strict	100.0	106.27	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MSYLFLSCTEIIIIEAPMNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	ATGAGTTATCTATTTTTATCGTGTACAGAGATTATTATTATAGAAGCCCCCATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	
8061	CARD	prokka_03774	contig_55	1150	141	219	999	1	156	APH(3')-VIa	3002652.0	523.857	500.0	Strict	99.61	100.0	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKMLSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIAIIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDLDTELWGDHKTYLSLWNELTETRVEERLVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKHLKNDRPDKRNYFLKLDELN	ATGGAATTGCCCAATATTATTCAACAATTTATCGGAAACAGCGTTTTAGAGCCAAATAAAATTGGTCAGTCGCCATCGGATGTTTATTCTTTTAATCGAAATAATGAAACTTTTTTTCTTAAGCGATCTAGCACTTTATATACAGAGACCACATACAGTGTCTCTCGTGAAGCGAAAATGTTGAGTTGGCTCTCTGAGAAATTAAAGGTGCCTGAACTCATCATGACTTTTCAGGATGAGCAGTTTGAATTCATGATCACTAAAGCGATCAATGCAAAACCAATTTCAGCGCTTTTTTTAACAGACCAAGAATTGCTTGCTATCTATAAGGAGGCACTCAATCTGTTAAATTCAATTGCTATTATTGATTGTCCATTTATTTCAAACATTGATCATCGGTTAAAAGAGTCAAAATTTTTTATTGATAACCAACTCCTTGACGATATAGATCAAGATGATTTGGACACTGAATTATGGGGAGACCATAAAACTTACCTAAGTCTATGGAATGAGTTAACCGAGACTCGTGTTGAAGAAAGATTGGTTTTTTCTCATGGCGATATCACGGATAGTAATATTTTTATAGATAAATTCAATGAAATTTATTTTTTAGATCTTGGTCGTGCTGGGTTAGCAGATGAATTTGTAGATATATCCTTTGTTGAACGTTGCCTAAGAGAGGATGCATCGGAGGAAACTGCGAAAATATTTTTAAAGCATTTAAAAAATGATAGACCTGACAAAAGGAATTATTTTTTAAAACTTGATGAATTGAATTGA	
8061	CARD	prokka_01440	contig_6	218954	69	55133	57848	1	73	Acinetobacter baumannii gyrA conferring resistance to fluoroquinolones	3003817.0	1835.08	1500.0	Strict	99.78	100.0	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S81L	fluoroquinolone antibiotic	MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKAYKKSARVVGDVIGKYHPHGDLAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRYTEVRMTKLAHELLADLEKDTVDWEDNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNMAPHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTGGIIYGKSGIVDAYRTGKGRLHIRGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMRIAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVVTRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVALLEKAGAISVRPDEIEGEDPNRPFGLSDSIYRLSPTQVGAILELRLHRLTGLEQDKLHAEYTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEEQVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVGKVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFPENHYVFMATASGTVKRVELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRTAKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSADSSLVSRIVSLVVVPETGEVLCASANGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRAAEVAMTGRNAQGVRLIRLSEEETLVGVVSIEAVEDEEELLEGEVDTTETDSEEAVSNNEDTSEE	ATGAGCGTATCGGAAATCCGACCGATTGCCATTGAGGACGAACTCAAGCATTCATATTTAGATTACGCGATGAGTGTAATTGTATCTCGTGCATTGCCGGATGTGAGAGACGGTCTTAAACCTGTTCACCGTCGTGTGCTTTATGCCATGCACGAATTGGGCAATGACTATAACAAAGCCTACAAGAAATCTGCTCGTGTCGTTGGGGACGTAATCGGTAAATATCACCCGCATGGTGACTTAGCTGTTTATGAAACCATTGTTCGTATGGCTCAAGACTTTAGCTTACGTTATTTATTGGTTGATGGTCAGGGTAACTTCGGTTCGATCGATGGTGATAGCGCTGCGGCAATGCGTTATACCGAAGTCCGTATGACTAAGCTGGCACATGAGCTTCTTGCAGATTTAGAAAAAGACACAGTTGACTGGGAAGATAACTACGACGGTTCGGAACGTATCCCTGAAGTACTTCCGACACGTGTTCCAAACTTGTTAATTAACGGTGCTGCTGGTATTGCTGTAGGTATGGCAACTAACATGGCACCACACAACATGACAGAAGTTGTGAATGCTTGTTTGGCTTATGCTGACAATCCGAATATCTCGATTGAAGGATTGATGGAATACATTACCGGCCCTGACTTCCCTACAGGCGGTATTATTTACGGTAAATCAGGTATTGTTGATGCCTACCGTACCGGTAAAGGTCGTTTACACATTCGTGGTAAATACCATTTCGAAGAAGATGAAAAGACAGGTCGTACAACCATCGTCTTTACTGAAATTCCATATCAAGTAAACAAAGCAAGAGTTATTGAACGTATTGCCGAGTTAGTAAAAGAGAAAAAGCTTGAAGGTATTTCAGAACTTCGTGATGAGTCTGATAAAGAAGGTATGCGTATTGCAATTGACTTGAAACGCGGTGAAAACGCAGAAGTCGTTGTAAATAACTTATTCTTAAATACCCAGCTTGAAAACTCATTCAGCATCAACATGGTTTGTCTAGACAATGGACAACCAAAATTGATGAATCTAAAAGATATTATTGCGGCATTTATTCGTCACCGCCAAGAAGTTGTGACACGCCGTACCATGTTCGAATTACGTAAAGCACGTGAACGTGGGCATATCTTGGAAGGCTTGACAGTTGCTTTAGCCAATATTGATGAAATTATTGAAACCATCAAAACTTCTGCAAACCCTGCTGAAGCGCGTGAGCGTTTACTTGCGGGTGAGTGGGCAGGTGGTGGCGTTGTTGCACTACTTGAAAAAGCTGGTGCAATTTCTGTTCGCCCAGATGAAATTGAAGGTGAAGATCCAAATCGTCCATTTGGTTTAAGTGATTCAATTTATCGTCTGTCACCAACACAAGTAGGCGCAATTTTAGAATTACGTTTACACCGTTTAACTGGTCTTGAACAAGACAAGTTACATGCGGAATATACTGAAATTTTAGGTCAAATTGCTGAACTTACTGCAATTTTAAATGACTTTAACTTGTTAATGGGTGTTATTCGCGAAGAGTTGGCACAAGTTTTACAACAATATGGTGATGCACGTCGTACCGAAATTGTTGAATCTCGTGTGGATTTCTGCCGTGAAGATTTGATTCCTGAAGAGCAAGTGGTATTAACTGTTTCACAAACGGGTTATGCAAAAACTCAACCACTTTCAGACTATCAGGCACAGCGCCGTGGTGGACGTGGTAAGTCTGCGACTTCAATGAAAGATGATGACTTTATTCAACATCTGATTGTGGCATCGAACCATGCGACCGTACTTTGCTTTACCAACGTGGGTAAAGTGTACCGTCTGAAAGTTTTTGAAGTTCCTCAAGCATCACGTGGGGCAAAAGGCCGTCCAATCGTGAATTTGTTACCACTAGATGCAACAGAAACCGTAACCGCAATCTTGCCGTTAACCGAGTTCCCGGAAAACCACTATGTGTTTATGGCGACAGCTTCTGGTACGGTTAAGCGTGTTGAGTTAGAACAATTTGCAAACATTCGTTCAAATGGTCTACGTGCTATTGAACTTAATGAAGAAGATACCTTAATTGGTGTTGCGATTACTGATGGTAATCAGCAAATCATGTTGTTCTCTAACGAAGGTAAAGCAATTCGTTTTGCTGAAACTGACGTACGTGCAATGGGTCGTACAGCGAAAGGTGTACGTGGTATGCGTGTAAGCTTTGCAAGCAGCACCTTAAGTGAAGAAGATGCAGATGTTGAAAATGATGATTCAGATGATAATGATGATTCAGCAGATTCAAGTCTAGTAAGTCGCATCGTATCGCTTGTTGTTGTACCTGAGACAGGCGAAGTACTGTGCGCGAGTGCCAACGGTTATGGTAAACGTACTCCAGTAAATGACTTCCCGACCAAGAAACGTGGTGGTAAGGGTGTTATTGCGATCAAGACAAGTGAACGTAACGGTGAGCTAGTTGGTGCAGTTTCTATTGATGAAACCAAAGAGTTATTATTAATTTCTGATGGTGGTACGCTTGTTCGTACGCGTGCTGCAGAAGTTGCAATGACAGGCCGTAATGCTCAAGGTGTTCGTCTGATCCGTTTAAGCGAAGAAGAAACGCTCGTTGGCGTAGTTTCAATTGAAGCTGTAGAAGACGAAGAAGAACTTCTTGAAGGTGAAGTAGATACGACTGAAACTGATAGCGAAGAAGCTGTATCTAATAATGAAGATACTTCTGAAGAGTAA	
8061	CARD	prokka_03603	contig_31	31969	74	18977	21197	1	77	Acinetobacter baumannii parC conferring resistance to fluoroquinolones	3003818.0	1509.2	1400.0	Strict	100.0	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S84L, V104I, D105E	fluoroquinolone antibiotic	MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKSSGKPKKSARTVGDVLGKYHPHGDLACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFAAMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGMATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGRGSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTRLVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKKTVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEAILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIIGELKEDAKKFGDERRSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAVGKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIAASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDLAELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRASKGQLLPRGYQKANKLLIQR	ATGACCAGCCTTGCGCATCATGCGACAGAAAACCGCTCTGTAGCCGAATTTACTGAACAGGCTTACTTGAATTATGCCATGTACGTCATTATGGACCGTGCATTGCCGCATATCAGTGATGGCTTAAAGCCCGTACAGCGCCGTATTGTCTATGCTATGAGCGAGCTAGGCTTAAAAAGCAGTGGCAAGCCAAAAAAATCAGCGCGTACAGTGGGTGATGTACTTGGTAAATACCACCCACATGGTGACTTGGCATGTTATGAAGCCATGGTACTCATGGCTCAGCCATTTAGTTACCGCTATCCTTTAATCGAAGGTCAGGGGAACTGGGGTTCACCAGATGATCCTAAATCTTTTGCTGCGATGCGTTATACCGAAGCCAAACTCTCGGCTTATAGTGAATTATTGCTGAGCGAATTAGGTCAGGGCACTAGCGAATGGCAAGATAACTTTGATGGTTCTTTAAAAGAACCGATCACTTTACCTGCACGTGTACCTAATATTCTTCTTAATGGTACGACAGGTATTGCTGTCGGGATGGCAACTGATATCCCGCCACATAATTTGCGTGAAGTTGTAAAAGGCACAATTGCTTTAATCCGTAATCCGCAAACCTCGGACGAAAAATTAGCTGAATATATTCCAGCTCCGGATTTACCAACCAAAGCTGAAATTATTACCCCGCCAGAAGAATTACTCAAAATCCAGACCACTGGTCGTGGCAGTTACCGTATGCGAGCGGTATATACCATTGAGAAAAATGAAATCGTAATTACTGAGCTGCCATATCAAGTCTCTGGTTCTAAGGTAATTACTCAAATTGCTGACCAGATGCAGGCTAAAAAGCTGCCATTAGTCGTCGATGTGCGTGATGAGTCGGATCATGAAAACCCGACACGACTCGTGATTGTACTGCGCTCTAACCGTATTGATGCGGAAGCAGTGATGAGTCACTTATTTGCGACCACCGATTTAGAATCAAGCTATCGTGTCAATTTAAACATGATTGGCGAAGATGGCCGTCCTCAGGTGAAATCAATTCGTCGTATTTTGCTGGAATGGATTGAGATCCGTAAAAAAACGGTAACTCGTCGTTTGCAGTACCATTTAAACCGTATTGAAAAGCGCCTGCATATTTTGGCAGGTCTTTTAATTGCTTATCTCGATATTGATACAGTCATTCGTATTATTCGTGAAGAAGACCAGCCTAAGCCAGTCTTGATGGAACACTTTAATATTGATGAGATACAGGCCGAGGCGATTTTAGAGCTTAAATTACGTCATTTGGCAAAGCTTGAAGAGATGGAAATTCGTCATGAACAAGATGAGCTTTCCGCGAAAGCTGCCATTATTCGTGAACAACTCGAAAATCCTGAATCTTTAAAAAATTTGATTATTGGCGAATTAAAAGAAGATGCGAAAAAGTTCGGTGATGAGCGCCGTTCTCCAATTGTTGCACGTGCTGAAGCGGTTCAAATTAAAGAACAGGATTTAATGCCAGCCGAAACGGTAACAGTCGTGTTGTCTGAAGCAGGCTGGGTTCGTGCGGCAAAAGGTGCGGATGTGGATGCTGAAAATCTGAACTACCGTGCTGGGGACCAATATTTAAGTCATGCTGTCGGGAAAACCAATCAGCGAGTTTACTTCCTTGATGAAACAGGGCGCAGCTATGCCTTGCCAATTAGTAACTTACCTTCAGCGAGAGGCTTGGGGGATCCATTAAGTTCTAAATTATCACCAGCAAGTGGCGTATCGTTTATTCAGGTTTATTTAGATGATGATGAGTCTGAATTGATTGCTGCAAGTTCGGCAGGTTATGGTTTTAAAACGCAAACCAAGCAATTAGATACCAATGCGAAAGCCGGTAAGACATTCTTAACGGTTCCGGATAAGGCAAAGGCTTTACCACTCATTTCTGCCCAAAACATGACGCATCTGGCTGTACTGAGCTCAGCAGGGCGTTTGTTAATTTTAGATTTGGCAGAACTACCAAATTTAAATAAAGGTAAAGGTAATAAGTTGATACAACTTGAAGGAAAAGAGCAAATTTTATCCATGACAACCCTGAACTTAGATGAAATAATTCAGGTGGTTGCAGGTCAACAACATCTCAAATTAAAAGGTGATGATCTACAAAAATACATGGGTAAACGTGCTTCGAAAGGTCAGCTCTTACCACGTGGATATCAAAAAGCAAATAAACTGTTGATTCAGAGATAA	
8061	CARD	prokka_03090	contig_21	67943	75	3687	4311	1	93	tetR	3003479.0	427.172	400.0	Strict	100.0	99.52	major facilitator superfamily (MFS) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		tetracycline antibiotic	MSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	ATGTCTAGATTAGATAAAAGTAAAGTGATTAACAGCGCATTAGAGCTGCTTAATGAGGTCGGAATCGAAGGTTTAACAACCCGTAAACTCGCCCAGAAGCTAGGTGTAGAGCAGCCTACATTGTATTGGCATGTAAAAAATAAGCGGGCTTTGCTCGACGCCTTAGCCATTGAGATGTTAGATAGGCACCATACTCACTTTTGCCCTTTAGAAGGGGAAAGCTGGCAAGATTTTTTACGTAATAACGCTAAAAGTTTTAGATGTGCTTTACTAAGTCATCGCGATGGAGCAAAAGTACATTTAGGTACACGGCCTACAGAAAAACAGTATGAAACTCTCGAAAATCAATTAGCCTTTTTATGCCAACAAGGTTTTTCACTAGAGAATGCATTATATGCACTCAGCGCTGTGGGGCATTTTACTTTAGGTTGCGTATTGGAAGATCAAGAGCATCAAGTCGCTAAAGAAGAAAGGGAAACACCTACTACTGATAGTATGCCGCCATTATTACGACAAGCTATCGAATTATTTGATCACCAAGGTGCAGAGCCAGCCTTCTTATTCGGCCTTGAATTGATCATATGCGGATTAGAAAAACAACTTAAATGTGAAAGTGGGTCTTAA	
8118	BLDB	prokka_01681	contig_5	214600	60	106876	108019	1	64	PRS-10		424.2		Perfect	100.0	98.7	class C beta-lactamase	protein homolog model			Beta-Lactam	MKNIFRQGRLFIALSLAMTSISAFALTQQEVDDIIKPLMKQEQIPGMSVAISVNGKQAIYHYGVQSKQTQIPVSDRTLYEIGSLSKTFTATLATYAQIQGKLDFSQSVSHYLPELKGSAFDNLSVMNLATHTSGLSLFVPSDIKTNDQLMAYYQKWLPDNEVGQYRSYSNLGVGLLGIVTAKQLNMPFSQAMEKLMLPSLGLKHTYIHVPKSQEKYYAQGYNKQNQPVRLNLEILGPEAYGLKSNAKDLIRYLEINMQSIKVAKTWQEAIENTHTGVYLTDSFVQDMMWESYPWPVSLSQLLQGNRDDMALKPQKVELIKPAMAPEVRAYYNKTGSSNGFATYAIFIPEEKIAIVMLSNKWIPIPQRITATYQLLEKIER	ATGAAAAATATTTTTCGTCAGGGGCGGCTTTTTATCGCCTTAAGTTTAGCAATGACATCGATTTCCGCCTTTGCCCTTACACAGCAAGAGGTCGATGACATTATCAAGCCCCTGATGAAACAAGAACAGATCCCGGGTATGTCTGTTGCCATCTCAGTGAATGGCAAACAAGCTATTTACCATTACGGTGTTCAGTCAAAACAGACCCAAATTCCTGTTTCTGATAGGACGCTGTATGAAATTGGCTCCTTATCAAAAACCTTTACCGCAACACTGGCAACTTATGCGCAAATTCAAGGAAAACTCGACTTTAGCCAAAGTGTCAGTCATTACCTACCTGAATTAAAAGGCAGTGCTTTTGATAATCTTAGCGTGATGAATTTAGCCACCCATACATCAGGGTTATCGCTATTTGTACCTAGCGATATCAAAACCAACGATCAATTAATGGCGTATTATCAAAAATGGCTTCCTGACAATGAGGTTGGACAATATCGTTCTTATTCAAATTTAGGGGTTGGGTTACTTGGTATCGTGACGGCAAAGCAACTTAATATGCCTTTTTCTCAGGCTATGGAAAAATTGATGCTGCCTTCACTTGGCTTAAAACATACTTATATCCATGTTCCCAAAAGCCAAGAGAAATATTACGCACAAGGCTACAATAAGCAAAATCAGCCTGTTCGCTTAAACCTAGAAATCCTTGGTCCAGAGGCTTATGGCCTAAAGTCCAATGCCAAAGATTTGATCCGTTATTTAGAAATCAATATGCAATCCATTAAAGTGGCGAAAACTTGGCAAGAAGCGATTGAAAACACCCATACTGGCGTTTACCTAACCGATTCGTTTGTGCAGGATATGATGTGGGAAAGCTATCCATGGCCGGTGTCGCTTTCACAATTACTGCAAGGCAACCGTGATGATATGGCTCTCAAACCACAAAAAGTGGAATTGATTAAGCCAGCCATGGCGCCAGAAGTACGCGCTTATTATAACAAGACTGGCTCTAGCAATGGCTTTGCGACATACGCGATATTTATTCCAGAAGAGAAGATTGCCATTGTTATGCTATCCAATAAATGGATACCTATTCCTCAGCGCATTACAGCGACTTACCAGTTACTAGAGAAAATCGAACGCTAA	
8118	BLDB	prokka_03987	contig_30	14399	77	10054	10915	-1	111	TEM-1		80.1		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase TEM-1	protein homolog model			Beta-Lactam	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	ATGAGTATTCAACATTTTCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGTGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCTGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	
8118	BLDB	prokka_04036	contig_36	5110	79	154	955	-1	79	OXA-10		281.7		Perfect	100.0	99.62	oxacillin-hydrolyzing class D beta-lactamase OXA-10	protein homolog model			Beta-Lactam	MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG	ATGAAAACATTTGCCGCATATGTAATTATCGCGTGTCTTTCGAGTACGGCATTAGCTGGTTCAATTACAGAAAATACGTCTTGGAACAAAGAGTTCTCTGCCGAAGCCGTCAATGGTGTCTTCGTGCTTTGTAAAAGTAGCAGTAAATCCTGCGCTACCAATGACTTAGCTCGTGCATCAAAGGAATATCTTCCAGCATCAACATTTAAGATCCCCAACGCAATTATCGGCCTAGAAACTGGTGTCATAAAGAATGAGCATCAGGTTTTCAAATGGGACGGAAAGCCAAGAGCCATGAAGCAATGGGAAAGAGACTTGACCTTAAGAGGGGCAATACAAGTTTCAGCTGTTCCCGTATTTCAACAAATCGCCAGAGAAGTTGGCGAAGTAAGAATGCAGAAATACCTTAAAAAATTTTCCTATGGCAACCAGAATATCAGTGGTGGCATTGACAAATTCTGGTTGGAAGGCCAGCTTAGAATTTCCGCAGTTAATCAAGTGGAGTTTCTAGAGTCTCTATATTTAAATAAATTGTCAGCATCTAAAGAAAACCAGCTAATAGTAAAAGAGGCTTTGGTAACGGAGGCGGCACCTGAATATCTAGTGCATTCAAAAACTGGTTTTTCTGGTGTGGGAACTGAGTCAAATCCTGGTGTCGCATGGTGGGTTGGGTGGGTTGAGAAGGAGACAGAGGTTTACTTTTTCGCCTTTAACATGGATATAGACAACGAAAGTAAGTTGCCGCTAAGAAAATCCATTCCCACCAAAATCATGGAAAGTGAGGGCATCATTGGTGGCTAA	
8118	BLDB	prokka_04040	contig_36	5110	79	4014	4914	-1	65	VEB-1		71.7		Perfect	100.0	99.67	class A extended-spectrum beta-lactamase VEB-1	protein homolog model			Beta-Lactam	MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK	ATGAAAATCGTAAAAAGGATATTATTAGTATTGTTAAGTTTATTTTTTACAATTGTGTATTCAAATGCTCAAACTGACAACTTAACTTTGAAAATTGAGAATGTTTTAAAGGCAAAAAATGCCAGAATAGGAGTAGCAATATTCAACAGCAATGAGAAGGATACTTTGAAGATTAATAACGACTTCCATTTCCCGATGCAAAGCGTTATGAAATTTCCGATTGCTTTAGCCGTTTTGTCTGAGATAGATAAAGGGAATCTTTCTTTTGAACAAAAAATAGAGATTACCCCTCAAGACCTTTTGCCTAAAACGTGGAGTCCGATTAAAGAGGAATTCCCTAATGGAACAACTTTGACGATTGAACAAATACTAAATTATACAGTATCAGAGAGCGACAATATTGGTTGTGATATTTTGCTAAAATTAATCGGAGGAACTGATTCTGTTCAAAAATTCTTGAATGCTAATCATTTCACTGATATTTCAATCAAAGCAAACGAAGAACAAATGCACAAGGATTGGAATACCCAATATCAAAATTGGGCAACCCCAACAGCGATGAACAAACTGTTAATAGATACTTATAATAATAAGAACCAATTACTTTCTAAAAAAAGTTATGATTTTATTTGGAAAATTATGAGAGAAACAACAACAGGAAGTAACCGATTAAAAGGACAATTACCAAAGAATACAATTGTTGCTCATAAAACAGGGACTTCCGGAATAAATAATGGAATTGCAGCAGCCACTAATGATGTTGGGGTAATTACTTTACCGAATGGACAATTAATTTTTATAAGCGTATTTGTTGCAGAGTCCAAAGAAACTTCGGAAATTAATGAAAAGATTATTTCAGACATTGCAAAAATAACGTGGAATTACTATTTGAATAAATAA	
8118	BLDB	prokka_04063	contig_42	2353	94	154	955	1	91	VIM-1		236.9		Perfect	100.0	99.62	subclass B1 metallo-beta-lactamase VIM-1	protein homolog model			Beta-Lactam	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	ATGTTAAAAGTTATTAGTAGTTTATTGGTCTACATGACCGCGTCTGTCATGGCTGTCGCAAGTCCGTTAGCCCATTCCGGGGAGCCGAGTGGTGAGTATCCGACAGTCAACGAAATTCCGGTCGGAGAGGTCCGACTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCGGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAAAAGCAAATTGGACTTCCCGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGCAGAGGGGAACGAGATTCCCACGCATTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAGCTCTTCTATCCTGGTGCTGCGCATTCGACCGACAATCTGGTTGTATACGTCCCGTCAGCGAACGTGCTATACGGTGGTTGTGCCGTTCATGAGTTGTCAAGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCGTTGAGCGGATTCAAAAACACTACCCGGAAGCAGAGGTCGTCATTCCCGGGCACGGTCTACCGGGCGGTCTAGACTTGCTCCAGCACACAGCGAACGTTGTCAAAGCACACAAAAATCGCTCAGTCGCCGAGTAG	
8118	CARD	prokka_00003	contig_1	479671	52	2579	3221	1	47	catIII	3002685.0	444.891	400.0	Strict	99.53	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQAVNQFDELRMAIKDDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVMERYKSDTKLFPQGVTSENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEGDRLLLPLSVQVHHAVCDGFHVARFINRLQELCNSKLK	ATGAACTATACAAAATTTGATGTAAAAAATTGGGTTCGCCGTGAGCATTTTGAGTTTTATCGGCATCGTTTACCATGTGGTTTTAGCTTAACAAGCAAAATTGATATCACGACGTTAAAAAAGTCATTGGATGATTCAGCGTATAAGTTTTATCCGGTAATGATCTATCTGATTGCTCAGGCCGTGAATCAATTTGATGAGTTGAGAATGGCGATAAAAGATGATGAATTGATCGTATGGGATTCAGTCGACCCACAATTCACCGTATTCCATCAAGAAACAGAGACATTTTCAGCACTGAGTTGCCCATACTCATCCGATATTGATCAATTTATGGTGAATTATTTATCGGTAATGGAACGTTATAAAAGTGATACCAAGTTATTTCCTCAAGGGGTAACATCAGAAAATCATTTAAATATTTCAGCATTACCTTGGGTTAATTTTGATAGCTTTAATTTAAATGTTGCTAATTTTACCGATTATTTTGCACCCATTATAACAATGGCAAAATATCAGCAAGAAGGGGATAGACTGTTATTGCCGCTCTCAGTACAGGTTCATCATGCAGTTTGTGATGGCTTCCATGTTGCACGCTTTATTAATCGGCTACAAGAGTTGTGTAACAGTAAATTAAAATAA	
8118	CARD	prokka_00468	contig_2	473858	57	10161	11697	-1	62	Klebsiella pneumoniae KpnH	3004597.0	804.668	700.0	Strict	76.55	99.8	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MTNTPLTGSKLAWMTIALSLATFMQVLDSTIANVAIPTIAGNLGASNSQGTWVITSFGVANAISIPITGWLARRIGEVRLFLWSTGLFALTSWLCGISGSLEMLILFRVLQGLVAGPLIPLSQSLLLNNYPPAKRNMALALWSMTIVIAPICGPILGGYISDNYHWGWIFFINVPFSIAIIFAIMQTLKGRETKISIQPIDTIGLVLLVIGIGALQIMLDQGKELDWFNSTEIIVLTVIAVVAISFLIVWELTDDHPVIDLSLFKERNFTIGCLSLSLAYMLYFGTIVLLPQLLQEVYGYTATWAGLASAPVGLLPLLITPIIGRFGNRIDMRYIVTFSFIVYAVCYYWRAYTFEPDMGFAAAAWPQFVQGLAIACFFMPLTTITLSGLPPEKMASASSLSNFTRTLAGAIGTSITTTMWTQREAMHHENLTEFINPYNPNSQHMYSELAQIGMNEQQSAAYLAKTITDQGLILSANEIFWLSAGIFILLMVIVWFAKPPFGAGSKGGGAH	GTGACAAATACACCGTTAACAGGATCAAAACTCGCGTGGATGACCATTGCTCTGTCATTGGCCACATTTATGCAAGTACTTGATTCAACAATTGCTAACGTTGCCATTCCAACGATTGCAGGTAATCTTGGCGCCTCTAACTCGCAGGGAACGTGGGTAATTACCTCTTTTGGTGTGGCAAATGCGATTTCAATTCCTATTACCGGATGGTTAGCCCGCAGGATTGGTGAAGTTAGGCTATTTTTATGGTCGACAGGCCTATTTGCACTAACTTCATGGTTATGTGGTATCTCTGGCAGCCTTGAAATGCTGATTTTATTCCGTGTGTTACAAGGGCTGGTTGCGGGGCCATTAATTCCCCTATCCCAAAGTTTATTGCTCAATAACTACCCCCCTGCCAAACGGAATATGGCCTTGGCGCTTTGGTCAATGACCATCGTTATCGCGCCAATTTGTGGGCCAATATTGGGTGGCTACATCAGTGATAATTATCATTGGGGTTGGATATTCTTTATCAACGTTCCATTTAGTATCGCAATTATTTTTGCCATTATGCAGACACTAAAAGGGCGTGAAACCAAAATTTCTATTCAACCCATTGATACTATCGGGCTAGTACTGCTAGTTATCGGTATTGGTGCCCTGCAAATCATGCTAGACCAAGGGAAAGAGCTAGATTGGTTTAATTCCACTGAAATTATTGTGCTGACCGTCATTGCTGTTGTTGCGATATCGTTCTTAATTGTTTGGGAACTCACTGACGATCACCCTGTCATTGATCTTTCGTTATTTAAGGAGCGCAACTTCACCATCGGTTGTTTATCGCTTAGTCTTGCATATATGCTCTACTTCGGAACAATCGTACTACTTCCCCAACTCCTACAGGAAGTTTATGGTTATACAGCAACCTGGGCGGGTCTTGCTTCCGCCCCAGTAGGCTTATTGCCCTTGTTGATCACACCAATTATTGGACGTTTCGGTAATCGCATTGATATGCGTTATATCGTAACCTTTAGCTTTATTGTTTATGCTGTTTGTTACTATTGGCGTGCTTATACATTTGAGCCGGATATGGGATTTGCCGCCGCAGCATGGCCACAATTTGTGCAGGGGCTAGCGATTGCCTGTTTCTTTATGCCATTGACGACCATTACTTTATCAGGGCTTCCTCCTGAAAAAATGGCCTCAGCATCAAGTTTATCTAACTTCACACGGACATTAGCGGGTGCGATTGGTACATCCATTACAACCACAATGTGGACACAACGCGAAGCGATGCACCATGAGAATCTGACGGAGTTTATTAACCCGTACAATCCAAATTCTCAACATATGTACAGTGAATTAGCCCAAATTGGTATGAATGAGCAGCAAAGTGCCGCCTATTTAGCGAAAACAATTACCGACCAAGGGCTGATCTTATCTGCAAATGAGATTTTCTGGTTATCTGCTGGGATCTTTATTTTGCTCATGGTCATTGTTTGGTTCGCCAAACCACCTTTTGGCGCAGGCTCTAAAGGTGGCGGAGCACACTAA	
8118	CARD	prokka_00826	contig_2	473858	57	397068	397605	1	51	AAC(2')-Ia	3002523.0	366.311	300.0	Perfect	100.0	100.0	AAC(2')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MGIEYRSLHTSQLTLSEKEALYDLLIEGFEGDFSHDDFAHTLGGMHVMAFDQQKLVGHVAIIQRHMALDNTPISVGYVEAMVVEQSYRRQGIGRQLMLQTNKIIASCYQLGLLSASDDGQKLYHSVGWQIWKGKLFELKQGSYIRSIEEEGGVMGWKADGEVDFTASLYCDFRGGDQW	ATGGGCATAGAATACCGCAGTCTGCATACCAGCCAATTGACACTGAGTGAAAAAGAAGCGCTTTACGATTTATTAATTGAAGGTTTTGAAGGCGATTTTTCGCATGACGATTTCGCGCACACTTTAGGTGGAATGCACGTCATGGCTTTTGATCAACAAAAATTGGTTGGTCATGTTGCAATTATTCAACGCCATATGGCCCTAGATAATACGCCTATCTCTGTAGGGTATGTTGAAGCGATGGTGGTTGAACAAAGTTATCGTCGCCAAGGTATTGGGCGGCAATTGATGCTGCAAACCAATAAAATTATAGCTTCGTGTTATCAATTAGGGCTGCTGTCGGCTTCAGATGATGGACAAAAATTGTATCATTCGGTTGGATGGCAAATCTGGAAAGGTAAGTTGTTTGAATTGAAACAAGGGAGCTATATCCGTTCTATTGAAGAAGAAGGCGGAGTCATGGGCTGGAAAGCGGATGGTGAGGTTGATTTTACCGCTTCGCTTTACTGTGATTTTCGTGGCGGTGATCAGTGGTAA	
8118	CARD	prokka_01561	contig_4	344941	56	322937	324143	-1	60	tet(B)	3000166.0	782.326	700.0	Strict	99.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLQAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNADTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	ATGAATAGTTCGACAAAGATCGCATTGGTAATTACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAACGTTATTACGTGAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTGCACTTTATGCGTTAATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGATTTGGTCGGCGCCCAGTGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATTGCAGGCTTTTTCAAGTGCGCTTTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCACAGGAGCTACTGGGGCTGTCGCGGCATCGGTCATTGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGTTTAATAGCGGGGCCTATTATTGGTGGTTTTGCAGGAGAGATTTCACCGCATAGTCCCTTTTTTATCGCTGCGTTGCTAAATATTGTCACTTTCCTTGTGGTTATGTTTTGGTTCCGTGAAACCAAAAATACGCGTGATAATGCAGATACCGAAGTAGGGGTTGAGACGCAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTTGATTATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATTTACCGAAAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGGTCTTTTACACTCAGTATTTCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGCGAAAAAACGGCAGTACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTTTATATCTGAAGGTTGGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTTACCTGCATTACAGGGAGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTACAGGGATTATTGGTGAGCCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGTTATTTATAATCATTCACTACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTTACTGTATTATTATCCTGCTATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAAACAGGAGACAAGTGCTTAG	
8118	CARD	prokka_01609	contig_5	214600	60	22019	22652	1	57	CRP	3000518.0	429.098	400.0	Strict	98.1	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKSACEVAEISYKKFRQLIQVNPDILMRLSAQMASRLQTTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTTCTCGGCAAGCCACAAACAGACCCTACTCTTGAATGGTTTTTGTCACACTGCCATATTCATAAATATCCATCCAAGAGCACTCTGATTCATCAGGGTGAAAAAGCAGAAACCCTTTACTATATCGTTAAAGGCTCAGTGGCTGTTTTAATCAAAGATGAAGAAGGCAAAGAAATGATCCTCTCCTATTTAAATCAGGGAGATTTCATTGGTGAACTAGGGTTATTTGAAGAAGGACAAGAACGTTCAGCTTGGGTTAGAGCAAAAAGTGCCTGCGAAGTCGCTGAAATTTCTTACAAAAAATTCCGTCAACTTATTCAGGTCAATCCTGATATTCTTATGCGCCTTTCTGCGCAAATGGCAAGTCGCCTGCAAACCACCTCAGAAAAAGTAGGTAACCTTGCTTTCCTTGATGTGACAGGCCGTATTGCACAAACTCTGCTTAATTTAGCGAAACAGCCCGATGCGATGACGCATCCAGATGGGATGCAAATTAAGATCACTCGCCAAGAAATTGGCCAAATCGTTGGTTGTTCACGCGAAACCGTTGGTCGCATTTTGAAAATGCTAGAAGACCAAAATCTGATCTCCGCACACGGTAAAACGATTGTCGTGTACGGTACTCGTTAA	
8118	CARD	prokka_01795	contig_6	212445	61	18360	21501	1	65	adeF	3000777.0	1215.68	750.0	Strict	60.25	98.77	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MNFPRFFIQRPIFAMVLSIFILIAGILSFYKLPLSEYPSVTPPTVQVIASYPGATPKVIADTVASPIEQAVNGVEGMLYMSSQMSTDGKMVLTISFRQDVDPDIAQIQVQNLVSRVIPRLPQEVQQIGVTTEKTSPDVLMVVHMYSPNNVYDPLFVSNYTLLNVRDEIARLPGVASALVWGEGEYAMRAWIDPTKVASLGLTANDIVTAIREQNIQVATGSIGQQPNSTSSFQISVNALGRLTTEEQFGNIIIQTGEDGQSTYLKDVARLELGADNYSLRSLLNGQNAVGLQIVMSPGANALEVAESVRETMARLQANFIEGIDYKIAYDPTIFVSASLKSVAITLLEATILVVIVVVLFLQSWRASIIPLVAVPVSLVGTFAFMYLFGFSLNTLSLFGLVISIGIVVDDAIVVVENVERHITEGLTPKEAAFKAMEEVTGPIIAITSVLAAVFIPTAFLSGLQGEFYRQFSLTIVISTIISAINSLTLSPALSAILLKPHDKNSKPDWLTRIINAIFSRFFAKFNLFFNALSNKYVQIVRRCIRGSLIILVLYLGFVGLTALGFKVVPNGFVPAQDKYYLIGVAQLPSGASLDRTEAVVKEMSRLALMEPGVENVVAFPGLSVNGPVNLPNSALMFAMLKPFDERTDPSLSANAIAERLMGKFSQIPDGFVGIFPPPPVPGLGSMGGFKVQIEDRADLGFDALAQVQEQVLMKAMQAPELTGMMASFQTNSPQIDVDIDREKAKAQGVTLTDIFDALQINLGSLYVNDFNRFGRTYRVIVQADTPFRMDPKDIELIKVRNKHGEMIPLSSLVTITRTNGPDRVIHYNGYPSVDITGNAAPGFTSGQATDAMEKILRETLPEGMSFEWTDLTYQEQLAGNSALYIFPLAVLFAFLILAAQYNSWSLPFSVLLIAPMALLSAIAGVWLLNGDNNIFTQIAFIVLVGLAAKNAILIVEFAIAQERQGKDPLAAVSEAAHLRLRPILMTSFAFIAGVIPLVLATGAGSEMRQAVGVAVFFGMLGVTLFGLLLTPVFYMMIRKLAGKKSP	ATGAATTTTCCCCGTTTCTTTATACAGCGCCCTATCTTTGCCATGGTCTTATCAATATTTATATTGATAGCAGGGATTTTGAGCTTTTATAAATTGCCCCTAAGCGAATATCCATCCGTGACTCCCCCTACGGTTCAGGTTATCGCCAGTTATCCAGGTGCAACACCCAAGGTGATTGCTGATACGGTGGCCTCCCCCATCGAACAAGCGGTTAATGGGGTAGAAGGCATGCTCTATATGAGCTCGCAAATGTCGACCGATGGAAAAATGGTACTGACCATCTCTTTTAGGCAAGATGTCGACCCCGATATTGCACAAATTCAAGTGCAAAACTTAGTTTCGCGCGTCATTCCTCGCTTGCCTCAAGAAGTTCAACAAATTGGCGTCACAACGGAAAAAACGTCACCGGATGTCCTAATGGTCGTCCATATGTACTCACCCAATAATGTCTATGACCCACTGTTTGTCTCTAATTACACTTTACTCAATGTGCGTGATGAAATTGCTAGATTACCCGGTGTTGCCAGCGCATTAGTTTGGGGGGAAGGTGAATATGCGATGCGAGCATGGATTGATCCCACAAAAGTCGCATCATTAGGCTTAACGGCAAATGATATCGTTACGGCTATTCGCGAACAAAATATTCAAGTCGCTACAGGTTCGATTGGGCAGCAGCCGAACTCAACGTCCTCATTTCAAATCAGCGTCAATGCACTTGGTCGACTCACAACCGAAGAGCAATTTGGCAATATTATTATTCAAACAGGCGAAGATGGGCAGTCGACCTATTTAAAAGATGTCGCTCGATTAGAGCTAGGTGCCGATAATTATTCACTTCGCAGCTTACTGAATGGGCAAAATGCGGTTGGCTTACAGATTGTCATGAGCCCCGGAGCAAATGCGTTGGAAGTGGCGGAGTCGGTACGAGAAACCATGGCTCGTTTACAGGCTAACTTTATCGAAGGGATCGACTATAAAATTGCCTACGATCCAACCATTTTTGTCAGCGCCTCACTAAAATCGGTCGCTATCACCTTACTTGAAGCCACCATATTAGTGGTTATTGTCGTGGTGCTCTTTTTACAAAGTTGGCGAGCATCAATCATTCCGTTAGTAGCTGTTCCCGTATCACTCGTGGGAACATTTGCCTTTATGTACCTATTCGGCTTTTCTCTCAATACACTATCGCTATTCGGTTTAGTTATCTCAATAGGGATAGTGGTGGATGACGCGATAGTCGTCGTTGAAAACGTTGAAAGGCATATCACGGAAGGATTAACACCAAAAGAAGCCGCCTTTAAAGCGATGGAAGAGGTCACAGGCCCTATTATTGCCATTACATCAGTATTAGCGGCTGTTTTTATTCCAACCGCATTTTTATCCGGTTTACAAGGTGAGTTTTATCGACAATTTTCATTAACGATCGTGATTTCAACGATTATTTCTGCGATTAACTCATTGACCTTATCTCCTGCTCTCAGTGCTATCTTACTGAAGCCCCATGATAAAAATAGCAAACCAGACTGGTTGACTCGCATTATCAATGCGATATTTAGTCGCTTTTTCGCTAAATTTAATCTCTTTTTCAATGCATTATCCAACAAATACGTTCAGATTGTACGCCGCTGCATACGAGGAAGTTTAATTATTCTTGTGCTATATCTTGGCTTTGTTGGGCTAACCGCACTCGGGTTTAAAGTGGTTCCTAATGGCTTTGTTCCTGCACAGGATAAATATTACTTAATTGGCGTCGCGCAATTGCCTTCGGGTGCTTCTCTCGATAGAACAGAAGCGGTTGTTAAAGAGATGTCACGCCTCGCACTGATGGAGCCTGGTGTTGAAAACGTGGTAGCGTTCCCTGGCCTCTCTGTAAATGGCCCCGTTAACTTACCGAATTCAGCACTCATGTTTGCAATGCTCAAACCGTTTGATGAGCGTACTGATCCTTCACTATCAGCAAATGCCATCGCCGAACGCCTAATGGGTAAATTTAGTCAAATACCGGATGGTTTTGTTGGCATATTCCCTCCACCTCCGGTTCCCGGCTTGGGTTCGATGGGGGGCTTTAAGGTACAAATAGAAGATAGGGCTGATCTTGGCTTTGATGCGTTAGCGCAAGTGCAAGAGCAAGTGTTGATGAAAGCAATGCAAGCCCCCGAATTAACTGGCATGATGGCAAGTTTCCAGACCAATTCGCCACAAATCGATGTGGATATTGATCGCGAAAAAGCCAAAGCGCAAGGTGTTACGCTCACCGATATCTTTGATGCATTACAGATTAATTTGGGATCACTCTACGTCAATGATTTCAATCGTTTTGGTCGAACCTATCGCGTCATTGTGCAAGCAGATACGCCCTTTAGAATGGATCCTAAAGATATTGAACTCATCAAGGTGCGTAATAAGCATGGGGAGATGATCCCTCTGAGTAGCTTAGTGACGATTACCCGTACAAATGGCCCTGATCGCGTGATCCACTATAACGGTTACCCTTCTGTCGATATCACCGGCAACGCGGCTCCTGGCTTTACTTCAGGACAAGCCACTGATGCGATGGAGAAGATCTTACGTGAAACATTGCCCGAAGGCATGAGCTTTGAATGGACAGATCTAACCTATCAAGAGCAGTTAGCGGGTAATTCAGCACTCTATATTTTCCCATTAGCAGTGCTATTTGCTTTCTTGATCTTGGCTGCTCAATATAACAGTTGGTCATTACCATTCTCTGTACTATTAATCGCGCCAATGGCTCTACTTTCTGCTATTGCCGGCGTATGGTTGCTCAATGGAGATAATAATATCTTCACACAAATCGCTTTCATTGTGCTGGTCGGCCTTGCTGCAAAAAATGCGATTTTGATTGTTGAATTTGCGATCGCCCAAGAGAGACAAGGAAAAGATCCTTTAGCCGCCGTATCAGAAGCCGCTCATCTACGATTACGCCCTATTTTGATGACATCCTTTGCCTTTATTGCTGGCGTGATCCCGCTTGTTTTAGCGACGGGAGCGGGTTCAGAGATGAGACAAGCCGTGGGGGTTGCGGTGTTCTTCGGCATGCTAGGTGTAACGCTATTTGGTTTACTATTAACCCCTGTTTTCTACATGATGATACGTAAATTAGCGGGTAAAAAATCCCCATAA	
8118	CARD	prokka_03010	contig_14	110331	59	22247	22433	-1	71	rsmA	3005069.0	106.686	100.0	Strict	86.89	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKTQPDNQ	ATGCTTATTCTGACTCGTCGAGTTGGTGAAACACTCATGATAGGCGATGAGGTAACAGTTACGGTACTGGGAGTAAAAGGCAATCAAGTTCGTATTGGTGTCAATGCCCCAAAGGAAGTTTCTGTTCACCGTGAAGAAATTTATCAACGGATCCAGGCTGAAAAGACTCAACCAGACAATCAATAA	
8118	CARD	prokka_03359	contig_17	99311	60	96679	97183	-1	69	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	46.595	32.0	Strict	26.0	94.35	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MNISLIAAMAIDQVIGMEKAMPWHLPGDLAWFKRNTLNKPVIMGRVTYESIGRPLPQRVNIVLSSKPGSDKNVIWVSSVEEALAAAKQTKTGSDDDEVIVIGGGKVYQQFLPLANKLYLTHVDAEVIGDTHFPIYEPDEWDSIFTEYHEADENNSHGYCFEILTKRI	ATGAATATTAGTTTAATCGCAGCGATGGCGATTGATCAGGTTATCGGCATGGAAAAAGCGATGCCTTGGCATTTACCCGGTGATCTTGCTTGGTTTAAACGTAATACGTTAAATAAGCCAGTCATAATGGGTCGAGTGACTTACGAATCAATTGGTCGTCCGCTTCCACAGCGCGTCAACATTGTATTAAGTAGTAAGCCGGGTTCGGATAAAAATGTTATCTGGGTCTCCTCCGTAGAAGAAGCATTGGCGGCGGCTAAGCAAACCAAGACAGGCTCTGACGATGACGAAGTCATTGTGATTGGAGGCGGAAAAGTTTACCAACAGTTTTTACCTCTGGCGAATAAGCTGTATTTAACTCACGTGGATGCAGAAGTGATTGGCGACACTCATTTCCCAATTTACGAGCCAGATGAGTGGGATTCTATTTTCACCGAGTACCATGAGGCGGATGAGAACAATTCACATGGTTATTGTTTTGAGATTTTAACCAAAAGAATTTAA	
8118	CARD	prokka_03535	contig_19	86745	96	79393	80209	1	62	sul2	3000412.0	528.865	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	ATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	
8118	CARD	prokka_03536	contig_19	86745	96	80269	81073	1	78	APH(3'')-Ib	3002639.0	541.191	500.0	Strict	99.63	100.0	APH(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTCATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	
8118	CARD	prokka_03537	contig_19	86745	96	81072	81909	1	77	APH(6)-Id	3002660.0	568.155	500.0	Strict	99.64	100.0	APH(6)	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	
8118	CARD	prokka_03539	contig_19	86745	96	83244	84444	1	72	tet(A)	3000165.0	788.1039999999998	700.0	Strict	99.75	94.1	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT	GTGAAACCCAACAGACCCCTGATCGTAATTCTGAGCACTGTCGCGCTCGACGCTGTCGGCATCGGCCTGATTATGCCGGTGCTGCCGGGCCTCCTGCGCGATCTGGTTCACTCGAACGACGTCACCGCCCACTATGGCATTCTGCTGGCGCTGTATGCGTTGATGCAATTTGCCTGCGCACCTGTGCTGGGCGCGCTGTCGGATCGTTTCGGGCGGCGGCCGGTCTTGCTCGTCTCGCTGGCCGGCGCTGCTGTCGACTACGCCATCATGGCGACGGCGCCTTTCCTTTGGGTTCTCTATATCGGGCGGATCGTGGCCGGCATCACCGGGGCGACTGGGGCGGTAGCCGGCGCTTATATTGCCGATATCACTGATGGCGATGAGCGCGCGCGGCACTTCGGCTTCATGAGCGCCTGTTTCGGGTTCGGGATGGTCGCGGGACCTGTGCTCGGTGGGCTGATGGGCGGTTTCTCCCCCCACGCTCCGTTCTTCGCCGCGGCAGCCTTGAACGGCCTCAATTTCCTGACGGGCTGTTTCCTTTTGCCGGAGTCGCACAAAGGCGAACGCCGGCCGTTACGCCGGGAGGCTCTCAACCCGCTCGCTTCGTTCCGGTGGGCCCGGGGCATGACCGTCGTCGCCGCCCTGATGGCGGTCTTCTTCATCATGCAACTTGTCGGACAGGTGCCGGCCGCGCTTTGGGTCATTTTCGGCGAGGATCGCTTTCACTGGGACGCGACCACGATCGGCATTTCGCTTGCCGCATTTGGCATTCTGCATTCACTCGCCCAGGCAATGATCACCGGCCCTGTAGCCGCCCGGCTCGGCGAAAGGCGGGCACTCATGCTCGGAATGATTGCCGACGGCACAGGCTACATCCTGCTTGCCTTCGCGACACGGGGATGGATGGCGTTCCCGATCATGGTCCTGCTTGCTTCGGGTGGCATCGGAATGCCGGCGCTGCAAGCAATGTTGTCCAGGCAGGTGGATGAGGAACGTCAGGGGCAGCTGCAAGGCTCACTGGCGGCGCTCACCAGCCTGACCTCGATCGTCGGACCCCTCCTCTTCACGGCGATCTATGCGGCTTCTATAACAACGTGGAACGGGTGGGCATGGATTGCAGGCGCTGCCCTCTACTTGCTCTGCCTGCCGGCGCTGCGTCGCGGGCTTTGGAGAAATTCTTCAAATTCCCGTTGCACATAG	
8118	CARD	prokka_03977	contig_30	14399	77	960	2001	1	83	cmlA9	3005043.0	670.618	750.0	Strict	100.0	85.64	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		phenicol antibiotic	MVMLGVGQVIFGPLSDRVGRRPILLVGATAFVAASLGAACSSTALAFVAFRLVQAVGASAMLVATFATVRDVYANRPEGAVIYGLFSSMLAFVPALGPIAGALIGEFWGWQAIFITLAALASLALLNASFRWHETRPLDQARTQRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAGYSEIGFSLAFATVALVMVTTTRFAKSFVAKWGIAGCVARGMALLVSGAILLGIGQLFGSPSFFSFILPMWVVAVGIVFTVSVTANGALAQFDDIAGSAVAFYFCIQSLIVSIVGTLAVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV	ATGGTGATGCTCGGTGTGGGCCAAGTGATCTTTGGGCCACTCTCCGATCGCGTCGGGCGACGGCCGATCCTGCTTGTAGGCGCAACGGCTTTCGTTGCTGCGTCTCTGGGAGCGGCTTGTTCTTCAACTGCATTAGCCTTTGTTGCGTTTCGTCTGGTTCAGGCTGTTGGAGCATCGGCCATGCTGGTGGCCACCTTCGCGACCGTGCGCGACGTATATGCCAATCGTCCCGAAGGTGCCGTCATCTACGGCCTTTTCAGTTCGATGCTGGCGTTCGTGCCTGCGCTCGGCCCTATAGCCGGTGCGCTGATCGGCGAGTTTTGGGGATGGCAGGCGATCTTCATCACACTGGCTGCACTGGCTTCGCTCGCACTCTTAAACGCCAGTTTCAGGTGGCATGAAACCCGACCGTTGGATCAGGCCAGAACGCAACGATCTGTTTTGCCGATCTTCGCGAGTCCGGCCTTTTGGGTTTACACGGTCGGATTTAGTGCCGGCATGGGCACATTCTTCGTTTTCTTCTCGACAGCCCCCCGTGTTCTCATAGGCCAAGCCGGCTATTCCGAGATCGGATTTAGCTTGGCCTTCGCGACTGTCGCGCTGGTCATGGTCACGACAACCCGCTTCGCAAAGTCCTTCGTTGCCAAATGGGGTATCGCGGGATGCGTAGCGCGCGGGATGGCGTTGCTCGTTTCCGGCGCGATCCTGTTGGGGATCGGCCAACTTTTCGGATCGCCGTCATTTTTCAGCTTCATCCTGCCGATGTGGGTTGTCGCGGTCGGCATTGTCTTCACGGTGTCCGTTACCGCCAACGGCGCACTTGCGCAGTTCGACGACATCGCTGGATCAGCGGTTGCGTTCTACTTCTGCATCCAAAGCCTGATAGTCAGTATCGTCGGGACATTGGCGGTGACGCTGTTAAACGGCGATACAGCGTGGCCCGTGATTTGTTACGCCACGGCAATGGCAGTGCTGGTGTCGTTGGGGCTGGCGCTCCTTCGATCCCGTGATGCTGCCACCGAGAAGTCGCCAGTCGTCTAG	loose hit with at least 95 percent identity pushed strict
8118	CARD	prokka_03979	contig_30	14399	77	2937	4113	1	77	tet(D)	3000168.0	387.111	250.0	Strict	53.2	99.24	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MRSSAIIALLIVGLDAMGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPMLGQLSDSYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIADSTGEGSRARWFGYMGACYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETHHSHGGTGKPVRIKPFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQWNTATVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFVLLAFATQGWMVFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATAGAWNGWVWIVGAILYLICLPILRRPFATSL	GTGCGCAGCTCTGCCATCATTGCCCTGCTGATCGTGGGTCTTGACGCCATGGGTCTCGGCCTCATCATGCCCGTCCTTCCGACGCTTCTGCGTGAGCTTGTGCCAGCAGAGCAGGTCGCTGGACACTATGGTGCCTTGCTGTCGCTCTATGCATTGATGCAGGTCGTCTTCGCGCCCATGCTTGGACAGCTTTCGGATTCTTACGGTCGGCGTCCGGTACTTCTGGCTTCTCTTGCAGGAGCCGCAGTCGATTACACGATTATGGCATCAGCGCCGGTCTTATGGGTGCTCTATATCGGCCGACTCGTGTCCGGCGTCACGGGCGCAACCGGAGCTGTAGCAGCCTCAACCATTGCCGATTCGACGGGGGAAGGTTCTCGCGCACGCTGGTTCGGCTACATGGGGGCCTGTTATGGGGCGGGCATGATTGCCGGGCCAGCACTTGGTGGCATGCTCGGTGGTATCTCTGCTCATGCCCCGTTTATCGCCGCCGCCCTTCTCAACGGGTTCGCGTTCCTGCTTGCCTGCATTTTCCTCAAGGAGACTCATCACAGCCATGGCGGGACCGGAAAGCCGGTTCGCATCAAACCATTCGTTCTGTTACGGCTGGATGATGCATTGCGCGGGCTAGGTGCGCTTTTCGCAGTTTTCTTCATTATTCAACTGATCGGCCAAGTGCCTGCAGCCCTATGGGTCATATATGGCGAGGACCGTTTTCAGTGGAACACCGCGACCGTTGGTTTGTCGCTCGCGGCGTTTGGGGCAACACATGCGATCTTCCAAGCGTTTGTTACCGGCCCGCTTTCAAGCCGGCTTGGAGAGCGGCGCACGCTGCTGTTTGGCATGGCTGCGGATGCGACTGGCTTCGTTCTTCTGGCTTTTGCCACGCAGGGATGGATGGTGTTCCCGATTCTGTTGCTGCTTGCCGCCGGGGGTGTTGGCATGCCGGCCTTGCAGGCAATGCTCTCAAACAATGTCAGCAGTAACAAGCAAGGGGCTTTGCAAGGAACGCTAACGAGCCTCACCAATCTAAGCTCTATCGCAGGACCGCTTGGCTTCACAGCACTCTATTCTGCCACCGCCGGGGCATGGAACGGTTGGGTTTGGATTGTCGGCGCGATCCTCTATTTAATATGTCTGCCAATACTACGCAGACCATTCGCAACTTCATTGTGA	
8118	CARD	prokka_03986	contig_30	14399	77	9129	9885	-1	85	rmtB	3000860.0	514.612	450.0	Perfect	100.0	100.0	16S rRNA methyltransferase (G1405)	protein homolog model	antibiotic target alteration		aminoglycoside antibiotic	MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTPESLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALYERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLLEREQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTIGTELIYLIKKNG	ATGAACATCAACGATGCCCTCACCTCCATCCTGGCCTCAAAAAAATACCGCGCCCTTTGCCCGGATACCGTGCGGCGCATCCTGACTGAGGAATGGGGGCGGCATAAATCCCCCAAACAGACCGTAGAGGCTGCACGCACCCGGCTGCATGGAATTTGCGGGGCATATGTCACCCCGGAATCGCTCAAGGCTGCTGCCGCCGCGCTTTCTGCGGGCGATGTAAAAAAGGCATTGTCGCTGCATGCCTCCACCAAGGAGCGACTGGCCGAGCTGGATACCCTGTACGATTTTATCTTTTCAGCCGAAACTCCCCGCCGCGTGCTGGATATCGCCTGCGGTCTTAACCCCTTGGCGCTATACGAGCGCGGCATTGCATCCGTGTGGGGCTGTGATATCCACCAGGGATTGGGGGATGTCATCACCCCCTTTGCTAGGGAAAAAGATTGGGATTTTACCTTTGCCCTGCAGGATGTGCTGTGTGCGCCGCCCGCCGAAGCCGGCGACCTGGCGCTGATTTTTAAGCTTTTGCCCCTGCTGGAGCGGGAGCAGGCCGGTTCTGCCATGGCACTTTTACAATCCCTCAATACCCCGCGCATGGCTGTCAGCTTTCCCACGCGTAGTTTAGGCGGGCGTGGAAAAGGCATGGAGGCGAACTACGCCGCATGGTTCGAGGGCGGCTTGCCCGCCGAGTTTGAGATTGAGGATAAAAAGACCATCGGAACAGAACTTATATACTTGATAAAAAAGAATGGATAA	
8118	CARD	prokka_04037	contig_36	5110	79	1219	2479	-1	91	cmlA5	3002695.0	824.313	750.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		phenicol antibiotic	MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR	GTGCGCTCAAAAAACTTTAGTTGGCGGTACTCCCTTGCCGCCACGGTGTTGTTGTTATCACCGTTCGATTTATTGGCATCACTCGGCATGGACATGTACTTGCCAGCAGTGCCGTTTATGCCAAACGCGCTTGGTACGACAGCGAGCACAATTCAGCTTACGCTGACAACGTACTTGGTCATGATTGGTGCCGGTCAGCTCTTGTTTGGACCGCTATCGGACCGACTGGGGCGCCGCCCCGTTCTACTGGGAGGTGGCCTCGCCTACGTTGTGGCGTCAATGGGCCTCGCTCTTACGTCATCGGCTGAAGTCTTTCTGGGGCTTCGGATTCTTCAGGCTTGTGGTGCCTCGGCGTGCCTTGTTTCCACATTTGCAACAGTACGTGACATTTACGCAGGTCGCGAGGAAAGTAATGTCATTTACGGCATACTCGGATCCATGCTGGCCATGGTCCCGGCGGTAGGCCCATTGCTCGGAGCGCTCGTCGACATGTGGCTTGGGTGGCGGGCTATCTTTGCGTTTCTAGGTTTGGGCATGATCGCTGCATCTGCAGCAGCGTGGCGATTCTGGCCTGAAACCCGGGTGCAACGAGTTGCGGGCTTGCAATGGTCGCAGCTGCTACTCCCCGTTAAGTGCCTGAACTTCTGGTTGTACACGTTGTGTTACGCCGCTGGAATGGGTAGCTTCTTCGTCTTTTTCTCCATTGCGCCCGGACTAATGATGGGCAGGCAAGGTGTGTCTCAGCTTGGCTTCAGCCTGCTGTTCGCCACAGTGGCAATTGCCATGGTGTTTACGGCTCGTTTTATGGGGCGTGTGATACCCAAGTGGGGCAGCCCAAGTGTCTTGCGAATGGGAATGGGATGCCTGATAGCTGGAGCAGTATTGCTTGCCATCACCGAAATATGGGCTTCGCAGTCCGTGTTAGGCTTTATTGCTCCAATGTGGCTAGTGGGTATTGGTGTCGCCACAGCGGTATCTGTGTCGCCCAATGGCGCTCTTCGAGGATTCGACCATGTTGCTGGAACGGTCACGGCAGTCTACTTCTGCTTGGGCGGTGTACTGCTAGGAAGCATCGGAACGTTGATCATTTCGCTGTTGCCGCGCAACACGGCTTGGCCGGTTGTCGTGTACTGTTTGACCCTTGCAACAGTCGTGCTCGGTCTGTCTTGTGTTTCCCGAGTGAAGGGCTCTCGCGGCCAGGGGGAGCATGATGTGGTCGCGCTACAAAGTGCGGAAAGTACATCAAATCCCAATCGTTGA	
8118	CARD	prokka_04038	contig_36	5110	79	2799	3252	-1	104	arr-2	3002847.0	311.997	250.0	Perfect	100.0	100.0	rifampin ADP-ribosyltransferase (Arr)	protein homolog model	antibiotic inactivation		rifamycin antibiotic	MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKKFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED	ATGGTAAAAGATTGGATTCCCATCTCTCATGATAATTACAAGCAGGTGCAAGGACCGTTCTATCATGGAACCAAAGCCAATTTGGCGATTGGTGACTTGCTAACCACAGGGTTCATCTCTCATTTCGAGGACGGTCGTATTCTTAAGCACATCTACTTTTCAGCCTTGATGGAGCCAGCAGTTTGGGGAGCTGAACTTGCTATGTCACTGTCTGGCCTCGAGGGTCGCGGCTACATATACATAGTTGAGCCAACAGGACCGTTCGAAGACGATCCGAATCTTACGAACAAAAAATTTCCCGGTAATCCAACACAGTCCTATAGAACCTGCGAACCCTTGAGAATTGTTGGCGTTGTTGAAGACTGGGAGGGGCATCCTGTTGAATTAATAAGGGGAATGTTGGATTCGTTAGAGGACTTAAAGCGCCGTGGTTTACACGTCATTGAAGACTAG	
8118	CARD	prokka_04039	contig_36	5110	79	3336	3870	-1	84	ANT(2'')-Ia	3000230.0	358.992	300.0	Perfect	100.0	100.0	ANT(2'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA	ATGGACACAACGCAGGTCACATTGATACACAAAATTCTAGCTGCGGCAGATGAGCGAAATCTGCCGCTCTGGATCGGTGGGGGCTGGGCGATCGATGCACGGCTAGGGCGTGTAACACGCAAGCACGATGATATTGATCTGACGTTTCCCGGCGAGAGGCGCGGCGAGCTCGAGGCAATAGTTGAAATGCTCGGCGGGCGCGTCATGGAGGAGTTGGACTATGGATTCTTAGCGGAGATCGGGGATGAGTTACTTGACTGCGAACCTGCTTGGTGGGCAGACGAAGCGTATGAAATCGCGGAGGCTCCGCAGGGCTCGTGCCCAGAGGCGGCTGAGGGCGTCATCGCCGGGCGGCCAGTCCGTTGTAACAGCTGGGAGGCGATCATCTGGGATTACTTTTACTATGCCGATGAAGTACCACCAGTGGACTGGCCTACAAAGCACATAGAGTCCTACAGGCTCGCATGCACCTCACTCGGGGCGGAAAAGGTTGAGGTCTTGCGTGCCGCTTTCAGGTCGCGATATGCGGCCTAA	
8118	CARD	prokka_04056	contig_39	3485	75	195	1101	1	78	mphA	3000316.0	604.364	500.0	Perfect	100.0	100.0	macrolide phosphotransferase (MPH)	protein homolog model	antibiotic inactivation		macrolide antibiotic	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	ATGACCGTAGTCACGACCGCCGATACCTCCCAACTGTACGCACTTGCAGCCCGACATGGGCTCAAGCTCCATGGCCCGCTGACTGTCAATGAGCTTGGGCTCGACTATAGGATCGTGATCGCCACCGTCGACGATGGACGTCGGTGGGTGCTGCGCATCCCGCGCCGAGCCGAGGTAAGCGCGAAGGTCGAACCAGAGGCGCGGGTGCTGGCAATGCTCAAGAATCGCCTGCCGTTCGCGGTGCCGGACTGGCGCGTGGCCAACGCCGAGCTCGTTGCCTATCCCATGCTCGAAGACTCGACTGCGATGGTCATCCAGCCTGGTTCGTCCACGCCCGACTGGGTCGTGCCGCAGGACTCGGAGGTCTTCGCGGAGAGCTTCGCGACCGCGCTCGCCGCCCTGCATGCCGTCCCCATTTCCGCCGCCGTGGATGCGGGGATGCTCATCCGTACACCGACGCAGGCCCGTCAGAAGGTGGCCGACGACGTTGACCGCGTCCGACGCGAGTTCGTGGTGAACGACAAGCGCCTCCACCGGTGGCAGCGCTGGCTCGACGACGATTCGTCGTGGCCAGATTTCTCCGTGGTGGTGCATGGCGATCTCTACGTGGGCCATGTGCTCATCGACAACACGGAGCGCGTCAGCGGGATGATCGACTGGAGCGAGGCCCGCGTTGATGACCCTGCCATCGACATGGCCGCGCACCTTATGGTCTTTGGTGAAGAGGGGCTCGCGAAGCTCCTCCTCACGTATGAAGCGGCCGGTGGCCGGGTGTGGCCGCGGCTCGCCCACCACATCGCGGAGCGCCTTGCGTTCGGGGCGGTCACCTACGCACTCTTCGCCCTCGACTCGGGTAACGAAGAGTACCTCGCTGCGGCGAAGGCGCAGCTCGCCGCAGCGGAATGA	
8118	CARD	prokka_04064	contig_42	2353	94	1048	1507	1	94	AAC(6')-Il	3004635.0	311.612	275.0	Perfect	100.0	100.0	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDGEALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFASDTQLTNSASTSAHLAAGFTEVAQVRCFRKPL	ATGGATAGTTCGCCGCTCGTCAGGCCTGTTGAAACTACCGATTCGGCCAGTTGGCTAAGCATGCGCTGTGAGCTGTGGCCAGATGGCACATGTCAAGAGCACCAGTCAGAGATCGCAGAATTTCTGTCCGGAAAAGTCGCCCGGCCTGCTGCTGTCCTCATTGCTGTAGCACCCGACGGAGAAGCACTAGGGTTTGCCGAGCTTTCGATCCGCCCGTATGCGGAGGAGTGCTACTCCGGCAACGTTGCGTTCTTGGAGGGTTGGTACGTTGTGCCAAGTGCGCGGCGTCAGGGCGTAGGTGTAGCTCTGGTAAAAGCCGCCGAGCATTGGGCTCGTGGTCGCGGATGCACCGAATTCGCCTCCGACACTCAACTTACCAACAGCGCAAGCACCTCGGCGCACCTGGCGGCTGGATTCACGGAGGTTGCTCAAGTACGCTGCTTCCGGAAACCGTTGTGA	
8118	CARD	prokka_04065	contig_42	2353	94	1649	2123	1	95	dfrA1	3002854.0	322.783	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG	GTGAAACTATCACTAATGGTAGCTATATCGAAGAATGGAGTTATCGGGAATGGCCCTGATATTCCATGGAGTGCCAAAGGTGAACAGCTCCTGTTTAAAGCTATTACCTATAACCAATGGCTGTTGGTTGGACGCAAGACTTTTGAATCAATGGGAGCATTACCCAACCGAAAGTATGCGGTCGTAACACGTTCAAGTTTTACATCTGACAATGAGAACGTAGTGATCTTTCCATCAATTAAAGATGCTTTAACCAACCTAAAGAAAATAACGGATCATGTCATTGTTTCAGGTGGTGGGGAGATATACAAAAGCCTGATCGATCAAGTAGATACACTACATATATCTACAATAGACATCGAGCCGGAAGGTGATGTTTACTTTCCTGAAATCCCCAGCAATTTTAGGCCAGTTTTTACCCAAGACTTCGCCTCTAACATAAATTATAGTTACCAAATCTGGCAAAAGGGTTAA	
8118	CARD	prokka_04069	contig_45	2008	86	179	959	-1	88	aadA2	3002602.0	522.316	450.0	Perfect	100.0	100.0	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	GTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTGATTTGTTGGTTACTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGATCTTATGGAGGCTTCGGCTTTCCCTGGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATAAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGA	
8118	CARD	prokka_04070	contig_45	2008	86	1378	1876	-1	104	dfrA12	3002858.0	339.732	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG	ATGAACTCGGAATCAGTACGCATTTATCTCGTTGCTGCGATGGGAGCCAATCGGGTTATTGGCAATGGTCCTAATATCCCCTGGAAAATTCCGGGTGAGCAGAAGATTTTTCGCAGACTCACTGAGGGAAAAGTCGTTGTCATGGGGCGAAAGACCTTTGAGTCTATCGGCAAGCCTCTACCGAACCGTCACACATTGGTAATCTCACGCCAAGCTAACTACCGCGCCACTGGCTGCGTAGTTGTTTCAACGCTGTCGCACGCTATCGCTTTGGCATCCGAACTCGGCAATGAACTCTACGTCGCGGGCGGAGCTGAGATATACACTCTGGCACTACCTCACGCCCACGGCGTGTTTCTATCTGAGGTACATCAAACCTTCGAGGGTGACGCCTTCTTCCCAATGCTCAACGAAACAGAATTCGAGCTTGTCTCAACCGAAACCATTCAAGCTGTAATTCCGTACACCCACTCCGTTTATGCGCGTCGAAACGGCTAA	
8118	CARD	prokka_04074	contig_50	1291	90	263	1079	-1	92	APH(3')-Ia	3002641.0	560.066	500.0	Strict	98.52	100.0	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAA	
8118	CARD	prokka_04079	contig_55	981	155	111	459	1	170	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8118	CARD	prokka_04082	contig_59	836	166	55	835	-1	177	ANT(3'')-IIa	3004089.0	518.0790000000002	450.0	Strict	99.23	80.19	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	GTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAGAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAA	
8118	CARD	prokka_01317	contig_4	344941	56	39085	40852	-1	55	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	584.719	500.0	Strict	51.49	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAPKSARNKKQSENTSFVSWRFALLCGGILLALVGLLVRVAYLQIISPEKLVKEGDMRSLRVQEVSTARGMISDREGRQLAVSVPVNAIWADPKVVFEKGGVNNDEHWKALADALEIPLEQITAKISANPKGRFVYLARQVNPSIGEYITKLKLPGIYLRKESRRYYPSGPVAAHLIGVTNIDGEGIEGVEKSFERWLKGEPGERIVRKDRNGRVIETVSSVDSQAAHNLVLSIDERIQSIVYRELTKGVQENKAESGVAILVDVHTGEILAMANSPSYNPNNLAGTPMDAMRNRAITDIFEPGSTVKPLVVMSALNNRIVKENTVLNTYPYRVNGHEIKDVARYPELSITGILQKSSNVGVSKLALAMPATELVDVYSRFGFGKPTNLGLVGESSGIFPSKKTRWSDLERATFSFGYGQMVTPLQLARAYATIGSFGIYRPLSITKVDPPVPGTRVFPEHIMRTVVHMMESVALPGGGGTRASIKGYRIAIKTGTAKKVGPEGRYINQYIAYTAGVAPASNPRYALVVLINEPKAGKYYGGAVSAPVFGSIMGGVLRMMNVEPDALQTDDKNDTVLNRKEVKSGRS	ATGAAAGCACCTAAGTCAGCTAGGAATAAAAAACAGTCTGAAAATACCAGCTTTGTTAGCTGGCGTTTTGCCTTGTTGTGCGGCGGTATTCTACTGGCTTTAGTCGGGCTTTTAGTGCGTGTAGCTTATCTACAAATCATTTCGCCTGAAAAGTTAGTTAAAGAAGGGGATATGCGCTCCTTACGTGTTCAAGAGGTCTCTACAGCACGTGGCATGATAAGCGATAGGGAAGGGCGGCAACTGGCTGTTAGTGTGCCTGTTAATGCGATTTGGGCTGACCCAAAAGTGGTATTTGAAAAAGGTGGGGTGAACAATGATGAACATTGGAAAGCGCTCGCTGATGCATTGGAGATCCCACTTGAGCAGATCACCGCTAAAATTTCTGCCAATCCAAAAGGGCGCTTTGTGTACCTCGCTCGTCAAGTCAACCCTTCTATTGGCGAATACATCACGAAACTAAAATTACCCGGTATCTATTTACGCAAAGAATCACGCCGTTACTACCCCTCAGGGCCTGTTGCAGCGCACTTAATTGGTGTGACAAATATTGATGGCGAAGGGATAGAAGGCGTCGAGAAAAGCTTTGAGCGCTGGTTAAAAGGGGAGCCAGGTGAGCGTATTGTTCGTAAAGACCGTAATGGGCGTGTGATTGAAACGGTTTCTTCCGTTGATAGCCAAGCGGCTCATAACTTAGTGCTAAGTATTGATGAACGCATTCAATCTATCGTTTATCGAGAATTAACGAAAGGTGTTCAGGAAAACAAAGCTGAATCAGGTGTTGCCATTTTAGTGGATGTGCACACGGGGGAGATTTTAGCGATGGCGAATAGCCCATCCTATAACCCGAACAATTTGGCAGGAACCCCCATGGATGCTATGCGTAACCGTGCGATCACCGATATTTTTGAACCGGGTTCAACGGTCAAGCCGCTCGTCGTTATGAGTGCATTAAATAACCGTATTGTCAAAGAAAATACCGTATTGAATACCTATCCATATCGAGTTAATGGTCATGAAATCAAAGACGTAGCTCGTTATCCTGAATTGTCAATTACAGGTATTTTACAGAAGTCGAGTAACGTGGGTGTGTCAAAACTGGCGTTAGCGATGCCTGCTACAGAGCTGGTGGATGTGTATAGCCGCTTTGGGTTTGGCAAGCCGACTAATCTGGGGTTAGTCGGGGAAAGTAGTGGCATCTTTCCAAGTAAAAAAACACGGTGGTCTGATTTAGAAAGGGCCACCTTTTCTTTCGGGTATGGGCAAATGGTAACACCGTTACAGTTAGCCCGTGCCTATGCAACAATTGGTAGTTTCGGGATTTATCGCCCGCTATCGATTACTAAAGTTGACCCTCCTGTGCCGGGAACACGCGTTTTTCCTGAGCATATAATGCGCACCGTTGTGCACATGATGGAAAGTGTTGCCTTGCCGGGTGGTGGGGGAACAAGAGCCTCAATAAAAGGCTATCGTATCGCGATAAAAACAGGTACTGCGAAAAAAGTAGGGCCGGAAGGGCGCTACATTAATCAATATATTGCTTATACCGCAGGCGTCGCGCCTGCAAGTAACCCACGCTATGCCCTTGTCGTTCTTATCAATGAGCCTAAAGCGGGTAAATATTATGGTGGTGCAGTATCGGCACCCGTGTTTGGTTCAATTATGGGCGGTGTTTTACGCATGATGAACGTTGAACCTGATGCACTACAAACAGACGATAAAAACGACACAGTTCTTAACAGAAAAGAGGTTAAAAGTGGCAGATCGTAA	
8118	CARD	prokka_01562	contig_4	344941	56	324224	324848	1	57	tetR	3003479.0	427.172	400.0	Strict	100.0	99.52	major facilitator superfamily (MFS) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		tetracycline antibiotic	MSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	ATGTCTAGATTAGATAAAAGTAAAGTGATTAACAGCGCATTAGAGCTGCTTAATGAGGTCGGAATCGAAGGTTTAACAACCCGTAAACTCGCCCAGAAGCTAGGTGTAGAGCAGCCTACATTGTATTGGCATGTAAAAAATAAGCGGGCTTTGCTCGACGCCTTAGCCATTGAGATGTTAGATAGGCACCATACTCACTTTTGCCCTTTAGAAGGGGAAAGCTGGCAAGATTTTTTACGTAATAACGCTAAAAGTTTTAGATGTGCTTTACTAAGTCATCGCGATGGAGCAAAAGTACATTTAGGTACACGGCCTACAGAAAAACAGTATGAAACTCTCGAAAATCAATTAGCCTTTTTATGCCAACAAGGTTTTTCACTAGAGAATGCATTATATGCACTCAGCGCTGTGGGGCATTTTACTTTAGGTTGCGTATTGGAAGATCAAGAGCATCAAGTCGCTAAAGAAGAAAGGGAAACACCTACTACTGATAGTATGCCGCCATTATTACGACAAGCTATCGAATTATTTGATCACCAAGGTGCAGAGCCAGCCTTCTTATTCGGCCTTGAATTGATCATATGCGGATTAGAAAAACAACTTAAATGCGAAAGTGGGTCTTAA	
8160	BLDB	prokka_01198	contig_4	348350	56	176681	177992	1	29	AFAM2584-37		352.2		Strict	91.41	58.52	RDfusion [Ribosome display vector pRDV]	protein homolog model			Beta-Lactam	MSKATEQNDKLKRAIIISAVLHVILFAALIWSSFDENIEASAGGGGGSSIDAVMVDSGAVVEQYKRMQSQESSAKRSDEQRKMKEQQAAEELREKQAAEQERLKQLEKERLAAQEQKKQAEEAAKQAELKQKQAEEAAAKAAADAKAKAEADAKAAEEAAKKAAADAKKKAEAEAAKAAVEAQKKAEAAAAALKKKAEAAEAAAAEARKKAATEAAEKAKAEAEKKAAAEKAAADKKAAEKAAAEKAAADKKAAAEKAAADKKAAEKAAAEKAAADKKAAAEKAAADKKAAAAKAAAEKAAAAKAAAEADDIFGELSSGKNAPKTGGGAKGNNASPAGSGNTKNNGASGADINNYAGQIKSAIESKFYDASSYAGKTCTLRIKLAPDGMLLDIKPEGGDPALCQAALAAAKLAKIPKPPSQAVYEVFKNAPLDFKP	GTGTCAAAGGCAACCGAACAAAACGACAAGCTCAAGCGGGCGATAATTATTTCAGCAGTGCTGCATGTCATCTTATTTGCGGCGCTGATCTGGAGTTCGTTCGATGAGAATATAGAAGCTTCAGCCGGAGGCGGCGGTGGTTCGTCCATCGACGCTGTCATGGTTGATTCAGGTGCGGTAGTTGAGCAGTACAAACGCATGCAAAGCCAGGAATCAAGCGCGAAGCGTTCTGATGAGCAGCGCAAGATGAAAGAGCAGCAGGCTGCTGAAGAACTGCGTGAGAAACAAGCGGCTGAACAGGAACGCCTGAAGCAACTTGAGAAAGAGCGGTTAGCGGCTCAGGAGCAGAAAAAGCAGGCTGAAGAAGCCGCAAAACAGGCCGAGTTAAAGCAGAAGCAAGCGGAAGAGGCGGCAGCGAAAGCGGCGGCAGATGCTAAAGCGAAGGCCGAAGCGGATGCTAAAGCTGCGGAAGAAGCAGCGAAGAAAGCGGCGGCAGACGCGAAGAAAAAAGCAGAAGCAGAAGCCGCCAAAGCCGCAGTCGAAGCGCAGAAAAAAGCCGAGGCTGCTGCTGCGGCGCTGAAGAAGAAAGCTGAAGCGGCAGAAGCAGCTGCAGCTGAAGCAAGAAAGAAAGCGGCAACCGAAGCTGCTGAAAAAGCCAAGGCAGAAGCTGAGAAGAAAGCGGCAGCAGAGAAAGCGGCAGCCGACAAAAAAGCAGCAGAAAAAGCGGCTGCTGAAAAGGCTGCAGCTGATAAGAAAGCGGCAGCAGAGAAAGCGGCAGCCGACAAAAAAGCAGCAGAAAAAGCGGCTGCTGAAAAGGCAGCAGCTGATAAGAAAGCAGCGGCAGAAAAAGCCGCCGCAGACAAAAAAGCGGCAGCGGCAAAAGCAGCAGCTGAAAAAGCCGCTGCAGCAAAAGCTGCCGCTGAGGCAGATGATATTTTCGGTGAGCTAAGCTCTGGTAAGAATGCACCGAAAACGGGGGGAGGGGCGAAAGGGAACAATGCTTCGCCTGCCGGGAGTGGTAATACTAAAAACAATGGCGCATCAGGGGCCGATATCAATAACTATGCCGGGCAGATTAAATCTGCTATCGAAAGTAAGTTCTATGACGCATCGTCCTATGCAGGCAAAACCTGTACGCTGCGCATAAAACTGGCACCCGATGGTATGTTACTGGATATCAAACCTGAAGGTGGCGATCCCGCACTTTGTCAAGCTGCGTTGGCAGCAGCTAAACTTGCGAAGATCCCGAAACCACCAAGCCAGGCAGTATATGAAGTGTTCAAAAACGCGCCATTGGACTTCAAACCGTAA	
8160	BLDB	prokka_01493	contig_5	336402	60	131381	132386	1	70	EC-683		380.1		Strict	100.0	88.33	TPA: BlaEC family class C beta-lactamase [Escherichia coli]	protein homolog model			Beta-Lactam	MAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNTLQ	ATGGCGGTAGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCACAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTCGCAACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAGGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGAAAACTCGTGTCTTCCAGCCACTCAAACTCAATCATACGTGGATTAATGTACCGTCCGCAGAAGAAAAGAACTACGCCTGGGGATATCGCGAAGGTAAGGCAGTACATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTGCAAAGCAATTTAAAACCCCTTGATATCAATGAGAAAATACTTCAACAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGTCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACATCATCATTAACGGCAGTGACAATAAAATTGCACTGGCAGCACGCCCCGTAAAACCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACGGGGGCGACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATCGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGAGTTACCGCCGCCTGGCAGATTCTCAACACTCTACAGTAA	
8160	BLDB	prokka_04260	contig_24	60514	801	10377	11238	1	945	TEM-1		80.1		Perfect	100.0	99.65	class A broad-spectrum beta-lactamase TEM-1	protein homolog model			Beta-Lactam	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	ATGAGTATTCAACATTTTCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGTGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCTGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	
8160	CARD	prokka_00090	contig_1	376564	54	103370	103703	1	96	Escherichia coli emrE	3004039.0	216.083	190.0	Strict	98.18	100.0	small multidrug resistance (SMR) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic	MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSAPH	ATGAACCCTTATATTTATCTTGGTGGCGCAATACTTGCAGAGGTCATTGGTACAACCTTAATGAAGTTTTCAGAGGGGTTTACACGGTTATGGCCCTCTGTTGGCACAATTATTTGCTATTGTGCATCATTCTGGTTATTAGCTCAGACGCTGGCTTATATACCTACAGGGATTGCTTATGCTATCTGGTCAGGAGTCGGTATCGTTCTGATTAGTTTGCTTTCCTGGGGATTTTTTGGTCAACGACTGGACCTGCCAGCTATCATAGGCATGATGTTGATTTGTGCCGGTGTGTTAGTCATTAACTTGTTGTCACGAAGTGCACCGCATTAA	
8160	CARD	prokka_00472	contig_2	362451	56	96000	97194	1	70	Escherichia coli acrA	3004043.0	795.808	670.0	Strict	99.75	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQAAYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	ATGAACAAAAACAGAGGGTTTACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCCCTAACAGGATGTGACGACAAACAGGCCCAACAAGGTGGCCAGCAGATGCCCGCCGTTGGCGTAGTAACAGTCAAAACTGAACCTCTGCAGATCACAACCGAGCTTCCGGGTCGCACCAGTGCCTACCGGATCGCAGAAGTTCGTCCTCAAGTTAGCGGGATTATCCTGAAGCGTAATTTCAAAGAAGGTAGCGACATCGAAGCAGGTGTCTCTCTCTATCAGATTGATCCTGCGACCTATCAGGCGGCATACGACAGTGCGAAAGGTGATCTGGCGAAAGCCCAGGCTGCAGCCAATATCGCGCAATTGACGGTGAATCGTTATCAGAAATTGCTCGGTACTCAGTACATCAGTAAACAAGAGTACGATCAGGCTCTGGCTGATGCGCAACAGGCGAATGCTGCGGTAACTGCGGCGAAAGCTGCCGTTGAAACTGCGCGAATCAATCTGGCTTACACCAAAGTCACCTCTCCGATTAGTGGTCGCATTGGTAAGTCAAACGTGACGGAAGGCGCATTGGTACAGAACGGTCAGGCGACTGCGCTGGCAACCGTGCAGCAACTTGATCCGATCTACGTTGATGTGACCCAGTCCAGCAACGACTTCCTGCGCCTGAAACAGGAACTGGCGAATGGCACGCTGAAACAAGAGAACGGCAAAGCCAAAGTGTCGCTGATCACCAGTGACGGCATTAAGTTCCCGCAGGACGGTACGCTGGAATTCTCTGACGTTACCGTTGATCAGACCACTGGGTCTATCACCCTACGCGCTATCTTCCCGAACCCGGATCACACTCTGCTGCCGGGTATGTTCGTGCGTGCACGTCTGGAAGAAGGGCTTAATCCAAACGCTATTTTAGTCCCGCAACAGGGCGTAACCCGTACGCCACGTGGCGATGCCACCGTACTGGTGGTTGGCGCGGATGACAAAGTGGAAACCCGTCCGATCGTTGCAAGCCAGGCTATCGGCGATAAGTGGCTGGTGACAGAAGGTCTGAAAGCAGGCGATCGCGTAGTAATAAGTGGGCTGCAGAAAGTGCGTCCTGGTGTCCAGGTAAAAGCACAAGAAGTTACCGCTGATAATAACCAGCAAGCCGCAAGCGGTGCTCAGCCTGAACAGTCCAAGTCTTAA	
8160	CARD	prokka_00473	contig_2	362451	56	97216	100366	1	66	acrB	3000216.0	2133.22	1900.0	Strict	99.81	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTNYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHNHTVDHH	ATGCCTAATTTCTTTATCGATCGCCCAATTTTTGCGTGGGTGATCGCCATTATCATCATGTTGGCAGGGGGGCTGGCGATCCTCAAACTGCCGGTGGCGCAATATCCTACGATTGCACCGCCGGCAGTAACGATCTCCGCCTCCTACCCTGGCGCTGATGCGAAAACAGTGCAGGACACGGTGACACAGGTTATCGAACAGAATATGAACGGTATCGATAACCTGATGTACATGTCCTCTAACAGTGACTCCACGGGTACCGTGCAGATCACCCTGACCTTTGAGTCTGGTACTGATGCGGATATCGCGCAGGTTCAGGTGCAGAACAAACTGCAGCTGGCGATGCCGTTGCTGCCGCAAGAAGTACAGCAGCAAGGGGTGAGCGTTGAGAAATCATCCAGCAGCTTCCTGATGGTTGTCGGCGTTATCAACACCGATGGCACCATGACGCAGGAGGATATCTCCGACTACGTGGCGGCGAATATGAAAGATGCCATCAGCCGTACGTCGGGCGTGGGTGACGTTCAGTTGTTCGGTTCACAGTACGCGATGCGTATCTGGATGAACCCGAATGAACTGAACAAATTCCAGCTAACGCCGGTTGATGTCATTACCGCCATCAAAGCACAGAACGCCCAGGTTGCAGCTGGTCAGCTCGGTGGTACGCCGCCGGTGAAAGGCCAACAGCTTAACGCCTCTATTATTGCTCAGACGCGTCTGACCTCTACTGAAGAGTTCGGCAAAATCCTGCTGAAAGTGAATCAGGATGGTTCCCGCGTGCTGCTGCGTGATGTGGCGAAAATTGAGCTGGGTGGTGAGAACTACGACATCATCGCAGAGTTTAACGGCCAACCGGCTTCCGGTCTGGGGATCAAGCTGGCGACCGGTGCGAACGCGCTGGATACCGCTGCGGCAATCCGTGCTGAACTGGCGAAGATGGAACCGTTCTTCCCGTCGGGTCTGAAAATTGTTTACCCGTATGACACCACACCGTTCGTGAAAATCTCTATTCACGAAGTGGTTAAAACGCTGGTCGAAGCGATCATCCTCGTGTTCCTGGTAATGTATCTGTTCTTGCAGAACTTCCGCGCGACGTTGATTCCGACCATTGCCGTACCGGTGGTATTGCTCGGGACCTTTGCCGTCCTTGCCGCCTTTGGCTTCTCGATAAACACGCTAACAATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTTGTGGTAGAAAACGTTGAGCGTGTGATGGCGGAAGAAGGTTTGCCACCAAAAGAAGCCACCCGTAAGTCGATGGGGCAGATTCAGGGCGCTCTGGTCGGTATCGCGATGGTACTGTCGGCGGTATTCGTACCGATGGCCTTCTTTGGCGGTTCTACTGGTGCTATCTATCGTCAGTTCTCTATTACCATTGTTTCAGCAATGGCGCTGTCGGTACTGGTGGCGTTGATCCTGACTCCGGCTCTTTGTGCCACCATGCTGAAACCGATTGCCAAAGGCGATCACGGGGAAGGTAAAAAAGGCTTCTTCGGCTGGTTTAACCGCATGTTCGAGAAGAGCACGCACCACTACACCGACAGCGTAGGCGGTATTCTACGCAGTACGGGGCGTTACCTGGTGCTGTATCTGATCATCGTGGTCGGCATGGCCTATCTGTTCGTGCGTCTGCCAAGCTCCTTCTTGCCAGATGAGGACCAGGGCGTATTTATGACCATGGTTCAGCTGCCAGCAGGTGCAACGCAGGAACGTACGCAGAAAGTGCTCAATGAGGTAACGAATTACTATCTGACCAAAGAAAAGAACAACGTTGAGTCGGTGTTCGCCGTTAACGGCTTCGGCTTTGCGGGACGTGGTCAGAATACCGGTATTGCGTTCGTTTCCTTGAAGGACTGGGCCGATCGTCCGGGCGAAGAAAACAAAGTTGAAGCGATTACCATGCGTGCAACACGTGCTTTCTCGCAAATCAAAGATGCGATGGTTTTCGCCTTTAACCTGCCCGCAATCGTGGAACTGGGTACCGCAACCGGCTTTGACTTTGAGCTGATTGACCAGGCTGGCCTTGGTCACGAAAAACTGACTCAGGCGCGTAACCAGTTGCTTGCAGAAGCAGCGAAGCACCCTGATATGTTGACCAGCGTACGTCCAAACGGTCTGGAAGATACCCCGCAGTTTAAGATTGATATCGACCAGGAAAAAGCGCAGGCGCTGGGTGTTTCTATCAACGACATTAACACCACTCTGGGCGCTGCATGGGGCGGTAGCTATGTGAACGACTTTATCGACCGCGGTCGTGTGAAGAAAGTTTACGTCATGTCAGAGGCGAAATACCGTATGCTGCCGGATGATATCGGCGACTGGTATGTTCGTGCTGCTGATGGTCAGATGGTGCCGTTCTCGGCGTTCTCCTCTTCTCGTTGGGAGTACGGTTCGCCGCGTCTGGAACGTTACAACGGCCTGCCATCTATGGAAATCTTAGGCCAGGCGGCACCGGGTAAAAGTACCGGTGAAGCAATGGAGCTGATGGAACAACTGGCGAGCAAACTGCCTACCGGTGTTGGCTATGACTGGACGGGGATGTCCTATCAGGAACGTCTCTCCGGCAACCAGGCACCTTCACTGTACGCGATTTCGTTGATTGTCGTGTTCCTGTGTCTGGCTGCGCTGTACGAGAGCTGGTCGATTCCGTTCTCCGTTATGCTGGTCGTTCCGCTGGGGGTTATCGGTGCGTTGCTGGCTGCCACCTTCCGTGGCCTGACCAATGACGTTTACTTCCAGGTAGGCCTGCTCACAACCATTGGTTTGTCGGCGAAGAACGCGATACTTATCGTCGAATTCGCCAAAGACTTGATGGATAAAGAAGGTAAAGGTCTGATTGAAGCGACGCTTGATGCGGTGCGGATGCGTTTACGCCCAATCCTGATGACCTCGTTGGCGTTTATCCTCGGCGTTATGCCGCTGGTTATCAGTACTGGTGCTGGTTCCGGCGCGCAGAACGCAGTAGGTACCGGTGTAATGGGCGGGATGGTGACCGCAACGGTACTGGCAATCTTCTTCGTTCCGGTATTCTTTGTGGTGGTTCGCCGCCGCTTTAGCCGCAAGAATGAAGATATCGAGCACAACCATACTGTCGATCATCATTGA	
8160	CARD	prokka_00558	contig_2	362451	56	185115	186273	1	68	Escherichia coli ampH beta-lactamase	3004612.0	790.801	500.0	Strict	99.22	100.0	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRSLLFSAVLYSASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQRVFRSYGETRPGNNVRPQLDSVIRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS	TTGAAACGTAGTCTGCTTTTTTCTGCCGTGCTGTATTCGGCGTCATTGACCTCCGTCCATGCGGCTCAGCCGATCACTGAACCGGAGTTTGCCTCTGATATTGTCGATCGTTATGCCGATCATATTTTTTACGGCAGCGGTGCCACGGGGATGGCGCTGGTTGTTATCGACGGTAACCAGCGCGTCTTTCGCAGTTATGGCGAAACGCGACCTGGTAATAACGTTCGCCCGCAGCTGGATTCCGTCATACGTATTGCTTCCCTCACCAAGTTAATGACCAGTGAGATGCTGGTAAAATTGCTCGACCAGGGGACCGTGAAGTTAAACGATCCGCTAAGTAAATATGCTCCGCCAGGCGCACGCGTACCGACCTACAATGGGACGCCCATTACGCTGGTGAATCTGGCAACCCATACCAGCGCCCTGCCCCGTGAACAGCCCGGTGGCGCGGCACATCGTCCGGTATTTGTCTGGCCAACGCGCGAGCAACGCTGGAAATACCTTTCCACTGCCAAACTAAAAGCCGCGCCGGGCAGCCAGGCCGCGTACTCCAACCTCGCATTCGATCTGCTGGCAGATGCACTGGCGAATGCGTCCGGCAAGCCTTATACCCAGTTGTTTGAAGAGCAGATTACCCGTCCGTTGGGGATGAAAGACACCACCTACACCCCCTCACCGGATCAGTGCCGCCGTTTAATGGTTGCTGAGCGCGGTGCCAGTCCGTGCAATAACACGCTGGCGGCAATTGGCAGCGGCGGCGTCTATTCCACGCCAGGCGATATGATGCGCTGGATGCAGCAGTATTTGTCATCTGATTTTTATCAACGCAGTAACCAGGCTGATCGCATGCAGACGTTGATTTATCAGCGCGCGCAGTTTACAAAAGTGATTGGCATGGATGTCCCCGGCAAAGCGGATGCGCTTGGTTTAGGCTGGGTATATATGGCCCCGAAAGAGGGTCGTCCGGGGATTATTCAGAAGACAGGTGGTGGTGGCGGTTTCATTACCTATATGGCGATGATCCCGCAGAAGAATATTGGTGCGTTTGTGGTGGTCACTCGTTCGCCGTTGACGCGCTTTAAAAATATGAGCGATGGCATCAATGACCTGGTGACCGAGCTAAGCGGGAATAAACCGTTGGTTATCCCCGCATCCTGA	
8160	CARD	prokka_00824	contig_3	355584	55	102822	103791	-1	41	PmrF	3003578.0	661.3739999999998	550.0	Strict	99.07	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHVLVEASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	ATGTTTGAAATCCACCCTGTTAAGAAAGTCTCGGTGGTTATTCCCGTTTATAACGAGCAGGAAAGCTTACCGGAATTAATCAGGCGCACCACCGCAGCCTGTGAATCACTGGGGAAAGAGTATGAAATCCTGCTGATTGATGACGGCAGTAGCGATAATTCCGCGCATGTGCTGGTCGAAGCCTCACAAGCGGAGGGCAGCCATATTGTGTCTATTTTGCTTAACCGCAATTACGGGCAACATTCAGCGATTATGGCGGGATTCAGTCACGTCACCGGCGACTTAATTATTACCCTCGATGCCGATCTCCAGAATCCGCCAGAGGAGATCCCCCGTCTGGTGGCAAAAGCCGATGAAGGTTACGACGTGGTAGGGACTGTACGCCAGAACCGCCAGGACAGCTGGTTTCGTAAAACCGCTTCGAAGATGATTAACCGGCTTATTCAGCGCACCACCGGCAAAGCGATGGGTGACTATGGTTGTATGCTGCGCGCCTATCGCCGTCATATTGTCGATGCGATGTTGCACTGCCATGAACGCAGCACCTTTATCCCGATTCTGGCGAATATCTTCGCCCGCCGTGCCATTGAAATTCCAGTGCACCATGCCGAGCGTGAGTTTGGTGAATCCAAATACAGCTTTATGCGCCTGATTAATTTGATGTACGACCTGGTGACCTGCCTTACCACAACGCCGCTACGTATGTTGAGTTTGCTCGGCAGCATTATTGCGATTGGCGGTTTTAGCATTGCGGTGCTGCTGGTGATTTTACGCCTGACCTTCGGACCACAATGGGCGGCAGAAGGCGTCTTTATGCTATTTGCCGTGCTGTTTACTTTTATTGGCGCTCAGTTTATCGGCATGGGATTGCTCGGTGAATATATCGGCAGGATCTACACCGATGTCCGCGCCCGCCCCCGCTATTTTGTTCAGCAAGTTATCCGTCCATCCAGCAAGGAAAATGAATAA	
8160	CARD	prokka_00866	contig_3	355584	55	161995	163639	1	50	YojI	3003952.0	1103.58	1050.0	Strict	99.09	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		peptide antibiotic	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAVTIWGGFILVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFSYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQNGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGQPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	ATGGAACTTCTTGTACTTGTCTGGCGGCAGTATCGCTGGCCATTTATCAGTGTGATGGCGCTAAGCCTCGCCAGTGCGGCATTAGGCATTGGCTTAATTGCTTTTATCAATCAGCGCCTTATCGAAACGGCGGATACCAGTCTGCTGGTATTGCCGGAGTTTCTGGGGTTATTGCTGCTGTTGATGGCAGTCACTCTCGGATCGCAACTGGCGCTCACCACTTTGGGGCATCACTTCGTTTACCGACTGCGTAGTGAATTTATCAAGCGGATTCTGGATACCCATGTCGAGCGCATTGAACAACTTGGTAGCGCCTCGTTGCTGGCGGGGTTAACCAGCGATGTGCGCAATATCACCATTGCTTTTGTGCGTCTGCCGGAACTGGTGCAGGGGATCATTCTCACTATCGGTTCAGCGGCGTATTTGTGGATGCTGTCGGGCAAAATGTTGCTGGTAACGGCTATCTGGATGGCAGTCACCATCTGGGGTGGTTTTATACTGGTGGCGCGGGTGTACAAACATATGGCGACCCTGCGTGAAACCGAAGATAAGCTGTACACGGATTTTCAAACCGTACTCGAAGGGCGCAAAGAGCTGACTCTGAACCGTGAACGCGCCGAGTATGTGTTTAACAACCTCTACATTCCTGATGCGCAAGAGTATCGCCATCATATTATCCGCGCAGACACCTTCCATCTTAGTGCCGTGAACTGGTCAAACATCATGATGCTGGGCGCAATCGGCCTGGTGTTCTGGATGGCGAACAGTCTCGGTTGGGCTGATACCAACGTTGCCGCGACCTATTCGTTGACGTTGTTATTCCTGCGTACGCCGCTGCTTTCGGCGGTTGGCGCGTTGCCGACGCTACTGACGGCGCAGGTGGCGTTTAATAAGCTGAACAAATTCGCGCTCGCGCCTTTCAAAGCAGAGTTTCCGCGCCCGCAGGCGTTTCCCAACTGGCAAACGCTGGAGCTGCGTAACGTGACGTTTAGCTATCAGGATAACGCGTTTTCCGTTGGTCCAATTAATCTCACCATTAAACGTGGCGAGCTGCTGTTTCTGATTGGTGGCAACGGTAGTGGAAAATCGACGCTGGCGATGTTGCTGACGGGCTTGTACCAGCCACAAAATGGCGAAATCTTGCTGGATGGCAAACCTGTCAGCGGCGAACAACCGGAAGATTATCGAAAACTGTTTTCGGCAGTGTTTACCGATGTCTGGCTGTTTGATCAACTGCTGGGGCCGGAGGGGCAACCCGCTAACCCGCAACTGGTTGAGAAGTGGCTGGCGCAGCTGAAAATGGCTCATAAGCTTGAGTTAAGCAACGGGCGTATTGTTAACCTGAAGTTATCAAAAGGGCAGAAAAAACGCGTGGCGCTGTTGCTGGCGCTGGCAGAAGAACGCGATATTATCCTGCTGGATGAATGGGCGGCGGATCAGGATCCACACTTCCGTCGTGAGTTTTATCAGGTGCTGCTGCCGCTGATGCAGGAGATGGGTAAAACTATTTTCGCCATCAGTCATGATGATCATTACTTTATCCACGCCGACCGCCTGCTGGAAATGCGCAACGGGCAACTTAGCGAGCTGACAGGCGAAGAGCGCGATGCTGCTTCGCGTGATGCCGTTGCCCGGACAGCATAA	
8160	CARD	prokka_00994	contig_3	355584	55	303243	303966	-1	56	baeR	3000828.0	486.49300000000005	450.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV	ATGACCGAGTTACCAATCGACGAAAACACACCGCGTATTTTGATCGTGGAAGATGAACCGAAGCTGGGGCAGTTGCTCATTGATTATCTGCGTGCTGCGAGCTATGCGCCAACGTTGATTAGCCACGGCGATCAGGTACTGCCATATGTGCGCCAGACACCACCGGATCTGATCCTGTTGGATCTGATGCTCCCTGGCACCGATGGCCTGACGCTGTGCCGGGAAATTCGTCGTTTTTCTGACATTCCGATCGTGATGGTGACGGCAAAAATCGAAGAGATCGACCGCCTGCTGGGGTTGGAGATTGGCGCAGATGACTATATCTGCAAGCCGTACAGCCCACGGGAAGTGGTAGCGCGCGTCAAAACCATTTTGCGCCGTTGCAAACCGCAGCGTGAGTTGCAGCAACAGGATGCTGAAAGCCCGTTGATTATCGACGAAGGTCGTTTTCAGGCTTCCTGGCGCGGTAAAATGCTTGACCTGACGCCTGCAGAATTTCGACTGCTGAAAACGCTCTCTCATGAACCAGGAAAAGTGTTCTCCCGCGAGCAGTTGCTGAACCATCTTTATGACGACTACCGCGTGGTAACCGACCGTACCATCGACAGCCACATTAAAAACCTGCGCCGCAAGCTGGAATCTCTCGACGCCGAACAGTCATTTATCCGCGCCGTTTACGGCGTCGGTTACCGCTGGGAAGCCGACGCCTGCCGCATCGTTTAA	
8160	CARD	prokka_00995	contig_3	355584	55	303962	305366	-1	55	baeS	3000829.0	897.5010000000002	850.0	Strict	95.93	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MKFWRPGITGKLFLAIFATCIVLLITMHWAVRISFERGFIDYIKHGNEQRLQMLGDALGEQYAQHGNWRFLRNNDRFVFQILRSLEHDNNEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPVPPDGTRRPIMVNGAEVGAVIASPVERLTRNTDINFDRQQRQTSWLIVALSTLLAALATFPLARGLLAPVKRLVDGTHKLAAGDFTTRVAPTSEDELGRLAEDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETLASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPIDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLKISAEQHDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGLSITVELPLERDLQREV	ATGAAGTTCTGGCGACCCGGTATTACCGGCAAACTGTTTCTGGCGATTTTCGCCACCTGCATTGTCTTATTGATCACGATGCACTGGGCGGTACGTATCAGTTTTGAGCGCGGCTTTATCGATTACATCAAGCATGGTAATGAACAACGGCTGCAAATGCTCGGCGATGCGCTTGGTGAGCAGTACGCCCAGCACGGGAACTGGCGCTTCCTGCGTAATAACGATCGCTTTGTATTTCAGATCCTACGTTCACTGGAGCATGATAACAACGAAGATAAGCCCGGCCCCGGTATGCCGCCACACGGCTGGCGCACACAATTTTGGGTGGTTGATCAAAACAACAAAGTGCTGGTTGGCCCGCGAGCACCAGTTCCACCCGACGGCACACGGCGGCCCATTATGGTCAATGGTGCGGAAGTTGGCGCGGTGATCGCCTCCCCTGTTGAACGACTGACCCGTAATACTGATATCAATTTTGACAGACAACAGCGGCAAACCAGTTGGCTGATTGTGGCTTTATCTACCTTATTAGCGGCGCTGGCGACATTCCCACTGGCGCGCGGTTTGCTGGCTCCGGTAAAACGACTGGTGGATGGCACGCACAAACTGGCAGCGGGTGATTTCACTACTCGCGTAGCCCCCACCAGCGAAGATGAGTTGGGCAGACTGGCAGAGGATTTCAATCAACTCGCCAGCACACTGGAGAAAAACCAGCAGATGCGCCGCGATTTTATGGCCGATATTTCTCATGAACTGCGCACGCCTTTAGCAGTACTGCGCGGCGAACTGGAAGCCATTCAGGATGGTGTGCGTAAATTCACGCCGGAGACGCTGGCTTCTTTACAGGCAGAAGTAGGTACACTGACAAAACTGGTTGACGATCTCCATCAATTGTCTATGTCTGATGAAGGCGCTCTCGCCTATCAAAAAGCACCGATAGATTTGATCCCACTGCTGGAAGTGGCGGGAGGCGCATTTCGCGAACGATTCGCCAGCCGTGGCCTGAAATTGCAATTTTCCCTGCCAGACAGTATTACCGTATTTGGCGATCGCGATCGTTTAATGCAGTTGTTCAATAACTTACTGGAAAACAGCCTGCGCTACACTGACAGCGGCGGCAGCCTGAAAATCTCTGCCGAGCAGCACGACAAAACGGTGCGCCTGACCTTTGCCGACAGTGCGCCGGGTGTCAGTGACGATCAGCTACAAAAATTGTTTGAACGTTTTTATCGCACCGAAGGTTCCCGCAACCGCGCCAGCGGTGGTTCCGGGCTGGGGCTGGCGATTTGCCTGAACATTGTTGAAGCACATAACGGCCGCATTATTGCCGCCCATTCGCCTTTTGGCGGGCTTAGCATTACAGTAGAGTTACCGCTGGAACGGGATTTACAGAGAGAAGTATGA	
8160	CARD	prokka_00997	contig_3	355584	55	306778	309856	-1	50	mdtC	3000794.0	2052.33	1800.0	Strict	98.73	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAISNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQSTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATIIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRGERSETAQQIIDRLRKKLAKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQEDNGAEMNLIYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRMRFSRKPKQAVTE	GTGAAGTTTTTTGCCCTCTTCATTTACCGCCCGGTGGCGACGATTTTACTGTCGGTCGCCATTACCCTGTGCGGCATACTGGGTTTCCGTATGCTGCCAGTCGCCCCGCTGCCGCAGGTCGATTTTCCGGTGATCATGGTCAGCGCCTCGCTGCCCGGTGCGTCACCAGAAACAATGGCGTCTTCCGTTGCCACGCCGCTGGAGCGCTCACTTGGGCGCATTGCCGGAGTCAGCGAAATGACCTCCAGCAGTTCGCTCGGCAGCACGCGCATTATTTTGCAGTTTGATTTTGACCGGGATATCAACGGCGCAGCGCGCGATGTGCAGGCGGCGATCAACGCCGCGCAAAGTCTGCTACCCAGCGGGATGCCCAGCCGTCCGACCTATCGCAAAGCGAACCCATCGGATGCGCCAATTATGATCCTCACGCTGACATCCGATACTTATTCGCAGGGTGAACTGTACGATTTCGCCTCGACACAGCTGGCTCCGACGATTTCGCAAATCGACGGTGTCGGTGATGTCGATGTTGGCGGCAGCTCGCTGCCCGCCGTACGCGTCGGGCTGAATCCGCAGGCGCTGTTTAATCAGGGCGTCTCGCTGGACGACGTACGCACCGCCATCAGCAATGCCAACGTGCGTAAACCGCAGGGGGCGCTGGAAGATGGTACTCACCGCTGGCAGATCCAGACTAACGATGAACTGAAAACCGCCGCTGAATATCAGCCGCTGATTATTCATTACAACAACGGCGGAGCGGTTCGTCTGGGCGATGTGGCGACGGTGACCGACTCAGTACAGGATGTGCGCAACGCCGGGATGACCAACGCCAAACCGGCTATTTTGCTGATGATCCGCAAGCTGCCGGAAGCCAATATTATCCAGACGGTAGACAGCATCCGCGCCCGTCTGCCGGAATTACAATCCACCATCCCGGCAGCAATTGATCTGCAAATTGCCCAAGATCGCTCCCCTACTATCCGCGCGTCGCTGGAAGAGGTTGAGCAGACGCTGGTAATCTCAGTTGCACTGGTGATTCTGGTGGTGTTTTTGTTCCTGCGTTCGGGTCGCGCCACCATTATTCCCGCCGTTGCGGTGCCGGTTTCGCTGATTGGTACGTTTGCGGCGATGTACCTGTGTGGTTTCAGTCTCAATAATCTTTCGTTAATGGCGCTCACTATCGCCACTGGCTTTGTGGTGGATGACGCCATCGTGGTGCTGGAAAACATTGCCCGTCATCTGGAAGCGGGGATGAAACCGCTACAGGCCGCGCTACAAGGTACTCGCGAAGTCGGCTTTACGGTGCTGTCGATGAGTCTGTCACTGGTGGCGGTGTTCCTGCCGCTGCTGTTGATGGGCGGATTGCCGGGTCGCCTGTTACGCGAGTTTGCCGTGACGCTTTCTGTCGCCATTGGTATTTCGCTGCTGGTTTCCCTGACGTTAACGCCGATGATGTGCGGCTGGATGCTAAAAGCCAGCAAGCCGCGCGAGCAAAAGCGACTGCGTGGCTTTGGTCGCATGTTGGTAGCCCTGCAACAAGGCTATGGCAAGTCGCTGAAATGGGTGCTCAATCATACCCGTCTGGTGGGCGTGGTGCTGCTTGGCACCATTGCGCTGAATATCTGGCTGTATATCTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGCGTACTGATGGGTGGGATACAGGCTGACCAGAGTATTTCGTTTCAGGCGATGCGCGGTAAGTTGCAGGACTTCATGAAAATTATCCGTGACGATCCGGCGGTGGATAATGTCACCGGCTTTACCGGCGGTTCACGGGTGAACAGTGGAATGATGTTTATCACCCTTAAACCACGCGGCGAGCGGAGCGAAACGGCCCAACAGATTATCGATCGCTTGCGTAAAAAACTGGCTAAAGAACCGGGAGCGAATCTGTTCCTGATGGCGGTACAGGATATTCGCGTTGGCGGACGTCAGGCTAACGCCAGTTACCAGTACACGTTGTTATCCGACGACCTGGCGGCACTGCGCGAATGGGAGCCGAAAATCCGCAAAAAACTGGCGACATTGCCAGAGCTGGCTGATGTTAACTCCGATCAGGAAGATAATGGCGCGGAGATGAACCTTATTTACGATCGCGACACCATGGCGCGATTGGGAATTGACGTGCAAGCCGCCAACAGCCTGTTAAATAACGCCTTCGGTCAGCGGCAAATCTCGACCATTTACCAGCCGATGAACCAGTACAAAGTGGTGATGGAAGTGGATCCGCGCTATACCCAGGACATCAGTGCACTGGAAAAAATGTTCGTTATCAATAACGAAGGAAAAGCGATCCCGCTGTCGTATTTCGCTAAATGGCAACCGGCGAACGCTCCACTGTCGGTGAATCATCAGGGATTATCGGCGGCCTCGACCATTTCGTTCAACCTGCCGACCGGGAAATCGCTCTCGGACGCCAGTGCGGCGATCGATCGCGCAATGACCCAGCTTGGTGTGCCTTCGACGGTGCGCGGCAGTTTTGCCGGAACAGCGCAGGTGTTCCAGGAGACGATGAACTCACAGGTGATCCTGATTATCGCCGCCATCGCCACGGTATATATCGTACTGGGTATCCTTTACGAGAGTTATGTGCATCCACTGACGATTCTCTCCACCCTACCTTCGGCGGGCGTCGGAGCGCTGTTGGCGCTGGAGCTGTTCAATGCCCCGTTCAGCCTAATTGCGCTGATAGGGATCATGTTATTAATCGGCATCGTGAAGAAAAACGCCATTATGATGGTCGATTTTGCGCTTGAAGCCCAACGGCACGGTAACCTGACGCCGCAGGAAGCTATTTTCCAGGCCTGTCTGCTGCGTTTTCGCCCGATTATGATGACTACCCTGGCGGCGCTGTTTGGTGCGCTGCCGCTGGTATTGTCGGGCGGTGACGGCTCGGAGTTGCGGCAACCATTGGGGATCACCATTGTCGGCGGTCTGGTCATGAGCCAGCTTCTGACGCTGTATACCACGCCGGTGGTGTATCTCTTTTTCGACCGTCTGCGGATGCGTTTTTCGCGTAAACCTAAACAAGCGGTAACCGAGTAA	
8160	CARD	prokka_00998	contig_3	355584	55	309856	312979	-1	55	mdtB	3000793.0	2079.29	1800.0	Strict	99.81	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSESVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALMIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA	ATGCAGGTGTTACCCCCGAGCAGCACAGGCGGCCCGTCGCGCCTGTTTATTATGCGTCCTGTCGCCACCACGCTGCTGATGGTGGCGATCTTACTCGCCGGGATTATCGGTTATCGCGCCCTGCCCGTTTCGGCGCTGCCGGAAGTGGACTATCCAACCATTCAGGTGGTCACGCTTTATCCAGGTGCAAGCCCGGATGTCATGACCTCTGCCGTTACCGCGCCGCTCGAACGCCAGTTCGGGCAGATGTCTGGCCTGAAACAGATGTCGTCGCAAAGTTCCGGCGGTGCGTCAGTTATCACTTTACAGTTCCAGCTAACATTGCCGCTGGATGTCGCCGAGCAGGAAGTGCAGGCCGCGATTAACGCTGCGACCAACCTGCTACCGAGCGATCTGCCTAACCCGCCGGTTTACAGCAAAGTGAACCCGGCAGATCCACCGATCATGACGCTCGCTGTCACCTCAACCGCCATGCCGATGACGCAGGTGGAAGATATGGTGGAAACCCGCGTCGCGCAGAAAATCTCGCAGATTTCCGGCGTAGGGCTGGTGACACTTTCCGGCGGGCAGCGTCCGGCGGTACGCGTAAAACTCAACGCTCAGGCAATTGCCGCTCTCGGCCTGACCAGCGAAAGTGTGCGCACCGCCATTACTGGCGCGAACGTTAACTCAGCGAAAGGGAGCCTTGACGGCCCTTCTCGCGCGGTCACGCTGTCAGCGAATGACCAGATGCAATCCGCCGAAGAGTATCGCCAGCTAATCATCGCCTACCAGAACGGCGCACCAATTCGTCTTGGCGATGTCGCAACCGTAGAGCAAGGAGCAGAAAACAGCTGGCTCGGCGCGTGGGCGAACAAAGAACAGGCCATTGTGATGAATGTTCAGCGCCAGCCCGGTGCTAACATTATCTCCACCGCCGACAGCATCCGGCAGATGCTACCACAGCTCACCGAGAGTCTGCCGAAATCGGTGAAGGTGACGGTACTTTCTGACCGTACCACCAATATCCGCGCATCGGTCGACGATACCCAGTTTGAGCTGATGATGGCTATCGCGCTGGTAGTCATGATTATCTACCTGTTTTTGCGCAATATTCCGGCGACCATCATTCCCGGTGTTGCTGTACCGCTGTCGTTAATTGGCACCTTTGCGGTCATGGTGTTTCTCGATTTTTCAATCAATAACCTGACGTTGATGGCGTTAACTATCGCCACCGGATTCGTGGTCGATGACGCCATCGTGGTGATCGAAAACATTTCCCGCTATATCGAAAAAGGCGAAAAACCGCTGGCAGCCGCGCTCAAAGGCGCGGGTGAAATCGGCTTTACCATTATCTCGCTGACCTTCTCGCTGATTGCGGTATTGATCCCCCTGCTGTTTATGGGCGATATCGTCGGGCGACTGTTCCGCGAATTTGCTATTACCCTGGCAGTCGCGATTTTGATCTCAGCAGTGGTGTCGCTGACCCTGACACCGATGATGTGCGCGCGGATGCTCAGCCAGGAGTCGCTGCGTAAACAGAACCGCTTCTCCCGTGCCTCGGAGAAAATGTTCGACAGGATAATCGCCGCCTATGGTCGTGGACTGGCGAAAGTGCTGAATCATCCGTGGCTGACCTTAAGCGTAGCGCTCAGCACGCTGCTGCTTAGCGTGCTGCTGTGGGTGTTCATTCCGAAAGGTTTCTTCCCGGTACAGGACAACGGCATAATTCAGGGCACTTTGCAGGCACCGCAATCCAGCTCCTTTGCCAATATGGCCCAGCGGCAACGCCAGGTCGCGGACGTGATTTTGCAGGATCCGGCAGTGCAAAGTTTGACCTCATTTGTTGGCGTTGATGGCACTAACCCGTCGCTGAACAGTGCGCGTTTACAGATCAATCTCAAACCACTGGATGAACGAGATGACCGGGTGCAAAAAGTCATCGCCCGTCTGCAAACGGCGGTGGATAAAGTGCCGGGCGTAGATCTCTTCCTGCAACCAACGCAGGACCTGACTATTGATACTCAGGTCAGCCGCACCCAGTACCAGTTTACCTTGCAGGCCACGTCACTGGATGCGCTCAGTACCTGGGTGCCACAGTTGATGGAAAAACTCCAGCAGCTGCCACAGCTTTCTGATGTCTCCAGCGACTGGCAGGACAAAGGGCTGGTGGCGTATGTCAATGTCGACAGGGACAGCGCCAGCCGTCTGGGGATCAGCATGGCGGATGTCGATAACGCCCTGTACAACGCGTTTGGTCAGCGACTGATTTCCACTATTTATACTCAGGCTAACCAGTATCGCGTGGTGCTGGAACACAACACCGAAAATACCCCAGGCCTCGCGGCGCTGGATACCATTCGCCTGACCAGCAGCGACGGTGGCGTGGTGCCGTTAAGCTCAATTGCCAAAATTGAGCAGCGTTTTGCGCCGCTTTCCATCAACCATCTGGATCAGTTCCCGGTAACGACTATCTCCTTTAACGTGCCGGATAACTATTCGCTGGGCGATGCGGTGCAGGCGATTATGGACACAGAGAAGACGCTGAATCTGCCGGTGGATATCACCACGCAGTTCCAGGGCAGCACCCTCGCCTTCCAGTCGGCGCTGGGCAGCACTGTCTGGCTGATTGTCGCGGCGGTGGTGGCGATGTATATCGTGCTCGGCATTCTGTACGAGAGCTTTATTCACCCGATCACCATTCTCTCGACGCTACCCACCGCAGGGGTCGGCGCGCTGCTGGCGTTAATGATTGCCGGTAGCGAACTGGATGTGATTGCCATTATCGGCATTATTTTGCTGATCGGTATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCTGCTGAGCGCGAGCAAGGCATGTCGCCGCGCGAAGCTATTTACCAGGCCTGTCTGTTGCGTTTTCGTCCGATCCTGATGACCACTCTGGCGGCTCTGCTTGGTGCGCTGCCGCTGATGTTGAGTACCGGGGTCGGCGCGGAACTGCGTCGTCCGTTAGGTATCGGCATGGTCGGCGGTCTGATTGTCAGCCAGGTGCTGACGCTGTTTACCACGCCGGTGATTTATCTGTTGTTCGACCGTCTGGCATTGTGGACCAAAAGCCGTTTTGCCCGTCATGAAGAGGAGGCGTAA	
8160	CARD	prokka_00999	contig_3	355584	55	312978	314226	-1	55	mdtA	3000792.0	822.002	725.0	Strict	98.55	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKGSYKSRWVIVIVVVIAAIAAFWFWQGRNDSQSAAPGATKQAQQSPAGGRRGMRAGPLAPVQAATAVEQAVPRYLTGLGTITAANTVTVRSRVDGQLMALHFQEGQQVKAGDLLAEIDPSQFKVALAQAQGQLAKDKATLANARRDLARYQQLAKTNLVSRQELDAQQALVSETEGTIKADEASVASAQLQLDWSRITAPVDGRVGLKQVDVGNQISSGDTTGIVVITQTHPIDLVFTLPESDIATVVQAQKAGKPLVVEAWDRTNSKKLSEGTLLSLDNQIDATTGTIKVKARFNNQDDALFPNQFVNARMLVDTEQNAVVIPTAALQMGNEGHFVWVLNSENKVSKHLVTPGIQDSQKVVIRAGISAGDRVVTDGIDRLTEGAKVEVVEAQSATTPEEKAASREDTKKGARS	ATGAAAGGCAGTTATAAATCCCGTTGGGTAATCGTAATCGTGGTGGTTATCGCCGCCATCGCCGCATTCTGGTTCTGGCAAGGCCGCAATGACTCCCAGAGTGCAGCCCCTGGGGCGACGAAACAAGCGCAGCAATCGCCAGCGGGTGGTCGCCGTGGTATGCGTGCCGGCCCATTAGCTCCTGTTCAGGCGGCGACCGCAGTAGAACAGGCTGTTCCACGTTACCTCACCGGGCTTGGCACCATTACCGCCGCTAATACTGTTACGGTGCGCAGCCGCGTGGACGGTCAACTGATGGCGTTACATTTCCAGGAAGGCCAGCAGGTCAAAGCCGGCGATTTACTGGCAGAAATTGACCCAAGCCAGTTCAAAGTTGCATTAGCACAAGCCCAGGGCCAACTGGCAAAAGATAAAGCCACGCTCGCCAACGCCCGCCGTGACCTGGCGCGTTATCAACAACTGGCAAAAACCAATCTCGTATCTCGTCAGGAACTGGATGCCCAACAAGCGCTGGTCAGTGAAACCGAAGGCACCATTAAGGCTGATGAAGCAAGCGTCGCCAGCGCGCAGTTGCAACTCGACTGGAGCCGTATCACCGCACCAGTTGATGGTCGCGTTGGTCTCAAGCAGGTTGATGTTGGTAACCAAATCTCCAGTGGCGACACCACCGGGATTGTGGTGATCACCCAAACACATCCTATCGATCTGGTCTTTACTCTGCCGGAAAGCGATATCGCCACCGTTGTGCAGGCGCAAAAAGCCGGAAAACCGCTGGTGGTAGAAGCCTGGGATCGCACCAACTCGAAGAAATTAAGTGAAGGCACACTGTTAAGCCTTGATAACCAAATCGATGCCACTACCGGTACGATTAAAGTGAAAGCACGCTTTAATAATCAGGATGATGCGCTGTTTCCCAATCAGTTTGTTAACGCACGCATGTTAGTCGACACCGAACAAAACGCCGTGGTGATCCCAACCGCCGCCCTGCAAATGGGCAACGAAGGCCATTTTGTCTGGGTGCTGAATAGCGAAAACAAGGTCAGCAAACATCTGGTGACACCAGGCATTCAGGACAGTCAGAAAGTGGTGATCCGCGCAGGTATTTCTGCGGGCGACCGCGTAGTGACGGACGGAATTGATCGCCTGACCGAAGGGGCGAAAGTGGAAGTGGTGGAAGCCCAGAGCGCCACTACTCCGGAAGAAAAAGCCGCCAGCCGCGAAGACACGAAAAAAGGAGCACGCTCCTGA	
8160	CARD	prokka_01153	contig_4	348350	56	126480	127158	-1	26	kdpE	3003841.0	450.284	400.0	Strict	99.55	100.0	kdpDE	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATAAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFMP	GTGACAAACGTTCTGATTGTTGAAGATGAACAGGCTATTCGTCGCTTTCTGCGCACGGCGCTGGAGGGCGATGGGATGCGCGTCTTTGAGGCCGAAACGCTGCAACGCGGCTTGCTGGAAGCGGCTACCCGTAAGCCAGATTTGATTATTCTCGATCTCGGCCTGCCCGATGGTGATGGGATTGAGTTTATCCGCGACCTGCGCCAGTGGAGCGCGGTGCCGGTGATTGTGCTTTCCGCACGTAGCGAAGAGAGCGACAAAATCGCCGCGCTGGATGCCGGAGCGGATGATTATCTGAGTAAGCCGTTTGGCATTGGCGAATTGCAGGCCCGTCTGCGCGTCGCTTTACGTCGCCACTCCGCCACCGCCGCGCCCGATCCGCTGGTGAAATTTTCCGATGTTACCGTCGATTTAGCCGCCCGCGTTATCCATCGGGGCGAGGAAGAGGTGCATCTCACCCCGATTGAGTTCCGCCTGCTGGCAGTGTTGCTCAACAACGCCGGAAAAGTGCTCACCCAGCGCCAGTTACTCAATCAGGTGTGGGGACCAAACGCGGTCGAACACAGCCACTATTTGCGTATTTATATGGGGCATCTGCGACAAAAACTGGAGCAAGATCCCGCCCGCCCCCGCCATTTTATTACTGAAACCGGTATTGGGTATCGGTTTATGCCATGA	
8160	CARD	prokka_01300	contig_4	348350	56	281277	282510	1	48	Escherichia coli mdfA	3001328.0	786.949	700.0	Strict	97.07	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG	ATGCAAAATAAATTAGCTTCCGGTGCCAGGCTTGGACGTCAGGCGTTACTTTTCCCTCTCTGTCTGGTGCTTTACGAATTTTCAACCTATATCGGCAACGATATGATTCAACCCGGTATGTTGGCCGTGGTGGAACAATATCAGGCGGGCATTGATTGGGTTCCTACTTCGATGACTGCGTATCTGGCGGGCGGGATGTTTTTACAATGGCTCCTGGGGCCGTTGTCGGATCGTATTGGCCGCCGTCCGGTGATGCTGGCGGGAGTGGTGTGGTTTATCGTCACCTGTCTGGCAATATTACTGGCACAAAACATTGAACAATTCACCCTGTTGCGCTTCTTGCAGGGTATAAGCCTCTGTTTCATTGGCGCTGTGGGATACGCCGCAATTCAGGAATCCTTCGAAGAGGCGGTTTGTATCAAGATCACCGCGCTAATGGCGAACGTGGCGCTGATTGCTCCACTACTTGGTCCGCTGGTGGGCGCGGCGTGGATCCATGTGCTGCCCTGGGAAGGGATGTTTGTCTTGTTTGCCGCATTGGCAGCGATCTCCTTTTTCGGTCTGCAACGAGCTATGCCTGAAACCGCCACGCGTATAGGCGAGAAACTGTCGCTGAAAGAACTCGGTCGTGACTATAAGCTGGTGCTGAAGAACGGTCGCTTTGTGGCGGGGGCGCTGGCGCTGGGATTCGTTAGCCTGCCGTTGCTGGCGTGGATCGCCCAGTCGCCGATTATCATTATTACCGGTGAGCAGTTGAGCAGCTATGAATATGGCCTGCTGCAAGTGCCTATTTTTGGGGCGTTAATTGCGGGTAACTTGCTGTTAGCGCGTCTGACCTCGCGCCGCACCGTACGTTCGCTGATTATTATGGGCGGCTGGCCGATTATGATTGGTCTGTTGGTCGCTGCTGCGGCAACGGTTATCTCATCGCACGCGTATTTATGGATGACCGCCGGGTTAAGTATTTATGCTTTCGGTATTGGTCTGGCGAATGCGGGACTGGTGCGATTAACCCTGTTTGCCAGCGATATGAGTAAAGGTACGGTTTCTGCGGCGATGGGGATGCTGCAAATGCTGATCTTTACCGTCGGTATTGAAATCAGCAAACATGCCTGGCTGAACGGGGGCAACGGACTGTTTAATCTCTTCAACCTTGTCAACGGCATTTTGTGGCTGTCGCTGATGGTTATCTTTTTAAAAGATAAACAGATGGGAAATTCGCACGAAGGGTAA	
8160	CARD	prokka_01540	contig_5	336402	60	188135	189779	1	79	eptA	3003576.0	1104.74	1000.0	Strict	96.53	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MLKRLLKRPSLNLFSWLLLATFYISVCLNIAFFKQVLQVLPLDSLHNVLVFLSMPVVAFSVINIVLTLGSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMITNIIDTTPAESYALMTPRMLLTLGLSGVLAAIIACWIKIKPTTSRLRSVLFRGANILISVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRSANLPLIRIGEDAHRNPLMQNGKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGVCDRVPHQNVTALNLPGQCINGECYDEVLFHGLEDYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTQEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE	ATGTTGAAGCGCCTACTAAAAAGACCCTCTTTGAATTTATTCTCCTGGTTATTACTTGCTACTTTTTATATCTCAGTCTGCCTGAATATCGCCTTTTTTAAACAGGTGCTACAGGTGTTACCGCTGGATTCACTGCATAACGTGCTGGTTTTCTTGTCGATGCCGGTCGTCGCATTCAGCGTGATTAATATTGTCCTGACACTAGGCTCTTTCTTATGGCTTAATCGTCCACTCGCCTGCCTGTTTATTCTGGTCGGTGCGGCTGCGCAATATTTCATCATGACCTATGGCATCGTCATCGACCGTTCAATGATCACCAATATCATTGATACTACGCCGGCGGAAAGTTATGCCCTGATGACGCCACGAATGTTATTAACGCTGGGGTTAAGTGGCGTATTAGCCGCGATTATTGCCTGCTGGATCAAAATCAAACCCACCACCTCACGCCTGCGCAGCGTTCTTTTCCGCGGGGCCAACATCCTGATTTCTGTACTGCTGATTCTGCTGGTTGCCGCACTGTTCTACAAAGACTATGCCTCGCTGTTTCGCAACAACAAAGAACTGGTGAAATCCTTAAGCCCGTCCAACAGCATTGTTGCTAGCTGGTCGTGGTACTCTCACCAGCGGTCAGCCAACCTGCCACTGATACGCATTGGTGAAGATGCTCACCGCAACCCATTAATGCAAAATGGGAAACGTAAAAACCTGACCATTTTGATCGTCGGAGAAACGTCGCGCGCAGAGAATTTCTCGCTGAATGGTTATCCACGCGAAACCAATCCTCGTCTGGCAAAAGATAACGTGGTCTATTTCCCTAATACCGCCTCTTGCGGCACGGCAACGGCAGTTTCAGTACCATGCATGTTCTCGGATATGCCGCGTGAGCACTACAAAGAAGAGCTGGCACAGCACCAGGAAGGCGTGCTGGATATCATTCAGCGAGCGGGCATCAACGTGCTGTGGAATGACAACGATGGCGGCTGTAAAGGCGTTTGCGATCGCGTACCTCACCAGAACGTCACCGCGCTGAACCTGCCTGGTCAGTGCATCAACGGCGAATGCTATGATGAAGTGCTGTTCCACGGGCTGGAAGATTACATCAATAACCTGCAGGGTGATGGCGTGATTGTCTTACACACCATCGGCAGCCACGGCCCGACCTATTACAACCGCTATCCGCCGCAGTTCAGGAAATTTACCCCAACCTGCGACACTAACGAGATCCAGACCTGTACCCAAGAGCAACTGGTGAACACTTACGACAACACGCTGGTTTACGTCGACTATATTGTTGATAAAGCGATTAATCTGCTGAAAGAACATCAGGATAAATTTACCACCAGCCTGGTTTATCTTTCTGACCACGGTGAATCGTTAGGTGAAAATGGCATCTATCTGCACGGTCTGCCTTATGCCATCGCCCCGGATAGCCAAAAACAGGTGCCGATGCTGCTGTGGCTATCGGAGGATTATCAAAAACGGTATCAGGTTGACCAGAACTGCCTGCAAAAACAGGCGCAAACGCAACACTATTCACAAGACAATTTATTCTCAACCTTATTGGGCCTGACTGGCGTTGAGACGAAGTATTACCAGGCTGCGGATGATATTCTGCAAACTTGCAGGAGAGTGAGTGAATGA	
8160	CARD	prokka_01573	contig_5	336402	60	219002	220034	1	40	mdtN	3003548.0	680.633	600.0	Strict	98.83	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		nucleoside antibiotic; acridine dye; disinfecting agents and intercalating dyes	MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIVELAVSDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVNATVEKARAAAKQASDTLRRTEPLLREGFVSAEEVDRARTAQRAAEADLNAVLLQAQSAASAVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLIDTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGLPKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ	ATGGAAAGTACGCCGAAAAAAGCTCCTCGCAGTAAATTCCCTGCTCTGTTAGTGGTTGCGTTGGCGCTGGTTGCCCTTGTTTTCGTTATCTGGCGCGTAGACAGTGCGCCATCAACTAATGACGCTTACGCGTCAGCAGATACCATTGATGTGGTGCCGGAAGTCAGCGGTCGCATTGTAGAACTGGCGGTCAGCGACAACCAGGCGGTGAAACAGGGCGATTTGCTGTTCCGCATTGACCCGCGCCCGTACGAAGCCAATCTGGCGAAAGCTGAAGCCTCCCTCGCGGCGCTGGATAAGCAAATTATGCTCACCCAGCGTAGCGTTGACGCGCAACAGTTTGGTGCCGACTCGGTTAATGCCACGGTAGAAAAAGCCCGTGCCGCCGCGAAACAAGCCAGCGATACGTTACGCCGTACCGAACCGCTACTGCGAGAAGGTTTTGTTTCTGCGGAAGAGGTTGACCGTGCAAGAACCGCCCAGCGTGCGGCAGAAGCGGACCTTAATGCCGTATTGTTGCAGGCGCAGTCAGCCGCCAGTGCCGTCAGCGGCGTCGATGCGCTGGTCGCCCAACGTGCGGCGGTCGAAGCGGATATTGCCCTGACCAAACTGCATCTGGAAATGGCGACCGTTCGCGCGCCGTTTGATGGCCGGGTCATTTCCCTCAAAACCTCCGTCGGGCAATTTGCTTCTGCCATGCGCCCTATTTTCACCCTAATCGACACTCGTCACTGGTACGTGATCGCCAATTTCCGCGAAACTGATCTGAAAAATATTCGCTCAGGTACACCCGCAACGATTCGCCTGATGAGCGACAGCGGCAAAACCTTCGAGGGTAAAGTGGATTCGATTGGCTACGGCGTGCTACCGGATGACGGCGGCCTGGTGCTGGGCGGCCTGCCGAAAGTGTCGCGTTCTATTAACTGGGTCCGCGTTGCCCAGCGTTTTCCGGTCAAAATCATGGTTGATAAACCTGACCCGGAAATGTTCCGCATCGGCGCTTCGGCAGTCGCTAATCTTGAGCCGCAATAA	
8160	CARD	prokka_01574	contig_5	336402	60	220033	222085	1	57	mdtO	3003549.0	1384.39	1300.0	Strict	98.39	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		nucleoside antibiotic; acridine dye; disinfecting agents and intercalating dyes	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAIAEGQCWQSDWRITESEAMAARECNLENICQTLLQLGQMDPNTPPTPATKPPSIVADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVVLERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPAKEQAQGATQ	ATGAGCGCGCTCAACTCCCTGCCATTACCGGTGGTCAGGCTGCTGGCGTTCTTTCATGAAGAGTTAAGCGAGCGGCGGCCAGGTCGTGTGCCGCAGACCGTGCAACTCTGGGTAGGCTGCCTACTGGTGATTCTGATCTCGATGACTTTTGAGATCCCTTTTGTGGCGTTATCGCTGGCAGTGCTGTTTTACGGTATTCAGTCGAACGCGTTTTACACCAAATTTGTGGCGATCTTGTTTGTGGTTGCCACGGTGCTGGAGATCGGCAGCCTGTTTTTGATCTACAAATGGTCATACGGCGAACCGTTGATCCGATTGATCATCGCCGGGCCGATCCTGATGGGCTGCATGTTTTTGATGCGCACCCATCGGCTGGGGCTGGTCTTTTTCGCCGTCGCCATTGTCGCTATTTACGGGCAAACCTTCCCCGCCATGCTCGACTATCCGGAAGTGGTCGTGCGCTTAACCCTGTGGTGTATCGTTGTCGGCCTCTACCCGACGTTATTGATGACGTTAATCGGCGTGCTGTGGTTTCCCAGCCGCGCTATCACGCAGATGCATCAGGCGCTTAATGATCGGCTTGATGATGCCATTAGCCACCTGACGGACAGCCTCGCACCGCTACCCGAAACGCGGATTGAAAGAGAGGCGCTGGCGCTGCAAAAACTCAATGTCTTTTGCCTCGCGGACGATGCCAACTGGCGAACTCAGAGCGCATGGTGGCAAAGCTGCGTGGCAACGGTAACCTACATTTACTCGACGCTGAATCGCTACGATCCCACCTCTTTTGCTGATTCTCAGGCAATTATTGAATTCCGACAAAAATTAGCCTCAGAAATCAACAAACTGCAGCATGCCATTGCCGAAGGTCAGTGCTGGCAAAGCGACTGGCGGATCACTGAAAGTGAAGCGATGGCGGCACGGGAATGTAACCTGGAGAATATCTGCCAGACATTGTTGCAACTGGGTCAGATGGACCCGAATACGCCGCCAACGCCCGCCACCAAACCGCCATCAATAGTCGCCGACGCTTTTACCAATCCAGACTATATGCGCTACGCGGTAAAAACGCTGCTCGCCTGTTTGATCTGTTACACCTTCTACAGCGGCGTGGACTGGGAAGGCATTCACACCTGTATGCTGACCTGCGTGATCGTCGCTAATCCAAATGTCGGTTCGTCGTACCAGAAGATGGTGCTGCGTTTTGGCGGGGCCTTTTGCGGCGCGATTCTGGCGCTGTTATTCACGCTACTGGTCATGCCCTGGCTGGACAATATTGTCGAATTGCTGTTTGTGCTGGCACCGATTTTCCTGTTGGGCGCATGGATTGCCACCAGCTCTGAACGCTCTTCTTATATCGGCACACAGATGGTGGTCACCTTCGCGCTCGCCACGCTCGAAAACGTTTTTGGCCCGGTGTACGACCTGGTGGAAATTCGCGATCGCGCTCTGGGTATCATCATTGGTACCGTGGTGTCGGCGGTGATTTACACCTTTGTCTGGCCTGAAAGCGAAGCGCGCACGCTGCCGCAAAAACTGGCTGGCGCGCTGGGTATGTTGAGTAAAGTAATGCGGATCCCACGCCAGCAGGAAGTCACGGCTCTGCGCACTTATCTGCAAATTCGCATAGGTCTGCATGCGGCGTTTAATGCCTGTGAAGAGATGTGCCAACGCGTGGTGCTGGAGCGTCAACTGGACAGCGAAGAACGCGCCTTACTGATTGAACGTTCGCAAACGGTTATTCGTCAGGGCCGCGATATTCTTCACGCCTGGGATGCCACCTGGAACTCGGCGCAGGCGCTGGATAACGCACTACAGCCGGACAGAGCAGGTCAGTTTGCCGACGCACTGGAGAAATACGCCGCTGGTCTGGCAACCGCACTCAGCCGTTCTCCTCAAATAACGCTTGAAGAAACACCCGCCTCGCAGGCCATCCTGCCCACCTTATTAAAACAGGAGCAACACGTCTGCCAGCTTTTCGCCCGCTTGCCAGACTGGACAGCCCCGGCATTAACGCCCGCCAAGGAACAGGCACAAGGAGCCACACAATGA	
8160	CARD	prokka_01575	contig_5	336402	60	222081	223548	1	62	mdtP	3003550.0	977.622	875.0	Strict	98.16	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		nucleoside antibiotic; acridine dye; disinfecting agents and intercalating dyes	MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLNGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAISAHNAALAETAAVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPQVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAAPVVEKK	ATGATCAATCGTCAACTTTCACGTCTGCTGTTGTGCAGCATTCTCGGCAGCACGACGCTGATTTCCGGCTGTGCCCTGGTACGTAAGGATTCTGCGCCTCATCAACAGCTCAAACCGGAACAAATCAAACTGGCCGATGATATTCATCTTGCCAGCTCCGGCTGGCCGCAGGCGCAGTGGTGGAAACAACTCAATGACCCGCAGCTGGATGCGCTGATCCAACGGACTCTAAATGGTTCACACACCCTCGCCGAAGCGAAACTGCGGGAAGAAAAAGCGCAGTCCCAGGCCGATTTGTTAGATGCCGGTTCACAATTACAGGTCGCAGCGTTAGGGATGCTCAACCGCCAACGCGTCTCGGCGAACGGCTTTTTAAGCCCTTATGCGATGGATGCGCCAGCACTGGGTATGGACGGGCCGTACTATACGGAAGCCACAGTCGGTTTGTTTGCCGGACTGGATCTCGATTTGTGGGGTGTGCATCGCTCAGCGGTTGCTGCCGCCATTAGCGCGCATAATGCCGCGCTGGCAGAAACCGCAGCAGTAGAGCTATCGCTGACCACGGGCGTAGCGCAGCTTTATTACAGTATGCAGGCCAGCTATCAGATGCTCGATCTGTTAGAACAAACTCGCGATGTGATTGATTACGCGGTGAAAGCGCACCAGAGTAAAGTGGCGCACGGTCTGGAAGCGCAAGTGCCTTTCCACGGCGCGCGGGCACAGATTCTGGCGGTCGATAAACAAATTGCTGCCGTCAAAGGGCAAATCACCGAAACGCGAGAATCTCTGCGTGCATTGATTGGCGCGGGAGCCAGCGATATGCCGGAGATCAAACCGGTGGCATTACCGCAAGTCCAGACCGGTATTCCGGCGACACTCTCTTATGAGTTGCTCGCCAGACGCCCGGATCTGCAAGCCATGCGCTGGTATGTTCAGGCGTCATTAGATCAGGTGGATTCCGCGCGGGCGCTGTTCTATCCGAGCTTTGATATCAAAGCGTTTTTCGGCCTGGATTCTATCCACCTGGATACCTTATTCAAAAAAACCAGTCGCCAGTTCAACTTTATCCCAGGTCTGAAATTGCCGCTGTTTGACGGTGGACGGTTGAATGCCAATCTCGAAGGCACTCGCGCCGCCAGCAACATGATGATTGAACGTTACAACCAGTCAGTACTGAACGCGGTGCGTGACGTTGCCGTCAACGGCACACGTCTGCAAACGCTCAACGACGAGCGAGAGATGCAGGCTGAACGCGTAGAAGCAACGCGCTTCACCCAGCGCGCAGCCGAGGCCGCCTACCAACGCGGCTTAACCAGCCGCTTACAGGCCACCGAAGCCCGGTTGCCAGTGCTTGCCGAAGAGATGTCATTACTGATGCTGGACAGCCGCCGGGTGATCCAAAGCATTCAGTTGATGAAATCGCTGGGCGGCGGGTATCAGGCGGCTCCCGTCGTCGAGAAAAAATAA	
8160	CARD	prokka_01766	contig_6	291411	57	71672	73421	1	54	msbA	3003950.0	1189.48	1000.0	Strict	99.66	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLMWMPLVVIGLMILRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	ATGCATAACGACAAAGATCTCTCTACGTGGCAGACGTTCCGCCGACTGTGGCCAACCATTGCGCCTTTTAAAGCGGGTCTGATCGTGGCGGGCGTAGCGTTAATCCTCAACGCAGCCAGCGATACCTTCATGTTATCGCTCCTTAAGCCACTTCTTGATGATGGCTTTGGTAAAACAGATCGCTCCGTGCTGATGTGGATGCCGCTGGTGGTGATCGGGCTGATGATTTTACGTGGTATCACCAGCTATATCTCCAGCTACTGTATCTCCTGGGTATCAGGAAAGGTGGTAATGACTATGCGTCGCCGCCTGTTTGGTCACATGATGGGAATGCCGGTTTCATTCTTTGACAAACAGTCAACGGGTACGCTGTTGTCACGTATCACCTACGATTCCGAACAGGTCGCTTCTTCTTCTTCCGGCGCACTGATTACTGTTGTGCGTGAAGGTGCGTCGATCATCGGCCTGTTCATCATGATGTTCTATTACAGTTGGCAACTGTCGATCATTTTGATTGTGCTGGCACCGATTGTTTCGATTGCGATTCGCGTTGTATCGAAGCGTTTTCGCAACATCAGTAAAAACATGCAGAACACCATGGGGCAGGTGACCACCAGCGCCGAACAAATGCTGAAAGGCCATAAAGAAGTATTGATTTTCGGTGGTCAGGAAGTGGAAACGAAACGCTTCGATAAAGTCAGCAACCGAATGCGTCTTCAGGGGATGAAAATGGTTTCAGCCTCTTCCATCTCTGATCCGATCATTCAGCTGATCGCCTCTTTGGCGCTGGCGTTTGTTCTGTATGCGGCAAGCTTCCCAAGTGTCATGGATAGCCTGACTGCCGGTACGATTACCGTTGTTTTCTCTTCAATGATTGCACTTATGCGTCCGCTGAAATCGCTGACCAACGTTAACGCCCAGTTCCAGCGCGGTATGGCGGCTTGTCAGACGCTGTTTACCATTCTGGACAGTGAGCAGGAGAAAGACGAAGGTAAGCGCGTGATCGAGCGTGCGACTGGCGACGTGGAGTTTCGCAATGTCACCTTTACTTATCCGGGACGTGATGTGCCTGCATTGCGTAACATCAACCTGAAAATTCCGGCAGGGAAGACGGTTGCTCTGGTTGGCCGCTCTGGTTCAGGTAAATCAACCATCGCCAGCCTAATCACACGTTTTTACGATATTGATGAAGGCGAAATCCTGATGGATGGTCACGATCTGCGCGAGTATACCCTGGCGTCGTTACGTAACCAGGTTGCTCTGGTGTCGCAGAATGTCCATCTGTTTAACGATACGGTTGCCAACAACATTGCTTACGCAAGGACTGAACAGTACAGCCGTGAGCAAATTGAAGAAGCTGCGCGTATGGCCTACGCCATGGACTTCATCAATAAGATGGATAACGGTCTCGATACAGTCATTGGTGAAAACGGCGTGTTGCTCTCTGGCGGTCAGCGTCAGCGTATTGCTATCGCTCGAGCCTTGTTGCGTGATAGCCCGATACTGATTCTGGACGAAGCTACCTCGGCGTTGGATACCGAATCCGAACGTGCGATTCAGGCAGCACTGGATGAGTTGCAGAAAAACCGTACCTCTCTGGTGATTGCCCACCGCTTGTCTACCATTGAAAAGGCAGACGAAATCGTGGTTGTCGAGGATGGTGTCATTGTGGAACGCGGTACGCATAACGATTTGCTTGAGCACCGTGGCGTTTACGCGCAACTTCACAAAATGCAGTTTGGCCAATGA	
8160	CARD	prokka_01883	contig_6	291411	57	198067	199294	-1	58	mdtG	3001329.0	806.5939999999998	700.0	Strict	99.75	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fosfomycin	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN	ATGTCACCCTGTGAAAATGACACCCCTATAAACTGGAAACGAAACCTGATCGTCGCCTGGCTAGGCTGTTTTCTTACCGGTGCCGCCTTCAGCCTGGTAATGCCCTTCTTACCCCTCTACGTTGAGCAGCTTGGCGTTACCGGCCACTCCGCCCTGAATATGTGGTCCGGTATTGTCTTCAGCATTACATTTTTATTTTCGGCCATCGCCTCACCGTTTTGGGGTGGACTCGCCGATCGTAAAGGCCGAAAACTCATGCTATTACGCTCTGCTCTCGGCATGGGCATCGTGATGGTGTTGATGGGACTGGCACAAAATATCTGGCAGTTTTTGATCCTGCGGGCGCTTCTTGGTTTACTTGGCGGATTTGTCCCCAACGCTAATGCTCTTATCGCCACACAAGTACCGCGTAATAAAAGCGGCTGGGCGCTGGGTACGCTCTCCACAGGCGGCGTTAGCGGCGCGTTGCTCGGCCCAATGGCTGGCGGTTTGCTCGCCGATAGCTACGGCTTACGTCCGGTATTCTTTATTACCGCCAGTGTGCTCATACTCTGCTTTTTCGTCACCCTGTTTTGCATCAGAGAAAAATTCCAGCCGGTCAGCAAAAAAGAGATGCTGCACATGCGGGAAGTGGTGACATCACTTAAAAACCCGAAACTGGTACTCAGCCTGTTTGTCACCACGTTAATCATCCAGGTGGCGACGGGCTCAATTGCCCCCATTCTGACGCTGTATGTCCGCGAACTGGCGGGTAACGTCAGTAACGTCGCCTTTATCAGTGGCATGATCGCCTCGGTGCCAGGCGTGGCGGCTCTGCTAAGTGCACCACGACTCGGCAAACTTGGCGATCGAATCGGACCCGAAAAGATCCTGATTACGGCGCTGATCTTTTCTGTACTGCTGTTGATCCCAATGTCTTACGTTCAGACGCCATTGCAACTTGGGATTTTACGTTTTTTGCTCGGTGCCGCCGATGGTGCACTACTCCCCGCCGTACAGACACTATTAGTTTATAACTCGAGCAACCAGATCGCCGGGCGTATCTTCAGCTATAACCAATCGTTTCGTGATATTGGCAACGTTACCGGACCATTGATGGGAGCAGCGATTTCAGCGAACTACGGTTTTAGGGCGGTATTTCTCGTCACCGCTGGCGTAGTGTTATTCAACGCAGTCTATTCATGGAACAGTCTACGTCGTCGTCGAATCCCCCAGATATCGAACTGA	
8160	CARD	prokka_01895	contig_6	291411	57	207922	209131	-1	55	mdtH	3001216.0	801.201	750.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	ATGTCCCGCGTGTCGCAGGCGAGGAACCTGGGTAAATATTTCCTGCTCATCGATAATATGCTGGTCGTGCTGGGGTTCTTTGTTGTCTTCCCGCTGATCTCTATCCGCTTCGTTGATCAAATGGGCTGGGCCGCCGTCATGGTCGGTATTGCCCTCGGTCTACGCCAGTTTATTCAGCAAGGTCTGGGTATTTTCGGCGGCGCAATTGCCGACCGCTTTGGTGCCAAACCGATGATTGTCACCGGTATGCTGATGCGTGCCGCCGGATTCGCCACAATGGGTATCGCCCACGAACCGTGGCTACTGTGGTTTTCATGCCTGCTTTCGGGACTCGGCGGCACGTTGTTTGATCCTCCGCGTTCGGCGCTGGTGGTGAAACTAATCCGTCCACAACAGCGTGGTCGTTTTTTCTCGCTGTTGATGATGCAGGACAGTGCCGGTGCGGTCATTGGCGCATTGTTGGGGAGCTGGCTGTTGCAATACGACTTTCGCCTGGTCTGCGCCACAGGGGCAGTTTTGTTTGTGCTGTGTGCGGCGTTCAATGCGTGGTTGTTACCAGCATGGAAACTCTCCACCGTACGCACGCCCGTTCGCGAAGGCATGACCCGCGTGATGCGCGACAAGCGTTTTGTCACCTATGTCCTGACGCTGGCGGGTTACTACATGCTGGCTGTACAAGTGATGCTGATGCTGCCAATTATGGTCAACGACGTGGCTGGCGCGCCCTCTGCCGTTAAATGGATGTATGCCATTGAAGCGTGTCTGTCGTTAACGTTGCTCTACCCTATCGCCCGCTGGAGTGAAAAGCATTTTCGTCTGGAACACCGGTTAATGGCTGGGCTGTTGATAATGTCATTAAGCATGATGCCAGTGGGCATGGTCAGCGGCCTGCAACAACTTTTCACCCTGATTTGTCTGTTTTATATCGGGTCGATCATTGCCGAGCCTGCGCGTGAAACCTTAAGTGCTTCGCTGGCAGACGCAAGAGCTCGCGGCAGCTATATGGGATTTAGCCGTCTGGGTCTGGCGATTGGCGGCGCTATTGGTTATATCGGTGGCGGCTGGCTGTTTGACCTGGGCAAATCGGCGCACCAGCCAGAGCTTCCGTGGATGATGCTGGGCATTATTGGCATCTTCACTTTCCTTGCGCTGGGTTGGCAGTTTAGCCAGAAACGCGCCGCGCGTCGTTTGCTTGAACGCGACGCCTGA	
8160	CARD	prokka_02307	contig_8	229899	56	127276	130390	-1	58	acrD	3000491.0	2125.13	1900.0	Strict	99.9	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNKIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	ATGGCGAATTTCTTTATTGATCGCCCCATTTTTGCCTGGGTGCTGGCAATCCTGTTGTGTCTGACAGGTACCCTGGCGATTTTTTCATTGCCCGTTGAACAATACCCCGATCTCGCGCCACCGAATGTGCGAGTGACCGCTAACTATCCCGGCGCATCGGCCCAGACGCTGGAAAACACCGTGACCCAGGTTATCGAGCAAAATATGACCGGCCTCGATAATCTGATGTATATGTCATCTCAGAGCAGCGGCACCGGTCAGGCATCTGTCACGTTAAGTTTTAAAGCAGGCACCGATCCGGACGAAGCCGTGCAGCAAGTACAAAACCAGCTGCAATCAGCCATGCGAAAGTTACCGCAGGCGGTGCAAAATCAGGGCGTGACGGTGCGTAAAACCGGCGATACCAACATTCTGACCATTGCCTTCGTCTCTACCGATGGTTCGATGGATAAACAGGATATTGCCGATTATGTTGCCAGTAATATTCAGGACCCGTTAAGCCGCGTGAATGGCGTCGGGGATATCGATGCCTATGGTTCGCAATATTCCATGCGTATCTGGCTGGACCCGGCGAAACTCAACAGTTTCCAGATGACGGCTAAAGATGTCACCGATGCCATTGAATCACAGAACGCGCAGATTGCGGTTGGGCAACTTGGTGGTACGCCTTCCGTCGATAAGCAGGCGCTCAACGCCACCATTAACGCCCAGTCACTGCTGCAAACACCAGAACAGTTCCGCGATATCACCTTGCGGGTGAATCAGGACGGCTCAGAGGTAAGGCTGGGCGATGTCGCCACCGTCGAAATGGGGGCGGAGAAATACGATTATCTTAGCCGCTTCAATGGTAAGCCAGCCTCCGGGCTGGGGGTAAAACTGGCCTCCGGCGCGAACGAAATGGCGACAGCGGAGCTGGTGCTCAATCGTCTCGACGAGCTGGCGCAGTATTTTCCACACGGACTGGAATACAAGGTGGCGTATGAAACCACCTCTTTTGTAAAAGCCTCCATTGAAGACGTGGTGAAAACGCTTCTGGAAGCTATCGCCCTGGTTTTCCTCGTTATGTATCTGTTCCTGCAAAACTTCCGCGCCACGCTGATACCCACTATCGCCGTGCCGGTGGTGTTGATGGGAACCTTCTCGGTGCTTTATGCCTTCGGCTATAGCGTCAACACCTTAACCATGTTCGCGATGGTGCTGGCGATCGGTCTGCTGGTGGATGATGCCATCGTGGTGGTGGAAAACGTCGAACGTATTATGAGTGAGGAAGGACTCACTCCTCGCGAAGCCACACGTAAATCGATGGGGCAGATCCAGGGGGCACTGGTCGGGATTGCGATGGTGCTTTCGGCGGTATTTGTGCCAATGGCCTTCTTCGGCGGCACCACCGGTGCCATCTATCGCCAGTTCTCTATTACCATTGTTGCGGCGATGGTGCTGTCAGTACTGGTAGCGATGATCCTCACTCCGGCTCTGTGTGCCACACTACTTAAGCCACTGAAAAAAGGTGAGCATCACGGGCAAAAAGGCTTTTTTGCCTGGTTTAACCAGATGTTTAACCGCAACGCCGAACGCTACGAAAAAGGGGTGGCGAAAATTCTCCACCGTAGCCTGCGCTGGATTGTGATTTATGTCCTGCTGCTTGGCGGCATGGTGTTCCTGTTCCTGCGTTTGCCGACGTCGTTCTTACCGCTGGAAGACCGTGGCATGTTTACTACCTCGGTACAGTTGCCCAGCGGTTCAACCCAGCAACAGACCCTGAAAGTCGTTGAGCAAATCGAGAAATATTACTTCACCCATGAAAAAGACAACATCATGTCGGTGTTTGCCACCGTGGGTTCTGGCCCTGGGGGGAACGGGCAAAACGTGGCGCGAATGTTTATCCGCCTGAAAGACTGGAGCGAACGCGACAGTAAGACCGGCACCTCGTTTGCCATTATCGAGCGTGCAACGAAGGCGTTTAACAAGATTAAAGAAGCTCGCGTTATCGCCAGCAGCCCGCCAGCAATTAGCGGTCTTGGTAGTTCTGCGGGTTTTGATATGGAGTTGCAGGACCACGCTGGAGCGGGTCACGATGCGCTGATGGCAGCACGAAACCAGTTGCTGGCGCTGGCAGCGGAAAACCCGGAGCTAACCCGTGTGCGCCATAACGGCCTCGACGACAGTCCGCAGTTGCAGATTGATATCGACCAGCGTAAAGCTCAGGCGCTGGGCGTTGCTATCGACGATATTAACGACACACTGCAAACCGCCTGGGGTTCGAGCTATGTGAATGACTTTATGGATCGCGGTCGCGTGAAGAAAGTCTATGTGCAGGCAGCTGCGCCGTATCGCATGCTGCCAGATGACATCAATCTCTGGTATGTCCGAAATAAAGATGGCGGCATGGTGCCCTTCTCTGCTTTCGCGACCTCACGCTGGGAGACAGGCTCGCCGCGTCTGGAACGCTATAACGGTTATTCTGCGGTTGAGATTGTTGGGGAAGCCGCACCGGGGGTCAGTACCGGTACGGCGATGGATATTATGGAATCGTTAGTGAAGCAGTTGCCAAACGGCTTTGGTCTGGAGTGGACGGCGATGTCGTATCAGGAGCGGCTTTCCGGCGCGCAGGCTCCGGCGCTGTACGCCATTTCCTTGCTGGTGGTATTCCTGTGTCTGGCTGCGCTGTATGAAAGCTGGTCGGTGCCGTTCTCGGTAATGCTGGTCGTGCCGCTGGGGGTTATCGGCGCGCTGCTGGCAACCTGGATGCGCGGGCTGGAAAACGATGTTTACTTCCAGGTGGGCCTGTTAACGGTCATTGGTTTATCGGCGAAAAACGCCATCCTGATCGTCGAGTTTGCTAACGAGATGAACCAAAAAGGCCACGACCTGTTTGAAGCGACGCTCCACGCCTGCCGTCAGCGTTTACGCCCGATTCTGATGACCTCGCTGGCATTTATCTTCGGCGTATTGCCAATGGCAACCAGCACAGGTGCCGGTTCCGGTGGTCAGCATGCGGTGGGTACTGGCGTAATGGGCGGGATGATTTCGGCCACTATTCTGGCTATTTACTTCGTGCCGCTGTTCTTTGTGCTGGTGCGCCGCCGCTTCCCGCTGAAGCCGCGCCCGGAATAA	
8160	CARD	prokka_02393	contig_8	229899	56	218368	221962	-1	63	evgS	3000833.0	2410.18	2300.0	Strict	96.57	100.0	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	MKFLPYIFLLCCGLWSTISFADGDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRIRGINADYLNLLKRALNIKLTLREYADHQKAMDALEDGEVDIVLSHLVASPPLNDDIAATNPLIITFPALVTTLHDSMRPLTSSKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGQNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFLLTRKDSIVLNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPDLKVLENPYSPPYSMTDETGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLNPGGWDILPAAIYSEDRENNVSFAEVFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIKVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVQNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSESPFKDVFSNTHEVTAETKENRKIYTQVFEIDNGIEKRCINHWHTLCNLPASEHAVYICGWQDITETRDLIHALEVERNKAINATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFAAIAASKSIALSCSSTLPERYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTIFTITIPVEITQQVAAVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKISMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLNCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFHALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEITVFCQQND	ATGAAGTTTTTACCCTATATTTTTCTTCTCTGTTGTGGTCTTTGGTCGACCATAAGTTTCGCAGACGGAGATTACATCGAATATCGTGGCATCAGTAGTAACAACCGTGTCACACTTGATCCACTACGTCTGAGCAACAAGGAATTACGTTGGCTAGCGAGCAAAAAAAATCTTGTGATTGCAGTACACAAGTCCCAAACAGCTACGTTGTTGCATACCGATTCGCAGCAACGGATTCGTGGTATTAATGCTGATTATTTAAATCTTTTAAAAAGAGCGTTAAATATCAAATTAACACTCCGGGAATACGCAGATCATCAAAAAGCAATGGACGCGCTGGAAGACGGTGAAGTTGATATAGTGTTATCACATTTAGTTGCTTCGCCGCCTCTTAATGATGACATTGCTGCAACTAATCCTCTGATAATTACCTTTCCGGCGCTGGTCACTACCCTTCACGATTCAATGCGACCGCTTACCTCATCAAAACCAGTAAATATTGCTCGAGTAGCAAATTATCCCCCAGACGAGGTAATTCATCAATCATTTCCAAAAGCAACAATTATCTCTTTTACAAATTTATATCAGGCATTAGCATCCGTCTCAGCCGGACAGAATGATTACTTTATTGGTAGTAACATCATTACCAGCAGTATGATTTCCCGTTATTTTACTCACTCCTTAAATGTAGTGAAGTATTATAACTCACCGCGTCAATATAACTTTTTATTAACCAGAAAAGATTCAATCGTTCTTAATGAAGTACTCAATCGATTTGTTGATGCTTTAACAAATGAAGTTCGCTATGAAGTATCACAAAATTGGCTTGATACAGGAAACCTGGCCTTTCTGAACAAACCATTAGAACTCACTGAACATGAAAAACAGTGGATTAAGCAGCATCCCGATTTAAAGGTGCTGGAAAATCCTTACTCGCCACCCTATTCTATGACAGATGAAACTGGCTCAGTTCGGGGCGTGATGGGTGATATTCTTAATATTATTACCTTGCAAACAGGTTTAAATTTTTCTCCGATCACCGTTTCACACAATATTCATGCTGGGACACAGCTTAACCCCGGTGGATGGGATATATTGCCCGCCGCTATTTATAGTGAAGATCGAGAAAATAATGTTTCATTTGCTGAAGTCTTCATAACAACGCCTTACGTTTTTGTCATGCAAAAAGCGCCTGACAGTGAACAAACATTAAAAAAAGGAATGAAAGTTGCCATTCCATATTATTATGAGCTTCATTCGCAATTAAAAGAGATGTATCCGGAGGTAGAGTGGATAAAAGTCGATAACGCCAGCGCTGCATTTCACAAGGTCAAGGAAGGTGAACTTGATGCTCTGGTCGCGACACAGTTAAATTCGCGTTACATGATCGACCATTACTATCCTAATGAACTTTATCATTTTCTTATTCCCGGCGTTCAGAATGCATCACTTTCGTTCGCTTTTCCTCGCGGAGAACCGGAACTTAAGGATATTATTAATAAAGCACTGAATGCAATTCCCCCAAGCGAAGTTCTGCGCCTGACCGAAAAATGGATTAAAATGCCCAATGTGACCATTGACACATGGGACCTCTATAGCGAGCAATTTTATATTGTTACGACATTATCCGTTTTATTAGTTGGCAGTAGCCTTTTATGGGGATTCTACCTGTTACGCTCAGTTCGTCGTCGTAAAGTTATTCAGGGTGATTTAGAAAACCAAATATCATTCCGGAAAGCGCTCTCGGATTCCTTACCTAATCCAACTTATGTTGTAAACTGGCAAGGTAATGTCATTAGTCACAATAGTGCATTTGAACATTATTTCACTGCTGATTACTATAAAAATGCAATGTTACCATTAGAAAACAGTGAATCCCCCTTTAAAGATGTTTTTTCTAATACGCATGAAGTCACAGCAGAAACGAAAGAAAACCGAAAAATATACACACAGGTATTTGAAATTGATAATGGCATCGAGAAAAGATGCATTAATCACTGGCATACCTTATGTAATCTGCCAGCAAGCGAACATGCTGTTTATATTTGTGGTTGGCAAGATATTACCGAGACGCGTGATTTAATTCATGCACTCGAAGTAGAGAGAAATAAAGCGATCAATGCAACTGTCGCAAAAAGCCAGTTTCTGGCAACAATGAGTCACGAAATAAGAACACCAATAAGCTCCATTATGGGCTTCCTGGAACTTCTGTCGGGTTCTGGTCTTAGCAAGGAACAACGGGTGGAGGCGATTTCACTTGCCTACGCCACCGGACAATCACTCCTCGGCTTAATTGGTGAAATCCTTGATGTCGACAAAATTGAATCGGGTAACTATCAACTTCAACCACAATGGGTCGATATCCCTACTTTAGTCCAGAACACTTGTCACTCTTTCGCTGCGATTGCTGCAAGCAAATCGATCGCATTAAGTTGCAGCAGTACGCTTCCTGAACGCTACCTGGTTAAGATCGACCCTCAGGCGTTTAAGCAGGTCTTATCTAATTTACTGAGTAATGCTCTCAAATTTACTACCGAGGGGGCAGTAAAAATTACGACCTCCCTGGGTCACATTGATGACAACCACGCTGTTATCAAAATGACGATTATGGATTCTGGAAGTGGATTATCGCAGGAAGAACAACAACAACTGTTTAAACGCTATAGCCAAACAAGTGCAGGTCGTCAGCAAACAGGTTCTGGTTTAGGCTTAATGATCTGCAAAGAATTAATTAAAAACATGCAGGGCGATTTGTCATTAGAAAGTCATCCAGGCATAGGAACGATATTTACGATCACAATCCCGGTAGAAATTACCCAACAAGTGGCGGCTGTCGAGGCAAAAGCAGAACAACCTATAACACTACCTGAAAAGTTGAGCATATTAATCGCGGATGATCATCCGACCAACAGGCTATTACTCAAACGCCAGCTAAATCTATTAGGATATGATGTTGATGAAGCCACTGATGGTGTGCAAGCGCTACACAAAATCAGTATGCAACATTATGATCTGCTTATTACTGACGTTAATATGCCGAATATGGATGGTTTTGAGTTGACTCGCAAACTCCGTGAGCAAAATTCTTCCTTACCCATCTGGGGGCTTACAGCCAACGCACAGGCTAACGAACGTGAAAAAGGGTTAAATTGCGGCATGAACTTATGTTTGTTCAAACCGTTGACTCTGGATGTACTGAAAACACATTTAAGTCAGTTACACCAGGTTGCGCATATTGCACCTCAGTATCGCCACCTTGATATCGAGGCCCTGAAGAATAATACGGCGAATGATCTACAACTGATGCAGGAGATTCTCATGACTTTCCAGCATGAAACGCATAAAGATCTACCCGCTGCGTTTCATGCACTAGAAGCTGGCGATAACAGAACTTTCCATCAGTGTATTCATCGCATCCACGGTGCGGCTAACATCCTGAATTTGCAAAAGTTGATTAATATTAGCCACCAGTTAGAAATAACACCTGTTTCAGATGACAGTAAGCCTGAAATTCTTCAGTTGCTGAACTCTGTAAAAGAACACATTGCAGAGCTGGACCAGGAGATTACTGTTTTCTGTCAGCAAAATGACTAA	
8160	CARD	prokka_02394	contig_8	229899	56	221966	222581	-1	61	evgA	3000832.0	417.157	390.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	ATGAACGCAATAATTATTGATGACCATCCTCTTGCTATCGCAGCAATTCGTAATTTATTGATCAAAAACGATATTGAAATCTTAGCAGAGTTGACTGAAGGCGGAAGCGCCGTTCAGCGGGTGGAAACACTTAAGCCTGATATCGTCATCATTGATGTCGATATCCCCGGAGTTAACGGTATCCAGGTGTTAGAAACGCTGAGAAAGCGCCAATATAGCGGAATTATTATTATTGTCTCCGCTAAAAATGACCATTTTTACGGGAAACATTGTGCTGATGCTGGCGCTAATGGTTTCGTGAGTAAAAAAGAAGGCATGAACAATATCATTGCAGCTATTGAAGCTGCAAAAAATGGCTACTGCTATTTCCCCTTCTCTCTCAACCGGTTTGTTGGAAGTTTAACGTCCGACCAGCAAAAACTCGACTCCTTATCGAAACAAGAAATTAGTGTCATGCGGTATATTCTTGATGGCAAGGATAATAATGACATTGCTGAAAAAATGTTCATCAGCAACAAAACTGTCAGCACTTATAAAAGTCGCTTGATGGAAAAATTAGAATGCAAATCACTGATGGATCTTTACACATTCGCACAACGTAACAAAATCGGCTAA	
8160	CARD	prokka_02395	contig_8	229899	56	222996	224160	1	78	emrK	3000206.0	711.835	600.0	Strict	98.86	110.26	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MEQINSNKKHSDRRKYFALLAVVLFIALSGAYAYWSMELKDMISTDDAYVTGNADPISAQVSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQQSLEDYNRRVPLAKQGVISKEALEHTKDTLISSKAALNAAIQAYKANKALVMNTPLNRQPQVIEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPDLASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL	GTGGAACAGATTAATTCAAATAAAAAACATTCTGACAGAAGAAAATATTTTGCTTTGTTAGCGGTAGTTTTATTTATTGCGCTTTCAGGTGCCTATGCCTATTGGTCAATGGAATTAAAAGACATGATTAGTACAGATGACGCCTATGTCACGGGAAATGCAGATCCAATTTCTGCACAAGTCTCAGGCAGTGTCACTGTCGTTAATCATAAAGATACGAACTACGTTCGACAAGGTGACATTTTAGTTTCACTGGATAAAACTGATGCCACTATCGCACTCAATAAAGCTAAAAATAATCTGGCAAATATTGTTCGGCAAACGAATAAACTATACTTACAGGATAAACAATACAGTGCCGAAGTCGCTTCAGCACGTATTCAGTATCAACAATCTTTAGAAGATTATAACCGTCGTGTGCCTTTAGCGAAGCAAGGGGTTATTTCAAAAGAAGCGCTGGAGCATACCAAAGATACGTTAATAAGTAGCAAAGCGGCATTGAATGCTGCTATCCAGGCTTATAAAGCGAATAAAGCTTTAGTAATGAACACACCATTAAACCGTCAGCCACAAGTCATTGAAGCTGCAGATGCAACCAAAGAAGCCTGGTTGGCGCTTAAACGTACGGATATTAAGAGTCCGGTTACCGGTTATATTGCCCAGAGAAGTGTTCAGGTCGGCGAAACAGTGAGTCCCGGACAATCGTTAATGGCTGTCGTACCGGCGCGTCAAATGTGGGTTAATGCCAACTTTAAAGAAACACAACTCACGGATGTACGGATTGGTCAATCGGTCAATATTATCAGCGATCTTTATGGTGAAAATGTTGTGTTTCATGGTCGGGTGACAGGGATCAATATGGGAACCGGCAATGCGTTCTCCTTATTACCTGCACAAAATGCGACAGGGAACTGGATCAAAATCGTTCAGCGTGTACCGGTTGAAGTTTCTCTGGATCCAAAAGAACTCATGGAACACCCTTTGCGCATTGGTTTATCGATGACTGCAACTATTGATACGAAGAATGAAGACATTGCCGAGATGCCCGATCTGGCTTCAACCGTGACGTCCATGCCTGCTTATACCAGTAAGGCTTTAGTTATCGATACCAGTCCGATAGAAAAAGAAATTAGCAACATTATTTCGCATAATGGACAACTTTAA	
8160	CARD	prokka_02396	contig_8	229899	56	224159	225698	1	58	emrY	3000254.0	1021.92	900.0	Strict	99.8	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MAITKSTPAPLTGGTLWCVTIALSLATFMQMLDSTISNVAIPTISGFLGASTDEGTWVITSFGVANAIAIPVTGRLAQRIGELRLFLLSVTFFSLSSLMCSLSTNLDVLIFFRVVQGLMAGPLIPLSQSLLLRNYPPEKRTFALALWSMTVIIAPICGPILGGYICDNFSWGWIFLINVPMGIIVLTLCLTLLKGRETETSPVKMNLPGLTLLVLGVGGLQIMLDKGRDLDWFNSSTIILLTVVSVISLISLVIWESTSENPILDLSLFKSRNFTIGIVSITCAYLFYSGAIVLMPQLLQETMGYNAIWAGLAYAPIGIMPLLISPLIGRYGNKIDMRLLVTFSFLMYAVCYYWRSVTFMPTIDFTGIILPQFFQGFAVACFFLPLTTISFSGLPDNKFANASSMSNFFRTLSGSVGTSLTMTLWGRRESLHHSQLTATIDQFNPVFNSSSQIMDKYYGSLSGVLNEINNEITQQSLSISANEIFRMAAIAFILLTVLVWFAKPPFTAKGVG	ATGGCAATCACTAAATCAACTCCTGCACCATTAACCGGTGGGACGTTATGGTGCGTCACTATTGCATTGTCATTAGCGACGTTTATGCAAATGTTGGATTCCACTATTTCTAACGTCGCAATACCGACAATATCTGGCTTTCTGGGAGCATCAACAGACGAAGGTACCTGGGTTATCACCTCGTTTGGCGTAGCAAATGCCATTGCGATCCCTGTTACCGGCAGGCTGGCACAAAGAATAGGCGAATTAAGGTTATTTTTACTTTCAGTAACCTTTTTTTCGCTGTCTTCATTAATGTGTAGTTTATCGACCAATCTTGATGTGCTGATATTTTTTAGAGTCGTTCAGGGGTTAATGGCGGGGCCGTTAATTCCACTGTCACAGAGTTTATTATTAAGGAATTATCCACCAGAAAAAAGAACATTTGCTCTGGCATTATGGTCAATGACCGTGATTATCGCTCCGATATGTGGGCCGATATTGGGCGGCTATATTTGCGATAACTTTAGCTGGGGTTGGATATTTTTAATCAATGTCCCTATGGGGATTATCGTCCTGACATTATGCTTAACCTTACTTAAAGGACGAGAAACTGAGACTTCACCGGTCAAAATGAATCTACCAGGACTGACCCTGTTAGTGCTCGGTGTTGGTGGCTTGCAAATTATGCTTGATAAAGGGCGCGATCTGGATTGGTTCAACTCGAGTACAATAATACTACTAACAGTAGTATCAGTTATTTCTCTGATCTCTTTAGTCATTTGGGAGTCGACCTCAGAGAATCCGATTCTTGACCTCAGTTTGTTTAAGTCCCGTAATTTCACCATTGGTATTGTGAGTATCACATGCGCGTATTTATTTTACTCTGGAGCGATAGTTCTTATGCCGCAGTTACTCCAGGAAACGATGGGGTATAATGCGATATGGGCCGGACTTGCCTATGCGCCCATCGGTATCATGCCGCTATTAATATCACCTTTGATAGGACGTTATGGCAACAAAATTGATATGCGGTTGTTGGTGACATTTAGTTTTTTGATGTATGCGGTTTGCTATTACTGGCGTTCTGTGACATTTATGCCAACGATTGATTTTACAGGCATCATTTTGCCACAGTTTTTTCAGGGATTCGCCGTTGCCTGTTTCTTTTTACCCTTAACAACGATTTCGTTTTCAGGCTTGCCAGATAATAAATTTGCCAATGCCTCGAGTATGAGTAATTTTTTTCGCACCTTGTCAGGATCAGTTGGTACGTCGTTGACAATGACACTGTGGGGACGCCGCGAATCGTTACACCATAGTCAGTTGACAGCAACCATCGATCAATTTAACCCCGTGTTTAATTCATCGTCACAAATTATGGATAAATACTATGGTTCGCTTTCAGGAGTTCTTAATGAAATTAATAATGAAATAACTCAGCAGTCACTTTCTATTTCTGCAAATGAGATTTTCCGTATGGCGGCTATTGCTTTTATCTTACTTACGGTTTTGGTTTGGTTTGCGAAACCGCCGTTTACAGCGAAAGGCGTTGGGTGA	
8160	CARD	prokka_02539	contig_9	209445	57	152080	152266	1	72	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGGGATGAGGTCACCGTGACAGTTTTAGGGGTAAAGGGCAACCAGGTACGTATTGGCGTAAATGCCCCGAAGGAAGTTTCTGTTCACCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	
8160	CARD	prokka_02551	contig_9	209445	57	158864	160403	-1	62	emrB	3000074.0	1028.08	900.0	Strict	99.8	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESLHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH	ATGCAACAGCAAAAACCGCTGGAAGGCGCACAACTGGTCATTATGACGATTGCGCTGTCACTGGCGACATTCATGCAGGTGCTGGACTCCACCATTGCTAACGTGGCGATCCCCACTATCGCCGGGAATCTGGGCTCATCGCTCAGCCAGGGAACGTGGGTAATCACTTCTTTCGGGGTGGCGAATGCCATCTCGATCCCGCTTACCGGCTGGCTGGCAAAGCGCGTCGGGGAAGTGAAACTGTTCCTCTGGTCCACCATCGCCTTTGCTATTGCGTCGTGGGCGTGTGGTGTCTCCAGCAGCCTGAATATGCTGATCTTCTTCCGCGTGATTCAGGGGATTGTCGCCGGGCCGTTAATTCCGCTTTCGCAAAGTCTATTGCTGAATAACTACCCGCCAGCCAAACGCTCGATCGCGCTGGCGTTGTGGTCGATGACGGTGATTGTTGCGCCAATTTGCGGCCCGATCCTCGGCGGTTATATCAGTGATAATTACCACTGGGGCTGGATATTCTTCATCAACGTGCCGATTGGCGTGGCGGTGGTGTTGATGACACTGCAAACTCTGCGCGGACGTGAAACCCGCACCGAACGGCGGCGGATTGATGCCGTGGGGCTGGCACTGCTGGTTATTGGTATCGGCAGCCTGCAGATTATGCTCGACCGCGGTAAAGAGCTGGACTGGTTCTCATCACAGGAAATTATCATCCTCACCGTGGTGGCGGTGGTGGCTATCTGCTTCCTGATTGTCTGGGAGCTGACCGACGATAACCCGATAGTCGATCTGTCGTTGTTTAAGTCGCGCAACTTCACCATCGGCTGCTTGTGTATCAGCCTCGCGTATATGCTCTACTTCGGCGCGATTGTTCTGCTGCCGCAGTTGTTGCAGGAGGTCTACGGTTACACGGCGACGTGGGCAGGGCTGGCCTCTGCGCCGGTAGGGATTATTCCGGTGATCCTGTCGCCGATTATCGGCCGCTTCGCGCATAAACTGGATATGCGCCGACTGGTAACCTTCAGCTTTATTATGTATGCCGTCTGCTTCTACTGGCGTGCCTATACCTTTGAACCGGGTATGGATTTTGGCGCGTCGGCCTGGCCACAGTTTATCCAGGGTTTTGCGGTGGCCTGCTTCTTTATGCCGCTGACCACCATTACGCTGTCCGGTTTGCCACCGGAACGACTGGCGGCGGCATCGAGCCTCTCCAACTTTACGCGAACGCTGGCGGGGTCTATCGGCACGTCGATAACCACGACCATGTGGACCAACCGCGAGTCGCTGCACCATGCACAGTTGACTGAGTCGGTAAACCCGTTCAACCCGAATGCTCAGGCGATGTACAGTCAACTGGAAGGGCTTGGTATGACGCAACAGCAGGCATCAGGCTGGATTGCCCAGCAGATAACCAATCAGGGGCTGATTATTTCCGCCAATGAGATCTTCTGGATGTCAGCCGGGATATTCCTCGTCCTGCTGGGGCTGGTGTGGTTTGCTAAACCGCCATTTGGCGCAGGTGGCGGCGGAGGCGGTGCGCACTAA	
8160	CARD	prokka_02552	contig_9	209445	57	160419	161592	-1	59	emrA	3000027.0	791.186	675.0	Strict	99.74	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	ATGAGCGCAAATGCGGAGACTCAAACCCCGCAGCAACCGGTAAAGAAGAGCGGCAAACGTAAGCGTCTGCTCCTCCTTCTCACCTTGCTCTTTATAATTATTGCCGTAGCGATAGGGATTTATTGGTTTTTGGTACTGCGTCATTTCGAAGAAACCGATGACGCATACGTGGCAGGGAATCAGATTCAAATTATGTCTCAGGTGTCTGGCAGCGTGACGAAAGTCTGGGCCGATAACACCGATTTTGTAAAAGAAGGCGACGTGCTGGTCACTCTCGACCCGACAGATGCTCGCCAGGCGTTTGAAAAAGCCAAAACTGCACTGGCTTCCAGCGTTCGCCAAACCCACCAGCTGATGATTAACAGCAAACAGTTGCAGGCGAATATTGAGGTGCAAAAAATCGCCCTCGCGAAAGCACAAAGCGACTACAACCGCCGTGTGCCGCTGGGCAATGCCAACCTGATTGGTCGCGAAGAGCTGCAACACGCCCGCGACGCCGTCACCAGTGCCCAGGCGCAACTGGACGTCGCTATTCAACAATACAATGCCAATCAGGCGATGATTCTGGGGACGAAACTGGAAGATCAGCCTGCCGTACAACAGGCTGCCACCGAAGTACGTAACGCCTGGCTGGCGCTGGAGCGTACCCGTATTGTCAGTCCGATGACCGGTTATGTCTCCCGCCGCGCGGTACAGCCTGGGGCGCAAATTAGCCCAACGACGCCGCTGATGGCGGTCGTTCCAGCCACCAATATGTGGGTGGATGCCAACTTTAAAGAGACGCAGATTGCCAATATGCGTATCGGTCAACCGGTCACCATCACCACCGATATTTACGGCGATGATGTGAAATACACCGGTAAAGTGGTTGGTCTGGATATGGGCACAGGTAGCGCGTTCTCACTGCTTCCGGCGCAAAACGCCACCGGTAACTGGATCAAAGTCGTTCAGCGTCTGCCTGTGCGTATTGAACTGGACCAGAAACAGCTGGAGCAATACCCGCTGCGTATCGGTTTATCCACGCTGGTGAGTGTCAATACCACTAACCGTGACGGTCAGGTACTGGCAAACAAAGTACGTTCCACACCGGTCGCGGTAAGCACCGCGCGTGAAATCAGCCTGGCACCTGTCAATAAACTGATCGACGATATCGTAAAAGCTAACGCTGGCTAA	
8160	CARD	prokka_02553	contig_9	209445	57	161718	162249	-1	44	emrR	3000516.0	354.755	280.0	Strict	98.86	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIECRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQGGVVLEAMS	ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTAAAATTTCGCGCCAGCCGCCACGAAGATTTTCCTTATCAGGAGATCCTTCTGACCCGTCTTTGCATGCATATGCAAAGCAAGCTGCTGGAAAACCGCAATAAAATGCTGAAGGCTCAGGGGATTAACGAGACGTTGTTTATGGCGTTGATTACGCTGGAGTCTCAGGAAAACCACAGTATTCAGCCTTCTGAATTGAGTTGTGCTCTTGGATCATCCCGTACCAACGCGACGCGTATTGCCGATGAACTGGAAAAACGCGGTTGGATCGAATGTCGTGAAAGCGATAACGATCGCCGCTGCCTGCATCTGCAATTAACGGAAAAAGGTCACGAGTTTTTGCGCGAGGTTTTACCGCCGCAGCATAACTGCCTGCATCAACTCTGGTCCGCGCTCAGCACAACAGAAAAAGACCAGCTCGAGCAAATCACCCGCAAATTGCTCTCCCGTCTCGACCAGATGGAACAGGGCGGTGTGGTTCTCGAAGCGATGAGCTAA	
8160	CARD	prokka_02657	contig_10	208775	59	52536	53358	1	56	bacA	3002986.0	542.347	500.0	Strict	99.27	100.0	undecaprenyl pyrophosphate related proteins	protein homolog model	antibiotic target alteration		peptide antibiotic	MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGENKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF	ATGAGCGATATGCACTCGCTGCTGATAGCGGCAATATTGGGTGTGGTCGAAGGATTGACAGAATTTCTGCCGGTATCCAGCACGGGCCATATGATTATTGTCGGTCACTTGTTGGGGTTTGAGGGCGACACGGCGAAAACCTTTGAAGTCGTGATCCAGTTAGGATCAATTCTGGCGGTAGTAGTGATGTTCTGGCGGCGTCTGTTTGGCCTGATTGGCATCCACTTTGGCCGCCCGTTGCAGCACGAAGGAGAAAACAAAGGTCGTTTAACGCTGATCCACATTTTGCTGGGGATGATTCCGGCGGTGGTACTGGGGCTGTTGTTCCACGACACGATTAAATCATTGTTTAACCCGATAAATGTCATGTATGCACTGGTCGTTGGCGGTCTGTTGCTGATTGCTGCCGAATGCCTGAAGCCGAAAGAGCCGCGTGCGCCGGGTCTTGATGATATGACCTATCGTCAGGCGTTTATGATTGGCTGTTTCCAGTGTCTGGCGCTGTGGCCGGGTTTCTCCCGTTCCGGGGCGACCATTTCAGGTGGGATGCTGATGGGGGTGAGCCGTTACGCTGCTTCCGAGTTCTCGTTCCTGCTGGCGGTGCCGATGATGATGGGCGCAACGGCGCTCGATCTCTACAAAAGCTGGGGCTTCCTGACTACCGGCGATATCCCGATGTTTGCCGTTGGGTTTATCACCGCTTTTGTGGTGGCGCTGATAGCGATTAAAACCTTCCTGCAATTGATTAAGCGCATTTCGTTTATCCCGTTCGCCATTTATCGCTTTATTGTGGCGGCTGCGGTGTACGTCGTGTTCTTTTGA	
8160	CARD	prokka_02680	contig_10	208775	59	79038	80520	-1	68	TolC	3000237.0	991.875	900.0	Strict	99.8	99.6	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNTLLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSARTTTSNGHNPFRN	ATGAAGAAATTGCTCCCCATTCTTATCGGCCTGAGCCTCTCTGGGTTCAGTTCGTTGAGCCAGGCCGAGAACCTGATGCAAGTTTATCAGCAAGCACGCCTTAGTAACCCGGAATTGCGTAAGTCTGCCGCCGATCGTGATGCTGCCTTTGAAAAAATTAATGAAGCGCGCAGTCCATTACTGCCACAGCTAGGTTTAGGTGCAGATTACACCTATAGCAACGGCTACCGCGACGCGAACGGCATCAACTCTAACGCGACCAGTGCGTCCCTGCAGTTAACTCAATCCATTTTTGATATGTCGAAATGGCGTGCGTTAACGCTGCAGGAAAAAGCAGCTGGGATTCAGGACGTCACGTATCAGACCGATCAACAAACCTTGATCCTCAACACCGCGACCGCTTATTTCAACGTGTTGAATGCGATTGACGTTCTTTCCTATACACAGGCGCAAAAAGAAGCGATCTACCGTCAATTAGATCAAACCACCCAACGTTTTAACGTGGGCCTGGTAGCGATCACCGACGTGCAGAACGCCCGCGCACAGTACGATACCGTGCTGGCGAACGAAGTGACCGCACGTAATAACCTTGATAACGCGGTAGAGCAGCTGCGCCAGATCACCGGTAACTACTATCCGGAACTGGCGGCGCTGAATGTCGAAAACTTTAAAACCGACAAACCACAGCCGGTTAACACGCTGCTGAAAGAAGCCGAAAAACGCAACCTGTCCCTGTTACAGGCGCGTTTGAGCCAGGACCTGGCGCGCGAGCAAATTCGCCAGGCGCAGGATGGTCACTTACCGACTCTGGATTTAACGGCTTCTACCGGGATTTCTGACACCTCTTATAGCGGTTCGAAAACCCGTGGTGCCGCTGGTACCCAGTATGACGATAGCAATATGGGCCAGAACAAAGTTGGCCTGAGCTTCTCGCTGCCGATTTATCAGGGCGGAATGGTTAACTCGCAGGTGAAACAGGCCCAGTACAACTTTGTTGGTGCCAGCGAGCAACTGGAAAGCGCGCATCGTAGCGTCGTACAAACCGTACGTTCCTCCTTCAACAACATTAATGCTTCTATCAGTAGCATTAACGCCTACAAACAAGCCGTAGTTTCCGCTCAAAGCTCATTAGACGCGATGGAGGCGGGTTACTCGGTCGGTACGCGTACCATTGTTGATGTGTTGGATGCGACCACCACGCTGTACAACGCTAAGCAAGAGCTGGCAAATGCGCGTTATAACTACCTGATTAACCAGTTGAATATTAAGTCAGCTCTGGGTACGTTGAACGAGCAGGATCTGCTGGCACTGAACAATGCGCTGAGCAAACCGGTTTCCACTAATCCGGAAAACGTTGCCCCGCAAACGCCGGAACAGAATGCTATTGCTGATGGTTATGCGCCTGATAGCCCGGCACCAGTCGTTCAGCAAACATCCGCACGCACTACCACCAGTAACGGTCATAACCCTTTCCGTAACTGA	
8160	CARD	prokka_02821	contig_11	191774	58	15763	16396	1	64	CRP	3000518.0	434.491	400.0	Strict	99.52	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCCAAGAGCACGCTTATTCACCAGGGTGAAAAAGCGGAAACGCTGTACTACATCGTTAAAGGCTCTGTGGCAGTGCTGATCAAAGACGAAGAGGGTAAAGAAATGATCCTCTCCTATCTGAATCAGGGTGATTTTATTGGCGAACTGGGCCTGTTTGAAGAGGGCCAGGAACGTAGCGCATGGGTACGTGCGAAAACCGCCTGTGAAGTGGCTGAAATTTCGTACAAAAAATTTCGCCAATTGATTCAGGTAAACCCGGACATTCTGATGCGTCTGTCTGCACAGATGGCGCGTCGTCTGCAAGTCACTTCAGAGAAAGTGGGCAACCTGGCGTTCCTCGACGTGACGGGCCGCATTGCACAGACTCTGCTGAATCTGGCAAAACAACCGGATGCTATGACTCACCCGGACGGTATGCAAATCAAAATTACCCGTCAGGAAATCGGTCAGATTGTCGGCTGTTCTCGTGAAACCGTGGGACGCATTCTGAAGATGCTGGAAGATCAGAACCTGATCTCCGCACACGGTAAAACCATCGTCGTTTACGGCACTCGTTAA	
8160	CARD	prokka_02979	contig_11	191774	58	184704	185862	1	59	mdtE	3000795.0	776.548	675.0	Strict	99.74	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYEVAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYGQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQNVLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGLQRIRPGIKARAISSSQENASTESKQ	ATGAACAGAAGAAGAAAACTGTTAATACCGTTGTTATTCTGCGGCGCGATGCTCACCGCCTGCGATGACAAATCGGCGGAAAACGCCGCCGCCATGACGCCTGAGGTCGGTGTCGTCACACTCTCCCCCGGTTCGGTCAATGTGTTGAGCGAATTGCCCGGTAGAACCGTTCCTTATGAAGTTGCCGAGATACGTCCCCAGGTGGGCGGAATTATCATTAAACGCAACTTTATCGAAGGCGATAAAGTGAACCAGGGCGATTCGCTGTATCAGATTGATCCTGCGCCTTTACAGGCAGAGCTGAACTCCGCCAAAGGCTCGCTGGCGAAAGCGCTCTCTACCGCCAGCAATGCCCGCATCACCTTTAACCGCCAGGCATCGTTGCTGAAGACCAACTATGTTAGCCGTCAGGATTACGACACCGCGCGCACCCAGTTGAATGAAGCAGAAGCCAATGTCACCGTCGCCAAAGCGGCTGTTGAACAGGCGACGATCAATCTGCAATACGCGAATGTCACCTCGCCGATTACGGGCGTCAGCGGGAAATCGTCGGTGACCGTCGGCGCACTCGTTACCGCTAATCAGGCAGATTCGCTGGTTACCGTACAACGTCTGGACCCGATTTATGTCGATCTCACGCAGTCGGTGCAGGATTTCTTGCGCATGAAAGAAGAGGTCGCCAGTGGGCAAATCAAACAGGTTCAGGGCAGTACGCCAGTACAGCTCAATCTGGAAAATGGTAAACGTTACGGCCAGACCGGCACGCTGAAATTCTCCGACCCGACGGTGGATGAAACCACGGGCTCCGTGACGTTACGGGCGATTTTCCCCAACCCAAATGGTGACTTGCTGCCTGGCATGTATGTTACGGCATTAGTGGATGAAGGTAGCCGCCAGAATGTATTACTGGTGCCGCAGGAAGGCGTCACCCACAACGCCCAGGGTAAAGCAACGGCACTCATTCTGGATAAAGACGATGTCGTGCAGCTACGCGAAATCGAAGCCAGCAAAGCCATCGGCGACCAGTGGGTTGTCACCTCTGGCTTGCAGGCTGGCGATCGGGTGATCGTTTCCGGCTTGCAACGCATTCGTCCGGGTATCAAAGCACGAGCAATTTCCTCCAGCCAGGAAAACGCCAGCACCGAATCGAAACAATAA	
8160	CARD	prokka_02980	contig_11	191774	58	185886	189000	1	61	mdtF	3000796.0	2097.78	1850.0	Strict	99.52	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA	ATGGCTAACTATTTTATTGATCGCCCGGTTTTTGCCTGGGTACTTGCCATTATTATGATGCTTGCAGGCGGTCTGGCGATCATGAACTTACCGGTTGCGCAGTATCCGCAGATTGCGCCACCGACCATTACCGTCAGCGCAACCTATCCGGGTGCCGATGCGCAAACGGTAGAAGACTCGGTCACTCAGGTGATTGAGCAAAATATGAATGGGCTTGATGGCCTGATGTACATGTCTTCAACCAGCGATGCGGCAGGTAATGCCTCCATCACTCTGACCTTCGAGACGGGGACATCGCCTGATATCGCACAGGTTCAGGTGCAAAATAAACTGCAACTCGCTATGCCTTCATTACCTGAAGCGGTGCAGCAGCAGGGGATTAGCGTCGATAAGTCGAGCAGTAATATCCTGATGGTAGCGGCATTTATTTCTGATAACGGCAGCCTCAACCAGTACGATATCGCGGACTATGTAGCGTCTAATATCAAAGACCCGCTAAGCCGTACCGCGGGCGTTGGTAGCGTACAGCTCTTTGGTTCCGAGTACGCCATGCGTATCTGGCTGGACCCGCAAAAACTCAATAAATATAACCTGGTACCTTCCGATGTTATTTCCCAGATTAAGGTGCAAAACAACCAGATTTCTGGTGGTCAACTGGGTGGCATGCCACAGGCGGCAGACCAGCAACTGAACGCCTCGATCATTGTGCAGACGCGTCTGCAAACGCCGGAAGAATTTGGCAAAATCCTGTTGAAAGTTCAGCAAGATGGTTCGCAAGTGCTGCTGCGTGATGTCGCCCGCGTCGAACTTGGGGCGGAAGATTATTCCACCGTGGCGCGCTATAACGGCAAACCTGCCGCCGGGATCGCCATCAAACTGGCTACCGGAGCAAACGCCCTGGATACCTCGCGAGCGGTGAAAGAGGAGCTGAACCGTTTATCGGCTTATTTCCCTGCAAGCCTGAAGACGGTTTATCCTTACGACACCACACCGTTTATCAAAATTTCTATTCAGGAAGTTTTCAAAACGCTGGTTGAGGCTATCATCCTCGTCTTCCTGGTCATGTATCTGTTTTTGCAGAATTTCCGCGCCACAATCATCCCGACGATTGCCGTACCGGTGGTTATTCTCGGGACGTTTGCGATCTTGTCGGCAGTTGGTTTCACCATCAACACGTTAACTATGTTCGGGATGGTGCTGGCGATAGGGTTACTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTGTCATTGCGGAAGATAAGCTACCGCCGAAGGAAGCGACGCATAAATCGATGGGGCAGATCCAACGTGCGCTGGTCGGGATTGCCGTTGTTCTTTCCGCAGTGTTTATGCCGATGGCCTTTATGAGCGGTGCGACCGGGGAGATCTACCGCCAGTTCTCCATCACGCTGATCTCCTCCATGCTGCTTTCAGTATTTGTAGCAATGAGCCTGACCCCTGCCCTGTGCGCCACCATTCTGAAAGCCGCGCCGGAGGGCGGTCACAAACCTAACGCCCTGTTCGCACGCTTCAACACGCTGTTTGAAAAATCAACTCAGCACTATACCGACAGCACCCGCTCGCTGTTGCGTTGTACCGGTCGCTACATGGTGGTCTACCTACTGATTTGCGCCGGGATGGCGGTGCTGTTCCTGCGTACGCCGACCTCTTTCTTACCAGAAGAGGATCAGGGGGTATTTATGACCACCGCGCAGTTACCTTCCGGTGCAACCATGGTTAACACCACGAAAGTGCTACAACAGGTGACGGATTATTATCTGACAAAAGAGAAAAATAATGTTCAGTCGGTGTTTACCGTTGGTGGCTTTGGCTTCAGTGGTCAGGGGCAAAACAACGGTCTGGCGTTTATCAGCCTCAAGCCGTGGTCTGAACGTGTCGGCGAGGAAAACTCGGTTACCGCGATTATTCAGCGGGCAATGATTGCGCTAAGCAGTATCAATAAAGCCGTCGTCTTCCCGTTCAACTTACCCGCGGTGGCTGAACTGGGTACCGCGTCAGGTTTTGATATGGAACTGCTGGACAACGGCAATCTGGGGCACGAAAAACTGACCCAGGCGCGAAACGAGCTGTTATCACTGGCAGCGCAATCACCGAATCAGGTCATCGGGGTACGCCCGAACGGCCTGGAAGATACGCCGATGTTCAAAGTGAACGTCAACGCTGCGAAAGCCGAGGCTATGGGTGTGGCGCTGTCTGATATCAACCAGACAATTTCCACCGCCTTCGGCAGCAGCTACGTGAACGACTTCCTCAACCAGGGGCGGGTGAAAAAAGTGTATGTCCAGGCAGGCACGCCGTTCCGTATGTTGCCGGATAACATCAACCAATGGTATGTACGCAACGCCTCTGGCACGATGGCACCGCTTTCTGCCTATTCGTCTACCGAATGGACCTATGGTTCACCGCGACTGGAACGCTACAACGGCATCCCGTCAATGGAGATTTTAGGTGAAGCGGCTGCCGGGAAAAGTACCGGTGACGCCATGAAATTTATGGCAGACCTGGTCGCAAAACTTCCGGCAGGCGTCGGCTACTCATGGACCGGACTGTCGTATCAGGAAGCGTTATCCTCAAATCAGGCTCCCGCGCTATATGCCATTTCACTGGTCGTGGTGTTCCTCGCCCTCGCCGCACTTTATGAAAGCTGGTCAATTCCGTTCTCGGTGATGTTGGTTGTTCCGTTAGGCGTCGTTGGCGCATTACTGGCCACCGATCTGCGCGGCTTAAGTAATGACGTTTACTTCCAGGTTGGTTTGCTGACCACCATCGGGCTTTCCGCCAAGAACGCCATCCTGATTGTCGAATTTGCCGTTGAGATGATGCAGAAAGAAGGGAAAACACCGGTAGAGGCAATCATCGAAGCAGCGCGTATGCGTTTACGCCCAATCCTGATGACTTCTCTGGCCTTTATTCTCGGCGTGCTGCCGCTGGTTATCAGTCATGGTGCCGGCTCTGGCGCGCAAAACGCGGTAGGTACCGGCGTAATGGGCGGGATGTTTGCCGCAACAGTGCTGGCAATTTACTTCGTTCCGGTCTTTTTCGTTGTAGTGGAACATCTCTTTGCCCGCTTTAAAAAAGCGTAA	
8160	CARD	prokka_02982	contig_11	191774	58	189362	190091	-1	77	gadW	3003838.0	498.049	470.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MAHVCSVILVRRSFDIHHEQQKISLHNESILLLDKNLADDFAFCSLDTRRLDIEELTVCHYLQNIRQLPRNLGLHSKDRLLINQSPPIQLVTAIFDSFNDPRVNSPILSKMLYLSCLSMFSHKKELIPLLFNSISTVSGKVERLISFDIAKRWYLRDIAERMYTSESLIKKKLQDENTCFSKILLASRMSMARRLLELRQIPLHTIAEKCGYSSTSYFINTFRQYYGVTPHQFSQHSPGTFS	ATGGCTCATGTCTGCTCGGTGATCCTCGTTCGTCGTTCATTCGATATTCATCATGAACAGCAAAAAATATCGTTGCATAACGAGAGTATCCTGCTGCTGGATAAAAATTTGGCAGACGATTTTGCGTTTTGTTCACTGGATACGCGACGGCTGGATATCGAAGAGCTGACAGTTTGCCATTACTTACAAAATATTCGTCAGTTGCCACGCAATTTAGGATTGCATAGCAAAGACCGTTTGTTAATTAACCAGTCACCCCCCATACAGCTGGTGACGGCGATTTTTGATAGTTTCAATGACCCCCGGGTCAATTCGCCGATACTGAGCAAAATGCTCTATCTTTCCTGTTTATCAATGTTTTCTCATAAGAAAGAACTGATCCCCTTACTTTTCAATAGTATCAGTACTGTTTCAGGAAAAGTTGAACGCCTTATTAGCTTTGATATCGCTAAACGTTGGTATCTACGCGATATCGCAGAAAGAATGTACACCAGCGAGAGTCTCATCAAAAAAAAGTTGCAGGATGAAAATACCTGTTTCAGTAAAATATTACTCGCCTCCAGGATGTCGATGGCCAGACGATTACTCGAGTTACGTCAAATACCTCTGCATACTATTGCGGAAAAATGTGGCTATAGCAGTACGTCATACTTTATAAATACATTTAGACAATATTATGGTGTAACGCCACATCAGTTTTCGCAACATTCGCCGGGTACCTTTTCCTGA	
8160	CARD	prokka_02983	contig_11	191774	58	190459	191284	-1	65	gadX	3000508.0	526.554	450.0	Strict	93.07	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MQPLHGNCLIAYARHKYILTMVNGEYRYFNGGDLVFADASQIQVDKCVENFVLVSRDTLSLFLPMLKEEALKLHVHKKVPSLLVHHCTRDIPVFQEVAQLSQNKNLRYAEMLRKRALIFALLSVFLEDTQFIPLLLNVLQPNMRTRVCTVINNNIAHEWTLARIASELLMSPSLLKKKLREEGTSYSQLLTECRMQRALQLIVIYGVSIKRVAVSCGYHSVSYFIYVFRNYYGMTPTEYQERSAQELPNCGSAASMAAQGIFYGTDRSAEGIRL	ATGCAACCACTACATGGTAATTGTCTAATTGCGTACGCAAGACATAAATATATTCTCACCATGGTTAATGGTGAATATCGCTATTTTAATGGCGGTGATCTGGTTTTTGCGGATGCAAGCCAAATTCAAGTAGATAAGTGTGTTGAGAATTTCGTATTAGTTTCAAGAGACACGCTTTCATTATTTCTCCCGATGCTCAAGGAGGAGGCATTAAAACTTCATGTACATAAAAAAGTTCCTTCATTACTCGTTCATCACTGTACCAGAGATATTCCTGTTTTTCAGGAAGTTGCGCAACTATCGCAGAATAAGAATCTTCGCTATGCAGAAATGCTACGTAAAAGGGCATTAATCTTTGCGTTGTTATCTGTTTTTCTTGAGGATACGCAGTTTATACCGTTACTTCTGAACGTGTTGCAACCGAATATGCGAACACGAGTTTGTACGGTCATCAATAATAATATCGCCCATGAGTGGACATTAGCCCGAATTGCTAGCGAATTGTTGATGAGTCCAAGCCTGTTAAAGAAAAAATTGCGCGAAGAAGGTACGTCATATTCACAGTTGCTTACTGAGTGTAGGATGCAGCGTGCTTTACAACTTATTGTTATATATGGGGTTTCAATTAAGCGAGTTGCAGTATCCTGTGGATATCACAGCGTGTCGTATTTCATTTACGTTTTTCGAAATTATTATGGGATGACGCCCACAGAGTATCAGGAGCGATCGGCGCAGGAATTACCGAACTGTGGCTCGGCGGCAAGTATGGCTGCGCAAGGGATTTTTTACGGCACTGACCGTTCTGCGGAAGGAATAAGATTATAG	
8160	CARD	prokka_02992	contig_12	159190	59	5484	8589	-1	60	AcrF	3000502.0	2090.85	1900.0	Strict	99.52	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRLKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIQEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPREATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERSGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKVYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	ATGGCAAACTTTTTTATTCGACGACCGATATTTGCATGGGTGCTGGCCATTATTCTGATGATGGCGGGCGCACTGGCGATCCTACAATTGCCCGTCGCCCAGTATCCAACCATTGCGCCGCCTGCGGTTTCTGTTTCGGCAAACTATCCGGGTGCTGATGCGCAGACCGTGCAGGATACAGTGACGCAGGTTATCGAACAGAATATGAACGGTATCGATAACCTGATGTATATGTCCTCCACCAGCGATTCCGCCGGTAGCGTGACAATTACCCTTACCTTCCAGTCCGGGACCGATCCTGATATCGCGCAAGTACAGGTGCAGAACAAACTCCAGCTCGCCACGCCGTTGCTGCCGCAGGAGGTTCAGCAGCAGGGGATCAGTGTTGAAAAGTCCAGTAGCAGCTATTTGATGGTGGCGGGCTTTGTCTCTGATAACCCTGGCACCACACAGGACGATATCTCGGACTATGTGGCCTCTAACGTTAAAGATACGCTTAGCCGTCTGAATGGCGTCGGTGACGTACAGCTTTTCGGCGCACAGTATGCGATGCGTATCTGGCTGGACGCCGATCTGCTAAACAAATATAAACTGACACCGGTTGATGTGATTAACCAGTTGAAGGTACAGAACGATCAGATCGCTGCCGGACAGTTGGGCGGAACGCCAGCGTTACCAGGGCAACAGTTGAACGCCTCGATTATTGCTCAGACGCGGTTAAAAAATCCGGAAGAATTCGGCAAAGTGACCCTGCGCGTAAACAGTGACGGCTCGGTGGTGCGTCTGAAAGATGTCGCACGGGTTGAACTTGGCGGTGAAAACTATAACGTTATCGCTCGCATCAACGGAAAACCGGCGGCGGGCCTGGGGATTAAGCTGGCAACCGGCGCGAATGCTCTCGATACCGCGAAAGCCATTAAGGCAAAACTGGCGGAATTACAGCCATTCTTCCCGCAGGGAATGAAGGTTCTTTACCCTTATGACACCACGCCTTTCGTCCAGCTTTCTATCCAGGAAGTGGTGAAAACGCTGTTCGAAGCCATTATGCTGGTGTTCCTGGTGATGTATCTGTTCTTGCAGAACATGCGGGCAACATTGATACCCACCATTGCTGTACCTGTCGTGTTGTTAGGGACATTTGCCATACTCGCCGCTTTTGGTTACTCCATCAATACGCTAACGATGTTTGGGATGGTACTTGCCATCGGACTTCTTGTTGATGATGCGATAGTCGTTGTGGAGAACGTCGAGCGCGTAATGATGGAGGATAAACTCCCCCCCAGAGAAGCGACGGAAAAATCGATGTCGCAAATCCAGGGCGCGCTGGTAGGTATCGCGATGGTACTGTCGGCGGTATTTATTCCGATGGCATTCTTCGGTGGCTCAACAGGGGCAATTTATCGCCAGTTCTCTATCACTATTGTTTCAGCAATGGCGCTTTCAGTACTGGTTGCGCTGATTCTCACCCCCGCGTTATGTGCAACATTGCTGAAACCAGTCTCTGCCGAGCATCACGAAAATAAGGGAGGATTCTTCGGCTGGTTTAACACCACTTTCGATCATAGCGTTAATCACTACACCAATAGCGTTGGCAAAATCCTCGGTTCCACAGGGCGATATTTACTGATCTATGCGCTGATTGTTGCAGGAATGGTGGTGTTGTTTTTACGTCTTCCGTCTTCCTTCTTACCTGAAGAGGATCAGGGTGTCTTTCTGACCATGATTCAGTTACCCGCTGGCGCGACGCAAGAGCGGACGCAAAAAGTGTTGGATCAAGTGACGGATTACTATCTGAAGAACGAGAAAGCGAACGTTGAAAGTGTCTTTACAGTTAACGGCTTTAGCTTCAGCGGCCAGGCACAAAACGCCGGTATGGCCTTCGTCAGTCTGAAACCGTGGGAAGAGCGTAGTGGTGACGAAAACAGTGCGGAAGCAGTAATCCATCGTGCCAAAATGGAATTGGGCAAGATCCGCGACGGTTTTGTCATTCCATTTAATATGCCAGCCATTGTTGAACTAGGCACGGCAACGGGTTTCGACTTTGAGTTAATTGATCAGGCTGGGCTGGGTCACGATGCCCTGACCCAGGCCCGTAACCAGTTGCTTGGCATGGCGGCGCAACATCCTGCCAGCTTAGTCAGCGTGCGCCCTAATGGCCTGGAAGACACCGCGCAGTTTAAACTGGAAGTTGACCAGGAAAAGGCGCAGGCATTAGGTGTTTCACTTTCTGACATCAATCAGACCATTTCAACGGCGTTGGGTGGGACTTACGTTAACGACTTCATCGACCGTGGTCGCGTGAAAAAGGTGTATGTTCAGGCGGATGCCAAATTCCGTATGCTGCCAGAAGATGTCGATAAACTTTATGTCCGCAGCGCCAACGGCGAAATGGTGCCATTCTCTGCCTTTACCACTTCACATTGGGTGTATGGCTCTCCGCGACTGGAACGCTACAACGGTCTGCCGTCAATGGAGATTCAGGGGGAAGCCGCGCCAGGAACCAGTTCCGGCGATGCTATGGCGTTGATGGAAAACCTTGCGTCAAAATTACCGGCGGGCATTGGTTATGACTGGACGGGTATGTCATATCAGGAACGTTTATCGGGAAACCAGGCTCCCGCTCTGGTAGCAATTTCCTTTGTGGTTGTTTTCCTGTGCCTTGCTGCACTCTATGAAAGCTGGTCAATTCCTGTCTCGGTTATGTTGGTCGTGCCGTTAGGGATTGTCGGCGTGCTACTGGCGGCAACACTCTTTAATCAAAAAAATGACGTCTACTTTATGGTGGGCTTGCTAACGACAATTGGCTTGTCGGCCAAAAACGCTATTTTGATTGTTGAGTTCGCTAAAGATCTCATGGAGAAAGAGGGTAAAGGTGTTGTTGAAGCGACACTAATGGCAGTACGTATGCGCCTGCGTCCTATCCTGATGACCTCTCTCGCCTTTATTCTCGGCGTATTACCGCTAGCTATCAGTAACGGTGCCGGCAGTGGCGCGCAGAACGCAGTGGGTATCGGGGTAATGGGCGGGATGGTTTCTGCAACGTTGCTGGCAATCTTCTTCGTGCCGGTGTTCTTTGTGGTGATCCGCCGTTGCTTTAAAGGATAA	
8160	CARD	prokka_02993	contig_12	159190	59	8600	9758	-1	72	AcrE	3000499.0	781.556	675.0	Strict	99.48	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	MTKHARFFLLPSFILISAALIAGCNDKGEEKAHVGEPQVTVHIVKTAPLEVKTELPGRTNAYRIAEVRPQVSGIVLNRNFTEGSDVQAGQSLYQIDPATYQASYDSAKGELAKSEAAAAIAHLTVKRYVPLVGTKYISQQEYDQAIADARQADAAVIAAKATVESARINLAYTKVTAPISGRIGKSTVTEGALVTNGQTTELATVQQLDPIYVDVTQSSNDFMRLKQSVEQGNLHKENATSNVELVMENGQTYPLKGTLQFSDVTVDESTGSITLRAVFPNPQHTLLPGMFVRARIDEGVQPDAILIPQQGVSRTPRGDATVLIVNNKSQVEARPVVASQAIGDKWLISEGLKSGDQVIVSGLQKARPGEQVKATTDTPADTASK	ATGACGAAACATGCCAGGTTTTTCCTCCTGCCCTCCTTTATTCTGATCTCCGCGGCTTTAATCGCCGGTTGTAACGATAAGGGAGAAGAGAAAGCTCACGTCGGTGAACCGCAGGTTACCGTTCATATTGTGAAAACGGCCCCGTTAGAAGTTAAGACTGAACTACCAGGCCGCACCAATGCTTACCGTATAGCCGAAGTTCGCCCACAGGTTAGCGGGATCGTACTGAATCGCAATTTCACTGAAGGCAGCGATGTGCAAGCAGGCCAGTCCCTGTACCAGATCGATCCCGCGACCTATCAGGCAAGTTATGACAGCGCGAAAGGCGAACTGGCGAAAAGTGAAGCCGCCGCCGCCATCGCGCATTTGACGGTAAAACGTTACGTTCCGCTCGTGGGTACGAAATACATCAGTCAGCAGGAGTACGACCAGGCCATTGCTGATGCTCGCCAGGCCGATGCCGCCGTGATTGCCGCAAAAGCCACAGTCGAAAGCGCTCGCATCAATCTCGCTTATACCAAAGTGACTGCGCCAATTAGCGGACGTATCGGCAAATCGACCGTGACCGAAGGCGCTCTTGTCACTAATGGGCAAACGACTGAACTGGCGACTGTCCAGCAGCTCGATCCTATCTACGTTGATGTGACCCAATCCAGCAACGATTTTATGAGGCTGAAGCAATCCGTAGAGCAAGGAAATTTGCATAAGGAAAACGCCACCAGCAACGTAGAGTTGGTCATGGAGAACGGTCAAACCTATCCCCTGAAAGGTACGCTGCAATTCTCCGATGTGACCGTTGATGAAAGCACCGGCTCCATAACCCTACGTGCTGTCTTCCCTAACCCGCAACATACGCTTTTGCCGGGTATGTTTGTGCGCGCACGGATTGATGAAGGCGTCCAACCTGACGCCATTCTTATCCCGCAACAAGGCGTTAGCCGCACACCACGTGGTGATGCAACCGTGCTGATTGTTAACAATAAAAGTCAGGTTGAAGCGCGCCCTGTCGTTGCCAGTCAGGCGATTGGCGATAAATGGTTGATTAGCGAAGGTCTGAAATCTGGCGATCAAGTCATTGTCAGCGGCCTGCAAAAAGCGCGTCCGGGAGAGCAGGTTAAAGCCACTACCGATACCCCCGCAGATACTGCATCGAAGTAA	
8160	CARD	prokka_02994	contig_12	159190	59	10156	10819	1	48	AcrS	3000656.0	453.366	380.0	Strict	98.64	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQDHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHKTNELSVI	ATGGCAAAAAGAACCAAAGCTGAAGCCCTGAAGACCCGGCAAGAACTGATTGAAACTGCCATCGCCCAGTTTGCGCAGCATGGCGTAAGCAAGACGACGCTCAACGACATTGCCGACGCTGCTAACGTTACGCGTGGCGCTATCTACTGGCACTTCGAAAACAAGACTCAACTGTTTAATGAGATGTGGTTGCAACAGCCTTCATTGCGGGAGTTAATCCAGGATCACTTGACCGCTGGGTTAGAGCATGACCCGTTTCAGCAATTGCGTGAAAAATTGATTGTCGGTTTGCAATATATTGCCAAAATTCCCCGCCAGCAGGCGTTGCTGAAAATCTTATATCACAAATGTGAATTTAATGATGAGATGCTGGCCGAGGGAGTGATACGCGAAAAGATGGGCTTTAATCCGCAGACTCTCCGCGAAGTATTGCAGGCGTGTCAGCAACAAGGTTGTGTAGCAAATAATCTCGATTTAGATGTTGTGATGATTATTATTGATGGTGCCTTCAGCGGAATTGTTCAAAACTGGTTAATGAATATGGCGGGTTATGATCTTTATAAACAAGCCCCCGCTCTGGTCGATAACGTATTAAGAATGTTCATGCCAGATGAAAACATAACGAAATTAATTCATAAAACGAATGAATTAAGTGTCATATAA	
8160	CARD	prokka_03231	contig_13	155834	57	94344	94710	1	52	Klebsiella pneumoniae KpnE	3004580.0	182.57	150.0	Strict	82.2	100.83	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MYIYWILLGLAIATEITGTLSMKWASVSEGNGGFILMLVMISLSYIFLSFAVKKIALGVAYALWEGIGILFITLFSVLLFDESLSLMKIAGLTTLVAGIVLIKSGTRKARKPELEVNHGAV	ATGTATATTTATTGGATTTTATTAGGCCTGGCTATTGCTACGGAAATTACCGGTACGCTGTCAATGAAATGGGCGAGCGTCAGTGAGGGAAATGGCGGCTTTATTTTAATGCTGGTGATGATTTCTCTGTCGTATATATTTCTCTCTTTCGCCGTTAAAAAAATCGCCTTAGGCGTAGCTTATGCGCTGTGGGAAGGTATTGGTATTTTATTTATTACCTTGTTTAGCGTTTTGTTATTCGACGAAAGTTTATCGCTGATGAAAATTGCCGGGTTAACCACCCTGGTGGCCGGGATTGTGTTGATCAAGTCAGGTACCCGTAAAGCGCGTAAACCTGAACTGGAGGTGAACCATGGCGCAGTTTGA	
8160	CARD	prokka_03232	contig_13	155834	57	94696	95026	1	47	Klebsiella pneumoniae KpnF	3004583.0	186.808	150.0	Strict	84.4	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MAQFEWVHAAWLALAIVLEIVANVFLKFSDGFRRKIFGLLSLAAVLAAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWILFGQRLNRKGWIGLVLLLAGMIMVKLA	ATGGCGCAGTTTGAATGGGTTCACGCCGCCTGGCTGGCATTGGCAATCGTGCTGGAAATCGTTGCTAACGTCTTTTTGAAATTTTCTGACGGCTTTCGTCGCAAAATATTTGGCTTGCTCTCTCTGGCGGCGGTGCTGGCTGCCTTTAGTGCGCTTTCTCAGGCCGTTAAAGGGATCGACTTGTCTGTCGCTTATGCATTGTGGGGCGGGTTTGGTATTGCCGCCACGTTAGCCGCAGGTTGGATCTTGTTTGGTCAACGGTTAAATCGTAAAGGCTGGATTGGCCTGGTGCTGCTGTTGGCTGGAATGATCATGGTGAAACTTGCCTGA	
8160	CARD	prokka_03264	contig_13	155834	57	125590	125974	-1	47	marA	3000263.0	265.003	230.0	Strict	99.21	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNN	ATGTCCAGACGCAATACTGACGCTATTACCATTCATAGCATTTTGGACTGGATCGAGGACAACCTGGAATCGCCACTGTCACTGGAGAAAGTGTCAGAGCGTTCGGGTTACTCCAAATGGCACCTGCAACGGATGTTTAAAAAAGAAACCGGTCATTCATTAGGCCAATACATCCGTAGCCGTAAGATGACGGAAATCGCGCAAAAGCTGAAGGAAAGTAACGAGCCGATACTCTATCTGGCAGAACGATATGGCTTCGAGTCCCAACAAACTCTGACCCGAACCTTCAAAAATTACTTTGATGTTCCGCCGCATAAATACCGGATGACCAATATGCAGGGTGAATCGCGCTTTTTACATCCATTAAATCATTACAACAACTAG	
8160	CARD	prokka_03468	contig_15	124147	57	66817	68191	1	52	cpxA	3000830.0	926.391	890.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	ATGATAGGCAGCTTAACCGCGCGCATCTTCGCCATCTTCTGGCTGACGCTGGCGCTGGTGTTGATGTTGGTTTTGATGTTACCCAAGCTCGATTCACGCCAGATGACCGAGCTTCTGGATAGCGAACAGCGTCAGGGTCTGATGATTGAGCAGCATGTCGAAGCGGAGCTGGCGAACGATCCGCCCAACGATTTAATGTGGTGGCGGCGTCTGTTCCGGGCGATTGATAAGTGGGCACCGCCAGGACAGCGTTTGTTACTGGTGACCACCGAAGGCCGCGTGATCGGCGCTGAACGCAGCGAAATGCAGATCATTCGTAACTTTATTGGTCAGGCCGATAACGCCGATCATCCGCAGAAGAAAAAGTATGGCCGCGTGGAACTGGTCGGTCCGTTCTCCGTGCGTGATGGCGAAGATAATTACCAACTTTATCTGATTCGTCCGGCCAGCAGTTCTCAATCCGATTTCATAAACTTACTGTTTGACCGCCCGCTATTACTGCTGATTGTCACCATGCTGGTCAGTACGCCGCTGCTGTTGTGGTTGGCCTGGAGTCTGGCAAAACCGGCGCGTAAGCTGAAAAACGCTGCCGATGAAGTTGCCCAGGGAAACTTACGCCAGCACCCGGAACTGGAAGCGGGGCCACAGGAATTCCTTGCCGCCGGTGCCAGTTTTAACCAGATGGTCACCGCGCTGGAGCGCATGATGACCTCTCAGCAGCGTCTACTTTCTGATATCTCTCACGAACTGCGCACCCCGCTGACGCGTCTGCAACTGGGTACGGCGTTACTGCGCCGTCGTAGCGGTGAAAGCAAGGAACTGGAGCGTATTGAAACCGAAGCGCAACGTCTGGACAGCATGATCAACGATCTGTTGGTGATGTCACGTAATCAGCAGAAAAATGCGCTGGTTAGCGAGACCATCAAAGCCAACCAGTTGTGGAGTGAAGTGCTGGATAACGCGGCGTTCGAAGCCGAGCAAATGGGCAAGTCGTTGACGGTTAACTTCCCACCTGGGCCGTGGCCGCTGTACGGCAACCCGAACGCCCTGGAAAGTGCGCTGGAAAACATTGTTCGTAATGCTCTGCGTTATTCCCATACGAAGATTGAAGTGGGCTTTGCGGTAGATAAAGACGGTATCACCATTACGGTGGACGACGATGGTCCTGGCGTTAGCCCGGAAGATCGCGAACAGATTTTCCGTCCGTTCTATCGGACCGATGAAGCACGCGATCGTGAATCTGGCGGTACAGGTTTGGGGCTGGCGATTGTTGAAACCGCCATTCAGCAGCATCGTGGCTGGGTGAAGGCAGAAGACAGCCCGCTGGGCGGTTTACGGCTGGTGATTTGGTTGCCGCTGTATAAGCGGTCATAA	
8160	CARD	prokka_03559	contig_16	119273	57	40124	40715	1	56	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	49.6766	32.0	Strict	27.27	110.73	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MDSPAEYKIFLNIILAPVDDGLRFTYSGDNFFYREISMISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVIMGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAACGDVPEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYCFEILERR	GTGGACTCGCCAGCAGAATATAAAATTTTCCTCAACATCATCCTCGCACCAGTCGACGACGGTTTACGCTTTACGTATAGTGGCGACAATTTTTTTTATCGGGAAATCTCAATGATCAGTCTGATTGCGGCGTTAGCGGTAGATCGCGTTATCGGCATGGAAAACGCCATGCCGTGGAACCTGCCTGCCGATCTCGCCTGGTTTAAACGCAACACTTTAAATAAACCCGTGATTATGGGCCGCCATACCTGGGAATCCATCGGTCGTCCGTTGCCAGGACGCAAAAATATTATCCTCAGCAGTCAACCGGGTACGGACGATCGCGTAACGTGGGTGAAGTCGGTGGATGAAGCCATTGCGGCGTGTGGTGACGTACCAGAAATCATGGTGATTGGCGGCGGTCGCGTTTATGAGCAGTTCCTGCCGAAAGCGCAAAAACTGTATCTGACGCATATCGACGCGGAAGTGGAAGGCGACACCCATTTCCCGGATTACGAGCCGGATGACTGGGAATCGGTATTCAGTGAATTCCACGACGCCGATGCGCAGAACTCTCACAGCTATTGCTTTGAGATTCTGGAGCGGCGGTAA	
8160	CARD	prokka_03661	contig_17	116694	59	34249	35482	-1	58	mdtM	3001214.0	794.2669999999998	700.0	Strict	97.07	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; lincosamide antibiotic; nucleoside antibiotic; acridine dye; phenicol antibiotic; disinfecting agents and intercalating dyes	MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIATVGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFISFVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATIALSYIPMMSWVAVSPVILIDAGGLTTSQFAWTQVPVFGAVIVANTIVARFIKDPTEPRFIWRAVPIQLAGLALLIVGNLLSPHVWQWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER	ATGCCACGTTTTTTTGCCCGCCATGCCGCCACGCTGTTTTTCCCGATGGCGTTGATTTTGTATGACTTTGCTGCGTATCTGTCGACGGACCTGATCCAGCCAGGGATCATTAATGTGGTCCGTGATTTTAATGCCGATGTCAGTCTGGCCCCGGCTGCCGTCAGTCTCTATCTCGCTGGAGGCATGGCATTGCAGTGGCTGCTGGGGCCGCTTTCCGACAGGATTGGCCGCAGGCCGGTGCTGATTACCGGGGCGTTAATTTTTACCCTTGCCTGCGCCGCGACAATGTTCACCACGTCAATGACACAATTTCTTATCGCGCGTGCAATTCAGGGCACCAGTATCTGTTTTATTGCCACCGTTGGTTATGTCACGGTGCAGGAGGCGTTCGGACAGACAAAAGGGATCAAGTTGATGGCGATTATCACCTCCATCGTACTGATTGCGCCGATTATTGGCCCGCTTTCCGGCGCAGCTCTGATGCACTTTGTGCACTGGAAAGTCCTTTTTGCCATCATTGCGGTTATGGGTTTTATCTCATTTGTCGGCTTGCTGCTGGCGATGCCAGAGACGGTGAAGCGCGGCGCGGTTCCGTTTAGCGCCAAAAGCGTCTTGCGCGATTTTCGCAATGTCTTTTGCAACCGGCTGTTCCTCTTTGGCGCGGCAACCATCGCCCTCAGCTATATCCCAATGATGAGCTGGGTGGCTGTCTCGCCGGTGATCCTGATCGATGCGGGCGGCTTAACAACTTCGCAGTTCGCCTGGACGCAGGTTCCGGTATTCGGCGCGGTGATTGTCGCCAACACCATCGTGGCGCGATTTATCAAAGATCCGACCGAACCGCGGTTTATCTGGCGTGCCGTGCCCATTCAACTGGCCGGCCTCGCACTGTTGATTGTCGGCAATTTGCTGTCGCCACACGTCTGGCAGTGGTCGGTGCTCGGCACCAGTCTGTATGCTTTCGGGATTGGTTTAATCTTCCCGACCTTATTCCGCTTTACGCTGTTTTCCAATAACTTACCGAAAGGGACCGTCTCCGCATCACTGAATATGGTGATCCTGATGGTGATGTCTGTCTCGGTCGAAATCGGCCGCTGGCTGTGGTTTAACGGCGGTCGCTTGCCGTTTCATCTGTTAGCCGTCGTAGCGGGCGTTATCGTCGTTTTCACCCTGGCGGGATTGCTCAATCGCGTGCGCCAGCATCAGGCTGCCGAGCTGGCGGAGGAGCGGTGA	
8160	CARD	prokka_04074	contig_21	83139	58	43230	43644	-1	67	H-NS	3000676.0	276.944	240.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; cephamycin; penam; tetracycline antibiotic	MSEALKILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREMLIADGIDPNELLNSLAAVKSGTKAKRAQRPAKYSYVDENGETKTWTGQGRTPAVIKKAMDEQGKSLDDFLIKQ	ATGAGCGAAGCACTTAAAATTCTGAACAACATCCGTACTCTTCGTGCGCAGGCAAGAGAATGTACACTTGAAACGCTGGAAGAAATGCTGGAAAAATTAGAAGTTGTTGTTAACGAACGTCGCGAAGAAGAAAGCGCGGCTGCTGCTGAAGTTGAAGAGCGCACTCGTAAACTGCAGCAATATCGCGAAATGCTGATCGCTGACGGTATTGACCCGAACGAACTGCTGAATAGCCTTGCTGCCGTTAAATCTGGCACCAAAGCTAAGCGTGCTCAGCGTCCGGCAAAATATAGCTACGTTGACGAAAACGGCGAAACTAAAACCTGGACTGGCCAGGGCCGTACTCCAGCTGTAATCAAAAAAGCAATGGATGAGCAAGGTAAATCCCTCGACGATTTCCTGATCAAGCAATAA	
8160	CARD	prokka_04258	contig_24	60514	801	8788	9298	-1	881	dfrA8	3002863.0	351.288	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MIELHAILAATANGCIGKDNALPWPPLKGDLARFKKLTMGKVVIMGRKTYESLPVKLEGRTCIVMTRQALELPGVRDANGAIFVNNVSDAMRFAQEESVGDVAYVIGGAEIFKRLALMITQIELTFVKRLYEGDTYVDLAEMVKDYEQNGMEEHDLHTYFTYRKKELTE	ATGATCGAGCTTCATGCCATTTTAGCTGCCACCGCCAATGGTTGCATTGGGAAGGACAACGCACTTCCCTGGCCACCACTAAAAGGCGATCTGGCCAGATTCAAAAAATTGACCATGGGGAAGGTGGTCATTATGGGGCGCAAGACCTATGAGAGCTTGCCCGTCAAATTAGAAGGTCGCACCTGCATCGTTATGACGCGCCAAGCGCTGGAGCTTCCGGGTGTTCGTGACGCTAACGGCGCTATCTTCGTGAACAACGTCAGCGACGCCATGCGGTTCGCTCAAGAAGAGAGCGTGGGCGATGTGGCCTACGTCATTGGTGGCGCTGAGATATTCAAGCGACTTGCCTTGATGATCACGCAGATTGAATTGACCTTTGTTAAGCGACTGTACGAAGGCGACACCTACGTTGATCTGGCCGAAATGGTCAAAGACTACGAGCAGAATGGCATGGAAGAACATGACCTTCACACTTACTTCACTTACCGTAAAAAGGAGCTTACAGAATGA	
8160	CARD	prokka_04264	contig_24	60514	801	12740	13556	1	534	sul2	3000412.0	528.865	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	ATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	
8160	CARD	prokka_04265	contig_24	60514	801	13616	14420	1	676	APH(3'')-Ib	3002639.0	541.191	500.0	Strict	99.63	100.0	APH(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTCATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	
8160	CARD	prokka_04266	contig_24	60514	801	14419	15256	1	658	APH(6)-Id	3002660.0	566.614	500.0	Strict	99.28	100.0	APH(6)	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIKDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAAAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	
8160	CARD	prokka_04336	contig_25	55033	79	16639	17839	-1	94	tet(A)	3000165.0	768.459	700.0	Strict	98.48	94.1	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic	MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR	GTGAAACCCAACAGACCCCTGATCGTAATTCTGAGCACTGTCGCGCTCGACGCTGTCGGCATCGGCCTGATTATGCCGGTGCTGCCGGGCCTCCTGCGCGATCTGGTTCACTCGAACGACGTCACCGCCCACTATGGCATTCTGCTGGCGCTGTATGCGTTGATGCAATTTGCCTGCGCACCTGTGCTGGGCGCGCTGTCGGATCGTTTCGGGCGGCGGCCGGTCTTGCTCGTCTCGCTGGCCGGCGCTGCTGTCGACTACGCCATCATGGCGACGGCGCCTTTCCTTTGGGTTCTCTATATCGGGCGGATCGTGGCCGGCATCACCGGGGCGACTGGGGCGGTAGCCGGCGCTTATATTGCCGATATCACTGATGGCGATGAGCGCGCGCGGCACTTCGGCTTCATGAGCGCCTGTTTCGGGTTCGGGATGGTCGCGGGACCTGTGCTCGGTGGGCTGATGGGCGGTTTCTCCCCCCACGCTCCGTTCTTCGCCGCGGCAGCCTTGAACGGCCTCAATTTCCTGACGGGCTGTTTCCTTTTGCCGGAGTCGCACAAAGGCGAACGCCGGCCGTTACGCCGGGAGGCTCTCAACCCGCTCGCTTCGTTCCGGTGGGCCCGGGGCATGACCGTCGTCGCCGCCCTGATGGCGGTCTTCTTCATCATGCAACTTGTCGGACAGGTGCCGGCCGCGCTTTGGGTCATTTTCGGCGAGGATCGCTTTCACTGGGACGCGACCACGATCGGCATTTCGCTTGCCGCATTTGGCATTCTGCATTCACTCGCCCAGGCAATGATCACCGGCCCTGTAGCCGCCCGGCTCGGCGAAAGGCGGGCACTCATGCTCGGAATGATTGCCGACGGCACAGGCTACATCCTGCTTGCCTTCGCGACACGGGGATGGATGGCGTTCCCGATCATGGTCCTGCTTGCTTCGGGTGGCATCGGAATGCCGGCGCTGCAAGCAATGTTGTCCAGGCAGGTGGATGAGGAACGTCAGGGGCAGCTGCAAGGCTCACTGGCGGCGCTCACCAGCCTGACCTCGATCGTCGGACCCCTCCTCTTCACGGCGATCTATGCGGCTTCTATAACAACGTGGAACGGGTGGGCATGGATTGCAGGCGCTGCCCTCTACTTGCTCTGCCTGCCGGCGCTGCGTCGCGGGCTTTGGAGCGGCGCAGGGCAACGAGCCGATCGCTGA	
8160	CARD	prokka_04370	contig_25	55033	79	47499	48315	-1	88	APH(3')-Ib	3002642.0	518.464	500.0	Strict	94.83	100.0	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDAFADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVVVDALAAFMRRLHAIPVSECSFNSDHACRLARARERIEAGVVDVDDFDKEREGWTAEQVWEAMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFEPSLQERLVAQYGIADPDRRKLQFHLLLDELF	GTGAACGATATTGATCGAGAAGAGCCCTGCGCAGCCGCTGCCGTGCCCGAGAGCATGGCGGCTCACGTGATGGGATACAAATGGGCGCGTGATAAGGTTGGTCAGTCCGGCTGCGCGGTCTATCGGCTGCATAGCAAGTCAGGCGGCTCCGACTTGTTTCTGAAGCACGGCAAAGATGCTTTTGCCGACGACGTGACTGATGAAATGGTGAGATTGCGTTGGCTGGCGGGGCACATTTCTGTGCCCTCCGTTGTAAGCTTCGTTCGCACGCCCAATCAGGCATGGCTCCTGACAACAGCAATACATGGAAAAACGGCATATCAAGTGCTGAAATCGGATTTCGGAGCCCGTCTCGTTGTTGTTGACGCATTGGCGGCGTTCATGCGCCGACTGCATGCGATCCCAGTGAGCGAATGCTCCTTCAACAGTGACCACGCATGCAGGCTTGCCCGAGCGCGGGAGCGTATCGAGGCGGGGGTTGTTGATGTCGATGACTTCGATAAGGAGCGCGAAGGGTGGACGGCCGAACAGGTTTGGGAGGCGATGCATCGCCTCCTACCGCTCGCGCCGGACCCAGTCGTGACGCACGGCGATTTTTCACTCGATAATCTACTTATCGTCGAAGGTAAGGTAGTCGGCTGCATCGACGTTGGGCGGGCTGGTATTGCTGATCGATACCAAGACCTTGCCGTGTTATGGAACTGTCTTGAGGAGTTCGAACCTTCGCTTCAGGAGAGGCTTGTTGCGCAATATGGCATTGCCGATCCGGATAGGCGCAAGCTGCAATTTCATCTCCTGCTGGACGAACTTTTCTAA	
8160	CARD	prokka_04513	contig_28	35415	56	24894	26061	-1	57	ugd	3003577.0	791.571	700.0	Strict	99.23	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGTIKQNIPTLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNTRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	ATGAAAATTACCATTTCCGGTACTGGCTATGTAGGCTTGTCAAACGGGCTTCTAATCGCACAAAATCATGAGGTTGTGGCATTAGATATTTTACCGTCACGCGTTGCTATGCTGAATGATCGGATATCTCCTATTGTTGATAAGGAAATTCAGCAGTTTTTGCAATCAGATAAAATACACTTTAATGCCACATTAGATAAAAATGAAGCCTACCGGGATGCTGATTATGTCATCATCGCCACTCCAACCGACTATGATCCTAAAACTAATTATTTCAATACATCCAGTGTAGAATCAGTAATTAAAGACGTAGTTGAGATAAACCCTTATGCGGTTATGGTCATCAAATCAACGGTTCCCGTTGGTTTTACCGCAGCGATGCATAAAAAATATCGTACTGAAAATATTATATTCTCCCCGGAATTTCTCCGTGAGGGTAAAGCCCTTTACGATAACCTTCATCCGTCACGTATTGTCATCGGTGAGCGTTCAGAACGCGCAGAACGTTTTGCTGCGTTGTTACAGGAAGGCACGATTAAGCAAAATATCCCGACCCTGTTTACCGACTCCACTGAAGCAGAAGCGATTAAACTTTTCGCTAATACCTATCTGGCGATGCGCGTGGCGTACTTTAACGAACTGGATAGCTATGCAGAAAGTTTGGGTCTGAATACGCGTCAGATTATCGAAGGTGTTTGTCTCGACCCGCGTATCGGCAACCATTACAACAATCCGTCGTTTGGTTATGGTGGTTATTGTTTGCCGAAAGATACCAAACAGTTATTGGCGAATTATCAGTCTGTGCCGAATAACCTGATTTCGGCAATTGTCGATGCTAACCGCACGCGTAAAGATTTTATTGCCGATGCCATTTTGTCACGCAAGCCGCAAGTGGTGGGTATTTATCGTCTGATTATGAAGAGCGGTTCAGACAACTTCCGCGCGTCTTCCATTCAGGGGATTATGAAACGTATCAAGGCGAAAGGCGTTGAAGTGATCATTTACGAACCGGTGATGAAAGAAGACTCATTCTTCAACTCTCGCCTGGAACGAGATCTCGCCACTTTCAAACAACAAGCTGATGTCATTATCTCCAATCGTATGGCAGAAGAGCTTAAGGATGTGGCAGATAAGGTATACACCCGCGATCTCTTTGGTAGCGATTAA	
8160	CARD	prokka_00839	contig_3	355584	55	118619	119978	1	64	Escherichia coli GlpT with mutation conferring resistance to fosfomycin	3003889.0	919.842	850.0	Strict	99.78	100.0	antibiotic-resistant GlpT	protein variant model	antibiotic target alteration	E448K	fosfomycin	MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGMAWFNDWHAALYMPAFCAILVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEQELTAKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPTVDMICMIVIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGSILAVILLIVVMIGEKRRHEQLLQKRNGG	ATGTTGAGTATTTTTAAACCAGCGCCACACAAAGCGCGCTTACCTGCCGCGGAGATCGATCCGACTTATCGTCGATTGCGCTGGCAAATTTTCCTGGGGATATTCTTTGGCTATGCTGCTTACTATTTGGTTCGTAAGAACTTTGCGCTCGCTATGCCTTATCTGGTTGAGCAGGGATTCTCACGCGGTGATTTAGGTTTTGCCCTTTCGGGGATCTCGATTGCTTATGGATTTTCGAAATTCATCATGGGTTCGGTATCGGATCGCTCGAATCCGCGCGTTTTCCTGCCCGCAGGTTTGATTCTGGCGGCGGCAGTGATGTTGTTTATGGGCTTTGTGCCATGGGCGACGTCGAGCATTGCGGTGATGTTTGTACTGTTGTTCCTCTGCGGTTGGTTCCAGGGGATGGGGTGGCCGCCGTGTGGTCGTACTATGGTGCACTGGTGGTCGCAGAAAGAACGTGGCGGTATTGTGTCAGTGTGGAACTGTGCGCACAACGTCGGTGGTGGTATTCCGCCGCTGCTGTTCCTGCTGGGGATGGCCTGGTTCAATGACTGGCACGCGGCGCTCTATATGCCCGCTTTCTGCGCCATTCTGGTGGCACTGTTCGCCTTTGCGATGATGCGCGATACCCCGCAATCCTGTGGCCTGCCGCCGATTGAAGAGTACAAAAATGATTATCCGGACGACTATAACGAAAAAGCGGAACAGGAGCTGACCGCGAAGCAGATCTTCATGCAGTACGTGCTGCCGAACAAACTGCTGTGGTATATCGCCATCGCCAACGTGTTCGTTTATCTGCTGCGTTACGGCATCCTCGACTGGTCACCGACTTATCTGAAAGAGGTTAAGCATTTCGCGCTGGATAAATCCTCCTGGGCCTACTTTCTTTATGAATATGCAGGTATTCCGGGCACCCTGCTGTGCGGCTGGATGTCGGATAAAGTCTTTCGTGGTAACCGTGGGGCAACCGGCGTCTTCTTTATGACACTGGTGACCATCGCGACTATCGTTTACTGGATGAACCCGGCAGGTAACCCAACCGTCGATATGATTTGTATGATTGTTATCGGCTTCCTGATCTATGGCCCTGTGATGCTGATCGGTCTACATGCGCTGGAACTGGCACCGAAAAAAGCGGCAGGTACGGCAGCGGGTTTTACCGGGCTGTTTGGTTACCTGGGCGGTTCGGTGGCGGCGAGCGCGATTGTTGGCTACACCGTGGACTTCTTCGGCTGGGATGGCGGCTTTATGGTAATGATTGGCGGCAGCATTCTGGCGGTTATCTTGTTGATTGTTGTGATGATTGGCGAAAAACGTCGCCATGAACAATTACTGCAAAAACGCAACGGAGGCTAA	
8160	CARD	prokka_00847	contig_3	355584	55	131172	133800	1	55	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1765.74	1500.0	Strict	99.66	100.0	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	D87N, S83L	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDLAVYNTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMATNIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNVAAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVVVTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVYSMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVLTEFNRLRTAGKVAIKLVDGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTGVRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERNGLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTSEDENVVGLQRVAEPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTCAACATTGAGGAAGAGCTGAAGAGCTCCTATCTGGATTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCAGATGTCCGAGATGGCCTGAAGCCGGTACACCGTCGCGTACTTTACGCCATGAACGTACTAGGCAATGACTGGAACAAAGCCTATAAAAAATCTGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCATCCCCATGGTGACTTGGCGGTTTATAACACGATCGTCCGTATGGCGCAGCCATTCTCGCTGCGTTACATGCTGGTAGACGGTCAGGGTAACTTCGGTTCCATCGACGGCGACTCTGCGGCGGCAATGCGTTATACGGAAATCCGTCTGGCGAAAATTGCCCATGAACTGATGGCCGATCTCGAAAAAGAGACGGTCGATTTCGTTGATAACTATGACGGCACGGAAAAAATTCCGGACGTCATGCCAACCAAAATTCCTAACCTGCTGGTGAACGGTTCTTCCGGTATCGCCGTAGGTATGGCAACCAACATTCCGCCGCACAACCTGACGGAAGTCATCAACGGTTGTCTGGCGTATATCGATGATGAAGACATCAGCATTGAAGGGCTGATGGAACACATCCCGGGGCCGGACTTCCCGACGGCGGCAATCATTAACGGTCGTCGCGGTATTGAAGAAGCTTACCGTACCGGTCGCGGCAAGGTATATATCCGTGCCCGTGCCGAAGTAGAAGTTGACGCCAAAACCGGACGTGAAACCATTATCGTCCACGAAATTCCGTATCAGGTGAACAAAGCGCGCCTGATCGAAAAAATTGCGGAACTGGTAAAAGAAAAACGCGTGGAAGGCATCAGCGCGCTGCGTGACGAGTCTGACAAAGACGGTATGCGCATCGTGATTGAAGTCAAACGCGATGCGGTCGGTGAAGTGGTGCTCAACAACCTCTACTCCCAGACCCAGTTGCAGGTTTCTTTCGGTATTAACATGGTGGCATTGCACCATGGTCAGCCGAAGATCATGAACCTGAAAGACATCATCGCGGCGTTTGTTCGTCACCGCCGTGAAGTGGTGACCCGTCGTACCATTTTCGAACTGCGTAAAGCTCGCGATCGTGCTCATATTCTTGAAGCATTAGCCGTGGCGCTGGCGAACATCGACCCGATCATCGAACTGATCCGTCATGCGCCGACGCCTGCAGAAGCGAAAACTGCGCTGGTTGCTAATCCGTGGCAGCTGGGCAACGTTGCTGCGATGCTGGAACGTGCGGGCGATGATGCTGCGCGTCCGGAATGGCTGGAGCCAGAGTTCGGCGTGCGTGATGGTCTGTACTACCTGACCGAACAGCAAGCTCAGGCGATTCTGGATCTGCGTTTGCAGAAACTGACCGGCCTTGAGCACGAAAAACTGCTCGACGAATACAAAGAGCTGCTGGATCAGATTGCGGAGCTGTTGCGTATTCTGGGTAGCGCCGATCGTCTGATGGAAGTGATCCGTGAAGAGCTGGAGCTGGTTCGTGAACAGTTCGGTGACAAACGTCGTACCGAAATCACCGCTAACAGCGCCGACATCAACCTGGAAGATCTGATCACACAGGAAGATGTGGTGGTCACGCTTTCTCACCAGGGTTACGTGAAGTATCAGCCGCTTTCTGAATACGAAGCGCAGCGTCGTGGCGGGAAAGGTAAATCTGCCGCACGTATTAAAGAAGAAGACTTTATTGACCGACTGCTGGTGGCGAACACCCACGACCATATTCTGTGCTTCTCCAGCCGTGGCCGCGTCTATTCGATGAAGGTCTACCAGTTGCCAGAAGCTACTCGTGGCGCACGTGGTCGTCCGATCGTCAACCTGCTGCCGCTGGAACAGGACGAACGTATCACCGCGATCCTGCCGGTGACCGAGTTTGAAGAAGGCGTGAAAGTCTTCATGGCGACCGCTAACGGTACTGTGAAGAAAACCGTCCTCACCGAGTTCAACCGTCTGCGTACCGCCGGTAAAGTGGCGATCAAACTGGTTGACGGCGATGAGCTGATCGGCGTTGACCTGACCAGCGGCGAAGACGAAGTAATGCTGTTCTCCGCTGAAGGTAAAGTGGTGCGCTTTAAAGAGTCTTCTGTCCGTGCGATGGGCTGCAACACCACCGGTGTTCGTGGTATTCGTTTAGGCGAAGGCGATAAAGTCGTCTCTCTGATCGTGCCTCGTGGCGATGGCGCAATCCTCACCGCAACGCAGAACGGTTATGGTAAACGTACCGCAGTGGCGGAATACCCAACCAAGTCGCGTGCGACGAAAGGGGTTATCTCCATCAAGGTTACCGAACGTAACGGTTTAGTGGTTGGCGCGGTGCAGGTAGATGATTGCGACCAGATCATGATGATCACCGACGCCGGTACGCTGGTACGTACTCGCGTGTCGGAAATCAGCATCGTAGGCCGTAACACCCAGGGCGTAATCCTTATCCGTACTTCGGAAGATGAAAACGTGGTGGGTCTGCAACGTGTTGCTGAACCGGTTGACGAGGAAGATCTGGATACCATCGACGGCAGTGCCGCGGAAGGGGACGATGAAATCGCTCCGGAAGTGGACGTTGACGACGAGCCAGAAGAAGAATAA	
8160	CARD	prokka_02116	contig_7	240706	59	147868	149260	-1	55	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	932.169	850.0	Strict	99.78	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNQYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA	ATGCTGGCTTTCTTAAACCAGGTTCGCAAGCCGACCCTGGACCTTCCGCTCGAAGTGCGGCGCAAAATGTGGTTCAAACCGTTCATGCAATCCTACCTGGTGGTCTTTATCGGCTACCTTACGATGTACCTGATTCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCGACCTACGGGTTGAGCATGACGCAGCTGGGGATGATCGGCCTGGGCTTCTCCATCACTTATGGCGTGGGTAAAACGCTGGTTTCTTACTACGCCGACGGCAAAAACACCAAACAATTCCTGCCGTTCATGCTGATCCTGTCTGCCATTTGTATGCTGGGCTTCAGTGCCAGTATGGGCAGCGGCTCGGTTAGCCTGTTCCTGATGATTGCCTTCTACGCCTTGAGCGGCTTTTTCCAGAGTACCGGCGGTTCATGCAGTTACTCCACCATCACCAAATGGACGCCGCGTCGTAAACGCGGGACATTCCTCGGTTTCTGGAACATTTCTCACAACCTTGGTGGTGCAGGCGCAGCAGGTGTGGCGCTGTTCGGCGCAAATTACCTGTTCGATGGTCATGTCATCGGCATGTTTATTTTCCCGTCGATTATCGCGCTGATTGTTGGTTTTATCGGTCTGCGTTACGGCAGCGACTCCCCGGAATCTTATGGCCTCGGCAAAGCTGAAGAGCTGTTTGGCGAGGAGATCAGTGAAGAGGATAAAGAGACAGAATCTACCGATATGACCAAGTGGCAGATCTTTGTTGAGTATGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCGCCAACATTTTCCTCTATGTGGTGCGTATTGGTATCGACCAGTGGTCAACTGTGTATGCGTTCCAGGAACTGAAACTCTCTAAAGCGGTGGCGATTCAGGGCTTTACGCTGTTTGAAGCTGGTGCGCTGGTCGGTACGCTGCTGTGGGGCTGGCTCTCTGACCTGGCGAACGGTCGCCGTGGCCTGGTGGCCTGTATCGCGCTGGCGCTGATTATCGCCACGCTCGGTGTGTATCAACACGCCAGCAACCAATATATCTACCTGGCTTCTCTCTTTGCGTTGGGTTTCCTGGTCTTTGGCCCGCAACTGTTGATTGGCGTGGCGGCTGTTGGCTTTGTACCTAAAAAAGCGATTGGCGCTGCCGATGGTATTAAAGGCACCTTCGCTTACCTGATTGGTGACAGCTTTGCCAAGTTAGGTCTGGGAATGATTGCCGATGGGACGCCGGTATTTGGCCTTACCGGCTGGGCAGGCACCTTCGCCGCGCTGGATATCGCCGCGATTGGTTGTATCTGCCTGATGGCGATAGTGGCGGTGATGGAAGAACGCAAAATCCGCCGCGAGAAAAAAATTCAGCAGTTGACAGTGGCATAA	
8160	CARD	prokka_02349	contig_8	229899	56	172038	173766	-1	60	Escherichia coli PtsI with mutation conferring resistance to fosfomycin	3003899.0	1162.52	1100.0	Strict	99.65	100.0	antibiotic-resistant ptsI phosphotransferase	protein variant model	antibiotic target alteration	V25I	fosfomycin	MISGILASPGIAFGKALLLKEDEIIIDRKKISADQVDQEVERFLSGRAKASAQLETIKTKAGETFGEEKEAIFEGHIMLLEDEELEQEIIALIKDKHMTADAAAHEVIEGQASALEELDDEYLKERAADVRDIGKRLLRNILGLKIIDLSAIQDEVILVAADLTPSETAQLNLKKVLGFITDAGGRTSHTSIMARSLELPAIVGTGSVTSQVKNDDYLILDAVNNQVYVNPTNEVIDKMRAVQEQVASEKAELAKLKDLPAITLDGHQVEVCANIGTVRDVEGAERNGAEGVGLYRTEFLFMDRDALPTEEEQFAAYKAVAEACGSQAVIVRTMDIGGDKELPYMNFPKEENPFLGWRAIRIAMDRKEILRDQLRAILRASAFGKLRIMFPMIISVEEVRALRKEIEIYKQELRDEGKAFDESIEIGVMVETPAAATIARHLAKEVDFFSIGTNDLTQYTLAVDRGNDMISHLYQPMSPSVLNLIKQVIDASHAEGKWTGMCGELAGDERATLLLLGMGLDEFSMSAISIPRIKKIIRNTNFEDAKVLAEQALAQPTTDELMTLVNKFIEEKTIC	ATGATTTCAGGCATTTTAGCATCCCCGGGTATCGCTTTCGGTAAAGCTCTGCTTCTGAAAGAAGACGAAATTATCATTGACCGGAAAAAAATTTCTGCCGACCAGGTTGATCAGGAAGTTGAACGTTTTCTGAGCGGTCGTGCCAAGGCATCAGCCCAGCTGGAAACGATCAAAACGAAAGCTGGTGAAACGTTCGGTGAAGAAAAAGAAGCCATCTTTGAAGGGCATATTATGCTGCTCGAAGATGAGGAGCTGGAGCAGGAAATCATAGCCCTGATTAAAGATAAGCACATGACAGCTGACGCAGCTGCTCATGAAGTTATCGAAGGTCAGGCTTCTGCCCTGGAAGAGCTGGATGATGAATACCTGAAAGAACGTGCGGCTGACGTACGTGATATCGGTAAGCGCCTGCTGCGCAACATCCTGGGCCTGAAGATTATCGACCTGAGCGCCATTCAGGATGAAGTCATTCTGGTTGCCGCTGACCTGACGCCGTCCGAAACCGCACAGCTGAACCTGAAGAAGGTGCTGGGTTTCATCACCGACGCGGGTGGCCGTACTTCCCACACCTCTATCATGGCGCGTTCTCTGGAACTGCCTGCTATCGTGGGTACCGGTAGCGTCACCTCTCAGGTGAAAAATGACGACTATCTGATTCTGGATGCCGTAAATAATCAGGTTTACGTCAATCCAACCAACGAAGTTATTGATAAAATGCGCGCTGTTCAGGAGCAAGTGGCTTCTGAAAAAGCAGAGCTTGCTAAACTGAAAGATCTGCCAGCTATTACGCTGGACGGTCACCAGGTAGAAGTGTGCGCTAACATTGGTACGGTTCGTGACGTTGAAGGTGCAGAGCGTAACGGCGCTGAAGGCGTTGGTCTGTATCGTACTGAGTTCCTGTTCATGGACCGCGACGCGTTGCCCACTGAAGAAGAACAGTTTGCTGCTTACAAAGCAGTGGCTGAAGCGTGTGGCTCGCAGGCGGTTATCGTTCGTACCATGGACATCGGCGGCGACAAAGAGCTGCCATACATGAACTTCCCGAAAGAAGAGAACCCGTTCCTCGGCTGGCGCGCTATCCGTATCGCGATGGATCGTAAAGAGATCCTGCGCGATCAGCTCCGTGCTATCCTGCGTGCCTCTGCTTTCGGTAAATTGCGCATCATGTTCCCGATGATCATCTCTGTTGAAGAAGTGCGTGCACTGCGCAAAGAGATCGAAATCTACAAACAGGAACTGCGCGACGAAGGTAAAGCGTTTGACGAGTCAATTGAAATCGGCGTAATGGTGGAAACACCGGCTGCCGCAACAATTGCACGTCATTTAGCCAAAGAAGTTGATTTCTTTAGTATCGGCACCAATGATTTAACGCAGTACACTCTGGCAGTTGACCGTGGTAATGATATGATTTCACACCTTTACCAGCCAATGTCACCGTCCGTGCTGAACTTGATCAAGCAAGTTATTGATGCTTCTCATGCTGAAGGCAAATGGACTGGCATGTGTGGTGAGCTTGCTGGCGATGAACGTGCTACACTTCTGTTGCTGGGGATGGGTCTGGACGAATTCTCTATGAGCGCCATTTCTATCCCGCGCATTAAGAAGATTATCCGTAACACGAACTTCGAAGATGCGAAGGTGTTAGCAGAGCAGGCTCTTGCTCAACCGACAACGGACGAGTTAATGACGCTGGTTAACAAGTTCATTGAAGAAAAAACAATCTGCTAA	
8160	CARD	prokka_02702	contig_10	208775	59	100123	102382	1	45	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1524.99	1400.0	Strict	99.2	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDIACYVAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYSELLLSELGQGTADWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAQAVIALIDQPKTTLDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVRMRAVWKKEDGAVVISALPHQVSGARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRNEDEPKPALMSRFGLTETQAEAILELKLRHLAKLEEMKIRGEQSELEKERDQLQGILASERKMNNLLKKELQADAQGYGDERRSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSNQPVVFVDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALITLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDLPQLSKGKGNKIINIPSAEAARGEDGLAQLYVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGTLMRGLQRIDRVEIDSPRRASSGDSEE	ATGAGCGATATGGCAGAGCGCCTTGCGCTACATGAATTTACGGAAAACGCCTACTTAAACTACTCCATGTACGTGATCATGGACCGTGCGTTGCCGTTTATTGGTGATGGTCTGAAACCTGTTCAGCGCCGCATTGTGTATGCGATGTCTGAGCTGGGCCTGAATGCCAGCGCCAAATTTAAAAAATCGGCCCGTACCGTCGGTGACGTACTGGGTAAATACCATCCGCACGGCGATATTGCCTGTTATGTAGCGATGGTCCTGATGGCGCAGCCGTTCTCTTACCGTTATCCGCTGGTTGATGGTCAGGGGAACTGGGGGGCGCCGGACGATCCGAAATCGTTCGCGGCAATGCGTTACACCGAATCCCGGTTGTCGAAATATTCCGAGCTGCTATTGAGCGAGCTGGGGCAGGGGACGGCTGACTGGGTGCCAAACTTCGACGGCACTTTGCAGGAGCCGAAAATGCTGCCTGCCCGTCTGCCAAACATTTTGCTTAACGGCACCACCGGTATTGCCGTCGGCATGGCGACCGATATTCCACCGCATAACCTGCGTGAAGTGGCTCAGGCGGTAATTGCCTTAATCGACCAGCCGAAAACCACGCTCGATCAGCTGCTGGATATCGTGCAGGGGCCGGATTATCCGACTGAAGCGGAAATTATCACTTCGCGCGCCGAGATTCGTAAAATCTACGAGAACGGACGTGGTTCAGTGCGTATGCGCGCGGTTTGGAAGAAGGAAGATGGCGCGGTGGTTATCAGCGCATTGCCGCATCAGGTTTCAGGTGCGCGCGTACTGGAGCAAATTGCTGCGCAAATGCGCAACAAAAAGCTGCCGATGGTTGACGATCTGCGCGATGAATCTGACCACGAGAACCCGACCCGTCTGGTGATTGTGCCGCGTTCCAACCGCGTGGATATGGATCAGGTGATGAACCACCTCTTTGCTACCACCGATCTGGAAAAGAGCTATCGCATTAACCTCAATATGATCGGTCTGGATGGTCGTCCGGCGGTGAAAAACCTGCTGGAAATCCTCTCCGAATGGCTGGTGTTCCGCCGCGATACCGTGCGCCGCCGACTGAACTATCGTCTGGAGAAAGTTCTCAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTTCTCAATATCGACGAAGTGATTGAGATCATTCGTAATGAAGATGAACCGAAACCGGCGCTGATGTCGCGGTTTGGCCTTACGGAAACCCAGGCGGAAGCGATCCTCGAACTGAAACTGCGTCATCTTGCCAAACTGGAAGAGATGAAGATTCGCGGTGAGCAGAGTGAGCTGGAAAAAGAGCGCGACCAGTTGCAGGGCATTTTGGCTTCCGAGCGTAAAATGAATAACCTGCTGAAGAAAGAACTGCAGGCAGACGCGCAAGGCTACGGTGACGAACGTCGTTCGCCGTTGCATGAACGCGAAGAAGCGAAAGCGATGAGCGAGCACGACATGCTGCCGTCTGAACCTGTCACCATTGTGCTGTCGCAGATGGGCTGGGTACGCAGCGCTAAAGGCCATGATATCGACGCGCCGGGCCTGAATTATAAAGCGGGTGATAGCTTCAAAGCGGCGGTGAAAGGTAAGAGCAACCAACCGGTAGTGTTTGTTGATTCCACCGGTCGTAGCTATGCCATCGACCCGATTACGCTGCCGTCGGCGCGTGGTCAGGGCGAGCCGCTCACCGGCAAATTAACGTTGCCGCCTGGAGCGACCGTTGACCATATGCTGATGGAAAGCGACGATCAGAAACTGCTGATGGCTTCCGATGCGGGTTACGGTTTCGTCTGCACCTTTAACGATCTGGTGGCGCGTAACCGTGCAGGTAAGGCTTTGATCACCTTACCGGAAAATGCCCATGTTATGCCGCCGGTGGTGATTGAAGATGCTTCCGATATGCTGCTGGCAATCACTCAGGCAGGCCGTATGTTGATGTTCCCGGTAAGCGATCTGCCGCAGCTGTCGAAGGGCAAAGGCAACAAGATTATCAACATTCCATCGGCAGAAGCCGCGCGTGGCGAGGATGGCCTGGCGCAACTGTACGTTCTGCCGCCGCAAAGCACGCTGACCATTCATGTTGGGAAACGCAAAATTAAACTGCGTCCGGAAGAGCTACAGAAAGTCACTGGCGAACGTGGACGCCGCGGTACGTTGATGCGCGGTTTGCAGCGTATCGATCGTGTTGAGATCGACTCTCCTCGCCGTGCCAGCAGCGGTGATAGCGAAGAGTAA	
8160	CARD	prokka_03598	contig_16	119273	57	85094	86861	1	49	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	596.275	500.0	Strict	53.2	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVKEGDMRSLRVQQVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALANALNIPLDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTITDVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDTLTTGDKNEFVINQGEGTGGRS	ATGAAAGCAGCGGCGAAAACGCAGAAACCAAAACGTCAGGAAGAACATGCCAACTTTATCAGTTGGCGTTTTGCGTTGTTATGCGGCTGTATTCTCCTGGCGCTGGCTTTTCTGCTCGGACGCGTAGCGTGGTTACAAGTTATCTCCCCGGATATGCTGGTGAAAGAGGGCGACATGCGTTCTCTTCGCGTTCAGCAAGTTTCCACCTCCCGCGGCATGATTACTGACCGTTCTGGTCGCCCGTTAGCGGTGAGTGTGCCAGTAAAAGCGATTTGGGCTGACCCGAAAGAAGTGCATGACGCTGGCGGTATCAGCGTCGGTGACCGCTGGAAGGCGCTGGCTAACGCGCTCAATATTCCGCTGGATCAGCTCTCAGCCCGCATTAACGCCAACCCGAAAGGGCGCTTTATTTATCTGGCGCGTCAGGTAAACCCTGACATGGCGGACTACATCAAAAAACTGAAACTGCCGGGAATTCATCTGCGTGAAGAATCTCGCCGTTATTATCCATCCGGCGAAGTGACTGCTCACCTCATCGGCTTTACTAACGTCGATAGCCAAGGGATTGAGGGGGTCGAGAAGAGTTTCGATAAATGGCTTACCGGGCAGCCGGGTGAGCGCATTGTGCGTAAAGACCGCTATGGTCGCGTAATTGAAGATATTTCTTCTACTGACAGCCAGGCAGCGCACAACCTGACGCTGAGTATTGATGAACGCCTGCAGGCGCTGGTTTATCGCGAACTGAACAACGCAGTGGCCTTTAACAAGGCTGAATCTGGTAGCGCCGTGCTGGTGGATGTCAACACCGGTGAAGTGCTGGCGATGGCTAACAGCCCGTCATACAACCCAAATAATCTGAGCGGCACGCCGAAAGAAGCGATGCGTAACCGTACCATCACCGACGTGTTTGAACCGGGCTCAACGGTTAAACCGATGGTGGTGATGACCGCGTTGCAACGTGGCGTGGTGCGGGAAAACTCGGTACTCAATACCGTTCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCACGCTACAGCGAATTAACCCTGACCGGGGTATTACAGAAGTCGAGTAACGTCGGTGTTTCCAAACTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTGGGAAAAGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACACCGTTACAGTTAGCGCGAGTCTACGCAACTATCGGCAGCTACGGCATTTATCGCCCACTGTCGATTACCAAAGTTGACCCCCCGGTTCCCGGTGAACGTGTCTTCCCGGAATCCATTGTTCGCACCGTGGTGCATATGATGGAAAGCGTGGCGCTACCGGGCGGCGGCGGCGTGAAGGCGGCGATTAAAGGCTATCGTATCGCCATTAAAACCGGTACCGCGAAAAAGGTCGGGCCGGATGGTCGCTACATCAATAAATATATTGCTTATACCGCAGGCGTTGCGCCTGCGAGTCAGCCGCGCTTCGCGCTGGTTGTTGTTATCAACGATCCGCAGGCGGGTAAATACTACGGCGGCGCCGTTTCCGCGCCGGTCTTTGGTGCCATCATGGGCGGCGTATTGCGTACCATGAACATCGAGCCGGATACGCTGACAACAGGCGATAAAAATGAATTTGTGATTAATCAAGGCGAGGGTACAGGTGGCAGATCGTAA	
8160	CARD	prokka_00471	contig_2	362451	56	95211	95859	-1	70	Escherichia coli acrR with mutation conferring multidrug antibiotic resistance	3003807.0	446.047	375.0	Strict	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	ATGGCACGAAAAACCAAACAAGAAGCGCAAGAAACGCGCCAACACATCCTCGATGTGGCTCTACGTCTTTTCTCACAGCAGGGGGTATCATCCACCTCGCTGGGTGAGATTGCAAAAGCAGCTGGCGTTACGCGCGGTGCAATCTACTGGCATTTTAAAGACAAGTCGGATTTGTTCAGTGAGATCTGGGAACTGTCAGAATCCAATATTGGTGAACTCGAGCTTGAGTATCAGGCAAAATTCCCTGGCGATCCACTCTCAGTATTAAGAGAGATATTAATTCATGTTCTTGAGTCCACGGTGACAGAAGAACGGCGTCGATTATTGATGGAGATTATATTCCACAAATGCGAATTTGTCGGAGAAATGGCTGTTGTGCAACAGGCACAACGTAATCTCTGTCTGGAAAGTTATGACCGTATAGAACAAACGTTAAAACATTGTATTGAAGCGAAAATGTTGCCTGCGGATTTAATGACGCGTCGCGCAGCAATTATTATGCGCGGCTATATTTCCGGCCTGATGGAAAACTGGCTCTTTGCCCCGCAATCTTTTGATCTTAAAAAAGAAGCCCGCGATTACGTCGCCATCTTACTGGAGATGTATCTCCTGTGCCCCACGCTTCGTAACCCTGCCACTAACGAATAA	
8160	CARD	prokka_01600	contig_5	336402	60	251028	251493	-1	60	Escherichia coli soxR with mutation conferring antibiotic resistance	3003381.0	310.457	300.0	Strict	99.35	100.0	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIREAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN	ATGGAAAAGAAATTACCCCGCATTAAAGCGCTGCTAACACCCGGCGAAGTGGCGAAACGCAGCGGTGTGGCGGTATCGGCGCTGCATTTCTATGAAAGCAAAGGGTTGATTACCAGTATCCGTAATAGCGGCAATCAGCGGCGATATAAACGTGATGTGTTGCGATATGTCGCAATTATCAAAATTGCTCAGCGTATTGGCATTCCGCTCGCAACCATTCGTGAAGCGTTTGGCGTGTTGCCAGAAGGGCATACGTTAAGTGCGAAAGAGTGGAAACAGCTTTCGTCCCAATGGCGAGAAGAGTTGGATCGGCGCATTCATACCTTAGTGGCGCTGCGTGACGAACTGGATGGATGTATTGGTTGTGGCTGCCTTTCGCGCAGTGATTGCCCGTTGCGTAACCCGGGCGACCGCTTAGGAGAAGAAGGTACCGGCGCACGCTTACTGGAAGATGAACAAAACTAA	
8160	CARD	prokka_01601	contig_5	336402	60	251578	251902	1	46	Escherichia coli soxS with mutation conferring antibiotic resistance	3003511.0	220.32	200.0	Strict	100.0	100.0	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein overexpression model	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL	ATGTCCCATCAGAAAATTATTCAGGATCTTATCGCATGGATTGACGAGCATATTGACCAGCCGCTTAACATTGATGTCGTCGCAAAAAAATCTGGCTATTCAAAGTGGTACTTGCAACGGATGTTCCGCACGGTGACGCATCAGACGCTTGGCGATTACATTCGCCAGCGCCGTCTGTTACTGGCCGCCGTTGAGTTGCGCACCACCGAGCGTCCGATTTTTGATATCGCAATGGACCTGGGTTATGTCTCTCAGCAGACCTTCTCCCGCGTTTTCCGTCGGCAGTTTGATCGCACTCCCAGCGATTATCGCCACCGCCTGTAG	
8160	CARD	prokka_03265	contig_13	155834	57	125994	126429	-1	67	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	287.73	210.0	Strict	97.92	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux	Y137H, G103S, R94H	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKHGVLVKLTTSGAAICEQCHQLVGQDLHQELTKNLTADEVATLEHLLKKVLP	GTGAAAAGTACCAGCGATCTGTTCAATGAAATTATTCCATTGGGTCGTTTAATCCATATGGTTAATCAGAAGAAAGATCGCCTGCTTAACGAGTATCTGTCTCCGCTGGATATTACCGCGGCACAGTTTAAGGTGCTCTGCTCTATCCGCTGCGCGGCGTGTATTACTCCGGTTGAACTGAAAAAAGTGTTGTCGGTCGACCTGGGGGCACTGACCCGTATGCTGGATCGCCTGGTCTGTAAAGGCTGGGTGGAAAGGTTGCCGAACCCGAATGATAAGCACGGCGTACTGGTAAAACTTACCACCAGCGGCGCGGCAATATGTGAACAATGCCATCAATTAGTTGGCCAGGACCTGCATCAAGAATTAACAAAAAACCTGACGGCGGACGAAGTGGCAACACTTGAGCATTTGCTTAAGAAAGTCCTGCCGTAA	
8057	BLDB	prokka_01475	contig_2	716548	57	624167	625304	1	44	SRT-C44		511.2		Perfect	100.0	99.74	SRT-SST family class C beta-lactamase	protein homolog model			Beta-Lactam	MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGIASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYHIIQALEKR	ATGACGAAAATGAACCGCCTGGCGGCCGCGCTGATCGCCGCACTGATCTTGCCGACCGCGCAGGCCGCGCAGCAGCAGGATATCGACGCCGTTATTCAGCCGCTGATGAAAAAATATGGCGTACCGGGCATGGCGATCGCCGTGTCGGTCGACGGCAAACAGCAGATTTACCCGTATGGCATCGCCTCGAAGCAGACCGGCAAACCGATCACCGAGGAGACGCTGTTCGAAGTGGGCTCGCTGAGCAAAACCTTTACCGCGACGCTGGCGGTCTATGCGCAGCAGCAGGGCAAGCTGTCGTTCAACGATCCGGCCAGCCGCTATCTGCCCGAGCTGCGCGGCAGCGCCTTCGACGGCGTCAGCCTGCTGAATCTGGCGACGCATACCTCCGGCCTGCCGCTGTTCGTGCCGGACGACGTCACTAACGACGCCCAGCTGATGGCCTACTACCGGGCCTGGCAGCCGAAACACCCGGCGGGCAGCTACCGCGTCTATTCCAACCTCGGCATCGGCATGCTGGGCATGATCGCCGCCAAGAGCCTCGACCAGCCGTTTATCCAGGCGATGGAACAGGGGATGCTGCCGGCGCTGGGCATGAGCCACACCTACGTTCAGGTGCCGGCGGCGCAGATGGCTAACTATGCGCAGGGTTACAGCAAGGACGATAAGCCGGTGCGGGTCAACCCCGGCCCGCTGGACGCCGAGTCTTACGGCATCAAATCCAACGCTCGCGATCTGATTCGCTATCTGGACGCCAACCTGCAGCAGGTGAAGGTGGCGCAGCCGTGGCGCGACGCGCTGGCCGCGACGCACGTCGGTTATTACAAGGCGGGCGCGTTCACGCAGGATCTGATGTGGGAGAACTACCCGTATCCGGTGAAACTGTCGCGTTTGATTGAAGGCAACAACGCCGGGATGATCATGAACGGCACGCCGGCCACCGCCATCACGCCGCCGCAGCCGGAATTGCGCGCCGGCTGGTATAACAAAACCGGCTCCACCGGCGGTTTCTCCACCTACGCGGTATTTATCCCGGCGAAGAATATCGCCGTGGTGATGCTGGCCAACAAGTGGTTCCCGAACGACGATCGCGTCGAAGCGGCTTACCACATCATCCAGGCGCTGGAGAAGCGCTGA	
8057	CARD	prokka_00474	contig_1	949995	53	492954	493284	1	58	Klebsiella pneumoniae KpnF	3004583.0	156.377	150.0	Strict	73.39	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFELYHIGFLGLAIVLEIIANIFLKMSDGFRKIWLGLLSLLSVLGAFSALAQAVKGIDLSIAYALWGGFGIAATIAAGWIMFGQRLNAKGWIGLALLLMGMVILKLS	ATGCAACAGTTTGAGTTGTACCACATTGGGTTCCTGGGGCTGGCGATCGTGCTGGAAATCATCGCCAACATCTTCCTGAAGATGTCGGACGGCTTCCGTAAAATTTGGCTGGGGCTGTTGTCGCTGCTGTCGGTGCTCGGCGCGTTCAGCGCCCTGGCGCAGGCGGTGAAGGGCATCGATCTTTCGATCGCTTATGCGCTGTGGGGCGGTTTCGGTATCGCCGCCACCATCGCCGCAGGCTGGATCATGTTCGGCCAGCGGTTGAACGCCAAAGGCTGGATTGGCCTGGCGCTGCTGCTGATGGGGATGGTGATCCTTAAACTGTCCTGA	
8057	CARD	prokka_00769	contig_1	949995	53	823769	826928	-1	49	adeF	3000777.0	1187.56	750.0	Strict	59.12	99.34	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MTFPRFFIKRPIFAIVLSILTLIAGTVALFQLPLSEYPAVTPPTVQVTASYPGANPKVIAETVAAPLEQAITGVEGMLYMSSQAATDGRMTLTVTFAQGTNADMAQIQVQNRVARALPRLPAEVQHQGVVTQKTSPDILMVVHLLSPDQRYDPLYISNYAYLQVRDELSRIPGVSDVQVWGAGEYSMRLWLDPDLIAARGLTAGDVIAAVREQNVQVAAGSVGQAPDSNAAFQVTVNTLGRLADEKQFGDIIIRTGSDGRVTRLRDVARIEMGADAYALRSLLDGEPAVALQIIQSPGANALDVAQAVRATVKRLEGNFPAGLSSRIAYDPTVFVRASLESVVTTLLEAILLVVIVVVVFLRSWRASLIPLLAVPVSLVGTFAIMYLLGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHIENGKTPQQAARLAMNEVTGPIVAITSVLAAVFVPTAFLSGLQGEFYRQFALTIAISTLLSALNSLTLSPALASMLLRPHPAKPRAPGRIGRVLQAAVRPFQRAPDAYANAVRKTVRVRGMALAIYGGLLVLTFFSFQAVPPGFVPMQDKYYLVGIAQLPNSASLDRTDAVVKQMSKIALAEPGVESVVAFPGLSINGFVNVPNAAVMFVMLDPFKDRATPDLAASAIAGRLQAKFADIPDGFLGVFPPPPVPGLGATGGFKMQVEDRSGAGLESLVEHTRILMMKATESGQVAGLMTSLDINAPQLDVVIDRTQAQSQGVSLADVFESLQIYLGSLYINDFNRFGRTYKVTAQADAAHRMQAEAIGRLQVRNAAGDMLPLSSFVTVTPGSGPDRIIRYNGYPSADISGGAAMGVSSGQAAALMERLAKETLPEGMTVEWTDLTYQQKLAGDAALFIFPLCVLLAYLILATQYNSWLLPLAVLLIVPMCLLSAMIGVWLLGGDNNVFVQIGLIVLVGLAAKNAILIVEFARSLEDEGANALEAVIKACRLRLRPIVMTSIAFIAGVIPLIFASGAGAEMRHAMGVAVFAGMLGVTLFGLFLTPVFYVVIRGLATRFEQYRAKAKASRKERV	ATGACTTTCCCTCGTTTCTTCATTAAACGCCCGATCTTCGCCATCGTGCTCTCCATCTTGACGCTGATCGCCGGCACCGTGGCGTTATTCCAGTTGCCGCTCAGCGAATACCCTGCGGTTACGCCGCCTACCGTACAAGTGACGGCGTCTTATCCCGGCGCCAACCCGAAAGTGATCGCGGAAACGGTGGCCGCACCGCTTGAGCAAGCCATCACCGGCGTCGAAGGCATGCTTTACATGTCTTCACAGGCGGCGACCGACGGCCGAATGACGTTGACCGTCACCTTTGCCCAGGGAACAAATGCCGACATGGCGCAGATCCAGGTGCAAAATCGGGTAGCGCGCGCGTTACCCCGCTTGCCTGCAGAGGTACAGCACCAGGGCGTGGTGACGCAGAAAACCTCACCGGACATCCTGATGGTGGTGCATCTCCTGTCGCCTGACCAACGCTACGATCCGCTTTATATCTCAAATTACGCTTATCTGCAGGTTCGTGATGAACTGTCCCGCATTCCGGGCGTCAGCGATGTCCAGGTCTGGGGAGCCGGCGAATACAGCATGCGGCTCTGGCTGGATCCGGATCTGATCGCCGCGCGCGGGCTAACCGCCGGCGATGTGATCGCTGCGGTGCGCGAGCAAAACGTTCAGGTGGCGGCCGGTTCCGTCGGTCAGGCGCCCGATTCCAATGCCGCATTTCAGGTTACGGTCAATACCCTCGGCCGTCTGGCCGATGAGAAACAGTTTGGCGATATCATCATCCGCACCGGCAGCGACGGCCGGGTGACCCGCTTGCGCGACGTCGCCCGTATAGAAATGGGCGCCGATGCGTATGCGCTGCGCAGCCTGCTCGACGGCGAGCCGGCCGTCGCGCTGCAAATCATTCAGAGCCCGGGCGCCAACGCGCTGGACGTCGCTCAGGCGGTCAGAGCGACCGTCAAGCGCCTGGAGGGCAACTTTCCTGCCGGACTCAGTTCACGGATCGCCTACGATCCCACGGTTTTCGTGCGGGCATCGCTCGAGTCGGTTGTGACGACCCTGCTGGAAGCGATCCTGCTGGTGGTGATCGTGGTAGTGGTGTTCCTGCGCAGCTGGCGAGCCTCGCTGATTCCGCTGCTCGCGGTGCCGGTTTCGCTGGTCGGCACGTTCGCCATCATGTACTTGCTGGGCTTCTCTCTCAATACGCTGTCCCTGTTCGGTTTGGTATTGTCTATCGGCATCGTCGTCGATGACGCGATCGTGGTGGTGGAAAACGTCGAACGACACATCGAAAACGGCAAAACGCCGCAGCAAGCCGCGCGACTCGCCATGAATGAAGTCACCGGGCCGATCGTCGCCATCACCTCGGTGCTGGCCGCGGTTTTCGTTCCAACAGCGTTCCTGAGCGGTTTACAGGGCGAGTTTTACCGGCAGTTCGCGCTGACCATCGCCATTTCAACCCTGCTGTCGGCGCTCAATTCGCTTACGCTCAGCCCGGCGCTGGCGAGCATGTTGCTGCGGCCTCATCCGGCGAAACCTCGCGCTCCCGGCCGCATTGGGCGCGTCTTGCAAGCCGCTGTCCGGCCTTTCCAACGCGCGCCGGACGCGTATGCCAATGCCGTGCGTAAAACGGTGCGCGTCCGCGGGATGGCGCTGGCTATTTACGGCGGGCTGCTCGTTCTGACGTTTTTCAGCTTCCAGGCCGTTCCGCCGGGCTTCGTGCCCATGCAGGATAAGTACTATCTGGTCGGCATCGCCCAACTGCCCAATTCGGCCTCGCTGGATCGCACCGATGCGGTCGTTAAACAGATGTCGAAGATCGCGCTGGCGGAACCCGGGGTGGAAAGCGTCGTGGCCTTTCCGGGGCTGTCGATTAACGGCTTCGTCAATGTGCCGAACGCCGCCGTGATGTTCGTCATGCTCGATCCGTTTAAAGATCGCGCCACGCCCGATCTGGCCGCCTCCGCCATAGCCGGTCGGCTGCAGGCGAAATTCGCCGACATTCCCGATGGTTTCCTCGGCGTATTTCCGCCACCGCCCGTTCCCGGTCTCGGCGCTACCGGCGGATTCAAGATGCAGGTGGAGGATCGCAGCGGCGCGGGGCTCGAGTCCCTGGTTGAGCACACGCGGATCCTGATGATGAAAGCCACCGAATCGGGCCAGGTCGCCGGTCTGATGACCAGTCTGGATATCAACGCACCGCAGCTCGATGTGGTTATCGACCGCACTCAGGCGCAAAGTCAGGGCGTCAGCCTGGCGGATGTGTTCGAGTCGCTGCAAATCTACCTCGGCTCGCTTTACATCAACGATTTCAACCGATTCGGCCGCACCTACAAAGTCACCGCTCAGGCCGATGCCGCCCATCGCATGCAGGCCGAAGCTATCGGCCGGCTGCAGGTGCGCAACGCGGCCGGCGACATGCTGCCGCTGTCTTCCTTTGTCACCGTTACGCCCGGCTCCGGTCCGGATCGCATCATTCGTTACAACGGCTATCCATCGGCTGATATTTCGGGCGGTGCGGCGATGGGCGTCAGTTCCGGTCAGGCGGCTGCATTGATGGAGCGCTTGGCGAAAGAGACGCTGCCGGAAGGCATGACCGTCGAATGGACCGATCTCACCTATCAGCAAAAGCTCGCGGGCGACGCGGCGCTGTTCATTTTTCCGCTGTGCGTGCTGCTCGCCTATCTCATTCTGGCCACGCAATACAACAGCTGGCTACTGCCTTTGGCCGTGCTGCTGATCGTGCCGATGTGTCTGTTGAGCGCCATGATTGGCGTCTGGCTGCTGGGCGGCGACAACAACGTTTTCGTGCAAATAGGCCTCATTGTGCTGGTCGGCCTGGCCGCCAAAAACGCCATTCTGATCGTCGAGTTCGCCCGCAGCCTGGAGGATGAAGGCGCCAACGCGCTCGAGGCGGTGATTAAGGCCTGCCGGCTGCGATTAAGACCGATAGTGATGACTTCAATCGCGTTTATCGCCGGCGTCATTCCATTGATCTTCGCCAGCGGCGCGGGGGCGGAAATGCGCCATGCCATGGGGGTGGCGGTCTTCGCCGGCATGCTGGGCGTGACCTTGTTCGGCCTGTTCCTGACGCCGGTCTTTTATGTCGTGATTCGCGGCCTGGCGACCCGATTCGAGCAATATCGTGCCAAAGCCAAAGCCAGCCGTAAGGAGCGAGTCTGA	
8057	CARD	prokka_00909	contig_2	716548	57	47012	48761	1	72	msbA	3003950.0	1061.6	1000.0	Strict	87.46	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MMNDKDLSTWQTFRRLWPMITPFKTGLIVAAIALIMNAAGDTLMLSLLKPLLDDGFGKTDSSVLVWMPLAVIALMLMRGVTSFVSSYCISWVSGMVVMQMRRRLFGHMMRMPVAFFDQQSTGTLLSRITYDSEQVASSSSSALVTVVREGASIIGLFIMMFYYSWQLSVILIVLAPIVSIAIRLVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQQVETERFNSVSNRMRQQGMKLVSASSISDPIIQLIASLALAFVLFAASFPSVMETLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFSILDMEQEKDTGTREVKRAKGDIEFRNVTFYYPAKETPALRDINLKIAEGKTVALVGRSGSGKSTIANLLTRFYDIQEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTIANNIAYARESEYSREQIEKAAEMAYAMDFINKMENGLDTVIGENGVMLSGGQRQRIAIARALLRDCPILILDEATSALDTESERAIQAALDELQKDRTSLVIAHRLSTIEKADEILVVEDGRIVERGEHAELLERQGAYAQLHRMQFGQ	ATGATGAATGATAAAGATCTCTCGACCTGGCAGACGTTCCGTCGACTCTGGCCGATGATCACTCCTTTTAAGACCGGGCTGATTGTGGCCGCCATTGCGTTGATTATGAACGCAGCGGGGGACACGCTGATGCTGTCTCTGCTTAAACCGTTATTGGACGATGGGTTTGGAAAAACCGACAGCAGCGTGCTGGTGTGGATGCCGCTGGCGGTGATTGCGCTGATGCTGATGCGCGGCGTGACCAGCTTTGTTTCAAGCTACTGCATTTCCTGGGTTTCCGGCATGGTGGTGATGCAGATGCGCCGCCGCCTGTTTGGCCACATGATGAGAATGCCGGTGGCCTTCTTCGATCAGCAATCCACCGGGACGTTGCTGTCGCGCATTACCTATGATTCCGAGCAGGTGGCGTCTTCTTCTTCCAGCGCGCTGGTGACCGTGGTGCGCGAAGGGGCCTCGATCATTGGCCTGTTCATCATGATGTTCTACTACAGCTGGCAGCTGTCGGTGATCCTGATCGTGCTGGCGCCGATCGTTTCCATCGCCATTCGCCTGGTGTCCAAGCGTTTTCGCAACATCAGCAAGAACATGCAGAACACCATGGGGCAGGTGACCACCAGCGCCGAACAGATGCTGAAAGGCCATAAAGAAGTGCTGATCTTCGGTGGCCAGCAGGTGGAAACCGAGCGCTTTAACTCGGTGAGCAACCGCATGCGTCAACAGGGCATGAAACTGGTCTCTGCGTCTTCCATTTCCGATCCGATCATTCAGCTGATCGCTTCGCTGGCCCTGGCGTTCGTGCTGTTTGCCGCCAGCTTCCCAAGCGTGATGGAAACCCTGACCGCCGGCACCATTACCGTGGTGTTCTCGTCAATGATCGCGCTGATGCGCCCGCTGAAATCGCTGACCAACGTCAATGCCCAGTTCCAGCGTGGGATGGCGGCCTGCCAGACGCTGTTCTCCATCTTGGATATGGAACAGGAAAAAGACACCGGCACCCGCGAAGTGAAGCGCGCGAAAGGCGACATCGAATTCCGCAACGTCACCTTCTACTATCCGGCTAAAGAAACGCCGGCGCTGCGTGATATCAACCTGAAAATCGCCGAAGGCAAGACTGTGGCGTTGGTGGGCCGCTCGGGTTCGGGTAAATCCACCATCGCCAACCTGCTGACGCGCTTCTACGATATTCAGGAAGGCGAAATCCTGATGGATGGCCACGATCTGCGTGAATATACCCTGGCCTCACTGCGTAATCAGGTGGCGCTGGTCTCGCAAAACGTGCATCTGTTCAACGACACCATCGCCAACAACATCGCCTATGCGCGCGAGAGCGAATACAGCCGCGAGCAGATTGAGAAAGCGGCCGAAATGGCGTACGCGATGGACTTCATCAACAAGATGGAAAACGGCCTGGATACGGTGATCGGTGAAAACGGCGTGATGCTGTCCGGCGGCCAACGTCAGCGCATCGCCATCGCGCGTGCTTTGCTGCGCGATTGCCCGATCCTGATCCTGGATGAGGCGACTTCTGCGCTGGATACCGAATCCGAGCGTGCCATTCAGGCCGCACTGGACGAGCTGCAGAAAGACCGTACTTCGCTGGTGATCGCACACCGTCTGTCGACGATTGAGAAGGCGGACGAGATCCTGGTGGTGGAGGACGGTCGCATCGTCGAACGCGGCGAACACGCCGAGTTGCTTGAACGGCAGGGTGCCTATGCGCAACTGCACCGCATGCAGTTTGGTCAATAA	
8057	CARD	prokka_01100	contig_2	716548	57	240069	243213	-1	58	adeF	3000777.0	1176.39	750.0	Strict	59.96	98.87	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MDFSRFFIDRPIFAAVLSILIFVAGVIAIPLLPISEYPDVVPPSVQVRAEYPGANPKEIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRQGITTQKQSPALTLVVHLVSPSGKYDSLYLRNYATLKVKDELARLPGVGQVQIFGAGEYAMRIWLDPNKVAARGLTASDVVSAMQEQNVQVSAGQLGAEPMPTRSDYLLSINAQGRLQTEEEFGNIILKSGDNGEIVRLRDVARIEMGSGSYALRAQLNNKDAVGIGIFQSPGANAIELSDAVRGKMAELATRFPDGMSWKSPYDPTVFVRDSIRAVVDTLLEAVILVVLVVILFLQTWRASIIPLLAVPISVVGTFAALYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLSPLAAAHQAMREVSGPIIAIAVVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAARLLKPHGAPKDLPSRLIDRLFGWLFRPFNRFFASSSQRYQRGVSRVLGRRGAVFVVYLLLLAAAGVMFKTVPGGFIPTQDKLYLIGGVKMPEGASLERTDAVIRKMSAIGLSVDGVTDAVAFPGLNALQFTNTPNTGTVFFALESLSTRTRTAAQINAEINARISQIQEGFAFSIMPPPILGIGQGSGYSLYVQDRAGLGYGALQTAINTMSGAIMQTPGMGFPISSYQANVPQLDAKIDRDKAKAQGVPLNALFSTLQTYLGSSYINDFNRYGRTWKVMAQADGQFRDSVEDIANLRTRNDKGEMVPIGSMVNIGTTYGPDPVIRYNGFPAADLIGDADPRVLSSTQAMGALTQMAGKLLPNGMNIQWTDLSYQQSTQGNAALVVFPVAVLLAFLALAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEMQGKGIVEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRRLVARKAQPQTV	ATGGACTTTTCCCGCTTTTTCATCGACCGACCGATCTTTGCCGCGGTGCTGTCGATACTGATTTTTGTCGCCGGGGTGATAGCCATCCCGCTGCTGCCGATCAGCGAGTACCCGGACGTAGTGCCGCCCAGCGTGCAGGTGCGCGCAGAATACCCGGGCGCCAACCCGAAAGAGATCGCTGAAACGGTGGCCACGCCGCTGGAAGAAGCGATCAACGGCGTCGAAAACATGATGTACATGAAATCGGTCGCCGGTTCCGACGGCGTGCTGGTGACCACCGTCACCTTCCGCCCCGGCACCGATCCCGATCAGGCCCAGGTGCAGGTGCAAAACCGCGTGGCGCAGGCCGAAGCGCGCCTCCCGGAAGACGTGCGCCGCCAGGGCATCACCACCCAGAAACAGTCCCCGGCGCTGACGCTGGTGGTGCATCTGGTCTCGCCTTCCGGCAAGTACGATTCGCTGTACCTGCGCAACTACGCCACCCTGAAGGTCAAGGATGAGCTGGCCCGCCTGCCGGGCGTCGGCCAGGTGCAGATCTTCGGCGCCGGTGAGTATGCGATGCGCATCTGGCTCGATCCGAACAAGGTCGCCGCGCGTGGGCTGACCGCCTCCGACGTGGTGAGCGCCATGCAGGAGCAAAACGTGCAGGTCTCCGCCGGCCAGCTCGGCGCGGAGCCGATGCCGACGCGCAGCGACTATCTGCTGTCGATCAATGCCCAGGGTCGCCTGCAAACCGAAGAAGAGTTCGGCAACATCATCCTCAAGAGCGGCGACAACGGCGAGATCGTGCGGCTGCGCGACGTGGCGCGCATCGAAATGGGCTCCGGCAGCTACGCGCTGCGCGCCCAGCTCAATAACAAGGATGCGGTCGGTATCGGTATCTTCCAGTCGCCGGGCGCCAACGCCATCGAGCTGTCGGACGCGGTGCGCGGCAAGATGGCCGAGCTGGCGACCCGCTTCCCGGACGGCATGAGCTGGAAATCGCCTTACGATCCGACGGTGTTCGTGCGCGATTCGATCCGCGCGGTGGTGGATACCCTGCTGGAAGCGGTGATCCTGGTGGTGCTGGTGGTCATACTGTTCCTGCAGACCTGGCGCGCCTCGATCATTCCGCTGTTGGCGGTCCCGATCTCCGTGGTCGGCACCTTCGCCGCGCTGTATCTGCTGGGCTTCTCGCTCAATACCCTCAGCCTGTTCGGGCTGGTGCTGGCGATCGGCATCGTGGTGGATGACGCCATCGTGGTGGTGGAAAACGTCGAGCGTAATATCGAAGAGGGGCTGTCGCCGCTGGCGGCGGCGCACCAGGCGATGCGCGAGGTTTCCGGCCCGATCATCGCCATCGCCGTGGTGCTGTGTGCGGTGTTCGTACCGATGGCGTTCCTCTCCGGCGTTACCGGGCAGTTCTATAAGCAGTTCGCCGTCACCATCGCCATCTCGACGGTGATCTCCGCCATCAACTCGCTGACTCTGTCGCCAGCGCTGGCGGCGCGCTTGCTCAAACCGCACGGCGCGCCGAAAGATCTGCCGTCGCGCCTGATCGACCGGCTGTTCGGCTGGCTGTTCCGGCCGTTCAACCGCTTCTTCGCCAGCAGTTCGCAACGCTACCAGCGCGGCGTCTCCCGCGTGCTGGGCCGGCGCGGCGCGGTGTTCGTCGTCTACCTGCTGCTGCTGGCCGCCGCCGGGGTGATGTTCAAGACCGTGCCCGGCGGCTTTATCCCGACGCAGGACAAGCTGTACCTGATCGGCGGCGTGAAAATGCCGGAAGGCGCCTCGCTGGAACGCACCGATGCGGTGATCCGCAAGATGAGCGCCATCGGCCTGAGCGTGGACGGCGTCACCGATGCGGTGGCCTTCCCCGGCCTGAACGCCCTGCAGTTCACCAATACGCCGAATACCGGCACGGTGTTCTTCGCGCTGGAGTCGTTGAGCACCCGTACCCGCACCGCGGCGCAGATCAACGCCGAGATCAACGCGCGCATTTCACAGATCCAGGAAGGCTTCGCCTTCTCAATCATGCCGCCGCCGATCCTCGGCATCGGCCAGGGCTCCGGCTATTCGCTGTACGTGCAGGATCGCGCCGGGCTGGGTTACGGCGCGCTGCAGACGGCGATCAACACCATGTCCGGCGCCATTATGCAAACGCCGGGCATGGGGTTCCCGATCTCCTCATATCAGGCCAACGTGCCGCAGCTGGACGCCAAAATCGATCGCGACAAGGCCAAGGCGCAGGGGGTGCCGCTCAATGCGCTGTTCAGCACGCTGCAGACCTACCTCGGTTCGTCTTATATCAACGACTTCAACCGCTATGGCCGCACCTGGAAGGTGATGGCGCAGGCCGACGGCCAGTTCCGCGACAGCGTAGAGGACATCGCCAACCTGCGCACCCGCAACGACAAGGGTGAAATGGTGCCGATCGGCAGCATGGTCAACATCGGCACCACCTACGGCCCGGATCCGGTGATCCGCTATAACGGCTTCCCGGCGGCGGATCTGATCGGCGACGCCGATCCGCGCGTGCTCTCTTCTACCCAGGCGATGGGCGCGCTGACGCAGATGGCCGGCAAGCTGTTGCCGAACGGCATGAACATCCAGTGGACCGATCTGAGCTACCAACAATCGACCCAGGGCAACGCCGCGCTGGTGGTGTTCCCGGTGGCGGTGCTGCTGGCGTTCCTCGCGCTGGCGGCGCTGTACGAAAGCTGGACGCTGCCGCTGGCGGTGATCCTGATCGTGCCGATGACCATGCTGTCGGCGCTGTTCGGCGTGTGGCTGACCGGCGGCGACAACAACGTGTTCGTGCAGGTCGGGTTGGTCGTTCTGATGGGGCTGGCCTGCAAGAACGCCATTCTGATCGTCGAGTTCGCCCGCGAGCTGGAAATGCAGGGCAAAGGCATCGTCGAGGCGGCGCTGGAGGCCTGTCGCCTGCGGTTGCGGCCGATCGTGATGACCTCCATCGCCTTCATCGCCGGCACCATCCCGCTGATCCTCGGCCACGGCGCCGGCGCCGAGGTGCGCGGCGTCACCGGCATCACGGTGTTCTCCGGCATGTTGGGGGTCACCCTGTTCGGGCTGTTCCTGACGCCGGTGTTCTACGTCACGCTGCGGCGCCTGGTGGCGCGCAAAGCGCAGCCGCAGACCGTCTGA	
8057	CARD	prokka_01945	contig_3	624400	57	399213	402360	1	77	adeF	3000777.0	762.681	750.0	Strict	41.75	98.96	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MAKFFIDRPIFAWVIAIIVMLAGVLAIMKLPIAQYPTIAPPAVSISANYPGADAKTVQDTVTQIIEQNMNGIDNLMYMSSTSDSSGSVTITLTFESGTDPDIAQVQVQNKLSLATPLLPQEVQQQGLKVEKSSSSFLMVAGFVSDDPNMTQDDIADYVASNIKDPISRSSGVGEVQLFGAQYAMRIWLDPNKLNNYQLTTTDVTSAITEQNNQIAAGQLGGLPPVPGQQLNASIIAQTRLTSPEEFGKILLKVNTDGSQVRLRDVAHIERGAESYAVTARYNGKPAAGLGIKLATGANALNTAKGVKDELAKMTPFFPQGMKVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIPKGDHGVKTGFFGWFNRMFEKSTHHYTDSVGNILRSTGRYLIIYLLIVVGMGLLFLRLPSSFLPDEDQGILLTMVQLPAGATESRTNKVLEEVSDYFLNKEKDNVVSVFTVAGFGFNGNGQNNGLAFVSLKDWGERPGSENKVEAIAGRAMGAFSQIKEGLVFPFNLPAIIELGTATGFDFELIDQGGLGHEKLTEARNQLLGMVAQHPDVLVGVRPNGLEDTPQFKLIVDQEKAKALGVSITTINSTLSTALGGSYVNDFIDRGRVKKVYVQADAPFRMLPEDINKWYVRGTSGQMVPFSAFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMNLMEQLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISILVVFLCLAALYESWSVPFSVMLVLPLGVIGALLAATMRGMNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFFVPVFFVVVRRRFSKKNEDLEHSHPVEHH	ATGGCTAAGTTCTTTATAGACCGCCCAATTTTCGCCTGGGTAATCGCCATCATCGTCATGTTGGCGGGGGTGCTTGCAATAATGAAACTGCCGATCGCGCAGTATCCCACTATTGCACCGCCGGCGGTGAGTATTTCCGCCAACTACCCGGGCGCAGATGCCAAAACGGTGCAGGATACCGTCACGCAGATTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCCACCAGTGATTCCTCTGGTAGCGTCACCATTACCCTGACGTTTGAATCCGGCACCGATCCTGACATCGCGCAGGTTCAGGTCCAGAACAAACTGTCGTTGGCCACCCCGTTGCTGCCGCAAGAAGTTCAGCAACAGGGCCTGAAAGTAGAAAAATCCAGCAGCAGCTTCCTGATGGTGGCCGGCTTCGTTTCCGACGATCCGAACATGACTCAGGACGATATTGCGGACTACGTGGCGTCCAACATCAAGGATCCGATCAGCCGTTCGTCCGGCGTGGGTGAAGTGCAGCTGTTCGGTGCCCAGTACGCGATGCGTATCTGGCTGGATCCGAACAAGCTGAACAACTACCAGCTGACGACCACGGACGTGACCTCCGCCATCACCGAGCAGAACAACCAGATCGCCGCAGGCCAGCTGGGCGGCCTGCCGCCGGTACCGGGGCAGCAGTTGAACGCCTCGATCATCGCGCAGACCCGTCTGACTTCGCCGGAAGAGTTCGGCAAGATCCTGCTGAAGGTGAATACCGACGGTTCCCAGGTACGCCTGCGCGACGTCGCTCACATCGAGCGCGGCGCGGAAAGCTATGCCGTTACCGCTCGCTATAACGGTAAGCCTGCCGCCGGTCTGGGTATCAAACTGGCAACCGGCGCCAACGCCTTGAACACCGCCAAAGGTGTGAAAGATGAGCTGGCCAAGATGACGCCATTCTTCCCGCAAGGGATGAAAGTGGTTTATCCGTACGACACCACCCCGTTCGTTAAGATCTCCATCAACGAAGTGGTGAAAACGCTGATCGAAGCCATCATCCTGGTATTCCTGGTGATGTATCTGTTCCTGCAGAACTTCCGCGCGACGCTGATCCCAACCATCGCGGTGCCGGTGGTGCTGCTGGGGACCTTTGCGATACTCGCGGCGTTCGGCTTCTCGATAAACACCCTGACGATGTTCGGCATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAAAACGTCGAGCGCGTCATGGCCGAAGAGGGGCTGCCGCCGAAAGAAGCCACCCGTAAATCGATGGGCCAGATTCAGGGCGCGCTGGTAGGTATCGCCATGGTGCTGTCGGCGGTATTCGTGCCGATGGCGTTCTTCGGCGGTTCAACCGGCGCCATCTATCGCCAGTTCTCGATCACCATCGTGTCCGCGATGGCGCTGTCGGTGCTGGTGGCCTTGATCCTGACGCCGGCGCTGTGCGCCACCATGCTCAAACCGATCCCGAAAGGCGATCACGGGGTTAAAACAGGCTTCTTCGGCTGGTTTAACCGCATGTTCGAGAAAAGCACGCATCACTATACCGACAGCGTGGGCAACATCCTGCGCAGCACCGGTCGCTATCTGATCATCTACCTGCTGATCGTGGTTGGCATGGGCCTGCTGTTCCTGCGCCTGCCTTCCTCGTTCCTGCCGGACGAAGATCAGGGCATCCTGTTAACCATGGTGCAGCTGCCTGCCGGCGCCACCGAGTCCCGCACCAACAAAGTGCTGGAAGAAGTCTCCGACTACTTCCTGAACAAGGAAAAGGACAACGTGGTTTCGGTGTTTACCGTCGCGGGCTTCGGCTTCAACGGTAACGGCCAGAACAACGGCCTGGCATTTGTCAGCCTGAAAGACTGGGGCGAGCGTCCAGGGAGCGAGAACAAGGTCGAAGCGATCGCGGGTCGCGCCATGGGCGCATTCTCGCAGATTAAAGAAGGCCTGGTATTCCCGTTCAACCTGCCGGCGATCATCGAACTCGGTACCGCCACCGGCTTCGACTTCGAGCTGATTGACCAGGGCGGCCTGGGGCACGAGAAACTGACCGAAGCGCGTAACCAGCTGTTGGGCATGGTTGCTCAACATCCGGACGTGCTGGTGGGCGTGCGCCCGAACGGCCTGGAAGATACGCCGCAGTTCAAACTGATCGTCGATCAGGAGAAAGCCAAGGCGCTGGGCGTCAGCATCACCACCATCAACAGCACGCTGAGCACCGCGCTGGGCGGCTCGTACGTCAACGACTTCATCGACCGCGGTCGTGTGAAGAAGGTATACGTACAGGCCGACGCGCCGTTCCGTATGCTGCCGGAAGACATCAACAAGTGGTACGTGCGCGGCACGAGCGGCCAGATGGTGCCATTCTCCGCCTTCTCTTCGGCGAAATGGGAATACGGCTCACCGCGCCTGGAACGCTATAACGGCTTGCCGTCGATGGAAATTCTGGGCCAGGCCGCACCGGGCAAGAGTACCGGTGAAGCGATGAACCTGATGGAACAGCTGGCGTCCAAACTGCCAAGCGGCATCGGTTACGACTGGACCGGCATGTCCTATCAGGAACGTCTGTCGGGTAACCAGGCGCCGGCGCTGTACGCCATCTCGATTCTGGTGGTGTTCCTGTGTCTGGCGGCGCTGTATGAAAGCTGGTCCGTGCCGTTCTCGGTCATGCTGGTATTGCCGCTGGGGGTTATCGGTGCGTTGCTGGCCGCGACGATGCGCGGCATGAACAACGACGTGTACTTCCAGGTGGGGCTGCTGACCACCATCGGTCTATCGGCGAAGAACGCCATCCTGATCGTGGAATTCGCCAAGGATCTGATGGAGAAAGAAGGCAAAGGCCTGATCGAAGCAACGTTGGAAGCGGTGCGTATGCGTCTGCGTCCAATCCTGATGACGTCTCTGGCCTTCATCCTCGGGGTTCTGCCGCTGGTTATCAGCAGCGGTGCGGGCTCCGGCGCACAGAACGCGGTAGGTACCGGCGTAATGGGCGGGATGATCACCGCCACCGTCTTGGCGATCTTCTTCGTACCGGTGTTCTTCGTGGTGGTTCGCCGCCGCTTCAGCAAGAAGAACGAAGACCTGGAACACAGCCATCCGGTAGAGCACCACTGA	
8057	CARD	prokka_02368	contig_4	413011	59	220246	220687	-1	47	AAC(6')-Ic	3002549.0	300.827	275.0	Strict	99.32	100.0	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MIVICDHDNLDAWLALRTALWPSGSPEDHRAEMREILASPHHTAFMARGLDGAFVGFAEVALRYDYVNGCESSPVAFLEGIYTAERARRQGWAARLIAQVQEWAKQQGCSELASDTDIANLDSQRLHAALGFAETERVVFYRKTLG	ATGATCGTCATCTGCGACCACGACAACCTCGACGCCTGGCTGGCGCTGCGCACCGCGCTGTGGCCGTCCGGCTCGCCTGAAGATCACCGCGCGGAAATGCGCGAGATACTGGCTTCACCGCACCACACCGCGTTTATGGCGCGGGGGCTGGACGGCGCTTTCGTTGGCTTTGCCGAGGTCGCGCTGCGCTACGATTACGTCAACGGCTGCGAATCGTCGCCGGTGGCGTTTTTGGAAGGGATTTATACCGCCGAACGCGCCCGCCGCCAGGGCTGGGCCGCGCGCCTGATCGCGCAGGTGCAGGAGTGGGCGAAGCAACAGGGGTGCAGCGAGCTGGCGTCGGATACCGATATCGCCAATCTGGACTCCCAGCGCCTGCATGCGGCGCTGGGCTTTGCCGAAACGGAGCGGGTAGTGTTTTACCGCAAAACGCTGGGCTGA	
8057	CARD	prokka_02564	contig_5	343274	59	23400	23586	-1	90	rsmA	3005069.0	108.612	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQTTY	ATGTTAATTCTGACTCGTCGAGTTGGTGAAACCCTCATGATTGGCGATGAGGTTACGGTTACTGTGCTAGGGGTAAAAGGCAACCAGGTGCGTATTGGTGTGAACGCCCCCAAAGAGGTTTCGGTTCACCGTGAAGAAATCTATCAGCGCATTCAGGCAGAGAAGTCTCAGCAGACGACTTACTGA	
8057	CARD	prokka_02683	contig_5	343274	59	164691	165174	-1	53	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	49.6766	32.0	Strict	28.47	90.4	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MIISLIAALAADRVIGMENAMPWHLPADLAWFKRNTLNKPVIMGRKTFESIGRPLPGRHNIVLSSRPGNAAGVTWVTSLDEALAAAGEVEEVMVIGGGRIYTQLLPRADRLYLTHIDAEVGGDTHFPDYEPDEWETTFSEFHDADDLNSHSYCFEILQRR	ATGATTATCAGCCTGATCGCTGCCTTGGCGGCGGATCGCGTTATTGGCATGGAAAACGCCATGCCGTGGCACCTGCCGGCGGACCTTGCGTGGTTTAAACGCAACACGTTGAATAAGCCGGTTATTATGGGCCGCAAGACCTTCGAGTCCATCGGCCGCCCGCTGCCAGGCCGCCACAATATCGTTTTGAGCAGCCGCCCGGGCAATGCCGCCGGGGTGACCTGGGTGACCTCGCTGGATGAAGCGCTGGCCGCCGCGGGCGAGGTGGAAGAAGTGATGGTGATCGGCGGTGGGCGCATCTATACCCAACTGCTGCCGCGCGCCGATCGCCTGTACCTGACGCACATCGACGCCGAAGTCGGCGGCGATACCCACTTCCCGGATTACGAGCCGGACGAGTGGGAAACCACGTTCAGCGAATTCCACGACGCCGACGATCTGAACTCGCACAGCTACTGCTTCGAAATCCTGCAGCGCCGCTGA	
8057	CARD	prokka_03428	contig_8	269975	57	6531	9669	1	61	adeF	3000777.0	768.459	750.0	Strict	42.31	98.68	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; tetracycline antibiotic	MANFFIDRPIFAWVLAIILCLTGALAIFSLPVEQYPNLAPPNVRISATYPGASAQTLENTVTQIIEQNMTGLDNMMYMSSQSTNTGQATVTLTFEAGTDPNEAMQQVQNQLQAAIKRLPQAVQNQGVTVSKSGDTTLMMVAFVSTDGSMDRQDIADYIVSNLQDPLSRINGVGSMDVYGSQYAMRIWLDPNKLNSYQLTTQDVVSAIQSQNAQVAVGQLGGTPSVDKQALNATINAQSQLQTPEQFRQITLRVNQDGSLVTLGNVATVELGGENYNYLSRYNGMQAAGMNIKLASGANELQTDQLVKDKIAELSQYFPHGLEAKVAYETTPFVKASIKDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAILSACGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEEGLPPREATRKSMGQIQSALVGIALVLSAVFVPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCATLLKPIAKGHHHGKRGFFGWFNRMFNRNAERYERGVGRILHASGRYMVIYLLLLGGMALLFIKLPTSFLPQEDRGIFTVQVQLPAGSTLQQTSKVVEKVEQYFLTEEKQDVLSVFAIIGSGPGGNGQNVARLFVRLKDWDLRTSGANSSFDIIDRATLAFNKINEARVIASSPPAITGLGNSSGFDMELEDHAGLGHAKLMAARDQLLQLAAQNPLLSRVRHNGLDDSPQLQIDIDQRKAQALGVSIDDINNTLSTAWGSTYVNDFVDRGRVKRVYVQAAAPFRMLPEDINKWYVRNSAGGMVPFSAFASSHWEYGSPRLERYNGNSALEIVGEAANGVSTGTAMAEMEKLVSQLPTGFGLEWTALSYQERLSGSQAPALYAISLLVVFLCLAALYESWSIPFSVMLVVPLGVIGAVAATWLRGLENDVYFQVGLLTIIGLSAKNAILIVEFANELNHKGQDLMSATLDASRMRLRPILMTSLAFIFGVLPMATSSGAGSGSQHAVGTGVMGGMISATLLAIFFVPLFFVLVRRRFPGKAHPAGNTTAAGE	ATGGCCAATTTTTTTATTGATCGCCCGATTTTCGCCTGGGTGCTGGCAATTATTCTTTGCCTGACCGGGGCGTTGGCGATTTTTTCTTTACCGGTAGAACAATACCCGAATTTGGCGCCGCCGAACGTGCGCATCAGCGCAACTTACCCAGGTGCTTCGGCGCAAACGCTGGAAAACACCGTTACCCAAATCATTGAACAGAATATGACCGGCCTCGACAACATGATGTACATGTCGTCGCAGAGCACCAATACCGGCCAGGCGACCGTGACGCTGACGTTCGAAGCCGGCACCGATCCCAACGAGGCGATGCAGCAGGTGCAAAACCAGCTGCAGGCCGCGATCAAACGCCTGCCGCAGGCGGTGCAAAATCAGGGGGTGACGGTCTCGAAATCCGGCGACACCACGCTGATGATGGTGGCGTTCGTCTCCACCGATGGCAGCATGGACAGGCAGGACATCGCCGATTACATCGTCTCCAACCTGCAGGATCCGCTCAGCCGCATCAACGGGGTCGGCAGCATGGACGTGTATGGCTCGCAATACGCCATGCGCATCTGGCTCGATCCCAACAAGCTCAACAGCTACCAGTTGACCACCCAGGATGTGGTCAGCGCCATTCAGTCGCAGAACGCCCAGGTCGCGGTCGGCCAGTTGGGCGGCACGCCATCGGTCGATAAGCAGGCGCTGAACGCCACCATTAACGCCCAGTCGCAGCTCCAGACGCCGGAACAGTTCCGCCAAATCACCCTGCGGGTCAATCAGGACGGTTCGCTGGTGACGCTGGGCAACGTTGCCACCGTCGAACTGGGCGGCGAAAACTACAACTACCTCAGCCGTTACAACGGCATGCAGGCCGCGGGCATGAACATCAAGCTGGCCTCCGGCGCCAACGAACTGCAGACCGACCAGTTGGTGAAAGACAAGATCGCCGAGCTGTCGCAATACTTCCCGCACGGGCTGGAGGCCAAAGTGGCCTATGAAACCACCCCCTTCGTCAAAGCCTCGATCAAGGACGTGGTGAAAACGCTGCTGGAAGCCATCCTGCTGGTGTTCCTGGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACGCTGATCCCCACCATCGCCGTGCCGGTGGTGCTGCTGGGCACCTTCGCCATCCTTTCCGCCTGCGGCTTCAGCATCAATACCCTTACCATGTTCGCCATGGTGCTGGCGATCGGCCTGCTGGTGGACGACGCCATCGTGGTGGTGGAAAACGTCGAACGCGTGATGAGCGAAGAAGGCCTGCCGCCGCGTGAAGCCACGCGCAAATCCATGGGGCAAATTCAGAGCGCGCTGGTCGGCATCGCCCTGGTGCTGTCGGCGGTGTTCGTGCCGATGGCGTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCCATCACCATCGTTTCCGCCATGGTGTTGTCGGTGCTGGTGGCGATGATCCTGACCCCGGCCCTGTGCGCCACGCTGCTCAAACCGATCGCCAAGGGGCACCATCACGGCAAGCGCGGCTTCTTCGGCTGGTTCAACCGCATGTTCAACCGCAACGCCGAACGCTATGAGCGCGGCGTGGGGCGCATTCTGCACGCCAGCGGCCGCTACATGGTGATTTATCTGCTGTTGCTCGGCGGCATGGCGCTGCTGTTCATCAAGCTGCCGACCTCGTTCCTGCCGCAGGAAGACCGCGGCATCTTCACCGTACAGGTACAGCTGCCGGCGGGCTCGACCCTGCAGCAAACCTCTAAAGTGGTGGAAAAGGTTGAGCAGTATTTCCTCACCGAAGAGAAACAGGACGTGTTGTCGGTGTTCGCCATCATCGGCTCCGGGCCGGGGGGCAACGGCCAAAACGTGGCGCGTCTGTTCGTTCGGCTGAAAGACTGGGATCTGCGCACCTCGGGCGCCAACAGCTCGTTCGACATCATCGATCGCGCCACGCTGGCATTCAACAAGATTAACGAAGCGCGAGTGATCGCCAGCAGCCCGCCGGCGATCACCGGCCTCGGCAACTCCTCCGGCTTCGACATGGAACTGGAAGATCACGCCGGGTTGGGGCACGCCAAACTGATGGCGGCTCGCGACCAACTGTTACAGCTGGCGGCGCAAAATCCGCTGCTGTCGCGCGTGCGCCACAACGGCCTGGACGACAGCCCGCAGCTGCAGATCGATATCGATCAGCGCAAGGCGCAGGCGCTGGGCGTATCTATCGACGACATCAACAATACCCTCTCTACCGCCTGGGGTTCGACCTACGTCAACGACTTCGTCGATCGCGGCCGGGTGAAGAGAGTTTACGTGCAGGCCGCCGCGCCGTTCCGCATGCTGCCGGAAGACATCAACAAATGGTATGTGCGCAACAGCGCGGGCGGCATGGTGCCGTTCTCGGCCTTCGCCAGTTCACACTGGGAATACGGCTCGCCGCGGCTGGAACGCTATAACGGCAACTCGGCGCTGGAAATCGTCGGCGAGGCGGCCAACGGCGTCAGCACCGGCACCGCCATGGCGGAAATGGAAAAACTGGTCAGCCAGTTACCGACCGGCTTCGGGCTGGAATGGACGGCGCTCTCCTACCAGGAACGCTTGTCCGGCTCGCAGGCGCCGGCGCTGTACGCCATCTCGCTGCTGGTAGTGTTCCTGTGCCTGGCGGCGCTGTATGAAAGCTGGTCGATACCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATCGGCGCGGTCGCCGCCACCTGGCTGCGCGGCCTGGAGAACGACGTTTATTTCCAGGTCGGCCTGTTGACCATCATTGGGCTGTCGGCGAAAAACGCCATTCTGATCGTCGAATTCGCCAACGAGCTGAACCACAAAGGGCAGGATCTGATGTCCGCGACGCTCGACGCATCACGCATGCGTCTGCGGCCGATCCTGATGACTTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCCACCAGCAGCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGGGTGATGGGCGGCATGATCTCCGCCACCCTGCTGGCGATTTTCTTCGTGCCGCTGTTCTTCGTGCTGGTGCGCCGCCGCTTCCCGGGCAAAGCGCATCCGGCAGGCAATACGACGGCCGCCGGGGAGTGA	
8057	CARD	prokka_03665	contig_8	269975	57	256465	256984	1	75	emrR	3000516.0	286.96	280.0	Strict	83.13	97.73	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MESSFAPIEQMLNFRATRQKDFPYQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLDAQESHSIQPSELSSALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLHLTPQGEEFLSQLLPPQHQCLHFLWSTLTDDEQKQLEQLTRKLLARLDQMEITEQLP	ATGGAAAGCTCGTTTGCCCCCATAGAACAAATGCTGAATTTCCGCGCCACGCGGCAGAAAGATTTCCCTTATCAGGAAATCCTGCTGACCCGCCTGTGCATGCACATGCAAGGCAAGCTGCTGGAAAACCGCAATAAGATGCTCAAGGCGCAGGGGATTAACGAAACACTGTTTATGGCGCTGATTACCCTGGATGCGCAGGAGAGCCACAGCATCCAACCTTCTGAGCTAAGCTCTGCCTTGGGCTCCTCGCGCACCAATGCGACCCGCATCGCCGATGAGCTGGAGAAACGCGGCTGGATCGAGCGCCGGGAAAGCGACAACGATCGCCGCTGCCTGCATCTGCATCTGACACCGCAGGGGGAAGAGTTTCTCAGTCAACTGCTGCCACCGCAGCACCAATGTCTGCATTTCCTGTGGTCCACGCTGACCGACGATGAGCAAAAACAGCTGGAACAGCTGACGCGCAAATTGCTGGCACGTCTGGATCAAATGGAAATCACAGAACAGTTACCCTAA	
8057	CARD	prokka_03668	contig_8	269975	57	259676	261215	1	56	Klebsiella pneumoniae KpnH	3004597.0	845.8839999999999	700.0	Strict	83.33	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MPQKPLEGAQLAWMTVALAMATFMQVLDSTIANVAIPTIAGNLGSSNSQGTWVITSFGVANAISIPITGWLAKRIGEVRLFLWSTALFVLASWLCGISNSLGMLIFFRVIQGVVAGPLIPLSQSLLLNNYPPAKRAMALALWSMTVIVAPIFGPILGGYISDNYHWGWIFFINIPIGAFVIVAAIATLKGRETKTEIKPIDTVGLVLLIVGIGSLQVMLDQGKELDWFNSTEIITLTVVAVVALLFLVVWELTDDHPVVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGLIPVLLSPIIGKFGNRLDMRKLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFVQGFAIACFFMPLTTITLSGLPPERMAAASSLSNFTRTLAGSIGTSITTTLWTQRESQHHSQLTEFVNPYNPQSQEMYRQLEQLGMSKQQASAYIANEITAQGLIISANEIFWLSAGVFLVLLALVWVAKPPFSSGGGGGGGAH	TTGCCACAGAAACCGCTTGAAGGCGCCCAGCTCGCCTGGATGACGGTCGCGCTCGCCATGGCGACCTTCATGCAGGTGCTGGACTCCACCATCGCCAACGTGGCGATCCCCACCATTGCCGGTAACCTCGGGTCTTCCAACTCGCAGGGCACCTGGGTGATCACCTCGTTCGGCGTGGCGAACGCCATCTCGATCCCGATCACCGGCTGGCTGGCGAAGCGCATCGGCGAAGTGCGGCTGTTCCTCTGGTCCACCGCGCTGTTCGTCCTCGCCTCCTGGCTGTGCGGCATCTCCAACAGCCTCGGCATGCTGATCTTCTTCCGCGTGATCCAGGGCGTGGTGGCCGGGCCGCTGATCCCGCTGTCGCAGAGCCTGTTGCTGAACAACTACCCGCCCGCCAAGCGGGCGATGGCCCTGGCGCTTTGGTCGATGACCGTTATCGTCGCGCCGATCTTCGGGCCGATCCTCGGCGGTTACATCAGCGACAACTACCATTGGGGCTGGATCTTCTTCATCAACATCCCGATCGGCGCCTTCGTGATCGTGGCGGCGATCGCGACGCTGAAGGGGCGAGAAACCAAAACCGAGATCAAACCGATCGACACCGTCGGCCTGGTGCTGCTGATCGTCGGCATCGGTTCGCTGCAGGTGATGCTCGATCAGGGCAAGGAGCTGGACTGGTTCAACTCGACCGAGATCATCACCCTGACCGTCGTGGCGGTGGTGGCGTTGCTGTTCCTGGTGGTCTGGGAGCTGACGGACGACCACCCGGTGGTGGATCTGTCACTGTTCAAGTCACGCAACTTCACCATCGGCTGCCTGTGCATCAGCCTGGCCTACATGCTGTACTTTGGCGCCATCGTGCTGTTGCCGCAGCTGCTGCAAGAGGTATACGGCTATACCGCCACCTGGGCGGGGCTGGCGTCGGCGCCGGTCGGGCTGATCCCGGTGCTGCTGTCGCCGATCATCGGTAAGTTCGGCAACCGGCTCGACATGCGCAAGCTGGTGACCTTCAGCTTCATCATGTATGCCGTGTGCTTCTACTGGCGCGCCTATACGTTTGAGCCAGGCATGGACTTCGGCGCTTCGGCCTGGCCGCAGTTCGTCCAGGGTTTCGCCATCGCCTGCTTCTTCATGCCGTTGACCACCATCACGCTGTCCGGCCTGCCGCCGGAACGCATGGCGGCGGCGTCGAGCCTGTCGAACTTTACGCGAACGCTGGCGGGTTCGATCGGTACCTCGATCACCACCACCCTGTGGACGCAGCGCGAATCACAGCACCATTCGCAGCTGACGGAGTTCGTCAATCCGTACAACCCGCAGTCGCAGGAGATGTACCGGCAGCTGGAGCAGCTCGGCATGAGCAAACAACAGGCGTCGGCCTACATCGCCAACGAGATCACCGCGCAAGGCCTGATCATCTCCGCCAACGAGATCTTCTGGCTGTCGGCCGGGGTATTCCTGGTGCTGCTGGCGCTGGTGTGGGTGGCGAAACCGCCGTTCAGCTCCGGCGGCGGTGGGGGCGGCGGCGCCCACTAA	
8057	CARD	prokka_04448	contig_12	213903	62	188782	189415	-1	63	CRP	3000518.0	432.18	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMASRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTTCTCGGCAAACCGCAAACAGACCCTACTCTCGAATGGTTCCTGTCTCATTGCCATATCCACAAATATCCATCGAAGAGTACGCTGATTCACCAAGGTGAAAAGGCCGAAACGCTTTACTACATCGTGAAAGGCTCCGTCGCGGTACTGATCAAGGATGAAGAAGGTAAAGAGATGATCCTGTCCTACCTCAACCAGGGGGATTTCATCGGCGAGCTCGGATTGTTCGAAGAAGGCCAGGAGCGCAGCGCCTGGGTTCGCGCGAAAACCGCCTGTGAAGTGGCCGAAATTTCCTACAAGAAATTCCGCCAGCTGATCCAGGTGAACCCGGACATCCTGATGCGTCTGTCCGCCCAAATGGCGAGCCGCCTGCAGGTCACCTCCGAAAAAGTGGGCAACCTCGCCTTCCTGGACGTGACCGGCCGCATCGCGCAAACCCTGCTGAATCTGGCGAAGCAACCCGACGCCATGACTCACCCGGACGGCATGCAGATCAAGATCACCCGCCAGGAGATCGGCCAGATCGTCGGCTGCTCGCGCGAAACCGTTGGCCGTATTCTGAAAATGCTGGAAGATCAAAACCTGATTTCCGCCCACGGCAAAACCATTGTCGTCTACGGCACCCGTTAA	
8057	CARD	prokka_02648	contig_5	343274	59	119293	121057	-1	72	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	588.571	500.0	Strict	52.62	96.23	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N	cephalosporin; cephamycin; penam	MKAARPGKLRRQEDQASFVSWRFALLCGCILLAMVGLMLRVAYLQVINPDRLVKEGDMRSLRVQEVPTARGMISDRAGRPLAVSVPVNAVWADPKELNERGGITLDSRWKALSDALNIPLDQLSNRINANPKGRFVYLARQVNPAIGDYIHKLKLPGIYLRQESRRYYPAGQVTSHIIGVTNIDGQGIEGVEKSFDRWLTGQPGERTVRKDRFGRVIEDISSVDSQAAHNLVLSVDERLQALVYRELNNAVAFNKAESGTAVLIDVNTGEVLAMANSPSYNPNNMAGTPKETMRNRAITDIFEPGSTVKPMVVMTALQNGVVRENSVLNTIPYRIQGHEIKDVARYSELSLTGILQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGESSGIYPKKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSLGVYRPLSITKVDPPVAGERVFPEPLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGKYVNRYIAYTAGVAPASNPRFALVVVINDPQGGKYYGGAISAPVFGAIMGGVLRTMNVEPDALPTGDKSELVINKKEGSGGRS	ATGAAAGCAGCGCGCCCCGGTAAGTTGAGACGCCAGGAAGATCAGGCCAGCTTTGTCAGCTGGCGTTTTGCGTTGCTGTGCGGCTGCATTTTGCTGGCGATGGTCGGCCTGATGCTGCGCGTCGCGTACCTGCAGGTCATCAACCCCGATCGTCTGGTGAAAGAAGGCGACATGCGTTCGCTGCGCGTGCAGGAAGTGCCGACCGCGCGCGGCATGATCAGCGATCGCGCCGGCCGTCCGTTGGCGGTCAGCGTGCCGGTCAATGCGGTGTGGGCGGATCCGAAAGAGCTGAACGAGCGCGGCGGTATCACGCTGGACAGCCGTTGGAAAGCGCTTTCCGATGCGCTGAACATCCCGCTGGACCAACTCTCCAACCGCATCAACGCCAACCCGAAAGGGCGCTTCGTTTATCTGGCGCGCCAGGTGAACCCGGCGATCGGCGACTACATCCACAAACTCAAGCTGCCGGGGATCTACCTGCGGCAGGAGTCGCGCCGTTACTATCCGGCGGGGCAGGTGACGTCGCATATCATCGGCGTGACCAATATCGACGGGCAAGGCATCGAAGGCGTCGAGAAGAGCTTCGACCGCTGGCTGACCGGGCAACCGGGCGAGAGAACGGTGCGTAAGGACCGCTTCGGCCGGGTGATCGAAGATATTTCCTCCGTCGACAGCCAGGCGGCGCACAACCTGGTGCTGAGCGTCGATGAACGCCTGCAGGCGCTGGTGTATCGCGAGCTGAACAACGCGGTGGCGTTCAACAAGGCCGAGTCGGGCACTGCGGTGCTGATCGACGTGAACACCGGCGAAGTGCTGGCGATGGCCAACAGCCCGTCTTACAACCCGAACAACATGGCCGGTACGCCGAAAGAGACCATGCGTAACCGTGCTATCACCGATATTTTTGAACCCGGTTCAACCGTGAAGCCGATGGTGGTGATGACCGCGCTGCAAAACGGCGTGGTGAGAGAAAACAGCGTGCTGAACACCATCCCGTACCGCATTCAGGGCCACGAGATCAAAGACGTGGCGCGGTACTCGGAGCTGTCATTGACCGGGATCTTGCAGAAGTCGAGTAACGTCGGTGTTTCAAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCTCGTTTTGGGCTGGGAAAAGCGACCAATTTGGGGCTGGTCGGAGAAAGCAGTGGCATATACCCAAAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTGATGGTAACTCCGTTACAGTTGGCGCGAGTCTATGCAACGATCGGCAGCCTGGGCGTATATCGCCCATTGTCGATCACCAAGGTTGACCCTCCGGTCGCCGGCGAGCGCGTTTTCCCTGAACCTCTGGTGCGCACCGTGGTGCACATGATGGAAAGCGTGGCCCTGCCGGGCGGCGGCGGCGTGAAAGCCGCCATCAAGGGATACCGTATCGCCATCAAAACCGGTACCGCGAAAAAAGTGGGCCCGGACGGCAAATACGTCAACCGATACATCGCTTATACCGCCGGCGTCGCGCCGGCAAGTAACCCCCGTTTTGCCCTGGTGGTCGTCATCAATGACCCGCAGGGTGGGAAATACTATGGTGGCGCAATCTCCGCGCCGGTGTTCGGCGCCATCATGGGCGGCGTATTGCGCACCATGAACGTCGAGCCTGACGCGTTGCCTACCGGTGACAAAAGCGAATTAGTGATTAACAAGAAAGAGGGTTCAGGTGGCAGATCGTAA	
8057	CARD	prokka_02931	contig_6	335656	56	93384	96027	-1	66	Salmonella enterica gyrA conferring resistance to fluoroquinolones	3003926.0	1570.44	1500.0	Strict	88.77	100.23	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	D87Y	fluoroquinolone antibiotic	MSDLAREITPVNIEDELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMSVLGNDWNKPYKKSARVVGDVIGKYHPHGDSAVYYTIVRMAQPFSLRYMLVDGQGNFGSVDGDSAAAMRYTEVRMSKIAHELLADLEKETVDFVPNYDGTEQIPAVMPTKIPNLLVNGSSGIAVGMATNIPPHNLAEVVNGCLAYIDDENISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYLRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYALTQLQVTFGINMVALHQGQPKLLNLKDILEAFVRHRREVVTRRTIFELRKARDRAHILEALAIALANIDPIIELIRRAPTPAEAKVALVAQPWDLGNVSAMLERAGDDAARPEWLEPEFGIRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLNFIAELIFILESPERLMEVIREELVAVKELYNDGRRTEITANTSDINIEDLINQEDVVVTLSHQGYVKYQPLSDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGRHVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTDGSNEVMLFSANGKVVRFPETQVRSMGRTATGVRGINLGEGDSVISLIVPRGEGDILTVTQNGFGKRTAVTEYPTKSRATQGVISIKVSERNGQVVGAVQVETSDQIMMITDAGTLVRTRVSEVSVVGRNTQGVTLIRTAEDENVVGLQRVAEPVEDEELDSLEPGAEAVEEDTTPLDDGDDAAEPMDDDNV	ATGAGCGACCTTGCCAGAGAAATCACACCGGTAAACATCGAAGACGAGTTGAAAAACTCGTATCTGGACTATGCGATGTCCGTTATTGTCGGACGTGCGCTGCCAGATGTTCGTGATGGACTGAAGCCGGTTCACCGCCGCGTTCTGTACGCGATGAGCGTATTGGGTAACGACTGGAATAAACCATACAAGAAATCGGCCCGTGTCGTCGGGGACGTGATCGGTAAATATCACCCGCACGGTGACAGCGCGGTTTACTACACTATCGTGCGTATGGCTCAGCCGTTTTCACTGCGCTACATGCTGGTGGACGGTCAGGGTAACTTCGGCTCCGTCGACGGCGACTCCGCCGCGGCGATGCGTTATACCGAAGTGCGCATGTCCAAGATTGCTCACGAACTGTTGGCGGATCTGGAAAAAGAAACCGTCGACTTCGTGCCTAACTATGATGGCACCGAGCAGATCCCGGCCGTCATGCCGACCAAGATCCCGAACCTGCTGGTCAACGGCTCGTCGGGCATCGCCGTGGGCATGGCCACCAATATCCCGCCGCACAACCTGGCGGAAGTCGTCAACGGCTGCCTGGCCTATATCGACGATGAAAACATCAGCATCGAAGGGCTGATGGAACACATCCCGGGGCCGGACTTCCCGACGGCGGCGATCATCAACGGCCGTCGCGGCATTGAAGAGGCCTACCGCACCGGGCGCGGCAAAGTCTACCTGCGCGCGCGCGCGGAAGTGGAAGCCGACGCCAAGACCGGGCGCGAAACCATCATCGTTCACGAGATCCCGTATCAGGTGAACAAGGCGCGTCTGATCGAGAAGATCGCCGAGCTGGTGAAAGAAAAGCGTGTGGAAGGCATCAGCGCGCTGCGCGACGAGTCCGATAAAGACGGCATGCGCATCGTGATCGAAGTCAAACGCGACGCGGTCGGCGAAGTGGTGCTGAACAACCTGTATGCGCTGACGCAACTGCAGGTCACTTTCGGCATCAACATGGTCGCGCTGCATCAGGGCCAGCCTAAGCTGCTGAACCTGAAAGACATCCTCGAAGCCTTCGTGCGTCACCGCCGCGAAGTGGTTACGCGTCGCACCATCTTCGAACTGCGCAAGGCCCGCGACCGCGCCCATATCCTGGAAGCGCTGGCTATCGCGCTGGCCAACATCGATCCGATCATCGAGCTGATTCGCCGTGCGCCGACCCCGGCCGAAGCGAAAGTCGCGCTGGTGGCGCAGCCGTGGGATCTGGGCAACGTCAGCGCCATGCTGGAGCGCGCCGGTGACGACGCCGCCCGCCCTGAGTGGCTGGAGCCGGAGTTCGGCATCCGCGACGGCAAATACTACCTGACCGAGCAGCAGGCTCAGGCGATTCTGGATCTGCGCCTGCAGAAACTGACCGGCCTGGAGCACGAGAAGCTGCTGGACGAATATAAAGAGCTGCTCAACTTTATCGCCGAGCTGATCTTTATCCTGGAAAGCCCAGAGCGCCTGATGGAAGTGATCCGCGAAGAGCTGGTGGCAGTCAAAGAGCTGTACAACGACGGCCGCCGCACCGAGATCACCGCCAATACTTCCGACATCAACATCGAAGACCTGATCAACCAGGAAGACGTGGTGGTGACCCTGTCTCACCAGGGCTACGTGAAGTATCAGCCGCTGTCCGACTATGAAGCGCAGCGCCGCGGCGGCAAAGGCAAGTCTGCGGCGCGTATCAAAGAAGAAGACTTTATCGATCGTCTGCTGGTGGCCAACACCCACGATACGATCCTGTGTTTCTCCAGCCGTGGCCGCCTGTACTGGATGAAGGTGTACCAACTGCCTGAAGCCAGCCGCGGCGCGCGCGGTCGCCCAATCGTCAACCTGCTGCCGCTGGAAGCCGATGAGCGTATCACCGCCATTCTGCCGGTGCGCGAGTATGAAGAAGGGCGCCACGTGTTCATGGCCACCGCCAGCGGTACCGTGAAGAAAACTGCGCTGACCGAGTTCAGCCGCCCACGCAGCGCCGGCATCATCGCCGTCAACCTCAACGAGGGTGACGAGCTGATCGGTGTCGATCTGACCGACGGCAGCAACGAAGTGATGCTGTTCTCCGCCAACGGTAAAGTGGTGCGCTTCCCGGAAACGCAGGTGCGTTCGATGGGCCGTACCGCGACCGGCGTGCGCGGCATCAACCTCGGCGAAGGCGACAGCGTGATCTCGCTGATTGTGCCGCGAGGCGAAGGCGACATCCTGACCGTCACGCAAAACGGCTTCGGTAAACGTACCGCGGTGACCGAGTACCCGACCAAGTCGCGCGCCACCCAGGGGGTTATCTCCATCAAGGTGAGCGAGCGTAACGGCCAGGTGGTCGGCGCCGTGCAGGTGGAAACCAGCGACCAGATCATGATGATCACCGATGCCGGCACGCTGGTGCGTACCCGCGTTTCGGAAGTCAGCGTGGTGGGCCGTAACACCCAGGGCGTGACGCTGATCCGTACGGCGGAAGACGAAAACGTCGTCGGTCTGCAGCGCGTGGCCGAGCCGGTGGAAGACGAAGAGCTGGACAGCCTGGAGCCGGGCGCGGAAGCGGTGGAAGAAGACACCACGCCGCTGGACGATGGCGACGACGCGGCTGAGCCGATGGATGACGACAACGTTTAA	
8161	BLDB	prokka_04861	contig_75	20426	19	8800	9682	-1	19	KPC-2		92.8		Perfect	100.0	99.66	carbapenem-hydrolyzing class A beta-lactamase KPC-2	protein homolog model			Beta-Lactam	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA	
8161	BLDB	prokka_05433	contig_149	1443	24	814	1150	-1	24	OXA-896		146.9		Strict	100.0	40.15	class D beta-lactamase OXA-896	protein homolog model			Beta-Lactam	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVV	ATGAAAAAAATTTTGCTGCTGCATATGTTGGTGTTCGTTTCCGCCACTCTCCCAATCAGTTCCGTGGCTTCTGATGAGGTTGAAACGCTTAAATGCACCATCATCGCAGACGCCATTACCGGAAATACCTTATATGAGACCGGAGAATGTGCCCGTCGTGTGTCTCCGTGCTCGTCTTTTAAACTTCCATTGGCAATCATGGGGTTTGATAGTGGAATCTTGCAGTCGCCAAAATCACCTACGTGGGAATTGAAGCCGGAATACAACCCGTCTCCGAGAGATCGCACATACAAACAAGTCTATCCGGCGCTATGGCAAAGCGACTCTGTTGTCTAG	
8161	CARD	prokka_00482	contig_3	175899	17	72280	72760	1	18	Trimethoprim-resistant dihydrofolate reductase DfrA42	3005334.0	53.9138	32.0	Strict	28.0	89.83	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVVMGRLTWESIGRPLPGRKNIVISSKPGSDDRVQWVSSVEEAIAACGDVEEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYDPDEWESVFSEFHDADAQNSHSYCFEILERR	ATGATCAGTCTGATTGCGGCGTTAGCGGTAGATCGCGTCATTGGTATGGAAAACGCCATGCCATGGAACCTGCCTGCCGATCTCGCCTGGTTCAAACGCAACACGTTAAATAAGCCGGTGGTGATGGGGCGTCTGACCTGGGAATCCATTGGGCGCCCATTGCCGGGGCGTAAAAATATCGTGATCAGCAGCAAACCCGGCAGCGACGATCGCGTGCAGTGGGTCTCCTCCGTAGAAGAAGCAATTGCCGCCTGCGGCGATGTGGAAGAGATTATGGTGATCGGCGGCGGCCGGGTGTATGAGCAGTTCCTGCCGAAAGCGCAGAAGCTCTACTTGACCCATATTGATGCGGAAGTGGAAGGCGATACCCATTTCCCGGATTACGATCCGGACGAATGGGAGTCGGTGTTCAGCGAGTTTCATGACGCCGACGCGCAGAACTCCCATAGCTACTGCTTTGAGATCCTCGAACGCCGTTAA	
8161	CARD	prokka_00488	contig_3	175899	17	77402	79751	-1	19	LptD	3005059.0	1619.75	1500.0	Perfect	100.0	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		carbapenem; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTATGATCGTCCGCTCGTGGAAGGTCGTCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAACTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATTAACCAGGGGAATAGTCGCCTCCGCGCCGACGAAGTTCAGCTGCACCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGGCCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAAATGGTCGGACGCCAGGGACGCGGCACCGCCGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTCGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTCGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTTGCCGAGATCTGGAACGCCCGCTTCAAGCTTGGCTCTGTGCCGATTTTCTATAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATTACTCCGCACTATATGAACAAACGCGGCGGCGTGATGTGGGAAAACGAGTTCCGCTATCTGACCCAGCTCGGCAGCGGCTTAACTGAATTCGACTACCTGCCGTCGGATAAAGTCTACGAAGACGACCACTCGAGCGACAGCAACAGCCGCCGCTGGCTGTTCTACTGGAACCACTCAGGGGTTATCGATCAGGTATGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGACTTCAGCTCGAAATATGGTTCCAGTACCGATGGCTATGCGACGCAGAAATTCAGCGCCGGTTACGTCAACCAGAACTTTGACGCCACGGTATCGACCAAACAGTTCCAGGTCTTTGACCGCGAATCGAGCAACTCCTATTCGGCTGAGCCGCAGCTCGACGTCAACTACTACCAGAATGATGTCGGTCCGTTCGATACCCATCTCTATGGACAGGTTGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCCAACGGTTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACTCACTACCAGCAGAGCAACCTCGATAAGTACAATGCCGCCAACGGCACTGACTATAAAGAGTCCGTCAGCCGCGTAATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTTGAACGCGACCTGCAGGAGGGATTCACCCAAACGCTGGAACCGCGCGTGCAGTATCTGTACGTGCCGTACCGCGATCAGAGTGAAATCGGCAACTACGACTCCACGCTGTTGCAGTCGGATTACACCGGTCTGTTCCGCGACCGTACCTATAGCGGTCTGGACCGCATCGCGTCGGCTAATCAGGTCACCACCGGGCTCACCTCGCGCGTGTATGATGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACGCACCGGTGATGACAACATCAACTGGGAGAACAACGATACCACGGGTTCACTGGTCTGGGCCGGCGATACCTACTGGCGCATTGCCGATGAATGGGGTCTGCGCGGAGGGATCCAGTACGATACGCGTCTGGATAACGTTGCCACTGGTAACGGCACCATTGAATACCGTCGCGATGAGAACCGCTTAGTTCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACGCTGCCGTCATATTCCACCGCGGCACAATATAAACAGGGTATTTCGCAGGTGGGGATGACCGCCAGTTGGCCGATTGTCGATCGCTGGTCCGTGGTCGGGGCCTACTACTACGATACTAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTGCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGTAAAGTCAACGGCTGGAACAGCAACGACAACGGCGGCGAGAGCAAATACGATAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGCTCGAACATTTTACCGTACCAGAGCTCCCTGTGA	
8161	CARD	prokka_00757	contig_5	142209	17	48572	51686	1	13	acrD	3000491.0	1951.79	1900.0	Strict	91.03	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic	MANFFIDRPIFAWVLAILLCLTGALAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQPASGLGIKLASGANEMATAERVINRLNELAQFFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPVKPGESHERTGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLIYVLLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGTSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAGKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ	ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCATGGGTGCTGGCAATCCTGTTATGCCTGACGGGCGCCCTTGCCATTTTGTCGCTGCCGGTTGAACAGTATCCCGACCTCGCCCCGCCGAATGTGCGGATCACCGCCAACTATCCCGGCGCTTCCGCGCAAACCCTGGAGAATACCGTCACTCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCCTCCCAGAGCAGCGCCACCGGCCAGGCGACGATCACCCTCAGCTTTACCGCCGGTACCGACCCGGATGAAGCCGTGCAGCAGGTTCAGAACCAGCTACAGTCGGCGATGCGTAAGCTGCCGCAGGCGGTGCAAAACCAGGGGGTGACGGTGCGCAAGACCGGTGATACCAATATCCTGACGCTCGCCTTCGTCTCCACTGACGGCAGTATGGATAAACAAGATATCGCCGACTACGTCGCCAGTAACATCCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGTTCGCAATACTCAATGCGCATCTGGCTCGACCCGGCGAAGCTCAACAGCTACCAGATGACCACCAAGGATGTTACCGACGCCATCAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTTGGCGGGACGCCTTCGGTCGATAAGCAAGCGCTGAACGCCACCATCAACTCGCAATCTCTGCTGCAAACCCCGGAGCAGTTCCGCAATATCACTCTGCGCGTCAATCAGGATGGTTCAGAGGTGACGCTGGGCGATGTCGCCACCGTCGAGATGGGGGCGGAGAAGTACGACTATCTTAGCCGCTACAACCGCCAGCCGGCCTCAGGCCTCGGGATCAAGCTGGCTTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCAATCGCCTCAATGAGCTGGCGCAGTTTTTCCCCCACGGTCTGGAATATAAGGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCCATCACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCGACCATCGCCGTGCCGGTGGTGCTGATGGGCACTTTCGCGGTGCTGTATGCCTGTGGCTACAGCATCAACACCCTGACGATGTTCGCGATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGAGCGAGGAGGGCCTGTCGCCACGCGAGGCGACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTATTTGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCAATCACTATCGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCTGCCCTTTGCGCCACGCTGCTTAAGCCTGTTAAGCCAGGTGAATCCCATGAAAGAACAGGCTTCTTCGGCTGGTTCAACCGCACCTTCAACCGCAGCGCCAGCCGCTACGAAACCTTCGTCGGCAAAATACTGCACCGCTCGCTGCGCTGGATGCTGATCTACGTCCTCCTGCTCGGCGGGATGGTGTTCCTGTTTCTGCATTTGCCGACCTCGTTCCTGCCGCTGGAGGATCGCGGGATGTTCACCACCTCGGTCCAGTTGCCGAGCGGCAGCACCCAGCAGCAGACGCTGAAGGTGGTGCAGAAGGCGGAAGATTACTTCCTCAATAACGAGAAGCAGAACGTCGAGTCGGTGTTCGCTACCGTTGGCTCCGGCCCCGGCGGCAATGGGCAGAACGTGGCCCGCATGTTCGTTCGTCTCAAAGACTGGGACCAGCGCGACCCGCAAACCGGCACCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATTAACGAAGCGCGGGTTATCGCCAGCAGCCCGCCGGCGATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGATATGGAGCTGGAGGATCATGCCGGGAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTACTTGAGCTGGCCGGGAAAAATCCGCTGTTGACCCGCGTCCGGCATAACGGGCTCGATGACAGTCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCGCAGGCGCTGGGCGTCTCCATTGACGACATCAACGATACGCTGCAAACCGCGTGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGCCGGGTAAAGAAAGTCTACGTCCAGGCGGCGGCGAAATACCGGATGCTGCCTGACGATATCAATCTTTGGTACGTGCGCAACAGCAGCGGCACGATGGTGCCATTCTCGGCCTTCGCCACCTCGCGCTGGGAGACCGGCTCGCCGCGGCTGGAGCGCTACAATGGCTACTCAGCGGTGGAGATCGTCGGTGAGGCGGCGCCGGGTATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGTTACCCACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCTCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCAGTGCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATTGGCGCCCTGCTGGCGACCTGGATGCGCGGGCTGGAGAATGACGTGTACTTCCAGGTGGGTCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTCAACGAGAAGGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCTTGCCGTCAGCGCCTGCGCCCCATCCTGATGACCTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGAGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCGATCTTTTTCGTGCCGCTGTTCTTTGTGCTGGTGCGTCGCCGTTTTCCGCTAAAGGAGCGTCCGCAATAA	
8161	CARD	prokka_00952	contig_6	141516	17	104526	106182	-1	14	ArnT	3005053.0	1097.03	1000.0	Strict	99.64	100.0	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSPIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAAQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTCTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGATCAACAGTATCGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCCTGTCGCCGATTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGCGCGGCGCAGGCGCACAGCCGCAGCGGCAAAATACTGGGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAGGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCTCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTAATCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCTCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCGCTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGGATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCCGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAAGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTCGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGATATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA	
8161	CARD	prokka_00955	contig_6	141516	17	109062	110046	-1	14	PmrF	3003578.0	577.785	550.0	Strict	83.69	101.55	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS	ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATCCCGGTTTATAACGAACAGGATAGCCTGCCGGAACTGCTTCGTCGTACGGATGCCGCCTGCGCCACCCTGGGGCGGCAATATGAAATTCTGTTGATCGACGATGGCAGCAGCGACGATTCCGCGCGCATGCTCACCGAAGCCGCCGAGGCGGAAGGCAGCCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGCCAGCACTCGGCGATCATGGCCGGCTTCAGCCATGTAACCGGCGATCTGATTATTACCCTCGACGCCGACCTGCAAAACCCGCCGGAGGAGATCCCGCGGCTGGTGGCGAAGGCTGATGAAGGTTACGACGTGGTGGGCACCGTCCGCCAGAACCGTCAGGACAGCATCTTCCGTAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTTATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATTGCCCTGCTGGGCTTCGCCTTCGGCCTGCTGCTGGTGGTGCTGCGTCTGGCCTTTGGCCCGCAGTGGGCGGCGGAAGGGGTGTTTATGCTCTTCGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCCCGCCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA	
8161	CARD	prokka_01231	contig_9	119440	15	20	584	1	17	oqxA	3003922.0	385.956	670.0	Strict	99.47	47.83	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	GTGCTCACCACCCTGGTCTCGCAAAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTCCACTATCAAAACCTCGCCCGCCGCGGGCAAGGCGCGTCCAGCGATAATCAGGCGCTCCCGGTGGAGATTGGCCTGGTGGGCGAGGAGGGTTACCCCCACCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGTACCGGCACCATCCGCATGCGTGCGCTGCTGGATAACTCGCAGCGTCTGTTCACGCCGGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCAGAGTTCAAAGCCACGCTGATCGACGACAAAGCGGTACTGACCGATCAGGATCGTAAATACGTCTATATCGTTGATAAAGATGGTAAAGCACAGCGCCGCGACATTACCCCAGGGCGGCTGGCAGACGGTTTACGCATCGTTCAGAAGGGGTTGAATCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCCAAAACCGTTGCCATGACCTCCAGCGCCACCCTTAACTGA	loose hit with at least 95 percent identity pushed strict
8161	CARD	prokka_01232	contig_9	119440	15	607	3760	1	13	oqxB	3003923.0	2118.2	2000.0	Perfect	100.0	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCACTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTCTCCCCCGGCGGGAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCTGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGTTGATCGCTGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCTATCGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGCTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTTTCCATCCTGCCGCCGCCGATTTTAGGTCTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAGACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGATCTGTTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCTGACGGACCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTACCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAAGAGCTGTCGAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCATTCCTCGTACTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTACCGATGACGATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGTCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATCCAGGGGAAAGGCATCATGGAAGCGGCGCTGGAGGCATGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTACGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG	
8161	CARD	prokka_01277	contig_9	119440	15	48029	48560	1	24	emrR	3000516.0	338.961	280.0	Strict	92.57	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic	MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR	ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTCCGCGCCAGCCGCCATGAAGATTTCCCGTTTCAGGAGATCCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCACAGGAAAACCACAGCATCCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCACGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAGCGCCGCGAGAGCGATAACGATCGTCGCTGTTTGCATCTGCAACTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTTAGCACCAGCGAAAAAGATCAGCTCGAACACATCACCCGCAAACTCCTGAGCCGCCTTGATCAGATGGAAGAAGAAGGCGTGCTAGCGGACTCTCTACGCTAA	
8161	CARD	prokka_01278	contig_9	119440	15	48685	49858	1	22	Klebsiella pneumoniae KpnG	3004588.0	788.875	700.0	Strict	99.74	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	ATGAGTGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGAAAGCGTAAAGGCGCCCTTCTGTTGCTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTGGCAGGGAATCAGGTACAAATTATGGCTCAGGTCGCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACTCTCGATCGGACCGATGCCCAACAGGCGTTTGAAAAGGCTAAGACCCAACTGGCCGCCAGCGTCCGTCAGACCCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCAAATATCGACGTCAAAAAAACCGCCCTCGCCCAGGCGCAGGCTGACCTGAACCGCCGCATCCCGCTGGGCGCCGCGAACCTCATTGGCCGCGAAGAGCTGCAGCACGCCCGCGATACCGTCGCCAGCGCACAGGCCGAACTCGACGTGGCAATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGCACCAGGCTGGAACAGCAGCCGGCGGTGCTCCAGGCGGCCACTGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATCGGCACCACCACGCCGCTGATGGCGGTGGTCCCGGCGACCAACCTGTGGATCGATGCTAACTTTAAAGAGACTCAGCTGGCGCATATGCGTATCGGCCAGCCGGCCACCGTGATCAGCGATATCTATGGCGATGACGTGAAATACACCGGTAAAGTGGTCGGTCTGGATATGGGCACCGGCAGCGCCTTCTCTCTGCTGCCGGCGCAGAATGCTACCGGCAACTGGATCAAAGTGGTACAGCGTCTGCCGGTTCGTATCGAGCTGGATGAAAAACAACTAGCGGAACACCCGCTGCGCATCGGCCTCTCGACGCTGGTGGAAGTCAACACCACCGATCGCGATGGTGAAATGCTGGCCAGCCAGGTGCGGAGCTCCCCGGTTTACGAGAGCAATGCCCGTGAAATCGCTCTCGATCCGGTTAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA	
8161	CARD	prokka_01279	contig_9	119440	15	49873	51412	1	19	Klebsiella pneumoniae KpnH	3004597.0	937.947	700.0	Strict	94.02	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATTGCCGGCAACCTTGGCTCGTCGCTGAGCCAGGGGACCTGGGTCATCACCTCGTTCGGGGTCGCTAACGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGCGTCGGCGAGGTGAAGCTGTTCCTGTGGTCAACCACCGCTTTCGCCATTGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTCATTCAGGGGATCGTCGCCGGACCGCTGATCCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCCCCGGCGAAGCGCTCTATCGCTCTGGCGCTGTGGTCAATGACGGTGATTGTCGCGCCCATCTGCGGTCCGATCCTCGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGGATCGACGGTGTCGGTCTGGCGCTGCTGATCATCGGTATCGGTAGCCTGCAGGTGATGCTGGACCGGGGTAAAGAGCTGGACTGGTTCTCCTCCAATGAGATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTAACCGACGATAACCCGATTGTCGATCTGTCGCTATTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGTATCAGTCTGGCCTATATGCTCTACTTCGGCGCCATCGTACTGCTGCCGCAGCTGTTGCAGGAGGTCTACGGCTACACCGCGACCTGGGCCGGCCTGGCGTCGGCGCCGGTGGGGGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTCGCGCATAAGCTCGACATGCGGCGGCTGGTCACCTTCAGCTTTATTATGTACGCGGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCACAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTCTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCCTGTCGAACTTCACCCGTACCCTTGCCGGCTCCATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCATCATGCGCAGCTCACCGAATCGGTGACCCCCTTTAACCCCAACGCGCAGCAGATATACGATCAGCTGCAGGGCATGGGAATGACGCAGCAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACCAACCAGGGGCTGATTATCTCCGCCAACGAAATCTTCTGGATTTCTGCGGCTATTTTCATCCTGCTGTTGGGGCTGGTGTGGTTCGCCAGACCACCGTTCAGCGCCGGCGGAGGCGGCGGCGGCGCGCACTAA	
8161	CARD	prokka_01292	contig_9	119440	15	59271	59457	-1	25	rsmA	3005069.0	109.383	100.0	Strict	85.25	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTGTCTGTTCACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	
8161	CARD	prokka_01469	contig_11	107852	17	17867	19616	1	19	msbA	3003950.0	1126.69	1000.0	Strict	92.78	100.0	ATP-binding cassette (ABC) antibiotic efflux pump	protein homolog model	antibiotic efflux		nitroimidazole antibiotic	MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE	ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATCGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTGGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGCCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATTTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGTATGCCGGTGGCCTTCTTTGACAAGCAGTCTACCGGAACGCTGCTGTCACGCATCACCTATGATTCTGAGCAGGTCGCCTCCTCTTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGAGCATCGATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTGATCGTACTGGCGCCGATTGTGTCGGTGGCGATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCCGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAAGTCAGCAATAAAATGCGTCTGCAGGGGATGAAGATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCCGGGACCATTACCGTGGTCTTCTCCTCGATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAGCGCGGGATGGCGGCGTGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAAAAAGACGAAGGTACGCGGGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTACCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATCCCGGAAGGGAAAACAGTGGCGCTGGTGGGGCGCTCAGGGTCGGGTAAATCGACCATTGCCAGCCTGATCACCCGCTTCTACGATGTCGACGAGGGGCAGATCCTGCTGGATGGCCACGACCTGCGCGAGTACAAGCTGAGCTCGCTGCGCGACCAGGTGGCGCTGGTTTCACAAAACGTGCATCTGTTCAACGATACCGTCGCCAACAATATCGCCTATGCCCGTACCGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCCGCGCGCATGGCCTACGCCATGGATTTCATTAACAAGATGGATAATGGTCTGGATACCATCATCGGCGAGAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATTGCCCGCGCGCTGCTGCGTAACAGCCCGATCCTGATCCTCGATGAAGCCACCTCGGCGCTGGATACCGAGTCCGAGCGTGCTATTCAGGCGGCGCTGGATGAGCTGCAGAAAAACCGTACCTCGCTGGTTATCGCTCACCGTCTGTCGACCATTGAGCAGGCTGATGAAATCGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCATGACCTGCTGGAGCATAAGGGCGTGTACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA	
8161	CARD	prokka_01510	contig_11	107852	17	69009	70080	-1	23	OmpA	3005044.0	729.169	700.0	Strict	99.72	95.19	General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	reduced permeability to antibiotic		monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTTGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA	
8161	CARD	prokka_01618	contig_12	100487	15	65830	66991	1	14	Escherichia coli ampH beta-lactamase	3004612.0	690.263	500.0	Strict	85.71	100.26	ampC-type beta-lactamase	protein homolog model	antibiotic inactivation		cephalosporin; penam	MKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKAAPGSQAAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ	TTGAAACGTAGTTTGCTCATTTTTGCTGCGCTGTGCGCGGCGTCGTGGACCTCGGTGCAGGCCGCACAGCCTACCGTTGACCCGGTTTTCGCCTCGGATGTGGTCGATCGTTACGCCAATCATATCTACTACGGCAGCGGCGCCACCGGCATGGCGCTGGTGGTTATCGATGGCAATCAGCGTGTTTTTCGCAGCTTTGGCGAAACCCGCCCGGGGAATAATCAGCACCCGCAGCTCGACTCGGTGATCCGTATCGCCTCCCTCAGCAAACTGATGACCAGCGAGATGCTGGTGAAGCTGCTCGACCAGGGGGTGGTGAAACTCAACGATCCGCTGAGTAAATACGCCCCGCCGGGCGCCCGGGTGCCTGACTGGCAGGGAAAACCAATCACCCTGGTGAATCTCGCGACCCATACCAGCGCCCTGCCGCGCGAGCAGCCTGGTGGCGCCGCTCATCGTCCGGTGTTTGTCTGGCCGACCCGCCAGCAGCGCTGGAACTGGCTCTCTACCGCGACCCTGAAAGCCGCGCCGGGCTCGCAGGCGGCCTACTCCAACCTGGCCTTCGATTTACTGGCAGACGCGCTCGCCACCGCCGCCGGCAAACCGTATCCGCAGCTGTTTGAAGAGCAGATCACCCGGCCGCTGGGGATGAAGGACACCACCTTTACCCCGTCACCGGATCAGTGCCAGCGGCTGATGATCCCGGAAAAAGGCGCCAGCCCATGCAACAACACCCTGGCGGCGATCGGCAGCGGCGGAGTCTACTCGACGCCGGGGGATATGATGCGCTGGATGCAGCAGTTCCTGTCATCCGATTTCTATACCCGCAGCCAGCAGGCCGACCGGATGCAGACGCTGATTTATCAGCGTAACCAGCTGACCCGGGTGATTGGTATGGACGTGCCGGGCCGCGCCGACGCGCTGGGCCTCGGCTGGGTGTATATGAAGCCGAAGAACGGCCATCCGGGGATTATTCAGAAAACCGGCGGCGGCGGCGGGTTTATCACCTATATGGCGATGAATCCGCAGGCTAACGTTGGCGCCTTTGTGGTGGTAACCCGCTCGCCGTTGACCCGCTTCAACAATATGAGCGATGGCATCAACGACCTGGTCAGCGAGCTGAGCGGCGCACAGCCCAACATGCAGACGGCCAGCCAGTAA	
8161	CARD	prokka_02352	contig_20	89586	17	67181	70304	1	12	mdtB	3000793.0	1832.0	1800.0	Strict	89.9	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSQASERFFERVIAVYGRWLSRVLNHPWLTLGVALSTLALSIILWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAERQRQVASIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVDGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANHYRVVLEQDTEATPGLAALENIRLTSSDGGIVPLTAIATVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILAAEQSLDFPTDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA	ATGCAGGTGTTACCCCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCGATCCTGCTGGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCCCTGCCGGAGGTCGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAGCGCCAGTTCGGCCAGATGTCCGGCCTCAAGCAGATGTCGTCGCAAAGCTCCGGCGGCGCCTCGGTAGTCACGCTGCAGTTCCAGCTGACCCTGCCGCTGGACGTCGCCGAGCAGGAAGTGCAGGCGGCCATTAACGCCGCCACCAACCTGCTGCCGAGCGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACCCTCGCCGTCACCTCCTCCGCCATCCCGATGACCCAGGTTGAGGACATGGTGGAGACCCGGGTGGCGCAGAAGATCTCCCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCTATCACCAGCGCCAACGTTAACTCCGCGAAAGGCAGCCTCGACGGCCCGGCCCGCGCGGTGACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTATCGCCGGCTGATTATCGCTTATCAGAACGGGGCGCCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTCGGGGCGTGGGCCAACCAGCAGCGGGCCATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATCATCGACACCGCCGACAGCATTCGCCAGATGCTGCCGCAGCTCACCGAGAGCCTACCGAAATCGGTGAAGGTGCAGGTCCTCTCCGACCGGACCACCAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTACCTGTTTCTGCGCAACGTGCCGGCGACCATTATTCCCGGCGTCGCGGTGCCGCTATCGCTGGTGGGCACTTTCGCGGTGATGGTATTCCTCGACTTCTCGATCAATAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCCATCGTGGTGATCGAGAACATCTCGCGCTATATCGAAAAAGGCGAGAAGCCGCTGGCCGCCGCGCTGAAGGGCGCGGGGGAGATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGCCTGTTCCGCGAATTCGCCGTCACCCTTGCCGTCGCTATTCTTATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGCATGTTAAGCCACGAATCGCTGCGTAAGCAGAACCGATTCTCGCAGGCCAGCGAGCGTTTCTTCGAACGGGTGATCGCCGTCTACGGCCGCTGGCTGAGCCGGGTGCTGAATCATCCGTGGCTGACGCTCGGCGTCGCCCTGAGCACCCTGGCGCTGTCGATTATCCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGTACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGCATGGCCGAGCGCCAGCGGCAGGTGGCCAGCATTATCCTTAAGGATCCGGCGGTGGAGAGTCTGACCTCCTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGCCTGCAGATCAACCTCAAGCCGCTGGACGAACGCGACGACCGCGTCCAGACGGTGATTAGCCGCCTGCAGCAGGCGGTGGACGGCGTCCCCGGCGTGGCGCTCTACCTGCAGCCGACCCAGGACCTGACCATCGACACCACGGTGAGCCGCACCCAGTATCAGTTCACCCTGCAGGCAAACTCCCTCGAGGCGCTGAGCACCTGGGTGCCGCCGCTGCTCAGCCGCCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGATCGCGACAGCGCCAGCCGCCTCGGTATCTCAATGGCCGATGTCGATAATGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACTATTTACACTCAGGCGAATCATTATCGCGTGGTGCTCGAGCAGGATACCGAGGCGACGCCGGGCCTGGCGGCGCTGGAGAATATCCGTCTCACCAGCAGCGACGGCGGCATCGTGCCGTTGACCGCCATCGCCACGGTGGAGCAGCGCTTTACCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTCCCGGACAACTACTCGCTGGGCGAAGCGGTGGAGGCGATCCTCGCCGCCGAACAGTCGCTCGATTTTCCGACCGATATTCGCACCCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTCGGCAGCACCGTCTGGCTGGTGGTCGCCGCGGTGGTGGCGATGTATATCGTGCTGGGGGTGCTGTACGAGAGCTTTATCCATCCGATCACGATTCTCTCCACCCTGCCCACCGCCGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCAGCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCTGAGCGCGAGCAGGGCATGCCGCCGCGGGAGGCGATCTACCAGGCCTGTCTGCTGCGTTTTCGGCCGATCCTGATGACCACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTCGGCGCCGAGCTGCGGCGTCCGCTGGGGATCGGCATGGTCGGCGGTCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA	
8161	CARD	prokka_02353	contig_20	89586	17	70304	73382	1	13	mdtC	3000794.0	1865.12	1800.0	Strict	91.61	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminocoumarin antibiotic	MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVQTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVLGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSDGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSSQPVSE	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTACTGCCGGTGGCCCCGCTGCCGCAGGTGGACTTCCCGGTGATCATGGTTAGCGCCTCGCTGCCGGGAGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGCTCGCTCGGCAGCACCCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGACGTTCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGAATGCCCAGCCGGCCGACCTATCGCAAAGCCAATCCGTCAGATGCGCCGATCATGATCCTGACGCTGACCTCGGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATCGACGGCGTGGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCACAGGCGCTGTTTAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAACCGCAGGGGGCGCTGGAGGACAGCGCGCACCGCTGGCAGGTGCAGACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCACTGATCGTCCACTATCAAAATGGCGCCGCGGTGCGGCTGGGAGATGTCGCTACCGTCTCGGATTCGGTGCAGGACGTACGCAACGCCGGGATGACCAACGCCAAACCGGCGATCCTGCTGATGATCCGCAAACTGCCGGAAGCCAATATCATTCAGACAGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATTCCGGCGGCTATCGACCTGCAGATCGCCCAGGACCGCTCGCCTACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACGCTGGTGATTTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCCGTCGCCGTCCCGGTTTCCTTAATCGGCACCTTCGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCTATCGTGGTGCTGGAGAATATCTCCCGCCATCTGGAAGCGGGGATGAAACCGCTGCAGGCGGCGCTGCAGGGGAGCCGTGAGGTCGGCTTTACCGTGCTCTCGATGAGCCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTACCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAGCCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTGCAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCATAGCCGCCTGACCGGCCTGGTGGTGCTGGGCACCATCGCCCTCAGCGTCTGGCTCTACATTTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAGATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCCAACCTGTTCCTGATGGCGGTGCAGGATATCCGCGTCGGCGGCCGGCAGTCGAACGCCAGCTATCAGTACACCCTGCTGTCCGACGACCTGTCGGCGCTGCGCGAGTGGGAGCCGAAGATCCGCAAAGCGCTGGCGGCGCTGCCGGAGCTGGCGGACGTCAACTCGGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATCAGCGTCCAGGACGCCAACAACCTGCTGAACAACGCCTTTGGCCAGCGGCAGATCTCTACCATCTACCAGCCGCTCAACCAGTATAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTCGTCATTAACAGCGACGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAATGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCATCCACTATCTCCTTTAACCTGCCCACCGGCCGCTCGCTGTCGGAAGCCAGCGAGGCCATTGACCGCGCGATGACCCAGCTCGGGGTGCCGTCGAGCGTGCGCGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTTGCGGCTATCGCCACGGTCTATATCGTGCTGGGGGTGCTATATGAGAGCTATGTGCATCCGTTGACCATCCTCTCGACGCTGCCCTCCGCCGGGGTGGGCGCTCTGCTGGCGCTGGAGATCTTCGATGCCCCGTTCAGCCTAATCGCCCTGATTGGGATTATGTTATTAATTGGCATCGTTAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTGGAGGCGCAGCGCAACGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTGCCGCTGGTGCTCTCCGGGGGCGATGGCTCTGAGCTGCGCCAGCCGCTGGGGATCACCATCGTCGGCGGTCTGGTGATGAGTCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTCTGCGGCTGCGTTTTTCGCGTCACTCCTCTCAACCGGTAAGCGAATAA	
8161	CARD	prokka_02356	contig_20	89586	17	76270	76993	1	15	baeR	3000828.0	452.981	450.0	Strict	91.67	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		aminoglycoside antibiotic; aminocoumarin antibiotic	MTELPGDENTPRILIVEDEPKLGQLLIDYLQAAGYAPALINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA	ATGACTGAATTGCCTGGAGATGAAAACACCCCACGCATCCTTATCGTGGAAGATGAACCGAAGCTCGGCCAGCTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTGCCTTGATTAACCACGGCGACAAGGTCCTGCCCTACGTCCGCCAGACGCCGCCGCACCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGTCTGACGCTGTGCCGGGAAATTCGCCGCTTCTCCGATGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATCGACCGTTTGCTGGGGCTGGAAATAGGCGCCGACGACTATATCTGCAAGCCCTACAGCCCCCGGGAAGTGGTCGCCCGGGTAAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGCGATCTGCAGGCGCTGGACGCCCAGAGCCCGCTGATTGTCGACGAAGGTCGTTTTCAGGCCTCCTGGCGCGACAAGCTGCTGGACCTCACTCCCGCCGAGTTCCGGCTGCTGAAAACCCTCTCCCAGGAGCCGGGCAAAGTGTTCTCCCGCGAACAGCTACTCAACCATCTGTATGACGATTATCGGGTAGTCACCGATCGCACCATCGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAGCAGTCGTTTATCCGCGCGGTGTATGGCGTTGGCTACCGCTGGGAAGCGGACGCCTGCCGGCTGGCGTAG	
8161	CARD	prokka_02698	contig_25	81754	16	1260	2493	-1	16	Escherichia coli mdfA	3001328.0	706.057	700.0	Strict	85.61	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		tetracycline antibiotic; benzalkonium chloride; rhodamine	MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVLAAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG	ATGCAAAATTATTCGCTTTCAGGCCGCCGCCTCGGAAGGCAGGCGCTGTTGTTCCCGTTATGTCTGGTGCTGTACGAGTTTTCCACTTATATCGGCAACGATATGATTCAGCCGGGCATGTTAGCCGTGGTGCAGGAATTTCAGGTGGGCAACGAATGGGTACCTACTTCAATGACTGCCTATCTGGCAGGCGGCATGTTTTTACAGTGGCTGCTGGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGTTGACCGGCGTAGTATGGTTTATCGTCACCTGCCTGGCGACGCTGCTGGCGCAGACCATTGAGCAGTTTACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGCTTTATCGGCGCGGTGGGCTATGCGGCGATACAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCCCTGATGGCTAACGTGGCGCTGATTGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATGTCCTGCCGTGGGAGATGATGTTTGTCCTGTTCGCCGTGCTGGCGGCCATCTCGTTCTTCGGCCTGCAGCGGGCGATGCCGGAGACCGCGACGCGGCTGGGCGAAAAGCTGTCGGTGAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTGAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCCACTGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCCACCAGCTATGAGTACGGCATGCTGCAGGTGCCGATTTTCGGGGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTGCGCGTCGGACCGTGCGCTCGCTGATTATCATGGGCGGTTGGCCGATCATGTTTGGCCTGATCCTCTCTGCGGCGGCGACCGTGGTCTCTTCCCACGCTTATCTGTGGATGACGGCCGGTCTGAGCTTCTACGCCTTCGGGATTGGCCTCGCGAACGCCGGCCTGGTGCGTTTAACCCTGTTCGCCAGCGAGATGAGTAAAGGCACGGTCTCGGCGGCGATGGGAATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTGGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGCTGGGTGGGGTACTATGGCTGGGGCTGATGATTTACTTTCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGGTAG	
8161	CARD	prokka_03064	contig_29	72463	18	59735	62882	-1	21	acrB	3000216.0	1941.39	1900.0	Strict	91.52	99.9	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAMALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKSEDIEHSHQVEHH	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATTATCATCATGCTGGCTGGGGGATTATCGATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACGGTGCAGAACACCGTAACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCAAATGGCGACTCCACCGGTACGGCAACCATTACGCTGACCTTCGAATCCGGTACCGATCCGGATATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCGCTGGCGACGCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATTAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTCATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGATCCGATTAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTATTCGGTTCCCAGTATGCGATGCGTATCTGGATGGATCCAAACAAACTGAACAACTTCCAGCTTACGCCGGTGGATGTGATCAGCGCCCTGAAAGCGCAGAACGCCCAGGTGGCCGCGGGCCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCCTCGATCATCGCGCAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGACGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGCGGCGAAAGCTATGACGTAGTGGCGAAGTTTAACGGCCAGCCGGCATCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCTATTCGCGCTGAACTGGCGAAGATGGAGCCGTTTTTCCCGTCGGGGATGAAGATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATTTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCCACCATCGCGGTACCGGTGGTCCTGTTAGGCACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTGGTGGTAGAGAACGTCGAGCGCGTGATGGCGGAAGAGGGTCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGACAGATTCAGGGCGCGCTGGTTGGTATCGCTATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTCTTCGGCGGCTCAACCGGGGCCATCTATCGCCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTGGCGTTAATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAACCCATTCAGAAAGGCAGCCATGGCGCGACCACCGGCTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGTTATCTGGTGCTGTATCTGATCATCGTGGTGGGTATGGCATGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCGGACGAGGACCAGGGTGTATTCCTGAGTATGGCGCAGCTGCCTGCCGGCGCCACCCAGGAGCGTACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGTTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTTTCGCTGAAAGACTGGAGCCAGCGTCCGGGTGAGGAAAACAAAGTTGAAGCGATCACCGCGAGAGCAATGGGCTACTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCGAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACCCAGGCGCGTAACCAACTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGCCCTAACGGTCTGGAAGATACACCGCAGTTTAAAATCGATATCGATCAGGAGAAAGCTCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTGGGCGCAGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATCATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATCGGCAAGTGGTATGTTCGCGGCAGCGATGGTCAGATGGTGCCGTTCTCTGCTTTCTCGACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCGTCACTGGAAATCCTCGGTCAGGCCGCGCCAGGCAAGAGTACCGGTGAGGCGATGGCGCTGATGGAAGAGCTGGCGGGTAAACTGCCTTCCGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGACTGTCCGGCAACCAGGCCCCTGCCCTGTATGCCATCTCGCTGATTGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTTATGCTGGTCGTCCCCTTGGGTGTGGTTGGTGCGCTGTTAGCCGCCACCTTCCGCGGGCTAACCAACGACGTTTACTTCCAGGTGGGTCTGCTGACCACCATCGGCCTGTCGGCGAAGAACGCAATATTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCAGTACGTATGCGTCTACGTCCAATCCTGATGACATCTCTGGCGTTCATCCTCGGGGTAATGCCGCTAGTTATCAGCTCCGGCGCCGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCGATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGCAAAAAATCGGAAGATATAGAGCACAGCCATCAGGTTGAGCATCATTAA	
8161	CARD	prokka_03065	contig_29	72463	18	62904	64098	-1	21	Klebsiella pneumoniae acrA	3004041.0	738.028	770.0	Strict	95.24	99.75	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSTVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAGGGAGCCCAGCACATGCCGGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGCACCAGCGCCTATCGCATTGCGGAAGTCCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTCTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTGGGCACCAAATATATTAGTCAACAAGACTACGATACCGCCGTTGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCGGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATCAGCGGCCGGATTGGTAAATCCACCGTGACCGAAGGGGCGCTGGTACAGAATGGTCAAACGACCGCCCTGGCAACCGTTCAGCAGCTGGATCCGATCTATGTTGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAGCAGGAGCTAGCCGACGGCCGCCTGAAACAGGAAAACGGCAAAGCGAAAGTGGAGCTAGTGACTAATGACGGTCTTAAGTATCCGCAGTCCGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCAATCACGCTACGCGCTATTTTCCCGAACCCGGATCACACCCTGCTACCGGGGATGTTCGTCCGTGCCCGTCTGGAAGAAGGGATTAACCCTGACGCCCTGCTGGTACCGCAACAGGGTGTTACCCGTACGCCGCGCGGCGACGCCAGCGTCATGGTAGTGGGGGAAGGCGATAAAGTCGAAGTCCGCCAGGTCACTGCTTCTCAGGCGATCGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACCGGCCTGCAAAAAATCAAACCAGGTGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA	loose hit with at least 95 percent identity pushed strict
8161	CARD	prokka_03173	contig_31	69568	17	39783	40008	-1	20	CBP-1	3004764.0	21.557	600.0	Strict	100.0	24.03	CBP beta-lactamase	protein homolog model	antibiotic inactivation		penam	MNHGQLSMKNVFPTLAVLFAIFSLTGCGLKGPLYFPPADKTAPPPTKPVNPGIQSATPDRNDRGDTGGPSQVNY	ATGAATCACGGGCAACTATCAATGAAAAACGTTTTTCCTACGCTTGCCGTTTTGTTTGCGATCTTCAGCCTGACCGGCTGCGGTCTGAAAGGGCCTCTCTATTTCCCACCGGCGGACAAAACCGCGCCGCCGCCGACCAAACCGGTTAACCCTGGCATTCAGAGCGCAACGCCGGATCGTAACGATCGTGGCGATACCGGTGGTCCGAGCCAGGTCAATTACTAA	loose hit with at least 95 percent identity pushed strict
8161	CARD	prokka_03806	contig_42	49719	15	29138	29513	1	15	marA	3000263.0	243.432	230.0	Strict	92.74	97.64	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	protein homolog model	antibiotic efflux; reduced permeability to antibiotic		fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN	ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCCGGTTACTCTAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACCGGCCATTCCCTCGGCCAGTACATCCGCAGCCGCAAGCTGACGGAGATTGCGCAGAAGCTCAAGCAGAGTAATGAGCCAATCCTGTACCTGGCGGAACGCTATGGTTTCGAGTCGCAGCAGACCCTGACGCGAACGTTCAAGAACTATTTCGATGTTCCGCCCCACAAGTATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTACATCCGCTAAATAACTGA	
8161	CARD	prokka_04033	contig_47	43585	16	29089	29509	-1	12	FosA6	3004111.0	283.108	280.0	Strict	97.84	100.0	fosfomycin thiol transferase	protein homolog model	antibiotic inactivation		fosfomycin	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFEQ	ATGCTGAGTGGACTGAATCACCTGACCCTGGCAGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTGCTGGGCATGACGCTGCATGCCCGCTGGGACAGCGGGGCTTATCTCTCCTGCGGCGATTTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTTACTCCGCCGGAAGAGAGCGACTACACCCATTATGCGTTTAGTATTAGCGAAGCCGATTTTGCTAGCTTCGCCGCCCGCCTTGAGGCTGCCGGCGTGGCGGTCTGGAAGCTGAACCGTAGCGAAGGTGCCTCGCACTATTTCCTCGATCCCGATGGCCATAAGCTGGAGCTGCACGTCGGCAGTCTCGCCCAGCGGCTGGCCGCCTGCCGCGAGCAGCCGTATAAGGGGATGGTGTTTTTTGAACAGTGA	
8161	CARD	prokka_04168	contig_51	40806	14	11772	12102	-1	15	Klebsiella pneumoniae KpnF	3004583.0	206.453	150.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGCTGGCAATCGCCATTGTGCTGGAAATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGCTTCCGCCGCAAGATCTACGGCATCCTGTCCCTGGCGGCAGTATTGGGCGCGTTCAGCGCCCTGTCGCAGGCGGTTAAAGGGATCGATCTCTCGGTCGCCTATGCGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGTCAGCGTCTGAATAACAAAGGCTGGGCGGGGGTTATCCTGCTGGTAGCCGGCATGGTGTTAATTAAACTCGCCTGA	
8161	CARD	prokka_04169	contig_51	40806	14	12088	12451	-1	15	Klebsiella pneumoniae KpnE	3004580.0	223.402	150.0	Strict	99.17	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSKQEVAHAAV	ATGTTTTATTGGATTTTATTAGCTTTAGCAATTATTGCTGAAATTACCGGCACCTTGTCTATGAAATGGGCAAGCGTGAGCGGCGGGCACACCGGCTTTATTTTAATGCTGGCCATGATTGCCCTGTCATATATTTTTCTTGCCTTTGCGGTTAAAAAGATTGCCCTCGGTGTGGCCTATGCGTTGTGGGAAGGGATCGGTATTTTACTGATTACCCTGTTCAGCGTGCTGCTGTTTGATGAGAGTCTGTCCCTGCTGAAAATAGCCGGCTTGACCACCCTGGTGATAGGGATCGTCTTAATTAAGTCCGGCACCCAGAAAAAAGCGTCTTCCAAGCAGGAGGTGGCCCATGCAGCAGTTTGA	
8161	CARD	prokka_04790	contig_72	21512	16	2002	3676	-1	20	eptB	3005047.0	1160.98	1000.0	Strict	99.46	97.04	pmr phosphoethanolamine transferase	protein homolog model	antibiotic target alteration		peptide antibiotic	MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELEKEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATCATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGCGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTGATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGTCTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGGCTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTCGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAACCCACAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCGCGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCTGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA	
8161	CARD	prokka_04814	contig_73	21136	19	5201	5834	-1	23	CRP	3000518.0	432.95	400.0	Strict	99.05	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein homolog model	antibiotic efflux		macrolide antibiotic; fluoroquinolone antibiotic; penam	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAACGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTCACGTCTGAGAAAGTGGGCAACCTGGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCGGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGCCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCGCACGGTAAAACCATCGTCGTCTACGGCACCCGTTAA	
8161	CARD	prokka_04993	contig_83	16826	10	194	1100	1	8	mphA	3000316.0	604.364	500.0	Perfect	100.0	100.0	macrolide phosphotransferase (MPH)	protein homolog model	antibiotic inactivation		macrolide antibiotic	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	ATGACCGTAGTCACGACCGCCGATACCTCCCAACTGTACGCACTTGCAGCCCGACATGGGCTCAAGCTCCATGGCCCGCTGACTGTCAATGAGCTTGGGCTCGACTATAGGATCGTGATCGCCACCGTCGACGATGGACGTCGGTGGGTGCTGCGCATCCCGCGCCGAGCCGAGGTAAGCGCGAAGGTCGAACCAGAGGCGCGGGTGCTGGCAATGCTCAAGAATCGCCTGCCGTTCGCGGTGCCGGACTGGCGCGTGGCCAACGCCGAGCTCGTTGCCTATCCCATGCTCGAAGACTCGACTGCGATGGTCATCCAGCCTGGTTCGTCCACGCCCGACTGGGTCGTGCCGCAGGACTCGGAGGTCTTCGCGGAGAGCTTCGCGACCGCGCTCGCCGCCCTGCATGCCGTCCCCATTTCCGCCGCCGTGGATGCGGGGATGCTCATCCGTACACCGACGCAGGCCCGTCAGAAGGTGGCCGACGACGTTGACCGCGTCCGACGCGAGTTCGTGGTGAACGACAAGCGCCTCCACCGGTGGCAGCGCTGGCTCGACGACGATTCGTCGTGGCCAGATTTCTCCGTGGTGGTGCATGGCGATCTCTACGTGGGCCATGTGCTCATCGACAACACGGAGCGCGTCAGCGGGATGATCGACTGGAGCGAGGCCCGCGTTGATGACCCTGCCATCGACATGGCCGCGCACCTTATGGTCTTTGGTGAAGAGGGGCTCGCGAAGCTCCTCCTCACGTATGAAGCGGCCGGTGGCCGGGTGTGGCCGCGGCTCGCCCACCACATCGCGGAGCGCCTTGCGTTCGGGGCGGTCACCTACGCACTCTTCGCCCTCGACTCGGGTAACGAAGAGTACCTCGCTGCGGCGAAGGCGCAGCTCGCCGCAGCGGAATGA	
8161	CARD	prokka_05000	contig_83	16826	10	6410	7250	-1	8	sul1	3000410.0	553.132	500.0	Perfect	100.0	100.0	sulfonamide resistant sul	protein homolog model	antibiotic target replacement		sulfonamide antibiotic	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	
8161	CARD	prokka_05001	contig_83	16826	10	7243	7591	-1	13	qacEdelta1	3005010.0	219.55	190.0	Perfect	100.0	100.0	major facilitator superfamily (MFS) antibiotic efflux pump	protein homolog model	antibiotic efflux		acridine dye; disinfecting agents and intercalating dyes	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	
8161	CARD	prokka_05002	contig_83	16826	10	7754	8534	-1	8	aadA2	3002602.0	522.316	450.0	Perfect	100.0	100.0	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	GTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTGATTTGTTGGTTACTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGATCTTATGGAGGCTTCGGCTTTCCCTGGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATAAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGA	
8161	CARD	prokka_05003	contig_83	16826	10	8953	9451	-1	16	dfrA12	3002858.0	339.732	300.0	Perfect	100.0	100.0	trimethoprim resistant dihydrofolate reductase dfr	protein homolog model	antibiotic target replacement		diaminopyrimidine antibiotic	MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG	ATGAACTCGGAATCAGTACGCATTTATCTCGTTGCTGCGATGGGAGCCAATCGGGTTATTGGCAATGGTCCTAATATCCCCTGGAAAATTCCGGGTGAGCAGAAGATTTTTCGCAGACTCACTGAGGGAAAAGTCGTTGTCATGGGGCGAAAGACCTTTGAGTCTATCGGCAAGCCTCTACCGAACCGTCACACATTGGTAATCTCACGCCAAGCTAACTACCGCGCCACTGGCTGCGTAGTTGTTTCAACGCTGTCGCACGCTATCGCTTTGGCATCCGAACTCGGCAATGAACTCTACGTCGCGGGCGGAGCTGAGATATACACTCTGGCACTACCTCACGCCCACGGCGTGTTTCTATCTGAGGTACATCAAACCTTCGAGGGTGACGCCTTCTTCCCAATGCTCAACGAAACAGAATTCGAGCTTGTCTCAACCGAAACCATTCAAGCTGTAATTCCGTACACCCACTCCGTTTATGCGCGTCGAAACGGCTAA	
8161	CARD	prokka_05009	contig_83	16826	10	15461	16121	-1	12	catI	3002683.0	465.692	400.0	Perfect	100.0	100.0	chloramphenicol acetyltransferase (CAT)	protein homolog model	antibiotic inactivation		phenicol antibiotic	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA	
8161	CARD	prokka_05444	contig_155	1292	12	213	1029	1	12	APH(3')-Ia	3002641.0	560.066	500.0	Strict	98.52	100.0	APH(3')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAA	
8161	CARD	prokka_05454	contig_163	1128	28	75	333	-1	26	ANT(3'')-IIa	3004089.0	135.961	450.0	Strict	97.14	26.32	ANT(3'')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETALLQIVGGDKLIIPFC	GTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACGGCACTGTTGCAAATAGTCGGTGGTGATAAACTTATCATCCCCTTTTGCTGA	loose hit with at least 95 percent identity pushed strict
8161	CARD	prokka_05455	contig_163	1128	28	414	1020	-1	35	AAC(6')-Ib10	3002581.0	399.4380000000001	275.0	Strict	98.97	99.01	AAC(6')	protein homolog model	antibiotic inactivation		aminoglycoside antibiotic	MSIQHFQTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA	ATGAGTATTCAACATTTCCAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGTTGCCTAA	
8161	CARD	prokka_05476	contig_188	548	8	46	289	1	9	SHV-51	3001108.0	165.236	550.0	Strict	100.0	27.97	SHV beta-lactamase	protein homolog model	antibiotic inactivation		carbapenem; cephalosporin; penam	MVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAACGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATTTATCTGCGGGATACGCCGGCGAGTATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA	loose hit with at least 95 percent identity pushed strict
8161	CARD	prokka_05477	contig_189	548	6	259	502	-1	10	SHV-105	3001154.0	164.851	550.0	Strict	100.0	27.97	SHV beta-lactamase	protein homolog model	antibiotic inactivation		carbapenem; cephalosporin; penam	MVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	ATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTAGCAAGCGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATTTATCTGCGGGATACGCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA	loose hit with at least 95 percent identity pushed strict
8161	CARD	prokka_00309	contig_2	198271	17	87888	90147	-1	15	Escherichia coli parC conferring resistance to fluoroquinolones	3003308.0	1470.29	1400.0	Strict	94.41	100.0	fluoroquinolone resistant parC	protein variant model	antibiotic target alteration	S80I	fluoroquinolone antibiotic	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDIACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYAELLLSELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAKAAITLIEQPKTTLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVRMRAVWSKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILELKLRHLAKLEEMKIRGEQSELEKERDQLQAILASERKMNNLLKKELQADADAFGDDRRSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAQGLSYKAGDSWKASAKGKSNQPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALITLPDNAHVMPPLVIEDESDMLLAITAAGRMLMFPVSDLPQLSKGKGNKIISIPAAEAAAGQDGLAHLFVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGSLMRGLQKIDRVEIDSPRRAAAGDSEE	ATGAGCGATATGGCAGAGCGCCTTGCGCTGCATGAATTTACGGAAAATGCTTACCTGAACTACTCCATGTACGTGATCATGGACAGGGCATTACCGTTTATTGGCGATGGCTTAAAACCGGTCCAGCGTCGCATCGTCTATGCGATGTCCGAGCTGGGGCTGAACGCCAGCGCGAAATTCAAAAAGTCCGCCCGCACCGTCGGCGACGTGTTGGGTAAATATCACCCGCACGGCGACATCGCCTGCTATGAAGCGATGGTGCTGATGGCGCAGCCGTTCTCTTACCGCTATCCGCTGGTGGATGGTCAGGGAAACTGGGGGGCGCCGGACGATCCCAAATCTTTCGCCGCCATGCGTTACACCGAATCCCGCCTGTCGAAGTATGCCGAGCTGCTGCTCAGCGAGCTGGGGCAGGGGACGGTCGACTGGGTGCCAAACTTTGACGGCACGCTGCAGGAGCCGAAAATGCTGCCAGCGCGTCTGCCGAACATCCTGCTGAACGGCACCACCGGCATCGCGGTAGGCATGGCGACCGATATTCCTCCGCACAACCTGCGGGAAGTGGCCAAAGCGGCGATTACGCTGATTGAGCAGCCGAAAACCACCCTCGACGAACTGCTGGATATCGTACAGGGGCCGGATTTCCCGACCGAGGCGGAGATCATCACCTCGCGGGCGGAAATTCGCAAAATCTACCAGAACGGGCGCGGCTCAGTGCGCATGCGTGCGGTGTGGAGTAAAGAGGACGGCGCGGTGGTGATCAGTGCGCTGCCGCATCAGGTCTCCGGCGCCAAAGTGCTGGAGCAGATTGCGGCGCAGATGCGCAATAAAAAGCTGCCGATGGTTGACGATCTGCGCGACGAATCGGACCACGAAAACCCGACCCGTCTGGTGATTGTCCCGCGCTCCAACCGGGTGGATATGGAACAGGTGATGAACCACCTGTTCGCCACCACCGATCTGGAGAAGAGCTACCGCATCAACCTCAATATGATCGGCCTTGACGGCCGCCCGGCGGTGAAAAACCTGCTGGAGATCCTCAGCGAGTGGCTGGTGTTCCGTCGCGATACCGTGCGTCGCCGTCTAAACCATCGGTTAGAGAAAGTGCTGAAGCGCCTGCATATCCTCGAAGGTTTGCTGGTGGCGTTTCTTAATATCGATGAAGTGATTGAGATCATCCGCACTGAAGATGAACCGAAGCCGGCCCTGATGTCGCGCTTTGGCATCAGCGAAACCCAGGCGGAAGCGATTCTGGAATTAAAACTGCGCCACCTCGCCAAACTGGAAGAGATGAAGATCCGCGGCGAGCAGAGCGAGCTGGAAAAAGAGCGCGACCAGCTGCAGGCGATTCTGGCGTCTGAACGTAAGATGAACAACCTGCTGAAAAAAGAGCTGCAGGCCGATGCCGATGCCTTCGGCGACGACCGTCGCTCGCCGCTTCACGAGCGTGAAGAAGCGAAAGCGATGAGCGAGCATGACATGCTGCCGTCTGAGCCGGTGACTATCGTTCTGTCGCAGATGGGCTGGGTGCGCAGCGCCAAAGGACACGACATTGACGCCCAGGGCTTGAGCTATAAGGCGGGCGACAGCTGGAAAGCCTCGGCGAAGGGCAAGAGCAACCAGCCGGTGGTGTTTATCGATACCACCGGACGCAGCTATGCCATCGATCCGATTACTCTGCCTTCCGCGCGTGGCCAGGGTGAACCGCTTACCGGCAAACTGACCCTGCCGCCGGGCGCGACCGTGGAGCATATGCTAATGGAAAGCGACGATCAGAAACTGCTGATGGCTTCCGACGCGGGCTACGGTTTCGTCTGTACCTTCAACGATCTGGTGGCGCGCAACCGTGCCGGTAAAGCGCTAATCACCCTGCCTGACAACGCGCACGTGATGCCGCCGCTGGTGATTGAGGATGAGTCCGATATGCTGCTGGCCATCACCGCCGCCGGGCGGATGCTGATGTTCCCGGTCAGCGATCTGCCGCAGCTGTCGAAAGGCAAGGGCAACAAAATTATCAGCATTCCGGCGGCGGAAGCCGCAGCCGGCCAGGACGGTCTGGCACATCTGTTTGTTCTGCCGCCGCAGAGTACGCTGACCATTCACGTCGGCAAACGGAAGATCAAACTGCGTCCGGAAGAGCTGCAAAAAGTCACCGGCGAGCGCGGCCGCCGCGGTTCGCTGATGCGCGGGCTGCAGAAAATTGACCGCGTGGAAATTGACTCGCCGCGTCGTGCCGCGGCAGGCGATAGCGAAGAGTAA	
8161	CARD	prokka_00525	contig_3	175899	17	125450	127217	1	20	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	3004446.0	595.89	500.0	Strict	52.37	96.39	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	protein variant model	antibiotic target alteration	D350N, S357N	cephalosporin; cephamycin; penam	MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTGCTGGCGCTGGCTTTTCTGCTGGGTCGCGTCGCCTGGCTACAGGTGATCAGCCCCGATATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTGTCCACCGCGCGCGGGATGATTACCGATCGCTCCGGACGTCCGCTGGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGACCCGAAAGAGCTCCATGACGCCGGCGGGGTTACCCTGGATACGCGCTGGAAAGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGGTTTATCTATCTGGCGCGTCAGGTTAACCCTGACATGGCCGATTACATCAAGAAGCTGAAGCTGCCGGGCATTCATCTGCGCGAAGAATCCCGTCGGTACTACCCTTCCGGGGAAGTAACCGCTCACCTCATCGGCTTTACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAAAAAAGCTTTGATAAATGGCTTACCGGTCAGCCGGGCGAGCGTATCGTGCGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCTACCGATAGCCAGGCAGCGCACAACCTGGCGCTGAGTATCGACGAACGCCTGCAGGCGCTGGTCTATCGCGAGCTAAACAACGCCGTGGCCTTTAACAAAGCCGAGTCGGGCAGCGCCGTGTTAGTAGATGTTAACACCGGTGAAGTGCTGGCGATGGCCAACAGCCCATCCTATAACCCGAACAACTTCGCCGGTACGGCAAAAGACACCATGCGTAACCGTGCGATTACCGACGTGTTTGAGCCGGGTTCGACGGTGAAACCGATGGTGGTCATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTATGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCGTTGTCGATTACCAAAGTTGATCCTCCGGTTCCGGGCGAGCGCGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGTGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTATATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	
8161	CARD	prokka_01355	contig_10	117518	17	7178	9812	-1	17	Escherichia coli gyrA conferring resistance to fluoroquinolones	3003294.0	1642.48	1500.0	Strict	92.23	100.23	fluoroquinolone resistant gyrA	protein variant model	antibiotic target alteration	S83I	fluoroquinolone antibiotic	MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDIAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMATNIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNVAAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVVVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLYWMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTALTEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATGVRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERNGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVAEPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE	ATGAGCGACCTTGCGAGAGAAATTACACCGGTCAACATTGAGGAAGAGCTTAAGAACTCTTATCTGGATTATGCGATGTCGGTCATTGTTGGCCGTGCGCTGCCGGATGTCCGAGATGGCCTGAAGCCGGTACACCGTCGCGTACTTTACGCCATGAACGTATTGGGCAATGACTGGAACAAAGCCTATAAAAAATCAGCCCGTGTCGTTGGTGACGTAATCGGTAAATACCACCCGCACGGCGACATCGCGGTATACGACACCATCGTGCGTATGGCGCAGCCGTTCTCGCTGCGTTACATGCTGGTGGACGGCCAGGGTAACTTTGGTTCCATCGACGGCGACTCCGCCGCGGCGATGCGTTATACCGAAATTCGTCTGGCGAAAATCGCTCATGAGCTGATGGCCGATCTTGAAAAAGAGACGGTCGATTTCGTCGACAACTATGACGGTACGGAGCGTATTCCGGACGTCATGCCGACCAAAATTCCTAACCTGCTGGTGAACGGCGCCTCCGGGATCGCCGTAGGGATGGCCACCAACATACCGCCGCATAACCTGACGGAAGTGATTAACGGCTGTCTGGCGTATGTTGACGATGAAGACATCAGCATTGAAGGGCTGATGGCGCATATTCCTGGCCCTGATTTCCCGACCGCCGCCATTATCAATGGCCGTCGCGGCATCGAAGAGGCCTATCGCACCGGTCGCGGTAAAGTGTACATCCGCGCGCGCGCGGAAGTGGAAGTGGACGCGAAATCCGGCCGCGAAACCATCATCGTGCACGAAATTCCGTATCAGGTGAACAAAGCGCGCCTGATCGAGAAAATCGCCGAGCTGGTCAAAGAAAAACGCGTGGAAGGCATCAGCGCGCTGCGTGACGAGTCTGATAAAGACGGGATGCGCATCGTGATTGAAGTGAAGCGCGATGCGGTAGGGGAAGTGGTGCTTAACAACCTCTATTCCCAGACCCAGCTGCAGGTCTCCTTCGGCATCAACATGGTAGCTCTGCACCATGGTCAGCCGAAGATCATGAACCTGAAGGACATCATCGCCGCGTTTGTACGCCACCGCCGTGAAGTGGTGACCCGTCGTACGATTTTCGAACTGCGCAAAGCGCGCGACCGGGCGCATATCCTCGAAGCGCTGGCCGTTGCGCTGGCCAACATCGACCCGATTATCGAACTGATCCGTCGCGCGCCGACCCCGGCAGAAGCGAAAACGGCGCTGGTTGCCCAGGCGTGGGATCTCGGTAACGTCGCGGCGATGCTGGAGCGCGCCGGGGATGACGCCGCGCGTCCGGAATGGCTGGAGCCAGAGTTCGGCGTGCGCGACGGTAAATACTATCTGACCGAGCAGCAGGCTCAGGCGATTCTGGATCTGCGTCTGCAGAAACTGACCGGCCTTGAGCATGAAAAACTGCTCGACGAATATAAAGAGCTGCTGGAGCAGATCGCGGAGCTGCTGCACATTCTCGGCAGCGCCGACCGTCTGATGGAAGTGATTCGCGAAGAGCTGGAGCTGATCCGCGATCAGTTCGGCGACGAACGTCGTACCGAAATCACCGCCAACAGCGCTGATATTAACATCGAAGATCTGATCAACCAGGAAGATGTGGTGGTCACCCTGTCGCATCAGGGGTATGTGAAGTATCAGCCGCTGACCGACTACGAAGCACAGCGTCGTGGCGGTAAAGGCAAATCGGCAGCGCGCATTAAAGAAGAAGACTTTATCGACCGCCTGCTGGTGGCTAACACCCATGACACCATCCTCTGCTTCTCAAGCCGCGGCCGTCTGTACTGGATGAAGGTCTATCAGCTGCCGGAAGCCAGCCGCGGCGCGCGCGGTCGGCCGATCGTCAACCTGCTGCCGCTGGAAGCCGATGAGCGCATCACCGCCATCCTGCCGGTCCGCGAGTACGAAGAGGGCGTCAACGTCTTTATGGCGACCGCCAGCGGTACCGTGAAGAAAACCGCGCTGACCGAGTTCAGCCGTCCGCGTTCCGCCGGTATCATCGCGGTCAACCTGAACGAAGGCGATGAGCTGATCGGCGTCGATCTGACCTCTGGTCAGGATGAAGTGATGCTGTTCTCCGCGGCCGGTAAGGTTGTACGCTTCAAGGAAGACGCCGTTCGCGCCATGGGCCGTACCGCCACCGGCGTACGCGGTATTAAGCTTGCGGAAAACGACAGCGTCGTCTCGCTGATTATTCCACGCGGCGAAGGCGCGATCCTGACGGTGACGCAAAACGGTTACGGTAAACGTACCGCGGCGGCGGAGTATCCGACCAAGTCGCGTGCCACCCAGGGCGTTATTTCGATCAAAGTCACCGAGCGTAACGGTTCCGTGGTCGGCGCCGTGCAGGTGGATGACTGCGATCAGATCATGATGATCACCGACGCCGGGACGCTGGTGCGTACCCGCGTTTCCGAAGTGAGCATCGTGGGCCGTAACACCCAGGGCGTGATCCTCATCCGCACCGCGGAAGATGAAAACGTGGTGGGTCTGCAGCGCGTGGCTGAGCCGGTGGATGATGAAGAGCTGGATGCCATCGATGGTAGCGCGGCGGAAGGCGATGACGATATCGCCCCGGAAGCGGATACCGATGACGACATCGCCGAAGACGAAGAATAA	
8161	CARD	prokka_03250	contig_32	64200	18	54065	56480	1	18	Salmonella serovars gyrB conferring resistance to fluoroquinolones	3003307.0	1568.52	1200.0	Strict	94.78	100.0	fluoroquinolone resistant gyrB	protein variant model	antibiotic target alteration	E466D	fluoroquinolone antibiotic	MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGYCKDIVVTIHSDNSVSVQDDGRGIPTGIHPEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGVSVVNALSQKLELVIQRDNKVHKQMYEHGVPQAPLAVTGETDKTGTMVRFWPSLETFTNVTEFEYDILAKRLRELSFLNSGVSIRLRDKRDGKEDHFHYEGGIKAFVEYLNKNKTPIHPNIFYFSTEKDGIGVEVALQWNDGFQENIYCFTNNIPQRDGGTHLAGFRAAMTRTLNAYMDKEGYSKKAKVSATGDDAREGLIAVVSVKVPDPKFSSQTKDKLVSSEVKSAVEQQMNELLSEYLLENPSDAKIVVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPALSELYLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLSSQDVATLITALGCGIGRDEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIVERGHVYIAQPPLYKVKKGKQEQYIKDDEAMDQYQISIALDGATLHTNANAPALAGEPLEKLVAEFNATQKMIGRMERRFPKALLKELIYQPTLTEADLADEQKVTRWVNTLVSELNEKEQHGSQWKFDLHENKELQHFEPVIRVRTHGVDTDYPLDNEFIMGPEYRRICALGEKLRGLMEEDAYIERGERRQPVASFEQALDWLVKESRRGLSIQRYKGLGEMNPDQLWETTMDPDSRRMLRVTVKDAIAADQLFTTLMGDAVEPRRAFIEENALKAANIDI	ATGTCGAATTCTTATGACTCCTCCAGTATCAAAGTCCTGAAAGGGCTGGATGCGGTGCGTAAGCGCCCGGGTATGTATATCGGCGACACGGATGACGGCACCGGTCTGCACCACATGGTATTCGAGGTTGTGGATAACGCTATCGACGAAGCGCTCGCGGGTTACTGCAAAGATATCGTTGTCACCATCCACAGCGATAACTCCGTCTCCGTCCAGGATGACGGCCGCGGCATCCCGACCGGCATTCACCCGGAAGAGGGCGTCTCCGCAGCGGAAGTTATCATGACCGTCCTGCACGCTGGCGGTAAATTCGATGATAACTCCTATAAAGTTTCCGGCGGTCTGCACGGCGTAGGCGTCTCGGTGGTTAACGCCCTGTCGCAGAAGCTGGAGCTGGTTATCCAGCGCGATAACAAAGTTCACAAGCAGATGTACGAACACGGTGTGCCGCAGGCACCGCTGGCCGTGACTGGCGAAACCGACAAAACCGGCACCATGGTGCGTTTCTGGCCAAGCCTGGAAACCTTCACCAATGTCACCGAATTTGAATATGACATCCTGGCGAAACGCCTGCGCGAGCTGTCGTTCCTGAACTCCGGCGTCTCTATCCGCCTGCGCGATAAGCGCGACGGCAAAGAAGACCATTTCCACTACGAAGGCGGCATCAAGGCGTTCGTTGAGTATCTCAACAAGAACAAAACGCCGATCCACCCGAATATTTTCTATTTCTCCACCGAAAAAGACGGTATCGGCGTGGAAGTGGCCCTGCAGTGGAACGACGGCTTCCAGGAAAACATCTACTGCTTTACCAACAACATTCCGCAGCGTGACGGCGGTACTCACCTCGCCGGCTTCCGCGCGGCGATGACCCGTACTCTTAACGCCTATATGGACAAAGAGGGCTATAGCAAAAAAGCGAAAGTCAGCGCCACCGGCGACGATGCGCGTGAAGGCCTGATTGCCGTGGTATCCGTGAAGGTGCCGGATCCGAAATTCTCCTCGCAGACCAAAGACAAGCTGGTCTCCTCCGAGGTGAAATCGGCGGTGGAGCAGCAGATGAACGAACTGCTGAGCGAATACCTGCTGGAAAATCCATCCGATGCGAAAATCGTGGTCGGCAAAATTATTGACGCCGCGCGCGCCCGTGAGGCCGCACGTCGCGCTCGTGAGATGACTCGTCGTAAAGGCGCGCTGGATCTGGCAGGCCTGCCGGGCAAACTGGCGGATTGCCAGGAGCGCGACCCGGCGCTGTCCGAACTGTACCTGGTGGAAGGGGACTCCGCGGGCGGCTCTGCTAAACAGGGTCGTAACCGCAAGAACCAGGCGATCCTGCCGCTGAAGGGTAAAATCCTTAACGTTGAGAAAGCCCGCTTCGATAAAATGCTCTCTTCCCAGGACGTGGCGACGCTGATCACCGCGCTGGGCTGCGGTATCGGTCGCGATGAGTACAATCCGGATAAACTGCGCTACCACAGCATCATCATCATGACCGATGCGGACGTCGACGGCTCGCACATTCGTACCCTGCTGTTGACCTTCTTCTATCGTCAGATGCCGGAGATCGTCGAGCGCGGCCACGTCTACATTGCCCAGCCGCCGCTGTACAAAGTGAAGAAAGGCAAGCAGGAACAGTACATTAAAGACGACGAAGCGATGGATCAGTATCAGATCTCCATCGCGCTCGACGGTGCGACCCTGCACACCAACGCCAATGCGCCGGCGCTGGCGGGCGAACCGCTGGAAAAACTGGTTGCCGAGTTCAATGCCACCCAGAAAATGATTGGCCGCATGGAGCGCCGCTTCCCGAAAGCGCTGCTGAAAGAGCTTATCTATCAGCCGACCCTGACCGAGGCCGACCTGGCGGACGAGCAGAAGGTGACCCGCTGGGTGAACACCCTGGTCTCCGAGCTGAACGAGAAAGAACAGCACGGCAGCCAGTGGAAATTCGATCTCCACGAGAACAAAGAACTGCAGCATTTTGAGCCGGTTATTCGCGTACGTACCCACGGCGTGGATACCGACTATCCGCTGGATAACGAGTTCATTATGGGGCCGGAATATCGTCGTATTTGTGCCCTGGGCGAGAAACTGCGCGGCCTGATGGAAGAAGATGCTTACATCGAGCGCGGCGAACGTCGTCAGCCGGTAGCCAGCTTCGAGCAGGCCCTGGACTGGCTGGTGAAAGAGTCCCGTCGCGGTCTCTCCATCCAGCGCTATAAAGGTCTGGGCGAGATGAACCCGGATCAGCTGTGGGAAACCACCATGGATCCGGACAGCCGTCGCATGCTGCGCGTGACCGTCAAGGATGCCATCGCTGCCGATCAGCTGTTCACCACCCTGATGGGTGATGCCGTTGAGCCGCGTCGCGCGTTTATCGAAGAGAATGCCCTGAAAGCGGCGAATATCGATATTTAA	
8161	CARD	prokka_04289	contig_54	36408	16	9983	11375	-1	16	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	3003890.0	864.3739999999998	850.0	Strict	95.03	100.0	antibiotic-resistant UhpT	protein variant model	antibiotic target alteration	E350Q	fosfomycin	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAVGCICLMAIVAIFEERKIRREKKNRILQTA	ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCTTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTTTTCATCGGCTACCTGACCATGTACTTGATCCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGCTGAGCATGACCCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAGACGCTGGTCTCTTATTATGCCGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCTACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACTTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTTGGCTTTATCGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCGAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAGGTCGGCGCGCTGGTCGGCACGCTGCTGTGGGGCTGGCTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACCCTCGGGGTTTACCAACACGCCAGCAACCAGTACGTCTATCTGGCCTCGTTATTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGGATCAAGGGCACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAACTGGGTCTCGGGATGATCGCCGACGGCACCCCGGTCTTCGGCCTGACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCGTCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTTGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACCGCCTGA	
8161	CARD	prokka_03805	contig_42	49719	15	28683	29118	1	15	Escherichia coli marR mutant conferring antibiotic resistance	3003378.0	251.906	210.0	Strict	83.33	100.0	resistance-nodulation-cell division (RND) antibiotic efflux pump	protein overexpression model	antibiotic target alteration; antibiotic efflux		fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	MKSTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIKRLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP	ATGAAAAGTACCAGCGACCTGTTTAATGAAATGATCCCGCTGGGTCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTACCTCTCACCTATGGATATTACCGCGACCCAGTTTCGCGTGCTCTGCTCCATTCGTTGCGAAGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGACCCGGGCGCAATGACGCGCATGCTCGACCGCCTGGCGTGCAAAGGCTGGATTAAACGGTTACCCAACCCCGCTGACAAGCGCGGCGTGCTGGTGCAGTTGACGCCGGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACGAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTGCTCAAGAAGGTCCTGCCGTAA	
